7352670
D009599_D006973 NONE nitroprusside_4\NN\0 (r_advmod) hypertensive_1\JJ\10405694
D009599_D006973 NONE snp_2\NNP\11493266 (r_compound) infusion_3\NN\14589223 (r_pobj) during_0\IN\0 (r_prep) demonstrated_7\VBD\2137132 (l_dobj) increase_10\NN\13576355 (l_prep) in_11\IN\13603305 (l_pobj) pressure_13\NN\11419404
D009599_D007022 CID nitroprusside_19\NN\0 (l_parataxis) evaluated_24\VBN\670261 (l_nsubjpass) hypotension_22\NN\14057371
D009599_D007022 CID snp)-induced_21\VBN\0 (r_amod) hypotension_22\NN\14057371
D009599_D007022 CID snp_19\NNP\11493266 (r_conj) halothane_17\NN\3570838 (r_pobj) of_16\IN\0 (r_prep) effects_15\NNS\13245626 (l_amod) hypotensive_14\JJ\10405694
D012504_D006973 NONE saralasin_7\NN\0 (r_pobj) by_6\IN\0 (r_agent) prevented_5\VBN\0 (r_acl) hypertensive_1\JJ\10405694
D012504_D006973 NONE saralasin_20\NN\0 (r_npadvmod) treated_22\VBN\2376958 (r_amod) animals_23\NNS\4475 (r_nsubj) showed_24\VBD\2137132 (r_advcl) demonstrated_7\VBD\2137132 (l_dobj) increase_10\NN\13576355 (l_prep) in_11\IN\13603305 (l_pobj) pressure_13\NN\11419404
D006221_D007022 CID halothane_15\NN\3570838 (r_compound) anesthesia_16\NN\14034177 (l_conj) nitroprusside_19\NN\0 (l_parataxis) evaluated_24\VBN\670261 (l_nsubjpass) hypotension_22\NN\14057371
D006221_D007022 CID halothane_17\NN\3570838 (r_pobj) of_16\IN\0 (r_prep) effects_15\NNS\13245626 (l_amod) hypotensive_14\JJ\10405694
D000809_D007022 NONE angiotensin_6\NN\4522421 (r_compound) system_7\NN\3575240 (l_prep) in_8\IN\13603305 (l_pobj) maintenance_10\NN\266806 (l_prep) during_14\IN\0 (l_pobj) anesthesia_16\NN\14034177 (l_conj) nitroprusside_19\NN\0 (l_parataxis) evaluated_24\VBN\670261 (l_nsubjpass) hypotension_22\NN\14057371
D000809_D007022 NONE angiotensin_8\NN\4522421 (r_compound) system_9\NN\3575240 (l_prep) in_10\IN\13603305 (l_pcomp) antagonizing_11\VBG\1787955 (l_dobj) effects_15\NNS\13245626 (l_amod) hypotensive_14\JJ\10405694
15145918
D008750_D007022 CID methyldopa_10\NN\2721160 (r_conj) rilmenidine_6\NN\0 (r_amod) rats_4\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) elicited_11\VBD\1617192 (l_dobj) hypotension_13\NN\14057371
D008750_D007022 CID methyldopa_9\NN\2721160 (r_pobj) to_6\IN\0 (r_prep) response_5\NN\11410625 (l_amod) hypotensive_4\JJ\10405694
D008750_D007022 CID methyldopa_9\NN\2721160 (r_pobj) to_6\IN\0 (r_prep) response_5\NN\11410625 (r_dobj) enhanced_2\VBD\227165 (l_prep) in_11\IN\13603305 (l_pobj) contrast_12\NN\13854649 (l_prep) to_13\IN\0 (l_pobj) effect_15\NN\34213 (l_prep) on_16\IN\0 (l_pobj) hypotension_18\NN\14057371
D008750_D007022 CID methyldopa_4\NN\2721160 (r_compound) hypotension_5\NN\14057371
D008750_D007022 CID methyldopa_25\NN\2721160 (r_compound) estrogen_27\NN\14745635 (r_compound) interaction_28\NN\37396 (r_pobj) in_22\IN\13603305 (r_prep) control_21\NN\5190804 (r_pobj) for_17\IN\0 (r_prep) role_16\NN\719494 (r_dobj) highlight_14\VB\13809920 (r_conj) downregulates_5\VBZ\0 (l_conj) hypotension_12\NN\14057371
D003000_D007022 NONE clonidine_12\NN\2721160 (r_pobj) of_11\IN\0 (r_prep) effect_10\NN\34213 (l_amod) hypotensive_9\JJ\10405694
C032302_D007022 CID rilmenidine_6\NN\0 (r_amod) rats_4\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) elicited_11\VBD\1617192 (l_dobj) hypotension_13\NN\14057371
C032302_D007022 CID rilmenidine_17\JJ\0 (r_amod) hypotension_18\NN\14057371 (r_pobj) on_16\IN\0 (r_prep) effect_15\NN\34213 (r_pobj) to_13\IN\0 (r_prep) contrast_12\NN\13854649 (r_pobj) in_11\IN\13603305 (r_prep) enhanced_2\VBD\227165 (l_dobj) response_5\NN\11410625 (l_amod) hypotensive_4\JJ\10405694
C032302_D007022 CID rilmenidine_17\JJ\0 (r_amod) hypotension_18\NN\14057371
D048288_D007022 NONE i1-imidazoline_7\NNP\0 (r_punct) mediated_10\VBN\761713 (r_conj) alpha2-adrenergic_5\JJ\0 (r_amod) hypotension_11\NN\14057371
D004967_D007022 NONE estrogen_3\NN\14745635 (l_prep) of_4\IN\0 (l_pobj) hypotension_11\NN\14057371
D004967_D007022 NONE estrogen_5\NN\14745635 (r_nsubj) modulates_7\VBZ\1724459 (l_dobj) effect_10\NN\34213 (l_amod) hypotensive_9\JJ\10405694
D004967_D007022 NONE estrogen_4\NN\14745635 (r_nsubj) downregulates_5\VBZ\0 (l_conj) hypotension_12\NN\14057371
D004967_D007022 NONE estrogen_27\NN\14745635 (r_compound) interaction_28\NN\37396 (r_pobj) in_22\IN\13603305 (r_prep) control_21\NN\5190804 (r_pobj) for_17\IN\0 (r_prep) role_16\NN\719494 (r_dobj) highlight_14\VB\13809920 (r_conj) downregulates_5\VBZ\0 (l_conj) hypotension_12\NN\14057371
D008750_D001523 NONE methyldopa_4\NN\2721160 (r_compound) hypotension_5\NN\14057371 (r_nsubjpass) paralleled_10\VBN\2657219 (l_prep) with_11\IN\0 (l_pobj) reduction_13\NN\351485 (l_conj) activity_20\NN\30358
11672959
D012460_D056486 CID sulphasalazine_27\NN\0 (r_pobj) of_25\IN\0 (r_prep) course_24\NN\883297 (r_pobj) of_22\IN\0 (r_prep) day_21\NN\15154774 (r_pobj) on_18\IN\0 (r_prep) beginning_17\VBG\7283608 (r_advcl) developed_5\VBD\1753788 (l_dobj) constellation_7\NN\5728678 (l_prep) of_8\IN\0 (l_pobj) dermatitis_9\NN\14226056 (l_conj) fever_11\NN\14299637 (l_conj) lymphadenopathy_13\NN\14204950 (l_conj) hepatitis_15\NN\14127211
D012460_D003872 CID sulphasalazine_27\NN\0 (r_pobj) of_25\IN\0 (r_prep) course_24\NN\883297 (r_pobj) of_22\IN\0 (r_prep) day_21\NN\15154774 (r_pobj) on_18\IN\0 (r_prep) beginning_17\VBG\7283608 (r_advcl) developed_5\VBD\1753788 (l_dobj) constellation_7\NN\5728678 (l_prep) of_8\IN\0 (l_pobj) dermatitis_9\NN\14226056
D012460_D008206 CID sulphasalazine_27\NN\0 (r_pobj) of_25\IN\0 (r_prep) course_24\NN\883297 (r_pobj) of_22\IN\0 (r_prep) day_21\NN\15154774 (r_pobj) on_18\IN\0 (r_prep) beginning_17\VBG\7283608 (r_advcl) developed_5\VBD\1753788 (l_dobj) constellation_7\NN\5728678 (l_prep) of_8\IN\0 (l_pobj) dermatitis_9\NN\14226056 (l_conj) fever_11\NN\14299637 (l_conj) lymphadenopathy_13\NN\14204950
D012460_D005334 CID sulphasalazine_27\NN\0 (r_pobj) of_25\IN\0 (r_prep) course_24\NN\883297 (r_pobj) of_22\IN\0 (r_prep) day_21\NN\15154774 (r_pobj) on_18\IN\0 (r_prep) beginning_17\VBG\7283608 (r_advcl) developed_5\VBD\1753788 (l_dobj) constellation_7\NN\5728678 (l_prep) of_8\IN\0 (l_pobj) dermatitis_9\NN\14226056 (l_conj) fever_11\NN\14299637
D012460_D001172 NONE sulphasalazine_27\NN\0 (l_prep) for_28\IN\0 (l_pobj) arthritis_33\NN\14171682
1664218
C042315_D002289 NONE ci-921_7\NNP\0 (r_punct) (_8\-LRB-\0 (r_punct) nsc_9\NNP\8123696 (r_appos) study_2\NN\635850 (l_prep) in_12\IN\13603305 (l_pobj) cancer_18\NN\14239425
C042315_D002289 NONE 343499_10\CD\0 (r_nummod) nsc_9\NNP\8123696 (r_appos) study_2\NN\635850 (l_prep) in_12\IN\13603305 (l_pobj) cancer_18\NN\14239425
D000677_D002289 NONE amsacrine_5\NN\0 (r_compound) analogue_6\NN\4743605 (r_pobj) of_3\IN\0 (r_prep) study_2\NN\635850 (l_prep) in_12\IN\13603305 (l_pobj) cancer_18\NN\14239425
6103707
D005445_D010146 CID flunitrazepam_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) injection_5\NN\320852 (r_pobj) on_3\IN\0 (r_prep) pain_2\NN\14299637
16787750
D014635_D003244 CID vpa_4\NNP\0 (r_npadvmod) induced_6\VBN\1627355 (r_amod) encephalopathy_7\NN\14084880 (r_pobj) of_3\IN\0 (r_prep) signs_2\NNS\6643763 (r_nsubj) are_8\VBP\13600404 (l_attr) consciousness_10\NN\5669934
D014635_D001855 CID vpa_17\NNP\0 (r_npadvmod) induced_19\VBN\1627355 (r_amod) hepatotoxicity_20\NN\0 (r_npadvmod) occur_4\VB\0 (l_prep) in_5\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) including_9\VBG\0 (l_pobj) pancreatitis_11\NN\14336539 (l_conj) suppression_15\NN\13489037
D014635_D001855 CID vpa_22\NNP\0 (r_npadvmod) induced_24\VBN\1627355 (r_compound) encephalopathy_25\NN\14084880 (r_conj) hepatotoxicity_20\NN\0 (r_npadvmod) occur_4\VB\0 (l_prep) in_5\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) including_9\VBG\0 (l_pobj) pancreatitis_11\NN\14336539 (l_conj) suppression_15\NN\13489037
D014635_D012640 NONE vpa_4\NNP\0 (r_npadvmod) induced_6\VBN\1627355 (r_amod) encephalopathy_7\NN\14084880 (r_pobj) of_3\IN\0 (r_prep) signs_2\NNS\6643763 (r_nsubj) are_8\VBP\13600404 (l_advcl) marked_13\VBD\1296462 (l_ccomp) slowing_16\VBG\7296428 (l_dobj) frequency_20\NN\15286249 (l_compound) seizure_19\NN\14081375
D014635_D056486 CID vpa_17\NNP\0 (r_npadvmod) induced_19\VBN\1627355 (r_amod) hepatotoxicity_20\NN\0
D014635_D056486 CID vpa_22\NNP\0 (r_npadvmod) induced_24\VBN\1627355 (r_compound) encephalopathy_25\NN\14084880 (r_conj) hepatotoxicity_20\NN\0
D014635_D001927 CID acid_1\NN\14818238 (r_nsubj) induced_2\VBD\1627355 (l_advmod) encephalopathy--19_3\NNP\0
D014635_D001927 CID vpa_18\NNP\0 (r_compound) therapy_20\NN\657604 (r_pobj) to_17\IN\0 (r_prep) associated_16\VBN\628491 (r_acl) effect_15\NN\34213 (r_pobj) to_10\IN\0 (r_prep) induced_2\VBD\1627355 (l_advmod) encephalopathy--19_3\NNP\0
D014635_D001927 CID vpa_17\NNP\0 (r_npadvmod) induced_19\VBN\1627355 (r_amod) hepatotoxicity_20\NN\0 (l_conj) encephalopathy_25\NN\14084880
D014635_D001927 CID vpa_22\NNP\0 (r_npadvmod) induced_24\VBN\1627355 (r_compound) encephalopathy_25\NN\14084880
D014635_D001927 CID vpa_4\NNP\0 (r_npadvmod) induced_6\VBN\1627355 (r_amod) encephalopathy_7\NN\14084880
D014635_D001927 CID vpa_9\NNP\0 (r_pobj) of_8\IN\0 (r_prep) effect_7\NN\34213 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) encephalopathy_13\JJ\14084880
D014635_D001927 CID vpa_5\NNP\0 (r_npadvmod) associated_7\VBN\628491 (r_amod) encephalopathy_8\NN\14084880
D014635_D022124 NONE vpa_4\NNP\0 (r_npadvmod) induced_6\VBN\1627355 (r_amod) encephalopathy_7\NN\14084880 (r_pobj) of_3\IN\0 (r_prep) signs_2\NNS\6643763 (r_nsubj) are_8\VBP\13600404 (l_advcl) marked_13\VBD\1296462 (l_ccomp) slowing_16\VBG\7296428 (l_dobj) frequency_20\NN\15286249 (l_prep) with_22\IN\0 (l_conj) without_24\IN\0 (l_pobj) hyperammonemia_25\NN\0
D014635_D010195 CID vpa_17\NNP\0 (r_npadvmod) induced_19\VBN\1627355 (r_amod) hepatotoxicity_20\NN\0 (r_npadvmod) occur_4\VB\0 (l_prep) in_5\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) including_9\VBG\0 (l_pobj) pancreatitis_11\NN\14336539
D014635_D010195 CID vpa_22\NNP\0 (r_npadvmod) induced_24\VBN\1627355 (r_compound) encephalopathy_25\NN\14084880 (r_conj) hepatotoxicity_20\NN\0 (r_npadvmod) occur_4\VB\0 (l_prep) in_5\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) including_9\VBG\0 (l_pobj) pancreatitis_11\NN\14336539
9931093
C079574_D006973 NONE 139317_14\CD\0 (r_nummod) fr_13\NNP\14625458 (l_prep) on_15\IN\0 (l_pobj) hypertension_18\NN\14057371
D016559_D007674 NONE 506_5\CD\0 (r_nummod) fk_4\NNP\0 (r_pobj) of_3\IN\0 (r_prep) utility_2\NN\8186047 (r_nsubjpass) complicated_7\VBN\126264 (l_agent) by_8\IN\0 (l_pobj) hypertension_10\NN\14057371 (l_conj) nephrotoxicity_12\NN\0
D009569_D006973 NONE oxide_44\NN\14818238 (r_compound) synthase_45\NN\0 (r_conj) expression_27\NN\4679549 (r_dobj) studied_10\VBD\0 (l_advcl) clarify_1\VB\939277 (l_dobj) mechanisms_3\NNS\13446390 (l_prep) of_4\IN\0 (l_pobj) hypertension_7\NN\14057371
D016559_D006973 CID 506-induced_3\JJ\0 (r_nummod) hypertension_4\NN\14057371
D016559_D006973 CID 506_5\CD\0 (r_nummod) fk_4\NNP\0 (r_pobj) of_3\IN\0 (r_prep) utility_2\NN\8186047 (r_nsubjpass) complicated_7\VBN\126264 (l_agent) by_8\IN\0 (l_pobj) hypertension_10\NN\14057371
D016559_D006973 CID 506-induced_6\JJ\0 (r_compound) hypertension_7\NN\14057371
D016559_D006973 CID 506_16\CD\0 (r_nummod) fk_15\NNP\0 (r_pobj) of_14\IN\0 (r_prep) effects_13\NNS\13245626 (r_dobj) studied_10\VBD\0 (l_advcl) clarify_1\VB\939277 (l_dobj) mechanisms_3\NNS\13446390 (l_prep) of_4\IN\0 (l_pobj) hypertension_7\NN\14057371
D016559_D006973 CID 506-induced_17\JJ\0 (r_nummod) fk_16\NNP\0 (r_poss) hypertension_18\NN\14057371
D016559_D006973 CID 506-induced_4\JJ\0 (r_nummod) hypertension_5\NN\14057371
230316
D007464_D001927 CID clioquinol_25\NN\2720201 (r_pobj) of_24\IN\0 (r_prep) dose_23\NN\3740161 (r_pobj) of_20\IN\0 (r_prep) ingestion_19\NN\13440063 (r_pobj) to_17\IN\0 (r_prep) related_16\VBN\628491 (r_acl) encephalopathy_14\NN\14084880
D006912_D020258 NONE hydroxyquinolines_3\NNS\0 (r_pobj) of_1\IN\0 (r_prep) neurotoxicity_0\NN\0
D006912_D020258 NONE hydroxyquinolines_13\NNS\0 (r_pobj) to_11\IN\0 (r_prep) reactions_10\NNS\13446390 (l_amod) neurotoxic_9\JJ\0
D007464_C538178 NONE clioquinol_13\NN\2720201 (l_prep) as_14\IN\14622893 (l_pobj) treatment_15\NN\654885 (l_prep) for_16\IN\0 (l_pobj) enteropathica_18\NN\0
D007464_D009422 NONE clioquinol_25\NN\2720201 (r_pobj) of_24\IN\0 (r_prep) dose_23\NN\3740161 (r_pobj) of_20\IN\0 (r_prep) ingestion_19\NN\13440063 (r_pobj) to_17\IN\0 (r_prep) related_16\VBN\628491 (r_acl) encephalopathy_14\NN\14084880 (r_pobj) of_10\IN\0 (r_prep) consisted_9\VBD\2603699 (l_nsubj) disturbance_8\NN\407535
9727773
D001067_D006976 CID suppressants_9\NNS\3247620 (r_pobj) with_7\IN\0 (r_prep) associated_6\VBN\628491 (r_acl) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) hypertension_5\NN\14057371
D001067_D006976 CID suppressant_21\NN\3247620 (r_compound) drugs_22\NNS\14778436 (r_pobj) of_19\IN\0 (r_prep) intake_18\NN\13440063 (r_pobj) with_16\IN\0 (r_prep) associated_15\VBN\628491 (r_relcl) disease_10\NN\14061805 (r_attr) is_3\VBZ\0 (l_nsubj) hypertension_2\NN\14057371
D001067_D006976 CID suppressants_18\NNS\3247620 (r_dobj) taken_16\VBN\2367363 (l_ccomp) was_9\VBD\0 (l_nsubj) diagnosis_4\NN\152018 (l_prep) of_5\IN\0 (l_pobj) hypertension_8\NN\14057371
D001067_D006976 CID suppressants_7\NNS\3247620 (r_pobj) of_5\IN\0 (r_prep) prescription_4\NN\6786629 (r_pobj) of_2\IN\0 (r_prep) policy_1\NN\5902545 (r_nsubj) lead_9\VB\5155821 (l_prep) to_10\IN\0 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) hypertension_18\NN\14057371
8302922
D000527_D007022 CID e1_5\NNP\0 (r_pobj) during_3\IN\0 (r_prep) flow_2\NN\7311115 (r_nsubj) induced_8\VBD\1627355 (l_dobj) hypotension_9\NN\14057371
D000527_D007022 CID e1_6\NNP\0 (r_nmod) pge1_8\NNP\0 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_dobj) evaluate_1\VB\670261 (r_csubj) induced_15\VBN\1627355 (l_dobj) hypotension_16\NN\14057371
D000527_D007022 CID pge1_8\NNP\0 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_dobj) evaluate_1\VB\670261 (r_csubj) induced_15\VBN\1627355 (l_dobj) hypotension_16\NN\14057371
D000527_D007022 CID pge1_2\NNP\0 (r_dobj) starting_1\VBG\457382 (r_pcomp) after_0\IN\0 (r_prep) decreased_14\VBD\169651 (l_conj) remained_34\VBD\2604760 (l_nsubj) degree_28\NN\4916342 (l_prep) of_29\IN\0 (l_pobj) hypotension_30\NN\14057371
D000527_D007022 CID pge1_33\NNP\0 (r_pobj) to_32\IN\0 (r_pcomp) due_31\IN\5174653 (r_prep) degree_28\NN\4916342 (l_prep) of_29\IN\0 (l_pobj) hypotension_30\NN\14057371
D000527_D007022 CID pge1_4\NNP\0 (r_nsubj) be_6\VB\14625458 (l_acomp) preferable_7\JJ\0 (l_xcomp) tmp_9\VB\0 (l_prep) for_10\IN\0 (l_pobj) anaesthesia_12\NN\14034177 (l_amod) hypotensive_11\JJ\10405694
D007530_D007022 NONE isoflurane_47\JJ\3570838 (r_amod) anaesthesia_48\NN\14034177 (r_pobj) under_46\IN\0 (r_prep) fusion_45\NN\7373277 (r_dobj) underwent_40\VBD\109660 (r_relcl) patients_38\NNS\9898892 (r_pobj) in_36\IN\13603305 (r_prep) using_31\VBG\418025 (r_advcl) measured_30\VBN\697589 (l_advcl) induced_15\VBN\1627355 (l_dobj) hypotension_16\NN\14057371
D014294_D007022 CID trimethaphan_7\RB\0 (r_conj) e1_5\NNP\0 (r_pobj) during_3\IN\0 (r_prep) flow_2\NN\7311115 (r_nsubj) induced_8\VBD\1627355 (l_dobj) hypotension_9\NN\14057371
D014294_D007022 CID trimethaphan_11\NN\0 (r_conj) pge1_8\NNP\0 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_dobj) evaluate_1\VB\670261 (r_csubj) induced_15\VBN\1627355 (l_dobj) hypotension_16\NN\14057371
D014294_D007022 CID tmp_13\NNP\0 (r_appos) trimethaphan_11\NN\0 (r_conj) pge1_8\NNP\0 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_dobj) evaluate_1\VB\670261 (r_csubj) induced_15\VBN\1627355 (l_dobj) hypotension_16\NN\14057371
D014294_D007022 CID tmp_4\NNP\0 (r_conj) pge1_2\NNP\0 (r_dobj) starting_1\VBG\457382 (r_pcomp) after_0\IN\0 (r_prep) decreased_14\VBD\169651 (l_conj) remained_34\VBD\2604760 (l_nsubj) degree_28\NN\4916342 (l_prep) of_29\IN\0 (l_pobj) hypotension_30\NN\14057371
D014294_D007022 CID tmp_9\VB\0 (l_prep) for_10\IN\0 (l_pobj) anaesthesia_12\NN\14034177 (l_amod) hypotensive_11\JJ\10405694
D014294_D007022 CID tmp_17\NNP\0 (r_nsubj) decreased_18\VBD\169651 (r_advcl) be_6\VB\14625458 (l_acomp) preferable_7\JJ\0 (l_xcomp) tmp_9\VB\0 (l_prep) for_10\IN\0 (l_pobj) anaesthesia_12\NN\14034177 (l_amod) hypotensive_11\JJ\10405694
3437726
D003647_D064420 NONE debrisoquine_13\JJ\0 (r_compound) polymorphism_14\NN\11418750 (r_pobj) of_10\IN\0 (r_prep) phenotype_9\NN\4933544 (r_pobj) to_4\IN\0 (r_prep) belonging_3\VBG\7526757 (r_acl) patients_2\NNS\9898892 (r_nsubj) experience_29\VB\5984287 (l_dobj) reactions_32\NNS\13446390
D013034_D064420 NONE sparteine_11\NN\0 (r_nmod) debrisoquine_13\JJ\0 (r_compound) polymorphism_14\NN\11418750 (r_pobj) of_10\IN\0 (r_prep) phenotype_9\NN\4933544 (r_pobj) to_4\IN\0 (r_prep) belonging_3\VBG\7526757 (r_acl) patients_2\NNS\9898892 (r_nsubj) experience_29\VB\5984287 (l_dobj) reactions_32\NNS\13446390
12789195
D008914_D004194 NONE minoxidil_9\NN\4522904 (r_pobj) of_8\IN\0 (r_prep) use_7\NN\407535 (r_pobj) by_2\IN\0 (r_agent) induced_1\VBN\1627355 (l_nsubj) pseudoacromegaly_0\NNS\0
D008914_D004194 NONE minoxidil_15\NN\4522904 (r_pobj) of_14\IN\0 (r_prep) use_13\NN\407535 (r_pobj) from_8\IN\0 (r_prep) resulted_7\VBD\2633881 (r_relcl) patient_3\NN\9898892 (l_prep) with_4\IN\0 (l_pobj) pseudoacromegaly_5\NNS\0
D008914_D004194 NONE minoxidil_13\JJ\4522904 (r_amod) use_14\NN\407535 (r_pobj) of_12\IN\0 (r_prep) effect_11\NN\34213 (r_pobj) as_8\IN\14622893 (r_prep) report_5\NN\6470073 (l_prep) of_6\IN\0 (l_pobj) pseudoacromegaly_7\NNS\0
12198388
D009388_D012640 CID neostigmine_12\NN\2718084 (r_conj) sensitivity_0\NN\5651971 (l_prep) to_1\IN\0 (l_pobj) endpoints_4\NNS\8566028 (l_compound) convulsion_3\NN\14081375
D009538_D012640 CID nicotine_7\NN\14712692 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (r_acl) endpoints_4\NNS\8566028 (l_compound) convulsion_3\NN\14081375
D009538_D014202 NONE nicotine_3\NN\14712692 (r_dobj) administered_2\VBN\2436349 (l_conj) recorded_25\VBN\2225492 (l_nsubjpass) latencies_17\NNS\15269513 (l_relcl) onset_19\VB\7325190 (l_prep) of_20\IN\0 (l_pobj) tremor_21\NN\345926
D009388_D014202 NONE neostigmine_8\JJ\2718084 (r_conj) carbachol_5\NN\0 (r_conj) nicotine_3\NN\14712692 (r_dobj) administered_2\VBN\2436349 (l_conj) recorded_25\VBN\2225492 (l_nsubjpass) latencies_17\NNS\15269513 (l_relcl) onset_19\VB\7325190 (l_prep) of_20\IN\0 (l_pobj) tremor_21\NN\345926
D000431_D012640 NONE alcohol_6\NN\7881800 (r_compound) na_8\TO\14625458 (r_aux) ve_9\VB\0 (l_dobj) mice_23\NNS\2329401 (l_nmod) prone_13\NNP\0 (l_compound) seizure_11\NN\14081375
D000431_D012640 NONE ethanol_18\NN\14708720 (r_compound) withdrawal_19\NN\7206096 (r_compound) severity_20\NN\5036394 (r_pobj) with_17\IN\0 (r_prep) associated_16\VBN\628491 (l_nsubjpass) differences_4\NNS\4723816 (l_prep) in_5\IN\13603305 (l_pobj) activity_7\NN\30358 (l_conj) sensitivity_10\NN\5651971 (l_prep) to_11\IN\0 (l_pobj) convulsants_13\NNS\0
D000431_D012640 NONE alcohol_26\NN\7881800 (r_compound) withdrawal_27\NN\7206096 (r_pobj) in_25\IN\13603305 (r_prep) mechanisms_24\NNS\13446390 (r_dobj) implicate_22\VB\2677097 (r_conj) associated_16\VBN\628491 (l_nsubjpass) differences_4\NNS\4723816 (l_prep) in_5\IN\13603305 (l_pobj) activity_7\NN\30358 (l_conj) sensitivity_10\NN\5651971 (l_prep) to_11\IN\0 (l_pobj) convulsants_13\NNS\0
D000109_D012640 NONE acetylcholine_4\NN\14807558 (r_compound) release_5\NN\3748886 (l_conj) sensitivity_9\NN\5651971 (l_prep) in_10\IN\13603305 (l_pobj) lines_22\NNS\8426461 (l_amod) prone_14\JJ\0 (l_npadvmod) seizure_12\NN\14081375
D000109_D012640 NONE acetylcholine_4\NN\14807558 (r_compound) release_5\NN\3748886 (l_conj) sensitivity_9\NN\5651971 (l_prep) in_10\IN\13603305 (l_pobj) lines_22\NNS\8426461 (l_amod) resistant_19\JJ\0 (l_npadvmod) seizure_17\NN\14081375
D000109_D012640 NONE ach_1\NNS\0 (r_nsubjpass) measured_4\VBN\697589 (l_prep) during_5\IN\0 (l_pobj) testing_6\VBG\639556 (l_prep) for_7\IN\0 (l_pobj) convulsions_11\NNS\14081375
D000109_D012640 NONE ach_2\NNS\0 (r_nsubjpass) measured_4\VBN\697589 (l_prep) during_5\IN\0 (l_pobj) testing_6\VBG\639556 (l_prep) for_7\IN\0 (l_pobj) convulsions_11\NNS\14081375
D000109_D012640 NONE ach_14\NNS\0 (r_nsubjpass) elevated_17\JJ\4048568 (l_advcl) measured_4\VBN\697589 (l_prep) during_5\IN\0 (l_pobj) testing_6\VBG\639556 (l_prep) for_7\IN\0 (l_pobj) convulsions_11\NNS\14081375
D002217_D014202 NONE carbachol_5\NN\0 (r_conj) nicotine_3\NN\14712692 (r_dobj) administered_2\VBN\2436349 (l_conj) recorded_25\VBN\2225492 (l_nsubjpass) latencies_17\NNS\15269513 (l_relcl) onset_19\VB\7325190 (l_prep) of_20\IN\0 (l_pobj) tremor_21\NN\345926
D002217_D012640 CID carbachol_9\NN\0 (r_conj) nicotine_7\NN\14712692 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (r_acl) endpoints_4\NNS\8566028 (l_compound) convulsion_3\NN\14081375
6518066
D008094_D006331 NONE lithium_9\NN\14625458 (r_pobj) to_8\IN\0 (r_prep) exposed_7\VBN\2110927 (r_csubj) provide_13\VB\2199590 (l_dobj) assessment_18\NN\5732756 (l_prep) of_19\IN\0 (l_pobj) presence_21\NN\13954253 (l_prep) of_24\IN\0 (l_pobj) malformations_29\NNS\14213199
D008094_D006331 NONE lithium_25\NN\14625458 (r_npadvmod) induced_27\VBN\1627355 (r_amod) malformations_29\NNS\14213199
D008094_D004437 CID lithium_1\NN\14625458 (l_conj) anomaly_6\NN\14501726
10520387
D004809_D013610 CID ephedrine_9\NN\14712692 (r_pobj) of_8\IN\0 (r_prep) use_7\NN\407535 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) tachycardia_3\NNS\14110674
D004809_D013610 CID ephedrine_24\NN\14712692 (r_nmod) mixtures_28\NNS\19613 (r_pobj) of_22\IN\0 (r_prep) any_21\DT\0 (r_pobj) of_20\IN\0 (r_prep) patients_19\NNS\9898892 (r_pobj) in_17\IN\13603305 (r_prep) use_16\NN\407535 (r_dobj) recommend_14\VB\875394 (l_prep) due_0\IN\5174653 (l_pobj) risk_3\NN\14541044 (l_prep) of_4\IN\0 (l_pobj) tachycardia_6\NN\14110674
D015742_D007022 CID propofol_13\NN\0 (l_prep) in_14\IN\13603305 (l_pobj) order_15\NN\7168131 (l_acl) obtund_17\VB\192051 (l_dobj) response_20\NN\11410625 (l_amod) hypotensive_19\JJ\10405694
D015742_D007022 CID propofol_5\NN\0 (r_acl) addition_1\NN\3081021 (r_nsubj) appears_6\VBZ\2604760 (l_xcomp) be_8\VB\14625458 (l_attr) method_11\NN\5616786 (l_prep) of_12\IN\0 (l_pcomp) obtunding_13\VBG\192051 (l_dobj) response_16\NN\11410625 (l_amod) hypotensive_15\JJ\10405694
D015742_D007022 CID propofol_18\NN\0 (r_advcl) obtunding_13\VBG\192051 (l_dobj) response_16\NN\11410625 (l_amod) hypotensive_15\JJ\10405694
D004809_D017202 NONE ephedrine_24\NN\14712692 (r_nmod) mixtures_28\NNS\19613 (r_pobj) of_22\IN\0 (r_prep) any_21\DT\0 (r_pobj) of_20\IN\0 (r_prep) patients_19\NNS\9898892 (r_pobj) in_17\IN\13603305 (r_prep) use_16\NN\407535 (r_dobj) recommend_14\VB\875394 (l_prep) due_0\IN\5174653 (l_pobj) risk_3\NN\14541044 (l_prep) of_4\IN\0 (l_pobj) tachycardia_6\NN\14110674 (l_acl) inducing_7\VBG\42311 (l_dobj) ischemia_9\NN\14195315
D004809_D007022 NONE ephedrine_11\NN\14712692 (r_pobj) of_10\IN\0 (r_prep) doses_9\NNS\3740161 (r_dobj) adding_7\VBG\156601 (l_xcomp) propofol_13\NN\0 (l_prep) in_14\IN\13603305 (l_pobj) order_15\NN\7168131 (l_acl) obtund_17\VB\192051 (l_dobj) response_20\NN\11410625 (l_amod) hypotensive_19\JJ\10405694
D004809_D007022 NONE ephedrine_3\NN\14712692 (r_pobj) of_2\IN\0 (r_prep) addition_1\NN\3081021 (r_nsubj) appears_6\VBZ\2604760 (l_xcomp) be_8\VB\14625458 (l_attr) method_11\NN\5616786 (l_prep) of_12\IN\0 (l_pcomp) obtunding_13\VBG\192051 (l_dobj) response_16\NN\11410625 (l_amod) hypotensive_15\JJ\10405694
D015742_D013610 CID propofol_13\NN\0 (r_pobj) with_12\IN\0 (r_prep) combination_11\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) use_7\NN\407535 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) tachycardia_3\NNS\14110674
D015742_D013610 CID propofol_26\NN\0 (r_nmod) mixtures_28\NNS\19613 (r_pobj) of_22\IN\0 (r_prep) any_21\DT\0 (r_pobj) of_20\IN\0 (r_prep) patients_19\NNS\9898892 (r_pobj) in_17\IN\13603305 (r_prep) use_16\NN\407535 (r_dobj) recommend_14\VB\875394 (l_prep) due_0\IN\5174653 (l_pobj) risk_3\NN\14541044 (l_prep) of_4\IN\0 (l_pobj) tachycardia_6\NN\14110674
D015742_D017202 NONE propofol_26\NN\0 (r_nmod) mixtures_28\NNS\19613 (r_pobj) of_22\IN\0 (r_prep) any_21\DT\0 (r_pobj) of_20\IN\0 (r_prep) patients_19\NNS\9898892 (r_pobj) in_17\IN\13603305 (r_prep) use_16\NN\407535 (r_dobj) recommend_14\VB\875394 (l_prep) due_0\IN\5174653 (l_pobj) risk_3\NN\14541044 (l_prep) of_4\IN\0 (l_pobj) tachycardia_6\NN\14110674 (l_acl) inducing_7\VBG\42311 (l_dobj) ischemia_9\NN\14195315
6888657
D004054_D009369 NONE des_12\NNP\14749794 (r_npadvmod) induced_14\VBN\1627355 (r_amod) tumor_15\NN\14234074
D004054_D010911 CID diethylstilbestrol_12\NN\14749794 (r_pobj) with_11\IN\0 (r_prep) treatment_10\NN\654885 (r_pobj) by_8\IN\0 (r_agent) induced_3\VBN\1627355 (l_nsubjpass) tumors_1\NNS\14234074
D004054_D010911 CID des_14\NNP\14749794 (r_npadvmod) implanted_21\VBN\1421622 (r_parataxis) induced_3\VBN\1627355 (l_nsubjpass) tumors_1\NNS\14234074
D004967_D010911 NONE estrogen_2\NN\14745635 (r_npadvmod) induced_4\VBN\1627355 (r_amod) tumors_6\NNS\14234074
15036754
D010755_D012640 NONE organophosphate_0\NNP\14919948 (r_npadvmod) induced_2\VBN\1627355 (r_amod) convulsions_3\NNS\14081375
D003975_D011041 NONE diazepam_3\NN\2830852 (r_nsubjpass) given_7\VBN\5892096 (r_advcl) prevented_16\VBD\0 (l_conj) delayed_18\VBN\439958 (l_conj) shortened_20\VBN\429060 (l_dobj) occurrence_22\NN\29378 (l_prep) of_23\IN\0 (l_pobj) signs_25\NNS\6643763 (l_prep) of_26\IN\0 (l_pobj) poisoning_27\NN\14034177
D003975_D011041 NONE diazepam_5\NN\2830852 (r_conj) cpa_3\NN\9761403 (r_nsubj) prevented_12\VBD\0 (l_dobj) occurrence_14\NN\29378 (l_prep) of_15\IN\0 (l_pobj) signs_17\NNS\6643763 (l_prep) of_18\IN\0 (l_pobj) poisoning_19\NN\14034177
D007531_D064420 NONE dfp_4\NNP\0 (r_compound) atropine_6\NN\14712692 (r_pobj) with_3\IN\0 (r_prep) treated_2\VBD\2376958 (l_conj) showed_7\VBD\2137132 (l_dobj) signs_14\NNS\6643763 (l_compound) toxicity_13\NN\13576101
D007531_D064420 NONE dfp_10\NNP\0 (r_compound) toxicity_11\NN\13576101
D007531_D064420 NONE dfp_26\NNP\0 (r_pobj) of_25\IN\0 (r_prep) toxicity_24\NN\13576101
D000109_D064420 NONE acetylcholine_25\NN\14807558 (r_nmod) levels_29\NNS\4916342 (r_dobj) elevates_24\VBZ\2391803 (r_relcl) system_18\NN\3575240 (r_pobj) in_14\IN\13603305 (r_prep) aches_13\NNP\14322699 (r_pobj) with_12\IN\0 (r_prep) binding_11\NN\4688246 (r_pobj) of_8\IN\0 (r_prep) result_7\NN\34213 (r_attr) is_5\VBZ\0 (l_nsubj) toxicity_2\NN\13576101
D000109_D064420 NONE ach_27\NNS\0 (r_nmod) levels_29\NNS\4916342 (r_dobj) elevates_24\VBZ\2391803 (r_relcl) system_18\NN\3575240 (r_pobj) in_14\IN\13603305 (r_prep) aches_13\NNP\14322699 (r_pobj) with_12\IN\0 (r_prep) binding_11\NN\4688246 (r_pobj) of_8\IN\0 (r_prep) result_7\NN\34213 (r_attr) is_5\VBZ\0 (l_nsubj) toxicity_2\NN\13576101
D010755_D064420 NONE ops_4\NNS\0 (r_pobj) of_3\IN\0 (r_prep) toxicity_2\NN\13576101
D010755_D064420 NONE op_10\NN\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) signs_14\NNS\6643763 (l_compound) toxicity_13\NN\13576101
D011220_D064420 NONE 2pam_7\CD\0 (r_conj) diazepam_5\NN\2830852 (r_conj) cpa_3\NN\9761403 (r_nsubj) prevented_12\VBD\0 (l_conj) reduced_22\VBD\441445 (l_dobj) toxicity_24\NN\13576101
D007531_D011041 NONE dfp_10\NNP\0 (r_compound) atropine_12\NN\14712692 (r_pobj) after_9\IN\0 (r_prep) given_7\VBN\5892096 (r_advcl) prevented_16\VBD\0 (l_conj) delayed_18\VBN\439958 (l_conj) shortened_20\VBN\429060 (l_dobj) occurrence_22\NN\29378 (l_prep) of_23\IN\0 (l_pobj) signs_25\NNS\6643763 (l_prep) of_26\IN\0 (l_pobj) poisoning_27\NN\14034177
D007531_D011041 NONE dfp_26\NNP\0 (r_pobj) of_25\IN\0 (r_prep) toxicity_24\NN\13576101 (r_dobj) reduced_22\VBD\441445 (r_conj) prevented_12\VBD\0 (l_dobj) occurrence_14\NN\29378 (l_prep) of_15\IN\0 (l_pobj) signs_17\NNS\6643763 (l_prep) of_18\IN\0 (l_pobj) poisoning_19\NN\14034177
D003975_D064420 NONE diazepam_5\NN\2830852 (r_conj) cpa_3\NN\9761403 (r_nsubj) prevented_12\VBD\0 (l_conj) reduced_22\VBD\441445 (l_dobj) toxicity_24\NN\13576101
C048599_D064420 NONE cpa_3\NN\9761403 (r_nsubj) prevented_12\VBD\0 (l_conj) reduced_22\VBD\441445 (l_dobj) toxicity_24\NN\13576101
D016291_D064420 NONE mk801_2\NNP\0 (r_nsubj) offer_5\VB\7160883 (l_dobj) protection_8\NN\407535 (l_prep) against_9\IN\0 (l_pobj) toxicity_11\NN\13576101
D010755_D004194 NONE organophosphate_0\NNP\14919948 (r_npadvmod) induced_2\VBN\1627355 (r_amod) convulsions_3\NNS\14081375 (l_prep) of_6\IN\0 (l_pobj) damages_8\NNS\13282550
D001285_D011041 NONE atropine_12\NN\14712692 (r_pobj) after_9\IN\0 (r_prep) given_7\VBN\5892096 (r_advcl) prevented_16\VBD\0 (l_conj) delayed_18\VBN\439958 (l_conj) shortened_20\VBN\429060 (l_dobj) occurrence_22\NN\29378 (l_prep) of_23\IN\0 (l_pobj) signs_25\NNS\6643763 (l_prep) of_26\IN\0 (l_pobj) poisoning_27\NN\14034177
D001285_D011041 NONE atropine_11\NN\14712692 (r_pobj) with_10\IN\0 (r_prep) combination_9\NN\7951464 (r_pobj) in_8\IN\13603305 (r_prep) diazepam_5\NN\2830852 (r_conj) cpa_3\NN\9761403 (r_nsubj) prevented_12\VBD\0 (l_dobj) occurrence_14\NN\29378 (l_prep) of_15\IN\0 (l_pobj) signs_17\NNS\6643763 (l_prep) of_18\IN\0 (l_pobj) poisoning_19\NN\14034177
D011220_D011041 NONE 2pam_5\CD\0 (r_conj) diazepam_3\NN\2830852 (r_nsubjpass) given_7\VBN\5892096 (r_advcl) prevented_16\VBD\0 (l_conj) delayed_18\VBN\439958 (l_conj) shortened_20\VBN\429060 (l_dobj) occurrence_22\NN\29378 (l_prep) of_23\IN\0 (l_pobj) signs_25\NNS\6643763 (l_prep) of_26\IN\0 (l_pobj) poisoning_27\NN\14034177
D011220_D011041 NONE 2pam_7\CD\0 (r_conj) diazepam_5\NN\2830852 (r_conj) cpa_3\NN\9761403 (r_nsubj) prevented_12\VBD\0 (l_dobj) occurrence_14\NN\29378 (l_prep) of_15\IN\0 (l_pobj) signs_17\NNS\6643763 (l_prep) of_18\IN\0 (l_pobj) poisoning_19\NN\14034177
D001285_D064420 NONE atropine_6\NN\14712692 (r_pobj) with_3\IN\0 (r_prep) treated_2\VBD\2376958 (l_conj) showed_7\VBD\2137132 (l_dobj) signs_14\NNS\6643763 (l_compound) toxicity_13\NN\13576101
D001285_D064420 NONE atropine_0\NNP\14712692 (r_compound) mk801_2\NNP\0 (r_nsubj) offer_5\VB\7160883 (l_dobj) protection_8\NN\407535 (l_prep) against_9\IN\0 (l_pobj) toxicity_11\NN\13576101
D001285_D064420 NONE atropine_11\NN\14712692 (r_pobj) with_10\IN\0 (r_prep) combination_9\NN\7951464 (r_pobj) in_8\IN\13603305 (r_prep) diazepam_5\NN\2830852 (r_conj) cpa_3\NN\9761403 (r_nsubj) prevented_12\VBD\0 (l_conj) reduced_22\VBD\441445 (l_dobj) toxicity_24\NN\13576101
C048599_D011041 NONE cpa_1\NN\9761403 (r_nsubjpass) given_7\VBN\5892096 (r_advcl) prevented_16\VBD\0 (l_conj) delayed_18\VBN\439958 (l_conj) shortened_20\VBN\429060 (l_dobj) occurrence_22\NN\29378 (l_prep) of_23\IN\0 (l_pobj) signs_25\NNS\6643763 (l_prep) of_26\IN\0 (l_pobj) poisoning_27\NN\14034177
C048599_D011041 NONE cpa_3\NN\9761403 (r_nsubj) prevented_12\VBD\0 (l_dobj) occurrence_14\NN\29378 (l_prep) of_15\IN\0 (l_pobj) signs_17\NNS\6643763 (l_prep) of_18\IN\0 (l_pobj) poisoning_19\NN\14034177
2887062
D001971_D000236 NONE bromocriptine_15\JJ\0 (r_amod) treatment_16\NN\654885 (l_prep) of_17\IN\0 (l_pobj) cells_20\NNS\3080309 (l_compound) adenoma_19\NN\14236226
D004967_D015175 CID estrogen_8\NN\14745635 (r_npadvmod) induced_10\VBN\1627355 (r_amod) prolactinomas_12\NNS\0
D004967_D015175 CID estrogen_21\NN\14745635 (r_npadvmod) induced_23\VBN\1627355 (r_amod) cells_26\NNS\3080309 (r_pobj) to_20\IN\0 (r_prep) applied_19\VBN\0 (l_advcl) clarify_1\VB\939277 (l_dobj) effects_3\NNS\13245626 (l_prep) on_6\IN\0 (l_pobj) cells_8\NNS\3080309 (l_compound) prolactinoma_7\NN\0
D004967_D015175 CID estrogen_21\NN\14745635 (r_npadvmod) induced_23\VBN\1627355 (r_amod) cells_26\NNS\3080309 (l_compound) prolactinoma_25\NN\0
D001971_D015175 NONE bromocriptine_14\NN\0 (r_amod) treatment_15\NN\654885 (r_pobj) after_13\IN\0 (r_prep) prolactinomas_12\NNS\0
D001971_D015175 NONE bromocriptine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (l_prep) on_6\IN\0 (l_pobj) cells_8\NNS\3080309 (l_compound) prolactinoma_7\NN\0
D001971_D015175 NONE bromocriptine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (r_dobj) clarify_1\VB\939277 (r_advcl) applied_19\VBN\0 (l_prep) to_20\IN\0 (l_pobj) cells_26\NNS\3080309 (l_compound) prolactinoma_25\NN\0
D001971_D015175 NONE bromocriptine_35\NN\0 (r_pobj) of_34\IN\0 (r_prep) injection_33\NN\320852 (r_pobj) after_32\IN\0 (r_prep) h_31\NN\14622893 (r_conj) applied_19\VBN\0 (l_advcl) clarify_1\VB\939277 (l_dobj) effects_3\NNS\13245626 (l_prep) on_6\IN\0 (l_pobj) cells_8\NNS\3080309 (l_compound) prolactinoma_7\NN\0
D001971_D015175 NONE bromocriptine_35\NN\0 (r_pobj) of_34\IN\0 (r_prep) injection_33\NN\320852 (r_pobj) after_32\IN\0 (r_prep) h_31\NN\14622893 (r_conj) applied_19\VBN\0 (l_prep) to_20\IN\0 (l_pobj) cells_26\NNS\3080309 (l_compound) prolactinoma_25\NN\0
10669626
D014807_D002114 NONE d_8\JJ\15089472 (r_conj) growth_5\NN\13526110 (r_nmod) treatment_9\NN\654885 (r_nsubj) enhance_10\VB\227165 (l_prep) given_18\VBN\5892096 (l_advcl) inhibit_24\VB\2510337 (l_dobj) carboxylation_27\NN\0 (l_prep) of_28\IN\0 (l_pobj) protein_31\NN\14944888 (l_appos) inhibitor_35\NN\20090 (l_compound) calcification_34\NN\13446390
D014807_D002114 NONE d_30\NN\15089472 (r_npadvmod) treated_32\VBN\2376958 (r_amod) rats_33\NNS\2329401 (r_pobj) of_28\IN\0 (r_prep) media_27\NNS\3575240 (r_pobj) in_25\IN\13603305 (r_prep) calcification_24\NN\13446390
D014807_D002114 NONE d_15\NN\15089472 (r_pobj) by_13\IN\0 (r_agent) produced_12\VBN\1617192 (r_acl) calcium_11\NN\14625458 (r_pobj) in_9\IN\13603305 (r_prep) elevation_8\NN\7445480 (r_pobj) on_6\IN\0 (r_prep) effect_5\NN\34213 (r_dobj) had_3\VBD\0 (r_advcl) explained_27\VBN\831651 (l_agent) by_28\IN\0 (l_pobj) hypothesis_30\NN\7162194 (l_acl) inhibits_33\VBZ\2510337 (l_prep) as_40\IN\14622893 (l_pobj) inhibitor_43\NN\20090 (l_compound) calcification_42\NN\13446390
D014807_D002114 NONE d_23\NN\15089472 (r_pobj) between_19\IN\0 (r_prep) synergy_18\NN\13518963 (r_appos) d_15\NN\15089472 (r_pobj) by_13\IN\0 (r_agent) produced_12\VBN\1617192 (r_acl) calcium_11\NN\14625458 (r_pobj) in_9\IN\13603305 (r_prep) elevation_8\NN\7445480 (r_pobj) on_6\IN\0 (r_prep) effect_5\NN\34213 (r_dobj) had_3\VBD\0 (r_advcl) explained_27\VBN\831651 (l_agent) by_28\IN\0 (l_pobj) hypothesis_30\NN\7162194 (l_acl) inhibits_33\VBZ\2510337 (l_prep) as_40\IN\14622893 (l_pobj) inhibitor_43\NN\20090 (l_compound) calcification_42\NN\13446390
D015055_D002114 NONE carboxyglutamate_8\NN\0 (r_compound) residues_9\NNS\20827 (r_nsubjpass) required_16\VBN\0 (l_prep) as_20\IN\14622893 (l_pobj) inhibitor_23\NN\20090 (l_compound) calcification_22\NN\13446390
D015055_D002114 NONE carboxyglutamate_8\NN\0 (r_compound) residues_9\NNS\20827 (r_nsubjpass) required_16\VBN\0 (r_advcl) required_28\VBN\0 (l_prep) for_29\IN\0 (l_pobj) accumulation_31\NN\13497135 (l_prep) at_32\IN\14622893 (l_pobj) sites_34\NNS\8673395 (l_compound) calcification_33\NN\13446390
D014859_D061205 CID warfarin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) calcification_4\NN\13446390
D014859_D061205 CID warfarin_22\NNP\2718259 (r_pobj) of_21\IN\0 (r_prep) doses_20\NNS\3740161 (r_dobj) given_18\VBN\5892096 (r_prep) enhance_10\VB\227165 (l_dobj) extent_12\NN\13939892 (l_prep) of_13\IN\0 (l_pobj) calcification_15\NN\13446390
D014859_D061205 CID warfarin_17\NNP\2718259 (r_npadvmod) treated_19\VBN\2376958 (r_amod) rats_20\NNS\2329401 (r_pobj) in_16\IN\13603305 (r_prep) calcification_15\NN\13446390
D014859_D061205 CID warfarin_5\NNP\2718259 (r_pobj) with_4\IN\0 (r_prep) treatment_0\NN\654885 (r_nsubj) caused_6\VBD\1617192 (l_dobj) calcification_9\NN\13446390 (l_prep) of_10\IN\0 (l_pobj) media_13\NNS\3575240 (l_compound) artery_12\NN\5417975
D014859_D061205 CID warfarin_20\NNP\2718259 (r_compound) treatment_21\NN\654885 (r_pobj) of_19\IN\0 (r_prep) weeks_18\NNS\15113229 (r_pobj) after_16\IN\0 (r_prep) detected_8\VBN\2163746 (l_nsubjpass) calcification_5\NN\13446390
D014859_D061205 CID warfarin_8\NNP\2718259 (r_npadvmod) induced_10\VBN\1627355 (r_amod) calcification_12\NN\13446390
D014859_D061205 CID warfarin_7\NNP\2718259 (r_pobj) with_6\IN\0 (r_prep) groups_5\NNS\2137 (r_pobj) of_2\IN\0 (r_prep) treatment_1\NN\654885 (r_nsubj) produced_8\VBD\1617192 (l_dobj) calcification_11\NN\13446390 (l_prep) of_12\IN\0 (l_pobj) media_15\NNS\3575240 (l_compound) artery_14\NN\5417975
D014859_D061205 CID warfarin_7\NNP\2718259 (r_pobj) with_6\IN\0 (r_prep) groups_5\NNS\2137 (r_pobj) of_2\IN\0 (r_prep) treatment_1\NN\654885 (r_nsubj) produced_8\VBD\1617192 (l_dobj) calcification_11\NN\13446390 (l_conj) calcification_27\NN\13446390
D014859_D061205 CID warfarin_61\NNP\2718259 (r_npadvmod) induced_63\VBN\1627355 (r_amod) calcification_65\NN\13446390 (r_pobj) to_60\IN\0 (r_prep) resistant_59\JJ\0 (r_acomp) was_58\VBD\0 (r_relcl) groups_56\NNS\2137 (r_pobj) of_54\IN\0 (r_prep) either_53\DT\0 (r_pobj) with_52\IN\0 (r_prep) compared_51\VBN\644583 (r_prep) rats_50\NNS\2329401 (r_appos) relationship_24\NN\31921 (r_attr) was_22\VBD\0 (l_advcl) determined_15\VBN\0 (l_nsubjpass) explanation_2\NN\6722453 (l_prep) for_3\IN\0 (l_pobj) association_5\NN\8008335 (l_prep) between_6\IN\0 (l_pobj) calcification_8\NN\13446390
D014859_D061205 CID warfarin_61\NNP\2718259 (r_npadvmod) induced_63\VBN\1627355 (r_amod) calcification_65\NN\13446390 (r_pobj) to_60\IN\0 (r_prep) resistant_59\JJ\0 (r_acomp) was_58\VBD\0 (r_relcl) groups_56\NNS\2137 (r_pobj) of_54\IN\0 (r_prep) either_53\DT\0 (r_pobj) with_52\IN\0 (r_prep) compared_51\VBN\644583 (r_prep) rats_50\NNS\2329401 (r_appos) relationship_24\NN\31921 (l_prep) between_25\IN\0 (l_pobj) phosphate_28\NN\15010703 (l_conj) susceptibility_30\NN\13920835 (l_prep) to_31\IN\0 (l_pobj) calcification_33\NN\13446390
D014859_D061205 CID warfarin_61\NNP\2718259 (r_npadvmod) induced_63\VBN\1627355 (r_amod) calcification_65\NN\13446390
D014859_D061205 CID warfarin_7\NNP\2718259 (r_npadvmod) induced_9\VBN\1627355 (r_amod) calcification_11\NN\13446390
D014859_D061205 CID warfarin_13\NNP\2718259 (r_conj) d_11\NN\15089472 (r_pobj) between_9\IN\0 (r_prep) synergy_8\NN\13518963 (l_prep) in_14\IN\13603305 (l_pobj) calcification_16\NN\13446390
D014859_D061205 CID warfarin_0\NNP\2718259 (r_nsubjpass) known_3\VBN\0 (l_xcomp) cause_5\VB\7323922 (l_dobj) calcification_6\NN\13446390 (l_prep) of_7\IN\0 (l_pobj) media_10\NNS\3575240 (l_compound) artery_9\NN\5417975
D014859_D061205 CID warfarin_20\NNP\2718259 (r_conj) d_18\NNP\15089472 (r_pobj) with_16\IN\0 (r_prep) treated_15\VBN\2376958 (r_acl) rats_14\NNS\2329401 (r_pobj) in_13\IN\13603305 (r_prep) calcification_12\NN\13446390
D010710_D061205 NONE phosphate_28\NN\15010703 (r_pobj) between_25\IN\0 (r_prep) relationship_24\NN\31921 (r_attr) was_22\VBD\0 (l_advcl) determined_15\VBN\0 (l_nsubjpass) explanation_2\NN\6722453 (l_prep) for_3\IN\0 (l_pobj) association_5\NN\8008335 (l_prep) between_6\IN\0 (l_pobj) calcification_8\NN\13446390
D010710_D061205 NONE phosphate_28\NN\15010703 (l_conj) susceptibility_30\NN\13920835 (l_prep) to_31\IN\0 (l_pobj) calcification_33\NN\13446390
D010710_D061205 NONE phosphate_28\NN\15010703 (r_pobj) between_25\IN\0 (r_prep) relationship_24\NN\31921 (l_appos) rats_50\NNS\2329401 (l_prep) compared_51\VBN\644583 (l_prep) with_52\IN\0 (l_pobj) either_53\DT\0 (l_prep) of_54\IN\0 (l_pobj) groups_56\NNS\2137 (l_relcl) was_58\VBD\0 (l_acomp) resistant_59\JJ\0 (l_prep) to_60\IN\0 (l_pobj) calcification_65\NN\13446390
D010710_D061205 NONE phosphate_42\NN\15010703 (r_pobj) of_40\IN\0 (r_prep) levels_39\NNS\4916342 (r_pobj) with_35\IN\0 (r_prep) relationship_24\NN\31921 (r_attr) was_22\VBD\0 (l_advcl) determined_15\VBN\0 (l_nsubjpass) explanation_2\NN\6722453 (l_prep) for_3\IN\0 (l_pobj) association_5\NN\8008335 (l_prep) between_6\IN\0 (l_pobj) calcification_8\NN\13446390
D010710_D061205 NONE phosphate_42\NN\15010703 (r_pobj) of_40\IN\0 (r_prep) levels_39\NNS\4916342 (r_pobj) with_35\IN\0 (r_prep) relationship_24\NN\31921 (l_prep) between_25\IN\0 (l_pobj) phosphate_28\NN\15010703 (l_conj) susceptibility_30\NN\13920835 (l_prep) to_31\IN\0 (l_pobj) calcification_33\NN\13446390
D010710_D061205 NONE phosphate_42\NN\15010703 (r_pobj) of_40\IN\0 (r_prep) levels_39\NNS\4916342 (r_pobj) with_35\IN\0 (r_prep) relationship_24\NN\31921 (l_appos) rats_50\NNS\2329401 (l_prep) compared_51\VBN\644583 (l_prep) with_52\IN\0 (l_pobj) either_53\DT\0 (l_prep) of_54\IN\0 (l_pobj) groups_56\NNS\2137 (l_relcl) was_58\VBD\0 (l_acomp) resistant_59\JJ\0 (l_prep) to_60\IN\0 (l_pobj) calcification_65\NN\13446390
D010710_D061205 NONE phosphate_18\NN\15010703 (r_compound) levels_19\NNS\4916342 (r_pobj) to_15\IN\0 (r_prep) related_14\VBN\628491 (l_nsubjpass) susceptibility_5\NN\13920835 (l_prep) to_6\IN\0 (l_pobj) calcification_11\NN\13446390
D002118_D002114 NONE calcium_11\NN\14625458 (r_pobj) in_9\IN\13603305 (r_prep) elevation_8\NN\7445480 (r_pobj) on_6\IN\0 (r_prep) effect_5\NN\34213 (r_dobj) had_3\VBD\0 (r_advcl) explained_27\VBN\831651 (l_agent) by_28\IN\0 (l_pobj) hypothesis_30\NN\7162194 (l_acl) inhibits_33\VBZ\2510337 (l_prep) as_40\IN\14622893 (l_pobj) inhibitor_43\NN\20090 (l_compound) calcification_42\NN\13446390
D014807_D061205 NONE d._11\NNP\0 (r_conj) growth_8\NN\13526110 (r_pobj) by_7\IN\0 (r_agent) accelerated_6\VBN\226566 (l_nsubjpass) calcification_4\NN\13446390
D014807_D061205 NONE d_8\JJ\15089472 (r_conj) growth_5\NN\13526110 (r_nmod) treatment_9\NN\654885 (r_nsubj) enhance_10\VB\227165 (l_dobj) extent_12\NN\13939892 (l_prep) of_13\IN\0 (l_pobj) calcification_15\NN\13446390
D014807_D061205 NONE d_11\NN\15089472 (r_pobj) between_9\IN\0 (r_prep) synergy_8\NN\13518963 (l_prep) in_14\IN\13603305 (l_pobj) calcification_16\NN\13446390
D014807_D061205 NONE d_4\NNP\15089472 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubjpass) known_6\VBN\0 (l_xcomp) cause_8\VB\7323922 (l_dobj) calcification_9\NN\13446390 (l_prep) of_10\IN\0 (l_pobj) media_13\NNS\3575240 (l_compound) artery_12\NN\5417975
D014807_D061205 NONE d_10\NN\15089472 (r_compound) dose_11\NN\3740161 (l_prep) on_12\IN\0 (l_pobj) calcification_14\NN\13446390
D014807_D061205 NONE d_10\NN\15089472 (r_compound) dose_11\NN\3740161 (r_pobj) of_8\IN\0 (r_prep) effect_7\NN\34213 (l_conj) effect_17\NN\34213 (l_prep) of_18\IN\0 (l_pobj) dose_21\NN\3740161 (l_prep) on_22\IN\0 (l_pobj) elevation_24\NN\7445480 (l_relcl) suggests_30\VBZ\1010118 (l_ccomp) induce_35\VB\1627355 (l_dobj) calcification_37\NN\13446390
D014807_D061205 NONE d_20\NNP\15089472 (r_compound) dose_21\NN\3740161 (r_pobj) of_18\IN\0 (r_prep) effect_17\NN\34213 (r_conj) effect_7\NN\34213 (l_prep) of_8\IN\0 (l_pobj) dose_11\NN\3740161 (l_prep) on_12\IN\0 (l_pobj) calcification_14\NN\13446390
D014807_D061205 NONE d_20\NNP\15089472 (r_compound) dose_21\NN\3740161 (l_prep) on_22\IN\0 (l_pobj) elevation_24\NN\7445480 (l_relcl) suggests_30\VBZ\1010118 (l_ccomp) induce_35\VB\1627355 (l_dobj) calcification_37\NN\13446390
D014807_D061205 NONE d_33\NN\15089472 (r_nsubj) induce_35\VB\1627355 (r_ccomp) suggests_30\VBZ\1010118 (r_relcl) elevation_24\NN\7445480 (r_pobj) on_22\IN\0 (r_prep) dose_21\NN\3740161 (r_pobj) of_18\IN\0 (r_prep) effect_17\NN\34213 (r_conj) effect_7\NN\34213 (l_prep) of_8\IN\0 (l_pobj) dose_11\NN\3740161 (l_prep) on_12\IN\0 (l_pobj) calcification_14\NN\13446390
D014807_D061205 NONE d_33\NN\15089472 (r_nsubj) induce_35\VB\1627355 (l_dobj) calcification_37\NN\13446390
D014807_D061205 NONE d_18\NNP\15089472 (r_pobj) with_16\IN\0 (r_prep) treated_15\VBN\2376958 (r_acl) rats_14\NNS\2329401 (r_pobj) in_13\IN\13603305 (r_prep) calcification_12\NN\13446390
D014859_D002114 NONE warfarin_22\NNP\2718259 (r_pobj) of_21\IN\0 (r_prep) doses_20\NNS\3740161 (r_dobj) given_18\VBN\5892096 (l_advcl) inhibit_24\VB\2510337 (l_dobj) carboxylation_27\NN\0 (l_prep) of_28\IN\0 (l_pobj) protein_31\NN\14944888 (l_appos) inhibitor_35\NN\20090 (l_compound) calcification_34\NN\13446390
D014859_D002114 NONE warfarin_5\NNP\2718259 (r_pobj) with_4\IN\0 (r_prep) treatment_0\NN\654885 (r_nsubj) caused_6\VBD\1617192 (l_dobj) calcification_9\NN\13446390 (l_conj) calcification_23\NN\13446390
D014859_D002114 NONE warfarin_17\NNP\2718259 (r_compound) administration_18\NN\1133281 (r_nsubj) increased_20\VBD\169651 (l_dobj) extent_22\NN\13939892 (l_prep) of_23\IN\0 (l_pobj) calcification_24\NN\13446390
D014859_D002114 NONE warfarin_1\NNP\2718259 (r_compound) treatment_2\NN\654885 (r_nsubj) had_3\VBD\0 (r_advcl) explained_27\VBN\831651 (l_agent) by_28\IN\0 (l_pobj) hypothesis_30\NN\7162194 (l_acl) inhibits_33\VBZ\2510337 (l_prep) as_40\IN\14622893 (l_pobj) inhibitor_43\NN\20090 (l_compound) calcification_42\NN\13446390
D014859_D002114 NONE warfarin_20\NNP\2718259 (r_nmod) d_23\NN\15089472 (r_pobj) between_19\IN\0 (r_prep) synergy_18\NN\13518963 (r_appos) d_15\NN\15089472 (r_pobj) by_13\IN\0 (r_agent) produced_12\VBN\1617192 (r_acl) calcium_11\NN\14625458 (r_pobj) in_9\IN\13603305 (r_prep) elevation_8\NN\7445480 (r_pobj) on_6\IN\0 (r_prep) effect_5\NN\34213 (r_dobj) had_3\VBD\0 (r_advcl) explained_27\VBN\831651 (l_agent) by_28\IN\0 (l_pobj) hypothesis_30\NN\7162194 (l_acl) inhibits_33\VBZ\2510337 (l_prep) as_40\IN\14622893 (l_pobj) inhibitor_43\NN\20090 (l_compound) calcification_42\NN\13446390
D014859_D002114 NONE warfarin_32\NNP\2718259 (r_nsubj) inhibits_33\VBZ\2510337 (l_prep) as_40\IN\14622893 (l_pobj) inhibitor_43\NN\20090 (l_compound) calcification_42\NN\13446390
D002118_D061205 NONE calcium_27\NN\14625458 (r_pobj) of_25\IN\0 (r_prep) elevation_24\NN\7445480 (r_pobj) on_22\IN\0 (r_prep) dose_21\NN\3740161 (r_pobj) of_18\IN\0 (r_prep) effect_17\NN\34213 (r_conj) effect_7\NN\34213 (l_prep) of_8\IN\0 (l_pobj) dose_11\NN\3740161 (l_prep) on_12\IN\0 (l_pobj) calcification_14\NN\13446390
D002118_D061205 NONE calcium_27\NN\14625458 (r_pobj) of_25\IN\0 (r_prep) elevation_24\NN\7445480 (l_relcl) suggests_30\VBZ\1010118 (l_ccomp) induce_35\VB\1627355 (l_dobj) calcification_37\NN\13446390
D002118_D061205 NONE calcium_43\NN\14625458 (r_pobj) on_41\IN\0 (r_prep) effect_40\NN\34213 (r_pobj) through_38\IN\0 (r_prep) induce_35\VB\1627355 (r_ccomp) suggests_30\VBZ\1010118 (r_relcl) elevation_24\NN\7445480 (r_pobj) on_22\IN\0 (r_prep) dose_21\NN\3740161 (r_pobj) of_18\IN\0 (r_prep) effect_17\NN\34213 (r_conj) effect_7\NN\34213 (l_prep) of_8\IN\0 (l_pobj) dose_11\NN\3740161 (l_prep) on_12\IN\0 (l_pobj) calcification_14\NN\13446390
D002118_D061205 NONE calcium_43\NN\14625458 (r_pobj) on_41\IN\0 (r_prep) effect_40\NN\34213 (r_pobj) through_38\IN\0 (r_prep) induce_35\VB\1627355 (l_dobj) calcification_37\NN\13446390
D015055_D061205 NONE carboxylated_36\JJ\515154 (r_acomp) was_31\VBD\0 (r_ccomp) showed_25\VBD\2137132 (r_conj) found_7\VBN\13279262 (l_prep) at_8\IN\14622893 (l_pobj) sites_9\NNS\8673395 (l_prep) of_10\IN\0 (l_pobj) calcification_12\NN\13446390
18004067
D000082_D056486 CID paracetamol_15\JJ\0 (r_pobj) of_14\IN\0 (r_prep) doses_13\NNS\3740161 (r_pobj) with_11\IN\0 (r_prep) associated_10\VBN\628491 (r_acl) hepatotoxicity_9\NN\0
D000082_D056486 CID acetaminophen_17\NN\2707683 (r_appos) paracetamol_15\JJ\0 (r_pobj) of_14\IN\0 (r_prep) doses_13\NNS\3740161 (r_pobj) with_11\IN\0 (r_prep) associated_10\VBN\628491 (r_acl) hepatotoxicity_9\NN\0
D000082_D056486 CID paracetamol_15\NN\0 (r_pobj) of_14\IN\0 (r_prep) doses_13\NNS\3740161 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (r_acl) patients_9\NNS\9898892 (r_pobj) in_8\IN\13603305 (r_prep) development_5\NN\248977 (l_prep) of_6\IN\0 (l_pobj) hepatotoxicity_7\NN\0
D000082_D017114 NONE paracetamol_11\NN\0 (r_dobj) ingesting_10\VBG\0 (r_acl) consumption_9\NN\13440063 (r_pobj) with_6\IN\0 (r_prep) patients_5\NNS\9898892 (r_pobj) in_3\IN\13603305 (r_prep) failure_2\NN\66216
D000431_D017114 NONE alcohol_8\NN\7881800 (r_compound) consumption_9\NN\13440063 (r_pobj) with_6\IN\0 (r_prep) patients_5\NNS\9898892 (r_pobj) in_3\IN\13603305 (r_prep) failure_2\NN\66216
D000431_D056486 NONE alcohol_4\NN\7881800 (r_pobj) of_3\IN\0 (r_prep) role_2\NN\719494 (l_prep) in_5\IN\13603305 (l_pobj) development_7\NN\248977 (l_prep) of_8\IN\0 (l_pobj) hepatotoxicity_9\NN\0
D000082_D017093 CID paracetamol_32\JJ\0 (r_advmod) 4_30\CD\13741022 (r_nummod) day_34\NN\15154774 (r_pobj) with_29\IN\0 (r_prep) treated_28\VBN\2376958 (r_advcl) stopping_23\VBG\3323703 (r_conj) developed_12\VBD\1753788 (l_dobj) failure_14\NN\66216
D000431_D017093 NONE alcohol_9\NN\7881800 (r_pobj) of_8\IN\0 (r_prep) consumers_7\NNS\10741590 (r_attr) were_5\VBD\0 (l_conj) developed_12\VBD\1753788 (l_dobj) failure_14\NN\66216
D000431_D017093 NONE alcohol_24\NN\7881800 (r_compound) consumption_25\NN\13440063 (r_dobj) stopping_23\VBG\3323703 (r_conj) developed_12\VBD\1753788 (l_dobj) failure_14\NN\66216
D000431_D017093 NONE alcohol_10\NN\7881800 (r_pobj) of_9\IN\0 (r_prep) consumption_8\NN\13440063 (r_appos) factors_4\NNS\7326557 (r_pobj) with_2\IN\0 (r_prep) patients_1\NNS\9898892 (r_pobj) in_0\IN\13603305 (r_prep) is_14\VBZ\0 (l_nsubj) failure_13\NN\66216
17439425
D003907_D015431 CID dex_0\NNP\0 (r_nsubj) increased_1\VBD\169651 (l_dep) p_13\NN\14622893 (l_conj) decreased_18\VBN\169651 (l_dobj) thymus_19\NN\11579418 (l_conj) bodyweights_26\NNS\0
D019820_D006973 NONE xanthine_2\NN\14727670 (r_compound) oxidase_3\NN\14732946 (r_pobj) of_1\IN\0 (r_prep) role_0\NN\719494 (l_prep) in_4\IN\13603305 (l_pobj) hypertension_8\NN\14057371
D019820_D006973 NONE xanthine_5\NN\14727670 (r_compound) oxidase_6\NN\14732946 (r_pobj) of_4\IN\0 (r_prep) role_3\NN\719494 (l_prep) in_22\IN\13603305 (l_pobj) hypertension_26\NN\14057371
D019820_D006973 NONE xanthine_5\NN\14727670 (r_compound) oxidase_6\NN\14732946 (r_pobj) of_4\IN\0 (r_prep) role_3\NN\719494 (l_prep) in_22\IN\13603305 (l_pobj) hypertension_26\NN\14057371 (l_appos) ht_30\NNP\0
D000493_D006973 NONE allopurinol_0\NNP\3740161 (r_nsubj) prevent_3\VB\0 (l_dobj) ht_6\NNP\0
D000493_D006973 NONE allopurinol_8\NN\3740161 (r_nsubj) failed_9\VBD\0 (r_acl) findings_6\NNS\7951464 (r_pobj) with_3\IN\0 (r_prep) induced_14\VBN\1627355 (l_dobj) hypertension_15\NN\14057371
D000493_D006973 NONE allopurinol_8\NN\3740161 (r_nsubj) failed_9\VBD\0 (r_acl) findings_6\NNS\7951464 (r_pobj) with_3\IN\0 (r_prep) induced_14\VBN\1627355 (r_ccomp) suggests_17\VBZ\1010118 (l_ccomp) is_21\VBZ\0 (l_attr) determinant_25\NN\5686481 (l_prep) of_26\IN\0 (l_pobj) ht_29\NNP\0
D003907_D006973 CID dexamethasone_5\NN\2721538 (r_npadvmod) induced_7\VBN\1627355 (r_amod) hypertension_8\NN\14057371
D003907_D006973 CID dexamethasone_23\NN\2721538 (r_npadvmod) induced_25\VBN\1627355 (r_amod) hypertension_26\NN\14057371
D003907_D006973 CID dexamethasone_23\NN\2721538 (r_npadvmod) induced_25\VBN\1627355 (r_amod) hypertension_26\NN\14057371 (l_appos) ht_30\NNP\0
D003907_D006973 CID dex_28\NN\0 (r_compound) ht_30\NNP\0 (r_appos) hypertension_26\NN\14057371
D003907_D006973 CID dex_28\NN\0 (r_compound) ht_30\NNP\0
D003907_D006973 CID dex_0\NNP\0 (r_nsubj) increased_1\VBD\169651 (l_dobj) sbp_2\NNP\0
D003907_D006973 CID dex_4\NN\0 (r_compound) ht_6\NNP\0
D009569_D006973 NONE oxide_16\NN\14818238 (r_compound) redox_18\NN\13447361 (r_compound) imbalance_19\NN\13934274 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (l_nsubjpass) hypertension_3\NN\14057371
D009569_D006973 NONE oxide_16\NN\14818238 (r_compound) redox_18\NN\13447361 (r_compound) imbalance_19\NN\13934274 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (l_nsubjpass) hypertension_3\NN\14057371 (l_appos) ht_7\NNP\0
18996674
D003042_D011317 CID cocaine_9\NN\3492717 (r_compound) user_10\NN\7846 (r_appos) man_4\NN\9605289 (r_nsubj) presented_12\VBN\2137132 (l_prep) on_20\IN\0 (l_pobj) occasions_23\NNS\5983801 (l_prep) with_24\IN\0 (l_pobj) history_26\NN\15120823 (l_prep) of_27\IN\0 (l_pobj) priapism_28\NN\14204950
D003042_D011317 CID cocaine_30\NN\3492717 (r_compound) use_31\NN\407535 (r_pobj) after_29\IN\0 (r_prep) history_26\NN\15120823 (l_prep) of_27\IN\0 (l_pobj) priapism_28\NN\14204950
D004837_D011317 NONE epinephrine_1\NN\14807929 (l_appos) treatment_6\NN\654885 (l_prep) for_7\IN\0 (l_pobj) priapism_8\NN\14204950
9653867
D013974_D013971 CID thyroxine_0\NNP\5413241 (r_compound) abuse_1\NN\418025 (l_appos) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) thyrotoxicosis_7\NN\14059928
D013974_D013971 CID thyroxine_28\NN\5413241 (r_compound) abuse_29\NN\418025 (r_nsubjpass) considered_32\VBN\689344 (l_advcl) remains_25\VBZ\2684 (l_nsubj) cause_22\NN\7323922 (l_prep) for_23\IN\0 (l_pobj) thyrotoxicosis_24\NN\14059928
D013974_D001068 NONE thyroxine_28\NN\5413241 (r_compound) abuse_29\NN\418025 (r_nsubjpass) considered_32\VBN\689344 (r_ccomp) reminds_17\VBZ\0 (r_conj) illustrates_3\VBZ\955601 (l_dobj) derangements_5\NNS\14395018 (l_prep) of_6\IN\0 (l_pobj) function_8\NN\13783581 (l_acl) seen_9\VBN\2106506 (l_prep) with_13\IN\0 (l_pcomp) eating_14\VBG\838098 (l_dobj) disorders_15\NNS\14034177
2348231
D010431_D006940 NONE pentoxifylline_0\NNP\3247620 (r_nsubj) inhibit_6\VB\2510337 (l_dobj) hyperemia_11\NN\14320394
D010431_D006940 NONE trental_2\NNP\3247620 (r_appos) pentoxifylline_0\NNP\3247620 (r_nsubj) inhibit_6\VB\2510337 (l_dobj) hyperemia_11\NN\14320394
D010431_D006940 NONE pentoxifylline_1\NN\3247620 (r_nsubj) inhibits_2\VBZ\2510337 (l_dobj) hyperemia_7\NN\14320394
D010431_D006940 NONE pentoxifylline_3\NN\3247620 (r_pobj) of_2\IN\0 (r_prep) dose_1\NN\3740161 (r_nsubj) decreased_5\VBD\169651 (l_dobj) hyperemia_10\NN\14320394
D010431_D006940 NONE pentoxyifylline_3\NN\0 (r_nsubj) inhibit_6\VB\2510337 (l_dobj) hyperemia_11\NN\14320394
D013793_D006940 NONE thallium-201_17\NN\0 (r_nmod) imaging_19\NN\5765159 (r_pobj) for_14\IN\0 (r_prep) implications_13\NNS\5774614 (r_appos) hyperemia_11\NN\14320394
D013793_D006940 NONE thallium-201_22\NN\0 (r_compound) imaging_23\NN\5765159 (r_pobj) to_19\IN\0 (r_prep) prior_18\RB\10675876 (r_advmod) stopped_17\VBN\0 (r_conj) inhibits_2\VBZ\2510337 (l_dobj) hyperemia_7\NN\14320394
C008514_D007383 NONE methylxanthine_12\NN\0 (r_compound) derivative_13\NN\5802185 (l_relcl) improve_16\VB\126264 (l_dobj) claudication_18\NN\14548913
D004176_D006940 CID dipyridamole_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hyperemia_11\NN\14320394
D004176_D006940 CID dipyridamole_15\JJ\0 (r_npadvmod) thallium-201_17\NN\0 (r_nmod) imaging_19\NN\5765159 (r_pobj) for_14\IN\0 (r_prep) implications_13\NNS\5774614 (r_appos) hyperemia_11\NN\14320394
D004176_D006940 CID dipyridamole_3\NN\0 (r_dep) induced_5\VBN\1627355 (r_amod) hyperemia_7\NN\14320394
D004176_D006940 CID dipyridamole_20\NN\0 (r_compound) thallium-201_22\NN\0 (r_compound) imaging_23\NN\5765159 (r_pobj) to_19\IN\0 (r_prep) prior_18\RB\10675876 (r_advmod) stopped_17\VBN\0 (r_conj) inhibits_2\VBZ\2510337 (l_dobj) hyperemia_7\NN\14320394
D004176_D006940 CID dipyridamole_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hyperemia_10\NN\14320394
D013806_D006940 NONE theophylline_13\NN\2905612 (r_pobj) as_12\IN\14622893 (r_prep) methylxanthines_10\NNS\0 (r_pobj) like_8\IN\5839024 (r_prep) hyperemia_7\NN\14320394
D013806_D006940 NONE theophylline_21\NN\2905612 (r_pobj) after_20\IN\0 (r_prep) was_17\VBD\0 (r_ccomp) peak_13\JJ\13758296 (r_advcl) decreased_5\VBD\169651 (l_dobj) hyperemia_10\NN\14320394
C008514_D006940 NONE methylxanthines_10\NNS\0 (r_pobj) like_8\IN\5839024 (r_prep) hyperemia_7\NN\14320394
D010431_D007383 CID pentoxifylline_6\NN\3247620 (r_dobj) taking_5\VBG\37396 (l_conj) derivative_13\NN\5802185 (l_relcl) improve_16\VB\126264 (l_dobj) claudication_18\NN\14548913
D010431_D007383 CID trental_8\NNP\3247620 (r_npadvmod) taking_5\VBG\37396 (l_conj) derivative_13\NN\5802185 (l_relcl) improve_16\VB\126264 (l_dobj) claudication_18\NN\14548913
10807237
D003042_D017542 CID cocaine_0\NN\3492717 (r_compound) use_1\NN\407535 (r_nsubj) predisposed_2\VBN\680841 (l_dobj) rupture_4\NN\14285662
D003042_D000783 NONE cocaine_12\NN\3492717 (r_npadvmod) related_14\VBN\628491 (r_amod) aneurysms_15\NNS\14057371
D003042_D000783 NONE cocaine_25\NN\3492717 (r_npadvmod) related_27\VBN\628491 (r_amod) aneurysms_28\NNS\14057371
D003042_D000783 NONE cocaine_0\NN\3492717 (r_compound) use_1\NN\407535 (r_nsubj) predisposed_2\VBN\680841 (l_prep) at_5\IN\14622893 (l_conj) in_11\IN\13603305 (l_pobj) aneurysms_14\NNS\14057371
3865016
D005047_D017254 NONE etoposide_4\NN\0 (r_nmod) a_7\NNP\13649268 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) resulted_8\VBD\2633881 (l_prep) in_9\IN\13603305 (l_pobj) eradication_10\NN\7334490 (l_prep) of_11\IN\0 (l_pobj) infiltration_15\NN\975452
D016572_D054218 NONE a_7\NNP\13649268 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (r_nsubjpass) observed_9\VBN\2163746 (l_prep) in_10\IN\13603305 (l_pobj) patient_12\NN\9898892 (l_prep) with_13\IN\0 (l_pobj) leukemia_18\NN\14239918
D016572_D017254 NONE a_7\NNP\13649268 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) resulted_8\VBD\2633881 (l_prep) in_9\IN\13603305 (l_pobj) eradication_10\NN\7334490 (l_prep) of_11\IN\0 (l_pobj) infiltration_15\NN\975452
D005047_D054218 NONE etoposide_4\NN\0 (r_nmod) a_7\NNP\13649268 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (r_nsubjpass) observed_9\VBN\2163746 (l_prep) in_10\IN\13603305 (l_pobj) patient_12\NN\9898892 (l_prep) with_13\IN\0 (l_pobj) leukemia_18\NN\14239918
10791295
D001058_D010554 CID apomorphine_2\NN\3786417 (r_pobj) of_1\IN\0 (r_prep) development_0\NN\248977 (r_nsubj) induced_4\VBN\1627355 (l_dobj) behavior_6\NN\407535
D001058_D010554 CID apomorphine_3\NN\3786417 (r_pobj) of_2\IN\0 (r_prep) development_1\NN\248977 (r_nsubj) induced_5\VBN\1627355 (l_dobj) behavior_14\NN\407535
D001058_D010554 CID apomorphine_5\NN\3786417 (r_compound) treatment_6\NN\654885 (r_nsubj) induced_7\VBD\1627355 (l_dobj) development_10\NN\248977 (l_prep) of_11\IN\0 (l_pobj) behavior_13\NN\407535
D001058_D010554 CID apomorphine_5\NN\3786417 (r_compound) treatment_6\NN\654885 (r_nsubj) induced_7\VBD\1627355 (l_advcl) evidenced_15\VBN\1015244 (l_agent) by_16\IN\0 (l_pobj) intensity_19\NN\5090441 (l_prep) of_20\IN\0 (l_pobj) aggressiveness_21\NN\4835724
D001058_D010554 CID apomorphine_14\NN\3786417 (r_preconj) the_13\DT\0 (r_det) behavior_18\NN\407535
1992636
D009853_D000743 CID omeprazole_7\NN\14778019 (r_pobj) of_6\IN\0 (r_prep) use_5\NN\407535 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) anemia_1\NN\14189204
D009853_D000743 CID omeprazole_17\NN\14778019 (r_pobj) of_16\IN\0 (r_prep) use_15\NN\407535 (r_pobj) with_13\IN\0 (r_prep) reaction_12\NN\13446390 (r_pobj) of_5\IN\0 (r_prep) case_4\NN\7283608 (l_appos) anemia_20\NN\14189204
D009853_D000743 CID omeprazole_4\NN\14778019 (r_nsubj) caused_5\VBD\1617192 (l_ccomp) is_11\VBZ\0 (l_nsubj) anemia_10\NN\14189204
D009853_D053609 CID omeprazole_17\NN\14778019 (r_pobj) with_16\IN\0 (r_prep) starting_14\VBG\457382 (r_pcomp) after_13\IN\0 (r_prep) weakness_3\NN\14462666 (l_conj) lethargy_5\NN\14014621
D009853_D004417 CID omeprazole_17\NN\14778019 (r_pobj) with_16\IN\0 (r_prep) starting_14\VBG\457382 (r_pcomp) after_13\IN\0 (r_prep) weakness_3\NN\14462666 (l_conj) lethargy_5\NN\14014621 (l_conj) shortness_8\NN\5129201 (l_prep) of_9\IN\0 (l_pobj) breath_10\NN\13440063
9660111
D006916_D007035 NONE 5-hydroxytryptophan_22\JJ\0 (r_poss) head_23\NN\5225090 (r_compound) twitches_24\NNS\14360459 (r_dobj) potentiate_20\VB\229605 (r_conj) antagonize_11\VB\1787955 (l_dobj) hypothermia_14\VBN\14034177
D003000_D010554 NONE clonidine_28\NN\2721160 (r_pobj) by_27\IN\0 (r_agent) evoked_26\VBN\1617192 (r_acl) aggressiveness_25\NN\4835724
D014299_D006948 CID tri_0\NNP\0 (r_nsubj) increases_5\VBZ\13576355 (l_dobj) hyperactivity_8\NN\14052403
D003913_D006948 CID amphetamine_13\NN\3248958 (r_pobj) by_10\IN\0 (r_agent) induced_9\VBN\1627355 (r_acl) hyperactivity_8\NN\14052403
D012110_D007035 CID reserpine_13\NN\2721160 (r_compound) hypothermia_14\VBN\14034177
D010656_D010554 NONE phenylephrine_7\NN\2682038 (l_acl) evaluated_15\VBN\670261 (l_conj) aggressiveness_25\NN\4835724
D019257_D006948 CID quinpirole_15\NN\0 (r_conj) amphetamine_13\NN\3248958 (r_pobj) by_10\IN\0 (r_agent) induced_9\VBN\1627355 (r_acl) hyperactivity_8\NN\14052403
D004298_D006948 NONE dopamine_24\NN\14807737 (r_compound) d2_25\NN\0 (r_appos) dipropyloaminotetralin_22\NN\0 (r_conj) quinpirole_15\NN\0 (r_conj) amphetamine_13\NN\3248958 (r_pobj) by_10\IN\0 (r_agent) induced_9\VBN\1627355 (r_acl) hyperactivity_8\NN\14052403
D014299_D007035 NONE tri_4\NNP\0 (r_nsubj) antagonize_11\VB\1787955 (l_dobj) hypothermia_14\VBN\14034177
19211690
D017673_D006973 NONE salt_11\NN\14818238 (r_npadvmod) sensitive_13\JJ\10488309 (r_amod) rats_14\NNS\2329401 (r_pobj) in_9\IN\13603305 (r_prep) upregulation_5\NN\0 (r_conj) hypertension_3\NN\14057371
D000809_D006973 NONE angiotensin_25\NN\4522421 (r_compound) system_26\NN\3575240 (r_pobj) of_20\IN\0 (r_prep) upregulation_19\NN\0 (r_pobj) through_18\IN\0 (r_prep) contributes_1\VBZ\126264 (l_prep) to_2\IN\0 (l_pobj) development_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) hypertension_6\NN\14057371
D013739_D006973 NONE testosterone_0\NN\14747587 (r_npadvmod) dependent_2\JJ\9627906 (r_amod) hypertension_3\NN\14057371
D013739_D006973 NONE testosterone_0\NN\14747587 (r_nsubj) contributes_1\VBZ\126264 (l_prep) to_2\IN\0 (l_pobj) development_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) hypertension_6\NN\14057371
D000809_D007674 NONE angiotensin_25\NN\4522421 (r_compound) system_26\NN\3575240 (r_pobj) of_20\IN\0 (r_prep) upregulation_19\NN\0 (r_pobj) through_18\IN\0 (r_prep) contributes_1\VBZ\126264 (l_prep) to_2\IN\0 (l_pobj) development_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) hypertension_6\NN\14057371 (l_conj) injury_9\NN\14052046
D013739_D007674 NONE testosterone_24\NN\14747587 (r_pobj) by_23\IN\0 (r_agent) mediated_22\VBN\761713 (r_acl) angiotensinogen_21\NN\0 (r_pobj) of_19\IN\0 (r_prep) upregulation_18\NN\0 (r_pobj) in_14\IN\13603305 (r_prep) dimorphism_13\NN\11492833 (l_relcl) causes_27\VBZ\7323922 (l_dobj) increases_28\NNS\13576355 (l_prep) in_29\IN\13603305 (l_pobj) bp_30\NNP\0 (l_conj) injury_33\NN\14052046
D013739_D007674 NONE testosterone_0\NN\14747587 (r_compound) replacement_1\NN\196485 (r_nsubj) increased_6\VBD\169651 (l_npadvmod) bp_7\NNP\0 (l_appos) injury_10\NN\14052046
D013739_D007674 NONE testosterone_0\NN\14747587 (r_nsubj) contributes_1\VBZ\126264 (l_prep) to_2\IN\0 (l_pobj) development_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) hypertension_6\NN\14057371 (l_conj) injury_9\NN\14052046
18410508
D015632_D009422 CID mptp_17\NNP\0 (r_npadvmod) induced_19\VBN\1627355 (r_amod) neurodegeneration_20\NN\0
D015632_D009422 CID mptp_8\NNP\0 (r_conj) meth_6\NNP\2704153 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) damage_3\NN\7296428
D008694_D020258 NONE methamphetamine_0\NN\2704153 (r_npadvmod) induced_2\VBN\1627355 (r_amod) activation_6\NN\13561719 (l_nmod) neurotoxicity_3\NN\0
D008694_D020258 NONE meth_6\NNP\2704153 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) damage_3\NN\7296428 (r_nsubj) is_9\VBZ\0 (l_prep) for_12\IN\0 (l_pobj) system_16\NN\3575240 (l_prep) in_17\IN\13603305 (l_pobj) models_19\NNS\5888929 (l_prep) of_20\IN\0 (l_pobj) neurotoxicity_21\NN\0
D008694_D020258 NONE meth_6\NNP\2704153 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) damage_3\NN\7296428 (r_nsubj) is_9\VBZ\0 (r_advcl) hypothesized_24\VBD\719734 (l_ccomp) plays_28\VBZ\7007684 (l_dobj) role_30\NN\719494 (l_prep) in_31\IN\13603305 (l_pobj) neurotoxicity_35\NN\0
D008694_D020258 NONE meth_32\NNP\2704153 (r_npadvmod) induced_34\VBN\1627355 (r_amod) neurotoxicity_35\NN\0 (r_pobj) in_31\IN\13603305 (r_prep) role_30\NN\719494 (r_dobj) plays_28\VBZ\7007684 (r_ccomp) hypothesized_24\VBD\719734 (l_advcl) is_9\VBZ\0 (l_prep) for_12\IN\0 (l_pobj) system_16\NN\3575240 (l_prep) in_17\IN\13603305 (l_pobj) models_19\NNS\5888929 (l_prep) of_20\IN\0 (l_pobj) neurotoxicity_21\NN\0
D008694_D020258 NONE meth_32\NNP\2704153 (r_npadvmod) induced_34\VBN\1627355 (r_amod) neurotoxicity_35\NN\0
D008694_D020258 NONE meth_25\NNP\2704153 (r_pobj) with_24\IN\0 (r_prep) treated_23\VBN\2376958 (l_conj) examined_27\VBN\0 (l_prep) for_28\IN\0 (l_pobj) neurotoxicity_30\NN\0
D008694_D020258 NONE meth_11\NNP\2704153 (r_compound) neurotoxicity_12\NN\0
D004298_D009422 NONE da_22\NNP\10484858 (r_compound) neurons_23\NNS\5430628 (r_pobj) of_21\IN\0 (r_prep) neurodegeneration_20\NN\0
D004298_D009422 NONE da_14\NNP\10484858 (r_compound) system_16\NN\3575240 (r_pobj) for_12\IN\0 (r_prep) is_9\VBZ\0 (l_nsubj) damage_3\NN\7296428
D004298_D020258 NONE da_14\NNP\10484858 (r_compound) system_16\NN\3575240 (l_prep) in_17\IN\13603305 (l_pobj) models_19\NNS\5888929 (l_prep) of_20\IN\0 (l_pobj) neurotoxicity_21\NN\0
D004298_D020258 NONE da_14\NNP\10484858 (r_compound) system_16\NN\3575240 (r_pobj) for_12\IN\0 (r_prep) is_9\VBZ\0 (r_advcl) hypothesized_24\VBD\719734 (l_ccomp) plays_28\VBZ\7007684 (l_dobj) role_30\NN\719494 (l_prep) in_31\IN\13603305 (l_pobj) neurotoxicity_35\NN\0
D008694_D009422 CID meth_6\NNP\2704153 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) damage_3\NN\7296428
D008694_D009422 CID meth_32\NNP\2704153 (r_npadvmod) induced_34\VBN\1627355 (r_amod) neurotoxicity_35\NN\0 (r_pobj) in_31\IN\13603305 (r_prep) role_30\NN\719494 (r_dobj) plays_28\VBZ\7007684 (r_ccomp) hypothesized_24\VBD\719734 (l_advcl) is_9\VBZ\0 (l_nsubj) damage_3\NN\7296428
D015632_D020258 NONE mptp_8\NNP\0 (r_conj) meth_6\NNP\2704153 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) damage_3\NN\7296428 (r_nsubj) is_9\VBZ\0 (l_prep) for_12\IN\0 (l_pobj) system_16\NN\3575240 (l_prep) in_17\IN\13603305 (l_pobj) models_19\NNS\5888929 (l_prep) of_20\IN\0 (l_pobj) neurotoxicity_21\NN\0
D015632_D020258 NONE mptp_8\NNP\0 (r_conj) meth_6\NNP\2704153 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) damage_3\NN\7296428 (r_nsubj) is_9\VBZ\0 (r_advcl) hypothesized_24\VBD\719734 (l_ccomp) plays_28\VBZ\7007684 (l_dobj) role_30\NN\719494 (l_prep) in_31\IN\13603305 (l_pobj) neurotoxicity_35\NN\0
10743446
D002211_D006930 CID capsaicin_16\NN\15032661 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_acl) effects_1\NNS\13245626 (l_prep) of_2\IN\0 (l_pobj) ketamine_5\NN\3054098 (l_prep) on_8\IN\0 (l_pobj) hyperalgesia_12\NN\0
D002211_D006930 CID capsaicin_30\NN\15032661 (r_pobj) by_29\IN\0 (r_agent) induced_28\VBN\1627355 (r_acl) effect_4\NN\34213 (l_prep) of_5\IN\0 (l_pobj) administration_7\NN\1133281 (l_prep) on_12\IN\0 (l_pobj) hyperalgesia_27\NN\0
D008012_D010146 NONE lidocaine_11\NN\3681148 (r_conj) ketamine_9\NN\3054098 (r_pobj) of_8\IN\0 (r_prep) administration_7\NN\1133281 (l_prep) on_12\IN\0 (l_pobj) hyperalgesia_27\NN\0 (l_nmod) pain_19\NN\14299637
D007649_D006930 NONE ketamine_5\NN\3054098 (l_prep) on_8\IN\0 (l_pobj) hyperalgesia_12\NN\0
D007649_D006930 NONE ketamine_9\NN\3054098 (r_pobj) of_8\IN\0 (r_prep) administration_7\NN\1133281 (l_prep) on_12\IN\0 (l_pobj) hyperalgesia_27\NN\0
D007649_D006930 NONE ketamine_0\NN\3054098 (r_nsubj) reduced_1\VBD\441445 (l_dobj) area_4\NN\8630985 (l_prep) of_5\IN\0 (l_pobj) hyperalgesia_13\NN\0
D007649_D006930 NONE ketamine_4\NN\3054098 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_prep) on_7\IN\0 (l_pobj) hyperalgesia_11\NN\0
D007649_D006930 NONE ketamine_4\NN\3054098 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubj) suggest_12\VBP\1010118 (l_ccomp) mediated_20\VBN\761713 (l_nsubjpass) types_16\NNS\5839024 (l_prep) of_17\IN\0 (l_pobj) hyperalgesia_18\NN\0
D008012_D006930 NONE lidocaine_7\NN\3681148 (r_conj) ketamine_5\NN\3054098 (l_prep) on_8\IN\0 (l_pobj) hyperalgesia_12\NN\0
D008012_D006930 NONE lidocaine_11\NN\3681148 (r_conj) ketamine_9\NN\3054098 (r_pobj) of_8\IN\0 (r_prep) administration_7\NN\1133281 (l_prep) on_12\IN\0 (l_pobj) hyperalgesia_27\NN\0
D008012_D006930 NONE lidocaine_0\NN\3681148 (r_nsubj) reduced_1\VBD\441445 (l_dobj) area_3\NN\8630985 (l_prep) of_4\IN\0 (l_pobj) hyperalgesia_8\NN\0
D008012_D006930 NONE lidocaine_6\NN\3681148 (r_conj) ketamine_4\NN\3054098 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_prep) on_7\IN\0 (l_pobj) hyperalgesia_11\NN\0
D008012_D006930 NONE lidocaine_6\NN\3681148 (r_conj) ketamine_4\NN\3054098 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubj) suggest_12\VBP\1010118 (l_ccomp) mediated_20\VBN\761713 (l_nsubjpass) types_16\NNS\5839024 (l_prep) of_17\IN\0 (l_pobj) hyperalgesia_18\NN\0
D002211_D010146 CID capsaicin_30\NN\15032661 (r_pobj) by_29\IN\0 (r_agent) induced_28\VBN\1627355 (r_acl) effect_4\NN\34213 (l_prep) of_5\IN\0 (l_pobj) administration_7\NN\1133281 (l_prep) on_12\IN\0 (l_pobj) hyperalgesia_27\NN\0 (l_nmod) pain_19\NN\14299637
D007649_D010146 NONE ketamine_9\NN\3054098 (r_pobj) of_8\IN\0 (r_prep) administration_7\NN\1133281 (l_prep) on_12\IN\0 (l_pobj) hyperalgesia_27\NN\0 (l_nmod) pain_19\NN\14299637
D007649_D010146 NONE ketamine_0\NN\3054098 (r_nsubj) reduced_1\VBD\441445 (l_conj) tended_17\VBD\2604760 (l_xcomp) reduce_19\VB\441445 (l_dobj) pain_23\NN\14299637
18442015
D004872_D014456 CID d2_47\NN\0 (r_pobj) of_45\IN\0 (r_prep) coadministration_44\NN\0 (r_pobj) by_43\IN\0 (r_prep) induced_42\VBN\1627355 (l_nsubj) release_20\NN\3748886 (l_conj) peroxide_23\NN\14780040 (l_appos) permeability_31\NN\4940146 (l_prep) in_32\IN\13603305 (l_pcomp) modulating_33\VBG\1724459 (l_dobj) hemorrhage_35\NN\14285662 (l_conj) ulcer_37\NN\14211294
D002784_D050197 CID cholesterol_49\NN\15058310 (r_conj) d2_47\NN\0 (r_pobj) of_45\IN\0 (r_prep) coadministration_44\NN\0 (r_pobj) by_43\IN\0 (r_prep) induced_42\VBN\1627355 (l_nsubj) release_20\NN\3748886 (l_conj) peroxide_23\NN\14780040 (l_appos) permeability_31\NN\4940146 (l_prep) in_32\IN\13603305 (l_pcomp) modulating_33\VBG\1724459 (l_dobj) hemorrhage_35\NN\14285662 (l_prep) in_38\IN\13603305 (l_pobj) rats_39\NNS\2329401 (l_prep) with_40\IN\0 (l_pobj) atherosclerosis_41\NN\14108324
D002784_D050197 CID cholesterol_23\NN\15058310 (r_conj) d2_21\NN\0 (r_dobj) containing_19\VBG\2632940 (l_advcl) induce_25\VB\1627355 (l_dobj) atherosclerosis_26\NN\14108324
D002784_D050197 CID cholesterol_10\NN\15058310 (r_conj) calcium_7\NN\14625458 (r_pobj) as_5\IN\14622893 (r_prep) parameters_2\NNS\5858936 (l_amod) atherosclerotic_1\JJ\0
D002784_D050197 CID cholesterol_10\NN\15058310 (r_conj) calcium_7\NN\14625458 (r_pobj) as_5\IN\14622893 (r_prep) parameters_2\NNS\5858936 (r_nsubjpass) obtained_18\VBN\2210855 (l_prep) in_19\IN\13603305 (l_pobj) rats_21\NNS\2329401 (l_amod) atherosclerotic_20\JJ\0
D002118_D050197 NONE calcium_7\NN\14625458 (r_pobj) as_5\IN\14622893 (r_prep) parameters_2\NNS\5858936 (l_amod) atherosclerotic_1\JJ\0
D002118_D050197 NONE calcium_7\NN\14625458 (r_pobj) as_5\IN\14622893 (r_prep) parameters_2\NNS\5858936 (r_nsubjpass) obtained_18\VBN\2210855 (l_prep) in_19\IN\13603305 (l_pobj) rats_21\NNS\2329401 (l_amod) atherosclerotic_20\JJ\0
D006632_D050197 NONE histamine_19\NN\14739004 (r_compound) release_20\NN\3748886 (l_conj) peroxide_23\NN\14780040 (l_appos) permeability_31\NN\4940146 (l_prep) in_32\IN\13603305 (l_pcomp) modulating_33\VBG\1724459 (l_dobj) hemorrhage_35\NN\14285662 (l_prep) in_38\IN\13603305 (l_pobj) rats_39\NNS\2329401 (l_prep) with_40\IN\0 (l_pobj) atherosclerosis_41\NN\14108324
D006632_D050197 NONE histamine_6\NN\14739004 (r_pobj) of_5\IN\0 (r_prep) correlation_4\NN\13841213 (r_nsubjpass) found_14\VBN\13279262 (l_prep) in_15\IN\13603305 (l_pobj) rats_18\NNS\2329401 (l_amod) atherosclerotic_17\JJ\0
D006632_D050197 NONE histamine_18\NN\14739004 (r_compound) release_19\NN\3748886 (r_conj) generation_16\NN\7942152 (l_ccomp) produce_2\VB\7555863 (l_nsubj) atherosclerosis_0\NN\14108324
D010634_D014456 NONE luminal_16\JJ\2792049 (r_amod) content_18\NN\7951464 (l_conj) areas_21\NNS\8630985 (l_compound) ulcer_20\NN\14211294
D010634_D014456 NONE luminal_22\JJ\2792049 (r_amod) content_24\NN\7951464 (r_conj) generation_20\NN\7942152 (r_conj) release_17\NN\3748886 (r_conj) diffusion_14\NN\13518963 (r_pobj) including_9\VBG\0 (r_prep) factors_7\NNS\7326557 (r_pobj) with_4\IN\0 (r_prep) accompanied_3\VBN\0 (l_nsubj) ulcers_2\NNS\14211294
D006632_D014456 NONE histamine_19\NN\14739004 (r_compound) release_20\NN\3748886 (l_conj) peroxide_23\NN\14780040 (l_appos) permeability_31\NN\4940146 (l_prep) in_32\IN\13603305 (l_pcomp) modulating_33\VBG\1724459 (l_dobj) hemorrhage_35\NN\14285662 (l_conj) ulcer_37\NN\14211294
D006632_D014456 NONE histamine_10\NN\14739004 (r_compound) concentration_11\NN\4916342 (l_conj) permeability_14\NN\4940146 (l_conj) content_18\NN\7951464 (l_conj) areas_21\NNS\8630985 (l_compound) ulcer_20\NN\14211294
D006632_D014456 NONE histamine_16\NN\14739004 (r_compound) release_17\NN\3748886 (r_conj) diffusion_14\NN\13518963 (r_pobj) including_9\VBG\0 (r_prep) factors_7\NNS\7326557 (r_pobj) with_4\IN\0 (r_prep) accompanied_3\VBN\0 (l_nsubj) ulcers_2\NNS\14211294
D006632_D014456 NONE histamine_6\NN\14739004 (r_pobj) of_5\IN\0 (r_prep) correlation_4\NN\13841213 (l_prep) to_7\IN\0 (l_conj) to_11\IN\0 (l_pobj) ulcer_12\NN\14211294
D006632_D014456 NONE histamine_18\NN\14739004 (r_compound) release_19\NN\3748886 (r_conj) generation_16\NN\7942152 (l_ccomp) produce_2\VB\7555863 (l_dobj) ulcer_5\NN\14211294
D002784_D014456 CID cholesterol_49\NN\15058310 (r_conj) d2_47\NN\0 (r_pobj) of_45\IN\0 (r_prep) coadministration_44\NN\0 (r_pobj) by_43\IN\0 (r_prep) induced_42\VBN\1627355 (l_nsubj) release_20\NN\3748886 (l_conj) peroxide_23\NN\14780040 (l_appos) permeability_31\NN\4940146 (l_prep) in_32\IN\13603305 (l_pcomp) modulating_33\VBG\1724459 (l_dobj) hemorrhage_35\NN\14285662 (l_conj) ulcer_37\NN\14211294
D004872_D006471 CID d2_47\NN\0 (r_pobj) of_45\IN\0 (r_prep) coadministration_44\NN\0 (r_pobj) by_43\IN\0 (r_prep) induced_42\VBN\1627355 (l_nsubj) release_20\NN\3748886 (l_conj) peroxide_23\NN\14780040 (l_appos) permeability_31\NN\4940146 (l_prep) in_32\IN\13603305 (l_pcomp) modulating_33\VBG\1724459 (l_dobj) hemorrhage_35\NN\14285662
D014700_D050197 NONE verapamil_3\NN\2938514 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) on_4\IN\0 (l_pobj) ulcers_7\NNS\14211294 (l_prep) in_8\IN\13603305 (l_pobj) rats_11\NNS\2329401 (l_amod) atherosclerotic_10\JJ\0
D014700_D050197 NONE verapamil_28\NN\2938514 (r_pobj) by_27\IN\0 (r_agent) ameliorated_26\VBN\126264 (r_relcl) generation_16\NN\7942152 (l_ccomp) produce_2\VB\7555863 (l_nsubj) atherosclerosis_0\NN\14108324
D002784_D006471 CID cholesterol_49\NN\15058310 (r_conj) d2_47\NN\0 (r_pobj) of_45\IN\0 (r_prep) coadministration_44\NN\0 (r_pobj) by_43\IN\0 (r_prep) induced_42\VBN\1627355 (l_nsubj) release_20\NN\3748886 (l_conj) peroxide_23\NN\14780040 (l_appos) permeability_31\NN\4940146 (l_prep) in_32\IN\13603305 (l_pcomp) modulating_33\VBG\1724459 (l_dobj) hemorrhage_35\NN\14285662
D014700_D006471 NONE verapamil_3\NN\2938514 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) on_4\IN\0 (l_pobj) ulcers_7\NNS\14211294 (l_amod) hemorrhagic_6\JJ\0
D014700_D006471 NONE verapamil_15\NN\2938514 (r_pobj) by_12\IN\0 (r_agent) ameliorated_11\VBN\126264 (r_acomp) were_7\VBD\0 (l_nsubj) ulcer_2\NN\14211294 (l_amod) hemorrhagic_1\JJ\0
D014700_D006471 NONE verapamil_28\NN\2938514 (r_pobj) by_27\IN\0 (r_agent) ameliorated_26\VBN\126264 (r_relcl) generation_16\NN\7942152 (l_ccomp) produce_2\VB\7555863 (l_dobj) ulcer_5\NN\14211294 (l_amod) hemorrhagic_4\JJ\0
D004872_D050197 CID d2_47\NN\0 (r_pobj) of_45\IN\0 (r_prep) coadministration_44\NN\0 (r_pobj) by_43\IN\0 (r_prep) induced_42\VBN\1627355 (l_nsubj) release_20\NN\3748886 (l_conj) peroxide_23\NN\14780040 (l_appos) permeability_31\NN\4940146 (l_prep) in_32\IN\13603305 (l_pcomp) modulating_33\VBG\1724459 (l_dobj) hemorrhage_35\NN\14285662 (l_prep) in_38\IN\13603305 (l_pobj) rats_39\NNS\2329401 (l_prep) with_40\IN\0 (l_pobj) atherosclerosis_41\NN\14108324
D004872_D050197 CID d2_21\NN\0 (r_dobj) containing_19\VBG\2632940 (l_advcl) induce_25\VB\1627355 (l_dobj) atherosclerosis_26\NN\14108324
D006632_D006471 NONE histamine_19\NN\14739004 (r_compound) release_20\NN\3748886 (l_conj) peroxide_23\NN\14780040 (l_appos) permeability_31\NN\4940146 (l_prep) in_32\IN\13603305 (l_pcomp) modulating_33\VBG\1724459 (l_dobj) hemorrhage_35\NN\14285662
D006632_D006471 NONE histamine_6\NN\14739004 (r_pobj) of_5\IN\0 (r_prep) correlation_4\NN\13841213 (l_prep) to_7\IN\0 (l_pobj) hemorrhage_9\NN\14285662
D006632_D006471 NONE histamine_18\NN\14739004 (r_compound) release_19\NN\3748886 (r_conj) generation_16\NN\7942152 (l_ccomp) produce_2\VB\7555863 (l_dobj) ulcer_5\NN\14211294 (l_amod) hemorrhagic_4\JJ\0
D014700_D014456 NONE verapamil_3\NN\2938514 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) on_4\IN\0 (l_pobj) ulcers_7\NNS\14211294
D014700_D014456 NONE verapamil_6\NN\2938514 (r_pobj) of_5\IN\0 (r_prep) effect_4\NN\34213 (l_prep) on_7\IN\0 (l_pobj) model_10\NN\5888929 (l_compound) ulcer_9\NN\14211294
D014700_D014456 NONE verapamil_15\NN\2938514 (r_pobj) by_12\IN\0 (r_agent) ameliorated_11\VBN\126264 (r_acomp) were_7\VBD\0 (l_nsubj) ulcer_2\NN\14211294
D014700_D014456 NONE verapamil_28\NN\2938514 (r_pobj) by_27\IN\0 (r_agent) ameliorated_26\VBN\126264 (r_relcl) generation_16\NN\7942152 (l_ccomp) produce_2\VB\7555863 (l_dobj) ulcer_5\NN\14211294
6286738
D002762_D054559 CID d3_5\NNP\0 (r_pobj) of_3\IN\0 (r_prep) doses_2\NNS\3740161 (r_nsubjpass) associated_18\VBN\628491 (l_prep) with_19\IN\0 (l_pobj) hypercalcemia_21\NN\14299637 (l_conj) hyperphosphatemia_23\NN\0
D002762_D054559 CID d3_15\NNP\0 (r_appos) doses_2\NNS\3740161 (r_nsubjpass) associated_18\VBN\628491 (l_prep) with_19\IN\0 (l_pobj) hypercalcemia_21\NN\14299637 (l_conj) hyperphosphatemia_23\NN\0
D002762_D054559 CID d3_30\NNP\0 (r_pobj) of_28\IN\0 (r_prep) increases_27\NNS\13576355 (r_conj) hyperphosphatemia_23\NN\0
D002762_D064420 NONE d3_1\NN\0 (r_compound) toxicity_2\NN\13576101
D002762_D064420 NONE d3_3\NNP\0 (r_compound) toxicity_4\NN\13576101
D002762_D064420 NONE d3_3\NNP\0 (r_compound) toxicity_4\NN\13576101 (r_pobj) of_1\IN\0 (r_prep) signs_0\NNS\6643763 (r_nsubjpass) observed_7\VBN\2163746 (r_ccomp) developed_18\VBN\1753788 (l_dobj) signs_20\NNS\6643763 (l_prep) of_21\IN\0 (l_pobj) toxicity_24\NN\13576101
D002762_D064420 NONE d3_23\NNP\0 (r_compound) toxicity_24\NN\13576101 (r_pobj) of_21\IN\0 (r_prep) signs_20\NNS\6643763 (r_dobj) developed_18\VBN\1753788 (l_ccomp) observed_7\VBN\2163746 (l_nsubjpass) signs_0\NNS\6643763 (l_prep) of_1\IN\0 (l_pobj) toxicity_4\NN\13576101
D002762_D064420 NONE d3_23\NNP\0 (r_compound) toxicity_24\NN\13576101
D002762_D064420 NONE d3_7\NN\0 (r_pobj) of_5\IN\0 (r_prep) toxicity_4\NN\13576101
D002762_D064420 NONE d3_22\NNP\0 (r_pobj) of_20\IN\0 (r_prep) doses_19\NNS\3740161 (r_pobj) between_18\IN\0 (r_prep) safety_17\NN\13920835 (r_pobj) of_16\IN\0 (r_prep) margin_15\NN\13903079 (r_conj) toxicity_4\NN\13576101
D002762_D064420 NONE d3_38\NNP\0 (r_nsubjpass) used_42\VBN\0 (r_ccomp) concluded_35\VBD\628491 (l_prep) because_0\IN\0 (l_pobj) toxicity_4\NN\13576101
D002762_D010319 NONE d3_7\NNP\0 (r_pobj) with_5\IN\0 (r_prep) treated_4\VBN\2376958 (r_acl) cows_3\NNS\2402010 (r_pobj) of_1\IN\0 (r_prep) none_0\NN\15228378 (r_nsubj) showed_8\VBD\2137132 (l_dobj) signs_9\NNS\6643763 (l_prep) of_10\IN\0 (l_pobj) fever_12\NN\14299637
D002762_D010319 NONE d3_7\NNP\0 (r_pobj) with_5\IN\0 (r_prep) treated_4\VBN\2376958 (r_acl) cows_3\NNS\2402010 (r_pobj) of_1\IN\0 (r_prep) none_0\NN\15228378 (r_nsubj) showed_8\VBD\2137132 (r_ccomp) developed_26\VBD\1753788 (l_dobj) signs_28\NNS\6643763 (l_prep) of_29\IN\0 (l_pobj) fever_31\NN\14299637
D002762_D010319 NONE d3_7\NN\0 (r_pobj) of_5\IN\0 (r_prep) toxicity_4\NN\13576101 (l_conj) margin_15\NN\13903079 (l_prep) of_16\IN\0 (l_pobj) safety_17\NN\13920835 (l_prep) between_18\IN\0 (l_pobj) doses_19\NNS\3740161 (l_prep) of_20\IN\0 (l_pobj) d3_22\NNP\0 (l_relcl) prevent_24\VBP\0 (l_dobj) fever_26\NN\14299637
D002762_D010319 NONE d3_7\NN\0 (r_pobj) of_5\IN\0 (r_prep) toxicity_4\NN\13576101 (l_conj) margin_15\NN\13903079 (l_prep) of_16\IN\0 (l_pobj) safety_17\NN\13920835 (l_prep) between_18\IN\0 (l_pobj) doses_19\NNS\3740161 (l_prep) of_20\IN\0 (l_pobj) d3_22\NNP\0 (l_relcl) prevent_24\VBP\0 (l_dobj) fever_26\NN\14299637 (l_relcl) induce_30\VBP\1627355 (l_dobj) fever_32\NN\14299637
D002762_D010319 NONE d3_7\NN\0 (r_pobj) of_5\IN\0 (r_prep) toxicity_4\NN\13576101 (r_pobj) because_0\IN\0 (r_prep) concluded_35\VBD\628491 (l_ccomp) used_42\VBN\0 (l_xcomp) prevent_45\VB\0 (l_dobj) fever_47\NN\14299637
D002762_D010319 NONE d3_22\NNP\0 (l_relcl) prevent_24\VBP\0 (l_dobj) fever_26\NN\14299637
D002762_D010319 NONE d3_22\NNP\0 (l_relcl) prevent_24\VBP\0 (l_dobj) fever_26\NN\14299637 (l_relcl) induce_30\VBP\1627355 (l_dobj) fever_32\NN\14299637
D002762_D010319 NONE d3_22\NNP\0 (r_pobj) of_20\IN\0 (r_prep) doses_19\NNS\3740161 (r_pobj) between_18\IN\0 (r_prep) safety_17\NN\13920835 (r_pobj) of_16\IN\0 (r_prep) margin_15\NN\13903079 (r_conj) toxicity_4\NN\13576101 (r_pobj) because_0\IN\0 (r_prep) concluded_35\VBD\628491 (l_ccomp) used_42\VBN\0 (l_xcomp) prevent_45\VB\0 (l_dobj) fever_47\NN\14299637
D002762_D010319 NONE d3_38\NNP\0 (r_nsubjpass) used_42\VBN\0 (r_ccomp) concluded_35\VBD\628491 (l_prep) because_0\IN\0 (l_pobj) toxicity_4\NN\13576101 (l_conj) margin_15\NN\13903079 (l_prep) of_16\IN\0 (l_pobj) safety_17\NN\13920835 (l_prep) between_18\IN\0 (l_pobj) doses_19\NNS\3740161 (l_prep) of_20\IN\0 (l_pobj) d3_22\NNP\0 (l_relcl) prevent_24\VBP\0 (l_dobj) fever_26\NN\14299637
D002762_D010319 NONE d3_38\NNP\0 (r_nsubjpass) used_42\VBN\0 (r_ccomp) concluded_35\VBD\628491 (l_prep) because_0\IN\0 (l_pobj) toxicity_4\NN\13576101 (l_conj) margin_15\NN\13903079 (l_prep) of_16\IN\0 (l_pobj) safety_17\NN\13920835 (l_prep) between_18\IN\0 (l_pobj) doses_19\NNS\3740161 (l_prep) of_20\IN\0 (l_pobj) d3_22\NNP\0 (l_relcl) prevent_24\VBP\0 (l_dobj) fever_26\NN\14299637 (l_relcl) induce_30\VBP\1627355 (l_dobj) fever_32\NN\14299637
D002762_D010319 NONE d3_38\NNP\0 (r_nsubjpass) used_42\VBN\0 (l_xcomp) prevent_45\VB\0 (l_dobj) fever_47\NN\14299637
D002762_D006934 CID d3_5\NNP\0 (r_pobj) of_3\IN\0 (r_prep) doses_2\NNS\3740161 (r_nsubjpass) associated_18\VBN\628491 (l_prep) with_19\IN\0 (l_pobj) hypercalcemia_21\NN\14299637
D002762_D006934 CID d3_15\NNP\0 (r_appos) doses_2\NNS\3740161 (r_nsubjpass) associated_18\VBN\628491 (l_prep) with_19\IN\0 (l_pobj) hypercalcemia_21\NN\14299637
D002762_D006934 CID d3_30\NNP\0 (r_pobj) of_28\IN\0 (r_prep) increases_27\NNS\13576355 (r_conj) hyperphosphatemia_23\NN\0 (r_conj) hypercalcemia_21\NN\14299637
603022
D005702_D062787 NONE hydrobromide_1\RB\0 (r_nsubjpass) used_16\VBN\0 (l_prep) in_17\IN\13603305 (l_pobj) patient_19\JJ\9898892 (l_acl) demonstrating_20\NN\2137132 (l_dobj) effects_22\NNS\13245626 (l_prep) of_23\IN\0 (l_pobj) overdosage_28\NN\0
D012601_D062787 CID scopolamine_24\NN\14712692 (r_nmod) overdosage_28\NN\0
D012601_D062787 CID hyoscine_26\NN\14712692 (r_nmod) overdosage_28\NN\0
1601297
D003042_D009203 CID cocaine_3\NN\3492717 (r_compound) abusers_4\NNS\9633969 (r_pobj) of_1\IN\0 (r_prep) eleven_0\CD\13745420 (r_nsubj) had_10\VBD\0 (l_dobj) evidence_12\NN\5816287 (l_prep) of_13\IN\0 (l_pobj) injury_16\NN\14052046 (l_acl) defined_17\VBN\2604760 (l_prep) as_18\IN\14622893 (l_pobj) infarction_20\NN\14204950
D003042_D007511 NONE cocaine_3\NN\3492717 (r_compound) abusers_4\NNS\9633969 (r_pobj) of_1\IN\0 (r_prep) eleven_0\CD\13745420 (r_nsubj) had_10\VBD\0 (l_dobj) evidence_12\NN\5816287 (l_prep) of_13\IN\0 (l_pobj) injury_16\NN\14052046 (l_acl) defined_17\VBN\2604760 (l_prep) as_18\IN\14622893 (l_pobj) infarction_20\NN\14204950 (l_conj) ischemia_22\NN\14195315
D003042_D012559 NONE cocaine_7\NN\3492717 (r_npadvmod) abusing_9\VBG\2514187 (r_amod) patients_10\NNS\9898892 (r_pobj) of_5\IN\0 (r_prep) ecg_3\NNP\7000195 (r_appos) electrocardiograms_1\NNS\7000195 (r_nsubjpass) compared_12\VBN\644583 (l_prep) with_13\IN\0 (l_pobj) ecgs_15\NNS\7000195 (l_prep) of_16\IN\0 (l_pobj) controls_19\NNS\5190804 (l_amod) schizophrenic_18\JJ\10490141
D003042_D009202 NONE cocaine_8\NN\3492717 (r_compound) abusers_9\NNS\9633969 (r_pobj) in_5\IN\13603305 (r_prep) injury_4\NN\14052046
D003042_D009202 NONE cocaine_3\NN\3492717 (r_compound) abusers_4\NNS\9633969 (r_pobj) of_1\IN\0 (r_prep) eleven_0\CD\13745420 (r_nsubj) had_10\VBD\0 (l_dobj) evidence_12\NN\5816287 (l_prep) of_13\IN\0 (l_pobj) injury_16\NN\14052046
D003042_D002037 CID cocaine_3\NN\3492717 (r_compound) abusers_4\NNS\9633969 (r_pobj) of_1\IN\0 (r_prep) eleven_0\CD\13745420 (r_nsubj) had_10\VBD\0 (l_dobj) evidence_12\NN\5816287 (l_prep) of_13\IN\0 (l_pobj) injury_16\NN\14052046 (l_acl) defined_17\VBN\2604760 (l_prep) as_18\IN\14622893 (l_pobj) infarction_20\NN\14204950 (l_conj) ischemia_22\NN\14195315 (l_conj) block_27\NN\21939
8643971
D017239_D064420 NONE paclitaxel_16\NN\0 (r_compound) doses_17\NNS\3740161 (r_pobj) of_14\IN\0 (r_prep) response_11\NN\11410625 (l_conj) toxicity_13\NN\13576101
D017239_D064420 NONE paclitaxel_5\NN\0 (r_compound) doses_6\NNS\3740161 (r_dobj) incorporate_3\VBP\1461328 (l_conj) permitted_17\VBN\797697 (l_advcl) permits_20\VBZ\6479665 (l_nsubj) toxicity_19\NN\13576101
D002945_D064420 NONE cisplatin_23\NN\0 (r_pobj) with_19\IN\0 (r_prep) combined_18\VBN\2630189 (r_acl) doses_17\NNS\3740161 (r_pobj) of_14\IN\0 (r_prep) response_11\NN\11410625 (l_conj) toxicity_13\NN\13576101
D017239_D006258 NONE paclitaxel_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) study_5\NN\635850 (r_dobj) phase_1\NN\15113229 (l_conj) cisplatin_9\NN\0 (l_prep) as_10\IN\14622893 (l_pobj) therapy_14\NN\657604 (l_prep) for_15\IN\0 (l_pobj) cancers_19\NNS\14239425
D017239_D006258 NONE paclitaxel_13\NN\0 (r_pobj) of_9\IN\0 (r_prep) study_8\NN\635850 (r_pobj) of_2\IN\0 (r_prep) results_1\NNS\34213 (r_nsubj) reported_27\VBD\831651 (l_dobj) rate_32\NN\13815152 (l_prep) in_33\IN\13603305 (l_pobj) patients_34\NNS\9898892 (l_prep) with_35\IN\0 (l_pobj) cancer_39\NN\14239425
D017239_D006258 NONE taxol_15\NNP\0 (r_appos) paclitaxel_13\NN\0 (r_pobj) of_9\IN\0 (r_prep) study_8\NN\635850 (r_pobj) of_2\IN\0 (r_prep) results_1\NNS\34213 (r_nsubj) reported_27\VBD\831651 (l_dobj) rate_32\NN\13815152 (l_prep) in_33\IN\13603305 (l_pobj) patients_34\NNS\9898892 (l_prep) with_35\IN\0 (l_pobj) cancer_39\NN\14239425
D017239_D006258 NONE paclitaxel_43\NN\0 (r_nmod) combination_46\NN\7951464 (r_nsubjpass) used_49\VBN\0 (r_conj) reported_27\VBD\831651 (l_dobj) rate_32\NN\13815152 (l_prep) in_33\IN\13603305 (l_pobj) patients_34\NNS\9898892 (l_prep) with_35\IN\0 (l_pobj) cancer_39\NN\14239425
D017239_D006258 NONE paclitaxel_16\NN\0 (r_compound) doses_17\NNS\3740161 (l_acl) combined_18\VBN\2630189 (l_prep) with_24\IN\0 (l_pobj) support_30\NN\407535 (l_prep) in_31\IN\13603305 (l_pobj) patients_32\NNS\9898892 (l_prep) with_33\IN\0 (l_pobj) head_38\NN\5225090 (l_conj) carcinoma_41\NN\14239918
D017239_D006258 NONE paclitaxel_0\NNP\0 (r_nsubj) is_3\VBZ\0 (l_attr) regimen_9\NN\5898568 (l_prep) for_10\IN\0 (l_pobj) head_13\NN\5225090 (l_conj) cancer_16\NN\14239425
D017239_D010051 NONE paclitaxel_13\NN\0 (r_pobj) of_9\IN\0 (r_prep) study_8\NN\635850 (r_pobj) of_2\IN\0 (r_prep) results_1\NNS\34213 (r_nsubj) reported_27\VBD\831651 (l_conj) used_49\VBN\0 (l_conj) improved_54\VBN\126264 (l_dobj) duration_57\NN\15113229 (l_prep) in_58\IN\13603305 (l_pobj) patients_61\NNS\9898892 (l_compound) cancer_60\NN\14239425
D017239_D010051 NONE taxol_15\NNP\0 (r_appos) paclitaxel_13\NN\0 (r_pobj) of_9\IN\0 (r_prep) study_8\NN\635850 (r_pobj) of_2\IN\0 (r_prep) results_1\NNS\34213 (r_nsubj) reported_27\VBD\831651 (l_conj) used_49\VBN\0 (l_conj) improved_54\VBN\126264 (l_dobj) duration_57\NN\15113229 (l_prep) in_58\IN\13603305 (l_pobj) patients_61\NNS\9898892 (l_compound) cancer_60\NN\14239425
D017239_D010051 NONE paclitaxel_43\NN\0 (r_nmod) combination_46\NN\7951464 (r_nsubjpass) used_49\VBN\0 (l_conj) improved_54\VBN\126264 (l_dobj) duration_57\NN\15113229 (l_prep) in_58\IN\13603305 (l_pobj) patients_61\NNS\9898892 (l_compound) cancer_60\NN\14239425
D002945_D010051 NONE cisplatin_45\NN\0 (r_compound) combination_46\NN\7951464 (r_nsubjpass) used_49\VBN\0 (l_conj) improved_54\VBN\126264 (l_dobj) duration_57\NN\15113229 (l_prep) in_58\IN\13603305 (l_pobj) patients_61\NNS\9898892 (l_compound) cancer_60\NN\14239425
D002945_D006258 NONE cisplatin_9\NN\0 (l_prep) as_10\IN\14622893 (l_pobj) therapy_14\NN\657604 (l_prep) for_15\IN\0 (l_pobj) cancers_19\NNS\14239425
D002945_D006258 NONE cisplatin_45\NN\0 (r_compound) combination_46\NN\7951464 (r_nsubjpass) used_49\VBN\0 (r_conj) reported_27\VBD\831651 (l_dobj) rate_32\NN\13815152 (l_prep) in_33\IN\13603305 (l_pobj) patients_34\NNS\9898892 (l_prep) with_35\IN\0 (l_pobj) cancer_39\NN\14239425
D002945_D006258 NONE cisplatin_23\NN\0 (r_pobj) with_19\IN\0 (r_prep) combined_18\VBN\2630189 (l_prep) with_24\IN\0 (l_pobj) support_30\NN\407535 (l_prep) in_31\IN\13603305 (l_pobj) patients_32\NNS\9898892 (l_prep) with_33\IN\0 (l_pobj) head_38\NN\5225090 (l_conj) carcinoma_41\NN\14239918
D002945_D006258 NONE cisplatin_2\NN\0 (r_advmod) is_3\VBZ\0 (l_attr) regimen_9\NN\5898568 (l_prep) for_10\IN\0 (l_pobj) head_13\NN\5225090 (l_conj) cancer_16\NN\14239425
9523805
D008012_D009422 CID lidocaine_16\NN\3681148 (r_pobj) with_15\IN\0 (r_prep) than_14\IN\0 (r_prep) incidence_9\NN\13821570 (r_appos) symptoms_2\NNS\5823932
D008012_D009422 CID lidocaine_12\NN\3681148 (r_amod) anesthesia_14\NN\14034177 (r_dobj) follow_11\VBP\1835496 (l_nsubj) symptoms_6\NNS\5823932
D008012_D009422 CID lidocaine_12\NN\3681148 (r_amod) anesthesia_14\NN\14034177 (r_dobj) follow_11\VBP\1835496 (l_nsubj) symptoms_6\NNS\5823932 (l_appos) tnss_8\NNS\0
D008012_D009422 CID lidocaine_13\NN\3681148 (l_conj) bupivacaine_15\NN\0 (l_prep) with_16\IN\0 (l_pobj) respect_17\NN\5817845 (l_prep) to_18\IN\0 (l_pobj) duration_19\NN\15113229 (l_prep) of_20\IN\0 (l_pobj) action_21\NN\30358 (l_conj) risk_24\NN\14541044 (l_prep) of_25\IN\0 (l_pobj) tnss_26\NNS\0
D008012_D009422 CID lidocaine_6\NN\3681148 (r_dobj) receiving_5\VBG\2210855 (l_dobj) tnss_8\NNS\0
D008012_D009422 CID lidocaine_6\NN\3681148 (r_dobj) receiving_5\VBG\2210855 (r_acl) patients_4\NNS\9898892 (r_nsubj) had_21\VBD\0 (l_conj) had_31\VBD\0 (l_dobj) tnss_32\NNS\0
D008012_D009422 CID lidocaine_5\NN\3681148 (r_xcomp) preferable_3\JJ\0 (r_acomp) be_2\VB\14625458 (l_advcl) has_12\VBZ\13888491 (l_dobj) duration_15\NN\15113229 (l_conj) incidence_21\NN\13821570 (l_prep) of_22\IN\0 (l_pobj) tnss_23\NNS\0
D011318_D009422 CID prilocaine_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_appos) symptoms_2\NNS\5823932
D011318_D009422 CID prilocaine_11\JJ\0 (l_prep) with_12\IN\0 (l_pobj) lidocaine_13\NN\3681148 (l_conj) bupivacaine_15\NN\0 (l_prep) with_16\IN\0 (l_pobj) respect_17\NN\5817845 (l_prep) to_18\IN\0 (l_pobj) duration_19\NN\15113229 (l_prep) of_20\IN\0 (l_pobj) action_21\NN\30358 (l_conj) risk_24\NN\14541044 (l_prep) of_25\IN\0 (l_pobj) tnss_26\NNS\0
D011318_D009422 CID prilocaine_15\NN\0 (r_dobj) receiving_14\VBG\2210855 (r_acl) patients_13\NNS\9898892 (r_nsubj) had_21\VBD\0 (l_nsubj) patients_4\NNS\9898892 (l_acl) receiving_5\VBG\2210855 (l_dobj) tnss_8\NNS\0
D011318_D009422 CID prilocaine_15\NN\0 (r_dobj) receiving_14\VBG\2210855 (r_acl) patients_13\NNS\9898892 (r_nsubj) had_21\VBD\0 (l_conj) had_31\VBD\0 (l_dobj) tnss_32\NNS\0
D011318_D009422 CID prilocaine_0\NNP\0 (r_nsubj) be_2\VB\14625458 (l_advcl) has_12\VBZ\13888491 (l_dobj) duration_15\NN\15113229 (l_conj) incidence_21\NN\13821570 (l_prep) of_22\IN\0 (l_pobj) tnss_23\NNS\0
D002045_D009422 NONE bupivacaine_13\NN\0 (r_conj) prilocaine_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_appos) symptoms_2\NNS\5823932
D002045_D009422 NONE bupivacaine_19\NN\0 (r_pobj) with_18\IN\0 (r_prep) infrequent_17\JJ\0 (r_acomp) are_16\VBP\13600404 (r_conj) follow_11\VBP\1835496 (l_nsubj) symptoms_6\NNS\5823932
D002045_D009422 NONE bupivacaine_19\NN\0 (r_pobj) with_18\IN\0 (r_prep) infrequent_17\JJ\0 (r_acomp) are_16\VBP\13600404 (r_conj) follow_11\VBP\1835496 (l_nsubj) symptoms_6\NNS\5823932 (l_appos) tnss_8\NNS\0
D002045_D009422 NONE bupivacaine_15\NN\0 (l_prep) with_16\IN\0 (l_pobj) respect_17\NN\5817845 (l_prep) to_18\IN\0 (l_pobj) duration_19\NN\15113229 (l_prep) of_20\IN\0 (l_pobj) action_21\NN\30358 (l_conj) risk_24\NN\14541044 (l_prep) of_25\IN\0 (l_pobj) tnss_26\NNS\0
D002045_D009422 NONE bupivacaine_30\NN\0 (r_dobj) receiving_29\VBG\2210855 (r_acl) patients_28\NNS\9898892 (r_pobj) of_26\IN\0 (r_prep) none_25\NN\15228378 (r_nsubj) had_31\VBD\0 (r_conj) had_21\VBD\0 (l_nsubj) patients_4\NNS\9898892 (l_acl) receiving_5\VBG\2210855 (l_dobj) tnss_8\NNS\0
D002045_D009422 NONE bupivacaine_30\NN\0 (r_dobj) receiving_29\VBG\2210855 (r_acl) patients_28\NNS\9898892 (r_pobj) of_26\IN\0 (r_prep) none_25\NN\15228378 (r_nsubj) had_31\VBD\0 (l_dobj) tnss_32\NNS\0
16167916
D020849_D054556 CID raloxifene_11\NN\0 (r_compound) treatment_12\NN\654885 (r_pobj) to_10\IN\0 (r_pcomp) due_9\IN\5174653 (r_amod) thromboembolism_8\NN\14100769
8092427
-1_D007645 NONE bpo_8\NNP\0 (r_pobj) to_7\IN\0 (r_prep) negative_6\JJ\7204401 (r_amod) test_5\NN\5798043 (r_attr) were_3\VBD\0 (r_ccomp) were_17\VBD\0 (l_acomp) negative_19\JJ\7204401 (l_prep) to_20\IN\0 (l_pobj) mdm_21\NNP\0
D047090_D004342 NONE lactam_12\NN\0 (r_amod) antibiotics_13\NNS\2716205 (r_pobj) to_9\IN\0 (r_prep) reactions_8\NNS\13446390
D047090_D004342 NONE lactam_31\NN\0 (r_amod) antibiotics_32\NNS\2716205 (r_pobj) to_28\IN\0 (r_prep) allergic_27\JJ\0
D047090_D004342 NONE lactam_31\NN\0 (r_amod) antibiotics_32\NNS\2716205 (r_pobj) to_28\IN\0 (r_prep) allergic_27\JJ\0 (r_ccomp) establish_24\VB\2426171 (r_xcomp) used_22\VBN\0 (l_conj) had_33\VBD\0 (l_dobj) responses_37\NNS\11410625 (l_amod) allergic_36\JJ\0
D047090_D004342 NONE lactam_12\NN\0 (r_amod) antibiotics_13\NNS\2716205 (r_pobj) to_9\IN\0 (r_prep) allergic_8\JJ\0
D010400_D004342 NONE pg_17\NNP\0 (r_pobj) of_16\IN\0 (r_prep) tolerance_15\NN\5032565 (r_pobj) with_13\IN\0 (r_prep) allergy_12\NN\14533203
D010400_D004342 NONE pg_13\NNP\0 (r_dobj) tolerated_12\VBN\802318 (r_relcl) patients_9\NNS\9898892 (l_amod) allergic_8\JJ\0
D000658_D004342 CID amoxicillin_4\NNP\3910033 (r_pobj) to_3\IN\0 (r_prep) reactions_2\NNS\13446390
D000658_D004342 CID amoxicillin_39\NNP\3910033 (r_pobj) to_38\IN\0 (r_prep) responses_37\NNS\11410625 (r_dobj) had_33\VBD\0 (r_conj) used_22\VBN\0 (l_xcomp) establish_24\VB\2426171 (l_ccomp) allergic_27\JJ\0
D000658_D004342 CID amoxicillin_39\NNP\3910033 (r_pobj) to_38\IN\0 (r_prep) responses_37\NNS\11410625 (l_amod) allergic_36\JJ\0
D000658_D004342 CID ax_41\NN\3265032 (r_appos) amoxicillin_39\NNP\3910033 (r_pobj) to_38\IN\0 (r_prep) responses_37\NNS\11410625 (r_dobj) had_33\VBD\0 (r_conj) used_22\VBN\0 (l_xcomp) establish_24\VB\2426171 (l_ccomp) allergic_27\JJ\0
D000658_D004342 CID ax_41\NN\3265032 (r_appos) amoxicillin_39\NNP\3910033 (r_pobj) to_38\IN\0 (r_prep) responses_37\NNS\11410625 (l_amod) allergic_36\JJ\0
D000658_D004342 CID ax_11\NNP\3265032 (r_compound) allergy_12\NN\14533203
D000658_D004342 CID ax_3\NN\3265032 (r_pobj) with_2\IN\0 (r_prep) tests_1\NNS\5798043 (r_nsubjpass) performed_5\VBN\0 (l_advcl) establish_14\VB\2426171 (l_dobj) diagnosis_16\NN\152018 (l_prep) of_17\IN\0 (l_pobj) reaction_20\NN\13446390
D000658_D004342 CID ax_22\NN\3265032 (r_pobj) to_21\IN\0 (r_prep) reaction_20\NN\13446390
D000658_D004342 CID ax_38\NN\3265032 (r_pobj) for_37\IN\0 (r_prep) rast_36\NNP\0 (r_conj) test_34\NN\5798043 (r_appos) %_30\NN\0 (r_nsubj) were_39\VBD\0 (r_conj) performed_5\VBN\0 (l_advcl) establish_14\VB\2426171 (l_dobj) diagnosis_16\NN\152018 (l_prep) of_17\IN\0 (l_pobj) reaction_20\NN\13446390
D000658_D004342 CID ax_6\NN\3265032 (r_npadvmod) allergic_8\JJ\0
D010406_D004342 NONE penicillin_50\NN\2716866 (r_compound) derivatives_51\NNS\5802185 (r_pobj) with_48\IN\0 (r_prep) reacting_47\VBG\2367363 (r_acomp) were_44\VBD\0 (r_conj) had_33\VBD\0 (r_conj) used_22\VBN\0 (l_xcomp) establish_24\VB\2426171 (l_ccomp) allergic_27\JJ\0
D010406_D004342 NONE penicillin_50\NN\2716866 (r_compound) derivatives_51\NNS\5802185 (r_pobj) with_48\IN\0 (r_prep) reacting_47\VBG\2367363 (r_acomp) were_44\VBD\0 (r_conj) had_33\VBD\0 (l_dobj) responses_37\NNS\11410625 (l_amod) allergic_36\JJ\0
D010400_D007645 NONE pg_32\NNP\0 (r_pobj) to_31\IN\0 (r_prep) 44_24\CD\0 (r_conj) were_17\VBD\0 (l_acomp) negative_19\JJ\7204401 (l_prep) to_20\IN\0 (l_pobj) mdm_21\NNP\0
11807648
D014148_D012640 CID tamca_5\NN\0 (r_nsubj) retains_6\VBZ\2700867 (l_dobj) action_9\NN\30358 (l_amod) convulsive_8\JJ\0
D014148_D012640 CID tamca_4\NN\0 (r_appos) findings_0\NNS\7951464 (r_nsubj) caused_5\VBD\1617192 (l_dobj) activity_8\NN\30358 (l_relcl) associated_11\VBN\628491 (l_prep) with_12\IN\0 (l_pobj) behaviours_15\NNS\14006945 (l_amod) convulsive_14\JJ\0
D014148_D012640 CID tamca_10\CD\0 (r_pobj) of_9\IN\0 (r_prep) concentration_8\NN\4916342 (r_pobj) with_6\IN\0 (r_prep) increased_5\VBD\169651 (l_nsubj) degree_1\NN\4916342 (l_prep) of_2\IN\0 (l_pobj) seizures_4\NNS\14081375
D014148_D012640 CID tamca_0\NN\0 (r_advmod) evoked_1\VBD\1617192 (l_dobj) seizures_3\NNS\14081375
D014148_D012640 CID tamca_0\NN\0 (r_advmod) evoked_1\VBD\1617192 (l_advcl) evoked_24\VBD\1617192 (l_dobj) episodes_26\NNS\7283608 (l_prep) of_27\IN\0 (l_pobj) potentials_32\NNS\14481929 (l_amod) convulsive_31\JJ\0
D014148_D012640 CID tamca_16\NN\0 (r_nmod) ml_21\NNS\13616054 (r_pobj) of_15\IN\0 (r_prep) concentration_14\NN\4916342 (r_nsubj) evoked_24\VBD\1617192 (r_advcl) evoked_1\VBD\1617192 (l_dobj) seizures_3\NNS\14081375
D014148_D012640 CID tamca_16\NN\0 (r_nmod) ml_21\NNS\13616054 (r_pobj) of_15\IN\0 (r_prep) concentration_14\NN\4916342 (r_nsubj) evoked_24\VBD\1617192 (l_dobj) episodes_26\NNS\7283608 (l_prep) of_27\IN\0 (l_pobj) potentials_32\NNS\14481929 (l_amod) convulsive_31\JJ\0
D014148_D012640 CID acid_1\NN\14818238 (r_nsubj) retains_2\VBZ\2700867 (l_dobj) action_5\NN\30358 (l_amod) convulsive_4\JJ\0
D014148_D004827 NONE acid_10\NN\14818238 (r_dobj) containing_8\VBG\2632940 (r_acl) sealants_7\NNS\14705533 (r_pobj) of_5\IN\0 (r_prep) application_4\NN\947128 (r_dobj) following_2\VBG\8180190 (r_prep) seizures_1\NNS\14081375
D014148_D004827 NONE tamca_2\NN\0 (r_nsubjpass) shown_5\VBN\2137132 (l_xcomp) cause_7\VB\7323922 (l_dobj) seizures_9\NNS\14081375
3101906
D007654_D003643 NONE ketoconazole_9\JJ\0 (r_compound) treatment_10\NN\654885 (r_pobj) with_8\IN\0 (r_prep) associated_7\VBN\628491 (r_acl) deaths_5\NNS\7296428
D007654_D056486 CID ketoconazole_9\JJ\0 (r_compound) treatment_10\NN\654885 (r_pobj) with_8\IN\0 (r_prep) associated_7\VBN\628491 (r_acl) deaths_5\NNS\7296428 (r_pobj) of_2\IN\0 (r_prep) two_1\CD\13741022 (r_pobj) in_0\IN\13603305 (r_prep) continued_15\VBN\2367363 (l_prep) after_16\IN\0 (l_pobj) onset_18\NN\7325190 (l_prep) of_19\IN\0 (l_pobj) jaundice_20\NN\14299637 (l_conj) symptoms_23\NNS\5823932 (l_prep) of_24\IN\0 (l_pobj) hepatitis_25\NN\14127211
D007654_D056486 CID ketoconazole_18\NN\0 (r_pobj) with_17\IN\0 (r_prep) treatment_16\NN\654885 (r_pobj) during_13\IN\0 (r_prep) advised_12\VBN\813978 (l_nsubjpass) monitoring_3\NN\879759 (l_prep) for_7\IN\0 (l_pobj) evidence_8\NN\5816287 (l_prep) of_9\IN\0 (l_pobj) hepatitis_10\NN\14127211
D007654_D056486 CID ketoconazole_18\NN\0 (r_pobj) with_17\IN\0 (r_prep) treatment_16\NN\654885 (r_pobj) during_13\IN\0 (r_prep) advised_12\VBN\813978 (l_advcl) prevent_20\VB\0 (l_dobj) injury_24\NN\14052046
D007654_D007565 CID ketoconazole_9\JJ\0 (r_compound) treatment_10\NN\654885 (r_pobj) with_8\IN\0 (r_prep) associated_7\VBN\628491 (r_acl) deaths_5\NNS\7296428 (r_pobj) of_2\IN\0 (r_prep) two_1\CD\13741022 (r_pobj) in_0\IN\13603305 (r_prep) continued_15\VBN\2367363 (l_prep) after_16\IN\0 (l_pobj) onset_18\NN\7325190 (l_prep) of_19\IN\0 (l_pobj) jaundice_20\NN\14299637
17244258
D003520_D003556 CID cyclophosphamide_9\NN\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) cystitis_12\NN\14566129
D003520_D003556 CID cyclophosphamide_1\NN\0 (r_npadvmod) induced_3\VBN\1627355 (r_amod) cystitis_4\NN\14566129
26094
D008750_D001523 NONE dopa_13\NN\14601829 (r_pobj) in_11\IN\13603305 (r_prep) occurring_10\VBG\0 (r_acl) depressions_9\NNS\14373582 (r_pobj) of_8\IN\0 (r_prep) number_7\NN\5107765 (l_acl) treated_14\VBD\2376958 (l_dobj) patients_15\NNS\9898892 (l_prep) with_16\IN\0 (l_pobj) histories_18\NNS\15120823 (l_amod) psychiatric_17\JJ\0
D008750_D003866 CID dopa_13\NN\14601829 (r_pobj) in_11\IN\13603305 (r_prep) occurring_10\VBG\0 (r_acl) depressions_9\NNS\14373582
1428568
D015784_D003866 NONE betaxolol_4\NN\0 (r_nsubj) be_6\VB\14625458 (l_attr) less_7\JJR\14187378 (l_prep) of_8\IN\0 (l_pobj) inducer_12\NN\14778436 (l_compound) depression_10\NN\14373582
D013999_D003866 CID timolol_6\NN\2832168 (r_compound) 0.5%/12h_7\CD\0 (r_pobj) with_5\IN\0 (r_prep) treated_4\VBN\2376958 (l_advcl) suffering_9\VBG\14322699 (l_prep) from_10\IN\0 (l_pobj) depression_11\NN\14373582
D013999_D003866 CID timolol_15\NN\2832168 (r_compound) treatment_16\NN\654885 (r_pobj) under_14\IN\0 (r_prep) patients_13\NNS\9898892 (r_nsubj) presented_17\VBD\2137132 (l_dobj) values_20\NNS\5941423 (l_compound) depression_19\NN\14373582
D013999_D003866 CID timolol_14\NN\2832168 (r_pobj) than_13\IN\0 (r_prep) less_7\JJR\14187378 (l_prep) of_8\IN\0 (l_pobj) inducer_12\NN\14778436 (l_compound) depression_10\NN\14373582
D013999_D005901 NONE timolol_6\NN\2832168 (r_compound) 0.5%/12h_7\CD\0 (r_pobj) with_5\IN\0 (r_prep) treated_4\VBN\2376958 (l_nsubj) patients_2\NNS\9898892 (l_amod) glaucomatous_1\JJ\0
20722491
D005472_D009369 NONE 5-fu_1\CD\0 (r_nsubj) been_5\VBN\0 (l_attr) mainstay_7\NN\10677713 (l_prep) of_8\IN\0 (l_pobj) treatment_9\NN\654885 (l_prep) for_10\IN\0 (l_pobj) tumors_13\NNS\14234074
C110904_D007674 NONE capecitabine_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) safety_8\NN\13920835 (l_prep) in_11\IN\13603305 (l_pobj) populations_13\NNS\7942152 (l_prep) as_15\IN\14622893 (l_pobj) patients_16\NNS\9898892 (l_prep) with_17\IN\0 (l_pobj) disease_24\NN\14061805
C110904_D007674 NONE capecitabine_0\NNP\0 (r_nsubj) has_1\VBZ\13888491 (l_conj) given_11\VBN\5892096 (l_prep) to_13\IN\0 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) dysfunctions_22\NNS\14204950
D005472_D001943 NONE 5-fu_1\CD\0 (r_nsubj) been_5\VBN\0 (l_attr) mainstay_7\NN\10677713 (l_prep) of_8\IN\0 (l_pobj) treatment_9\NN\654885 (l_prep) for_10\IN\0 (l_pobj) tumors_13\NNS\14234074 (l_prep) including_15\VBG\0 (l_pobj) colorectal_16\NN\0 (l_conj) breast_18\NN\5225090 (l_conj) cancers_23\NNS\14239425
C110904_D014839 CID capecitabine_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (r_nsubj) are_8\VBP\13600404 (l_attr) diarrhea_9\NN\14299637 (l_appos) nausea_11\NN\14299637 (l_conj) vomiting_13\NN\116687
C110904_D013280 CID capecitabine_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (r_nsubj) are_8\VBP\13600404 (l_attr) diarrhea_9\NN\14299637 (l_appos) nausea_11\NN\14299637 (l_conj) vomiting_13\NN\116687 (l_conj) stomatitis_15\JJ\14336539
C110904_D003967 CID capecitabine_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (r_nsubj) are_8\VBP\13600404 (l_attr) diarrhea_9\NN\14299637
C110904_D009325 CID capecitabine_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (r_nsubj) are_8\VBP\13600404 (l_attr) diarrhea_9\NN\14299637 (l_appos) nausea_11\NN\14299637
C110904_D008107 NONE capecitabine_0\NNP\0 (r_nsubj) has_1\VBZ\13888491 (l_conj) given_11\VBN\5892096 (l_prep) to_13\IN\0 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) dysfunctions_22\NNS\14204950
D005472_D015179 NONE 5-fu_1\CD\0 (r_nsubj) been_5\VBN\0 (l_attr) mainstay_7\NN\10677713 (l_prep) of_8\IN\0 (l_pobj) treatment_9\NN\654885 (l_prep) for_10\IN\0 (l_pobj) tumors_13\NNS\14234074 (l_prep) including_15\VBG\0 (l_pobj) colorectal_16\NN\0 (l_conj) breast_18\NN\5225090 (l_conj) cancers_23\NNS\14239425
C110904_D060831 CID capecitabine_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (r_nsubj) are_8\VBP\13600404 (l_attr) diarrhea_9\NN\14299637 (l_appos) nausea_11\NN\14299637 (l_conj) vomiting_13\NN\116687 (l_conj) stomatitis_15\JJ\14336539 (l_conj) syndrome_20\NN\5870365
D005472_D006258 NONE 5-fu_1\CD\0 (r_nsubj) been_5\VBN\0 (l_attr) mainstay_7\NN\10677713 (l_prep) of_8\IN\0 (l_pobj) treatment_9\NN\654885 (l_prep) for_10\IN\0 (l_pobj) tumors_13\NNS\14234074 (l_prep) including_15\VBG\0 (l_pobj) colorectal_16\NN\0 (l_conj) breast_18\NN\5225090 (l_conj) cancers_23\NNS\14239425
9855119
D016559_D007674 NONE fk506_28\NN\0 (r_compound) nephropathy_29\NN\14573196
D016559_D007674 NONE fk506_28\NN\0 (r_compound) nephropathy_29\NN\14573196 (l_conj) nephropathy_41\NN\14573196
D016559_D007674 NONE fk506_40\NN\0 (r_compound) nephropathy_41\NN\14573196 (r_conj) nephropathy_29\NN\14573196
D016559_D007674 NONE fk506_40\NN\0 (r_compound) nephropathy_41\NN\14573196
D016559_D007674 NONE fk506_18\NN\0 (r_compound) nephropathy_19\NN\14573196
D016559_D007674 NONE fk506_1\NNP\0 (r_compound) nephropathy_2\NN\14573196
D016559_D007674 NONE fk506_12\NN\0 (r_compound) nephropathy_13\NN\14573196
D016559_D007674 NONE fk506_12\NN\0 (r_compound) nephropathy_13\NN\14573196 (r_compound) group_14\NN\2137 (r_pobj) in_6\IN\13603305 (r_prep) patients_5\NNS\9898892 (r_pobj) of_4\IN\0 (r_prep) levels_3\NNS\4916342 (r_nsubj) were_22\VBD\0 (l_acomp) higher_24\JJR\0 (l_prep) than_25\IN\0 (l_pobj) those_26\DT\0 (l_prep) in_27\IN\13603305 (l_pobj) group_34\NN\2137 (l_compound) fk506-nephropathy_33\NNP\0
D016559_D007674 NONE fk506-nephropathy_33\NNP\0 (r_compound) group_34\NN\2137 (r_pobj) in_27\IN\13603305 (r_prep) those_26\DT\0 (r_pobj) than_25\IN\0 (r_prep) higher_24\JJR\0 (r_acomp) were_22\VBD\0 (l_nsubj) levels_3\NNS\4916342 (l_prep) of_4\IN\0 (l_pobj) patients_5\NNS\9898892 (l_prep) in_6\IN\13603305 (l_pobj) group_14\NN\2137 (l_compound) nephropathy_13\NN\14573196
D016559_D007674 NONE fk506-nephropathy_33\NNP\0
D016559_D007674 NONE fk506_5\NNP\0 (r_compound) nephropathy_6\NN\14573196
D016559_D007674 NONE fk506_5\NNP\0 (r_compound) nephropathy_6\NN\14573196 (r_nsubj) consists_7\VBZ\2603699 (r_ccomp) demonstrates_2\VBZ\2137132 (l_conj) suggests_21\VBZ\1010118 (l_ccomp) is_29\VBZ\0 (l_nsubj) nephropathy_28\NN\14573196
D016559_D007674 NONE fk506_27\NN\0 (r_compound) nephropathy_28\NN\14573196 (r_nsubj) is_29\VBZ\0 (r_ccomp) suggests_21\VBZ\1010118 (r_conj) demonstrates_2\VBZ\2137132 (l_ccomp) consists_7\VBZ\2603699 (l_nsubj) nephropathy_6\NN\14573196
D016559_D007674 NONE fk506_27\NN\0 (r_compound) nephropathy_28\NN\14573196
D003404_D007674 NONE creatinine_2\NN\0 (r_compound) levels_3\NNS\4916342 (l_prep) of_4\IN\0 (l_pobj) patients_5\NNS\9898892 (l_prep) in_6\IN\13603305 (l_pobj) group_14\NN\2137 (l_compound) nephropathy_13\NN\14573196
D003404_D007674 NONE creatinine_2\NN\0 (r_compound) levels_3\NNS\4916342 (r_nsubj) were_22\VBD\0 (l_acomp) higher_24\JJR\0 (l_prep) than_25\IN\0 (l_pobj) those_26\DT\0 (l_prep) in_27\IN\13603305 (l_pobj) group_34\NN\2137 (l_compound) fk506-nephropathy_33\NNP\0
D016559_D005923 CID fk506_1\NNP\0 (r_compound) nephropathy_2\NN\14573196 (r_nsubj) consisted_3\VBD\2603699 (r_ccomp) angiodegeneration_17\NN\0 (l_appos) biopsies_24\NNS\5739043 (l_conj) glomerulosclerosis_29\NN\0
D016559_D005355 NONE fk506_1\NNP\0 (r_compound) nephropathy_2\NN\14573196 (r_nsubj) consisted_3\VBD\2603699 (r_ccomp) angiodegeneration_17\NN\0 (l_appos) biopsies_24\NNS\5739043 (l_conj) glomerulosclerosis_29\NN\0 (l_conj) form_37\NN\6286395 (l_prep) of_38\IN\0 (l_pobj) fibrosis_40\NN\14204950
D016559_D005922 NONE fk506_28\NN\0 (r_compound) nephropathy_29\NN\14573196 (r_conj) findings_17\NNS\7951464 (r_conj) nephropathy_9\NN\14573196
D016559_D005922 NONE fk506_40\NN\0 (r_compound) nephropathy_41\NN\14573196 (r_conj) nephropathy_29\NN\14573196 (r_conj) findings_17\NNS\7951464 (r_conj) nephropathy_9\NN\14573196
16755009
D003975_D000647 CID diazepam-_0\NN\0 (l_appos) amnesia_7\NN\5669934
D003975_D000647 CID diazepam_16\NN\2830852 (r_conj) scopolamine_8\NN\14712692 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (r_acl) amnesia_5\NN\5669934
D012601_D000647 CID scopolamine-_2\NN\0 (r_nmod) amnesia_7\NN\5669934
D012601_D000647 CID scopolamine_8\NN\14712692 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (r_acl) amnesia_5\NN\5669934
D002784_D003072 NONE cholesterol_30\NN\15058310 (r_nsubj) lowering_31\VBG\351638 (r_conj) property_28\NN\32613 (r_dobj) improving_27\VBG\126264 (r_acl) remedy_9\NN\258854 (l_prep) for_10\IN\0 (l_pobj) management_12\NN\1123598 (l_prep) of_13\IN\0 (l_pobj) dysfunctions_15\NNS\14204950
D010936_D000647 NONE dce_2\NNP\0 (r_nsubj) reversed_3\VBD\109660 (l_dobj) amnesia_5\NN\5669934
D010936_D003072 NONE dce_2\NNP\0 (r_nsubj) prove_4\VB\2604760 (l_xcomp) be_6\VB\14625458 (l_attr) remedy_9\NN\258854 (l_prep) for_10\IN\0 (l_pobj) management_12\NN\1123598 (l_prep) of_13\IN\0 (l_pobj) dysfunctions_15\NNS\14204950
19843802
D004837_D006973 CID epinephrine_5\NN\14807929 (r_pobj) of_4\IN\0 (r_prep) bolus_3\NN\13899404 (r_nsubj) provoked_11\VBD\1617192 (l_dobj) crisis_14\NN\14411243 (l_amod) hypertensive_13\JJ\10405694
6534871
D007545_D009203 CID isoproterenol_8\NN\3740161 (r_npadvmod) induced_10\VBN\1627355 (r_amod) infarction_12\NN\14204950
7449470
D004317_D066126 NONE doxorubicin_3\NN\2716866 (r_compound) cardiotoxicity_4\NN\0
D004317_D066126 NONE adriamycin_11\NNS\0 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_dobj) limits_7\VBZ\5123416 (r_relcl) complication_5\NN\1073995 (r_attr) is_2\VBZ\0 (l_nsubj) toxicity_1\NN\13576101
11419773
D002110_D008945 NONE caffeine_34\NN\14712692 (r_pobj) of_33\IN\0 (r_prep) concentration_32\NN\4916342 (r_dobj) containing_29\VBG\2632940 (r_acl) drink_28\NN\7578363 (r_dobj) consuming_20\VBG\1168468 (r_pcomp) after_19\IN\0 (r_prep) developed_15\VBD\1753788 (r_relcl) woman_6\NN\9605289 (l_prep) with_7\IN\0 (l_pobj) prolapse_13\NN\14548343
D002110_D014693 CID caffeine_34\NN\14712692 (r_pobj) of_33\IN\0 (r_prep) concentration_32\NN\4916342 (r_dobj) containing_29\VBG\2632940 (r_acl) drink_28\NN\7578363 (r_dobj) consuming_20\VBG\1168468 (r_pcomp) after_19\IN\0 (r_prep) developed_15\VBD\1753788 (l_dobj) fibrillation_18\NN\14361664
D002110_D001145 NONE caffeine_0\NN\14712692 (r_nsubj) induced_2\VBN\1627355 (r_amod) arrhythmia_4\NN\14103288
6287825
D007538_D009422 NONE isoniazid_0\NNP\2716205 (r_nsubj) was_1\VBD\0 (l_attr) agent_5\NN\7347 (l_prep) in_6\IN\13603305 (l_pobj) neuropathy_10\NN\14204950
D013831_D044342 NONE thiamine_7\NN\15090742 (r_pobj) of_6\IN\0 (r_prep) deficiency_5\NN\14449126
D013831_D010523 CID thiamine_7\NN\15090742 (r_pobj) of_6\IN\0 (r_prep) deficiency_5\NN\14449126 (r_pobj) due_2\IN\5174653 (r_prep) neuropathy_1\NNS\14204950
D013831_D010523 CID thiamine_7\NN\15090742 (r_pobj) of_6\IN\0 (r_prep) deficiency_5\NN\14449126 (r_pobj) due_2\IN\5174653 (r_prep) neuropathy_1\NNS\14204950 (r_nsubj) was_10\VBD\0 (l_conj) presented_17\VBN\2137132 (l_prep) as_19\IN\14622893 (l_pobj) neuropathy_25\NN\14204950
D012256_D044342 NONE riboflavin_9\NN\15090742 (r_conj) thiamine_7\NN\15090742 (r_pobj) of_6\IN\0 (r_prep) deficiency_5\NN\14449126
D012256_D010523 CID riboflavin_9\NN\15090742 (r_conj) thiamine_7\NN\15090742 (r_pobj) of_6\IN\0 (r_prep) deficiency_5\NN\14449126 (r_pobj) due_2\IN\5174653 (r_prep) neuropathy_1\NNS\14204950
D012256_D010523 CID riboflavin_9\NN\15090742 (r_conj) thiamine_7\NN\15090742 (r_pobj) of_6\IN\0 (r_prep) deficiency_5\NN\14449126 (r_pobj) due_2\IN\5174653 (r_prep) neuropathy_1\NNS\14204950 (r_nsubj) was_10\VBD\0 (l_conj) presented_17\VBN\2137132 (l_prep) as_19\IN\14622893 (l_pobj) neuropathy_25\NN\14204950
19820426
C558899_D066126 NONE ritonavir_10\NNS\4013993 (r_compound) therapy_11\NN\657604 (r_appos) lopinavir_8\NNS\0 (r_pobj) to_7\IN\0 (r_prep) related_6\VBN\628491 (r_acl) toxicity_5\NN\13576101
C558899_D001919 CID ritonavir_15\NNS\4013993 (r_compound) therapy_16\NN\657604 (r_appos) lopinavir_13\NNS\0 (r_pobj) to_12\IN\0 (r_prep) related_11\VBN\628491 (r_acl) cardiomyopathy_10\NN\14103288 (r_conj) block_7\NN\21939 (r_dobj) developed_4\VBD\1753788 (l_advcl) developed_29\VBD\1753788 (l_dobj) bradycardia_31\NNS\14110674
C558899_D002311 CID ritonavir_15\NNS\4013993 (r_compound) therapy_16\NN\657604 (r_appos) lopinavir_13\NNS\0 (r_pobj) to_12\IN\0 (r_prep) related_11\VBN\628491 (r_acl) cardiomyopathy_10\NN\14103288
C558899_D006327 CID ritonavir_15\NNS\4013993 (r_compound) therapy_16\NN\657604 (r_appos) lopinavir_13\NNS\0 (r_pobj) to_12\IN\0 (r_prep) related_11\VBN\628491 (r_acl) cardiomyopathy_10\NN\14103288 (r_conj) block_7\NN\21939
9766615
D003024_D015430 NONE clozapine_40\NN\3713736 (r_appos) threshold_37\NN\15265518 (r_dobj) lowered_35\VBD\1850315 (l_nsubj) effects_21\NNS\13245626 (l_conj) effects_24\NNS\13245626 (l_conj) gain_27\NN\13576355
D003024_D015430 NONE clozapine_46\NN\3713736 (r_appos) agranulocytosis_44\NN\14189204 (r_conj) lowered_35\VBD\1850315 (l_nsubj) effects_21\NNS\13245626 (l_conj) effects_24\NNS\13245626 (l_conj) gain_27\NN\13576355
D003024_D012640 NONE clozapine_40\NN\3713736 (r_appos) threshold_37\NN\15265518 (l_compound) seizure_36\NN\14081375
D003024_D012640 NONE clozapine_46\NN\3713736 (r_appos) agranulocytosis_44\NN\14189204 (r_conj) lowered_35\VBD\1850315 (l_dobj) threshold_37\NN\15265518 (l_compound) seizure_36\NN\14081375
D003024_D001480 NONE clozapine_40\NN\3713736 (r_appos) threshold_37\NN\15265518 (r_dobj) lowered_35\VBD\1850315 (r_conj) associated_13\VBN\628491 (r_conj) have_4\VBP\7846 (l_dobj) risk_7\NN\14541044 (l_prep) of_8\IN\0 (l_pobj) eps_9\NNP\0
D003024_D001480 NONE clozapine_46\NN\3713736 (r_appos) agranulocytosis_44\NN\14189204 (r_conj) lowered_35\VBD\1850315 (r_conj) associated_13\VBN\628491 (r_conj) have_4\VBP\7846 (l_dobj) risk_7\NN\14541044 (l_prep) of_8\IN\0 (l_pobj) eps_9\NNP\0
D003024_D000380 CID clozapine_40\NN\3713736 (r_appos) threshold_37\NN\15265518 (r_dobj) lowered_35\VBD\1850315 (l_conj) agranulocytosis_44\NN\14189204
D003024_D000380 CID clozapine_46\NN\3713736 (r_appos) agranulocytosis_44\NN\14189204
D003024_D012735 NONE clozapine_40\NN\3713736 (r_appos) threshold_37\NN\15265518 (r_dobj) lowered_35\VBD\1850315 (l_nsubj) effects_21\NNS\13245626 (l_conj) effects_24\NNS\13245626 (l_conj) gain_27\NN\13576355 (l_conj) dysfunction_30\NN\14204950
D003024_D012735 NONE clozapine_46\NN\3713736 (r_appos) agranulocytosis_44\NN\14189204 (r_conj) lowered_35\VBD\1850315 (l_nsubj) effects_21\NNS\13245626 (l_conj) effects_24\NNS\13245626 (l_conj) gain_27\NN\13576355 (l_conj) dysfunction_30\NN\14204950
16330766
C040029_D009437 NONE gabapentin_11\NN\2718469 (l_appos) drug_14\NN\14778436 (l_amod) effective_15\JJ\0 (l_prep) in_16\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_compound) pain_18\NN\14299637
D002211_D006930 CID capsaicin_32\NN\15032661 (r_npadvmod) induced_34\VBN\1627355 (r_amod) hyperalgesia_36\NN\0
C040029_D006930 NONE gabapentin_15\NN\2718469 (r_npadvmod) induced_17\VBN\1627355 (r_amod) modulation_18\NN\7044917 (l_prep) in_22\IN\13603305 (l_pobj) response_23\NN\11410625 (l_prep) to_24\IN\0 (l_pobj) stimulation_27\NN\242808 (l_prep) of_28\IN\0 (l_pobj) skin_30\NN\5237755 (l_conj) hyperalgesia_36\NN\0
6640832
D004317_D002277 NONE adriamycin_2\NNS\0 (l_prep) in_3\IN\13603305 (l_pobj) carcinoma_6\NN\14239918
D004317_D001749 NONE adriamycin_2\NNS\0 (l_prep) in_3\IN\13603305 (l_pobj) carcinoma_6\NN\14239918
D004317_D001749 NONE adriamycin_0\NNP\0 (r_nsubjpass) administered_7\VBN\2436349 (l_prep) after_12\IN\0 (l_pobj) resection_14\NN\671351 (l_prep) of_15\IN\0 (l_pobj) tumors_25\NNS\14234074
8421099
D015282_D002764 NONE octreotide_25\NN\0 (r_compound) therapy_26\NN\657604 (r_pobj) during_24\IN\0 (r_prep) formation_15\NN\7938773 (l_prep) of_16\IN\0 (l_pobj) sludge_18\NN\14591635 (l_conj) gallstones_20\NNS\9230768 (l_conj) cholecystitis_23\NN\14336539
D015282_D000172 NONE octreotide_12\NN\0 (r_appos) analog_10\NN\4743605 (r_pobj) of_8\IN\0 (r_prep) effects_7\NNS\13245626 (l_prep) on_14\IN\0 (l_pobj) function_16\NN\13783581 (l_prep) in_20\IN\13603305 (l_pobj) patients_23\NNS\9898892 (l_compound) acromegalic_22\JJ\0
D015282_D000172 NONE octreotide_26\NN\0 (r_appos) analog_25\NN\4743605 (r_pobj) of_22\IN\0 (r_prep) injection_21\NN\320852 (r_pobj) with_19\IN\0 (r_prep) treated_18\VBN\2376958 (r_acl) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) acromegaly_17\NNS\14366759
D015282_D000172 NONE octreotide_25\NN\0 (r_compound) therapy_26\NN\657604 (l_prep) in_27\IN\13603305 (l_pobj) patients_30\NNS\9898892 (l_compound) acromegalic_29\JJ\0
D015282_D000172 NONE octreotide_16\NN\0 (r_compound) therapy_17\NN\657604 (l_prep) of_18\IN\0 (l_pobj) patients_20\NNS\9898892 (l_compound) acromegalic_19\JJ\0
D015282_D042882 CID octreotide_12\NN\0 (r_appos) analog_10\NN\4743605 (r_pobj) of_8\IN\0 (r_prep) effects_7\NNS\13245626 (l_prep) on_14\IN\0 (l_pobj) function_16\NN\13783581 (l_conj) formation_19\NN\7938773 (l_compound) gallstone_18\NN\9230768
D015282_D042882 CID octreotide_3\NN\0 (r_pobj) with_2\IN\0 (r_prep) treatment_1\NN\654885 (r_pobj) during_0\IN\0 (r_prep) developed_7\VBD\1753788 (l_conj) had_11\VBD\0 (l_dobj) gallstones_12\NNS\9230768
D015282_D042882 CID octreotide_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) withdrawal_1\NN\7206096 (l_prep) in_4\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_prep) without_7\IN\0 (l_pobj) gallstones_8\NNS\9230768
D015282_D042882 CID octreotide_25\NN\0 (r_compound) therapy_26\NN\657604 (r_pobj) during_24\IN\0 (r_prep) formation_15\NN\7938773 (l_prep) of_16\IN\0 (l_pobj) sludge_18\NN\14591635 (l_conj) gallstones_20\NNS\9230768
D015282_D041881 CID octreotide_3\NN\0 (r_pobj) with_2\IN\0 (r_prep) treatment_1\NN\654885 (r_pobj) during_0\IN\0 (r_prep) developed_7\VBD\1753788 (l_conj) had_11\VBD\0 (l_conj) developed_16\VBD\1753788 (l_dobj) cholecystitis_18\NN\14336539
7453952
D011188_D003919 NONE potassium_48\NN\14625458 (r_compound) level_49\NN\4916342 (r_pobj) in_45\IN\13603305 (r_prep) elevation_44\NN\7445480 (r_conj) concentration_31\NN\4916342 (r_pobj) between_28\IN\0 (r_prep) ratio_27\NN\13815152 (r_pobj) of_25\IN\0 (r_prep) reduction_24\NN\351485 (r_pobj) by_22\IN\0 (r_agent) accompanied_21\VBN\0 (l_nsubjpass) attenuation_6\NN\7427337 (l_prep) of_7\IN\0 (l_pobj) syndrome_17\NN\5870365
D000584_D011141 NONE amiloride_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) on_4\IN\0 (l_pobj) polydipsia_8\NN\14040660 (l_conj) polyuria_10\NN\14113228
D000584_D011141 NONE amiloride_5\NN\0 (r_compound) administration_6\NN\1133281 (l_prep) to_7\IN\0 (l_pobj) patients_11\NNS\9898892 (l_acl) suffering_12\VBG\14322699 (l_prep) from_13\IN\0 (l_pobj) polydipsia_14\NN\14040660 (l_conj) polyuria_16\NN\14113228
D000584_D011141 NONE amiloride_23\JJ\0 (r_compound) supplementation_24\NN\5108947 (r_nsubj) result_26\VB\34213 (r_conj) relieve_18\VB\205885 (l_nsubj) administration_6\NN\1133281 (l_prep) to_7\IN\0 (l_pobj) patients_11\NNS\9898892 (l_acl) suffering_12\VBG\14322699 (l_prep) from_13\IN\0 (l_pobj) polydipsia_14\NN\14040660 (l_conj) polyuria_16\NN\14113228
D008094_D011141 NONE lithium_5\NN\14625458 (r_npadvmod) induced_7\VBN\1627355 (r_amod) polydipsia_8\NN\14040660 (l_conj) polyuria_10\NN\14113228
D008094_D011141 NONE lithium_14\NN\14625458 (r_compound) concentration_15\NN\4916342 (r_pobj) on_12\IN\0 (r_conj) on_4\IN\0 (l_pobj) polydipsia_8\NN\14040660 (l_conj) polyuria_10\NN\14113228
D008094_D011141 NONE lithium_8\NN\14625458 (r_npadvmod) treated_10\VBN\2376958 (r_amod) patients_11\NNS\9898892 (l_acl) suffering_12\VBG\14322699 (l_prep) from_13\IN\0 (l_pobj) polydipsia_14\NN\14040660 (l_conj) polyuria_16\NN\14113228
D008094_D011141 NONE lithium_29\NN\14625458 (r_compound) levels_30\NNS\4916342 (r_pobj) in_27\IN\13603305 (r_prep) result_26\VB\34213 (r_conj) relieve_18\VB\205885 (l_nsubj) administration_6\NN\1133281 (l_prep) to_7\IN\0 (l_pobj) patients_11\NNS\9898892 (l_acl) suffering_12\VBG\14322699 (l_prep) from_13\IN\0 (l_pobj) polydipsia_14\NN\14040660 (l_conj) polyuria_16\NN\14113228
D000584_D059606 NONE amiloride_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) on_4\IN\0 (l_pobj) polydipsia_8\NN\14040660
D000584_D059606 NONE amiloride_5\NN\0 (r_compound) administration_6\NN\1133281 (l_prep) to_7\IN\0 (l_pobj) patients_11\NNS\9898892 (l_acl) suffering_12\VBG\14322699 (l_prep) from_13\IN\0 (l_pobj) polydipsia_14\NN\14040660
D000584_D059606 NONE amiloride_23\JJ\0 (r_compound) supplementation_24\NN\5108947 (r_nsubj) result_26\VB\34213 (r_conj) relieve_18\VB\205885 (l_nsubj) administration_6\NN\1133281 (l_prep) to_7\IN\0 (l_pobj) patients_11\NNS\9898892 (l_acl) suffering_12\VBG\14322699 (l_prep) from_13\IN\0 (l_pobj) polydipsia_14\NN\14040660
D008094_D059606 NONE lithium_5\NN\14625458 (r_npadvmod) induced_7\VBN\1627355 (r_amod) polydipsia_8\NN\14040660
D008094_D059606 NONE lithium_14\NN\14625458 (r_compound) concentration_15\NN\4916342 (r_pobj) on_12\IN\0 (r_conj) on_4\IN\0 (l_pobj) polydipsia_8\NN\14040660
D008094_D059606 NONE lithium_8\NN\14625458 (r_npadvmod) treated_10\VBN\2376958 (r_amod) patients_11\NNS\9898892 (l_acl) suffering_12\VBG\14322699 (l_prep) from_13\IN\0 (l_pobj) polydipsia_14\NN\14040660
D008094_D059606 NONE lithium_29\NN\14625458 (r_compound) levels_30\NNS\4916342 (r_pobj) in_27\IN\13603305 (r_prep) result_26\VB\34213 (r_conj) relieve_18\VB\205885 (l_nsubj) administration_6\NN\1133281 (l_prep) to_7\IN\0 (l_pobj) patients_11\NNS\9898892 (l_acl) suffering_12\VBG\14322699 (l_prep) from_13\IN\0 (l_pobj) polydipsia_14\NN\14040660
D000584_D003919 NONE amiloride_13\NN\0 (r_pobj) by_12\IN\0 (r_prep) syndrome_11\NN\5870365
D000584_D003919 NONE amiloride_19\NN\0 (r_pobj) by_18\IN\0 (r_prep) syndrome_17\NN\5870365
D008094_D003919 CID lithium_3\NN\14625458 (r_npadvmod) induced_5\VBN\1627355 (r_amod) syndrome_11\NN\5870365
D008094_D003919 CID lithium_9\NN\14625458 (r_npadvmod) induced_11\VBN\1627355 (r_amod) syndrome_17\NN\5870365
D008094_D003919 CID lithium_30\NN\14625458 (r_compound) concentration_31\NN\4916342 (r_pobj) between_28\IN\0 (r_prep) ratio_27\NN\13815152 (r_pobj) of_25\IN\0 (r_prep) reduction_24\NN\351485 (r_pobj) by_22\IN\0 (r_agent) accompanied_21\VBN\0 (l_nsubjpass) attenuation_6\NN\7427337 (l_prep) of_7\IN\0 (l_pobj) syndrome_17\NN\5870365
D018021_D011141 NONE licl_37\NNP\0 (r_pobj) with_36\IN\0 (r_prep) treated_35\VBN\2376958 (r_conj) investigated_30\VBN\644583 (l_nsubjpass) effect_1\NN\34213 (l_prep) on_4\IN\0 (l_pobj) polydipsia_8\NN\14040660 (l_conj) polyuria_10\NN\14113228
D018021_D059606 NONE licl_37\NNP\0 (r_pobj) with_36\IN\0 (r_prep) treated_35\VBN\2376958 (r_conj) investigated_30\VBN\644583 (l_nsubjpass) effect_1\NN\34213 (l_prep) on_4\IN\0 (l_pobj) polydipsia_8\NN\14040660
3564823
D008012_D020301 NONE lidocaine_11\NN\3681148 (r_nsubjpass) given_13\VBN\5892096 (l_advcl) counteract_24\VB\2367363 (l_dobj) vasospasm_26\NN\0
D008012_D013035 NONE lidocaine_7\NN\3681148 (r_pobj) by_6\IN\0 (r_prep) relieved_5\VBN\205885 (l_nsubj) spasm_4\NN\14299637
D013874_D002545 NONE pentothal_12\NNS\2792049 (r_nsubjpass) infused_15\VBN\606335 (l_advcl) minimize_17\VB\441445 (l_dobj) ischaemia_19\NN\14195315
2304736
D011224_D014550 CID prazosin_0\NN\2698769 (r_npadvmod) induced_2\VBN\1627355 (r_amod) incontinence_4\NN\13473097
D011224_D014550 CID prazosin_8\NN\2698769 (r_pobj) due_6\IN\5174653 (r_amod) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) incontinence_5\NN\13473097
D011224_D014550 CID prazosin_8\NN\2698769 (r_dobj) taking_7\VBG\37396 (r_advcl) present_2\VBP\28270 (l_prep) with_3\IN\0 (l_pobj) incontinence_5\NN\13473097
D011224_D014549 NONE prazosin_8\NN\2698769 (r_dobj) taking_7\VBG\37396 (r_advcl) present_2\VBP\28270 (r_relcl) patients_0\NNS\9898892 (r_nsubj) change_10\VB\7283608 (l_advcl) resolve_22\VB\4616059 (l_nsubj) incontinence_20\NN\13473097
4071154
D007213_D001201 CID indomethacin_24\NN\3828465 (r_advcl) reported_2\VBN\831651 (l_dobj) case_4\NN\7283608 (l_prep) in_12\IN\13603305 (l_pobj) patient_14\NN\9898892 (l_prep) with_15\IN\0 (l_pobj) cirrhosis_16\NN\14116321 (l_conj) ascites_18\NNS\14204950
D007213_D006947 CID indomethacin_24\NN\3828465 (r_advcl) reported_2\VBN\831651 (l_dobj) case_4\NN\7283608 (l_prep) of_5\IN\0 (l_pobj) failure_9\NN\66216 (l_prep) with_10\IN\0 (l_pobj) hyperkalemia_11\NN\14299637
D007213_D051437 NONE indomethacin_0\NNP\3828465 (r_npadvmod) induced_2\VBN\1627355 (r_amod) insufficiency_4\NN\14462946
D007213_D051437 NONE indomethacin_24\NN\3828465 (r_advcl) reported_2\VBN\831651 (l_dobj) case_4\NN\7283608 (l_prep) of_5\IN\0 (l_pobj) failure_9\NN\66216
D007213_D011660 CID indomethacin_24\NN\3828465 (r_advcl) reported_2\VBN\831651 (l_dobj) case_4\NN\7283608 (l_prep) in_12\IN\13603305 (l_pobj) patient_14\NN\9898892 (l_prep) with_15\IN\0 (l_pobj) cirrhosis_16\NN\14116321 (l_conj) ascites_18\NNS\14204950 (l_conj) pulmonale_22\NN\0
D007213_D005355 CID indomethacin_24\NN\3828465 (r_advcl) reported_2\VBN\831651 (l_dobj) case_4\NN\7283608 (l_prep) in_12\IN\13603305 (l_pobj) patient_14\NN\9898892 (l_prep) with_15\IN\0 (l_pobj) cirrhosis_16\NN\14116321
D007213_D009846 CID indomethacin_18\NN\3828465 (r_pobj) of_17\IN\0 (r_prep) dose_16\NN\3740161 (r_pobj) to_13\IN\0 (r_punct) caused_19\VBD\1617192 (l_dobj) recurrence_20\NN\7342049 (l_prep) of_21\IN\0 (l_pobj) oliguria_24\NN\14299637
3800626
D010423_D020425 CID pentazocine_8\NN\2707683 (r_advmod) induced_10\VBN\1627355 (r_amod) myopathy_12\NNS\14204950 (r_pobj) due_6\IN\5174653 (r_prep) neuropathy_1\NN\14204950 (l_prep) of_2\IN\0 (l_pobj) nerve_5\NN\5475681
D010423_D005355 CID pentazocine_8\NN\2707683 (r_advmod) induced_10\VBN\1627355 (r_amod) myopathy_12\NNS\14204950
D010423_D005355 CID pentazocine_13\NN\2707683 (r_compound) injection_14\NN\320852 (r_pobj) of_11\IN\0 (r_prep) effect_10\NN\34213 (r_attr) is_2\VBZ\0 (l_nsubj) myopathy_1\NN\14204950
D010423_D005355 CID pentazocine_8\NN\2707683 (r_advmod) induced_10\VBN\1627355 (r_amod) myopathy_12\NNS\14204950 (r_pobj) with_6\IN\0 (r_prep) woman_5\NN\9605289 (r_pobj) in_0\IN\13603305 (r_prep) showed_32\VBD\2137132 (l_prep) in_51\IN\13603305 (l_pobj) addition_52\NN\3081021 (l_prep) to_53\IN\0 (l_pobj) myopathy_56\NN\14204950
D010423_D009135 CID pentazocine_8\NN\2707683 (r_advmod) induced_10\VBN\1627355 (r_amod) myopathy_12\NNS\14204950
D010423_D009135 CID pentazocine_13\NN\2707683 (r_compound) injection_14\NN\320852 (r_pobj) of_11\IN\0 (r_prep) effect_10\NN\34213 (r_attr) is_2\VBZ\0 (l_nsubj) myopathy_1\NN\14204950
D010423_D009135 CID pentazocine_10\NN\2707683 (r_npadvmod) induced_12\VBN\1627355 (r_compound) myopathy_13\NN\14204950
D010423_D009135 CID pentazocine_8\NN\2707683 (r_advmod) induced_10\VBN\1627355 (r_amod) myopathy_12\NNS\14204950 (r_pobj) with_6\IN\0 (r_prep) woman_5\NN\9605289 (r_pobj) in_0\IN\13603305 (r_prep) showed_32\VBD\2137132 (l_prep) in_51\IN\13603305 (l_pobj) addition_52\NN\3081021 (l_prep) to_53\IN\0 (l_pobj) myopathy_56\NN\14204950
D010423_D009408 CID pentazocine_8\NN\2707683 (r_advmod) induced_10\VBN\1627355 (r_amod) myopathy_12\NNS\14204950 (r_pobj) due_6\IN\5174653 (r_prep) neuropathy_1\NN\14204950 (l_prep) of_2\IN\0 (l_pobj) nerve_5\NN\5475681
D010423_D009408 CID pentazocine_10\NN\2707683 (r_npadvmod) induced_12\VBN\1627355 (r_compound) myopathy_13\NN\14204950 (r_pobj) by_9\IN\0 (r_agent) affected_8\VBN\126264 (r_acl) muscle_7\NN\5289601 (r_pobj) due_4\IN\5174653 (r_amod) neuropathy_3\NN\14204950
15804801
D017239_D003323 CID paclitaxel_6\NN\0 (r_compound) eluting_8\VBG\1270199 (r_amod) stent_9\NN\4493505 (r_pobj) of_4\IN\0 (r_prep) implantation_3\NN\13526110 (r_pobj) after_2\IN\0 (r_prep) aneurysm_1\NN\14057371
D017239_D003323 CID paclitaxel_22\NN\0 (r_compound) eluting_24\VBG\1270199 (r_amod) stent_25\NN\4493505 (r_dobj) receiving_20\VBG\2210855 (r_pcomp) after_19\IN\0 (r_prep) developed_8\VBD\1753788 (l_dobj) aneurysm_11\NN\14057371
11773892
D016559_D007674 CID tacrolimus_5\NN\0 (r_conj) cyclosporine_3\VBP\0 (r_appos) inhibitors_2\NNS\20090 (r_nsubjpass) known_8\VBN\0 (l_xcomp) be_10\VB\14625458 (l_acomp) nephrotoxic_11\JJ\0
D003404_D006530 NONE creatinine_13\NN\0 (r_compound) levels_14\NNS\4916342 (l_appos) percentage_18\NN\13815742 (l_prep) of_19\IN\0 (l_pobj) patients_20\NNS\9898892 (l_prep) with_21\IN\0 (l_pobj) syndrome_23\NN\5870365
D003404_D006530 NONE creatinine_42\NN\0 (r_conj) requirement_27\NN\1129920 (r_appos) levels_14\NNS\4916342 (l_appos) percentage_18\NN\13815742 (l_prep) of_19\IN\0 (l_pobj) patients_20\NNS\9898892 (l_prep) with_21\IN\0 (l_pobj) syndrome_23\NN\5870365
D003404_D006530 NONE creatinine_11\NN\0 (r_dobj) have_4\VBP\7846 (l_conj) are_13\VBP\13600404 (l_acomp) likely_15\JJ\0 (l_xcomp) have_17\VB\7846 (l_dobj) syndrome_19\NN\5870365
D016572_D007674 CID cyclosporine_3\VBP\0 (r_appos) inhibitors_2\NNS\20090 (r_nsubjpass) known_8\VBN\0 (l_xcomp) be_10\VB\14625458 (l_acomp) nephrotoxic_11\JJ\0
D003404_D007676 NONE creatinine_20\NN\0 (r_conj) crf_16\NNP\0 (r_conj) controls_7\NNS\5190804 (l_conj) crf_10\NNP\0
D003404_D007676 NONE creatinine_20\NN\0 (r_conj) crf_16\NNP\0 (r_conj) controls_7\NNS\5190804 (l_conj) crf_10\NNP\0 (l_conj) esrd_12\NNP\0
D003404_D007676 NONE creatinine_20\NN\0 (r_conj) crf_16\NNP\0
D003404_D007676 NONE creatinine_20\NN\0 (r_conj) crf_16\NNP\0 (r_conj) controls_7\NNS\5190804 (r_appos) groups_5\NNS\2137 (l_conj) n=45_32\JJ\0 (l_nmod) esrd_30\NNS\0
D003404_D007676 NONE creatinine_13\NN\0 (r_compound) levels_14\NNS\4916342 (r_dobj) had_9\VBD\0 (l_nsubj) patients_8\NNS\9898892 (l_nmod) crf_5\NNP\0
D003404_D007676 NONE creatinine_13\NN\0 (r_compound) levels_14\NNS\4916342 (r_dobj) had_9\VBD\0 (l_nsubj) patients_8\NNS\9898892 (l_compound) esrd_7\NNP\0
D003404_D007676 NONE creatinine_42\NN\0 (r_conj) requirement_27\NN\1129920 (r_appos) levels_14\NNS\4916342 (r_dobj) had_9\VBD\0 (l_nsubj) patients_8\NNS\9898892 (l_nmod) crf_5\NNP\0
D003404_D007676 NONE creatinine_42\NN\0 (r_conj) requirement_27\NN\1129920 (r_appos) levels_14\NNS\4916342 (r_dobj) had_9\VBD\0 (l_nsubj) patients_8\NNS\9898892 (l_compound) esrd_7\NNP\0
D003404_D007676 NONE creatinine_16\NN\0 (r_pobj) of_14\IN\0 (r_prep) increase_13\NN\13576355 (r_nsubj) were_31\VBD\0 (l_attr) factors_34\NNS\7326557 (l_prep) for_35\IN\0 (l_pobj) development_37\NN\248977 (l_prep) of_38\IN\0 (l_pobj) crf_39\NNP\0
D003404_D007676 NONE creatinine_16\NN\0 (r_pobj) of_14\IN\0 (r_prep) increase_13\NN\13576355 (r_nsubj) were_31\VBD\0 (l_attr) factors_34\NNS\7326557 (l_prep) for_35\IN\0 (l_pobj) development_37\NN\248977 (l_prep) of_38\IN\0 (l_pobj) crf_39\NNP\0 (l_conj) esrd_41\NNP\0
D003404_D007676 NONE creatinine_11\NN\0 (r_dobj) have_4\VBP\7846 (l_nsubj) patients_0\NNS\9898892 (l_relcl) develop_2\VBP\1753788 (l_dobj) esrd_3\NNS\0
D003404_D007676 NONE creatinine_6\NN\0 (r_pobj) of_4\IN\0 (r_prep) increase_3\NN\13576355 (r_nsubj) is_11\VBZ\0 (l_acomp) predictive_13\JJ\0 (l_prep) of_14\IN\0 (l_pobj) development_16\NN\248977 (l_prep) of_17\IN\0 (l_pobj) crf_18\NNP\0
D003404_D007676 NONE creatinine_6\NN\0 (r_pobj) of_4\IN\0 (r_prep) increase_3\NN\13576355 (r_nsubj) is_11\VBZ\0 (l_acomp) predictive_13\JJ\0 (l_prep) of_14\IN\0 (l_pobj) development_16\NN\248977 (l_prep) of_17\IN\0 (l_pobj) crf_18\NNP\0 (l_conj) esrd_20\NNP\0
17466854
D008775_D006261 CID methylprednisolone_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubjpass) related_15\VBN\628491 (l_prep) to_16\IN\0 (l_pobj) incidence_19\NN\13821570 (l_prep) of_20\IN\0 (l_pobj) effects_22\NNS\13245626 (l_prep) including_23\VBG\0 (l_pobj) nausea_24\NN\14299637 (l_conj) vomiting_26\NN\116687 (l_conj) headache_29\NN\5829480
D008775_D020250 CID methylprednisolone_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubjpass) related_15\VBN\628491 (l_prep) to_16\IN\0 (l_pobj) incidence_19\NN\13821570 (l_prep) of_20\IN\0 (l_pobj) effects_22\NNS\13245626 (l_prep) including_23\VBG\0 (l_pobj) nausea_24\NN\14299637 (l_conj) vomiting_26\NN\116687
D005839_D006261 CID gentamicin_5\NN\2716866 (r_conj) administration_1\NN\1133281 (r_nsubjpass) related_15\VBN\628491 (l_prep) to_16\IN\0 (l_pobj) incidence_19\NN\13821570 (l_prep) of_20\IN\0 (l_pobj) effects_22\NNS\13245626 (l_prep) including_23\VBG\0 (l_pobj) nausea_24\NN\14299637 (l_conj) vomiting_26\NN\116687 (l_conj) headache_29\NN\5829480
D008775_D002386 NONE methylprednisolone_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) administration_11\NN\1133281 (r_pobj) after_9\IN\0 (r_prep) incidence_3\NN\13821570 (r_dobj) assess_1\VB\5220461 (l_conj) gentamicin_15\NN\2716866 (l_prep) at_24\IN\14622893 (l_pobj) end_26\NN\8568978 (l_prep) of_27\IN\0 (l_pobj) surgery_30\NN\6045562 (l_compound) cataract_29\NN\14252864
D005839_D020250 CID gentamicin_5\NN\2716866 (r_conj) administration_1\NN\1133281 (r_nsubjpass) related_15\VBN\628491 (l_prep) to_16\IN\0 (l_pobj) incidence_19\NN\13821570 (l_prep) of_20\IN\0 (l_pobj) effects_22\NNS\13245626 (l_prep) including_23\VBG\0 (l_pobj) nausea_24\NN\14299637 (l_conj) vomiting_26\NN\116687
D005839_D002386 NONE gentamicin_15\NN\2716866 (l_prep) at_24\IN\14622893 (l_pobj) end_26\NN\8568978 (l_prep) of_27\IN\0 (l_pobj) surgery_30\NN\6045562 (l_compound) cataract_29\NN\14252864
8590259
C016986_D015814 CID apraclonidine_8\NN\0 (r_npadvmod) treated_10\VBN\2376958 (r_amod) eyes_11\NNS\5945642 (r_pobj) for_7\IN\0 (r_prep) significant_6\JJ\0 (r_acomp) were_4\VBD\0 (l_nsubj) effects_3\NNS\13245626 (l_amod) hypotensive_2\JJ\10405694
C016986_D015814 CID apraclonidine_31\NN\0 (r_pobj) of_28\IN\0 (r_prep) administration_27\NN\1133281 (r_pobj) after_25\IN\0 (r_prep) hours_24\NNS\15118228 (r_pobj) from_22\IN\0 (r_prep) significant_18\JJ\0 (r_conj) significant_6\JJ\0 (r_acomp) were_4\VBD\0 (l_nsubj) effects_3\NNS\13245626 (l_amod) hypotensive_2\JJ\10405694
14568327
D015632_D004409 NONE mptp_7\NNP\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) parkinsonism_10\NN\14085708 (r_pobj) of_6\IN\0 (r_prep) types_5\NNS\5839024 (r_pobj) with_3\IN\0 (r_prep) using_0\VBG\418025 (r_advcl) evaluated_15\VBD\670261 (l_dobj) degree_17\NN\4916342 (l_relcl) involved_38\VBN\2676054 (l_prep) in_39\IN\13603305 (l_pobj) development_41\NN\248977 (l_prep) of_42\IN\0 (l_pobj) lids_43\NNS\5313679
D015632_D004409 NONE mptp_8\NNP\0 (r_compound) exposure_9\NN\5042871 (r_pobj) with_1\IN\0 (r_prep) monkeys_0\NNS\2469914 (r_nsubj) developed_24\VBD\1753788 (l_dobj) dyskinesia_25\RB\14084880
D015632_D004409 NONE mptp_8\NNP\0 (r_compound) exposure_9\NN\5042871 (r_pobj) with_4\IN\0 (r_prep) monkeys_3\NNS\2469914 (r_nsubj) progression_13\NN\8457976 (r_nsubj) were_24\VBD\0 (l_acomp) resistant_26\JJ\0 (l_prep) to_27\IN\0 (l_pcomp) developing_28\VBG\13541167 (l_dobj) lids_29\NNS\5313679
D015632_D004409 NONE mptp_8\NNP\0 (r_compound) exposure_9\NN\5042871 (r_pobj) with_4\IN\0 (r_prep) monkeys_3\NNS\2469914 (r_nsubj) progression_13\NN\8457976 (r_nsubj) were_24\VBD\0 (l_parataxis) developed_34\VBD\1753788 (l_nsubj) dyskinesia_33\NN\14084880
D007980_D010302 NONE levodopa_34\NN\14604959 (r_compound) therapy_35\NN\657604 (r_pobj) of_33\IN\0 (r_prep) duration_32\NN\15113229 (r_conj) response_29\NN\11410625 (r_conj) severity_26\NN\5036394 (r_nsubjpass) involved_38\VBN\2676054 (r_relcl) degree_17\NN\4916342 (r_dobj) evaluated_15\VBD\670261 (l_advcl) using_0\VBG\418025 (l_prep) with_3\IN\0 (l_pobj) types_5\NNS\5839024 (l_prep) of_6\IN\0 (l_pobj) parkinsonism_10\NN\14085708
D007980_D004409 CID levodopa_2\NN\14604959 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesias_5\NNS\14084880
D007980_D004409 CID levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesias_3\NNS\14084880
D007980_D004409 CID levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesias_3\NNS\14084880 (l_appos) lids_5\NNPS\5313679
D007980_D004409 CID levodopa_34\NN\14604959 (r_compound) therapy_35\NN\657604 (r_pobj) of_33\IN\0 (r_prep) duration_32\NN\15113229 (r_conj) response_29\NN\11410625 (r_conj) severity_26\NN\5036394 (r_nsubjpass) involved_38\VBN\2676054 (l_prep) in_39\IN\13603305 (l_pobj) development_41\NN\248977 (l_prep) of_42\IN\0 (l_pobj) lids_43\NNS\5313679
D007980_D004409 CID levodopa_22\NN\14604959 (r_compound) therapy_23\NN\657604 (r_pobj) of_21\IN\0 (r_prep) initiation_20\NN\7450842 (r_pobj) to_19\IN\0 (r_prep) prior_18\RB\10675876 (r_advmod) developed_24\VBD\1753788 (l_dobj) dyskinesia_25\RB\14084880
D007980_D004409 CID levodopa_33\JJ\14604959 (r_compound) administration_34\NN\1133281 (r_pobj) of_31\IN\0 (r_prep) days_30\NNS\15140892 (r_npadvmod) developed_24\VBD\1753788 (l_dobj) dyskinesia_25\RB\14084880
D007980_D004409 CID levodopa_22\NN\14604959 (r_compound) therapy_23\NN\657604 (r_pobj) of_21\IN\0 (r_prep) initiation_20\NN\7450842 (r_pobj) to_19\IN\0 (r_prep) prior_18\RB\10675876 (r_advmod) progression_13\NN\8457976 (r_nsubj) were_24\VBD\0 (l_acomp) resistant_26\JJ\0 (l_prep) to_27\IN\0 (l_pcomp) developing_28\VBG\13541167 (l_dobj) lids_29\NNS\5313679
D007980_D004409 CID levodopa_22\NN\14604959 (r_compound) therapy_23\NN\657604 (r_pobj) of_21\IN\0 (r_prep) initiation_20\NN\7450842 (r_pobj) to_19\IN\0 (r_prep) prior_18\RB\10675876 (r_advmod) progression_13\NN\8457976 (r_nsubj) were_24\VBD\0 (l_parataxis) developed_34\VBD\1753788 (l_nsubj) dyskinesia_33\NN\14084880
D007980_D004409 CID levodopa_42\JJ\14604959 (r_compound) administration_43\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) days_39\NNS\15140892 (r_pobj) than_37\IN\0 (r_prep) sooner_36\RBR\9738708 (r_advmod) developed_34\VBD\1753788 (r_parataxis) were_24\VBD\0 (l_acomp) resistant_26\JJ\0 (l_prep) to_27\IN\0 (l_pcomp) developing_28\VBG\13541167 (l_dobj) lids_29\NNS\5313679
D007980_D004409 CID levodopa_42\JJ\14604959 (r_compound) administration_43\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) days_39\NNS\15140892 (r_pobj) than_37\IN\0 (r_prep) sooner_36\RBR\9738708 (r_advmod) developed_34\VBD\1753788 (l_nsubj) dyskinesia_33\NN\14084880
D007980_D004409 CID levodopa_24\VB\14604959 (r_pobj) to_23\IN\0 (r_prep) prior_22\RB\10675876 (r_advmod) develop_9\VB\1753788 (l_dobj) lids_10\NNS\5313679
D007980_D004409 CID levodopa_24\VB\14604959 (r_pobj) to_23\IN\0 (r_prep) prior_22\RB\10675876 (r_advmod) develop_9\VB\1753788 (r_acl) propensity_7\NN\7498854 (r_pobj) in_5\IN\13603305 (r_prep) differences_4\NNS\4723816 (r_dobj) suggest_2\VBP\1010118 (l_conj) demonstrate_26\VB\2137132 (l_dobj) value_28\NN\5856066 (l_prep) for_32\IN\0 (l_pcomp) studying_34\VBG\5808794 (l_dobj) pathophysiology_36\NN\0 (l_prep) of_37\IN\0 (l_pobj) lids_38\NNS\5313679
D007980_D010300 NONE levodopa_2\NN\14604959 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesias_5\NNS\14084880 (l_prep) in_6\IN\13603305 (l_pobj) monkeys_8\NNS\2469914 (l_amod) parkinsonian_7\JJ\0
D007980_D010300 NONE levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesias_3\NNS\14084880 (r_nsubj) present_7\VBP\28270 (l_dobj) problem_10\NN\14408086 (l_prep) for_11\IN\0 (l_pobj) management_16\NN\1123598 (l_prep) of_17\IN\0 (l_pobj) patients_24\NNS\9898892 (l_nmod) disease_20\NN\14061805
D007980_D010300 NONE levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesias_3\NNS\14084880 (r_nsubj) present_7\VBP\28270 (l_dobj) problem_10\NN\14408086 (l_prep) for_11\IN\0 (l_pobj) management_16\NN\1123598 (l_prep) of_17\IN\0 (l_pobj) patients_24\NNS\9898892 (l_nmod) pd_22\NNP\14625458
D015632_D010302 CID mptp_7\NNP\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) parkinsonism_10\NN\14085708
9522143
D011318_D034381 CID prilocaine_2\NN\0 (r_dobj) given_1\VBN\5892096 (r_acl) patients_0\NNS\9898892 (r_nsubj) were_3\VBD\0 (l_acomp) likely_5\JJ\0 (l_xcomp) develop_7\VB\1753788 (l_xcomp) hearing_8\VBG\1184814 (l_dobj) loss_9\NN\13252973
D011318_D034381 CID prilocaine_12\NN\0 (r_pobj) after_11\IN\0 (r_prep) was_7\VBD\0 (l_nsubj) loss_3\NN\13252973
D002045_D034381 CID bupivacaine_19\NN\0 (r_pobj) than_16\IN\0 (r_prep) loss_9\NN\13252973
D002045_D034381 CID bupivacaine_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) db_15\NN\14622893 (r_conj) prilocaine_12\NN\0 (r_pobj) after_11\IN\0 (r_prep) was_7\VBD\0 (l_nsubj) loss_3\NN\13252973
15233872
D007545_D009203 CID isoproterenol_7\NN\3740161 (r_npadvmod) induced_9\VBN\1627355 (r_amod) infarction_11\NN\14204950
C007145_D009203 NONE crataegus_5\NNP\11585340 (r_pobj) of_4\IN\0 (r_prep) tincture_3\NN\14984973 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) on_6\IN\0 (l_pobj) infarction_11\NN\14204950
C007145_D009203 NONE tcr_11\NNP\0 (r_pobj) of_10\IN\0 (r_prep) effect_9\NN\34213 (l_prep) on_12\IN\0 (l_pobj) infarction_16\NN\14204950
1378968
D008094_D007676 CID lithium_8\NN\14625458 (r_npadvmod) induced_10\VBN\1627355 (r_amod) failure_13\NN\66216
D008094_D051437 NONE lithium_2\NN\14625458 (r_npadvmod) induced_4\VBN\1627355 (r_amod) nephropathy_5\NN\14573196 (r_pobj) with_1\IN\0 (r_prep) rats_0\NNS\2329401 (r_nsubjpass) subjected_7\VBN\137313 (l_prep) in_26\IN\13603305 (l_pobj) attempt_28\NN\407535 (l_acl) induce_30\VB\1627355 (l_dobj) hyperfiltration_32\NN\0 (l_conj) progression_35\NN\8457976 (l_prep) of_36\IN\0 (l_pobj) failure_38\NN\66216
D008094_D051437 NONE lithium_21\NN\14625458 (r_nmod) rats_23\NNS\2329401 (r_pobj) in_20\IN\13603305 (r_prep) levels_19\NNS\4916342 (r_dobj) decrease_16\NN\7296428 (r_conj) increase_13\VB\13576355 (r_xcomp) tended_11\VBD\2604760 (r_conj) failed_1\VBD\0 (l_xcomp) accentuante_3\NN\0 (l_dobj) progression_4\NN\8457976 (l_prep) of_5\IN\0 (l_pobj) failure_7\NN\66216
D008094_D007674 NONE lithium_2\NN\14625458 (r_npadvmod) induced_4\VBN\1627355 (r_amod) nephropathy_5\NN\14573196
D008094_D007674 NONE li_4\NNP\14625458 (r_npadvmod) induced_6\VBN\1627355 (r_amod) nephropathy_7\NN\14573196
D008094_D005921 NONE lithium_0\NN\14625458 (r_nsubj) caused_2\VBD\1617192 (l_prep) in_7\IN\13603305 (l_pobj) absence_8\NN\14449405 (l_prep) of_9\IN\0 (l_pobj) glomerulosclerosis_10\NN\0
D003404_D051437 NONE creatinine_18\NN\0 (r_compound) levels_19\NNS\4916342 (r_dobj) decrease_16\NN\7296428 (r_conj) increase_13\VB\13576355 (r_xcomp) tended_11\VBD\2604760 (r_conj) failed_1\VBD\0 (l_xcomp) accentuante_3\NN\0 (l_dobj) progression_4\NN\8457976 (l_prep) of_5\IN\0 (l_pobj) failure_7\NN\66216
D008094_D006973 CID lithium_0\NN\14625458 (r_nsubj) caused_2\VBD\1617192 (l_dobj) proteinuria_3\NN\14299637 (l_conj) hypertension_6\NN\14057371
D008094_D006973 CID li_4\NNP\14625458 (r_npadvmod) induced_6\VBN\1627355 (r_amod) nephropathy_7\NN\14573196 (r_nsubjpass) associated_19\VBN\628491 (l_prep) with_20\IN\0 (l_pobj) proteinuria_21\NN\14299637 (l_conj) hypertension_25\NN\14057371
D008094_D011507 CID lithium_0\NN\14625458 (r_nsubj) caused_2\VBD\1617192 (l_dobj) proteinuria_3\NN\14299637
D008094_D011507 CID li_4\NNP\14625458 (r_npadvmod) induced_6\VBN\1627355 (r_amod) nephropathy_7\NN\14573196 (r_nsubjpass) associated_19\VBN\628491 (l_prep) with_20\IN\0 (l_pobj) proteinuria_21\NN\14299637
3503576
D003676_D014786 NONE deferoxamine_26\NN\0 (r_pobj) with_23\IN\0 (r_prep) receiving_19\VBG\2210855 (r_relcl) anemia_16\NN\14189204 (r_pobj) with_12\IN\0 (r_prep) patients_11\NNS\9898892 (r_pobj) in_7\IN\13603305 (r_prep) documented_6\VBN\1000214 (l_nsubjpass) neurotoxicity_3\NN\0
D003676_D000740 NONE deferoxamine_26\NN\0 (r_pobj) with_23\IN\0 (r_prep) receiving_19\VBG\2210855 (r_relcl) anemia_16\NN\14189204
D007501_D006311 NONE iron_20\NN\14625458 (r_compound) therapy_22\NN\657604 (r_dobj) receiving_19\VBG\2210855 (r_relcl) anemia_16\NN\14189204 (r_pobj) with_12\IN\0 (r_prep) patients_11\NNS\9898892 (r_pobj) in_7\IN\13603305 (r_prep) documented_6\VBN\1000214 (l_nsubjpass) neurotoxicity_3\NN\0
D003676_D064420 NONE deferoxamine_9\NN\0 (r_compound) doses_10\NNS\3740161 (r_dobj) receiving_8\VBG\2210855 (r_advcl) restarted_24\VBN\1857717 (l_conj) demonstrated_55\VBN\2137132 (l_nsubjpass) toxicity_53\NN\13576101
D007501_D014786 NONE iron_20\NN\14625458 (r_compound) therapy_22\NN\657604 (r_dobj) receiving_19\VBG\2210855 (r_relcl) anemia_16\NN\14189204 (r_pobj) with_12\IN\0 (r_prep) patients_11\NNS\9898892 (r_pobj) in_7\IN\13603305 (r_prep) documented_6\VBN\1000214 (l_nsubjpass) neurotoxicity_3\NN\0
D003676_D006311 NONE deferoxamine_8\NN\0 (r_compound) therapy_9\NN\657604 (r_dobj) receiving_7\VBG\2210855 (r_acl) patients_6\NNS\9898892 (r_pobj) in_5\IN\13603305 (r_prep) studies_1\NNS\635850 (l_prep) of_2\IN\0 (l_pobj) neurotoxicity_4\NN\0
D003676_D006311 NONE deferoxamine_26\NN\0 (r_pobj) with_23\IN\0 (r_prep) receiving_19\VBG\2210855 (r_relcl) anemia_16\NN\14189204 (r_pobj) with_12\IN\0 (r_prep) patients_11\NNS\9898892 (r_pobj) in_7\IN\13603305 (r_prep) documented_6\VBN\1000214 (l_nsubjpass) neurotoxicity_3\NN\0
D003676_D006311 NONE deferoxamine_9\NN\0 (r_compound) doses_10\NNS\3740161 (r_dobj) receiving_8\VBG\2210855 (r_advcl) restarted_24\VBN\1857717 (l_prep) with_25\IN\0 (l_pobj) doses_27\NNS\3740161 (l_prep) depending_36\VBG\2604760 (l_prep) on_37\IN\0 (l_pobj) degree_39\NN\4916342 (l_prep) of_40\IN\0 (l_pobj) abnormality_42\NN\14034177
D003676_D006311 NONE deferoxamine_14\NN\0 (r_dobj) receiving_13\VBG\2210855 (r_conj) receiving_10\VBG\2210855 (r_acl) patients_9\NNS\9898892 (r_pobj) in_7\IN\13603305 (r_prep) demonstrated_5\VBD\2137132 (l_prep) provided_18\VBD\2199590 (l_pcomp) convincing_19\JJ\766418 (l_dobj) evidence_20\NN\5816287 (l_prep) for_21\IN\0 (l_pobj) relation_28\NN\2137 (l_prep) between_29\IN\0 (l_pobj) administration_31\NN\1133281 (l_conj) ototoxicity_33\NN\0
D003676_D006311 NONE deferoxamine_30\NN\0 (r_compound) administration_31\NN\1133281 (l_conj) ototoxicity_33\NN\0
D007501_D000740 NONE iron_20\NN\14625458 (r_compound) therapy_22\NN\657604 (r_dobj) receiving_19\VBG\2210855 (r_relcl) anemia_16\NN\14189204
7628595
D002955_D064420 NONE acid_9\NN\14818238 (r_compound) supplementation_10\NN\5108947 (l_prep) in_11\IN\13603305 (l_pcomp) preventing_12\VBG\0 (l_dobj) toxicity_14\NN\13576101
D015215_D001855 CID zidovudine_20\NNP\3834836 (r_nmod) suppression_25\NN\13489037
D015215_D001855 CID zdv)-induced_22\VBN\0 (r_amod) suppression_25\NN\13489037
D015215_D001855 CID zdv_7\NNP\3834836 (r_compound) therapy_8\NN\657604 (r_pobj) of_6\IN\0 (r_prep) supplementation_5\NN\5108947 (r_conj) b12_1\NN\0 (r_nsubj) seem_11\VB\2604760 (l_oprd) useful_12\JJ\0 (l_prep) in_13\IN\13603305 (l_pcomp) preventing_14\VBG\0 (l_conj) reducing_16\VBG\13447361 (l_dobj) myelotoxicity_20\NN\0
D015215_D001855 CID zdv_17\NNP\3834836 (r_npadvmod) induced_19\VBN\1627355 (r_amod) myelotoxicity_20\NN\0
D015215_D015658 NONE zdv_21\NNP\3834836 (r_dobj) receive_19\VB\2210855 (r_xcomp) randomized_17\VBN\278117 (l_nsubjpass) virus_5\NN\9312843 (l_appos) patients_8\NNS\9898892 (l_amod) hiv)-infected_7\VBN\0
D005492_D001855 NONE folate_8\JJ\15090742 (r_compound) levels_9\NNS\4916342 (l_conj) development_11\NN\248977 (l_prep) of_12\IN\0 (l_pobj) myelosuppression_13\NN\0
D015215_D064420 NONE zidovudine_16\NN\3834836 (r_pobj) of_15\IN\0 (r_prep) toxicity_14\NN\13576101
D014805_D001855 NONE b12_13\NN\0 (l_conj) supplementation_17\NN\5108947 (l_prep) in_18\IN\13603305 (l_pcomp) preventing_19\VBG\0 (l_dobj) suppression_25\NN\13489037
D014805_D001855 NONE b12_6\NN\0 (l_conj) levels_9\NNS\4916342 (l_conj) development_11\NN\248977 (l_prep) of_12\IN\0 (l_pobj) myelosuppression_13\NN\0
D014805_D001855 NONE b12_1\NN\0 (r_nsubj) seem_11\VB\2604760 (l_oprd) useful_12\JJ\0 (l_prep) in_13\IN\13603305 (l_pcomp) preventing_14\VBG\0 (l_conj) reducing_16\VBG\13447361 (l_dobj) myelotoxicity_20\NN\0
D014805_D064420 NONE b12_6\NN\0 (l_conj) supplementation_10\NN\5108947 (l_prep) in_11\IN\13603305 (l_pcomp) preventing_12\VBG\0 (l_dobj) toxicity_14\NN\13576101
D002955_D001855 NONE acid_16\NN\14818238 (r_compound) supplementation_17\NN\5108947 (l_prep) in_18\IN\13603305 (l_pcomp) preventing_19\VBG\0 (l_dobj) suppression_25\NN\13489037
D002955_D001855 NONE acid_4\NN\14818238 (r_compound) supplementation_5\NN\5108947 (r_conj) b12_1\NN\0 (r_nsubj) seem_11\VB\2604760 (l_oprd) useful_12\JJ\0 (l_prep) in_13\IN\13603305 (l_pcomp) preventing_14\VBG\0 (l_conj) reducing_16\VBG\13447361 (l_dobj) myelotoxicity_20\NN\0
16298782
D019331_D034381 NONE name_2\NN\6284225 (r_nsubj) reduced_3\VBN\441445 (l_dobj) loss_8\NN\13252973
D009569_D006319 NONE no_17\DT\7204911 (r_pobj) of_16\IN\0 (r_prep) production_15\NN\30358 (r_dobj) involves_13\VBZ\2676054 (r_conj) is_2\VBZ\0 (r_ccomp) need_20\VBP\13920835 (l_xcomp) assess_22\VB\5220461 (l_dobj) use_24\NN\407535 (l_prep) for_28\IN\0 (l_pobj) prevention_30\NN\1073995 (l_prep) of_31\IN\0 (l_pobj) loss_37\NN\13252973
D009569_D006319 NONE no_26\DT\7204911 (r_det) inhibitors_27\NNS\20090 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (l_prep) for_28\IN\0 (l_pobj) prevention_30\NN\1073995 (l_prep) of_31\IN\0 (l_pobj) loss_37\NN\13252973
D019331_D006311 NONE ester_6\NN\14727670 (l_appos) protector_10\NN\10466918 (l_prep) against_11\IN\0 (l_pobj) ototoxicity_13\NN\0
D019331_D006316 NONE ester_13\NN\14727670 (r_appos) oxide_2\NN\14818238 (r_nsubj) act_20\VB\6479665 (l_prep) as_21\IN\14622893 (l_pobj) otoprotectant_23\NN\0 (l_prep) against_24\IN\0 (l_pobj) loss_29\NN\13252973
D019331_D006316 NONE name_17\NN\6284225 (r_appos) ester_13\NN\14727670 (r_appos) oxide_2\NN\14818238 (r_nsubj) act_20\VB\6479665 (l_prep) as_21\IN\14622893 (l_pobj) otoprotectant_23\NN\0 (l_prep) against_24\IN\0 (l_pobj) loss_29\NN\13252973
D005839_D006316 NONE gentamicin_32\NN\2716866 (r_pobj) by_31\IN\0 (r_agent) caused_30\VBN\1617192 (r_acl) loss_29\NN\13252973
D005839_D006311 NONE gentamicin_12\NN\2716866 (r_compound) ototoxicity_13\NN\0
D000617_D006319 NONE aminoglycoside_32\NN\0 (r_npadvmod) induced_34\VBN\1627355 (r_amod) loss_37\NN\13252973
D009569_D006311 NONE no_17\DT\7204911 (r_pobj) of_16\IN\0 (r_prep) production_15\NN\30358 (r_dobj) involves_13\VBZ\2676054 (r_conj) is_2\VBZ\0 (l_nsubj) ototoxicity_1\NN\0
D009569_D006311 NONE no_17\DT\7204911 (r_pobj) of_16\IN\0 (r_prep) production_15\NN\30358 (r_dobj) involves_13\VBZ\2676054 (l_nsubj) mechanism_12\NN\13446390 (l_compound) ototoxic_11\JJ\0
D009569_D006311 NONE no_26\DT\7204911 (r_det) inhibitors_27\NNS\20090 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_dobj) assess_22\VB\5220461 (r_xcomp) need_20\VBP\13920835 (l_ccomp) is_2\VBZ\0 (l_nsubj) ototoxicity_1\NN\0
D009569_D006311 NONE no_26\DT\7204911 (r_det) inhibitors_27\NNS\20090 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_dobj) assess_22\VB\5220461 (r_xcomp) need_20\VBP\13920835 (l_ccomp) is_2\VBZ\0 (l_conj) involves_13\VBZ\2676054 (l_nsubj) mechanism_12\NN\13446390 (l_compound) ototoxic_11\JJ\0
D005839_D034381 CID gentamicin_4\NN\2716866 (r_npadvmod) induced_6\VBN\1627355 (r_amod) loss_8\NN\13252973
D009569_D006316 NONE oxide_2\NN\14818238 (r_nsubj) act_20\VB\6479665 (l_prep) as_21\IN\14622893 (l_pobj) otoprotectant_23\NN\0 (l_prep) against_24\IN\0 (l_pobj) loss_29\NN\13252973
D009569_D006316 NONE no_4\NNP\7204911 (r_intj) ester_13\NN\14727670 (r_appos) oxide_2\NN\14818238 (r_nsubj) act_20\VB\6479665 (l_prep) as_21\IN\14622893 (l_pobj) otoprotectant_23\NN\0 (l_prep) against_24\IN\0 (l_pobj) loss_29\NN\13252973
D000617_D006311 NONE aminoglycoside_32\NN\0 (r_npadvmod) induced_34\VBN\1627355 (r_amod) loss_37\NN\13252973 (r_pobj) of_31\IN\0 (r_prep) prevention_30\NN\1073995 (r_pobj) for_28\IN\0 (r_prep) use_24\NN\407535 (r_dobj) assess_22\VB\5220461 (r_xcomp) need_20\VBP\13920835 (l_ccomp) is_2\VBZ\0 (l_nsubj) ototoxicity_1\NN\0
D000617_D006311 NONE aminoglycoside_32\NN\0 (r_npadvmod) induced_34\VBN\1627355 (r_amod) loss_37\NN\13252973 (r_pobj) of_31\IN\0 (r_prep) prevention_30\NN\1073995 (r_pobj) for_28\IN\0 (r_prep) use_24\NN\407535 (r_dobj) assess_22\VB\5220461 (r_xcomp) need_20\VBP\13920835 (l_ccomp) is_2\VBZ\0 (l_conj) involves_13\VBZ\2676054 (l_nsubj) mechanism_12\NN\13446390 (l_compound) ototoxic_11\JJ\0
6538499
D004317_D009202 CID adr_8\NNP\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) alterations_13\NNS\7283608
D004317_D002286 NONE adr_6\NNP\0 (r_compound) activity_8\NN\30358 (l_relcl) tumor_16\NN\14234074
D004317_D064420 NONE adriamycin_6\JJ\0 (l_dobj) toxicity_7\NN\13576101
D011092_D064420 NONE 400_4\CD\0 (r_nummod) glycol_3\NN\14766364 (l_advcl) adriamycin_6\JJ\0 (l_dobj) toxicity_7\NN\13576101
D004317_D007939 NONE adr_6\NNP\0 (r_compound) activity_8\NN\30358 (l_prep) in_9\IN\13603305 (l_pobj) leukemia_11\NN\14239918
12653683
D000450_D009404 NONE aldosterone_38\NN\14751863 (r_pobj) by_37\IN\0 (r_prep) regulation_36\NN\6652242 (r_pobj) from_34\IN\0 (r_prep) escape_33\VB\46177 (r_xcomp) appears_31\VBZ\2604760 (r_conj) increased_11\VBN\169651 (l_prep) in_12\IN\13603305 (l_pobj) phase_16\NN\15113229 (l_prep) of_17\IN\0 (l_pobj) model_20\NN\5888929 (l_prep) of_21\IN\0 (l_pobj) syndrome_26\NN\5870365
D012964_D009404 NONE sodium_1\NN\14625458 (r_compound) channel_2\NN\6251781 (l_appos) subunit_6\NN\13604718 (l_appos) mrna_7\NN\14832193 (l_conj) expression_10\NN\4679549 (l_prep) in_11\IN\13603305 (l_pobj) rats_12\NNS\2329401 (l_prep) with_13\IN\0 (l_pobj) syndrome_19\NN\5870365
D012964_D009404 NONE sodium_6\NN\14625458 (r_compound) excretion_7\NN\13466586 (r_nsubjpass) decreased_9\VBN\169651 (l_prep) in_0\IN\13603305 (l_pobj) syndrome_3\NN\5870365
D000450_D011507 NONE aldosterone_9\NN\14751863 (r_compound) concentration_10\NN\4916342 (l_conj) proteinuria_12\NN\14299637
D011692_D009404 CID aminonucleoside_15\RB\0 (r_advmod) induced_17\VBN\1627355 (r_amod) syndrome_19\NN\5870365
D011692_D009404 CID aminonucleoside_12\NN\0 (l_pobj) syndrome_16\NN\5870365
D011692_D009404 CID pan)-induced_14\VBN\0 (r_amod) syndrome_16\NN\5870365
D011692_D009404 CID pan_22\NNP\3101986 (r_npadvmod) induced_24\VBN\1627355 (r_amod) syndrome_26\NN\5870365
D011692_D011507 CID pan_28\NNP\3101986 (r_pobj) of_26\IN\0 (r_prep) dose_25\NN\3740161 (r_pobj) with_22\IN\0 (r_prep) treated_21\VBN\2376958 (r_acl) rats_20\NNS\2329401 (r_pobj) in_15\IN\13603305 (r_prep) studied_14\VBN\0 (l_nsubjpass) courses_2\NNS\883297 (l_prep) of_3\IN\0 (l_pobj) excretion_6\NN\13466586 (l_conj) concentration_10\NN\4916342 (l_conj) proteinuria_12\NN\14299637
D012964_D011507 NONE sodium_5\NN\14625458 (r_compound) excretion_6\NN\13466586 (l_conj) concentration_10\NN\4916342 (l_conj) proteinuria_12\NN\14299637
D012964_D011507 NONE sodium_4\NN\14625458 (r_compound) excretion_5\NN\13466586 (r_pobj) of_2\IN\0 (r_prep) kinetics_1\NNS\6100236 (l_conj) appearance_8\NN\4723816 (l_prep) of_9\IN\0 (l_pobj) proteinuria_10\NN\14299637
3615541
D000661_D006948 CID amphetamine_6\NN\3248958 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hyperactivity_9\NN\14052403
D002116_D006948 NONE calcitonin_12\NN\5413241 (r_compound) injections_13\NNS\320852 (r_pobj) by_10\IN\0 (r_prep) antagonism_4\NN\24720 (l_prep) of_5\IN\0 (l_pobj) hyperactivity_9\NN\14052403
20084309
D008874_D000402 NONE mz_42\NNP\0 (r_compound) use_43\NN\407535 (r_pobj) by_41\IN\0 (r_agent) caused_40\VBN\1617192 (r_acl) hypoxia_39\NN\14035298 (r_pobj) due_37\JJ\5174653 (r_prep) presented_20\VBD\2137132 (l_prep) due_23\IN\5174653 (l_pobj) obstruction_27\NN\4341686
D008874_D009202 NONE mz_38\NNP\0 (r_compound) dose_39\NN\3740161 (r_conj) mr_34\NNP\6339416 (r_appos) regurgitation_32\NN\7406350 (r_conj) duration_26\NN\15113229 (r_dobj) test_7\VB\5798043 (l_dobj) influence_9\NN\5190804 (l_prep) of_10\IN\0 (l_pobj) variables_13\NNS\2452 (l_appos) age_15\NN\4916342 (l_conj) sex_17\NN\13440063 (l_conj) stroke_19\UH\556313 (l_conj) mp_23\NNP\10249459 (l_amod) myocardiopathy_21\NN\14103288
D008874_D009202 NONE mz_38\NNP\0 (r_compound) dose_39\NN\3740161 (r_conj) mr_34\NNP\6339416 (r_appos) regurgitation_32\NN\7406350 (r_conj) duration_26\NN\15113229 (r_dobj) test_7\VB\5798043 (l_dobj) influence_9\NN\5190804 (l_prep) of_10\IN\0 (l_pobj) variables_13\NNS\2452 (l_appos) age_15\NN\4916342 (l_conj) sex_17\NN\13440063 (l_conj) stroke_19\UH\556313 (l_conj) mp_23\NNP\10249459
D008874_D009202 NONE mz_17\NNP\0 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_appos) mp_8\NNP\10249459
D008874_D020521 NONE mz_38\NNP\0 (r_compound) dose_39\NN\3740161 (r_conj) mr_34\NNP\6339416 (r_appos) regurgitation_32\NN\7406350 (r_conj) duration_26\NN\15113229 (r_dobj) test_7\VB\5798043 (l_dobj) influence_9\NN\5190804 (l_prep) of_10\IN\0 (l_pobj) variables_13\NNS\2452 (l_appos) age_15\NN\4916342 (l_conj) sex_17\NN\13440063 (l_conj) stroke_19\UH\556313
D008874_D000860 CID mz_42\NNP\0 (r_compound) use_43\NN\407535 (r_pobj) by_41\IN\0 (r_agent) caused_40\VBN\1617192 (r_acl) hypoxia_39\NN\14035298 (r_pobj) due_37\JJ\5174653 (r_prep) presented_20\VBD\2137132 (l_dobj) hypoxia_22\NN\14035298
D008874_D000860 CID mz_42\NNP\0 (r_compound) use_43\NN\407535 (r_pobj) by_41\IN\0 (r_agent) caused_40\VBN\1617192 (r_acl) hypoxia_39\NN\14035298
D008874_D008944 NONE mz_38\NNP\0 (r_compound) dose_39\NN\3740161 (r_conj) mr_34\NNP\6339416 (r_appos) regurgitation_32\NN\7406350
D008874_D008944 NONE mz_38\NNP\0 (r_compound) dose_39\NN\3740161 (r_conj) mr_34\NNP\6339416
D008874_D008944 NONE mz_17\NNP\0 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_appos) mp_8\NNP\10249459 (l_nmod) mr_6\NNP\6339416
1786266
D000928_D001480 NONE antidepressant_3\NN\3740161 (r_compound) use_4\NN\407535 (r_conj) syndrome_1\NN\5870365
15325671
D017239_D001943 NONE paclitaxel_2\NN\0 (l_conj) melphalan_4\NN\2722458 (l_conj) cyclophosphamide_9\NN\0 (l_conj) thiotepa_11\NNS\2722458 (l_conj) carboplatin_14\VB\0 (l_dobj) regimen_22\NN\5898568 (l_prep) for_23\IN\0 (l_pobj) patients_24\NNS\9898892 (l_prep) with_25\IN\0 (l_pobj) cancer_28\NN\14239425
D003520_D001943 NONE cyclophosphamide_9\NN\0 (r_npadvmod) based_11\VBN\0 (r_amod) chemotherapy_12\NN\661091 (l_prep) for_13\IN\0 (l_pobj) cancer_16\NN\14239425
D003520_D001943 NONE cyclophosphamide_9\NN\0 (l_conj) thiotepa_11\NNS\2722458 (l_conj) carboplatin_14\VB\0 (l_dobj) regimen_22\NN\5898568 (l_prep) for_23\IN\0 (l_pobj) patients_24\NNS\9898892 (l_prep) with_25\IN\0 (l_pobj) cancer_28\NN\14239425
D003520_D001943 NONE cyclophosphamide_16\NN\0 (r_dobj) receiving_13\VBG\2210855 (r_acl) cancer_12\NN\14239425
D008558_D001943 NONE melphalan_4\NN\2722458 (l_conj) cyclophosphamide_9\NN\0 (l_conj) thiotepa_11\NNS\2722458 (l_conj) carboplatin_14\VB\0 (l_dobj) regimen_22\NN\5898568 (l_prep) for_23\IN\0 (l_pobj) patients_24\NNS\9898892 (l_prep) with_25\IN\0 (l_pobj) cancer_28\NN\14239425
D003520_D066126 NONE cyclophosphamide_9\NN\0 (r_npadvmod) based_11\VBN\0 (r_amod) chemotherapy_12\NN\661091 (r_pobj) with_5\IN\0 (r_prep) association_4\NN\8008335 (r_pobj) in_3\IN\13603305 (r_prep) observed_2\VBD\2163746 (l_nsubj) toxicity_1\NN\13576101
D003520_D066126 NONE cyclophosphamide_3\NN\0 (r_npadvmod) related_5\VBN\628491 (r_amod) toxicity_7\NN\13576101
D003520_D003920 NONE cyclophosphamide_16\NN\0 (r_dobj) receiving_13\VBG\2210855 (r_acl) cancer_12\NN\14239425 (l_conj) characteristics_44\NNS\5849040 (l_appos) presence_46\NN\13954253 (l_appos) history_60\NN\15120823 (l_conj) smoking_62\NN\831191 (l_conj) mellitus_65\NN\0
D016190_D001943 NONE carboplatin_14\VB\0 (l_dobj) regimen_22\NN\5898568 (l_prep) for_23\IN\0 (l_pobj) patients_24\NNS\9898892 (l_prep) with_25\IN\0 (l_pobj) cancer_28\NN\14239425
D018943_D006973 NONE anthracyclines_70\NNS\0 (r_pobj) of_69\IN\0 (r_prep) use_68\NN\407535 (r_conj) mellitus_65\NN\0 (r_conj) smoking_62\NN\831191 (r_conj) history_60\NN\15120823 (r_appos) presence_46\NN\13954253 (l_prep) of_47\IN\0 (l_pobj) electrocardiogram_48\NN\7000195 (l_appos) abnormalities_52\NNS\14034177 (l_appos) hypertension_56\NN\14057371
D003520_D006973 NONE cyclophosphamide_16\NN\0 (r_dobj) receiving_13\VBG\2210855 (r_acl) cancer_12\NN\14239425 (l_conj) characteristics_44\NNS\5849040 (l_appos) presence_46\NN\13954253 (l_prep) of_47\IN\0 (l_pobj) electrocardiogram_48\NN\7000195 (l_appos) abnormalities_52\NNS\14034177 (l_appos) hypertension_56\NN\14057371
D013852_D001943 NONE thiotepa_11\NNS\2722458 (l_conj) carboplatin_14\VB\0 (l_dobj) regimen_22\NN\5898568 (l_prep) for_23\IN\0 (l_pobj) patients_24\NNS\9898892 (l_prep) with_25\IN\0 (l_pobj) cancer_28\NN\14239425
D018943_D001943 NONE anthracyclines_70\NNS\0 (r_pobj) of_69\IN\0 (r_prep) use_68\NN\407535 (r_conj) mellitus_65\NN\0 (r_conj) smoking_62\NN\831191 (r_conj) history_60\NN\15120823 (r_appos) presence_46\NN\13954253 (r_appos) characteristics_44\NNS\5849040 (r_conj) cancer_12\NN\14239425
D018943_D006333 NONE anthracyclines_70\NNS\0 (r_pobj) of_69\IN\0 (r_prep) use_68\NN\407535 (r_conj) mellitus_65\NN\0 (r_conj) smoking_62\NN\831191 (r_conj) history_60\NN\15120823 (r_appos) presence_46\NN\13954253 (r_appos) characteristics_44\NNS\5849040 (r_conj) cancer_12\NN\14239425 (l_acl) receiving_13\VBG\2210855 (l_prep) as_17\IN\14622893 (l_pobj) part_18\NN\31921 (l_prep) of_19\IN\0 (l_pobj) regimen_26\NN\5898568 (l_acl) assess_28\VB\5220461 (l_dobj) association_29\NN\8008335 (l_prep) between_30\IN\0 (l_pobj) presence_31\NN\13954253 (l_prep) of_32\IN\0 (l_pobj) failure_36\NN\66216
D018943_D006333 NONE anthracyclines_70\NNS\0 (r_pobj) of_69\IN\0 (r_prep) use_68\NN\407535 (r_conj) mellitus_65\NN\0 (r_conj) smoking_62\NN\831191 (r_conj) history_60\NN\15120823 (r_appos) presence_46\NN\13954253 (r_appos) characteristics_44\NNS\5849040 (r_conj) cancer_12\NN\14239425 (l_acl) receiving_13\VBG\2210855 (l_prep) as_17\IN\14622893 (l_pobj) part_18\NN\31921 (l_prep) of_19\IN\0 (l_pobj) regimen_26\NN\5898568 (l_acl) assess_28\VB\5220461 (l_dobj) association_29\NN\8008335 (l_prep) between_30\IN\0 (l_pobj) presence_31\NN\13954253 (l_prep) of_32\IN\0 (l_pobj) failure_36\NN\66216 (l_appos) chf_38\NNP\0
D003520_D006333 CID cyclophosphamide_16\NN\0 (r_dobj) receiving_13\VBG\2210855 (l_prep) as_17\IN\14622893 (l_pobj) part_18\NN\31921 (l_prep) of_19\IN\0 (l_pobj) regimen_26\NN\5898568 (l_acl) assess_28\VB\5220461 (l_dobj) association_29\NN\8008335 (l_prep) between_30\IN\0 (l_pobj) presence_31\NN\13954253 (l_prep) of_32\IN\0 (l_pobj) failure_36\NN\66216
D003520_D006333 CID cyclophosphamide_16\NN\0 (r_dobj) receiving_13\VBG\2210855 (l_prep) as_17\IN\14622893 (l_pobj) part_18\NN\31921 (l_prep) of_19\IN\0 (l_pobj) regimen_26\NN\5898568 (l_acl) assess_28\VB\5220461 (l_dobj) association_29\NN\8008335 (l_prep) between_30\IN\0 (l_pobj) presence_31\NN\13954253 (l_prep) of_32\IN\0 (l_pobj) failure_36\NN\66216 (l_appos) chf_38\NNP\0
D003520_D006333 CID cyclophosphamide_16\NN\0 (r_dobj) following_14\VBG\8180190 (r_prep) developed_8\VBD\1753788 (l_dobj) grade_11\NN\7975026 (l_appos) chf_13\NNP\0
D003520_D006333 CID cyclophosphamide_5\NN\0 (r_pobj) during_3\IN\0 (r_prep) monitoring_2\NN\879759 (r_nsubj) predict_8\VB\916909 (l_dobj) development_10\NN\248977 (l_compound) chf_9\NNP\0
D018943_D003920 NONE anthracyclines_70\NNS\0 (r_pobj) of_69\IN\0 (r_prep) use_68\NN\407535 (r_conj) mellitus_65\NN\0
2802551
D000666_D007674 CID b_5\NN\1355326 (r_compound) nephrotoxicity_6\NN\0
D000666_D007674 CID b_5\NNP\1355326 (r_pobj) of_3\IN\0 (r_prep) potential_2\NN\14481929 (l_amod) nephrotoxic_1\JJ\0
D012964_D007674 NONE sodium_0\NN\14625458 (r_compound) status_1\NN\24720 (r_nsubj) influences_2\VBZ\5190804 (l_dobj) nephrotoxicity_6\NN\0
2505783
C004656_D006470 CID chloroacetaldehyde_7\NN\0 (r_nsubj) is_11\VBZ\0 (l_attr) metabolite_14\NN\20090 (l_relcl) carried_23\VBN\1850315 (l_prep) in_25\IN\13603305 (l_pobj) order_26\NN\7168131 (l_acl) elucidate_28\VB\939277 (l_prep) in_33\IN\13603305 (l_pobj) development_35\NN\248977 (l_prep) of_36\IN\0 (l_pobj) cystitis_38\NN\14566129
C004656_D006470 CID caa_9\NNP\0 (r_appos) chloroacetaldehyde_7\NN\0 (r_nsubj) is_11\VBZ\0 (l_attr) metabolite_14\NN\20090 (l_relcl) carried_23\VBN\1850315 (l_prep) in_25\IN\13603305 (l_pobj) order_26\NN\7168131 (l_acl) elucidate_28\VB\939277 (l_prep) in_33\IN\13603305 (l_pobj) development_35\NN\248977 (l_prep) of_36\IN\0 (l_pobj) cystitis_38\NN\14566129
C004656_D006470 CID caa_32\NNP\0 (r_pobj) of_31\IN\0 (r_prep) role_30\NN\719494 (r_dobj) elucidate_28\VB\939277 (l_prep) in_33\IN\13603305 (l_pobj) development_35\NN\248977 (l_prep) of_36\IN\0 (l_pobj) cystitis_38\NN\14566129
C004656_D001745 NONE caa_4\NNP\0 (r_nsubj) contribute_10\VB\126264 (l_prep) to_11\IN\0 (l_pobj) damage_13\NN\7296428
C004656_D003556 CID chloroacetaldehyde_7\NN\0 (r_nsubj) is_11\VBZ\0 (l_attr) metabolite_14\NN\20090 (l_relcl) carried_23\VBN\1850315 (l_prep) in_25\IN\13603305 (l_pobj) order_26\NN\7168131 (l_acl) elucidate_28\VB\939277 (l_prep) in_33\IN\13603305 (l_pobj) development_35\NN\248977 (l_prep) of_36\IN\0 (l_pobj) cystitis_38\NN\14566129
C004656_D003556 CID caa_9\NNP\0 (r_appos) chloroacetaldehyde_7\NN\0 (r_nsubj) is_11\VBZ\0 (l_attr) metabolite_14\NN\20090 (l_relcl) carried_23\VBN\1850315 (l_prep) in_25\IN\13603305 (l_pobj) order_26\NN\7168131 (l_acl) elucidate_28\VB\939277 (l_prep) in_33\IN\13603305 (l_pobj) development_35\NN\248977 (l_prep) of_36\IN\0 (l_pobj) cystitis_38\NN\14566129
C004656_D003556 CID caa_32\NNP\0 (r_pobj) of_31\IN\0 (r_prep) role_30\NN\719494 (r_dobj) elucidate_28\VB\939277 (l_prep) in_33\IN\13603305 (l_pobj) development_35\NN\248977 (l_prep) of_36\IN\0 (l_pobj) cystitis_38\NN\14566129
11532387
D004298_D001480 NONE dopamine_26\NN\14807737 (r_compound) antagonist_27\NN\7846 (r_appos) risperidone_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) profile_19\NN\6999802 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (l_nsubjpass) mechanism_2\NN\13446390 (l_prep) of_3\IN\0 (l_pobj) rs_7\NN\13635336
D004298_D001480 NONE dopamine_26\NN\14807737 (r_compound) antagonist_27\NN\7846 (r_appos) risperidone_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) profile_19\NN\6999802 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (l_advcl) suggesting_29\VBG\1010118 (l_dobj) influence_32\NN\5190804 (l_prep) in_37\IN\13603305 (l_pobj) development_39\NN\248977 (l_prep) of_40\IN\0 (l_pobj) rs_41\NN\13635336
D012701_D001480 NONE serotonin_24\NN\14807737 (r_compound) dopamine_26\NN\14807737 (r_compound) antagonist_27\NN\7846 (r_appos) risperidone_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) profile_19\NN\6999802 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (l_nsubjpass) mechanism_2\NN\13446390 (l_prep) of_3\IN\0 (l_pobj) rs_7\NN\13635336
D012701_D001480 NONE serotonin_24\NN\14807737 (r_compound) dopamine_26\NN\14807737 (r_compound) antagonist_27\NN\7846 (r_appos) risperidone_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) profile_19\NN\6999802 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (l_advcl) suggesting_29\VBG\1010118 (l_dobj) influence_32\NN\5190804 (l_prep) in_37\IN\13603305 (l_pobj) development_39\NN\248977 (l_prep) of_40\IN\0 (l_pobj) rs_41\NN\13635336
D012701_D001480 NONE serotonin_35\NN\14807737 (r_compound) system_36\NN\3575240 (r_pobj) of_33\IN\0 (r_prep) influence_32\NN\5190804 (r_dobj) suggesting_29\VBG\1010118 (r_advcl) related_15\VBN\628491 (l_nsubjpass) mechanism_2\NN\13446390 (l_prep) of_3\IN\0 (l_pobj) rs_7\NN\13635336
D012701_D001480 NONE serotonin_35\NN\14807737 (r_compound) system_36\NN\3575240 (r_pobj) of_33\IN\0 (r_prep) influence_32\NN\5190804 (l_prep) in_37\IN\13603305 (l_pobj) development_39\NN\248977 (l_prep) of_40\IN\0 (l_pobj) rs_41\NN\13635336
D018967_D013375 CID risperidone_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) reduction_7\NN\351485 (r_pobj) during_5\IN\0 (r_prep) syndrome_4\NN\5870365
D018967_D013375 CID risperidone_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) profile_19\NN\6999802 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (l_nsubjpass) mechanism_2\NN\13446390 (l_prep) of_3\IN\0 (l_pobj) rs_7\NN\13635336
D004298_D013375 NONE dopamine_26\NN\14807737 (r_compound) antagonist_27\NN\7846 (r_appos) risperidone_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) profile_19\NN\6999802 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (l_nsubjpass) mechanism_2\NN\13446390 (l_prep) of_3\IN\0 (l_pobj) rs_7\NN\13635336
D012701_D013375 NONE serotonin_24\NN\14807737 (r_compound) dopamine_26\NN\14807737 (r_compound) antagonist_27\NN\7846 (r_appos) risperidone_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) profile_19\NN\6999802 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (l_nsubjpass) mechanism_2\NN\13446390 (l_prep) of_3\IN\0 (l_pobj) rs_7\NN\13635336
D012701_D013375 NONE serotonin_35\NN\14807737 (r_compound) system_36\NN\3575240 (r_pobj) of_33\IN\0 (r_prep) influence_32\NN\5190804 (r_dobj) suggesting_29\VBG\1010118 (r_advcl) related_15\VBN\628491 (l_nsubjpass) mechanism_2\NN\13446390 (l_prep) of_3\IN\0 (l_pobj) rs_7\NN\13635336
D018967_D001480 CID risperidone_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) reduction_7\NN\351485 (r_pobj) during_5\IN\0 (r_prep) syndrome_4\NN\5870365
D018967_D001480 CID risperidone_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) reduction_6\NN\351485 (r_pobj) during_4\IN\0 (r_prep) developed_2\VBN\1753788 (l_dobj) rs_3\NN\13635336
D018967_D001480 CID risperidone_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) profile_19\NN\6999802 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (l_nsubjpass) mechanism_2\NN\13446390 (l_prep) of_3\IN\0 (l_pobj) rs_7\NN\13635336
D018967_D001480 CID risperidone_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) profile_19\NN\6999802 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (l_advcl) suggesting_29\VBG\1010118 (l_dobj) influence_32\NN\5190804 (l_prep) in_37\IN\13603305 (l_pobj) development_39\NN\248977 (l_prep) of_40\IN\0 (l_pobj) rs_41\NN\13635336
7420681
D005839_D051437 CID sulfate_25\NN\15010703 (r_pobj) of_23\IN\0 (r_prep) day_22\NN\15154774 (r_appos) kg_20\NNS\13717155 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_conj) patients_5\NNS\9898892 (r_nsubjpass) followed_36\VBN\1835496 (l_prep) for_39\IN\0 (l_pobj) development_41\NN\248977 (l_prep) of_42\IN\0 (l_pobj) failure_47\NN\66216
D005839_D051437 CID gentamicin_23\NN\2716866 (r_npadvmod) treated_25\VBN\2376958 (r_amod) patients_26\NNS\9898892 (r_pobj) of_21\IN\0 (r_prep) 16_14\CD\13745420 (r_nsubj) had_27\VBD\0 (l_dobj) failure_29\NN\66216
D005839_D051437 CID gentamicin_2\NN\2716866 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) failure_7\NN\66216
D014031_D007674 NONE tobramycin_3\JJ\2716866 (r_pobj) of_2\IN\0 (r_prep) nephrotoxicity_1\NN\0
D014031_D007674 NONE sulfate_4\NN\15010703 (r_conj) sulfate_1\NN\15010703 (r_nsubj) continue_5\VBP\2367363 (l_xcomp) demonstrate_7\VB\2137132 (l_dobj) ototoxicity_8\NN\0 (l_conj) nephrotoxicity_10\NN\0
D005839_D007674 NONE gentamicin_5\NN\2716866 (r_conj) nephrotoxicity_1\NN\0
D005839_D007674 NONE sulfate_1\NN\15010703 (r_nsubj) continue_5\VBP\2367363 (l_xcomp) demonstrate_7\VB\2137132 (l_dobj) ototoxicity_8\NN\0 (l_conj) nephrotoxicity_10\NN\0
D014031_D006311 NONE sulfate_4\NN\15010703 (r_conj) sulfate_1\NN\15010703 (r_nsubj) continue_5\VBP\2367363 (l_xcomp) demonstrate_7\VB\2137132 (l_dobj) ototoxicity_8\NN\0
D005839_D006311 NONE sulfate_1\NN\15010703 (r_nsubj) continue_5\VBP\2367363 (l_xcomp) demonstrate_7\VB\2137132 (l_dobj) ototoxicity_8\NN\0
D000617_D051437 NONE aminoglycoside_43\NN\0 (r_npadvmod) related_45\VBN\628491 (r_amod) failure_47\NN\66216
D014031_D051437 CID sulfate_28\NN\15010703 (r_conj) sulfate_25\NN\15010703 (r_pobj) of_23\IN\0 (r_prep) day_22\NN\15154774 (r_appos) kg_20\NNS\13717155 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_conj) patients_5\NNS\9898892 (r_nsubjpass) followed_36\VBN\1835496 (l_prep) for_39\IN\0 (l_pobj) development_41\NN\248977 (l_prep) of_42\IN\0 (l_pobj) failure_47\NN\66216
D014031_D051437 CID tobramycin_9\RB\2716866 (r_npadvmod) treated_11\VBN\2376958 (r_amod) patients_12\NNS\9898892 (r_pobj) of_7\IN\0 (r_prep) %_5\NN\0 (r_pobj) of_1\IN\0 (r_prep) five_0\CD\13741022 (r_nsubj) had_27\VBD\0 (l_dobj) failure_29\NN\66216
D014031_D051437 CID tobramycin_16\JJ\2716866 (r_acomp) was_15\VBD\0 (r_advcl) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) failure_7\NN\66216
12905102
D003024_D003693 CID clozapine_2\NN\3713736 (r_amod) treatment_3\NN\654885 (r_pobj) during_1\IN\0 (r_prep) delirium_0\NN\14391660
D003024_D003693 CID clozapine_7\NN\3713736 (r_compound) treatment_8\NN\654885 (r_pobj) during_6\IN\0 (r_prep) factors_3\NNS\7326557 (l_prep) for_4\IN\0 (l_pobj) delirium_5\NN\14391660
D003024_D003693 CID clozapine_13\NN\3713736 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (r_acl) inpatients_10\NNS\10405694 (r_dobj) identify_6\VB\699815 (r_xcomp) used_1\VBD\0 (l_conj) reviewed_20\VBD\644583 (l_advcl) score_25\VB\5736149 (l_dobj) incidence_26\NN\13821570 (l_prep) of_29\IN\0 (l_pobj) delirium_30\NN\14391660
D003024_D003693 CID clozapine_7\NN\3713736 (r_npadvmod) treated_9\VBN\2376958 (r_amod) inpatients_10\NNS\10405694 (r_pobj) of_6\IN\0 (r_prep) %_5\NN\0 (r_pobj) in_3\IN\13603305 (r_prep) found_2\VBN\13279262 (l_nsubjpass) delirium_0\NNP\14391660
D003024_D001523 NONE clozapine_13\NN\3713736 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (r_acl) inpatients_10\NNS\10405694 (l_amod) psychiatric_9\JJ\0
8864707
D010672_D004827 NONE phenytoin_10\NNP\3550533 (r_compound) overdosages_11\NNS\0 (r_pobj) after_9\IN\0 (r_prep) volumetry_2\NN\0 (l_prep) in_6\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_amod) epileptic_7\JJ\10595647
D010672_D062787 CID phenytoin_10\NNP\3550533 (r_compound) overdosages_11\NNS\0
D010672_D062787 CID phenytoin_3\JJ\3550533 (r_compound) overdosage_4\NN\0
D010672_D062787 CID phenytoin_17\JJ\3550533 (r_compound) medication_18\NN\3247620 (r_nsubj) was_19\VBD\0 (r_ccomp) is_14\VBZ\0 (r_conj) result_8\VB\34213 (l_nsubj) overdosage_4\NN\0
D010672_D012640 NONE phenytoin_15\JJ\3550533 (r_compound) levels_17\NNS\4916342 (r_pobj) of_14\IN\0 (r_prep) elevation_13\NN\7445480 (r_conj) duration_11\NN\15113229 (l_compound) seizure_10\NN\14081375
D010672_D002526 NONE phenytoin_11\JJ\3550533 (r_compound) medication_12\NN\3247620 (l_conj) atrophy_15\NN\14299637
D010672_D002526 NONE phenytoin_3\JJ\3550533 (r_compound) overdosage_4\NN\0 (r_nsubj) result_8\VB\34213 (l_prep) in_9\IN\13603305 (l_pobj) atrophy_11\NN\14299637
D010672_D002526 NONE phenytoin_3\JJ\3550533 (r_compound) overdosage_4\NN\0 (r_nsubj) result_8\VB\34213 (l_conj) is_14\VBZ\0 (l_ccomp) was_19\VBD\0 (l_attr) cause_22\NN\7323922 (l_prep) of_23\IN\0 (l_pobj) atrophy_25\NN\14299637
D010672_D002526 NONE phenytoin_17\JJ\3550533 (r_compound) medication_18\NN\3247620 (r_nsubj) was_19\VBD\0 (r_ccomp) is_14\VBZ\0 (r_conj) result_8\VB\34213 (l_prep) in_9\IN\13603305 (l_pobj) atrophy_11\NN\14299637
D010672_D002526 NONE phenytoin_17\JJ\3550533 (r_compound) medication_18\NN\3247620 (r_nsubj) was_19\VBD\0 (l_attr) cause_22\NN\7323922 (l_prep) of_23\IN\0 (l_pobj) atrophy_25\NN\14299637
20003049
C031942_D013921 NONE argatroban_4\NN\0 (l_prep) in_5\IN\13603305 (l_pobj) patient_9\NN\9898892 (l_prep) with_10\IN\0 (l_pobj) history_13\NN\15120823 (l_prep) of_14\IN\0 (l_pobj) thrombocytopenia_18\NN\14189204
C031942_D013921 NONE argatroban_20\NN\0 (r_oprd) administered_19\VBN\2436349 (l_nsubjpass) patient_11\JJ\9898892 (l_prep) with_12\IN\0 (l_pobj) history_15\NN\15120823 (l_prep) of_16\IN\0 (l_pobj) hitt_17\NNP\0
C031942_D013927 NONE argatroban_4\NN\0 (l_prep) in_5\IN\13603305 (l_pobj) patient_9\NN\9898892 (l_prep) with_10\IN\0 (l_pobj) history_13\NN\15120823 (l_prep) of_14\IN\0 (l_pobj) thrombocytopenia_18\NN\14189204 (l_prep) with_19\IN\0 (l_pobj) thrombosis_20\NN\14100769
C031942_D013927 NONE argatroban_20\NN\0 (r_oprd) administered_19\VBN\2436349 (l_nsubjpass) patient_11\JJ\9898892 (l_prep) with_12\IN\0 (l_pobj) history_15\NN\15120823 (l_prep) of_16\IN\0 (l_pobj) hitt_17\NNP\0
C031942_D008107 NONE argatroban_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) concentrations_2\NNS\4916342 (r_nsubjpass) measured_6\VBN\697589 (l_conj) is_42\VBZ\0 (l_attr) minutes_46\NNS\6502378 (l_appos) minutes_52\NNS\6502378 (l_prep) with_53\IN\0 (l_pobj) impairment_55\NN\7296428
C031942_D008107 NONE argatroban_25\JJ\0 (r_amod) life_27\NN\13954253 (r_npadvmod) plasma_24\NN\5398023 (r_nsubjpass) observed_36\VBN\2163746 (r_conj) measured_6\VBN\697589 (l_conj) is_42\VBZ\0 (l_attr) minutes_46\NNS\6502378 (l_appos) minutes_52\NNS\6502378 (l_prep) with_53\IN\0 (l_pobj) impairment_55\NN\7296428
C031942_D001778 NONE argatroban_3\JJ\0 (r_amod) concentration_4\NN\4916342 (r_nsubj) suggest_14\VBP\1010118 (l_ccomp) contributed_24\VBN\126264 (l_prep) to_25\IN\0 (l_pobj) coagulopathy_30\NN\0
C031942_D001778 NONE argatroban_21\NN\0 (r_amod) levels_18\NNS\4916342 (r_nsubj) contributed_24\VBN\126264 (l_prep) to_25\IN\0 (l_pobj) coagulopathy_30\NN\0
C031942_D001778 NONE argatroban_8\JJ\0 (r_amod) concentration_9\NN\4916342 (r_dobj) measure_6\VB\168237 (l_conj) extended_16\VBN\153263 (l_dobj) coagulopathy_17\NN\0
C031942_D016638 NONE argatroban_20\NN\0 (r_oprd) administered_19\VBN\2436349 (l_nsubjpass) patient_11\JJ\9898892 (l_amod) ill_10\JJ\14052403
D006493_D013927 NONE heparin_15\NN\2718259 (r_npadvmod) induced_17\VBN\1627355 (r_amod) thrombocytopenia_18\NN\14189204 (l_prep) with_19\IN\0 (l_pobj) thrombosis_20\NN\14100769
D006493_D013927 NONE heparin_18\NN\2718259 (r_npadvmod) induced_20\VBN\1627355 (r_amod) thrombocytopenia_21\NN\14189204 (r_pobj) of_17\IN\0 (r_prep) history_16\NN\15120823 (r_pobj) with_14\IN\0 (r_prep) patients_13\NNS\9898892 (r_pobj) for_12\IN\0 (r_prep) anticoagulation_11\NN\657604 (r_pobj) of_10\IN\0 (r_prep) method_9\NN\5616786 (r_dobj) provide_6\VBP\2199590 (l_conj) hit_26\VB\36762 (l_prep) with_27\IN\0 (l_pobj) thrombosis_28\NN\14100769
D006493_D013927 NONE heparin_18\NN\2718259 (r_npadvmod) induced_20\VBN\1627355 (r_amod) thrombocytopenia_21\NN\14189204 (r_pobj) of_17\IN\0 (r_prep) history_16\NN\15120823 (r_pobj) with_14\IN\0 (r_prep) patients_13\NNS\9898892 (r_pobj) for_12\IN\0 (r_prep) anticoagulation_11\NN\657604 (r_pobj) of_10\IN\0 (r_prep) method_9\NN\5616786 (r_dobj) provide_6\VBP\2199590 (l_conj) hit_26\VB\36762 (l_prep) with_27\IN\0 (l_pobj) thrombosis_28\NN\14100769 (l_appos) hitt_30\NNP\0
D006493_D013921 NONE heparin_15\NN\2718259 (r_npadvmod) induced_17\VBN\1627355 (r_amod) thrombocytopenia_18\NN\14189204
D006493_D013921 NONE heparin_18\NN\2718259 (r_npadvmod) induced_20\VBN\1627355 (r_amod) thrombocytopenia_21\NN\14189204
D006493_D013921 NONE heparin_18\NN\2718259 (r_npadvmod) induced_20\VBN\1627355 (r_amod) thrombocytopenia_21\NN\14189204 (l_appos) hit_23\NNP\36762
D006493_D013921 NONE heparin_18\NN\2718259 (r_npadvmod) induced_20\VBN\1627355 (r_amod) thrombocytopenia_21\NN\14189204 (r_pobj) of_17\IN\0 (r_prep) history_16\NN\15120823 (r_pobj) with_14\IN\0 (r_prep) patients_13\NNS\9898892 (r_pobj) for_12\IN\0 (r_prep) anticoagulation_11\NN\657604 (r_pobj) of_10\IN\0 (r_prep) method_9\NN\5616786 (r_dobj) provide_6\VBP\2199590 (l_conj) hit_26\VB\36762
D006493_D013921 NONE heparin_18\NN\2718259 (r_npadvmod) induced_20\VBN\1627355 (r_amod) thrombocytopenia_21\NN\14189204 (r_pobj) of_17\IN\0 (r_prep) history_16\NN\15120823 (r_pobj) with_14\IN\0 (r_prep) patients_13\NNS\9898892 (r_pobj) for_12\IN\0 (r_prep) anticoagulation_11\NN\657604 (r_pobj) of_10\IN\0 (r_prep) method_9\NN\5616786 (r_dobj) provide_6\VBP\2199590 (l_conj) hit_26\VB\36762 (l_prep) with_27\IN\0 (l_pobj) thrombosis_28\NN\14100769 (l_appos) hitt_30\NNP\0
17111419
D002125_C536214 NONE gluconate_5\NN\0 (r_pobj) with_2\IN\0 (r_prep) treatment_1\NN\654885 (r_nsubjpass) initiated_7\VBN\1617192 (l_conj) subsided_13\VBD\223500 (l_nsubj) contractions_11\NNS\358931
D002034_D006996 NONE bumetanide_9\NN\0 (r_nsubj) is_10\VBZ\0 (l_attr) loop_12\NN\3323703 (l_relcl) cause_16\VB\7323922 (l_dobj) hypocalcemia_18\NN\14299637
D002118_D006996 NONE calcium_9\NN\14625458 (r_compound) chelation_10\NN\29677 (r_pobj) to_8\IN\0 (r_prep) reaction_7\NN\13446390 (l_acl) resulting_15\VBG\2633881 (l_prep) in_16\IN\13603305 (l_pobj) hypocalcemia_19\NN\14299637
D049994_D006996 NONE diuretic_13\NN\3247620 (r_amod) loop_12\NN\3323703 (l_relcl) cause_16\VB\7323922 (l_dobj) hypocalcemia_18\NN\14299637
C102006_D064420 NONE citrate_1\JJ\14850483 (r_compound) toxicity_2\NN\13576101
C102006_D064420 NONE citrate_6\JJ\14850483 (r_compound) toxicity_7\NN\13576101
C102006_D064420 NONE citrate_22\JJ\14850483 (r_compound) toxicity_23\NN\13576101
C102006_D006996 CID citrate_13\NN\14850483 (r_compound) anticoagulant_14\NN\3740161 (r_pobj) by_11\IN\0 (r_prep) reaction_7\NN\13446390 (l_acl) resulting_15\VBG\2633881 (l_prep) in_16\IN\13603305 (l_pobj) hypocalcemia_19\NN\14299637
C102006_D006996 CID citrate_22\JJ\14850483 (r_compound) toxicity_23\NN\13576101 (r_pobj) to_21\IN\0 (r_pcomp) due_20\IN\5174653 (r_amod) reactions_19\NNS\13446390 (r_dobj) prevent_17\VB\0 (r_xcomp) help_16\VB\407535 (r_xcomp) recommended_14\VBN\875394 (l_nsubjpass) screening_4\NN\6887726 (l_prep) for_5\IN\0 (l_pobj) medications_6\NNS\3247620 (l_conj) conditions_9\NNS\14512817 (l_acl) predisposing_10\VBG\680841 (l_prep) to_11\IN\0 (l_pobj) hypocalcemia_12\NN\14299637
2070391
D008012_D010146 CID lidocaine_6\NN\3681148 (r_dobj) using_4\VBG\418025 (r_acl) reduction_0\NN\351485 (l_prep) in_1\IN\13603305 (l_pobj) pain_3\NN\14299637
D008012_D010146 CID lidocaine_11\NN\3681148 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) with_7\IN\0 (r_prep) associated_6\VBN\628491 (r_acl) pain_5\NN\14299637
D008012_D010146 CID lidocaine_14\NN\3681148 (r_pobj) of_13\IN\0 (r_prep) ph_12\NN\5038959 (r_dobj) adjust_10\VB\126264 (r_relcl) solution_8\NN\14586258 (r_pobj) of_5\IN\0 (r_prep) addition_4\NN\3081021 (r_nsubj) reduce_20\VB\441445 (l_dobj) pain_21\NN\14299637
D008012_D010146 CID lidocaine_13\NN\3681148 (r_dobj) receiving_11\VBG\2210855 (r_pcomp) after_10\IN\0 (r_prep) quantify_5\VB\947077 (l_dobj) severity_7\NN\5036394 (l_prep) of_8\IN\0 (l_pobj) pain_9\NN\14299637
D008012_D010146 CID lidocaine_20\NN\3681148 (r_conj) receiving_11\VBG\2210855 (r_pcomp) after_10\IN\0 (r_prep) quantify_5\VB\947077 (l_dobj) severity_7\NN\5036394 (l_prep) of_8\IN\0 (l_pobj) pain_9\NN\14299637
D008012_D010146 CID lidocaine_6\NN\3681148 (r_pobj) for_4\IN\0 (r_prep) score_3\NN\5736149 (l_compound) pain_2\NN\14299637
D008012_D010146 CID lidocaine_16\NN\3681148 (r_pobj) for_14\IN\0 (r_prep) score_13\NN\5736149 (r_pobj) than_10\IN\0 (r_prep) lower_9\JJR\2831724 (r_acomp) was_7\VBD\0 (l_nsubj) score_3\NN\5736149 (l_compound) pain_2\NN\14299637
D008012_D010146 CID lidocaine_5\NN\3681148 (r_pobj) of_3\IN\0 (r_prep) adjustment_2\NN\7357388 (r_nsubjpass) accomplished_8\VBN\484166 (l_prep) in_10\IN\13603305 (l_pobj) laboratory_13\NN\4602044 (l_prep) before_14\IN\0 (l_pobj) injection_15\NN\320852 (l_prep) in_18\IN\13603305 (l_pobj) reduction_20\NN\351485 (l_prep) of_21\IN\0 (l_pobj) pain_23\NN\14299637
2611118
D004008_D056486 CID diclofenac_23\NNP\0 (r_pobj) by_22\IN\0 (r_agent) induced_21\VBN\1627355 (r_conj) recorded_13\VBN\2225492 (l_nsubjpass) abnormalities_7\NNS\14034177 (l_prep) of_8\IN\0 (l_pobj) function_10\NN\13783581
D004008_D056486 CID diclofenac_23\NNP\0 (r_pobj) by_22\IN\0 (r_agent) induced_21\VBN\1627355 (l_nsubj) hepatitis_20\NN\14127211
D004008_D006521 NONE sodium_6\NN\14625458 (r_compound) therapy_7\NN\657604 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) hepatitis_2\NN\14127211
D004008_D006521 NONE sodium_13\NN\14625458 (r_pobj) with_11\IN\0 (r_prep) therapy_10\NN\657604 (r_pobj) after_7\IN\0 (r_prep) developed_3\VBD\1753788 (l_dobj) hepatitis_6\NN\14127211
2484011
D002395_D011596 NONE catecholamine_18\NN\5407119 (r_compound) rate_20\NN\13815152 (r_pobj) of_17\IN\0 (r_prep) decrease_16\NN\7296428 (l_conj) increase_29\NN\13576355 (l_relcl) account_38\VB\6647206 (l_prep) for_39\IN\0 (l_pobj) depression_42\NN\14373582
D000547_D011596 CID amantadine_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) readministration_0\NN\0 (r_nsubj) increased_12\VBN\169651 (l_prep) with_21\IN\0 (l_pobj) exception_22\NN\5706954 (l_prep) of_23\IN\0 (l_pobj) mice_28\NNS\2329401 (l_relcl) occurred_33\VBD\0 (l_nsubj) suppression_30\NN\13489037 (l_prep) of_31\IN\0 (l_pobj) motility_32\NN\4773351
D000547_D011596 CID amantadine_45\NN\0 (r_pobj) by_44\IN\0 (r_agent) caused_43\VBN\1617192 (r_acl) depression_42\NN\14373582
D000588_D011596 NONE amines_6\NNS\14951377 (r_pobj) of_3\IN\0 (r_prep) results_2\NNS\34213 (r_nsubj) suggest_13\VBP\1010118 (l_dobj) decrease_16\NN\7296428 (l_conj) increase_29\NN\13576355 (l_relcl) account_38\VB\6647206 (l_prep) for_39\IN\0 (l_pobj) depression_42\NN\14373582
D009638_D011596 NONE norepinephrine_35\NN\14807929 (r_pobj) of_34\IN\0 (r_prep) methylation_33\NN\0 (r_pobj) in_30\IN\13603305 (r_prep) increase_29\NN\13576355 (l_relcl) account_38\VB\6647206 (l_prep) for_39\IN\0 (l_pobj) depression_42\NN\14373582
D000547_D003866 NONE amantadine_4\JJ\0 (r_nmod) activity_7\NN\30358 (l_amod) depressed_5\JJ\1819147
9754849
D003932_D002819 NONE heroine_30\NN\5929008 (r_dobj) abusing_29\VBG\2514187 (r_acl) inpatient_27\NN\10405694 (r_pobj) in_25\IN\13603305 (r_prep) adjustment_15\NN\7357388 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_xcomp) choreoathetoid_8\JJ\0 (l_dobj) movements_9\NNS\191142
D003042_D002819 CID cocaine_12\NN\3492717 (r_pobj) with_11\IN\0 (r_prep) intoxications_10\NNS\14034177 (r_pobj) during_9\IN\0 (r_prep) be_5\VB\14625458 (r_xcomp) known_3\VBN\0 (l_nsubjpass) hyperkinesias_1\NNS\0
D003042_D002819 CID cocaine_32\NN\3492717 (r_conj) heroine_30\NN\5929008 (r_dobj) abusing_29\VBG\2514187 (r_acl) inpatient_27\NN\10405694 (r_pobj) in_25\IN\13603305 (r_prep) adjustment_15\NN\7357388 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_xcomp) choreoathetoid_8\JJ\0 (l_dobj) movements_9\NNS\191142
D008691_D002819 CID methadone_7\NN\3808564 (r_pobj) to_6\IN\0 (r_prep) adjustment_5\NN\7357388 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) movements_1\NNS\191142
D008691_D002819 CID methadone_24\NN\3808564 (r_pobj) to_16\IN\0 (r_prep) adjustment_15\NN\7357388 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_xcomp) choreoathetoid_8\JJ\0 (l_dobj) movements_9\NNS\191142
D003042_D020820 NONE cocaine_12\NN\3492717 (r_pobj) with_11\IN\0 (r_prep) intoxications_10\NNS\14034177 (r_pobj) during_9\IN\0 (r_prep) be_5\VB\14625458 (l_attr) abnormalities_8\NNS\14034177
D003042_D006948 CID cocaine_12\NN\3492717 (r_pobj) with_11\IN\0 (r_prep) intoxications_10\NNS\14034177 (r_pobj) during_9\IN\0 (r_prep) be_5\VB\14625458 (r_xcomp) known_3\VBN\0 (l_nsubjpass) hyperkinesias_1\NNS\0
354896
D008012_D003866 NONE lidocaine_8\NN\3681148 (r_pobj) of_7\IN\0 (r_prep) bolus_6\NN\13899404 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) resulted_15\VBD\2633881 (l_prep) in_16\IN\13603305 (l_pobj) depression_18\NN\14373582
D008012_D006323 CID lidocaine_0\NN\3681148 (r_npadvmod) induced_2\VBN\1627355 (r_amod) asystole_4\NN\14204950
D008012_D001919 NONE lidocaine_29\NN\3681148 (r_pobj) to_28\IN\0 (r_prep) idiosyncrasy_27\NN\4763925 (r_dobj) represented_24\VBD\2664769 (r_conj) had_2\VBD\0 (l_dobj) conditions_6\NNS\14512817 (l_relcl) predisposed_10\VBN\680841 (l_prep) to_12\IN\0 (l_pobj) development_14\NN\248977 (l_prep) of_15\IN\0 (l_pobj) bradyarrhythmias_16\NNS\0
20619828
D002997_-1 NONE clomipramine_0\NNP\4482543 (r_compound) exposure_1\NN\5042871 (r_nsubj) produced_5\VBD\1617192 (l_npadvmod) inflexibility_25\NN\5023741
D002997_-1 NONE clomipramine_0\NNP\4482543 (r_compound) exposure_1\NN\5042871 (r_nsubj) produced_5\VBD\1617192 (l_npadvmod) inflexibility_25\NN\5023741 (l_appos) impairment_41\NN\7296428 (l_conj) hoarding_51\NN\4217882 (l_conj) dysfunction_55\NN\14204950
D002997_D060845 CID clomipramine_0\NNP\4482543 (r_compound) exposure_1\NN\5042871 (r_nsubj) produced_5\VBD\1617192 (l_npadvmod) inflexibility_25\NN\5023741 (l_appos) impairment_41\NN\7296428 (l_conj) hoarding_51\NN\4217882
D002997_D008569 CID clomipramine_0\NNP\4482543 (r_compound) exposure_1\NN\5042871 (r_nsubj) produced_5\VBD\1617192 (l_npadvmod) inflexibility_25\NN\5023741 (l_appos) impairment_41\NN\7296428
D002997_D001008 CID clomipramine_0\NNP\4482543 (r_compound) exposure_1\NN\5042871 (r_nsubj) produced_5\VBD\1617192 (l_dobj) changes_10\NNS\7283608 (l_relcl) include_12\VBP\0 (l_dobj) anxiety_14\NN\14373582
18329269
D006220_D002375 CID haloperidol_36\NN\3713736 (r_npadvmod) induced_38\VBN\1627355 (r_amod) model_40\NN\5888929 (l_compound) catalepsy_39\NN\14023236
D006220_D010300 NONE haloperidol_36\NN\3713736 (r_npadvmod) induced_38\VBN\1627355 (r_amod) model_40\NN\5888929 (l_prep) for_41\IN\0 (l_pobj) disease_44\NN\14061805
18752389
D019821_D017114 NONE simvastatin_21\NN\3676175 (r_nmod) day_25\NN\15154774 (r_pobj) from_20\IN\0 (r_prep) conversion_19\NN\7359599 (r_pobj) after_18\IN\0 (r_prep) necessitating_13\VBG\0 (r_acl) failure_12\NN\66216
C492458_D017093 NONE ezetimibe_2\NN\0 (r_npadvmod) induced_4\VBN\1627355 (r_amod) failure_6\NN\66216
C492458_D017093 NONE ezetimibe_13\NN\0 (r_npadvmod) induced_15\VBN\1627355 (r_amod) failure_17\NN\66216
C532833_D056486 NONE acid_25\NN\14818238 (r_pobj) of_22\IN\0 (r_prep) glucuronidation_21\NN\0 (r_dobj) inhibited_19\VBN\2510337 (l_advcl) resulting_27\VBG\2633881 (l_prep) in_28\IN\13603305 (l_pobj) exposure_31\NN\5042871 (l_conj) hepatotoxicity_34\NN\0
D015283_D003866 NONE escitalopram_2\NNP\0 (r_conj) simvastatinezetimibe_0\NNP\0 (l_relcl) taking_7\VBG\37396 (l_prep) for_8\IN\0 (l_pobj) depression_9\NN\14373582
C492458_D056486 CID ezetimibe_17\NN\0 (r_appos) agent_14\NN\7347 (r_conj) ezetimibe_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) published_8\VBN\1621555 (l_nsubjpass) events_3\NNS\23100 (l_amod) hepatotoxic_2\JJ\0
C492458_D056486 CID simvastatinezetimibe_0\NNP\0 (r_nsubjpass) discontinued_12\VBN\0 (l_conj) excluded_21\VBN\471711 (l_nsubjpass) causes_17\NNS\7323922 (l_prep) of_18\IN\0 (l_pobj) hepatotoxicity_19\NN\0
C492458_D056486 CID simvastatinezetimibe_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hepatotoxicity_10\NN\0
C492458_D056486 CID ezetimibe_10\NN\0 (r_pobj) with_7\IN\0 (r_prep) hepatotoxicity_6\NN\0
C492458_D003866 NONE simvastatinezetimibe_0\NNP\0 (l_relcl) taking_7\VBG\37396 (l_prep) for_8\IN\0 (l_pobj) depression_9\NN\14373582
C108606_D056486 NONE ezetimibe_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) published_8\VBN\1621555 (l_nsubjpass) events_3\NNS\23100 (l_amod) hepatotoxic_2\JJ\0
C108606_D056486 NONE ezetimibe_0\NNP\0 (r_nsubj) undergoes_1\VBZ\109660 (l_conj) inhibited_19\VBN\2510337 (l_advcl) resulting_27\VBG\2633881 (l_prep) in_28\IN\13603305 (l_pobj) exposure_31\NN\5042871 (l_conj) hepatotoxicity_34\NN\0
C108606_D056486 NONE ezetimibe_17\NN\0 (r_compound) inhibition_18\NN\1068773 (r_pobj) by_16\IN\0 (r_prep) exposure_15\NN\5042871 (r_attr) is_11\VBZ\0 (l_nsubj) mechanism_4\NN\13446390 (l_prep) of_5\IN\0 (l_pobj) hepatotoxicity_10\NN\0
D014530_D056486 NONE diphosphate_6\NN\0 (r_compound) glucoronosyltransferases_7\NNS\0 (r_pobj) by_4\IN\0 (r_prep) glucuronidation_3\NN\0 (r_dobj) undergoes_1\VBZ\109660 (l_conj) inhibited_19\VBN\2510337 (l_advcl) resulting_27\VBG\2633881 (l_prep) in_28\IN\13603305 (l_pobj) exposure_31\NN\5042871 (l_conj) hepatotoxicity_34\NN\0
D019821_D056486 NONE simvastatin_9\NN\3676175 (r_pobj) with_8\IN\0 (r_prep) maintained_7\VBN\0 (l_prep) for_10\IN\0 (l_pobj) months_12\NNS\15113229 (l_prep) before_13\IN\0 (l_pobj) conversion_15\NN\7359599 (l_prep) without_16\IN\0 (l_pobj) evidence_17\NN\5816287 (l_prep) of_18\IN\0 (l_pobj) hepatotoxicity_19\NN\0
D019821_D056486 NONE simvastatin_30\NN\3676175 (r_amod) exposure_31\NN\5042871 (l_conj) hepatotoxicity_34\NN\0
D019821_D056486 NONE simvastatin_14\NN\3676175 (r_amod) exposure_15\NN\5042871 (r_attr) is_11\VBZ\0 (l_nsubj) mechanism_4\NN\13446390 (l_prep) of_5\IN\0 (l_pobj) hepatotoxicity_10\NN\0
D015283_D056486 NONE escitalopram_2\NNP\0 (r_conj) simvastatinezetimibe_0\NNP\0 (r_nsubjpass) discontinued_12\VBN\0 (l_conj) excluded_21\VBN\471711 (l_nsubjpass) causes_17\NNS\7323922 (l_prep) of_18\IN\0 (l_pobj) hepatotoxicity_19\NN\0
C492458_D017114 CID mg_33\NN\13717155 (r_nummod) day_35\NN\15154774 (r_npadvmod) ezetimibe_31\NN\0 (r_dobj) simvastatin_27\NN\3676175 (r_advcl) necessitating_13\VBG\0 (r_acl) failure_12\NN\66216
8996652
D005665_D006311 NONE furosemide_19\NN\3214670 (r_conj) aminoglycosides_17\NNS\0 (r_appos) administration_7\NN\1133281 (r_pobj) to_4\IN\0 (r_prep) related_3\JJ\628491 (r_oprd) appeared_1\VBD\2604760 (l_nsubj) ototoxicity_0\NN\0
D005665_D006311 NONE furosemide_19\NN\3214670 (r_conj) aminoglycosides_17\NNS\0 (r_appos) administration_7\NN\1133281 (l_conj) dose_11\NN\3740161 (l_prep) of_12\IN\0 (l_pobj) drugs_14\NNS\14778436 (l_compound) ototoxic_13\JJ\0
D000617_D006311 NONE aminoglycosides_17\NNS\0 (r_appos) administration_7\NN\1133281 (r_pobj) to_4\IN\0 (r_prep) related_3\JJ\628491 (r_oprd) appeared_1\VBD\2604760 (l_nsubj) ototoxicity_0\NN\0
D000617_D006311 NONE aminoglycosides_17\NNS\0 (r_appos) administration_7\NN\1133281 (l_conj) dose_11\NN\3740161 (l_prep) of_12\IN\0 (l_pobj) drugs_14\NNS\14778436 (l_compound) ototoxic_13\JJ\0
19759529
D006220_D006948 NONE haloperidol_5\NN\3713736 (r_nmod) antipsychotics_16\NNS\4470232 (r_nsubj) were_17\VBD\0 (l_acomp) effective_18\JJ\0 (l_prep) in_19\IN\13603305 (l_pobj) models_22\NNS\5888929 (l_prep) of_23\IN\0 (l_pobj) hyperactivity_24\NN\14052403
-1_D006948 NONE ssr103800_12\NNP\0 (r_pobj) of_11\IN\0 (r_prep) properties_10\NNS\32613 (r_dobj) investigating_4\VBG\575741 (l_prep) with_14\IN\0 (l_pobj) focus_17\NN\5704266 (l_prep) on_18\IN\0 (l_pobj) models_19\NNS\5888929 (l_prep) of_20\IN\0 (l_pobj) hyperactivity_21\NN\14052403
-1_D006948 NONE ssr103800_3\NNP\0 (r_nmod) hyperactivity_12\NN\14052403
-1_D006948 NONE ssr103800_3\NNP\0 (r_nmod) hyperactivity_12\NN\14052403 (r_punct) that_2\IN\0 (r_dobj) showed_1\VBD\2137132 (l_conj) reversed_26\VBD\109660 (l_dobj) hyperactivity_28\NN\14052403
-1_D006948 NONE ssr103800_3\NNP\0 (r_nsubj) failed_4\VBD\0 (l_xcomp) affect_6\VB\26192 (l_dobj) hyperactivity_7\NN\14052403
-1_D002375 NONE ssr103800_6\NNP\0 (r_nsubj) produce_9\VB\7555863 (l_dobj) catalepsy_10\NN\14023236
D016202_D012559 NONE aspartate_15\NNP\0 (r_appos) methyl_11\NN\14617189 (r_nmod) receptor_19\NN\5225602 (r_pobj) of_6\IN\0 (r_prep) antagonists_5\NNS\7846 (r_nsubj) produce_20\VBP\7555863 (l_dobj) symptoms_24\NNS\5823932 (l_amod) like_23\JJ\5839024 (l_npadvmod) schizophrenic_21\JJ\10490141
D016202_D012559 NONE nmda_17\NNP\0 (r_nmod) receptor_19\NN\5225602 (r_pobj) of_6\IN\0 (r_prep) antagonists_5\NNS\7846 (r_nsubj) produce_20\VBP\7555863 (l_dobj) symptoms_24\NNS\5823932 (l_amod) like_23\JJ\5839024 (l_npadvmod) schizophrenic_21\JJ\10490141
D016202_D012559 NONE nmda_41\NNP\0 (r_compound) receptor_42\NN\5225602 (r_pobj) via_39\IN\0 (r_prep) dysfunctioning_34\NN\0 (r_pobj) of_32\IN\0 (r_prep) idea_31\NN\5809192 (r_pobj) to_29\IN\0 (r_prep) led_28\VBN\3202760 (l_nsubj) observation_3\NN\996969 (l_relcl) produce_20\VBP\7555863 (l_dobj) symptoms_24\NNS\5823932 (l_amod) like_23\JJ\5839024 (l_npadvmod) schizophrenic_21\JJ\10490141
D004298_D006948 NONE dopamine_15\NN\14807737 (r_compound) transporter_16\NN\4490091 (r_pobj) in_14\IN\13603305 (r_prep) observed_13\VBN\2163746 (r_conj) failed_4\VBD\0 (l_xcomp) affect_6\VB\26192 (l_dobj) hyperactivity_7\NN\14052403
D000661_D006948 CID amphetamine_30\NN\3248958 (r_appos) challenge_26\NN\13927383 (r_dobj) involving_23\VBG\2676054 (r_prep) properties_10\NNS\32613 (r_dobj) investigating_4\VBG\575741 (l_prep) with_14\IN\0 (l_pobj) focus_17\NN\5704266 (l_prep) on_18\IN\0 (l_pobj) models_19\NNS\5888929 (l_prep) of_20\IN\0 (l_pobj) hyperactivity_21\NN\14052403
D000661_D006948 CID amphetamine_10\NN\3248958 (r_pobj) by_9\IN\0 (r_agent) induced_8\VBN\1627355 (r_acl) hyperactivity_7\NN\14052403
D003024_D006948 NONE clozapine_12\NN\3713736 (r_nmod) antipsychotics_16\NNS\4470232 (r_nsubj) were_17\VBD\0 (l_acomp) effective_18\JJ\0 (l_prep) in_19\IN\13603305 (l_pobj) models_22\NNS\5888929 (l_prep) of_23\IN\0 (l_pobj) hyperactivity_24\NN\14052403
D016291_D006948 CID mk-801_32\NNP\0 (r_punct) )_33\-RRB-\0 (r_punct) amphetamine_30\NN\3248958 (r_appos) challenge_26\NN\13927383 (r_dobj) involving_23\VBG\2676054 (r_prep) properties_10\NNS\32613 (r_dobj) investigating_4\VBG\575741 (l_prep) with_14\IN\0 (l_pobj) focus_17\NN\5704266 (l_prep) on_18\IN\0 (l_pobj) models_19\NNS\5888929 (l_prep) of_20\IN\0 (l_pobj) hyperactivity_21\NN\14052403
D016291_D006948 CID mk-801_23\NNP\0 (r_punct) and_24\CC\0 (r_cc) showed_1\VBD\2137132 (l_dobj) that_2\IN\0 (l_punct) hyperactivity_12\NN\14052403
D016291_D006948 CID mk-801_23\NNP\0 (r_punct) and_24\CC\0 (r_cc) showed_1\VBD\2137132 (l_conj) reversed_26\VBD\109660 (l_dobj) hyperactivity_28\NN\14052403
C094645_D006948 NONE aripiprazole_14\NN\0 (r_conj) clozapine_12\NN\3713736 (r_nmod) antipsychotics_16\NNS\4470232 (r_nsubj) were_17\VBD\0 (l_acomp) effective_18\JJ\0 (l_prep) in_19\IN\13603305 (l_pobj) models_22\NNS\5888929 (l_prep) of_23\IN\0 (l_pobj) hyperactivity_24\NN\14052403
D004298_D012559 NONE dopamine_8\NN\14807737 (r_compound) neurotransmission_9\NN\0 (r_pobj) in_7\IN\13603305 (r_prep) dysfunction_6\NN\14204950 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (l_nsubjpass) schizophrenia_0\NNP\14398067
D018698_D012559 NONE glutamate_8\NN\15010703 (r_nmod) receptor_19\NN\5225602 (r_pobj) of_6\IN\0 (r_prep) antagonists_5\NNS\7846 (r_nsubj) produce_20\VBP\7555863 (l_dobj) symptoms_24\NNS\5823932 (l_amod) like_23\JJ\5839024 (l_npadvmod) schizophrenic_21\JJ\10490141
D016202_D006948 NONE nmda_40\NNP\0 (r_compound) nr1(neo-/-_41\NNP\0 (r_appos) mice_36\NNS\2329401 (r_conj) challenge_26\NN\13927383 (r_dobj) involving_23\VBG\2676054 (r_prep) properties_10\NNS\32613 (r_dobj) investigating_4\VBG\575741 (l_prep) with_14\IN\0 (l_pobj) focus_17\NN\5704266 (l_prep) on_18\IN\0 (l_pobj) models_19\NNS\5888929 (l_prep) of_20\IN\0 (l_pobj) hyperactivity_21\NN\14052403
D016202_D006948 NONE nmda_19\NNP\0 (r_compound) antagonist_21\NN\7846 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_acl) hyperactivity_12\NN\14052403
D016202_D006948 NONE nmda_19\NNP\0 (r_compound) antagonist_21\NN\7846 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_acl) hyperactivity_12\NN\14052403 (r_punct) that_2\IN\0 (r_dobj) showed_1\VBD\2137132 (l_conj) reversed_26\VBD\109660 (l_dobj) hyperactivity_28\NN\14052403
D016202_D006948 NONE nmda_30\NNP\0 (r_nmod) mice_33\NNS\2329401 (r_pobj) of_29\IN\0 (r_prep) hyperactivity_28\NN\14052403 (r_dobj) reversed_26\VBD\109660 (r_conj) showed_1\VBD\2137132 (l_dobj) that_2\IN\0 (l_punct) hyperactivity_12\NN\14052403
D016202_D006948 NONE nmda_30\NNP\0 (r_nmod) mice_33\NNS\2329401 (r_pobj) of_29\IN\0 (r_prep) hyperactivity_28\NN\14052403
C076029_D006948 NONE olanzapine_10\NN\0 (r_nmod) clozapine_12\NN\3713736 (r_nmod) antipsychotics_16\NNS\4470232 (r_nsubj) were_17\VBD\0 (l_acomp) effective_18\JJ\0 (l_prep) in_19\IN\13603305 (l_pobj) models_22\NNS\5888929 (l_prep) of_23\IN\0 (l_pobj) hyperactivity_24\NN\14052403
8170551
D000086_D053040 NONE acetazolamide_0\RB\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) nephrolithiasis_3\NN\14115914
D000086_D053040 NONE acetazolamide_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) complication_3\NN\1073995 (r_attr) is_1\VBZ\0 (l_nsubj) nephrolithiasis_0\NNP\14115914
D000086_D007669 CID acetazolamide_3\NN\0 (r_pobj) on_2\IN\0 (r_prep) patients_1\NNS\9898892 (r_nsubj) developed_8\VBN\1753788 (l_dobj) calculi_10\NNS\9416076
D000086_D009468 NONE acetazolamide_0\RB\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) nephrolithiasis_3\NN\14115914 (l_appos) implications_5\NNS\5774614 (l_prep) for_6\IN\0 (l_pobj) treatment_7\NN\654885 (l_prep) of_8\IN\0 (l_pobj) disorders_10\NNS\14034177
10342929
D000806_D000799 CID inhibitors_4\NNS\20090 (r_pobj) to_2\IN\0 (r_pcomp) due_1\IN\5174653 (r_prep) angioedema_0\NNP\14316714
D000806_D000799 CID inhibitor_13\NN\20090 (r_compound) treatment_14\NN\654885 (r_nsubj) is_15\VBZ\0 (l_nsubj) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) angioedema_4\NN\14316714
15275829
D009538_D012640 CID nicotine_11\NN\14712692 (r_npadvmod) induced_13\VBN\1627355 (r_amod) seizures_14\NNS\14081375
D009538_D012640 CID nicotine_2\NN\14712692 (r_pobj) of_1\IN\0 (r_prep) binding_0\NN\4688246 (r_nsubj) elicits_10\VBZ\1617192 (l_dobj) series_12\NN\8456993 (l_prep) of_13\IN\0 (l_pobj) behaviors_17\NNS\407535 (l_relcl) go_19\VBP\15291801 (l_prep) to_29\IN\0 (l_pobj) seizures_30\NNS\14081375
D009538_D012640 CID nicotine_9\NN\14712692 (r_npadvmod) induced_11\VBN\1627355 (r_amod) seizures_12\NNS\14081375
D009538_D012640 CID nicotine_10\NN\14712692 (r_pobj) of_9\IN\0 (r_prep) effects_8\NNS\13245626 (r_pobj) to_6\IN\0 (r_prep) sensitive_5\JJ\10488309 (r_acomp) were_3\VBD\0 (l_advcl) measured_16\VBN\697589 (l_conj) measured_30\VBN\697589 (l_prep) as_31\IN\14622893 (l_pobj) sensitivity_32\NN\5651971 (l_prep) to_33\IN\0 (l_pobj) seizures_37\NNS\14081375
D009538_D012640 CID nicotine_34\NN\14712692 (r_npadvmod) induced_36\VBN\1627355 (r_amod) seizures_37\NNS\14081375
D009538_D012640 CID nicotine_7\NN\14712692 (r_npadvmod) induced_9\VBN\1627355 (r_amod) seizures_10\NNS\14081375
D009538_D012640 CID nicotine_15\NN\14712692 (r_npadvmod) induced_17\VBN\1627355 (r_amod) seizures_18\NNS\14081375
D009538_D014202 NONE nicotine_2\NN\14712692 (r_pobj) of_1\IN\0 (r_prep) binding_0\NN\4688246 (r_nsubj) elicits_10\VBZ\1617192 (l_dobj) series_12\NN\8456993 (l_prep) of_13\IN\0 (l_pobj) behaviors_17\NNS\407535 (l_relcl) go_19\VBP\15291801 (l_prep) from_20\IN\0 (l_pobj) exploration_22\NN\309647 (l_conj) sedation_24\NN\14034177 (l_conj) tremors_27\NNS\345926
D000109_D006948 NONE acetylcholine_5\NN\14807558 (r_compound) subunits_7\NNS\13604718 (r_nsubj) are_8\VBP\13600404 (l_prep) for_10\IN\0 (l_pobj) seizures_14\NNS\14081375 (l_conj) hypolocomotion_16\NN\0
D009538_D006948 NONE nicotine_11\NN\14712692 (r_npadvmod) induced_13\VBN\1627355 (r_amod) seizures_14\NNS\14081375 (l_conj) hypolocomotion_16\NN\0
D009538_D006948 NONE nicotine_9\NN\14712692 (r_npadvmod) induced_11\VBN\1627355 (r_amod) seizures_12\NNS\14081375 (r_pobj) in_8\IN\13603305 (r_prep) subunits_7\NNS\13604718 (l_conj) hypolocomotion_14\NN\0
D009538_D006948 NONE nicotine_15\NN\14712692 (r_npadvmod) induced_17\VBN\1627355 (r_amod) seizures_18\NNS\14081375 (l_conj) hypolocomotion_20\NN\0
D000109_D003643 NONE acetylcholine_5\NN\14807558 (r_compound) receptors_6\NNS\5225602 (r_pobj) to_3\IN\0 (r_prep) binding_0\NN\4688246 (r_nsubj) elicits_10\VBZ\1617192 (l_dobj) series_12\NN\8456993 (l_prep) of_13\IN\0 (l_pobj) behaviors_17\NNS\407535 (l_relcl) go_19\VBP\15291801 (l_prep) to_29\IN\0 (l_pobj) seizures_30\NNS\14081375 (l_conj) death_32\NN\7296428
D000109_D012640 NONE acetylcholine_5\NN\14807558 (r_compound) subunits_7\NNS\13604718 (r_nsubj) are_8\VBP\13600404 (l_prep) for_10\IN\0 (l_pobj) seizures_14\NNS\14081375
D000109_D012640 NONE acetylcholine_5\NN\14807558 (r_compound) receptors_6\NNS\5225602 (r_pobj) to_3\IN\0 (r_prep) binding_0\NN\4688246 (r_nsubj) elicits_10\VBZ\1617192 (l_dobj) series_12\NN\8456993 (l_prep) of_13\IN\0 (l_pobj) behaviors_17\NNS\407535 (l_relcl) go_19\VBP\15291801 (l_prep) to_29\IN\0 (l_pobj) seizures_30\NNS\14081375
D000109_D014202 NONE acetylcholine_5\NN\14807558 (r_compound) receptors_6\NNS\5225602 (r_pobj) to_3\IN\0 (r_prep) binding_0\NN\4688246 (r_nsubj) elicits_10\VBZ\1617192 (l_dobj) series_12\NN\8456993 (l_prep) of_13\IN\0 (l_pobj) behaviors_17\NNS\407535 (l_relcl) go_19\VBP\15291801 (l_prep) from_20\IN\0 (l_pobj) exploration_22\NN\309647 (l_conj) sedation_24\NN\14034177 (l_conj) tremors_27\NNS\345926
D009538_D003643 NONE nicotine_2\NN\14712692 (r_pobj) of_1\IN\0 (r_prep) binding_0\NN\4688246 (r_nsubj) elicits_10\VBZ\1617192 (l_dobj) series_12\NN\8456993 (l_prep) of_13\IN\0 (l_pobj) behaviors_17\NNS\407535 (l_relcl) go_19\VBP\15291801 (l_prep) to_29\IN\0 (l_pobj) seizures_30\NNS\14081375 (l_conj) death_32\NN\7296428
9812111
D006220_D011595 NONE haloperidol_12\NN\3713736 (r_appos) a_7\NNP\13649268 (r_dobj) completed_5\VBD\352826 (r_relcl) patients_3\NNS\9898892 (r_pobj) for_0\IN\0 (r_prep) was_13\VBD\0 (l_acomp) efficacious_14\JJ\0 (l_prep) to_17\IN\0 (l_pobj) haloperidol_22\NN\3713736 (l_prep) for_25\IN\0 (l_pobj) scores_26\NNS\13757724 (l_prep) on_27\IN\0 (l_conj) on_36\IN\0 (l_pobj) agitation_38\NN\14373582
D006220_D011595 NONE haloperidol_22\NN\3713736 (l_prep) for_25\IN\0 (l_pobj) scores_26\NNS\13757724 (l_prep) on_27\IN\0 (l_conj) on_36\IN\0 (l_pobj) agitation_38\NN\14373582
D006220_D000544 NONE haloperidol_11\NN\3713736 (l_prep) for_12\IN\0 (l_pobj) psychosis_13\NN\14380140 (l_prep) in_17\IN\13603305 (l_pobj) disease_20\NN\14061805
D006220_D000544 NONE haloperidol_17\NN\3713736 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_pobj) of_13\IN\0 (r_prep) efficacy_9\NN\5199286 (r_dobj) compare_7\VB\4744814 (l_prep) in_20\IN\13603305 (l_pobj) treatment_22\NN\654885 (l_prep) in_28\IN\13603305 (l_pobj) patients_29\NNS\9898892 (l_prep) with_30\IN\0 (l_pobj) disease_33\NN\14061805
D006220_D000544 NONE haloperidol_20\NN\3713736 (r_appos) phase_16\NN\15113229 (r_preconj) in_0\IN\13603305 (r_prep) compared_48\VBN\644583 (l_prep) in_49\IN\13603305 (l_pobj) outpatients_51\NNS\10405694 (l_prep) with_52\IN\0 (l_pobj) disease_55\NN\14061805
D006220_D000544 NONE haloperidol_34\NN\3713736 (r_conj) phase_16\NN\15113229 (r_preconj) in_0\IN\13603305 (r_prep) compared_48\VBN\644583 (l_prep) in_49\IN\13603305 (l_pobj) outpatients_51\NNS\10405694 (l_prep) with_52\IN\0 (l_pobj) disease_55\NN\14061805
D006220_D000544 NONE haloperidol_6\NN\3713736 (r_pobj) with_5\IN\0 (r_prep) observed_4\VBN\2163746 (r_nsubj) apply_9\VB\0 (l_prep) to_10\IN\0 (l_pobj) neuroleptics_12\NNS\4470232 (l_acl) used_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_compound) disease_17\NN\14061805
D006220_D019958 NONE haloperidol_11\NN\3713736 (l_prep) for_12\IN\0 (l_pobj) psychosis_13\NN\14380140 (l_conj) behaviors_16\NNS\407535
D006220_D019958 NONE haloperidol_17\NN\3713736 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_pobj) of_13\IN\0 (r_prep) efficacy_9\NN\5199286 (r_dobj) compare_7\VB\4744814 (l_prep) in_20\IN\13603305 (l_pobj) treatment_22\NN\654885 (l_prep) of_23\IN\0 (l_pobj) psychosis_24\NN\14380140 (l_conj) behaviors_27\NNS\407535
D006220_D019958 NONE haloperidol_6\NN\3713736 (r_pobj) with_5\IN\0 (r_prep) observed_4\VBN\2163746 (r_nsubj) apply_9\VB\0 (l_prep) to_10\IN\0 (l_pobj) neuroleptics_12\NNS\4470232 (l_acl) used_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) psychosis_20\NN\14380140 (l_conj) behaviors_23\NNS\407535
D006220_D011618 NONE haloperidol_11\NN\3713736 (l_prep) for_12\IN\0 (l_pobj) psychosis_13\NN\14380140
D006220_D011618 NONE haloperidol_17\NN\3713736 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_pobj) of_13\IN\0 (r_prep) efficacy_9\NN\5199286 (r_dobj) compare_7\VB\4744814 (l_prep) in_20\IN\13603305 (l_pobj) treatment_22\NN\654885 (l_prep) of_23\IN\0 (l_pobj) psychosis_24\NN\14380140
D006220_D011618 NONE haloperidol_12\NN\3713736 (r_appos) a_7\NNP\13649268 (r_dobj) completed_5\VBD\352826 (r_relcl) patients_3\NNS\9898892 (r_pobj) for_0\IN\0 (r_prep) was_13\VBD\0 (l_acomp) efficacious_14\JJ\0 (l_prep) to_17\IN\0 (l_pobj) haloperidol_22\NN\3713736 (l_prep) for_25\IN\0 (l_pobj) scores_26\NNS\13757724 (l_prep) on_27\IN\0 (l_pobj) factor_34\NN\7326557 (l_compound) psychosis_33\NN\14380140
D006220_D011618 NONE haloperidol_22\NN\3713736 (l_prep) for_25\IN\0 (l_pobj) scores_26\NNS\13757724 (l_prep) on_27\IN\0 (l_pobj) factor_34\NN\7326557 (l_compound) psychosis_33\NN\14380140
D006220_D011618 NONE haloperidol_6\NN\3713736 (r_pobj) with_5\IN\0 (r_prep) observed_4\VBN\2163746 (r_nsubj) apply_9\VB\0 (l_prep) to_10\IN\0 (l_pobj) neuroleptics_12\NNS\4470232 (l_acl) used_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) psychosis_20\NN\14380140
D006220_D001480 CID haloperidol_8\NN\3713736 (r_pobj) for_7\IN\0 (r_prep) profile_6\NN\6999802 (r_dobj) indicated_2\VBD\952524 (l_advcl) developed_22\VBD\1753788 (l_acomp) moderate_23\JJ\9605289 (l_prep) to_24\TO\0 (l_pobj) signs_27\NNS\6643763
9351491
D018967_D010302 CID risperidone_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) treated_8\VBN\2376958 (r_acl) subjects_7\NNS\6598915 (r_pobj) in_6\IN\13603305 (r_prep) observed_5\VBN\2163746 (l_nsubjpass) parkinsonism_3\NN\14085708
D006220_D010302 CID haloperidol_16\NN\3713736 (r_conj) risperidone_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) treated_8\VBN\2376958 (r_acl) subjects_7\NNS\6598915 (r_pobj) in_6\IN\13603305 (r_prep) observed_5\VBN\2163746 (l_nsubjpass) parkinsonism_3\NN\14085708
D018967_D011618 NONE risperidone_6\NN\0 (r_poss) profile_9\NN\6999802 (r_nsubj) produce_11\VB\7555863 (l_dobj) efficacy_13\NN\5199286 (l_prep) for_14\IN\0 (l_pobj) symptoms_17\NNS\5823932
8829025
D016559_D007674 NONE tacrolimus_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) associated_10\VBN\628491 (r_acl) nephrotoxicity_9\NN\0
D009543_D006973 NONE nifedipine_23\NN\2938514 (r_dobj) receiving_22\VBG\2210855 (r_relcl) patients_19\NNS\9898892 (l_amod) hypertensive_18\JJ\10405694
D009543_D006973 NONE nifedipine_33\NN\2938514 (r_dobj) receiving_32\VBG\2210855 (r_acl) patients_30\NNS\9898892 (r_dobj) comprising_28\VBG\2604760 (r_acl) other_27\JJ\0 (r_conj) group_16\NN\2137 (l_acl) comprising_17\VBG\2604760 (l_dobj) patients_19\NNS\9898892 (l_amod) hypertensive_18\JJ\10405694
D009543_D006973 NONE nifedipine_5\NN\2938514 (r_pobj) of_4\IN\0 (r_prep) impact_3\NN\7339329 (r_nsubj) be_18\VB\14625458 (l_attr) factor_21\NN\7326557 (l_prep) in_22\IN\13603305 (l_pcomp) selecting_23\VBG\697589 (l_xcomp) treat_27\VB\7570720 (l_dobj) hypertension_28\NN\14057371
D009543_D007674 NONE nifedipine_5\NN\2938514 (r_pobj) of_4\IN\0 (r_prep) impact_3\NN\7339329 (l_prep) on_6\IN\0 (l_pcomp) reducing_7\VBG\13447361 (l_dobj) nephrotoxicity_9\NN\0
D016559_D006973 CID tacrolimus_5\NNS\0 (r_dobj) receiving_4\VBG\2210855 (r_acl) patients_3\NNS\9898892 (r_pobj) of_2\IN\0 (r_prep) groups_1\NNS\2137 (r_nsubjpass) compared_7\VBN\644583 (l_appos) group_16\NN\2137 (l_acl) comprising_17\VBG\2604760 (l_dobj) patients_19\NNS\9898892 (l_amod) hypertensive_18\JJ\10405694
D016559_D006973 CID tacrolimus_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) associated_10\VBN\628491 (r_acl) nephrotoxicity_9\NN\0 (r_dobj) reducing_7\VBG\13447361 (r_pcomp) on_6\IN\0 (r_prep) impact_3\NN\7339329 (r_nsubj) be_18\VB\14625458 (l_attr) factor_21\NN\7326557 (l_prep) in_22\IN\13603305 (l_pcomp) selecting_23\VBG\697589 (l_xcomp) treat_27\VB\7570720 (l_dobj) hypertension_28\NN\14057371
2670794
D002216_D011665 NONE captopril_9\NNP\2673637 (r_appos) enzyme_7\NN\14723628 (r_dobj) converting_6\VBG\126264 (l_prep) on_11\IN\0 (l_pobj) insufficiency_15\NN\14462946
D002216_D011665 NONE captopril_2\NNP\2673637 (r_pobj) of_1\IN\0 (r_prep) injection_0\NN\320852 (r_nsubj) reduced_18\VBD\441445 (l_dobj) insufficiency_23\NN\14462946
D014148_D004211 CID acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (l_prep) of_1\IN\0 (l_pobj) coagulation_3\NN\13518963
D014148_D004211 CID amca_16\NNP\0 (r_appos) acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (l_prep) of_1\IN\0 (l_pobj) coagulation_3\NN\13518963
D000809_D051437 NONE angiotensin_5\NN\4522421 (l_acl) converting_6\VBG\126264 (l_prep) on_11\IN\0 (l_pobj) insufficiency_15\NN\14462946
D000809_D051437 NONE angiotensin_11\NN\4522421 (r_pobj) of_10\IN\0 (r_prep) inhibitor_9\NN\20090 (r_appos) injection_0\NN\320852 (r_nsubj) reduced_18\VBD\441445 (l_dobj) insufficiency_23\NN\14462946
D002216_D007674 NONE captopril_17\NNP\2673637 (r_pobj) by_16\IN\0 (r_agent) prevented_15\VBN\0 (l_nsubjpass) damage_1\NN\7296428
D002216_D007674 NONE captopril_0\NNP\2673637 (r_nsubj) reduce_8\VB\441445 (l_advcl) diminishing_26\VBG\169651 (l_prep) with_36\IN\0 (l_pobj) result_38\NN\34213 (l_acl) deposited_44\VBN\1340439 (l_conj) produced_52\VBN\1617192 (l_nsubjpass) damage_49\NN\7296428
D002216_D051437 NONE captopril_9\NNP\2673637 (r_appos) enzyme_7\NN\14723628 (r_dobj) converting_6\VBG\126264 (l_prep) on_11\IN\0 (l_pobj) insufficiency_15\NN\14462946
D002216_D051437 NONE captopril_2\NNP\2673637 (r_pobj) of_1\IN\0 (r_prep) injection_0\NN\320852 (r_nsubj) reduced_18\VBD\441445 (l_dobj) insufficiency_23\NN\14462946
D002216_D004211 NONE captopril_9\NNP\2673637 (r_appos) enzyme_7\NN\14723628 (r_dobj) converting_6\VBG\126264 (r_acl) angiotensin_5\NN\4522421 (r_pobj) of_4\IN\0 (r_prep) inhibitor_3\NN\20090 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_amod) due_16\IN\5174653 (l_pobj) coagulation_19\NN\13518963
D014148_D051437 NONE acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (r_nsubj) gives_21\VBZ\5020358 (l_dobj) rise_22\NN\7324673 (l_prep) to_23\IN\0 (l_pobj) insufficiency_27\NN\14462946
D014148_D051437 NONE amca_16\NNP\0 (r_appos) acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (r_nsubj) gives_21\VBZ\5020358 (l_dobj) rise_22\NN\7324673 (l_prep) to_23\IN\0 (l_pobj) insufficiency_27\NN\14462946
D000809_D004211 NONE angiotensin_5\NN\4522421 (r_pobj) of_4\IN\0 (r_prep) inhibitor_3\NN\20090 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_amod) due_16\IN\5174653 (l_pobj) coagulation_19\NN\13518963
D014508_D007674 NONE urea_9\NN\14727670 (r_pobj) in_7\IN\13603305 (r_prep) increase_6\NN\13576355 (r_pobj) by_4\IN\0 (r_agent) reflected_3\VBN\923793 (r_advcl) damage_1\NN\7296428
D014148_D014947 NONE acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (r_nsubj) gives_21\VBZ\5020358 (l_advcl) resembling_28\VBG\2657219 (l_ccomp) occurring_30\VBG\0 (l_prep) after_31\IN\0 (l_pobj) trauma_32\NN\14052046
D014148_D014947 NONE amca_16\NNP\0 (r_appos) acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (r_nsubj) gives_21\VBZ\5020358 (l_advcl) resembling_28\VBG\2657219 (l_ccomp) occurring_30\VBG\0 (l_prep) after_31\IN\0 (l_pobj) trauma_32\NN\14052046
D000809_D011665 NONE angiotensin_5\NN\4522421 (l_acl) converting_6\VBG\126264 (l_prep) on_11\IN\0 (l_pobj) insufficiency_15\NN\14462946
D000809_D011665 NONE angiotensin_11\NN\4522421 (r_pobj) of_10\IN\0 (r_prep) inhibitor_9\NN\20090 (r_appos) injection_0\NN\320852 (r_nsubj) reduced_18\VBD\441445 (l_dobj) insufficiency_23\NN\14462946
D014148_D018805 NONE acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (r_nsubj) gives_21\VBZ\5020358 (l_advcl) resembling_28\VBG\2657219 (l_ccomp) occurring_30\VBG\0 (l_prep) after_31\IN\0 (l_pobj) trauma_32\NN\14052046 (l_conj) sepsis_34\NN\14174549
D014148_D018805 NONE amca_16\NNP\0 (r_appos) acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (r_nsubj) gives_21\VBZ\5020358 (l_advcl) resembling_28\VBG\2657219 (l_ccomp) occurring_30\VBG\0 (l_prep) after_31\IN\0 (l_pobj) trauma_32\NN\14052046 (l_conj) sepsis_34\NN\14174549
D014148_D011665 NONE acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (r_nsubj) gives_21\VBZ\5020358 (l_dobj) rise_22\NN\7324673 (l_prep) to_23\IN\0 (l_pobj) insufficiency_27\NN\14462946
D014148_D011665 NONE amca_16\NNP\0 (r_appos) acid_14\NN\14818238 (r_conj) thrombin_11\NN\14735953 (r_pobj) of_10\IN\0 (r_prep) injection_9\NN\320852 (r_pobj) by_8\IN\0 (r_prep) induction_0\NN\7450842 (r_nsubj) gives_21\VBZ\5020358 (l_dobj) rise_22\NN\7324673 (l_prep) to_23\IN\0 (l_pobj) insufficiency_27\NN\14462946
1728522
D019980_D056486 CID acid_9\NN\14818238 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (r_pobj) due_2\JJ\5174653 (r_prep) hepatitis_1\NN\14127211
D019980_D056486 CID acid_11\NN\14818238 (r_npadvmod) induced_13\VBN\1627355 (r_amod) hepatitis_14\NN\14127211
D019980_D006099 CID acid_9\NN\14818238 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (r_pobj) due_2\JJ\5174653 (r_prep) hepatitis_1\NN\14127211
D019980_D006099 CID acid_11\NN\14818238 (r_npadvmod) induced_13\VBN\1627355 (r_amod) hepatitis_14\NN\14127211 (r_pobj) with_7\IN\0 (r_prep) patient_6\NN\9898892 (r_pobj) of_4\IN\0 (r_prep) case_3\NN\7283608 (l_prep) with_15\IN\0 (l_pobj) granulomas_18\NNS\14235200
7890216
D014580_D042882 NONE acid_13\NN\14818238 (r_pobj) to_10\IN\0 (r_prep) response_9\NN\11410625 (r_appos) composition_0\NN\5075602 (l_prep) of_1\IN\0 (l_pobj) stones_4\NNS\19128
D015282_D000172 NONE octreotide_0\NNP\0 (l_appos) treatment_4\NN\654885 (l_prep) for_5\IN\0 (l_pobj) acromegaly_6\NNS\14366759
D015282_D000172 NONE octreotide_28\NN\0 (r_pobj) in_26\IN\13603305 (r_prep) methods_25\NNS\5616786 (r_pobj) by_21\IN\0 (r_agent) investigated_20\VBN\644583 (l_conj) treated_29\VBD\2376958 (l_dobj) patients_31\NNS\9898892 (l_compound) acromegalic_30\JJ\0
D002118_D042882 NONE calcium_41\NN\14625458 (r_dobj) containing_40\VBG\2632940 (r_acl) stones_39\NNS\19128 (r_conj) duct_35\NN\5248181 (r_dobj) have_31\VB\7846 (r_conj) induced_4\VBN\1627355 (l_dobj) stones_6\NNS\19128
D002118_D042882 NONE calcium_41\NN\14625458 (r_dobj) containing_40\VBG\2632940 (r_acl) stones_39\NNS\19128 (r_conj) duct_35\NN\5248181 (r_dobj) have_31\VB\7846 (r_conj) induced_4\VBN\1627355 (l_ccomp) are_7\VBP\13600404 (l_prep) in_18\IN\13603305 (l_pobj) common_19\JJ\8673395 (l_prep) with_20\IN\0 (l_pobj) disease_24\NN\14061805
D002118_D042882 NONE calcium_41\NN\14625458 (r_dobj) containing_40\VBG\2632940 (r_acl) stones_39\NNS\19128
D015282_D042882 CID octreotide_7\NN\0 (r_pobj) with_6\IN\0 (r_prep) associated_5\VBN\628491 (r_acl) stones_4\NNS\19128
D015282_D042882 CID octreotide_0\NNP\0 (r_nsubj) induces_8\VBZ\1627355 (l_dobj) stones_11\NNS\19128
D015282_D042882 CID octreotide_28\NN\0 (r_pobj) in_26\IN\13603305 (r_prep) methods_25\NNS\5616786 (r_pobj) by_21\IN\0 (r_agent) investigated_20\VBN\644583 (l_conj) treated_29\VBD\2376958 (l_prep) with_32\IN\0 (l_pobj) stones_34\NNS\19128
D015282_D042882 CID octreotide_3\NN\0 (r_advmod) induced_4\VBN\1627355 (l_dobj) stones_6\NNS\19128
D015282_D042882 CID octreotide_3\NN\0 (r_advmod) induced_4\VBN\1627355 (l_ccomp) are_7\VBP\13600404 (l_prep) in_18\IN\13603305 (l_pobj) common_19\JJ\8673395 (l_prep) with_20\IN\0 (l_pobj) disease_24\NN\14061805
D015282_D042882 CID octreotide_3\NN\0 (r_advmod) induced_4\VBN\1627355 (l_conj) have_31\VB\7846 (l_dobj) duct_35\NN\5248181 (l_conj) stones_39\NNS\19128
D002784_D042882 NONE cholesterol_21\NN\15058310 (r_conj) %_17\NN\0 (r_dobj) contained_15\VBD\2632940 (r_ccomp) showed_12\VBD\2137132 (l_nsubj) analysis_1\NN\633864 (l_prep) of_2\IN\0 (l_pobj) stones_4\NNS\19128
D002784_D042882 NONE cholesterol_36\NN\15058310 (r_nsubj) rich_37\JJ\7942152 (r_acomp) were_35\VBD\0 (r_ccomp) suggesting_31\VBG\1010118 (r_advcl) showed_12\VBD\2137132 (l_dobj) dissolution_29\NN\13518963 (l_compound) stone_28\NN\19128
D002784_D042882 NONE cholesterol_14\NN\15058310 (r_conj) multiple_11\JJ\5859630 (r_conj) small_9\JJ\5220461 (r_acomp) are_7\VBP\13600404 (r_ccomp) induced_4\VBN\1627355 (l_dobj) stones_6\NNS\19128
D002784_D042882 NONE cholesterol_14\NN\15058310 (r_conj) multiple_11\JJ\5859630 (r_conj) small_9\JJ\5220461 (r_acomp) are_7\VBP\13600404 (l_prep) in_18\IN\13603305 (l_pobj) common_19\JJ\8673395 (l_prep) with_20\IN\0 (l_pobj) disease_24\NN\14061805
D002784_D042882 NONE cholesterol_14\NN\15058310 (r_conj) multiple_11\JJ\5859630 (r_conj) small_9\JJ\5220461 (r_acomp) are_7\VBP\13600404 (r_ccomp) induced_4\VBN\1627355 (l_conj) have_31\VB\7846 (l_dobj) duct_35\NN\5248181 (l_conj) stones_39\NNS\19128
9390208
D002955_D064420 NONE leucovorin_19\NN\0 (r_conj) 5-fu_17\CD\0 (l_conj) benefit_26\NN\13278375 (l_conj) toxicity_32\NN\13576101
D005472_D001943 NONE 5-fu_17\CD\0 (r_pobj) of_13\IN\0 (r_prep) infusion_12\NN\14589223 (r_conj) treatment_0\NN\654885 (l_prep) of_1\IN\0 (l_pobj) cancer_6\NN\14239425
D005472_D001943 NONE 5-fu_34\CD\0 (r_pobj) of_33\IN\0 (r_prep) infusion_32\NN\14589223 (r_conj) day_28\NN\15154774 (r_pobj) on_27\IN\0 (r_prep) treated_8\VBD\2376958 (l_dobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) cancer_18\NN\14239425
D002955_D001943 NONE leucovorin_19\NN\0 (r_conj) 5-fu_17\CD\0 (r_pobj) of_13\IN\0 (r_prep) infusion_12\NN\14589223 (r_conj) treatment_0\NN\654885 (l_prep) of_1\IN\0 (l_pobj) cancer_6\NN\14239425
D002955_D001943 NONE leucovorin_43\NN\0 (r_pobj) with_42\IN\0 (r_prep) treated_8\VBD\2376958 (l_dobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) cancer_18\NN\14239425
D008942_D064420 NONE mitoxantrone_8\NN\0 (r_pobj) by_7\IN\0 (r_prep) cancer_6\NN\14239425 (r_pobj) of_1\IN\0 (r_prep) treatment_0\NN\654885 (l_conj) infusion_12\NN\14589223 (l_prep) of_13\IN\0 (l_pobj) 5-fu_17\CD\0 (l_conj) benefit_26\NN\13278375 (l_conj) toxicity_32\NN\13576101
C085788_D064420 NONE mfl_21\NNP\0 (r_appos) 5-fu_17\CD\0 (l_conj) benefit_26\NN\13278375 (l_conj) toxicity_32\NN\13576101
C085788_D064420 NONE regimen_2\NN\5898568 (r_nsubj) achieves_3\VBZ\2524171 (l_conj) induces_8\VBZ\1627355 (l_dobj) toxicity_10\NN\13576101
D008942_D001943 NONE mitoxantrone_8\NN\0 (r_pobj) by_7\IN\0 (r_prep) cancer_6\NN\14239425
D008942_D001943 NONE mitoxantrone_20\NN\0 (r_pobj) by_19\IN\0 (r_prep) treated_8\VBD\2376958 (l_dobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) cancer_18\NN\14239425
C085788_D001943 NONE mfl_21\NNP\0 (r_appos) 5-fu_17\CD\0 (r_pobj) of_13\IN\0 (r_prep) infusion_12\NN\14589223 (r_conj) treatment_0\NN\654885 (l_prep) of_1\IN\0 (l_pobj) cancer_6\NN\14239425
D005472_D064420 NONE 5-fu_17\CD\0 (l_conj) benefit_26\NN\13278375 (l_conj) toxicity_32\NN\13576101
7088431
D004054_D014625 CID diethylstilbestrol_21\NN\14749794 (r_pobj) to_20\IN\0 (r_prep) exposed_17\VBN\2110927 (r_acl) women_16\NNS\9605289 (r_pobj) in_14\IN\13603305 (r_prep) up_13\NN\153263 (r_pobj) at_10\IN\14622893 (r_prep) detected_9\VBD\2163746 (l_nsubj) cases_1\NNS\7283608 (l_prep) of_2\IN\0 (l_pobj) adenocarcinoma_5\NN\14242337 (l_prep) of_6\IN\0 (l_pobj) vagina_8\NN\5250659
D004054_D018262 CID des_6\NNP\14749794 (r_npadvmod) exposed_8\VBN\2110927 (r_amod) offspring_9\NN\10235549 (r_pobj) in_5\IN\13603305 (r_prep) development_0\NN\248977 (l_prep) of_1\IN\0 (l_pobj) adenocarcinoma_4\NN\14242337
D004054_D018262 CID diethylstilbestrol_21\NN\14749794 (r_pobj) to_20\IN\0 (r_prep) exposed_17\VBN\2110927 (r_acl) women_16\NNS\9605289 (r_pobj) in_14\IN\13603305 (r_prep) up_13\NN\153263 (r_pobj) at_10\IN\14622893 (r_prep) detected_9\VBD\2163746 (l_nsubj) cases_1\NNS\7283608 (l_prep) of_2\IN\0 (l_pobj) adenocarcinoma_5\NN\14242337 (l_prep) of_6\IN\0 (l_pobj) vagina_8\NN\5250659
18417364
D009538_D009759 CID nicotine_0\NN\14712692 (r_npadvmod) induced_2\VBN\1627355 (r_amod) nystagmus_3\NN\337486
D009538_D009759 CID nicotine_3\NN\14712692 (r_npadvmod) induced_5\VBN\1627355 (r_amod) nystagmus_6\NN\337486
D009538_D009759 CID nicotine_3\NN\14712692 (r_npadvmod) induced_5\VBN\1627355 (r_amod) nystagmus_6\NN\337486 (l_appos) nin_8\NNP\0
D010100_D009759 NONE oxygen_4\NN\14622893 (r_nmod) levels_12\NNS\4916342 (r_pobj) with_2\IN\0 (r_prep) correlated_1\VBD\2657219 (l_nsubj) nin_0\NNP\0
9869257
D012601_D000647 CID scopolamine_36\NN\14712692 (r_pobj) by_29\IN\0 (r_agent) induced_28\VBN\1627355 (r_acl) amnesia_27\NN\5669934
C098725_D000647 CID s-(-)-et-126_41\NNP\0 (r_appos) antagonist_40\NN\7846 (r_conj) scopolamine_36\NN\14712692 (r_pobj) by_29\IN\0 (r_agent) induced_28\VBN\1627355 (r_acl) amnesia_27\NN\5669934
C087567_D000647 NONE pg-9_8\NNP\0 (r_nsubj) administered_18\VBN\2436349 (l_conj) prevented_26\VBN\0 (l_dobj) amnesia_27\NN\5669934
C087567_D000647 NONE pg-9_6\NNP\0 (r_nmod) microg_11\NN\0 (r_nsubj) was_17\VBD\0 (l_acomp) able_19\JJ\0 (l_xcomp) prevent_21\VB\0 (l_dobj) amnesia_25\NN\5669934
3015567
D009599_D007022 CID nitroprusside_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hypotension_3\NN\14057371
D009599_D007022 CID nitroprusside_7\RB\0 (r_advmod) induced_9\VBN\1627355 (r_amod) hypotension_10\NN\14057371
D003345_D007022 NONE corticosterone_18\NN\14752057 (r_compound) level_19\NN\4916342 (r_pobj) at_15\IN\14622893 (r_prep) occurs_14\VBZ\0 (r_conj) observed_12\VBN\2163746 (l_nsubjpass) suppression_0\NN\13489037 (l_appos) secretion_3\NN\13526110 (l_prep) in_4\IN\13603305 (l_pobj) response_5\NN\11410625 (l_prep) to_6\IN\0 (l_pobj) hypotension_10\NN\14057371
8739323
D008466_D007674 NONE nitrogranulogen_8\NN\0 (r_pobj) as_7\IN\14622893 (r_prep) drugs_5\NNS\14778436 (r_pobj) of_3\IN\0 (r_prep) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D008466_D007674 NONE ng_10\NNP\13717155 (r_appos) nitrogranulogen_8\NN\0 (r_pobj) as_7\IN\14622893 (r_prep) drugs_5\NNS\14778436 (r_pobj) of_3\IN\0 (r_prep) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D005472_D003556 NONE 5-fu_20\CD\0 (r_pobj) with_19\IN\0 (r_prep) combined_18\VBN\2630189 (r_advcl) cause_14\VB\7323922 (r_conj) caused_1\VBD\1617192 (l_dobj) cystitis_3\NN\14566129
D008727_D007674 NONE methotrexate_13\NNP\2722166 (r_conj) nitrogranulogen_8\NN\0 (r_pobj) as_7\IN\14622893 (r_prep) drugs_5\NNS\14778436 (r_pobj) of_3\IN\0 (r_prep) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D008727_D007674 NONE mtx_15\NNP\0 (r_appos) methotrexate_13\NNP\2722166 (r_conj) nitrogranulogen_8\NN\0 (r_pobj) as_7\IN\14622893 (r_prep) drugs_5\NNS\14778436 (r_pobj) of_3\IN\0 (r_prep) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D008727_D007674 NONE mtx_33\NNP\0 (r_appos) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D008727_D007674 NONE mtx_6\NNP\0 (r_pobj) of_5\IN\0 (r_prep) nephrotoxicity_4\NN\0
D003520_D006470 CID cy_0\NNP\0 (r_nsubj) caused_1\VBD\1617192 (l_dobj) cystitis_3\NN\14566129
D005472_D007674 NONE 5-fluorouracil_18\CD\0 (r_punct) 5-fu_20\CD\0 (r_appos) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D005472_D007674 NONE 5-fu_20\CD\0 (r_appos) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D005472_D007674 NONE 5-fu_35\CD\0 (r_conj) mtx_33\NNP\0 (r_appos) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D005472_D007674 NONE 5-fu_8\CD\0 (r_nsubj) is_13\VBZ\0 (r_ccomp) indicate_2\VBP\952524 (l_dobj) nephrotoxicity_4\NN\0
D003520_D007674 NONE cyclophosphamide_23\NN\0 (r_conj) 5-fu_20\CD\0 (r_appos) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D003520_D007674 NONE cy_25\NNP\0 (r_appos) cyclophosphamide_23\NN\0 (r_conj) 5-fu_20\CD\0 (r_appos) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D003520_D007674 NONE cy_37\NNP\0 (r_conj) 5-fu_35\CD\0 (r_conj) mtx_33\NNP\0 (r_appos) action_2\NN\30358 (l_amod) nephrotoxic_1\JJ\0
D003520_D007674 NONE cy_10\NNP\0 (r_conj) 5-fu_8\CD\0 (r_nsubj) is_13\VBZ\0 (r_ccomp) indicate_2\VBP\952524 (l_dobj) nephrotoxicity_4\NN\0
D005472_D006470 NONE 5-fu_20\CD\0 (r_pobj) with_19\IN\0 (r_prep) combined_18\VBN\2630189 (r_advcl) cause_14\VB\7323922 (r_conj) caused_1\VBD\1617192 (l_dobj) cystitis_3\NN\14566129
D003520_D003556 CID cy_0\NNP\0 (r_nsubj) caused_1\VBD\1617192 (l_dobj) cystitis_3\NN\14566129
D008727_D006470 NONE mtx_22\NNP\0 (r_conj) 5-fu_20\CD\0 (r_pobj) with_19\IN\0 (r_prep) combined_18\VBN\2630189 (r_advcl) cause_14\VB\7323922 (r_conj) caused_1\VBD\1617192 (l_dobj) cystitis_3\NN\14566129
D008727_D003556 NONE mtx_22\NNP\0 (r_conj) 5-fu_20\CD\0 (r_pobj) with_19\IN\0 (r_prep) combined_18\VBN\2630189 (r_advcl) cause_14\VB\7323922 (r_conj) caused_1\VBD\1617192 (l_dobj) cystitis_3\NN\14566129
20880751
D018698_D004409 NONE glutamate_28\NN\15010703 (r_compound) receptors_29\NNS\5225602 (l_conj) systems_36\NNS\3575240 (l_prep) in_37\IN\13603305 (l_pobj) pathophysiology_39\NN\0 (l_prep) of_40\IN\0 (l_pobj) dyskinesias_44\NNS\14084880
D004298_D004409 NONE dopamine_9\NN\14807737 (r_compound) precursor_10\NN\14580897 (r_pobj) of_7\IN\0 (r_prep) use_6\NN\407535 (r_nsubjpass) complicated_12\VBN\126264 (l_agent) by_13\IN\0 (l_pobj) fluctuations_16\NNS\7345593 (l_conj) dyskinesias_18\NNS\14084880
D004298_D004409 NONE dopamine_21\NN\14807737 (r_compound) subtypes_23\NNS\0 (l_conj) receptors_29\NNS\5225602 (l_conj) systems_36\NNS\3575240 (l_prep) in_37\IN\13603305 (l_pobj) pathophysiology_39\NN\0 (l_prep) of_40\IN\0 (l_pobj) dyskinesias_44\NNS\14084880
D007980_D004409 CID levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) dyskinesias_3\NNS\14084880
D007980_D004409 CID levodopa_17\NN\14604959 (r_npadvmod) induced_19\VBN\1627355 (r_amod) dyskinesias_20\NNS\14084880
D007980_D004409 CID levodopa_41\NN\14604959 (r_npadvmod) induced_43\VBN\1627355 (r_amod) dyskinesias_44\NNS\14084880
D007980_D010300 NONE levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) dyskinesias_3\NNS\14084880 (l_prep) in_4\IN\13603305 (l_pobj) patients_5\NNS\9898892 (l_prep) with_6\IN\0 (l_pobj) disease_9\NN\14061805
D007980_D010300 NONE levodopa_0\NNP\14604959 (r_nsubj) is_1\VBZ\0 (l_attr) drug_5\NN\14778436 (l_prep) for_6\IN\0 (l_pobj) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) disease_12\NN\14061805
20098969
D008694_D006212 NONE methamphetamine_0\NN\2704153 (r_nsubj) is_1\VBZ\0 (l_attr) stimulant_7\NN\5816287 (l_relcl) increases_9\VBZ\13576355 (l_conj) produce_16\VB\7555863 (l_dobj) effects_18\NNS\13245626 (l_prep) as_20\IN\14622893 (l_pobj) dysrhythmias_22\NNS\0 (l_conj) hypertension_24\NN\14057371 (l_conj) hallucinations_26\NNS\14376855
D008694_D001523 NONE methamphetamine_0\NN\2704153 (r_nsubj) is_1\VBZ\0 (l_attr) stimulant_7\NN\5816287 (l_relcl) increases_9\VBZ\13576355 (l_conj) produce_16\VB\7555863 (l_dobj) effects_18\NNS\13245626 (l_prep) as_20\IN\14622893 (l_pobj) dysrhythmias_22\NNS\0 (l_conj) hypertension_24\NN\14057371 (l_conj) hallucinations_26\NNS\14376855 (l_conj) behavior_30\NN\407535
D008694_-1 NONE methamphetamine_3\NN\2704153 (r_dobj) abusing_2\VBG\2514187 (r_acl) patients_1\NNS\9898892 (r_nsubj) present_5\VB\28270 (l_prep) with_6\IN\0 (l_pobj) hygiene_9\NN\14494893 (l_conj) xerostomia_11\NN\14536438 (l_conj) caries_14\NNS\13456715 (l_appos) mouth_18\NN\5610008
D008694_-1 NONE methamphetamines_23\NNS\2704153 (r_dobj) abusing_22\VBG\2514187 (r_relcl) patients_18\NNS\9898892 (r_dobj) manage_17\VBP\2524171 (r_conj) recognize_15\VBP\686447 (r_ccomp) help_12\VB\407535 (r_advcl) presented_10\VBN\2137132 (l_nsubjpass) case_2\NN\7283608 (l_acl) showing_3\VBG\6887726 (l_dobj) manifestations_5\NNS\7321772 (l_prep) of_6\IN\0 (l_pobj) mouth_8\NN\5610008
D008694_D003731 CID methamphetamine_3\NN\2704153 (r_dobj) abusing_2\VBG\2514187 (r_acl) patients_1\NNS\9898892 (r_nsubj) present_5\VB\28270 (l_prep) with_6\IN\0 (l_pobj) hygiene_9\NN\14494893 (l_conj) xerostomia_11\NN\14536438 (l_conj) caries_14\NNS\13456715
D008694_D003731 CID methamphetamine_5\NN\2704153 (r_pobj) of_4\IN\0 (r_prep) use_3\NN\407535 (r_dobj) reported_1\VBD\831651 (l_conj) experienced_12\VBN\2108377 (l_dobj) episodes_16\NNS\7283608
D008694_D001145 NONE methamphetamine_0\NN\2704153 (r_nsubj) is_1\VBZ\0 (l_attr) stimulant_7\NN\5816287 (l_relcl) increases_9\VBZ\13576355 (l_conj) produce_16\VB\7555863 (l_dobj) effects_18\NNS\13245626 (l_prep) as_20\IN\14622893 (l_pobj) dysrhythmias_22\NNS\0
D008694_D006973 NONE methamphetamine_0\NN\2704153 (r_nsubj) is_1\VBZ\0 (l_attr) stimulant_7\NN\5816287 (l_relcl) increases_9\VBZ\13576355 (l_conj) produce_16\VB\7555863 (l_dobj) effects_18\NNS\13245626 (l_prep) as_20\IN\14622893 (l_pobj) dysrhythmias_22\NNS\0 (l_conj) hypertension_24\NN\14057371
D008694_D014987 NONE methamphetamine_3\NN\2704153 (r_dobj) abusing_2\VBG\2514187 (r_acl) patients_1\NNS\9898892 (r_nsubj) present_5\VB\28270 (l_prep) with_6\IN\0 (l_pobj) hygiene_9\NN\14494893 (l_conj) xerostomia_11\NN\14536438
D008694_D057085 NONE methamphetamine_3\NN\2704153 (r_dobj) abusing_2\VBG\2514187 (r_acl) patients_1\NNS\9898892 (r_nsubj) present_5\VB\28270 (l_prep) with_6\IN\0 (l_pobj) hygiene_9\NN\14494893 (l_conj) xerostomia_11\NN\14536438 (l_conj) caries_14\NNS\13456715 (l_conj) wear_25\NN\14561618
16428221
D008774_D019969 NONE methylphenidate_20\NN\4320126 (r_compound) intake_21\NN\13440063 (r_pobj) after_19\IN\0 (r_prep) reported_18\VBN\831651 (r_conj) documented_8\VBN\1000214 (l_nsubjpass) vasculitis_1\NN\14336539 (l_acl) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) abuse_5\NN\418025
D008774_D002544 NONE methylphenidate_20\NN\4320126 (r_compound) intake_21\NN\13440063 (r_pobj) after_19\IN\0 (r_prep) reported_18\VBN\831651 (l_nsubjpass) stroke_15\NN\556313
D008774_D002544 NONE methylphenidate_14\NN\4320126 (r_pobj) with_13\IN\0 (r_prep) treated_12\VBN\2376958 (l_conj) suffered_19\VBD\2110220 (l_prep) from_20\IN\0 (l_pobj) strokes_23\NNS\556313
D008774_D020293 CID methylphenidate_4\NN\4320126 (r_compound) intake_5\NN\13440063 (r_dobj) following_2\VBG\8180190 (r_prep) vasculitis_1\NNS\14336539
D008774_D020293 CID methylphenidate_20\NN\4320126 (r_compound) intake_21\NN\13440063 (r_pobj) after_19\IN\0 (r_prep) reported_18\VBN\831651 (r_conj) documented_8\VBN\1000214 (l_nsubjpass) vasculitis_1\NN\14336539
D008774_D014657 NONE methylphenidate_3\NN\4320126 (l_dobj) vasculitis_5\NN\14336539
D008774_D014657 NONE methylphenidate_18\NN\4320126 (r_compound) therapy_19\NN\657604 (r_pobj) of_17\IN\0 (r_prep) history_16\NN\15120823 (r_conj) symptoms_13\NNS\5823932 (r_pobj) with_11\IN\0 (r_prep) patients_10\NNS\9898892 (r_pobj) in_9\IN\13603305 (r_prep) considered_8\VBN\689344 (l_nsubjpass) methylphenidate_3\NN\4320126 (l_dobj) vasculitis_5\NN\14336539
D008774_D006948 NONE methylphenidate_14\NN\4320126 (r_pobj) with_13\IN\0 (r_prep) treated_12\VBN\2376958 (l_prep) due_15\IN\5174653 (l_pobj) hyperactivity_17\NN\14052403
220563
C023470_D010523 CID maleate_1\NN\2718811 (l_conj) neuropathy_4\NN\14204950
C023470_D010523 CID maleate_12\NN\2718811 (r_pobj) with_10\IN\0 (r_prep) complication_7\NN\1073995 (r_pobj) as_5\IN\14622893 (r_prep) noted_4\VBN\1009240 (l_nsubjpass) neuropathy_1\NN\14204950
C023470_D000787 NONE maleate_12\NN\2718811 (r_pobj) with_10\IN\0 (r_prep) complication_7\NN\1073995 (l_prep) for_30\IN\0 (l_pobj) treatment_33\NN\654885 (l_prep) of_34\IN\0 (l_pobj) pectoris_36\NN\0
9721172
D011241_D002779 NONE prednisone_6\NN\2721538 (l_conj) tacrolimus_10\VB\0 (l_conj) disease_14\NN\14061805
D007052_D001649 NONE ibuprofen_30\JJ\3828465 (r_compound) use_31\NN\407535 (r_pobj) with_29\IN\0 (r_prep) associated_28\VBN\628491 (l_nsubjpass) child_3\NN\9622049 (l_relcl) developed_5\VBD\1753788 (l_dobj) syndrome_15\NN\5870365
D016559_D002779 NONE tacrolimus_10\VB\0 (l_conj) disease_14\NN\14061805
D011241_D005355 NONE prednisone_6\NN\2721538 (r_conj) acid_4\NN\14818238 (r_pobj) with_2\IN\0 (r_prep) therapy_1\NN\657604 (r_pobj) despite_0\IN\7501545 (r_prep) was_15\VBD\0 (l_prep) with_18\IN\0 (l_pobj) cirrhosis_19\NN\14116321
D014580_D005355 NONE acid_4\NN\14818238 (r_pobj) with_2\IN\0 (r_prep) therapy_1\NN\657604 (r_pobj) despite_0\IN\7501545 (r_prep) was_15\VBD\0 (l_prep) with_18\IN\0 (l_pobj) cirrhosis_19\NN\14116321
D007052_D013262 CID ibuprofen_30\JJ\3828465 (r_compound) use_31\NN\407535 (r_pobj) with_29\IN\0 (r_prep) associated_28\VBN\628491 (l_nsubjpass) child_3\NN\9622049 (l_relcl) described_23\VBN\1001294 (l_nsubjpass) syndrome_21\NN\5870365
D016559_D005355 NONE tacrolimus_10\VB\0 (r_conj) prednisone_6\NN\2721538 (r_conj) acid_4\NN\14818238 (r_pobj) with_2\IN\0 (r_prep) therapy_1\NN\657604 (r_pobj) despite_0\IN\7501545 (r_prep) was_15\VBD\0 (l_prep) with_18\IN\0 (l_pobj) cirrhosis_19\NN\14116321
D014580_D002779 NONE acid_4\NN\14818238 (l_conj) prednisone_6\NN\2721538 (l_conj) tacrolimus_10\VB\0 (l_conj) disease_14\NN\14061805
7919560
D000667_D009205 CID ampicillin_7\NN\3910033 (r_pobj) by_6\IN\0 (r_agent) caused_5\VBN\1617192 (l_nsubj) multiforme_1\NN\0 (l_conj) myocarditis_4\NN\14338942
D000667_D009205 CID ampicillin_12\NN\3910033 (r_pobj) by_11\IN\0 (r_agent) caused_10\VBN\1617192 (r_acl) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) multiforme_6\NNS\0 (l_conj) myocarditis_9\NN\14338942
D000667_D004892 CID ampicillin_7\NN\3910033 (r_pobj) by_6\IN\0 (r_agent) caused_5\VBN\1617192 (l_nsubj) multiforme_1\NN\0
D000667_D004892 CID ampicillin_12\NN\3910033 (r_pobj) by_11\IN\0 (r_agent) caused_10\VBN\1617192 (r_acl) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) multiforme_6\NNS\0
D010406_D004342 NONE penicillins_11\NNS\2716866 (r_pobj) to_10\IN\0 (r_prep) is_2\VBZ\0 (l_attr) manifestation_7\NN\7321772 (l_prep) of_8\IN\0 (l_pobj) allergy_9\NN\14533203
D010406_D009205 NONE penicillins_11\NNS\2716866 (r_pobj) to_10\IN\0 (r_prep) is_2\VBZ\0 (l_nsubj) myocarditis_1\NN\14338942
D000667_D018805 NONE ampicillin_8\NN\3910033 (r_pobj) with_7\IN\0 (r_prep) treated_6\VBN\2376958 (l_conj) gentamicin_10\NN\2716866 (l_prep) because_11\IN\0 (l_pobj) septicemia_14\NN\14189204
D005839_D018805 NONE gentamicin_10\NN\2716866 (l_prep) because_11\IN\0 (l_pobj) septicemia_14\NN\14189204
2425813
D011239_D009133 CID prednisolone_14\NN\2721538 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) following_9\VBG\8180190 (r_prep) occurred_5\VBD\0 (l_nsubj) enlargement_1\NN\363260 (l_conj) wastage_4\NN\13458571
D011239_D006529 CID prednisolone_14\NN\2721538 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) following_9\VBG\8180190 (r_prep) occurred_5\VBD\0 (l_nsubj) enlargement_1\NN\363260
12695819
D016559_D009422 NONE tacrolimus_17\NNS\0 (l_relcl) developed_19\VBD\1753788 (l_dobj) complications_21\NNS\1073995
D016559_D020258 NONE tacrolimus_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) neurotoxicity_10\NN\0
D016559_D020258 NONE tacrolimus_15\NN\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) neurotoxicity_18\NN\0
6133211
D012460_D000013 NONE sulphasalazine_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) treatment_13\NN\654885 (r_dobj) received_12\VBD\2210855 (r_relcl) disease_10\NN\14061805 (r_pobj) with_7\IN\0 (r_prep) mothers_6\NNS\10399491 (r_pobj) of_4\IN\0 (r_prep) born_3\VBN\0 (r_acl) infants_1\NNS\9918248 (r_nsubjpass) found_20\VBN\13279262 (l_xcomp) have_22\VB\7846 (l_dobj) anomalies_25\NNS\14501726
D012460_D015212 NONE sulphasalazine_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) treatment_13\NN\654885 (r_dobj) received_12\VBD\2210855 (r_relcl) disease_10\NN\14061805
2355241
D007980_D002543 NONE levodopa_23\NN\14604959 (r_pobj) of_22\IN\0 (r_prep) effect_21\NN\34213 (r_dobj) reflect_18\VB\923793 (l_nsubj) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) haemorrhage_5\NN\14285662
D009638_D003643 NONE noradrenaline_31\NN\14807929 (r_amod) levels_32\NNS\4916342 (r_pobj) due_28\IN\5174653 (r_amod) mechanism_27\NN\13446390 (r_conj) effect_21\NN\34213 (r_dobj) reflect_18\VB\923793 (l_nsubj) incidence_2\NN\13821570 (l_prep) as_6\IN\14622893 (l_pobj) cause_8\NN\7323922 (l_prep) of_9\IN\0 (l_pobj) death_10\NN\7296428
D007980_D007022 CID levodopa_23\NN\14604959 (r_pobj) of_22\IN\0 (r_prep) effect_21\NN\34213 (l_amod) hypotensive_20\JJ\10405694
D007980_D007022 CID levodopa_23\NN\14604959 (r_pobj) of_22\IN\0 (r_prep) effect_21\NN\34213 (l_conj) mechanism_27\NN\13446390 (l_amod) hypotensive_26\JJ\10405694
D007980_D010300 NONE levodopa_23\NN\14604959 (r_pobj) of_22\IN\0 (r_prep) effect_21\NN\34213 (r_dobj) reflect_18\VB\923793 (l_nsubj) incidence_2\NN\13821570 (l_prep) as_6\IN\14622893 (l_pobj) cause_8\NN\7323922 (l_prep) in_11\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) disease_16\NN\14061805
D007980_D010300 NONE levodopa_23\NN\14604959 (r_pobj) of_22\IN\0 (r_prep) effect_21\NN\34213 (l_conj) mechanism_27\NN\13446390 (l_amod) due_28\IN\5174653 (l_pobj) levels_32\NNS\4916342 (l_prep) in_33\IN\13603305 (l_pobj) brain_36\NN\5462674 (l_amod) parkinsonian_35\JJ\0
D009638_D002543 NONE noradrenaline_31\NN\14807929 (r_amod) levels_32\NNS\4916342 (r_pobj) due_28\IN\5174653 (r_amod) mechanism_27\NN\13446390 (r_conj) effect_21\NN\34213 (r_dobj) reflect_18\VB\923793 (l_nsubj) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) haemorrhage_5\NN\14285662
D009638_D010300 NONE noradrenaline_31\NN\14807929 (r_amod) levels_32\NNS\4916342 (r_pobj) due_28\IN\5174653 (r_amod) mechanism_27\NN\13446390 (r_conj) effect_21\NN\34213 (r_dobj) reflect_18\VB\923793 (l_nsubj) incidence_2\NN\13821570 (l_prep) as_6\IN\14622893 (l_pobj) cause_8\NN\7323922 (l_prep) in_11\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) disease_16\NN\14061805
D009638_D010300 NONE noradrenaline_31\NN\14807929 (r_amod) levels_32\NNS\4916342 (l_prep) in_33\IN\13603305 (l_pobj) brain_36\NN\5462674 (l_amod) parkinsonian_35\JJ\0
D009638_D007022 NONE noradrenaline_31\NN\14807929 (r_amod) levels_32\NNS\4916342 (r_pobj) due_28\IN\5174653 (r_amod) mechanism_27\NN\13446390 (r_conj) effect_21\NN\34213 (l_amod) hypotensive_20\JJ\10405694
D009638_D007022 NONE noradrenaline_31\NN\14807929 (r_amod) levels_32\NNS\4916342 (r_pobj) due_28\IN\5174653 (r_amod) mechanism_27\NN\13446390 (l_amod) hypotensive_26\JJ\10405694
D007980_D003643 NONE levodopa_23\NN\14604959 (r_pobj) of_22\IN\0 (r_prep) effect_21\NN\34213 (r_dobj) reflect_18\VB\923793 (l_nsubj) incidence_2\NN\13821570 (l_prep) as_6\IN\14622893 (l_pobj) cause_8\NN\7323922 (l_prep) of_9\IN\0 (l_pobj) death_10\NN\7296428
17608141
D008070_D005334 NONE lipopolysaccharide_0\JJ\0 (r_compound) pretreatment_1\NN\0 (r_nsubj) affect_4\VB\26192 (l_dobj) temperature_8\NN\13575869 (l_conj) hyperthermia_13\NN\14034177
D008070_D020258 NONE lipopolysaccharide_11\NN\0 (r_compound) pretreatment_12\NN\0 (r_pobj) by_10\IN\0 (r_prep) neurotoxicity_7\NN\0
D008070_D020258 NONE lipopolysaccharide_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) roles_7\NNS\719494 (l_appos) factor_17\NN\7326557 (l_conj) treatment_19\NN\654885 (l_prep) in_20\IN\13603305 (l_pcomp) modulating_21\VBG\1724459 (l_dobj) neurotoxicity_28\NN\0
D008070_D020258 NONE lipopolysaccharide_8\NN\0 (r_compound) pretreatment_9\NN\0 (l_prep) in_10\IN\13603305 (l_pcomp) exerting_11\VBG\1158872 (l_dobj) protection_13\NN\407535 (l_prep) against_14\IN\0 (l_pobj) neurotoxicity_20\NN\0
D008694_D020258 NONE methamphetamine_2\NN\2704153 (r_npadvmod) induced_4\VBN\1627355 (l_dobj) neurotoxicity_7\NN\0
D008694_D020258 NONE methamphetamine_23\NN\2704153 (r_npadvmod) induced_25\VBN\1627355 (r_amod) neurotoxicity_28\NN\0
D008694_D020258 NONE methamphetamine_15\NN\2704153 (r_npadvmod) induced_17\VBN\1627355 (r_amod) neurotoxicity_20\NN\0
D004298_D020258 NONE dopamine_27\NN\14807737 (r_compound) neurotoxicity_28\NN\0
D004298_D020258 NONE dopamine_19\NN\14807737 (r_compound) neurotoxicity_20\NN\0
D008694_D009422 NONE methamphetamine_10\NN\2704153 (r_npadvmod) induced_12\VBN\1627355 (r_amod) damage_15\NN\7296428
D008694_D005334 CID methamphetamine_10\NN\2704153 (r_npadvmod) elicited_12\VBN\1617192 (r_amod) hyperthermia_13\NN\14034177
1130930
D002512_D007683 CID sodium_23\NN\14625458 (r_pobj) of_21\IN\0 (r_prep) combination_20\NN\7951464 (r_dobj) receiving_18\VBG\2210855 (r_advcl) developed_2\VBD\1753788 (l_dobj) necrosis_5\NN\11444117
D005839_D007683 CID sulfate_26\NN\15010703 (r_compound) therapy_27\NN\657604 (r_dobj) gentamicin_25\NN\2716866 (r_conj) receiving_18\VBG\2210855 (r_advcl) developed_2\VBD\1753788 (l_dobj) necrosis_5\NN\11444117
D005839_D007674 NONE gentamicin_5\NN\2716866 (r_compound) regimen_6\NN\5898568 (r_pobj) of_1\IN\0 (r_prep) nephrotoxicity_0\NN\0
D002512_D051437 NONE sodium_23\NN\14625458 (r_pobj) of_21\IN\0 (r_prep) combination_20\NN\7951464 (r_dobj) receiving_18\VBG\2210855 (r_advcl) developed_2\VBD\1753788 (l_dobj) necrosis_5\NN\11444117 (l_acl) characterized_7\VBN\609683 (l_agent) by_9\IN\0 (l_pobj) failure_13\NN\66216
D005839_D009846 NONE sulfate_26\NN\15010703 (r_compound) therapy_27\NN\657604 (r_dobj) gentamicin_25\NN\2716866 (r_conj) receiving_18\VBG\2210855 (r_advcl) developed_2\VBD\1753788 (l_dobj) necrosis_5\NN\11444117 (l_acl) characterized_7\VBN\609683 (l_agent) by_9\IN\0 (l_pobj) failure_13\NN\66216
D005839_D051437 NONE sulfate_26\NN\15010703 (r_compound) therapy_27\NN\657604 (r_dobj) gentamicin_25\NN\2716866 (r_conj) receiving_18\VBG\2210855 (r_advcl) developed_2\VBD\1753788 (l_dobj) necrosis_5\NN\11444117 (l_acl) characterized_7\VBN\609683 (l_agent) by_9\IN\0 (l_pobj) failure_13\NN\66216
D002512_D009846 NONE sodium_23\NN\14625458 (r_pobj) of_21\IN\0 (r_prep) combination_20\NN\7951464 (r_dobj) receiving_18\VBG\2210855 (r_advcl) developed_2\VBD\1753788 (l_dobj) necrosis_5\NN\11444117 (l_acl) characterized_7\VBN\609683 (l_agent) by_9\IN\0 (l_pobj) failure_13\NN\66216
D002512_D007674 NONE cephalothin_3\NN\2996840 (r_compound) gentamicin_5\NN\2716866 (r_compound) regimen_6\NN\5898568 (r_pobj) of_1\IN\0 (r_prep) nephrotoxicity_0\NN\0
8649546
D007980_D004409 CID levodopa_2\NN\14604959 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesia_5\NN\14084880
D007980_D004409 CID levodopa_14\RB\14604959 (r_npadvmod) induced_16\VBN\1627355 (r_amod) dyskinesia_20\NN\14084880
D011433_D004409 NONE propranolol_7\NN\0 (r_pcomp) by_6\IN\0 (r_prep) improvement_0\NN\7359599 (l_prep) of_1\IN\0 (l_pobj) dyskinesia_5\NN\14084880
D011433_D004409 NONE propranolol_18\NN\0 (r_dobj) received_14\VBN\2210855 (l_nsubj) patients_1\NNS\9898892 (l_acl) suffering_2\VBG\14322699 (l_prep) with_10\IN\0 (l_pobj) dyskinesia_13\NN\14084880
D011433_D010300 NONE propranolol_7\NN\0 (l_prep) in_8\IN\13603305 (l_pobj) disease_11\NN\14061805
D011433_D010300 NONE propranolol_18\NN\0 (r_dobj) received_14\VBN\2210855 (l_nsubj) patients_1\NNS\9898892 (l_acl) suffering_2\VBG\14322699 (l_prep) from_3\IN\0 (l_pobj) disease_6\NN\14061805
D011433_D010300 NONE propranolol_18\NN\0 (r_dobj) received_14\VBN\2210855 (l_nsubj) patients_1\NNS\9898892 (l_acl) suffering_2\VBG\14322699 (l_prep) from_3\IN\0 (l_pobj) disease_6\NN\14061805 (l_appos) pd_8\NNP\14625458
D007980_D010300 NONE levodopa_2\NN\14604959 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesia_5\NN\14084880 (r_pobj) of_1\IN\0 (r_prep) improvement_0\NN\7359599 (l_prep) by_6\IN\0 (l_pcomp) propranolol_7\NN\0 (l_prep) in_8\IN\13603305 (l_pobj) disease_11\NN\14061805
D007980_D010300 NONE levodopa_14\RB\14604959 (r_npadvmod) induced_16\VBN\1627355 (r_amod) dyskinesia_20\NN\14084880 (l_prep) in_21\IN\13603305 (l_pobj) pd_22\NNP\14625458
9406968
D001127_D011141 NONE vasopressin_4\NN\5407119 (r_pobj) of_2\IN\0 (r_prep) expression_1\NN\4679549 (r_nsubjpass) investigated_22\VBN\644583 (l_parataxis) polyuria_29\NN\14113228
D001127_D011141 NONE avp_6\NNP\0 (r_nmod) gene_8\NN\8459252 (r_nsubjpass) investigated_22\VBN\644583 (l_parataxis) polyuria_29\NN\14113228
D014667_D003919 NONE vasopressin_5\NN\5407119 (r_compound) gene_6\NN\8459252 (l_prep) in_7\IN\13603305 (l_pobj) nuclei_12\NNS\5445668 (l_prep) of_13\IN\0 (l_pobj) rat_20\NN\2329401 (l_compound) insipidus_19\NN\0
D008094_D003919 NONE lithium_15\NN\14625458 (r_npadvmod) induced_17\VBN\1627355 (r_amod) diabetes_18\NN\14075199 (r_compound) rat_20\NN\2329401 (l_compound) insipidus_19\NN\0
D008094_D003919 NONE li_35\NNP\14625458 (r_npadvmod) induced_37\VBN\1627355 (r_amod) diabetes_38\NN\14075199 (r_compound) rat_40\NN\2329401 (l_compound) insipidus_39\NN\0
D001127_D003681 NONE avp_19\NNP\0 (r_pobj) of_17\IN\0 (r_prep) elevation_16\NN\7445480 (r_pobj) to_14\IN\0 (r_prep) contribute_13\VB\126264 (l_nsubj) dehydration_4\NN\14536438
D001127_D003681 NONE avp_24\NNP\0 (r_compound) expression_26\NN\4679549 (r_pobj) of_23\IN\0 (r_prep) upregulation_22\NN\0 (r_conj) elevation_16\NN\7445480 (r_pobj) to_14\IN\0 (r_prep) contribute_13\VB\126264 (l_nsubj) dehydration_4\NN\14536438
D008094_D003681 NONE li_35\NNP\14625458 (r_npadvmod) induced_37\VBN\1627355 (r_amod) diabetes_38\NN\14075199 (r_compound) rat_40\NN\2329401 (r_pobj) of_33\IN\0 (r_prep) son_32\NN\10285938 (r_conj) pvn_29\NN\0 (r_pobj) in_27\IN\13603305 (r_prep) expression_26\NN\4679549 (r_pobj) of_23\IN\0 (r_prep) upregulation_22\NN\0 (r_conj) elevation_16\NN\7445480 (r_pobj) to_14\IN\0 (r_prep) contribute_13\VB\126264 (l_nsubj) dehydration_4\NN\14536438
D008094_D011141 NONE lithium_26\NN\14625458 (r_pobj) with_25\IN\0 (r_prep) rats_24\NNS\2329401 (r_pobj) in_23\IN\13603305 (r_prep) investigated_22\VBN\644583 (l_parataxis) polyuria_29\NN\14113228
D008094_D011141 NONE li)-induced_28\JJ\0 (r_amod) polyuria_29\NN\14113228
D018021_D011141 CID licl_9\NNP\0 (r_dobj) contained_8\VBD\2632940 (r_relcl) diet_6\NN\7560652 (r_dobj) consuming_4\VBG\1168468 (r_acl) rats_3\NNS\2329401 (r_nsubj) developed_19\VBN\1753788 (l_dobj) polyuria_21\NN\14113228
D001127_D003919 NONE avp_19\NNP\0 (r_pobj) of_17\IN\0 (r_prep) elevation_16\NN\7445480 (l_conj) upregulation_22\NN\0 (l_prep) of_23\IN\0 (l_pobj) expression_26\NN\4679549 (l_prep) in_27\IN\13603305 (l_pobj) pvn_29\NN\0 (l_conj) son_32\NN\10285938 (l_prep) of_33\IN\0 (l_pobj) rat_40\NN\2329401 (l_compound) insipidus_39\NN\0
D001127_D003919 NONE avp_24\NNP\0 (r_compound) expression_26\NN\4679549 (l_prep) in_27\IN\13603305 (l_pobj) pvn_29\NN\0 (l_conj) son_32\NN\10285938 (l_prep) of_33\IN\0 (l_pobj) rat_40\NN\2329401 (l_compound) insipidus_39\NN\0
3187073
D005472_D002637 CID 5-fu_6\CD\0 (r_compound) treatment_7\NN\654885 (r_pobj) on_5\IN\0 (r_prep) patients_4\NNS\9898892 (r_nsubj) be_9\VB\14625458 (l_conj) discontinued_19\VBN\0 (l_advcl) observed_26\VBN\2163746 (l_nsubjpass) pain_22\NN\14299637
D005472_D013610 NONE 5-fu_6\CD\0 (r_compound) treatment_7\NN\654885 (r_pobj) on_5\IN\0 (r_prep) patients_4\NNS\9898892 (r_nsubj) be_9\VB\14625458 (l_conj) discontinued_19\VBN\0 (l_advcl) observed_26\VBN\2163746 (l_nsubjpass) pain_22\NN\14299637 (l_conj) tachyarrhythmia_24\NN\0
17400887
D013726_D020078 NONE terbutaline_6\JJ\0 (r_compound) treatment_7\NN\654885 (r_pobj) after_4\IN\0 (r_prep) abnormalities_3\NNS\14034177 (l_nmod) neuroinflammation_0\NN\0
D013726_D001523 NONE terbutaline_6\JJ\0 (r_compound) treatment_7\NN\654885 (r_pobj) after_4\IN\0 (r_prep) abnormalities_3\NNS\14034177
D013726_D001321 CID terbutaline_6\JJ\0 (r_compound) treatment_7\NN\654885 (r_pobj) after_4\IN\0 (r_prep) abnormalities_3\NNS\14034177 (l_appos) implications_11\NNS\5774614 (l_prep) for_12\IN\0 (l_pobj) autism_13\NN\14304060
D013726_D001321 CID terbutaline_0\NNP\0 (r_nsubjpass) associated_13\VBN\628491 (l_prep) with_14\IN\0 (l_pobj) concordance_16\NN\13968547 (l_prep) for_17\IN\0 (l_pobj) autism_18\NN\14304060
D013726_D007752 NONE terbutaline_0\NNP\0 (l_appos) agonist_4\NN\0 (l_acl) used_5\VBN\0 (l_xcomp) arrest_7\VB\88481 (l_dobj) labor_9\NN\7974025
9522152
D002045_D009461 NONE bupivacaine_11\NN\0 (r_pobj) of_7\IN\0 (r_prep) injection_6\NN\320852 (r_dobj) following_4\VBG\8180190 (r_acl) deficit_3\NN\5113133
D002045_D009461 NONE bupivacaine_21\NN\0 (r_pobj) with_14\IN\0 (r_prep) anaesthesia_13\NN\14034177 (r_pobj) after_10\IN\0 (r_prep) occurred_9\VBD\0 (r_relcl) deficit_7\NN\5113133
17562951
C044834_D003920 NONE iodixanol_35\NN\0 (r_pobj) with_34\IN\0 (r_prep) with_23\IN\0 (r_prep) were_14\VBD\0 (r_conj) increases_6\VBZ\13576355 (l_prep) in_0\IN\13603305 (l_pobj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) diabetes_3\NNS\14075199
C044834_D003920 NONE iodixanol_25\NN\0 (r_conj) iopamidol_23\NN\0 (r_pobj) of_22\IN\0 (r_prep) administration_21\NN\1133281 (r_pobj) after_18\IN\0 (r_prep) is_14\VBZ\0 (l_prep) with_32\IN\0 (l_conj) without_34\IN\0 (l_pobj) mellitus_36\NN\0
D000111_D003920 NONE acetylcysteine_16\NN\0 (r_pobj) of_13\IN\0 (r_prep) use_12\NN\407535 (r_appos) volume_5\NN\33615 (l_appos) presence_7\NN\13954253 (l_prep) of_8\IN\0 (l_pobj) mellitus_10\NN\0
D007479_D007674 CID iopamidol_23\NN\0 (r_pobj) of_22\IN\0 (r_prep) administration_21\NN\1133281 (r_pobj) after_18\IN\0 (r_prep) is_14\VBZ\0 (l_nsubj) rate_1\NN\13815152 (l_prep) of_2\IN\0 (l_pobj) nephropathy_6\NN\14573196
C044834_D007674 CID iodixanol_25\NN\0 (r_conj) iopamidol_23\NN\0 (r_pobj) of_22\IN\0 (r_prep) administration_21\NN\1133281 (r_pobj) after_18\IN\0 (r_prep) is_14\VBZ\0 (l_nsubj) rate_1\NN\13815152 (l_prep) of_2\IN\0 (l_pobj) nephropathy_6\NN\14573196
D007479_D051436 NONE iopamidol_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) comparison_12\NN\635850 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) disease_22\NN\14061805
C044834_D051436 NONE iodixanol_16\NN\0 (r_conj) iopamidol_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) comparison_12\NN\635850 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) disease_22\NN\14061805
D007479_D003920 NONE iopamidol_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) were_14\VBD\0 (r_conj) increases_6\VBZ\13576355 (l_prep) in_0\IN\13603305 (l_pobj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) diabetes_3\NNS\14075199
D007479_D003920 NONE iopamidol_23\NN\0 (r_pobj) of_22\IN\0 (r_prep) administration_21\NN\1133281 (r_pobj) after_18\IN\0 (r_prep) is_14\VBZ\0 (l_prep) with_32\IN\0 (l_conj) without_34\IN\0 (l_pobj) mellitus_36\NN\0
12574103
D003907_D006973 CID dexamethasone_1\NN\2721538 (r_compound) programs_2\NNS\5833840 (r_compound) hypertension_3\NN\14057371
D003907_D006973 CID dexamethasone_11\NN\2721538 (r_nsubj) programmed_12\VBD\794981 (l_dobj) increase_15\NN\13576355 (l_prep) in_16\IN\13603305 (l_pobj) pressure_18\NN\11419404
D003907_D006973 CID dexamethasone_5\NN\2721538 (r_dobj) received_3\VBD\2210855 (r_relcl) rats_1\NNS\2329401 (r_nsubj) elevated_23\VBN\4048568 (l_dobj) pressures_25\NNS\11419404
D003907_D006973 CID dexamethasone_5\NN\2721538 (r_nsubj) results_8\VBZ\34213 (l_prep) in_9\IN\13603305 (l_pobj) reduction_11\NN\351485 (l_prep) in_12\IN\13603305 (l_pobj) number_14\NN\5107765 (l_conj) glomerulosclerosis_16\NN\0 (l_conj) hypertension_19\NN\14057371
D003907_D005921 NONE dexamethasone_3\NN\2721538 (r_dobj) given_2\VBN\5892096 (l_advcl) had_11\VBD\0 (l_dobj) glomeruli_13\NNS\5425910 (l_prep) with_14\IN\0 (l_pobj) glomerulosclerosis_15\NN\0
D003907_D005921 NONE dexamethasone_5\NN\2721538 (r_nsubj) results_8\VBZ\34213 (l_prep) in_9\IN\13603305 (l_pobj) reduction_11\NN\351485 (l_prep) in_12\IN\13603305 (l_pobj) number_14\NN\5107765 (l_conj) glomerulosclerosis_16\NN\0
D003907_D007674 CID dexamethasone_1\NN\2721538 (r_compound) programs_2\NNS\5833840 (r_compound) hypertension_3\NN\14057371 (l_conj) injury_6\NN\14052046
D003907_D007674 CID dexamethasone_11\NN\2721538 (r_nsubj) programmed_12\VBD\794981 (l_dobj) increase_15\NN\13576355 (l_prep) in_16\IN\13603305 (l_pobj) pressure_18\NN\11419404 (l_conj) injury_21\NN\14052046
D003907_D007674 CID dexamethasone_4\NN\2721538 (r_dobj) administered_3\VBN\2436349 (r_csubj) had_11\VBD\0 (l_dobj) reduction_15\NN\351485 (l_prep) in_16\IN\13603305 (l_pobj) number_18\NN\5107765
D003907_D007674 CID dexamethasone_5\NN\2721538 (r_dobj) received_3\VBD\2210855 (r_relcl) rats_1\NNS\2329401 (r_nsubj) elevated_23\VBN\4048568 (r_ccomp) have_37\VB\7846 (l_dobj) reduction_39\NN\351485 (l_prep) in_40\IN\13603305 (l_pobj) number_42\NN\5107765
D003907_D007674 CID dexamethasone_5\NN\2721538 (r_nsubj) results_8\VBZ\34213 (l_prep) in_9\IN\13603305 (l_pobj) reduction_11\NN\351485 (l_prep) in_12\IN\13603305 (l_pobj) number_14\NN\5107765
18023325
D004221_D010243 NONE disulfiram_24\NN\3740161 (r_compound) intoxication_25\NN\14034177 (r_pobj) by_20\IN\0 (r_agent) caused_19\VBN\1617192 (r_acl) polyneuropathy_18\NN\0 (r_dobj) superimposed_13\VBN\1494310 (r_conj) was_1\VBD\0 (l_attr) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) palsy_6\JJ\14557898
D004221_D014826 CID disulfiram_6\NN\3740161 (r_compound) intoxication_7\NN\14034177 (r_pobj) after_4\IN\0 (r_prep) palsy_3\JJ\14557898
D004221_D014826 CID disulfiram_6\NN\3740161 (r_compound) overdose_7\NN\84738 (r_pobj) by_4\IN\0 (r_agent) caused_3\VBN\1617192 (r_acl) neuropathy_2\NN\14204950 (r_nsubj) is_8\VBZ\0 (l_conj) is_13\VBZ\0 (l_attr) report_15\NN\6470073 (l_acl) leading_18\VBG\4339291 (l_prep) to_19\IN\0 (l_pobj) palsy_22\JJ\14557898
D004221_D010523 CID disulfiram_6\NN\3740161 (r_compound) overdose_7\NN\84738 (r_pobj) by_4\IN\0 (r_agent) caused_3\VBN\1617192 (r_acl) neuropathy_2\NN\14204950
D004221_D062787 NONE disulfiram_6\NN\3740161 (r_compound) overdose_7\NN\84738
D004221_D011115 NONE disulfiram_24\NN\3740161 (r_compound) intoxication_25\NN\14034177 (r_pobj) by_20\IN\0 (r_agent) caused_19\VBN\1617192 (r_acl) polyneuropathy_18\NN\0
12369736
C103477_D009069 NONE 55562_1\CD\0 (r_nummod) gr_0\NNP\0 (r_nsubj) administered_11\VBN\2436349 (l_conj) attenuated_23\VBD\224901 (l_dobj) hyperactivity_29\NN\14052403
C103477_D009069 NONE 55562_38\CD\0 (r_nummod) gr_37\NNP\0 (r_appos) antagonist_35\NN\7846 (r_pobj) of_31\IN\0 (r_prep) effects_30\NNS\13245626 (r_pobj) in_26\IN\13603305 (r_prep) consisting_25\VBG\2603699 (r_acl) modification_24\NN\191142 (r_conj) shell_17\NN\2703275 (r_pobj) into_14\IN\0 (r_prep) microinjected_13\VBN\0 (r_acl) ligands_12\NNS\20090 (r_pobj) by_9\IN\0 (r_agent) modified_8\VBN\109660 (l_nsubjpass) hyperlocomotion_6\NN\0
D003042_D009069 CID cocaine_14\NN\3492717 (r_npadvmod) induced_16\VBN\1627355 (r_amod) hyperactivity_18\NN\14052403
D003042_D009069 CID cocaine_34\NN\3492717 (r_pobj) by_33\IN\0 (r_agent) induced_32\VBN\1627355 (r_acl) hyperactivity_31\NN\14052403
D003042_D009069 CID cocaine_18\NN\3492717 (r_pobj) to_17\IN\0 (r_prep) prior_16\RB\10675876 (r_advmod) administered_11\VBN\2436349 (l_conj) attenuated_23\VBD\224901 (l_dobj) hyperactivity_29\NN\14052403
D003042_D009069 CID cocaine_4\NN\3492717 (r_nsubj) induced_5\VBN\1627355 (r_ccomp) indicate_2\VBP\952524 (l_ccomp) modified_8\VBN\109660 (l_nsubjpass) hyperlocomotion_6\NN\0
C065046_D009069 CID 93129_44\CD\0 (r_nummod) cp_43\NNP\0 (r_appos) agonist_41\NN\0 (r_conj) modification_24\NN\191142 (r_conj) shell_17\NN\2703275 (r_pobj) into_14\IN\0 (r_prep) microinjected_13\VBN\0 (r_acl) ligands_12\NNS\20090 (r_pobj) by_9\IN\0 (r_agent) modified_8\VBN\109660 (l_nsubjpass) hyperlocomotion_6\NN\0
8953972
D004837_D006323 CID epinephrine_0\NN\14807929 (r_nsubj) has_1\VBZ\13888491 (l_dobj) role_4\NN\719494 (l_prep) in_5\IN\13603305 (l_pobj) arrest_7\NN\88481
D004837_D013345 CID epinephrine_8\NN\14807929 (r_pobj) of_7\IN\0 (r_prep) use_6\NN\407535 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) bleeding_2\NN\14285662
D004837_D012128 NONE epinephrine_26\NN\14807929 (r_dobj) administer_24\VB\2436349 (r_xcomp) led_16\VBD\3202760 (l_nsubj) onset_2\NN\7325190 (l_prep) of_3\IN\0 (l_pobj) distress_5\NN\7494363
D004837_D005076 NONE epinephrine_26\NN\14807929 (r_dobj) administer_24\VB\2436349 (r_xcomp) led_16\VBD\3202760 (l_nsubj) onset_2\NN\7325190 (l_prep) of_3\IN\0 (l_pobj) distress_5\NN\7494363 (l_conj) rash_7\JJ\14321469
D004837_D004342 NONE epinephrine_0\NN\14807929 (r_nsubj) has_1\VBZ\13888491 (r_ccomp) use_14\NN\407535 (l_prep) by_15\IN\0 (l_pobj) paramedics_16\NNS\10398624 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) reaction_22\NN\13446390
D004837_D006973 NONE epinephrine_0\NN\14807929 (r_nsubj) has_1\VBZ\13888491 (r_ccomp) use_14\NN\407535 (l_prep) by_15\IN\0 (l_pobj) paramedics_16\NNS\10398624 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) reaction_22\NN\13446390 (l_conj) hypertension_25\NN\14057371
20588063
D011692_D009401 CID aminonucleoside_17\JJ\0 (r_amod) nephrosis_18\NN\14304060
D011692_D009401 CID aminonucleoside_2\JJ\0 (r_amod) nephrosis_3\NN\14304060
9293063
D003613_D006222 CID danazol_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) treatment_10\NN\654885 (r_pobj) with_6\IN\0 (r_prep) association_5\NN\8008335 (r_pobj) in_4\IN\13603305 (r_prep) occurring_3\VBG\0 (r_acl) hamartoma_2\NN\14234074
D003613_D006222 CID danazol_20\NN\0 (r_compound) treatment_21\NN\654885 (r_pobj) on_16\IN\0 (r_prep) been_15\VBN\0 (r_relcl) patient_12\NN\9898892 (r_pobj) in_10\IN\13603305 (r_prep) developed_9\VBD\1753788 (r_relcl) hamartoma_7\NN\14234074
D003613_D001650 CID danazol_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) treatment_10\NN\654885 (r_pobj) with_6\IN\0 (r_prep) association_5\NN\8008335 (r_pobj) in_4\IN\13603305 (r_prep) occurring_3\VBG\0 (r_acl) hamartoma_2\NN\14234074
D003613_D001650 CID danazol_20\NN\0 (r_compound) treatment_21\NN\654885 (r_pobj) on_16\IN\0 (r_prep) been_15\VBN\0 (r_relcl) patient_12\NN\9898892 (r_pobj) in_10\IN\13603305 (r_prep) developed_9\VBD\1753788 (r_relcl) hamartoma_7\NN\14234074
6634932
D010042_D017180 CID ouabain_20\RB\0 (r_npadvmod) induced_22\VBN\1627355 (r_amod) tachycardias_24\NNS\14110674
C002616_D017180 NONE um-272_0\NNP\0 (r_punct) dimethylpropranolol_6\NNP\0 (r_nsubjpass) administered_15\VBN\2436349 (l_prep) to_17\IN\0 (l_pobj) dogs_18\NNS\2083346 (l_prep) with_19\IN\0 (l_pobj) tachycardias_24\NNS\14110674
C002616_D017180 NONE dimethylpropranolol_6\NNP\0 (r_nsubjpass) administered_15\VBN\2436349 (l_prep) to_17\IN\0 (l_pobj) dogs_18\NNS\2083346 (l_prep) with_19\IN\0 (l_pobj) tachycardias_24\NNS\14110674
C002616_D017180 NONE um-272_1\NNP\0 (r_punct) converted_2\VBD\126264 (l_dobj) tachycardia_4\NN\14110674
15602202
D017963_D009395 CID azithromycin_6\PRP\2716205 (r_pobj) by_5\IN\0 (r_prep) induced_4\VBN\1627355 (l_nsubj) nephritis_3\NN\14113228
D017963_D009395 CID azithromycin_10\RB\2716205 (r_advmod) induced_12\VBN\1627355 (r_amod) nephritis_16\NN\14113228
8638206
D001279_D010243 CID atracurium_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) use_4\NN\407535 (r_pobj) after_2\IN\0 (r_prep) paralysis_1\NN\14557898
D001279_D010243 CID besylate_1\NN\0 (r_nsubjpass) associated_22\VBN\628491 (l_prep) with_23\IN\0 (l_pobj) paralysis_25\NN\14557898
D001279_D010243 CID atracurium_5\NN\0 (r_npadvmod) related_7\VBN\628491 (r_amod) paralysis_8\NN\14557898
D014673_D010243 CID bromide_21\NN\14904359 (r_pobj) as_19\IN\14622893 (r_prep) nmbas_17\NNS\0 (r_dobj) involved_13\VBN\2676054 (l_nsubj) reports_0\NNS\6470073 (l_prep) of_1\IN\0 (l_pobj) paralysis_3\NN\14557898
-1_D010243 NONE benzylisoquinolinium_7\NN\0 (r_amod) nmba_8\NNP\0 (r_appos) besylate_1\NN\0 (r_nsubjpass) associated_22\VBN\628491 (l_prep) with_23\IN\0 (l_pobj) paralysis_25\NN\14557898
15632880
D011188_D006947 NONE k(+_7\NNP\0 (r_appos) hyperkalemia_5\NN\14299637
D011188_D006947 NONE potassium_17\NN\14625458 (r_compound) levels_18\NNS\4916342 (r_dobj) had_13\VBD\0 (r_conj) were_4\VBD\0 (l_nsubj) patients_0\NNS\9898892 (l_relcl) developed_2\VBD\1753788 (l_dobj) hyperkalemia_3\NN\14299637
D011188_D006947 NONE potassium_22\NN\14625458 (r_compound) supplement_23\NN\6365467 (r_compound) doses_24\NNS\3740161 (r_conj) levels_18\NNS\4916342 (r_dobj) had_13\VBD\0 (r_conj) were_4\VBD\0 (l_nsubj) patients_0\NNS\9898892 (l_relcl) developed_2\VBD\1753788 (l_dobj) hyperkalemia_3\NN\14299637
D013148_D051437 CID spironolactone_0\NNP\2721160 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) insufficiency_4\NN\14462946
D013148_D051437 CID spironolactone_9\NN\2721160 (r_pobj) of_8\IN\0 (r_prep) use_7\NN\407535 (r_dobj) evaluating_5\VBG\670261 (r_acl) trial_4\NN\786195 (r_nsubj) reported_14\VBD\831651 (l_dobj) risk_17\NN\14541044 (l_prep) of_18\IN\0 (l_pobj) hyperkalemia_19\NN\14299637 (l_conj) insufficiency_26\NN\14462946
D013148_D051437 CID spironolactone_21\NN\2721160 (r_pobj) with_20\IN\0 (r_prep) treated_19\VBN\2376958 (r_acl) patients_18\NNS\9898892 (r_pobj) in_15\IN\13603305 (r_prep) insufficiency_14\NN\14462946
D013148_D051437 CID spironolactone_13\NN\2721160 (r_pobj) of_12\IN\0 (r_prep) discontinuation_11\NN\209943 (r_dobj) required_10\VBD\0 (l_prep) due_14\IN\5174653 (l_pobj) hyperkalemia_16\NN\14299637 (l_conj) failure_24\NN\66216
D013148_D051437 CID spironolactone_0\NNP\2721160 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hyperkalemia_3\NN\14299637 (r_nmod) insufficiency_6\NN\14462946
D011188_D003920 NONE potassium_17\NN\14625458 (r_compound) levels_18\NNS\4916342 (r_dobj) had_13\VBD\0 (r_conj) were_4\VBD\0 (l_acomp) older_5\JJR\0 (l_conj) likely_8\JJ\0 (l_xcomp) have_10\VB\7846 (l_dobj) diabetes_11\NNS\14075199
D011188_D003920 NONE potassium_22\NN\14625458 (r_compound) supplement_23\NN\6365467 (r_compound) doses_24\NNS\3740161 (r_conj) levels_18\NNS\4916342 (r_dobj) had_13\VBD\0 (r_conj) were_4\VBD\0 (l_acomp) older_5\JJR\0 (l_conj) likely_8\JJ\0 (l_xcomp) have_10\VB\7846 (l_dobj) diabetes_11\NNS\14075199
D013148_D006333 NONE spironolactone_0\NNP\2721160 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) insufficiency_4\NN\14462946 (l_prep) in_7\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_pobj) failure_11\NN\66216
D013148_D006333 NONE spironolactone_9\NN\2721160 (l_prep) in_10\IN\13603305 (l_pobj) patients_13\NNS\9898892 (l_compound) failure_12\NN\66216
D013148_D006333 NONE spironolactone_11\NN\2721160 (r_pobj) of_10\IN\0 (r_prep) benefits_9\NNS\13278375 (r_nsubjpass) reported_13\VBN\831651 (r_advcl) changed_6\VBN\0 (l_nsubj) treatments_1\NNS\654885 (l_prep) for_2\IN\0 (l_pobj) failure_4\NN\66216
D013148_D006333 NONE spironolactone_21\NN\2721160 (r_pobj) with_20\IN\0 (r_prep) treated_19\VBN\2376958 (r_acl) patients_18\NNS\9898892 (l_compound) failure_17\NN\66216
D013148_D006333 NONE spironolactone_12\NN\2721160 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (r_acl) patients_9\NNS\9898892 (l_compound) failure_8\NN\66216
D049971_D051437 NONE thiazide_31\NN\3214670 (r_amod) diuretics_32\NNS\3247620 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_xcomp) likely_26\JJ\0 (r_acomp) were_24\VBD\0 (r_conj) required_16\VBD\0 (r_conj) had_5\VBD\0 (l_nsubj) patients_0\NNS\9898892 (l_relcl) developed_2\VBD\1753788 (l_dobj) insufficiency_4\NN\14462946
D013148_D006947 CID spironolactone_0\NNP\2721160 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) insufficiency_4\NN\14462946 (l_conj) hyperkalemia_6\NN\14299637
D013148_D006947 CID spironolactone_9\NN\2721160 (r_pobj) of_8\IN\0 (r_prep) use_7\NN\407535 (r_dobj) evaluating_5\VBG\670261 (r_acl) trial_4\NN\786195 (r_nsubj) reported_14\VBD\831651 (l_dobj) risk_17\NN\14541044 (l_prep) of_18\IN\0 (l_pobj) hyperkalemia_19\NN\14299637
D013148_D006947 CID spironolactone_21\NN\2721160 (r_pobj) with_20\IN\0 (r_prep) treated_19\VBN\2376958 (r_acl) patients_18\NNS\9898892 (r_pobj) in_15\IN\13603305 (r_prep) insufficiency_14\NN\14462946 (r_conj) hyperkalemia_11\NN\14299637
D013148_D006947 CID spironolactone_13\NN\2721160 (r_pobj) of_12\IN\0 (r_prep) discontinuation_11\NN\209943 (r_dobj) required_10\VBD\0 (l_prep) due_14\IN\5174653 (l_pobj) hyperkalemia_16\NN\14299637
D013148_D006947 CID spironolactone_0\NNP\2721160 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hyperkalemia_3\NN\14299637
D003404_D051437 NONE creatinine_14\NN\0 (r_conj) weight_9\NN\5009170 (r_dobj) had_5\VBD\0 (l_nsubj) patients_0\NNS\9898892 (l_relcl) developed_2\VBD\1753788 (l_dobj) insufficiency_4\NN\14462946
D011188_D051437 NONE k(+_7\NNP\0 (r_appos) hyperkalemia_5\NN\14299637 (r_dobj) developed_4\VBD\1753788 (r_relcl) patients_2\NNS\9898892 (r_attr) were_1\VBD\0 (l_nsubj) cases_0\NNS\7283608 (l_appos) l_13\NN\13616054 (l_conj) insufficiency_17\NN\14462946
6386793
D000639_D014786 CID amitriptyline_27\NN\4482543 (r_pobj) with_26\IN\0 (r_prep) than_25\IN\0 (r_prep) less_22\JJR\14187378 (r_acomp) were_20\VBD\0 (l_nsubj) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) effects_5\NNS\13245626 (l_conj) frequency_8\NN\15286249 (l_prep) of_11\IN\0 (l_pobj) vision_13\NN\5767733
D004308_D014987 NONE dothiepin_24\JJ\0 (r_pobj) with_23\IN\0 (r_prep) less_22\JJR\14187378 (r_acomp) were_20\VBD\0 (l_nsubj) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) effects_5\NNS\13245626 (l_conj) frequency_8\NN\15286249 (l_prep) of_11\IN\0 (l_pobj) vision_13\NN\5767733 (l_conj) mouth_16\NN\5610008
D000928_D003866 NONE antidepressant_8\NN\3740161 (r_amod) drug_9\NN\14778436 (l_acl) associated_10\VBN\628491 (l_prep) with_11\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) than_15\IN\0 (l_pobj) amitriptyline_16\NN\4482543 (l_prep) in_17\IN\13603305 (l_pobj) treatment_19\NN\654885 (l_prep) of_20\IN\0 (l_pobj) outpatients_22\NNS\10405694 (l_amod) depressed_21\JJ\1819147
D000639_D014987 CID amitriptyline_27\NN\4482543 (r_pobj) with_26\IN\0 (r_prep) than_25\IN\0 (r_prep) less_22\JJR\14187378 (r_acomp) were_20\VBD\0 (l_nsubj) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) effects_5\NNS\13245626 (l_conj) frequency_8\NN\15286249 (l_prep) of_11\IN\0 (l_pobj) vision_13\NN\5767733 (l_conj) mouth_16\NN\5610008
D004308_D003866 NONE hydrochloride_12\NN\14817592 (r_pobj) of_10\IN\0 (r_prep) efficacy_7\NN\5199286 (r_pobj) of_5\IN\0 (r_prep) study_4\NN\635850 (l_prep) in_13\IN\13603305 (l_pobj) treatment_15\NN\654885 (l_prep) of_16\IN\0 (l_pobj) disorder_19\NN\14034177
D004308_D003866 NONE dothiepin_10\JJ\0 (r_nsubjpass) compared_14\VBN\644583 (l_prep) to_15\IN\0 (l_pobj) placebo_16\NN\3740161 (l_prep) in_17\IN\13603305 (l_pobj) treatment_19\NN\654885 (l_prep) of_20\IN\0 (l_pobj) outpatients_23\NNS\10405694 (l_amod) depressed_22\JJ\1819147
D004308_D003866 NONE dothiepin_0\JJ\0 (r_nsubj) were_3\VBD\0 (l_acomp) effective_5\JJ\0 (l_prep) in_6\IN\13603305 (l_pcomp) alleviating_7\VBG\205885 (l_dobj) symptoms_9\NNS\5823932 (l_prep) of_10\IN\0 (l_pobj) illness_12\NN\14052046
D004308_D003866 NONE dothiepin_0\NNP\0 (r_nsubjpass) found_3\VBN\13279262 (l_xcomp) be_5\VB\14625458 (l_attr) drug_9\NN\14778436 (l_acl) associated_10\VBN\628491 (l_prep) with_11\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) than_15\IN\0 (l_pobj) amitriptyline_16\NN\4482543 (l_prep) in_17\IN\13603305 (l_pobj) treatment_19\NN\654885 (l_prep) of_20\IN\0 (l_pobj) outpatients_22\NNS\10405694 (l_amod) depressed_21\JJ\1819147
D004308_D014786 NONE dothiepin_24\JJ\0 (r_pobj) with_23\IN\0 (r_prep) less_22\JJR\14187378 (r_acomp) were_20\VBD\0 (l_nsubj) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) effects_5\NNS\13245626 (l_conj) frequency_8\NN\15286249 (l_prep) of_11\IN\0 (l_pobj) vision_13\NN\5767733
D000639_D003866 NONE amitriptyline_12\NN\4482543 (r_conj) dothiepin_10\JJ\0 (r_nsubjpass) compared_14\VBN\644583 (l_prep) to_15\IN\0 (l_pobj) placebo_16\NN\3740161 (l_prep) in_17\IN\13603305 (l_pobj) treatment_19\NN\654885 (l_prep) of_20\IN\0 (l_pobj) outpatients_23\NNS\10405694 (l_amod) depressed_22\JJ\1819147
D000639_D003866 NONE amitriptyline_2\NN\4482543 (r_conj) dothiepin_0\JJ\0 (r_nsubj) were_3\VBD\0 (l_acomp) effective_5\JJ\0 (l_prep) in_6\IN\13603305 (l_pcomp) alleviating_7\VBG\205885 (l_dobj) symptoms_9\NNS\5823932 (l_prep) of_10\IN\0 (l_pobj) illness_12\NN\14052046
D000639_D003866 NONE amitriptyline_16\NN\4482543 (l_prep) in_17\IN\13603305 (l_pobj) treatment_19\NN\654885 (l_prep) of_20\IN\0 (l_pobj) outpatients_22\NNS\10405694 (l_amod) depressed_21\JJ\1819147
2673163
D003042_D002532 NONE cocaine_14\NN\3492717 (r_compound) use_15\NN\407535 (r_pobj) to_13\IN\0 (r_prep) related_12\VBN\628491 (r_acl) stroke_11\NN\556313 (r_pobj) of_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_nsubj) increasing_17\VBG\169651 (r_ccomp) indicate_2\VBP\952524 (r_ccomp) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313 (l_advcl) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371
D003042_D002532 NONE cocaine_22\NN\3492717 (r_npadvmod) associated_24\VBN\628491 (r_amod) stroke_25\NN\556313 (r_nsubj) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313 (l_advcl) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371
D003042_D002532 NONE cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) route_39\NN\8593262 (r_dobj) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313 (l_advcl) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371
D003042_D002532 NONE cocaine_49\NN\3492717 (r_compound) use_50\NN\407535 (r_nsubjpass) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371
D003042_D002532 NONE cocaine_66\NN\3492717 (r_npadvmod) associated_68\VBN\628491 (r_amod) stroke_69\NN\556313 (r_pobj) in_65\IN\13603305 (r_prep) 5_63\CD\13741022 (r_conj) stroke_47\NN\556313 (l_advcl) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371
D003042_D020521 NONE cocaine_3\NN\3492717 (r_compound) use_4\NN\407535 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) stroke_0\NN\556313
D003042_D020521 NONE cocaine_6\NN\3492717 (r_compound) use_7\NN\407535 (r_nsubjpass) related_9\VBN\628491 (l_prep) to_10\IN\0 (l_pobj) stroke_11\NN\556313
D003042_D020521 NONE cocaine_2\NN\3492717 (r_compound) use_3\NN\407535 (r_dobj) followed_1\VBD\1835496 (l_nsubj) stroke_0\NN\556313
D003042_D020521 NONE cocaine_14\NN\3492717 (r_compound) use_15\NN\407535 (r_pobj) to_13\IN\0 (r_prep) related_12\VBN\628491 (r_acl) stroke_11\NN\556313
D003042_D020521 NONE cocaine_14\NN\3492717 (r_compound) use_15\NN\407535 (r_pobj) to_13\IN\0 (r_prep) related_12\VBN\628491 (r_acl) stroke_11\NN\556313 (r_pobj) of_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_nsubj) increasing_17\VBG\169651 (r_ccomp) indicate_2\VBP\952524 (r_ccomp) occurs_26\VBZ\0 (l_nsubj) stroke_25\NN\556313
D003042_D020521 NONE cocaine_14\NN\3492717 (r_compound) use_15\NN\407535 (r_pobj) to_13\IN\0 (r_prep) related_12\VBN\628491 (r_acl) stroke_11\NN\556313 (r_pobj) of_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_nsubj) increasing_17\VBG\169651 (r_ccomp) indicate_2\VBP\952524 (r_ccomp) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (l_nsubj) stroke_35\NN\556313
D003042_D020521 NONE cocaine_14\NN\3492717 (r_compound) use_15\NN\407535 (r_pobj) to_13\IN\0 (r_prep) related_12\VBN\628491 (r_acl) stroke_11\NN\556313 (r_pobj) of_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_nsubj) increasing_17\VBG\169651 (r_ccomp) indicate_2\VBP\952524 (r_ccomp) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313
D003042_D020521 NONE cocaine_14\NN\3492717 (r_compound) use_15\NN\407535 (r_pobj) to_13\IN\0 (r_prep) related_12\VBN\628491 (r_acl) stroke_11\NN\556313 (r_pobj) of_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_nsubj) increasing_17\VBG\169651 (r_ccomp) indicate_2\VBP\952524 (r_ccomp) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313 (l_conj) 5_63\CD\13741022 (l_prep) in_65\IN\13603305 (l_pobj) stroke_69\NN\556313
D003042_D020521 NONE cocaine_22\NN\3492717 (r_npadvmod) associated_24\VBN\628491 (r_amod) stroke_25\NN\556313 (r_nsubj) occurs_26\VBZ\0 (l_ccomp) indicate_2\VBP\952524 (l_ccomp) increasing_17\VBG\169651 (l_nsubj) incidence_9\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) stroke_11\NN\556313
D003042_D020521 NONE cocaine_22\NN\3492717 (r_npadvmod) associated_24\VBN\628491 (r_amod) stroke_25\NN\556313
D003042_D020521 NONE cocaine_22\NN\3492717 (r_npadvmod) associated_24\VBN\628491 (r_amod) stroke_25\NN\556313 (r_nsubj) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (l_nsubj) stroke_35\NN\556313
D003042_D020521 NONE cocaine_22\NN\3492717 (r_npadvmod) associated_24\VBN\628491 (r_amod) stroke_25\NN\556313 (r_nsubj) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313
D003042_D020521 NONE cocaine_22\NN\3492717 (r_npadvmod) associated_24\VBN\628491 (r_amod) stroke_25\NN\556313 (r_nsubj) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313 (l_conj) 5_63\CD\13741022 (l_prep) in_65\IN\13603305 (l_pobj) stroke_69\NN\556313
D003042_D020521 NONE cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) route_39\NN\8593262 (r_dobj) follow_37\VB\1835496 (l_ccomp) occurs_26\VBZ\0 (l_ccomp) indicate_2\VBP\952524 (l_ccomp) increasing_17\VBG\169651 (l_nsubj) incidence_9\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) stroke_11\NN\556313
D003042_D020521 NONE cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) route_39\NN\8593262 (r_dobj) follow_37\VB\1835496 (l_ccomp) occurs_26\VBZ\0 (l_nsubj) stroke_25\NN\556313
D003042_D020521 NONE cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) route_39\NN\8593262 (r_dobj) follow_37\VB\1835496 (l_nsubj) stroke_35\NN\556313
D003042_D020521 NONE cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) route_39\NN\8593262 (r_dobj) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313
D003042_D020521 NONE cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) route_39\NN\8593262 (r_dobj) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313 (l_conj) 5_63\CD\13741022 (l_prep) in_65\IN\13603305 (l_pobj) stroke_69\NN\556313
D003042_D020521 NONE cocaine_49\NN\3492717 (r_compound) use_50\NN\407535 (r_nsubjpass) associated_53\VBN\628491 (r_advcl) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (r_nsubj) exceeds_76\VBZ\0 (l_ccomp) follow_37\VB\1835496 (l_ccomp) occurs_26\VBZ\0 (l_ccomp) indicate_2\VBP\952524 (l_ccomp) increasing_17\VBG\169651 (l_nsubj) incidence_9\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) stroke_11\NN\556313
D003042_D020521 NONE cocaine_49\NN\3492717 (r_compound) use_50\NN\407535 (r_nsubjpass) associated_53\VBN\628491 (r_advcl) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (r_nsubj) exceeds_76\VBZ\0 (l_ccomp) follow_37\VB\1835496 (l_ccomp) occurs_26\VBZ\0 (l_nsubj) stroke_25\NN\556313
D003042_D020521 NONE cocaine_49\NN\3492717 (r_compound) use_50\NN\407535 (r_nsubjpass) associated_53\VBN\628491 (r_advcl) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (r_nsubj) exceeds_76\VBZ\0 (l_ccomp) follow_37\VB\1835496 (l_nsubj) stroke_35\NN\556313
D003042_D020521 NONE cocaine_49\NN\3492717 (r_compound) use_50\NN\407535 (r_nsubjpass) associated_53\VBN\628491 (r_advcl) stroke_47\NN\556313
D003042_D020521 NONE cocaine_49\NN\3492717 (r_compound) use_50\NN\407535 (r_nsubjpass) associated_53\VBN\628491 (r_advcl) stroke_47\NN\556313 (l_conj) 5_63\CD\13741022 (l_prep) in_65\IN\13603305 (l_pobj) stroke_69\NN\556313
D003042_D020521 NONE cocaine_66\NN\3492717 (r_npadvmod) associated_68\VBN\628491 (r_amod) stroke_69\NN\556313 (r_pobj) in_65\IN\13603305 (r_prep) 5_63\CD\13741022 (r_conj) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (r_nsubj) exceeds_76\VBZ\0 (l_ccomp) follow_37\VB\1835496 (l_ccomp) occurs_26\VBZ\0 (l_ccomp) indicate_2\VBP\952524 (l_ccomp) increasing_17\VBG\169651 (l_nsubj) incidence_9\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) stroke_11\NN\556313
D003042_D020521 NONE cocaine_66\NN\3492717 (r_npadvmod) associated_68\VBN\628491 (r_amod) stroke_69\NN\556313 (r_pobj) in_65\IN\13603305 (r_prep) 5_63\CD\13741022 (r_conj) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (r_nsubj) exceeds_76\VBZ\0 (l_ccomp) follow_37\VB\1835496 (l_ccomp) occurs_26\VBZ\0 (l_nsubj) stroke_25\NN\556313
D003042_D020521 NONE cocaine_66\NN\3492717 (r_npadvmod) associated_68\VBN\628491 (r_amod) stroke_69\NN\556313 (r_pobj) in_65\IN\13603305 (r_prep) 5_63\CD\13741022 (r_conj) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (r_nsubj) exceeds_76\VBZ\0 (l_ccomp) follow_37\VB\1835496 (l_nsubj) stroke_35\NN\556313
D003042_D020521 NONE cocaine_66\NN\3492717 (r_npadvmod) associated_68\VBN\628491 (r_amod) stroke_69\NN\556313 (r_pobj) in_65\IN\13603305 (r_prep) 5_63\CD\13741022 (r_conj) stroke_47\NN\556313
D003042_D020521 NONE cocaine_66\NN\3492717 (r_npadvmod) associated_68\VBN\628491 (r_amod) stroke_69\NN\556313
D003042_D002544 CID cocaine_14\NN\3492717 (r_compound) use_15\NN\407535 (r_pobj) to_13\IN\0 (r_prep) related_12\VBN\628491 (r_acl) stroke_11\NN\556313 (r_pobj) of_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_nsubj) increasing_17\VBG\169651 (r_ccomp) indicate_2\VBP\952524 (r_ccomp) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_dobj) that_77\DT\0 (l_prep) of_78\IN\0 (l_pobj) infarction_80\NN\14204950
D003042_D002544 CID cocaine_22\NN\3492717 (r_npadvmod) associated_24\VBN\628491 (r_amod) stroke_25\NN\556313 (r_nsubj) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_dobj) that_77\DT\0 (l_prep) of_78\IN\0 (l_pobj) infarction_80\NN\14204950
D003042_D002544 CID cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) route_39\NN\8593262 (r_dobj) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_dobj) that_77\DT\0 (l_prep) of_78\IN\0 (l_pobj) infarction_80\NN\14204950
D003042_D002544 CID cocaine_49\NN\3492717 (r_compound) use_50\NN\407535 (r_nsubjpass) associated_53\VBN\628491 (r_advcl) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (r_nsubj) exceeds_76\VBZ\0 (l_dobj) that_77\DT\0 (l_prep) of_78\IN\0 (l_pobj) infarction_80\NN\14204950
D003042_D002544 CID cocaine_66\NN\3492717 (r_npadvmod) associated_68\VBN\628491 (r_amod) stroke_69\NN\556313 (r_pobj) in_65\IN\13603305 (r_prep) 5_63\CD\13741022 (r_conj) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (r_nsubj) exceeds_76\VBZ\0 (l_dobj) that_77\DT\0 (l_prep) of_78\IN\0 (l_pobj) infarction_80\NN\14204950
D003042_D001165 NONE cocaine_14\NN\3492717 (r_compound) use_15\NN\407535 (r_pobj) to_13\IN\0 (r_prep) related_12\VBN\628491 (r_acl) stroke_11\NN\556313 (r_pobj) of_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_nsubj) increasing_17\VBG\169651 (r_ccomp) indicate_2\VBP\952524 (r_ccomp) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313 (l_advcl) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371 (l_conj) malformations_59\NNS\14213199
D003042_D001165 NONE cocaine_22\NN\3492717 (r_npadvmod) associated_24\VBN\628491 (r_amod) stroke_25\NN\556313 (r_nsubj) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313 (l_advcl) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371 (l_conj) malformations_59\NNS\14213199
D003042_D001165 NONE cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) route_39\NN\8593262 (r_dobj) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_nmod) stroke_47\NN\556313 (l_advcl) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371 (l_conj) malformations_59\NNS\14213199
D003042_D001165 NONE cocaine_49\NN\3492717 (r_compound) use_50\NN\407535 (r_nsubjpass) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371 (l_conj) malformations_59\NNS\14213199
D003042_D001165 NONE cocaine_66\NN\3492717 (r_npadvmod) associated_68\VBN\628491 (r_amod) stroke_69\NN\556313 (r_pobj) in_65\IN\13603305 (r_prep) 5_63\CD\13741022 (r_conj) stroke_47\NN\556313 (l_advcl) associated_53\VBN\628491 (l_prep) with_54\IN\0 (l_pobj) aneurysms_56\NNS\14057371 (l_conj) malformations_59\NNS\14213199
D003042_D020300 NONE cocaine_14\NN\3492717 (r_compound) use_15\NN\407535 (r_pobj) to_13\IN\0 (r_prep) related_12\VBN\628491 (r_acl) stroke_11\NN\556313 (r_pobj) of_10\IN\0 (r_prep) incidence_9\NN\13821570 (r_nsubj) increasing_17\VBG\169651 (r_ccomp) indicate_2\VBP\952524 (r_ccomp) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_prep) of_73\IN\0 (l_pobj) hemorrhage_75\NN\14285662
D003042_D020300 NONE cocaine_22\NN\3492717 (r_npadvmod) associated_24\VBN\628491 (r_amod) stroke_25\NN\556313 (r_nsubj) occurs_26\VBZ\0 (r_ccomp) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_prep) of_73\IN\0 (l_pobj) hemorrhage_75\NN\14285662
D003042_D020300 NONE cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (r_pobj) of_40\IN\0 (r_prep) route_39\NN\8593262 (r_dobj) follow_37\VB\1835496 (r_ccomp) exceeds_76\VBZ\0 (l_nsubj) frequency_72\NN\15286249 (l_prep) of_73\IN\0 (l_pobj) hemorrhage_75\NN\14285662
D003042_D020300 NONE cocaine_49\NN\3492717 (r_compound) use_50\NN\407535 (r_nsubjpass) associated_53\VBN\628491 (r_advcl) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (l_prep) of_73\IN\0 (l_pobj) hemorrhage_75\NN\14285662
D003042_D020300 NONE cocaine_66\NN\3492717 (r_npadvmod) associated_68\VBN\628491 (r_amod) stroke_69\NN\556313 (r_pobj) in_65\IN\13603305 (r_prep) 5_63\CD\13741022 (r_conj) stroke_47\NN\556313 (r_nmod) frequency_72\NN\15286249 (l_prep) of_73\IN\0 (l_pobj) hemorrhage_75\NN\14285662
19803309
D013390_D009224 NONE suxamethonium_29\NN\0 (r_pobj) of_27\IN\0 (r_prep) dose_26\NN\3740161 (r_pobj) following_23\VBG\8180190 (r_prep) threatening_20\VBG\2603699 (r_ccomp) developed_18\VBD\1753788 (r_relcl) primigravida_15\NN\10144838 (r_pobj) in_8\IN\13603305 (r_prep) case_4\NN\7283608 (l_prep) of_5\IN\0 (l_pobj) congenita_7\NN\0
D013390_D014313 CID suxamethonium_29\NN\0 (r_pobj) of_27\IN\0 (r_prep) dose_26\NN\3740161 (r_pobj) following_23\VBG\8180190 (r_prep) threatening_20\VBG\2603699 (l_dobj) spasm_22\NN\14299637
234669
D002245_D014693 NONE dioxide_32\NN\14971519 (r_conj) po2_28\NNP\0 (r_appos) oxygen_26\NN\14622893 (r_pobj) of_25\IN\0 (r_prep) pressures_24\NNS\11419404 (r_nsubjpass) kept_37\VBN\0 (r_advcl) reduced_11\VBN\441445 (l_nsubjpass) threshold_9\NN\15265518 (l_compound) fibrillation_8\NN\14361664
D002245_D014693 NONE co2_34\NNP\14836127 (r_appos) dioxide_32\NN\14971519 (r_conj) po2_28\NNP\0 (r_appos) oxygen_26\NN\14622893 (r_pobj) of_25\IN\0 (r_prep) pressures_24\NNS\11419404 (r_nsubjpass) kept_37\VBN\0 (r_advcl) reduced_11\VBN\441445 (l_nsubjpass) threshold_9\NN\15265518 (l_compound) fibrillation_8\NN\14361664
C093415_D014693 NONE po2_28\NNP\0 (r_appos) oxygen_26\NN\14622893 (r_pobj) of_25\IN\0 (r_prep) pressures_24\NNS\11419404 (r_nsubjpass) kept_37\VBN\0 (r_advcl) reduced_11\VBN\441445 (l_nsubjpass) threshold_9\NN\15265518 (l_compound) fibrillation_8\NN\14361664
D000628_D012131 NONE aminophylline_2\NN\2905612 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_prep) for_6\IN\0 (l_pcomp) initiating_7\VBG\1617192 (l_prep) during_10\IN\0 (l_pobj) failure_12\NN\66216
D000628_D012131 NONE aminophylline_3\NN\2905612 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_conj) during_16\IN\0 (l_pobj) failure_18\NN\66216
D000628_D012131 NONE aminophylline_30\NN\2905612 (r_pobj) of_29\IN\0 (r_prep) infusion_28\NN\14589223 (r_nsubj) resulted_31\VBD\2633881 (l_advcl) produced_4\VBN\1617192 (l_nsubjpass) failure_2\NN\66216
D000628_D012131 NONE aminophylline_24\NN\2905612 (r_appos) agents_21\NNS\7347 (r_nsubj) play_27\VB\7007684 (l_advcl) contribute_8\VB\126264 (l_prep) to_9\IN\0 (l_pobj) incidence_12\NN\13821570 (l_prep) of_13\IN\0 (l_pobj) arrhythmias_15\NNS\14103288 (l_prep) in_16\IN\13603305 (l_pobj) failure_18\NN\66216
D010100_D014693 NONE oxygen_26\NN\14622893 (r_pobj) of_25\IN\0 (r_prep) pressures_24\NNS\11419404 (r_nsubjpass) kept_37\VBN\0 (r_advcl) reduced_11\VBN\441445 (l_nsubjpass) threshold_9\NN\15265518 (l_compound) fibrillation_8\NN\14361664
D000628_D014693 CID aminophylline_2\NN\2905612 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_prep) for_6\IN\0 (l_pcomp) initiating_7\VBG\1617192 (l_dobj) fibrillation_9\NN\14361664
D000628_D014693 CID aminophylline_3\NN\2905612 (l_prep) on_4\IN\0 (l_pobj) threshold_8\NN\15265518 (l_compound) fibrillation_7\NN\14361664
D000628_D014693 CID aminophylline_4\NN\2905612 (r_pobj) of_3\IN\0 (r_prep) infusion_2\NN\14589223 (r_pobj) during_0\IN\0 (r_prep) reduced_11\VBN\441445 (l_nsubjpass) threshold_9\NN\15265518 (l_compound) fibrillation_8\NN\14361664
D000628_D014693 CID aminophylline_30\NN\2905612 (r_pobj) of_29\IN\0 (r_prep) infusion_28\NN\14589223 (r_nsubj) resulted_31\VBD\2633881 (l_prep) in_32\IN\13603305 (l_pobj) decrease_36\NN\7296428 (l_prep) in_37\IN\13603305 (l_pobj) threshold_40\NN\15265518 (l_compound) fibrillation_39\NN\14361664
D000628_D007040 NONE aminophylline_30\NN\2905612 (r_pobj) of_29\IN\0 (r_prep) infusion_28\NN\14589223 (r_nsubj) resulted_31\VBD\2633881 (l_advcl) produced_4\VBN\1617192 (l_agent) by_5\IN\0 (l_pobj) hypoventilation_6\NN\0
D000628_D001145 NONE aminophylline_24\NN\2905612 (r_appos) agents_21\NNS\7347 (r_nsubj) play_27\VB\7007684 (l_advcl) contribute_8\VB\126264 (l_prep) to_9\IN\0 (l_pobj) incidence_12\NN\13821570 (l_prep) of_13\IN\0 (l_pobj) arrhythmias_15\NNS\14103288
3985451
D014859_D003286 NONE warfarin_12\NN\2718259 (r_compound) therapy_13\NN\657604 (r_pobj) on_10\IN\0 (r_prep) man_9\NN\9605289 (l_relcl) sustained_15\VBD\2679899 (l_conj) developed_21\VBD\1753788 (l_dobj) pain_23\NN\14299637 (l_conj) contracture_27\NN\369802
D014859_D003286 NONE warfarin_12\RB\2718259 (r_npadvmod) induced_14\VBN\1627355 (r_amod) neuropathy_16\NN\14204950 (r_pobj) of_11\IN\0 (r_prep) form_10\NN\6286395 (r_dobj) represents_6\VBZ\2664769 (r_ccomp) characterized_20\VBN\609683 (l_agent) by_21\IN\0 (l_pobj) pain_23\NN\14299637 (l_conj) degrees_30\NNS\4916342 (l_conj) contracture_39\NN\369802
D014859_D010523 NONE warfarin_12\RB\2718259 (r_npadvmod) induced_14\VBN\1627355 (r_amod) neuropathy_16\NN\14204950
D014859_D020428 CID warfarin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hemorrhage_4\NN\14285662 (l_prep) with_5\IN\0 (l_pobj) palsy_9\JJ\14557898
D014859_D020428 CID warfarin_12\RB\2718259 (r_npadvmod) induced_14\VBN\1627355 (r_amod) neuropathy_16\NN\14204950 (r_pobj) of_11\IN\0 (r_prep) form_10\NN\6286395 (r_dobj) represents_6\VBZ\2664769 (l_nsubj) palsy_5\JJ\14557898
D014859_D006470 NONE warfarin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hemorrhage_4\NN\14285662
D014859_D009135 CID warfarin_12\NN\2718259 (r_compound) therapy_13\NN\657604 (r_pobj) on_10\IN\0 (r_prep) man_9\NN\9605289 (l_relcl) sustained_15\VBD\2679899 (l_dobj) tear_19\NN\13771404
D014859_D010146 NONE warfarin_12\NN\2718259 (r_compound) therapy_13\NN\657604 (r_pobj) on_10\IN\0 (r_prep) man_9\NN\9605289 (l_relcl) sustained_15\VBD\2679899 (l_conj) developed_21\VBD\1753788 (l_dobj) pain_23\NN\14299637
D014859_D010146 NONE warfarin_12\RB\2718259 (r_npadvmod) induced_14\VBN\1627355 (r_amod) neuropathy_16\NN\14204950 (r_pobj) of_11\IN\0 (r_prep) form_10\NN\6286395 (r_dobj) represents_6\VBZ\2664769 (r_ccomp) characterized_20\VBN\609683 (l_agent) by_21\IN\0 (l_pobj) pain_23\NN\14299637
D014859_D015417 NONE warfarin_12\RB\2718259 (r_npadvmod) induced_14\VBN\1627355 (r_amod) neuropathy_16\NN\14204950 (r_pobj) of_11\IN\0 (r_prep) form_10\NN\6286395 (r_dobj) represents_6\VBZ\2664769 (r_ccomp) characterized_20\VBN\609683 (l_agent) by_21\IN\0 (l_pobj) pain_23\NN\14299637 (l_conj) degrees_30\NNS\4916342 (l_prep) of_31\IN\0 (l_pobj) impairment_35\NN\7296428
19356053
D020123_D009404 NONE sirolimus_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) initiation_14\NN\7450842 (l_conj) development_19\NN\248977 (l_prep) of_20\IN\0 (l_pobj) proteinuria_24\NN\14299637 (l_compound) range_23\NN\5123416 (l_amod) nephrotic_21\JJ\0
D003404_D011507 NONE creatinine_22\NN\0 (r_compound) ratios_23\NNS\13815152 (r_conj) measurement_16\NN\407535 (r_pobj) by_14\IN\0 (r_agent) assessed_9\VBN\670261 (l_nsubjpass) magnitude_5\NN\4916342 (l_prep) of_6\IN\0 (l_pobj) proteinuria_7\NN\14299637
D003404_D011507 NONE creatinine_22\NN\0 (r_compound) ratios_23\NNS\13815152 (l_appos) estimate_26\NN\5802185 (l_prep) of_27\IN\0 (l_pobj) grams_28\NNS\13717155 (l_prep) of_29\IN\0 (l_pobj) proteinuria_30\NN\14299637
D020123_D011507 CID sirolimus_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) following_3\VBG\8180190 (r_prep) proteinuria_2\NN\14299637
D020123_D011507 CID sirolimus_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) use_14\NN\407535 (r_pobj) with_12\IN\0 (r_prep) linked_11\VBN\628491 (r_acl) proteinuria_10\NN\14299637
D020123_D011507 CID sirolimus_11\NN\0 (r_compound) use_12\NN\407535 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) proteinuria_8\NN\14299637
D020123_D011507 CID sirolimus_12\NN\0 (r_compound) therapy_13\NN\657604 (l_conj) proteinuria_15\NN\14299637
D020123_D011507 CID sirolimus_12\NN\0 (r_compound) therapy_13\NN\657604 (r_pobj) of_11\IN\0 (r_prep) commencement_10\NN\15180528 (r_pobj) between_8\IN\0 (r_prep) association_7\NN\8008335 (r_nsubj) implicated_16\VBN\2677097 (l_prep) as_18\IN\14622893 (l_pobj) etiology_22\NN\7326557 (l_prep) of_23\IN\0 (l_pobj) proteinuria_25\NN\14299637
D020123_D011507 CID sirolimus_17\NN\0 (r_dobj) implicated_16\VBN\2677097 (l_nsubj) association_7\NN\8008335 (l_prep) between_8\IN\0 (l_pobj) commencement_10\NN\15180528 (l_prep) of_11\IN\0 (l_pobj) therapy_13\NN\657604 (l_conj) proteinuria_15\NN\14299637
D020123_D011507 CID sirolimus_17\NN\0 (r_dobj) implicated_16\VBN\2677097 (l_prep) as_18\IN\14622893 (l_pobj) etiology_22\NN\7326557 (l_prep) of_23\IN\0 (l_pobj) proteinuria_25\NN\14299637
D020123_D011507 CID sirolimus_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) initiation_14\NN\7450842 (l_conj) development_19\NN\248977 (l_prep) of_20\IN\0 (l_pobj) proteinuria_24\NN\14299637
D020123_D011507 CID sirolimus_5\NN\0 (r_compound) therapy_6\NN\657604 (r_pobj) with_4\IN\0 (r_prep) correlated_1\VBD\2657219 (l_nsubj) proteinuria_0\NNP\14299637
D020123_D011507 CID sirolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) discontinuation_4\NN\209943 (r_nsubj) resulted_7\VBD\2633881 (l_conj) resolution_14\NN\6470073 (l_prep) of_16\IN\0 (l_pobj) proteinuria_17\NN\14299637
D020123_D011507 CID sirolimus_0\NNP\0 (r_nsubj) induces_1\VBZ\1627355 (l_conj) aggravates_3\VBZ\126264 (l_dobj) proteinuria_7\NN\14299637
D020123_D011507 CID sirolimus_10\NN\0 (r_nsubjpass) withdrawn_12\VBN\1835496 (r_advcl) resolve_7\VB\4616059 (r_conj) improve_2\VB\126264 (l_nsubj) proteinuria_0\NNP\14299637
D020123_D007674 NONE sirolimus_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_conj) have_13\VB\7846 (l_dobj) nephrotoxicity_15\NN\0
7802851
D000525_D003866 CID alprazolam_5\NN\2830852 (r_compound) patients_6\NNS\9898892 (r_nsubj) developed_7\VBD\1753788 (l_dobj) reactions_10\NNS\13446390 (l_prep) of_18\IN\0 (l_pobj) depression_19\NN\14373582
D000525_D008569 CID alprazolam_5\NN\2830852 (r_compound) patients_6\NNS\9898892 (r_nsubj) developed_7\VBD\1753788 (l_dobj) reactions_10\NNS\13446390 (l_conj) effects_31\NNS\13245626 (l_appos) sedation_34\NN\14034177 (l_conj) irritability_36\NN\7552087 (l_conj) memory_39\NN\5926676
D000525_D016584 NONE alprazolam_3\NN\2830852 (r_pobj) of_2\IN\0 (r_prep) efficacy_1\NN\5199286 (l_prep) in_6\IN\13603305 (l_pobj) disorder_8\NN\14034177
D000525_D016584 NONE alprazolam_20\NN\2830852 (r_xcomp) randomised_18\VBN\278117 (l_prep) in_0\IN\13603305 (l_pobj) london_1\NNP\0 (l_conj) patients_5\NNS\9898892 (l_relcl) met_7\VBD\0 (l_dobj) criteria_11\NNS\13577171 (l_prep) for_12\IN\0 (l_pobj) disorder_14\NN\14034177
D000525_D001259 CID alprazolam_5\NN\2830852 (r_compound) patients_6\NNS\9898892 (r_nsubj) developed_7\VBD\1753788 (l_dobj) reactions_10\NNS\13446390 (l_conj) effects_31\NNS\13245626 (l_appos) sedation_34\NN\14034177 (l_conj) irritability_36\NN\7552087 (l_conj) memory_39\NN\5926676 (l_conj) loss_42\NN\13252973 (l_conj) ataxia_44\NN\14084880
D000525_D001523 NONE alprazolam_5\NN\2830852 (r_compound) patients_6\NNS\9898892 (r_nsubj) developed_7\VBD\1753788 (l_dobj) reactions_10\NNS\13446390 (l_prep) of_18\IN\0 (l_pobj) depression_19\NN\14373582 (l_conj) enuresis_21\NN\13496972 (l_conj) disinhibition_23\NN\0 (l_conj) aggression_25\NN\4657876
D000525_D001523 NONE alprazolam_5\NN\2830852 (r_compound) patients_6\NNS\9898892 (r_nsubj) developed_7\VBD\1753788 (l_dobj) reactions_10\NNS\13446390 (l_conj) effects_31\NNS\13245626 (l_appos) sedation_34\NN\14034177 (l_conj) irritability_36\NN\7552087
D000525_D015431 CID alprazolam_5\NN\2830852 (r_compound) patients_6\NNS\9898892 (r_nsubj) developed_7\VBD\1753788 (l_dobj) reactions_10\NNS\13446390 (l_conj) effects_31\NNS\13245626 (l_appos) sedation_34\NN\14034177 (l_conj) irritability_36\NN\7552087 (l_conj) memory_39\NN\5926676 (l_conj) loss_42\NN\13252973
D000525_D000379 NONE alprazolam_3\NN\2830852 (r_pobj) of_2\IN\0 (r_prep) efficacy_1\NN\5199286 (l_prep) in_6\IN\13603305 (l_pobj) disorder_8\NN\14034177 (l_prep) with_9\IN\0 (l_pobj) agoraphobia_10\NNP\14381416
D000525_D000379 NONE alprazolam_20\NN\2830852 (r_xcomp) randomised_18\VBN\278117 (l_prep) in_0\IN\13603305 (l_pobj) london_1\NNP\0 (l_conj) patients_5\NNS\9898892 (l_relcl) met_7\VBD\0 (l_dobj) criteria_11\NNS\13577171 (l_prep) for_12\IN\0 (l_pobj) disorder_14\NN\14034177 (l_prep) with_15\IN\0 (l_pobj) agoraphobia_16\NNP\14381416
D000525_D004775 CID alprazolam_5\NN\2830852 (r_compound) patients_6\NNS\9898892 (r_nsubj) developed_7\VBD\1753788 (l_dobj) reactions_10\NNS\13446390 (l_prep) of_18\IN\0 (l_pobj) depression_19\NN\14373582 (l_conj) enuresis_21\NN\13496972
6503301
D003606_D008545 NONE dacarbazine_6\NN\0 (r_compound) therapy_7\NN\657604 (l_prep) for_11\IN\0 (l_pobj) melanoma_12\NN\14252320
D003606_D008545 NONE dtic_9\NNP\8337324 (r_appos) therapy_7\NN\657604 (l_prep) for_11\IN\0 (l_pobj) melanoma_12\NN\14252320
D003606_D008545 NONE dacarbazine_14\NN\0 (r_nmod) therapy_18\NN\657604 (l_prep) for_19\IN\0 (l_pobj) melanoma_20\NN\14252320
D003606_D008545 NONE dtic_16\NNP\8337324 (r_nmod) therapy_18\NN\657604 (l_prep) for_19\IN\0 (l_pobj) melanoma_20\NN\14252320
D003606_D006504 CID dacarbazine_6\NN\0 (r_compound) therapy_7\NN\657604 (r_pobj) after_5\IN\0 (r_prep) disease_4\NN\14061805
D003606_D006504 CID dtic_9\NNP\8337324 (r_appos) therapy_7\NN\657604 (r_pobj) after_5\IN\0 (r_prep) disease_4\NN\14061805
D003606_D006504 CID dacarbazine_14\NN\0 (r_nmod) therapy_18\NN\657604 (r_nsubjpass) reported_22\VBN\831651 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) disease_6\NN\14061805 (l_prep) of_7\IN\0 (l_pobj) liver_9\NN\5298729
D003606_D006504 CID dtic_16\NNP\8337324 (r_nmod) therapy_18\NN\657604 (r_nsubjpass) reported_22\VBN\831651 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) disease_6\NN\14061805 (l_prep) of_7\IN\0 (l_pobj) liver_9\NN\5298729
3714122
D010755_D020258 NONE organophosphate_33\NN\14919948 (r_appos) mipafox_24\NNP\0 (r_pobj) to_23\IN\0 (r_prep) exposed_22\VBN\2110927 (r_acl) rats_20\NNS\2329401 (r_pobj) in_19\IN\13603305 (r_prep) examined_18\VBN\0 (l_nsubjpass) correlation_1\NN\13841213 (l_prep) between_2\IN\0 (l_pobj) damage_4\NN\7296428 (l_prep) of_7\IN\0 (l_pobj) esterase_9\NN\0 (l_amod) neurotoxic_8\JJ\0
D010755_D020258 NONE organophosphate_33\NN\14919948 (l_amod) neurotoxic_32\JJ\0
C005238_D013118 CID mipafox_5\NNP\0 (r_pobj) of_4\IN\0 (r_prep) dosages_3\NNS\13576355 (r_nsubj) produced_39\VBN\1617192 (l_dobj) degree_41\NN\4916342 (l_prep) of_42\IN\0 (l_pobj) damage_44\NN\7296428
C005238_D009422 NONE mipafox_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) damage_11\NN\7296428
C005238_D009422 NONE mipafox_24\NNP\0 (r_pobj) to_23\IN\0 (r_prep) exposed_22\VBN\2110927 (r_acl) rats_20\NNS\2329401 (r_pobj) in_19\IN\13603305 (r_prep) examined_18\VBN\0 (l_nsubjpass) correlation_1\NN\13841213 (l_prep) between_2\IN\0 (l_pobj) damage_4\NN\7296428
C005238_D009422 NONE mipafox_24\NNP\0 (r_pobj) to_23\IN\0 (r_prep) exposed_22\VBN\2110927 (r_acl) rats_20\NNS\2329401 (r_pobj) in_19\IN\13603305 (r_prep) examined_18\VBN\0 (l_nsubjpass) correlation_1\NN\13841213 (l_prep) between_2\IN\0 (l_pobj) damage_4\NN\7296428 (l_prep) of_7\IN\0 (l_pobj) esterase_9\NN\0 (l_conj) enzyme_13\NN\14723628 (l_compound) target_12\NN\7258332 (l_compound) neuropathy_11\NN\14204950
C005238_D009422 NONE n'-diisopropylphosphorodiamidofluoridate_28\NNP\0 (r_appos) mipafox_24\NNP\0 (r_pobj) to_23\IN\0 (r_prep) exposed_22\VBN\2110927 (r_acl) rats_20\NNS\2329401 (r_pobj) in_19\IN\13603305 (r_prep) examined_18\VBN\0 (l_nsubjpass) correlation_1\NN\13841213 (l_prep) between_2\IN\0 (l_pobj) damage_4\NN\7296428
C005238_D009422 NONE n'-diisopropylphosphorodiamidofluoridate_28\NNP\0 (r_appos) mipafox_24\NNP\0 (r_pobj) to_23\IN\0 (r_prep) exposed_22\VBN\2110927 (r_acl) rats_20\NNS\2329401 (r_pobj) in_19\IN\13603305 (r_prep) examined_18\VBN\0 (l_nsubjpass) correlation_1\NN\13841213 (l_prep) between_2\IN\0 (l_pobj) damage_4\NN\7296428 (l_prep) of_7\IN\0 (l_pobj) esterase_9\NN\0 (l_conj) enzyme_13\NN\14723628 (l_compound) target_12\NN\7258332 (l_compound) neuropathy_11\NN\14204950
C005238_D009422 NONE mipafox_18\NNP\0 (r_compound) exposure_19\NN\5042871 (r_nsubj) predict_21\VB\916909 (l_dobj) damage_23\NN\7296428
D010755_D009422 NONE organophosphate_33\NN\14919948 (r_appos) mipafox_24\NNP\0 (r_pobj) to_23\IN\0 (r_prep) exposed_22\VBN\2110927 (r_acl) rats_20\NNS\2329401 (r_pobj) in_19\IN\13603305 (r_prep) examined_18\VBN\0 (l_nsubjpass) correlation_1\NN\13841213 (l_prep) between_2\IN\0 (l_pobj) damage_4\NN\7296428
D010755_D009422 NONE organophosphate_33\NN\14919948 (r_appos) mipafox_24\NNP\0 (r_pobj) to_23\IN\0 (r_prep) exposed_22\VBN\2110927 (r_acl) rats_20\NNS\2329401 (r_pobj) in_19\IN\13603305 (r_prep) examined_18\VBN\0 (l_nsubjpass) correlation_1\NN\13841213 (l_prep) between_2\IN\0 (l_pobj) damage_4\NN\7296428 (l_prep) of_7\IN\0 (l_pobj) esterase_9\NN\0 (l_conj) enzyme_13\NN\14723628 (l_compound) target_12\NN\7258332 (l_compound) neuropathy_11\NN\14204950
C005238_D020258 NONE mipafox_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) damage_11\NN\7296428 (r_conj) inhibition_5\NN\1068773 (l_amod) neurotoxic_3\JJ\0
C005238_D020258 NONE mipafox_24\NNP\0 (r_pobj) to_23\IN\0 (r_prep) exposed_22\VBN\2110927 (r_acl) rats_20\NNS\2329401 (r_pobj) in_19\IN\13603305 (r_prep) examined_18\VBN\0 (l_nsubjpass) correlation_1\NN\13841213 (l_prep) between_2\IN\0 (l_pobj) damage_4\NN\7296428 (l_prep) of_7\IN\0 (l_pobj) esterase_9\NN\0 (l_amod) neurotoxic_8\JJ\0
C005238_D020258 NONE mipafox_24\NNP\0 (l_appos) organophosphate_33\NN\14919948 (l_amod) neurotoxic_32\JJ\0
C005238_D020258 NONE n'-diisopropylphosphorodiamidofluoridate_28\NNP\0 (r_appos) mipafox_24\NNP\0 (r_pobj) to_23\IN\0 (r_prep) exposed_22\VBN\2110927 (r_acl) rats_20\NNS\2329401 (r_pobj) in_19\IN\13603305 (r_prep) examined_18\VBN\0 (l_nsubjpass) correlation_1\NN\13841213 (l_prep) between_2\IN\0 (l_pobj) damage_4\NN\7296428 (l_prep) of_7\IN\0 (l_pobj) esterase_9\NN\0 (l_amod) neurotoxic_8\JJ\0
C005238_D020258 NONE n'-diisopropylphosphorodiamidofluoridate_28\NNP\0 (r_appos) mipafox_24\NNP\0 (l_appos) organophosphate_33\NN\14919948 (l_amod) neurotoxic_32\JJ\0
2559236
D004317_D000419 CID adriamycin_7\NNS\0 (r_pobj) of_6\IN\0 (r_prep) dose_5\NN\3740161 (r_dobj) given_2\VBN\5892096 (l_advcl) divided_12\VBD\140123 (l_prep) into_13\IN\0 (l_pobj) groups_15\NNS\2137 (l_acl) matched_16\VBN\2664769 (l_prep) for_17\IN\0 (l_pobj) albuminuria_18\NN\14299637
D004656_D009401 NONE enalapril_10\NN\2673637 (r_appos) inhibitor_6\NN\20090 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) assessed_12\VBN\670261 (l_prep) with_18\IN\0 (l_pobj) nephrosis_21\NN\14304060
D004656_D009401 NONE enalapril_17\NN\2673637 (r_pobj) of_16\IN\0 (r_prep) effect_15\NN\34213 (l_prep) on_18\IN\0 (l_pobj) progression_19\NN\8457976 (l_prep) of_20\IN\0 (l_pobj) injury_22\NN\14052046 (l_prep) in_23\IN\13603305 (l_pobj) nephrosis_25\NN\14304060
D004656_D007674 NONE enalapril_17\NN\2673637 (r_pobj) of_16\IN\0 (r_prep) effect_15\NN\34213 (l_prep) on_18\IN\0 (l_pobj) progression_19\NN\8457976 (l_prep) of_20\IN\0 (l_pobj) injury_22\NN\14052046
D004317_D009401 CID adriamycin_20\NNS\0 (r_amod) nephrosis_21\NN\14304060
D004317_D009401 CID adriamycin_24\JJ\0 (r_amod) nephrosis_25\NN\14304060
D004656_D000419 NONE enalapril_7\DT\2673637 (r_nsubj) reduced_8\JJ\441445 (l_prep) vs._16\IN\0 (l_pobj) hg_21\NNP\14625458 (l_conj) pressure_36\NN\11419404 (l_appos) +/-_39\SYM\0 (l_prep) without_53\IN\0 (l_pcomp) reducing_54\VBG\13447361 (l_dobj) albuminuria_55\NN\14299637
D004656_D000419 NONE enalapril_1\NN\2673637 (r_compound) treatment_2\NN\654885 (r_nsubj) reduced_3\VBN\441445 (r_amod) pressure_5\NN\11419404 (l_prep) without_6\IN\0 (l_pcomp) reducing_7\VBG\13447361 (l_dobj) albuminuria_8\NN\14299637
D004317_D007674 NONE adriamycin_9\NNS\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) nephropathy_12\NN\14573196
D004317_D007674 NONE adriamycin_24\JJ\0 (r_amod) nephrosis_25\NN\14304060 (r_pobj) in_23\IN\13603305 (r_prep) injury_22\NN\14052046
10739826
D003276_D054556 CID contraceptives_5\NNS\3183080 (l_conj) risk_8\NN\14541044 (l_prep) of_9\IN\0 (l_pobj) thromboembolism_11\NN\14100769
D003276_D054556 CID contraceptives_17\NNS\3183080 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (r_acl) thromboembolism_9\NN\14100769
D003276_D054556 CID contraceptives_17\NNS\3183080 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (r_acl) thromboembolism_9\NN\14100769 (l_appos) vte_11\NNP\0
D003276_D054556 CID oc_19\NNP\0 (r_appos) contraceptives_17\NNS\3183080 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (r_acl) thromboembolism_9\NN\14100769
D003276_D054556 CID oc_19\NNP\0 (r_appos) contraceptives_17\NNS\3183080 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (r_acl) thromboembolism_9\NN\14100769 (l_appos) vte_11\NNP\0
D003276_D054556 CID oc_27\NNP\0 (r_compound) use_28\NN\407535 (r_pobj) of_26\IN\0 (r_prep) patterns_25\NNS\5726345 (r_pobj) between_24\IN\0 (r_prep) distinguish_23\VB\618878 (l_nsubj) studies_2\NNS\635850 (l_relcl) assessed_4\VBD\670261 (l_dobj) risk_6\NN\14541044 (l_prep) of_7\IN\0 (l_pobj) thromboembolism_9\NN\14100769
D003276_D054556 CID oc_27\NNP\0 (r_compound) use_28\NN\407535 (r_pobj) of_26\IN\0 (r_prep) patterns_25\NNS\5726345 (r_pobj) between_24\IN\0 (r_prep) distinguish_23\VB\618878 (l_nsubj) studies_2\NNS\635850 (l_relcl) assessed_4\VBD\670261 (l_dobj) risk_6\NN\14541044 (l_prep) of_7\IN\0 (l_pobj) thromboembolism_9\NN\14100769 (l_appos) vte_11\NNP\0
D003276_D054556 CID oc_12\NNP\0 (r_pobj) of_9\IN\0 (r_prep) users_8\NNS\7846 (r_pobj) for_6\IN\0 (r_prep) ratio_3\NN\13815152 (l_prep) of_4\IN\0 (l_pobj) vte_5\NN\0
12627929
C067311_D054556 CID docetaxel_9\NNS\0 (r_pobj) of_8\IN\0 (r_prep) combination_7\NN\7951464 (r_pobj) with_5\IN\0 (r_prep) thromboembolism_4\NN\14100769
C067311_D054556 CID docetaxel_26\NNS\0 (r_pobj) with_25\IN\0 (r_prep) treated_24\VBN\2376958 (r_relcl) cancer_21\NN\14239425 (r_pobj) with_15\IN\0 (r_prep) patients_14\NNS\9898892 (r_pobj) in_13\IN\13603305 (r_prep) frequency_6\NN\15286249 (l_prep) of_7\IN\0 (l_pobj) thromboembolism_9\NN\14100769
C067311_D054556 CID docetaxel_26\NNS\0 (r_pobj) with_25\IN\0 (r_prep) treated_24\VBN\2376958 (r_relcl) cancer_21\NN\14239425 (r_pobj) with_15\IN\0 (r_prep) patients_14\NNS\9898892 (r_pobj) in_13\IN\13603305 (r_prep) frequency_6\NN\15286249 (l_prep) of_7\IN\0 (l_pobj) thromboembolism_9\NN\14100769 (l_appos) vte_11\NNP\0
C067311_D054556 CID docetaxel_6\NNS\0 (r_dobj) received_5\VBD\2210855 (r_relcl) patients_3\NNS\9898892 (r_pobj) of_1\IN\0 (r_prep) none_0\NN\15228378 (r_nsubj) developed_8\VBN\1753788 (l_dobj) vte_9\NNP\0
C067311_D054556 CID docetaxel_6\NNS\0 (r_dobj) received_5\VBD\2210855 (r_relcl) patients_3\NNS\9898892 (r_pobj) of_1\IN\0 (r_prep) none_0\NN\15228378 (r_nsubj) developed_8\VBN\1753788 (l_advcl) developed_25\VBD\1753788 (l_dobj) vte_26\NNP\0
C067311_D054556 CID docetaxel_22\NNS\0 (r_dobj) received_21\VBD\2210855 (r_relcl) patients_15\NNS\9898892 (r_pobj) of_13\IN\0 (r_prep) 9_12\CD\13741022 (r_nsubj) developed_25\VBD\1753788 (r_advcl) developed_8\VBN\1753788 (l_dobj) vte_9\NNP\0
C067311_D054556 CID docetaxel_22\NNS\0 (r_dobj) received_21\VBD\2210855 (r_relcl) patients_15\NNS\9898892 (r_pobj) of_13\IN\0 (r_prep) 9_12\CD\13741022 (r_nsubj) developed_25\VBD\1753788 (l_dobj) vte_26\NNP\0
C067311_D054556 CID docetaxel_5\NNS\0 (r_relcl) addition_1\NN\3081021 (r_nsubj) increases_13\VBZ\13576355 (l_dobj) frequency_15\NN\15286249 (l_prep) of_16\IN\0 (l_pobj) vte_17\NNP\0
D013792_D011471 NONE thalidomide_11\NN\4166841 (r_conj) docetaxel_9\NNS\0 (r_pobj) of_8\IN\0 (r_prep) combination_7\NN\7951464 (l_prep) in_12\IN\13603305 (l_pobj) patients_13\NNS\9898892 (l_prep) with_14\IN\0 (l_pobj) cancer_20\NN\14239425
D013792_D011471 NONE thalidomide_32\NN\4166841 (r_pobj) with_31\IN\0 (r_prep) combination_30\NN\7951464 (r_pobj) in_29\IN\13603305 (r_conj) alone_27\RB\0 (r_advmod) treated_24\VBN\2376958 (r_relcl) cancer_21\NN\14239425
D013792_D011471 NONE thalidomide_3\NN\4166841 (r_pobj) of_2\IN\0 (r_prep) addition_1\NN\3081021 (l_relcl) docetaxel_5\NNS\0 (l_prep) in_6\IN\13603305 (l_pobj) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) cancer_11\NN\14239425
D013792_D054556 CID thalidomide_11\NN\4166841 (r_conj) docetaxel_9\NNS\0 (r_pobj) of_8\IN\0 (r_prep) combination_7\NN\7951464 (r_pobj) with_5\IN\0 (r_prep) thromboembolism_4\NN\14100769
D013792_D054556 CID thalidomide_32\NN\4166841 (r_pobj) with_31\IN\0 (r_prep) combination_30\NN\7951464 (r_pobj) in_29\IN\13603305 (r_conj) alone_27\RB\0 (r_advmod) treated_24\VBN\2376958 (r_relcl) cancer_21\NN\14239425 (r_pobj) with_15\IN\0 (r_prep) patients_14\NNS\9898892 (r_pobj) in_13\IN\13603305 (r_prep) frequency_6\NN\15286249 (l_prep) of_7\IN\0 (l_pobj) thromboembolism_9\NN\14100769
D013792_D054556 CID thalidomide_32\NN\4166841 (r_pobj) with_31\IN\0 (r_prep) combination_30\NN\7951464 (r_pobj) in_29\IN\13603305 (r_conj) alone_27\RB\0 (r_advmod) treated_24\VBN\2376958 (r_relcl) cancer_21\NN\14239425 (r_pobj) with_15\IN\0 (r_prep) patients_14\NNS\9898892 (r_pobj) in_13\IN\13603305 (r_prep) frequency_6\NN\15286249 (l_prep) of_7\IN\0 (l_pobj) thromboembolism_9\NN\14100769 (l_appos) vte_11\NNP\0
D013792_D054556 CID thalidomide_24\NN\4166841 (r_conj) 9_12\CD\13741022 (r_nsubj) developed_25\VBD\1753788 (r_advcl) developed_8\VBN\1753788 (l_dobj) vte_9\NNP\0
D013792_D054556 CID thalidomide_24\NN\4166841 (r_conj) 9_12\CD\13741022 (r_nsubj) developed_25\VBD\1753788 (l_dobj) vte_26\NNP\0
D013792_D054556 CID thalidomide_3\NN\4166841 (r_pobj) of_2\IN\0 (r_prep) addition_1\NN\3081021 (r_nsubj) increases_13\VBZ\13576355 (l_dobj) frequency_15\NN\15286249 (l_prep) of_16\IN\0 (l_pobj) vte_17\NNP\0
C067311_D011471 NONE docetaxel_9\NNS\0 (r_pobj) of_8\IN\0 (r_prep) combination_7\NN\7951464 (l_prep) in_12\IN\13603305 (l_pobj) patients_13\NNS\9898892 (l_prep) with_14\IN\0 (l_pobj) cancer_20\NN\14239425
C067311_D011471 NONE docetaxel_26\NNS\0 (r_pobj) with_25\IN\0 (r_prep) treated_24\VBN\2376958 (r_relcl) cancer_21\NN\14239425
C067311_D011471 NONE docetaxel_5\NNS\0 (l_prep) in_6\IN\13603305 (l_pobj) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) cancer_11\NN\14239425
8919272
D014635_D009422 NONE valproate_10\NN\0 (l_dobj) disorders_43\NNS\14034177
D014635_D009422 NONE valproate_49\NNP\0 (r_amod) encephalopathy_50\JJ\14084880 (r_appos) damage_46\NN\7296428 (r_dobj) indicating_44\VBG\952524 (r_acl) disorders_43\NNS\14034177
D014635_D056486 NONE valproate_15\NNP\0 (r_amod) encephalopathy_16\NNP\14084880 (r_pobj) of_14\IN\0 (r_prep) development_13\NN\248977 (r_pobj) upon_11\IN\0 (r_prep) hyperammonemia_9\NN\0 (l_nsubj) influence_2\NN\5190804 (l_prep) of_3\IN\0 (l_pobj) damage_6\NN\7296428
D014635_D001927 CID valproate_11\NN\0 (l_nsubj) features_1\NNS\5849040 (l_prep) of_2\IN\0 (l_pobj) encephalopathy_3\NN\14084880
D014635_D001927 CID valproate_10\NN\0 (l_dobj) disorders_43\NNS\14034177 (l_acl) indicating_44\VBG\952524 (l_dobj) damage_46\NN\7296428 (l_appos) encephalopathy_50\JJ\14084880
D014635_D001927 CID valproate_49\NNP\0 (r_amod) encephalopathy_50\JJ\14084880
D014635_D001927 CID valproate_15\NNP\0 (r_amod) encephalopathy_16\NNP\14084880
D014635_D002526 NONE valproate_10\NN\0 (l_dobj) disorders_43\NNS\14034177 (l_acl) indicating_44\VBG\952524 (l_dobj) damage_46\NN\7296428
D014635_D002526 NONE valproate_49\NNP\0 (r_amod) encephalopathy_50\JJ\14084880 (r_appos) damage_46\NN\7296428
D014635_D022124 NONE valproate_15\NNP\0 (r_amod) encephalopathy_16\NNP\14084880 (r_pobj) of_14\IN\0 (r_prep) development_13\NN\248977 (r_pobj) upon_11\IN\0 (r_prep) hyperammonemia_9\NN\0
18439803
D010862_D012640 CID pilocarpine_10\NN\14712692 (r_npadvmod) induced_12\VBN\1627355 (r_amod) seizure_13\NN\14081375
D010862_D012640 CID pilocarpine_23\NN\14712692 (r_npadvmod) induced_25\VBN\1627355 (r_amod) seizure_26\NN\14081375
D010862_D012640 CID pilocarpine_13\NN\14712692 (r_npadvmod) induced_15\VBN\1627355 (r_amod) seizure_16\NN\14081375
D010862_D012640 CID pilocarpine_12\NN\14712692 (r_npadvmod) induced_14\VBN\1627355 (r_amod) increases_15\NNS\13576355 (r_dobj) reduce_11\VB\441445 (r_relcl) finding_6\NN\43195 (r_appos) vpa_3\NNP\0 (r_pobj) like_2\IN\5839024 (r_prep) account_21\VB\6647206 (l_prep) for_27\IN\0 (l_pobj) activity_30\NN\30358 (l_acl) observed_31\VBN\2163746 (l_prep) in_32\IN\13603305 (l_pobj) seizure_36\NN\14081375
D010862_D012640 CID pilocarpine_33\NN\14712692 (r_npadvmod) induced_35\VBN\1627355 (r_amod) seizure_36\NN\14081375
D000596_D012640 NONE acid_7\NN\14818238 (r_compound) neurotransmitters_8\NNS\14807410 (r_pobj) on_4\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) in_9\IN\13603305 (l_pobj) seizure_13\NN\14081375
D000596_D012640 NONE acid_26\NN\14818238 (r_compound) neurotransmitters_27\NNS\14807410 (r_pobj) of_23\IN\0 (r_prep) reduction_22\NN\351485 (r_nsubj) was_28\VBD\0 (r_ccomp) suggested_19\VBN\1010118 (l_prep) based_0\VBN\0 (l_prep) on_1\IN\0 (l_pobj) finding_3\NN\43195 (l_acl) protect_9\VB\1127795 (l_dobj) animals_11\NNS\4475 (l_prep) against_12\IN\0 (l_pobj) seizure_16\NN\14081375
C108761_D012640 NONE n-(2-propylpentanoyl)urea_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) in_9\IN\13603305 (l_pobj) seizure_13\NN\14081375
C108761_D012640 NONE vpu_0\NNS\0 (r_nsubj) was_1\VBD\0 (l_advcl) exhibiting_7\VBG\2632167 (l_dobj) dose_11\NN\3740161 (l_prep) of_16\IN\0 (l_pobj) mg/kg_18\NNS\0 (l_prep) in_19\IN\13603305 (l_pcomp) protecting_20\VBG\1127795 (l_prep) against_22\IN\0 (l_pobj) seizure_26\NN\14081375
C108761_D012640 NONE vpu_5\NNPS\0 (r_nsubj) protect_9\VB\1127795 (l_dobj) animals_11\NNS\4475 (l_prep) against_12\IN\0 (l_pobj) seizure_16\NN\14081375
C108761_D012640 NONE vpu_8\NNP\0 (r_nsubj) reduce_11\VB\441445 (r_relcl) finding_6\NN\43195 (r_appos) vpa_3\NNP\0 (r_pobj) like_2\IN\5839024 (r_prep) account_21\VB\6647206 (l_prep) for_27\IN\0 (l_pobj) activity_30\NN\30358 (l_acl) observed_31\VBN\2163746 (l_prep) in_32\IN\13603305 (l_pobj) seizure_36\NN\14081375
D001224_D012640 NONE aspartate_40\NN\0 (r_conj) glutamate_38\NN\15010703 (r_pobj) of_37\IN\0 (r_prep) reduction_36\NN\351485 (r_pobj) by_33\IN\0 (r_agent) offset_32\VBN\15180528 (r_conj) was_28\VBD\0 (r_ccomp) suggested_19\VBN\1010118 (l_prep) based_0\VBN\0 (l_prep) on_1\IN\0 (l_pobj) finding_3\NN\43195 (l_acl) protect_9\VB\1127795 (l_dobj) animals_11\NNS\4475 (l_prep) against_12\IN\0 (l_pobj) seizure_16\NN\14081375
D001224_D012640 NONE aspartate_19\NN\0 (r_conj) glutamate_17\NN\15010703 (r_pobj) in_16\IN\13603305 (r_prep) increases_15\NNS\13576355 (r_dobj) reduce_11\VB\441445 (r_relcl) finding_6\NN\43195 (r_appos) vpa_3\NNP\0 (r_pobj) like_2\IN\5839024 (r_prep) account_21\VB\6647206 (l_prep) for_27\IN\0 (l_pobj) activity_30\NN\30358 (l_acl) observed_31\VBN\2163746 (l_prep) in_32\IN\13603305 (l_pobj) seizure_36\NN\14081375
D014635_D012640 NONE vpa_5\NNP\0 (r_pobj) than_4\IN\0 (r_prep) potent_3\JJ\0 (r_acomp) was_1\VBD\0 (l_advcl) exhibiting_7\VBG\2632167 (l_dobj) dose_11\NN\3740161 (l_prep) of_16\IN\0 (l_pobj) mg/kg_18\NNS\0 (l_prep) in_19\IN\13603305 (l_pcomp) protecting_20\VBG\1127795 (l_prep) against_22\IN\0 (l_pobj) seizure_26\NN\14081375
D014635_D012640 NONE vpa_32\NNP\0 (r_pobj) for_31\IN\0 (r_prep) value_30\NN\5856066 (r_nsubj) was_33\VBD\0 (r_advcl) exhibiting_7\VBG\2632167 (l_dobj) dose_11\NN\3740161 (l_prep) of_16\IN\0 (l_pobj) mg/kg_18\NNS\0 (l_prep) in_19\IN\13603305 (l_pcomp) protecting_20\VBG\1127795 (l_prep) against_22\IN\0 (l_pobj) seizure_26\NN\14081375
D014635_D012640 NONE vpa_7\NNP\0 (r_conj) vpu_5\NNPS\0 (r_nsubj) protect_9\VB\1127795 (l_dobj) animals_11\NNS\4475 (l_prep) against_12\IN\0 (l_pobj) seizure_16\NN\14081375
D014635_D012640 NONE vpa_3\NNP\0 (r_pobj) like_2\IN\5839024 (r_prep) account_21\VB\6647206 (l_prep) for_27\IN\0 (l_pobj) activity_30\NN\30358 (l_acl) observed_31\VBN\2163746 (l_prep) in_32\IN\13603305 (l_pobj) seizure_36\NN\14081375
D018698_D012640 NONE glutamate_38\NN\15010703 (r_pobj) of_37\IN\0 (r_prep) reduction_36\NN\351485 (r_pobj) by_33\IN\0 (r_agent) offset_32\VBN\15180528 (r_conj) was_28\VBD\0 (r_ccomp) suggested_19\VBN\1010118 (l_prep) based_0\VBN\0 (l_prep) on_1\IN\0 (l_pobj) finding_3\NN\43195 (l_acl) protect_9\VB\1127795 (l_dobj) animals_11\NNS\4475 (l_prep) against_12\IN\0 (l_pobj) seizure_16\NN\14081375
D018698_D012640 NONE glutamate_17\NN\15010703 (r_pobj) in_16\IN\13603305 (r_prep) increases_15\NNS\13576355 (r_dobj) reduce_11\VB\441445 (r_relcl) finding_6\NN\43195 (r_appos) vpa_3\NNP\0 (r_pobj) like_2\IN\5839024 (r_prep) account_21\VB\6647206 (l_prep) for_27\IN\0 (l_pobj) activity_30\NN\30358 (l_acl) observed_31\VBN\2163746 (l_prep) in_32\IN\13603305 (l_pobj) seizure_36\NN\14081375
1720453
D007069_D064420 NONE ifosfamide_15\NN\0 (r_pobj) of_14\IN\0 (r_prep) m2_13\NN\13357178 (r_pobj) of_9\IN\0 (r_prep) dose_8\NN\3740161 (r_pobj) with_4\IN\0 (r_prep) correlated_3\VBN\2657219 (l_nsubjpass) toxicity_1\NN\13576101
D007069_C535700 NONE ifosfamide_7\JJ\0 (r_amod) toxicity_9\NN\13576101 (r_pobj) of_6\IN\0 (r_prep) up_5\NN\153263 (r_nsubj) treated_12\VBN\2376958 (l_prep) for_13\IN\0 (l_pobj) tumors_16\NNS\14234074
D007069_C535700 NONE ifosfamide_19\JJ\0 (r_compound) protocol_21\NN\6652242 (r_dobj) received_16\VBN\2210855 (r_relcl) function_2\NN\13783581 (l_prep) with_6\IN\0 (l_pobj) tumors_9\NNS\14234074
D007069_C535700 NONE ifosfamide_19\JJ\0 (r_compound) protocol_21\NN\6652242 (l_appos) society_24\NNP\7950920 (l_prep) of_25\IN\0 (l_pobj) study_31\NNP\635850 (l_compound) tumor_30\NNP\14234074
D007069_C535700 NONE ifosfamide_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) efficacy_16\NN\5199286 (l_prep) in_19\IN\13603305 (l_pobj) treatment_21\NN\654885 (l_prep) of_22\IN\0 (l_pobj) tumors_24\NNS\14234074
D010710_D011507 NONE phosphate_25\NN\15010703 (r_nmod) reabsorption_27\NN\13526110 (r_conj) clearance_23\NN\5089947 (r_conj) osmolarity_20\NN\0 (r_conj) ph_18\NN\5038959 (r_conj) aminoaciduria_15\JJ\14299637 (r_conj) proteinuria_13\NN\14299637
D010710_D064420 NONE phosphate_51\NN\15010703 (r_compound) reabsorption_52\NN\13526110 (r_conj) microglobulinuria_48\NN\0 (r_pobj) with_44\IN\0 (r_prep) patients_43\NNS\9898892 (r_dobj) included_41\VBD\0 (r_conj) included_13\VBD\0 (l_dobj) patients_15\NNS\9898892 (l_relcl) developed_25\VBD\1753788 (l_dobj) toxicity_27\NN\13576101
D007069_D009369 NONE ifosfamide_15\NN\0 (r_pobj) of_14\IN\0 (r_prep) m2_13\NN\13357178 (r_pobj) of_9\IN\0 (r_prep) dose_8\NN\3740161 (l_conj) predominance_31\NN\14441825 (l_prep) of_32\IN\0 (l_pobj) involvement_35\NN\1080366 (l_compound) tumor_34\NN\14234074
D003404_D011507 NONE creatinine_22\NN\0 (r_compound) clearance_23\NN\5089947 (r_conj) osmolarity_20\NN\0 (r_conj) ph_18\NN\5038959 (r_conj) aminoaciduria_15\JJ\14299637 (r_conj) proteinuria_13\NN\14299637
D003404_D000608 NONE creatinine_22\NN\0 (r_compound) clearance_23\NN\5089947 (r_conj) osmolarity_20\NN\0 (r_conj) ph_18\NN\5038959 (r_conj) aminoaciduria_15\JJ\14299637
D003404_D006030 NONE creatinine_22\NN\0 (r_compound) clearance_23\NN\5089947 (r_conj) osmolarity_20\NN\0 (r_conj) ph_18\NN\5038959 (r_conj) aminoaciduria_15\JJ\14299637 (r_conj) proteinuria_13\NN\14299637 (r_conj) glucosuria_11\NN\14267841
D010710_D006030 NONE phosphate_25\NN\15010703 (r_nmod) reabsorption_27\NN\13526110 (r_conj) clearance_23\NN\5089947 (r_conj) osmolarity_20\NN\0 (r_conj) ph_18\NN\5038959 (r_conj) aminoaciduria_15\JJ\14299637 (r_conj) proteinuria_13\NN\14299637 (r_conj) glucosuria_11\NN\14267841
D007069_D007674 CID ifosfamide_7\JJ\0 (r_amod) toxicity_9\NN\13576101
D010710_D000608 NONE phosphate_25\NN\15010703 (r_nmod) reabsorption_27\NN\13526110 (r_conj) clearance_23\NN\5089947 (r_conj) osmolarity_20\NN\0 (r_conj) ph_18\NN\5038959 (r_conj) aminoaciduria_15\JJ\14299637
D010710_D005198 NONE phosphate_51\NN\15010703 (r_compound) reabsorption_52\NN\13526110 (r_conj) microglobulinuria_48\NN\0 (r_pobj) with_44\IN\0 (r_prep) patients_43\NNS\9898892 (r_dobj) included_41\VBD\0 (r_conj) included_13\VBD\0 (l_dobj) patients_15\NNS\9898892 (l_relcl) developed_25\VBD\1753788 (l_dobj) toxicity_27\NN\13576101 (l_acl) resulting_28\VBG\2633881 (l_prep) in_29\IN\13603305 (l_pobj) syndrome_32\NN\5870365
D010710_D005198 NONE phosphate_51\NN\15010703 (r_compound) reabsorption_52\NN\13526110 (r_conj) microglobulinuria_48\NN\0 (r_pobj) with_44\IN\0 (r_prep) patients_43\NNS\9898892 (r_dobj) included_41\VBD\0 (r_conj) included_13\VBD\0 (l_dobj) patients_15\NNS\9898892 (l_relcl) developed_25\VBD\1753788 (l_dobj) toxicity_27\NN\13576101 (l_acl) resulting_28\VBG\2633881 (l_prep) in_29\IN\13603305 (l_pobj) syndrome_32\NN\5870365 (l_appos) tdfs_34\NNP\0
9245658
D009538_D013927 NONE nicotine_0\NN\14712692 (r_nsubj) appear_3\VB\2604760 (l_xcomp) enhance_5\VB\227165 (l_dobj) thrombosis_6\NN\14100769
D009538_D050197 CID nicotine_7\NN\14712692 (r_nsubj) play_9\VB\7007684 (l_dobj) role_11\NN\719494 (l_prep) in_12\IN\13603305 (l_pcomp) accelerating_13\VBG\226566 (l_dobj) atherosclerosis_14\NN\14108324
D009538_D002318 CID nicotine_3\NN\14712692 (r_pobj) of_2\IN\0 (r_prep) role_1\NN\719494 (l_prep) in_4\IN\13603305 (l_pobj) disease_9\NN\14061805
D009538_D002318 CID nicotine_0\NNP\14712692 (r_nsubj) activates_1\VBZ\1641914 (l_conj) contribute_11\VB\126264 (l_prep) to_12\IN\0 (l_pobj) disease_14\NN\14061805
9746003
D002220_D009207 CID carbamazepine_9\NN\0 (l_conj) two_11\CD\13741022 (l_prep) of_12\IN\0 (l_pobj) jerks_16\NNS\10322238
D002220_D009207 CID carbamazepine_23\NN\0 (r_pobj) of_22\IN\0 (r_prep) withdrawal_21\NN\7206096 (r_pobj) on_20\IN\0 (r_prep) resolved_19\VBD\352826 (r_relcl) jerks_16\NNS\10322238
D020888_D004832 CID vigabatrin_5\VBP\0 (l_prep) in_6\IN\13603305 (l_pobj) seizures_9\NNS\14081375
D020888_D004832 CID vigabatrin_2\NN\0 (r_conj) carbamazepine_0\NNP\0 (r_nsubjpass) contraindicated_4\VBN\872886 (l_prep) in_5\IN\13603305 (l_pobj) seizures_8\NNS\14081375
D002220_D004832 CID carbamazepine_3\NN\0 (l_conj) vigabatrin_5\VBP\0 (l_prep) in_6\IN\13603305 (l_pobj) seizures_9\NNS\14081375
D002220_D004832 CID carbamazepine_0\NNP\0 (r_nsubjpass) contraindicated_4\VBN\872886 (l_prep) in_5\IN\13603305 (l_pobj) seizures_8\NNS\14081375
18081909
C026098_D001927 CID levetiracetam_3\NN\0 (r_pcomp) by_2\IN\0 (r_prep) induced_1\VBN\1627355 (l_nsubj) encephalopathy_0\JJ\14084880
C026098_D001927 CID levetiracetam_7\FW\0 (r_amod) encephalopathy_10\JJ\14084880
C026098_D001927 CID lev)-induced_9\VBN\0 (r_amod) encephalopathy_10\JJ\14084880
C026098_C562694 NONE lev_15\NNP\13685678 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (l_nsubjpass) man_4\NN\9605289 (l_acl) suffering_5\VBG\14322699 (l_prep) from_6\IN\0 (l_pobj) epilepsy_8\NN\14085708
C026098_D012640 NONE lev_15\NNP\13685678 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (l_nsubjpass) man_4\NN\9605289 (l_acl) suffering_5\VBG\14322699 (l_prep) with_9\IN\0 (l_pobj) seizures_11\NNS\14081375
C026098_D012640 NONE lev_3\NNP\13685678 (r_pobj) of_2\IN\0 (r_prep) discontinuation_1\NN\209943 (r_pobj) following_0\VBG\8180190 (l_preconj) improved_9\VBN\126264 (l_conj) decreased_13\VBD\169651 (l_nsubj) frequency_12\NN\15286249 (l_compound) seizure_11\NN\14081375
D014635_C562694 NONE valproate_22\VB\0 (r_xcomp) added_20\VBN\156601 (r_conj) treated_13\VBN\2376958 (l_nsubjpass) man_4\NN\9605289 (l_acl) suffering_5\VBG\14322699 (l_prep) from_6\IN\0 (l_pobj) epilepsy_8\NN\14085708
D014635_C562694 NONE vpa_24\NNP\0 (r_dobj) valproate_22\VB\0 (r_xcomp) added_20\VBN\156601 (r_conj) treated_13\VBN\2376958 (l_nsubjpass) man_4\NN\9605289 (l_acl) suffering_5\VBG\14322699 (l_prep) from_6\IN\0 (l_pobj) epilepsy_8\NN\14085708
D014635_D001927 CID valproate_6\VB\0 (r_xcomp) added_4\VBN\156601 (r_conj) induced_1\VBN\1627355 (l_nsubj) encephalopathy_0\JJ\14084880
D014635_D012640 NONE valproate_22\VB\0 (r_xcomp) added_20\VBN\156601 (r_conj) treated_13\VBN\2376958 (l_nsubjpass) man_4\NN\9605289 (l_acl) suffering_5\VBG\14322699 (l_prep) with_9\IN\0 (l_pobj) seizures_11\NNS\14081375
D014635_D012640 NONE vpa_24\NNP\0 (r_dobj) valproate_22\VB\0 (r_xcomp) added_20\VBN\156601 (r_conj) treated_13\VBN\2376958 (l_nsubjpass) man_4\NN\9605289 (l_acl) suffering_5\VBG\14322699 (l_prep) with_9\IN\0 (l_pobj) seizures_11\NNS\14081375
20520283
C522667_D001480 CID asenapine_21\NN\0 (r_pobj) of_19\IN\0 (r_prep) %_18\NN\0 (r_conj) %_14\NN\0 (r_appos) %_8\NN\0 (r_pobj) in_6\IN\13603305 (r_prep) occurred_5\VBD\0 (r_advcl) reported_2\VBD\831651 (l_nsubj) symptoms_1\NNS\5823932
C522667_D001480 CID asenapine_9\NN\0 (r_pobj) with_8\IN\0 (r_prep) similar_7\JJ\0 (r_acomp) was_6\VBD\0 (r_ccomp) indicated_3\VBD\952524 (r_ccomp) seen_16\VBN\2106506 (l_prep) in_17\IN\13603305 (l_pobj) aes_18\NNS\0 (l_appos) symptoms_22\NNS\5823932
C522667_D001714 NONE asenapine_0\NNP\0 (r_nsubjpass) approved_2\VBN\803325 (l_prep) in_9\IN\13603305 (l_pobj) adults_10\NNS\7846 (l_prep) for_11\IN\0 (l_conj) of_17\IN\0 (l_pobj) episodes_21\NNS\7283608 (l_amod) manic_18\JJ\0
C522667_D001714 NONE asenapine_0\NNP\0 (r_nsubjpass) approved_2\VBN\803325 (l_prep) in_9\IN\13603305 (l_pobj) adults_10\NNS\7846 (l_prep) for_11\IN\0 (l_conj) of_17\IN\0 (l_pobj) episodes_21\NNS\7283608 (l_acl) associated_22\VBN\628491 (l_prep) with_23\IN\0 (l_pobj) disorder_26\NN\14034177
C522667_D011618 NONE asenapine_0\NNP\0 (r_nsubjpass) approved_2\VBN\803325 (l_prep) in_9\IN\13603305 (l_pobj) adults_10\NNS\7846 (l_prep) for_11\IN\0 (l_conj) of_17\IN\0 (l_pobj) episodes_21\NNS\7283608 (l_acl) associated_22\VBN\628491 (l_prep) with_23\IN\0 (l_pobj) disorder_26\NN\14034177 (l_prep) with_27\IN\0 (l_conj) without_29\IN\0 (l_pobj) features_31\NNS\5849040 (l_amod) psychotic_30\JJ\10595647
D006220_D001480 CID haloperidol_29\NN\3713736 (r_conj) bid_27\NN\7160883 (r_pobj) at_22\IN\14622893 (r_prep) %_18\NN\0 (r_conj) %_14\NN\0 (r_appos) %_8\NN\0 (r_pobj) in_6\IN\13603305 (r_prep) occurred_5\VBD\0 (r_advcl) reported_2\VBD\831651 (l_nsubj) symptoms_1\NNS\5823932
D006220_D001480 CID haloperidol_11\NN\3713736 (r_conj) asenapine_9\NN\0 (r_pobj) with_8\IN\0 (r_prep) similar_7\JJ\0 (r_acomp) was_6\VBD\0 (r_ccomp) indicated_3\VBD\952524 (r_ccomp) seen_16\VBN\2106506 (l_prep) in_17\IN\13603305 (l_pobj) aes_18\NNS\0 (l_appos) symptoms_22\NNS\5823932
C522667_D012559 NONE asenapine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) efficacy_0\NN\5199286 (l_prep) in_5\IN\13603305 (l_pobj) trial_12\NN\786195 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) exacerbation_17\NN\374224 (l_prep) of_18\IN\0 (l_pobj) schizophrenia_19\NN\14398067
C522667_D012559 NONE asenapine_0\NNP\0 (r_nsubjpass) approved_2\VBN\803325 (l_prep) in_9\IN\13603305 (l_pobj) adults_10\NNS\7846 (l_prep) for_11\IN\0 (l_pobj) treatment_13\NN\654885 (l_prep) of_14\IN\0 (l_pobj) schizophrenia_15\NN\14398067
C522667_D012559 NONE asenapine_22\NN\0 (r_pobj) with_21\IN\0 (r_prep) treatment_20\NN\654885 (r_pobj) to_16\IN\0 (r_prep) assigned_15\VBN\2475922 (l_nsubjpass) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) schizophrenia_12\NN\14398067
C522667_D012559 NONE asenapine_32\NN\0 (r_dep) assigned_15\VBN\2475922 (l_nsubjpass) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) schizophrenia_12\NN\14398067
D006220_D012559 NONE haloperidol_9\NN\3713736 (r_npadvmod) controlled_11\VBN\0 (r_amod) trial_12\NN\786195 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) exacerbation_17\NN\374224 (l_prep) of_18\IN\0 (l_pobj) schizophrenia_19\NN\14398067
D006220_D012559 NONE haloperidol_41\NN\3713736 (r_conj) placebo_38\NN\3740161 (r_conj) bid_36\NN\7160883 (r_pobj) at_33\IN\14622893 (r_prep) asenapine_32\NN\0 (r_dep) assigned_15\VBN\2475922 (l_nsubjpass) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) schizophrenia_12\NN\14398067
7504976
D002231_D002779 CID carbimazole_8\NN\0 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (l_nsubj) hepatitis_5\NN\14127211
D002231_D002779 CID omercazole_11\NN\0 (r_appos) carbimazole_8\NN\0 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (l_nsubj) hepatitis_5\NN\14127211
D002231_D002779 CID carbimazole_12\NN\0 (l_amod) mixed_4\JJ\140123 (l_conj) cholestatic_6\JJ\0
D002231_D056486 CID carbimazole_16\NN\0 (r_pobj) between_15\IN\0 (r_prep) reactivity_14\NN\5652926 (r_pobj) with_11\IN\0 (r_prep) one_10\CD\13741022 (r_pobj) including_9\VBG\0 (r_prep) cases_8\NNS\7283608 (r_appos) induced_2\VBN\1627355 (l_nsubj) hepatitis_1\NN\14127211
D002231_D056486 CID carbimazole_8\NN\0 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (l_nsubj) hepatitis_5\NN\14127211
D002231_D056486 CID omercazole_11\NN\0 (r_appos) carbimazole_8\NN\0 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (l_nsubj) hepatitis_5\NN\14127211
D002231_D056486 CID carbimazole_12\NN\0 (l_amod) following_11\VBG\8180190 (l_compound) hepatitis_10\NN\14127211
D002231_D056486 CID carbimazole_21\NN\0 (r_dobj) replaced_20\VBN\1631072 (l_nsubj) experienced_7\VBD\2108377 (l_dobj) hepatitis_10\NN\14127211
C019269_D056486 NONE benzylthiouracil_18\NN\0 (r_conj) carbimazole_16\NN\0 (r_pobj) between_15\IN\0 (r_prep) reactivity_14\NN\5652926 (r_pobj) with_11\IN\0 (r_prep) one_10\CD\13741022 (r_pobj) including_9\VBG\0 (r_prep) cases_8\NNS\7283608 (r_appos) induced_2\VBN\1627355 (l_nsubj) hepatitis_1\NN\14127211
C019269_D056486 NONE benzylthiouracil_14\NNP\0 (r_pobj) after_13\IN\0 (r_prep) appeared_12\VBD\2604760 (r_relcl) hepatitis_10\NN\14127211
C019269_D056486 NONE ne_17\NNP\14622893 (r_appos) benzylthiouracil_14\NNP\0 (r_pobj) after_13\IN\0 (r_prep) appeared_12\VBD\2604760 (r_relcl) hepatitis_10\NN\14127211
11007689
D016559_D057049 CID tacrolimus_2\NN\0 (r_npadvmod) associated_4\VBN\628491 (r_amod) microangiopathy_6\NN\0
D016559_D057049 CID tacrolimus_6\NN\0 (r_pobj) to_5\IN\0 (r_prep) switching_4\VBG\191142 (r_nsubjpass) reported_9\VBN\831651 (l_xcomp) be_11\VB\14625458 (l_attr) option_15\NN\6480506 (l_prep) in_16\IN\13603305 (l_pobj) setting_18\NN\8567235 (l_prep) of_19\IN\0 (l_pobj) tma_23\NNP\0
D016559_D057049 CID tacrolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) application_4\NN\947128 (r_pobj) with_0\IN\0 (r_prep) recognized_18\VBN\686447 (l_nsubjpass) tma_14\NNP\0
D016559_D057049 CID tacrolimus_11\NN\0 (r_npadvmod) associated_13\VBN\628491 (r_amod) tma_14\NNP\0
D016559_D057049 CID tacrolimus_18\NN\0 (r_conj) cyclosporine_16\NN\0 (r_pobj) to_15\IN\0 (r_prep) exposed_13\VBN\2110927 (r_acl) patients_12\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) recurrence_8\NN\7342049 (l_prep) of_9\IN\0 (l_pobj) tma_10\NNP\0
D016559_D057049 CID tacrolimus_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) introduction_0\NN\235435 (r_nsubj) resulted_8\VBD\2633881 (l_prep) in_9\IN\13603305 (l_pobj) recurrence_11\NN\7342049 (l_prep) of_12\IN\0 (l_pobj) tma_13\NNP\0
D016559_D057049 CID tacrolimus_7\NN\0 (r_pobj) to_6\IN\0 (r_prep) switched_3\VBN\138508 (r_relcl) patients_0\NNS\9898892 (r_nsubjpass) monitored_14\VBN\2169352 (l_prep) for_15\IN\0 (l_pobj) signs_17\NNS\6643763 (l_prep) of_20\IN\0 (l_pobj) tma_22\NNP\0
D016572_D057049 CID cyclosporine_0\NN\0 (l_conj) microangiopathy_6\NN\0
D016572_D057049 CID cyclosporine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (r_acl) microangiopathy_4\NN\0
D016572_D057049 CID cyclosporine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (r_acl) microangiopathy_4\NN\0 (l_appos) tma_6\NNP\0
D016572_D057049 CID cyclosporine_20\NN\0 (r_npadvmod) induced_22\VBN\1627355 (r_amod) tma_23\NNP\0
D016572_D057049 CID cyclosporine_16\NN\0 (r_pobj) to_15\IN\0 (r_prep) exposed_13\VBN\2110927 (r_acl) patients_12\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) recurrence_8\NN\7342049 (l_prep) of_9\IN\0 (l_pobj) tma_10\NNP\0
D016572_D057049 CID cyclosporine_13\NN\0 (r_npadvmod) induced_15\VBN\1627355 (r_amod) tma_16\NNP\0
D016572_D057049 CID cyclosporine_23\NN\0 (r_pobj) of_22\IN\0 (r_prep) withdrawal_21\NN\7206096 (r_pobj) to_19\IN\0 (r_prep) responded_18\VBD\2367363 (r_relcl) tma_16\NNP\0
D016572_D057049 CID cyclosporine_5\NN\0 (r_pobj) from_4\IN\0 (r_prep) switched_3\VBN\138508 (r_relcl) patients_0\NNS\9898892 (r_nsubjpass) monitored_14\VBN\2169352 (l_prep) for_15\IN\0 (l_pobj) signs_17\NNS\6643763 (l_prep) of_20\IN\0 (l_pobj) tma_22\NNP\0
8682684
D000082_D007022 CID acetaminophen_0\NNP\2707683 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hypotension_3\NN\14057371
D000082_D007022 CID acetaminophen_2\RB\2707683 (r_nsubjpass) demonstrated_5\VBN\2137132 (l_xcomp) produce_7\VB\7555863 (l_dobj) symptoms_8\NNS\5823932 (l_prep) including_12\VBG\0 (l_pobj) hypotension_13\NN\14057371
D000082_D007022 CID acetaminophen_18\NN\2707683 (r_pobj) of_17\IN\0 (r_prep) administration_16\NN\1133281 (r_pobj) after_15\IN\0 (r_prep) developed_14\VBN\1753788 (l_nsubj) episodes_10\NNS\7283608 (l_prep) of_11\IN\0 (l_pobj) hypotension_12\NN\14057371
D000082_D007022 CID acetaminophen_9\NN\2707683 (r_dobj) consider_8\VB\689344 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) hypotension_13\NN\14057371
D000082_D002318 NONE acetaminophen_3\NN\2707683 (r_pobj) for_2\IN\0 (r_prep) potential_1\NN\14481929 (l_acl) produce_5\VB\7555863 (l_dobj) toxicities_7\NNS\13576101
D000082_D000707 NONE acetaminophen_2\RB\2707683 (r_nsubjpass) demonstrated_5\VBN\2137132 (l_xcomp) produce_7\VB\7555863 (l_dobj) symptoms_8\NNS\5823932 (l_prep) of_9\IN\0 (l_pobj) anaphylaxis_10\NN\14533203
D000082_D016638 NONE acetaminophen_18\NN\2707683 (r_pobj) of_17\IN\0 (r_prep) administration_16\NN\1133281 (r_pobj) after_15\IN\0 (r_prep) developed_14\VBN\1753788 (r_relcl) patients_6\NNS\9898892 (l_amod) ill_5\JJ\14052403
15737522
D002443_D001660 CID ceftriaxone_0\NN\2996840 (r_npadvmod) associated_2\VBN\628491 (r_amod) pseudolithiasis_4\NN\0
D002443_D001660 CID ceftriaxone_5\NN\2996840 (r_nsubj) leads_6\VBZ\5155821 (l_xcomp) pseudolithiasis_8\NN\0
D002443_D001660 CID ceftriaxone_19\CD\2996840 (r_compound) treatment_20\NN\654885 (r_dobj) receiving_18\VBG\2210855 (r_acl) patients_17\NNS\9898892 (r_pobj) in_14\IN\13603305 (r_prep) pseudolithiasis_13\NN\0
19767176
D010100_D009410 NONE oxygen_5\NN\14622893 (r_compound) species_6\NNS\7992450 (r_pobj) of_3\IN\0 (r_prep) production_2\NN\30358 (r_nsubjpass) implicated_17\VBN\2677097 (l_prep) in_18\IN\13603305 (l_pobj) damage_21\NN\7296428
D010100_D009410 NONE oxygen_9\NN\14622893 (r_compound) species_10\NNS\7992450 (r_pobj) of_7\IN\0 (r_prep) generation_6\NN\7942152 (r_nsubj) plays_17\VBZ\7007684 (l_dobj) role_21\NN\719494 (l_prep) in_22\IN\13603305 (l_pobj) damage_27\NN\7296428
C020972_D013226 NONE dithiocarbamate_1\NN\0 (r_nsubj) protects_2\VBZ\1127795 (l_dobj) cortex_5\NN\5462674 (l_prep) in_6\IN\13603305 (l_pobj) model_11\NN\5888929 (l_amod) epilepticus_10\NN\0
C020972_D013226 NONE pdtc_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) on_4\IN\0 (l_pobj) loss_10\NN\13252973 (l_amod) associated_8\VBN\628491 (l_npadvmod) epilepticus_6\NN\0
C020972_D013226 NONE pdtc_4\NNP\0 (r_pobj) with_1\IN\0 (r_prep) treatment_0\NN\654885 (r_nsubj) increased_11\VBD\169651 (l_advmod) epilepticus_9\NN\0
C020972_D013226 NONE pdtc_4\NNP\0 (r_nmod) dose_8\NN\3740161 (r_pobj) of_1\IN\0 (r_prep) administration_0\NN\1133281 (r_nsubj) exert_12\VB\1158872 (l_dobj) effects_14\NNS\13245626 (l_prep) on_15\IN\0 (l_pobj) development_17\NN\248977 (l_prep) of_18\IN\0 (l_pobj) epilepticus_21\NN\0
C020972_D013226 NONE pdtc_16\NNP\0 (r_npadvmod) treated_18\VBN\2376958 (r_amod) rats_19\NNS\2329401 (r_conj) vehicle-_14\NN\0 (r_pobj) in_13\IN\13603305 (r_prep) identified_12\VBN\699815 (l_prep) following_20\VBG\8180190 (l_pobj) epilepticus_22\NN\0
D010862_D013226 CID pilocarpine_8\NN\14712692 (r_amod) model_11\NN\5888929 (l_amod) epilepticus_10\NN\0
D010862_D013226 CID pilocarpine_23\NN\14712692 (r_compound) model_24\NN\5888929 (r_pobj) in_19\IN\13603305 (r_prep) evaluated_18\VBN\670261 (l_nsubjpass) effect_1\NN\34213 (l_prep) on_4\IN\0 (l_pobj) loss_10\NN\13252973 (l_amod) associated_8\VBN\628491 (l_npadvmod) epilepticus_6\NN\0
D010100_D012640 NONE oxygen_9\NN\14622893 (r_compound) species_10\NNS\7992450 (r_pobj) of_7\IN\0 (r_prep) generation_6\NN\7942152 (r_nsubj) plays_17\VBZ\7007684 (l_dobj) role_21\NN\719494 (l_prep) in_22\IN\13603305 (l_pobj) damage_27\NN\7296428 (l_amod) associated_25\VBN\628491 (l_npadvmod) seizure_23\NN\14081375
C020972_D009410 NONE pdtc_10\NNP\0 (r_conj) inhibitor_7\NN\20090 (r_nsubj) protected_11\VBD\1127795 (l_advcl) affect_20\VB\26192 (l_dobj) loss_23\NN\13252973
10193204
D001241_D013927 NONE acid_36\NN\14818238 (r_dobj) acetylsalicylic_35\JJ\0 (r_advcl) showed_20\VBD\2137132 (l_dobj) inhibition_22\NN\1068773 (l_prep) of_23\IN\0 (l_pobj) thrombosis_24\NN\14100769
D001241_D013927 NONE asa_38\NNP\0 (r_appos) acid_36\NN\14818238 (r_dobj) acetylsalicylic_35\JJ\0 (r_advcl) showed_20\VBD\2137132 (l_dobj) inhibition_22\NN\1068773 (l_prep) of_23\IN\0 (l_pobj) thrombosis_24\NN\14100769
D004837_D001791 NONE epinephrine_21\NN\14807929 (r_conj) collagen_19\NN\15026716 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) thrombosis_16\NN\14100769 (r_pobj) on_13\IN\0 (r_prep) effects_8\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_advcl) undertaken_4\VBN\1641914 (l_conj) in_34\IN\13603305 (l_nsubj) aggregation_30\NN\31264
D004837_D001791 NONE ep_23\NN\0 (r_appos) epinephrine_21\NN\14807929 (r_conj) collagen_19\NN\15026716 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) thrombosis_16\NN\14100769 (r_pobj) on_13\IN\0 (r_prep) effects_8\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_advcl) undertaken_4\VBN\1641914 (l_conj) in_34\IN\13603305 (l_nsubj) aggregation_30\NN\31264
C009438_D001791 NONE tetrandrine_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_prep) on_5\IN\0 (l_pobj) thrombosis_7\NN\14100769 (l_prep) in_8\IN\13603305 (l_pobj) mice_9\NNS\2329401 (l_conj) aggregation_13\NN\31264
C009438_D001791 NONE tet_10\NNP\15157225 (r_pobj) of_9\IN\0 (r_prep) effects_8\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_advcl) undertaken_4\VBN\1641914 (l_conj) in_34\IN\13603305 (l_nsubj) aggregation_30\NN\31264
C009438_D001791 NONE tet_14\NNP\15157225 (r_nsubj) showed_17\VBD\2137132 (l_prep) in_0\IN\13603305 (l_pobj) aggregations_5\NNS\31264
C060802_D001778 NONE fan_12\NNP\3183080 (r_conj) tet_10\NNP\15157225 (r_pobj) of_9\IN\0 (r_prep) effects_8\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_advcl) undertaken_4\VBN\1641914 (l_conj) in_34\IN\13603305 (l_nsubj) aggregation_30\NN\31264 (l_conj) coagulation_33\NN\13518963
C009438_D001778 NONE tet_10\NNP\15157225 (r_pobj) of_9\IN\0 (r_prep) effects_8\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_advcl) undertaken_4\VBN\1641914 (l_conj) in_34\IN\13603305 (l_nsubj) aggregation_30\NN\31264 (l_conj) coagulation_33\NN\13518963
D004837_D001778 NONE epinephrine_21\NN\14807929 (r_conj) collagen_19\NN\15026716 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) thrombosis_16\NN\14100769 (r_pobj) on_13\IN\0 (r_prep) effects_8\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_advcl) undertaken_4\VBN\1641914 (l_conj) in_34\IN\13603305 (l_nsubj) aggregation_30\NN\31264 (l_conj) coagulation_33\NN\13518963
D004837_D001778 NONE ep_23\NN\0 (r_appos) epinephrine_21\NN\14807929 (r_conj) collagen_19\NN\15026716 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) thrombosis_16\NN\14100769 (r_pobj) on_13\IN\0 (r_prep) effects_8\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_advcl) undertaken_4\VBN\1641914 (l_conj) in_34\IN\13603305 (l_nsubj) aggregation_30\NN\31264 (l_conj) coagulation_33\NN\13518963
C060802_D001791 NONE fangchinoline_4\NN\0 (r_conj) tetrandrine_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_prep) on_5\IN\0 (l_pobj) thrombosis_7\NN\14100769 (l_prep) in_8\IN\13603305 (l_pobj) mice_9\NNS\2329401 (l_conj) aggregation_13\NN\31264
C060802_D001791 NONE fan_12\NNP\3183080 (r_conj) tet_10\NNP\15157225 (r_pobj) of_9\IN\0 (r_prep) effects_8\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_advcl) undertaken_4\VBN\1641914 (l_conj) in_34\IN\13603305 (l_nsubj) aggregation_30\NN\31264
C060802_D001791 NONE fan_16\NNP\3183080 (r_conj) tet_14\NNP\15157225 (r_nsubj) showed_17\VBD\2137132 (l_prep) in_0\IN\13603305 (l_pobj) aggregations_5\NNS\31264
C060802_D013927 NONE fangchinoline_4\NN\0 (r_conj) tetrandrine_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_prep) on_5\IN\0 (l_pobj) thrombosis_7\NN\14100769
C060802_D013927 NONE fan_12\NNP\3183080 (r_conj) tet_10\NNP\15157225 (r_pobj) of_9\IN\0 (r_prep) effects_8\NNS\13245626 (l_prep) on_13\IN\0 (l_pobj) thrombosis_16\NN\14100769
C060802_D013927 NONE fan_17\NNP\3183080 (r_conj) tet_15\NNP\15157225 (r_pobj) of_14\IN\0 (r_prep) administration_7\NN\1133281 (r_nsubj) showed_20\VBD\2137132 (l_dobj) inhibition_22\NN\1068773 (l_prep) of_23\IN\0 (l_pobj) thrombosis_24\NN\14100769
C009438_D013927 NONE tetrandrine_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_prep) on_5\IN\0 (l_pobj) thrombosis_7\NN\14100769
C009438_D013927 NONE tet_10\NNP\15157225 (r_pobj) of_9\IN\0 (r_prep) effects_8\NNS\13245626 (l_prep) on_13\IN\0 (l_pobj) thrombosis_16\NN\14100769
C009438_D013927 NONE tet_15\NNP\15157225 (r_pobj) of_14\IN\0 (r_prep) administration_7\NN\1133281 (r_nsubj) showed_20\VBD\2137132 (l_dobj) inhibition_22\NN\1068773 (l_prep) of_23\IN\0 (l_pobj) thrombosis_24\NN\14100769
D004837_D013927 CID epinephrine_21\NN\14807929 (r_conj) collagen_19\NN\15026716 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) thrombosis_16\NN\14100769
D004837_D013927 CID ep_23\NN\0 (r_appos) epinephrine_21\NN\14807929 (r_conj) collagen_19\NN\15026716 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) thrombosis_16\NN\14100769
7083920
D000638_D013617 NONE amiodarone_13\NN\2715941 (r_compound) treatment_14\NN\654885 (l_prep) for_15\IN\0 (l_pobj) tachycardia_17\NNS\14110674
D000638_D006345 NONE amiodarone_13\NN\2715941 (r_compound) treatment_14\NN\654885 (r_pobj) under_12\IN\0 (r_prep) occurring_11\VBG\0 (l_prep) without_21\IN\0 (l_pobj) abnormalities_25\NNS\14034177
D000638_D006327 CID amiodarone_13\NN\2715941 (r_compound) treatment_14\NN\654885 (r_pobj) under_12\IN\0 (r_prep) occurring_11\VBG\0 (r_acl) block_10\NN\21939
D000638_D001282 NONE amiodarone_3\NN\2715941 (r_compound) discontinuation_4\NN\209943 (r_pobj) after_2\IN\0 (r_prep) showed_9\VBD\2137132 (l_dobj) flutter_11\NN\331950
8558192
D002945_D064420 NONE cisplatin_9\NN\0 (r_npadvmod) based_11\VBN\0 (r_amod) chemotherapy_12\NN\661091 (r_pobj) with_8\IN\0 (r_prep) pretreated_7\VBN\0 (r_csubj) were_13\VBD\0 (l_acomp) assessable_14\JJ\0 (l_prep) for_15\IN\0 (l_pobj) toxicity_16\NN\13576101
C030852_D064420 NONE vnb_0\NNP\0 (r_nsubjpass) tolerated_3\VBN\802318 (l_conj) occurred_13\VBD\0 (l_nsubj) toxicity_12\NN\13576101
C030852_D064420 NONE vnb_12\NNP\0 (r_pobj) of_11\IN\0 (r_prep) evaluation_10\NN\874067 (r_nsubjpass) warranted_17\VBN\1012073 (l_prep) given_0\VBN\5892096 (l_pobj) profile_4\NN\6999802 (l_conj) toxicity_7\NN\13576101
C030852_C562729 NONE vinorelbine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) trial_2\NN\786195 (l_prep) in_5\IN\13603305 (l_pobj) carcinoma_10\NN\14239918
C030852_C562729 NONE vinorelbine_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) effects_7\NNS\13245626 (r_conj) rate_4\NN\13815152 (l_acl) administered_13\VBN\2436349 (l_prep) as_14\IN\14622893 (l_pobj) agent_17\NN\7347 (l_prep) in_18\IN\13603305 (l_pobj) carcinoma_23\NN\14239918
C030852_C562729 NONE vnb_11\NNP\0 (r_appos) vinorelbine_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) effects_7\NNS\13245626 (r_conj) rate_4\NN\13815152 (l_acl) administered_13\VBN\2436349 (l_prep) as_14\IN\14622893 (l_pobj) agent_17\NN\7347 (l_prep) in_18\IN\13603305 (l_pobj) carcinoma_23\NN\14239918
C030852_C562729 NONE vnb_4\NNP\0 (r_nsubj) is_5\VBZ\0 (l_attr) agent_8\NN\7347 (l_prep) in_9\IN\13603305 (l_pobj) carcinoma_14\NN\14239918
19299179
D015662_D008100 NONE trimoxazole_35\NN\0 (r_amod) treatment_36\NN\654885 (r_dobj) report_3\VBP\6470073 (l_dobj) cases_5\NNS\7283608 (l_conj) in_20\IN\13603305 (l_pobj) lesions_23\NNS\14204950 (l_acl) mimicking_24\VBG\1742886 (l_dobj) formation_27\NN\7938773 (l_compound) abscess_26\NN\14299637
D015662_D009894 NONE trimoxazole_25\NN\0 (r_punct) ._26\.\0 (r_punct) treated_18\VBN\2376958 (l_nsubjpass) pneumonia_1\NN\14145095 (l_appos) infection_9\NN\14052046
D015662_D015658 NONE trimoxazole_11\NN\0 (r_amod) treatment_12\NN\654885 (l_prep) for_13\IN\0 (l_pobj) pneumonia_15\NN\14145095 (l_prep) in_16\IN\13603305 (l_pobj) patients_20\NNS\9898892 (l_amod) infected_19\VBN\2316868
D015662_D015658 NONE trimoxazole_25\NN\0 (r_punct) ._26\.\0 (r_punct) treated_18\VBN\2376958 (l_nsubjpass) pneumonia_1\NN\14145095 (l_appos) infection_9\NN\14052046 (l_prep) in_10\IN\13603305 (l_pobj) individuals_14\NNS\7347 (l_amod) infected_13\VBN\2316868
D015662_D015658 NONE trimoxazole_35\NN\0 (r_amod) treatment_36\NN\654885 (r_dobj) report_3\VBP\6470073 (l_dobj) cases_5\NNS\7283608 (l_prep) of_6\IN\0 (l_pobj) patients_12\NNS\9898892 (l_amod) infected_11\VBN\2316868
D015662_D011020 NONE trimoxazole_11\NN\0 (r_amod) treatment_12\NN\654885 (l_prep) for_13\IN\0 (l_pobj) pneumonia_15\NN\14145095
D015662_D011020 NONE trimoxazole_25\NN\0 (r_punct) ._26\.\0 (r_punct) treated_18\VBN\2376958 (l_nsubjpass) pneumonia_1\NN\14145095
D015662_D011020 NONE trimoxazole_25\NN\0 (r_punct) ._26\.\0 (r_punct) treated_18\VBN\2376958 (l_nsubjpass) pneumonia_1\NN\14145095 (l_appos) pcp_3\NNP\10480253
D015662_D011020 NONE trimoxazole_35\NN\0 (r_amod) treatment_36\NN\654885 (l_prep) for_37\IN\0 (l_pobj) pcp_38\NNP\10480253
D015662_D002779 NONE trimoxazole_11\NN\0 (r_amod) treatment_12\NN\654885 (r_pobj) after_5\IN\0 (r_prep) cholestasis_4\NN\14052403
D015662_D002780 CID trimoxazole_35\NN\0 (r_amod) treatment_36\NN\654885 (r_dobj) report_3\VBP\6470073 (l_dobj) cases_5\NNS\7283608 (l_prep) of_6\IN\0 (l_pobj) patients_12\NNS\9898892 (l_relcl) developed_14\VBD\1753788 (l_dobj) cholestasis_17\NN\14052403
12639165
D013988_D007565 CID ticlopidine_7\NN\0 (r_pobj) with_6\IN\0 (r_prep) treatment_5\NN\654885 (r_pobj) following_4\VBG\8180190 (r_prep) developed_2\VBD\1753788 (l_dobj) jaundice_3\NN\14299637
D013988_D056486 CID ticlopidine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hepatitis_4\NN\14127211
D013988_D056486 CID ticlopidine_5\NN\0 (r_npadvmod) induced_7\VBN\1627355 (r_amod) hepatitis_9\NN\14127211
D013988_D056486 CID ticlopidine_8\NN\0 (r_advmod) receiving_7\VBG\2210855 (r_pcomp) after_6\IN\0 (r_prep) developed_2\VBD\1753788 (l_dobj) hepatitis_5\NN\14127211
D013988_D056486 CID ticlopidine_10\NN\0 (r_advmod) complication_5\NN\1073995 (r_attr) is_2\VBZ\0 (l_nsubj) hepatitis_1\NN\14127211
D013988_D056486 CID ticlopidine_7\NN\0 (r_pobj) with_6\IN\0 (r_prep) treatment_5\NN\654885 (r_pobj) following_4\VBG\8180190 (r_prep) developed_2\VBD\1753788 (l_conj) showed_9\VBD\2137132 (l_dobj) characteristics_14\NNS\5849040 (l_prep) of_15\IN\0 (l_pobj) hepatitis_17\NN\14127211
D013988_D056486 CID ticlopidine_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (r_attr) is_2\VBZ\0 (l_nsubj) hepatitis_1\NN\14127211
D013988_D002779 CID ticlopidine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hepatitis_4\NN\14127211
D013988_D002779 CID ticlopidine_5\NN\0 (r_npadvmod) induced_7\VBN\1627355 (r_amod) hepatitis_9\NN\14127211
D013988_D002779 CID ticlopidine_8\NN\0 (r_advmod) receiving_7\VBG\2210855 (r_pcomp) after_6\IN\0 (r_prep) developed_2\VBD\1753788 (l_dobj) hepatitis_5\NN\14127211
D013988_D002779 CID ticlopidine_10\NN\0 (r_advmod) complication_5\NN\1073995 (r_attr) is_2\VBZ\0 (l_nsubj) hepatitis_1\NN\14127211
D013988_D002779 CID ticlopidine_7\NN\0 (r_pobj) with_6\IN\0 (r_prep) treatment_5\NN\654885 (r_pobj) following_4\VBG\8180190 (r_prep) developed_2\VBD\1753788 (l_conj) showed_9\VBD\2137132 (l_dobj) characteristics_14\NNS\5849040 (l_prep) of_15\IN\0 (l_pobj) hepatitis_17\NN\14127211
D013988_D002779 CID ticlopidine_4\NN\0 (r_npadvmod) induced_6\VBN\1627355 (r_amod) cholestasis_7\NN\14052403
D013988_D002779 CID ticlopidine_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (r_attr) is_2\VBZ\0 (l_nsubj) hepatitis_1\NN\14127211
12063090
D004177_D059350 NONE metamizol_9\NN\0 (r_conj) morphine_7\NN\2707683 (r_pobj) between_6\IN\0 (r_prep) interaction_5\NN\37396 (r_dobj) show_2\VBP\429048 (l_advcl) suggesting_15\VBG\1010118 (l_ccomp) be_20\VB\14625458 (l_acomp) useful_21\JJ\0 (l_prep) for_22\IN\0 (l_pobj) treatment_24\NN\654885 (l_prep) of_25\IN\0 (l_pobj) pain_27\NN\14299637
D009020_D059350 NONE morphine_7\NN\2707683 (r_pobj) between_6\IN\0 (r_prep) interaction_5\NN\37396 (r_dobj) show_2\VBP\429048 (l_advcl) suggesting_15\VBG\1010118 (l_ccomp) be_20\VB\14625458 (l_acomp) useful_21\JJ\0 (l_prep) for_22\IN\0 (l_pobj) treatment_24\NN\654885 (l_prep) of_25\IN\0 (l_pobj) pain_27\NN\14299637
D004177_D003248 NONE metamizol_0\NNP\0 (r_nsubj) potentiates_1\VBZ\229605 (l_dobj) antinociception_3\NN\0 (l_conj) constipation_6\NN\14299637
D004177_D003248 NONE metamizol_20\NN\0 (r_pobj) with_16\IN\0 (r_prep) effects_7\NNS\13245626 (l_amod) antinociceptive_4\NN\0 (l_conj) constipating_6\JJ\440786
D004177_D003248 NONE metamizol_20\NN\0 (r_nsubj) potentiate_23\VB\229605 (l_dobj) constipation_27\NN\14299637
D002606_D010146 NONE charcoal_25\NN\14633206 (r_compound) meal_26\NN\7570720 (r_compound) test_27\NN\5798043 (r_nsubjpass) used_29\VBN\0 (r_conj) assessed_8\VBN\670261 (l_conj) model_21\NN\5888929 (l_amod) induced_18\VBN\1627355 (l_npadvmod) pain_16\NN\14299637
D009020_D003248 CID morphine_2\NN\2707683 (r_compound) antinociception_3\NN\0 (l_conj) constipation_6\NN\14299637
D009020_D003248 CID morphine_15\NN\2707683 (r_pobj) of_11\IN\0 (r_prep) combination_10\NN\7951464 (r_pobj) of_8\IN\0 (r_prep) effects_7\NNS\13245626 (l_amod) antinociceptive_4\NN\0 (l_conj) constipating_6\JJ\440786
D009020_D003248 CID morphine_4\NN\2707683 (r_nsubj) inhibited_5\VBD\2510337 (l_advcl) suggesting_23\VBG\1010118 (l_ccomp) develop_28\VB\1753788 (l_prep) to_29\IN\0 (l_pobj) effects_32\NNS\13245626 (l_amod) constipating_31\JJ\440786
D009020_D003248 CID morphine_10\NN\2707683 (r_pobj) by_9\IN\0 (r_agent) produced_8\VBN\1617192 (r_acl) that_7\DT\0 (r_pobj) to_6\IN\0 (r_prep) similar_5\JJ\0 (r_amod) transit_4\NN\4365484 (r_dobj) inhibited_2\VBD\2510337 (l_advcl) suggesting_18\VBG\1010118 (l_ccomp) potentiate_23\VB\229605 (l_dobj) constipation_27\NN\14299637
D009020_D003248 CID morphine_24\NN\2707683 (r_npadvmod) induced_26\VBN\1627355 (r_amod) constipation_27\NN\14299637
9672936
D008614_D010149 NONE pethidine_0\NNP\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) seizure_3\NN\14081375 (l_prep) in_4\IN\13603305 (l_pobj) adolescent_7\JJ\9622049 (l_acl) receiving_8\VBG\2210855 (l_prep) for_10\IN\0 (l_pobj) control_13\NN\5190804 (l_compound) pain_12\NN\14299637
D008614_D010149 NONE pethidine_9\NN\0 (r_dobj) receiving_8\VBG\2210855 (l_prep) for_10\IN\0 (l_pobj) control_13\NN\5190804 (l_compound) pain_12\NN\14299637
D008614_D010149 NONE pethidine_11\NN\0 (r_pobj) of_10\IN\0 (r_prep) doses_9\NNS\3740161 (r_nsubj) pump_21\NN\3736970 (l_prep) for_22\IN\0 (l_pobj) management_23\NN\1123598 (l_prep) of_24\IN\0 (l_pobj) control_27\NN\5190804 (l_compound) pain_26\NN\14299637
D008614_D012640 CID pethidine_0\NNP\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) seizure_3\NN\14081375
D008614_D012640 CID pethidine_9\NN\0 (r_dobj) receiving_8\VBG\2210855 (r_acl) adolescent_7\JJ\9622049 (r_pobj) in_4\IN\13603305 (r_prep) seizure_3\NN\14081375
1749407
D003042_D009203 CID cocaine_0\NN\3492717 (r_npadvmod) induced_2\VBN\1627355 (r_amod) infarction_4\NN\14204950
D003042_D009203 CID cocaine_13\NN\3492717 (r_nsubj) result_15\VB\34213 (l_prep) in_16\IN\13603305 (l_pobj) infarction_19\NN\14204950
D003042_D009203 CID cocaine_26\NN\3492717 (r_npadvmod) induced_28\VBN\1627355 (r_amod) increase_29\NN\13576355 (r_pobj) with_25\IN\0 (r_prep) associated_24\VBN\628491 (r_acl) demand_23\NN\6513366 (r_pobj) in_20\IN\13603305 (r_prep) increase_19\NN\13576355 (r_pobj) from_17\IN\0 (r_prep) result_16\VB\34213 (l_nsubj) infarction_14\NN\14204950
D003042_D013035 NONE cocaine_16\NN\3492717 (r_npadvmod) induced_18\VBN\1627355 (r_amod) vasoconstriction_19\NN\1149911 (r_pobj) of_15\IN\0 (r_prep) locus_14\NN\8645963 (r_nsubj) remains_20\VBZ\2684 (r_conj) are_8\VBP\13600404 (l_prep) with_0\IN\0 (l_pobj) regard_1\NN\5817845 (l_prep) to_2\IN\0 (l_pobj) spasm_3\NN\14299637
D010100_D009203 NONE oxygen_22\NN\14622893 (r_compound) demand_23\NN\6513366 (r_pobj) in_20\IN\13603305 (r_prep) increase_19\NN\13576355 (r_pobj) from_17\IN\0 (r_prep) result_16\VB\34213 (l_nsubj) infarction_14\NN\14204950
D003042_D013927 NONE cocaine_11\NN\3492717 (r_pobj) of_10\IN\0 (r_prep) effect_9\NN\34213 (l_amod) thrombotic_8\JJ\0
4812392
D001379_D011565 NONE azathioprine_4\NN\3740161 (r_pobj) with_3\IN\0 (r_prep) psoriasis_2\NN\14219661
D001379_D011565 NONE azathioprine_0\JJ\3740161 (r_det) treatment_1\NN\654885 (r_nsubj) benefited_2\VBD\2210855 (l_prep) out_8\IN\66636 (l_prep) of_9\IN\0 (l_pobj) patients_11\NNS\9898892 (l_acl) suffering_12\VBG\14322699 (l_prep) from_13\IN\0 (l_pobj) psoriasis_15\NN\14219661
D001379_D056486 NONE azathioprine_9\JJ\3740161 (r_amod) therapy_10\NN\657604 (r_nsubjpass) continued_12\VBN\2367363 (l_advcl) detected_20\VBN\2163746 (l_nsubjpass) damage_17\NN\7296428
18343374
D002996_D012170 CID clomiphene_6\NN\3329880 (r_npadvmod) induced_8\VBN\1627355 (r_amod) ovulation_9\NN\13526110 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) occlusion_3\NN\14081375
D002996_D012170 CID citrate_12\NN\14850483 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) occlusion_8\NN\14081375
D002996_D012170 CID cc_14\NN\13616054 (r_appos) citrate_12\NN\14850483 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) occlusion_8\NN\14081375
D002996_D012170 CID cc_13\NN\13616054 (r_pobj) with_12\IN\0 (r_prep) induction_11\NN\7450842 (r_pobj) after_9\IN\0 (r_prep) occlusion_8\NN\14081375
D002996_D012170 CID cc_18\NN\13616054 (r_pobj) of_17\IN\0 (r_prep) courses_16\NNS\883297 (r_pobj) after_14\IN\0 (r_prep) developed_9\VBD\1753788 (l_dobj) occlusion_13\NN\14081375
D002996_D012170 CID cc_15\NN\13616054 (r_pobj) with_14\IN\0 (r_prep) treatment_13\NN\654885 (r_pobj) after_12\IN\0 (r_prep) occlusion_11\NN\14081375
D002996_D014786 CID cc_10\NN\13616054 (r_pobj) of_9\IN\0 (r_prep) complications_8\NNS\1073995 (r_pobj) on_5\IN\0 (r_prep) search_1\NN\407535 (r_nsubj) include_13\VB\0 (l_advcl) is_26\VBZ\0 (l_nsubj) disturbance_22\NN\407535
D002996_D014786 CID cc_24\NN\13616054 (r_compound) intake_25\NN\13440063 (r_pobj) after_23\IN\0 (r_prep) disturbance_22\NN\407535
D002996_D007247 NONE cc_9\NN\13616054 (r_pobj) with_8\IN\0 (r_prep) treating_5\VBG\2376958 (l_dobj) patients_7\NNS\9898892 (l_compound) infertility_6\NN\14034177
D002996_D013923 NONE cc_10\NN\13616054 (r_pobj) of_9\IN\0 (r_prep) complications_8\NNS\1073995 (l_compound) thromboembolic_7\JJ\0
D002996_D013923 NONE cc_24\NN\13616054 (r_compound) intake_25\NN\13440063 (r_pobj) after_23\IN\0 (r_prep) disturbance_22\NN\407535 (r_nsubj) is_26\VBZ\0 (r_advcl) include_13\VB\0 (l_nsubj) search_1\NN\407535 (l_prep) on_5\IN\0 (l_pobj) complications_8\NNS\1073995 (l_compound) thromboembolic_7\JJ\0
6203452
D001761_D002277 NONE bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) carcinoma_3\NN\14239918
D002945_D013921 NONE cisplatin_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0 (l_acl) characterized_8\VBN\609683 (l_conj) anemia_15\NN\14189204 (l_conj) thrombocytopenia_19\JJ\14189204
D002945_D013921 NONE cisplatin_30\VB\0 (r_amod) nephrotoxicity_31\NN\0 (l_conj) thrombocytopenia_36\NN\14189204
D002945_D051437 NONE cisplatin_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0 (l_acl) characterized_8\VBN\609683 (l_agent) by_9\IN\0 (l_pobj) insufficiency_11\NN\14462946
D002945_D051437 NONE cisplatin_30\VB\0 (r_amod) nephrotoxicity_31\NN\0 (r_pobj) to_29\IN\0 (r_prep) ascribed_28\VBN\670261 (l_nsubjpass) failure_25\NN\66216
D001761_D000743 NONE bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0 (l_acl) characterized_8\VBN\609683 (l_conj) anemia_15\NN\14189204
D014748_D057049 NONE alkaloid_31\NN\14727670 (r_amod) vinca_30\JJ\11567411 (r_conj) bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0
D002945_D007674 CID cisplatin_30\VB\0 (r_amod) nephrotoxicity_31\NN\0
D002945_D002277 NONE cisplatin_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) carcinoma_3\NN\14239918
D014748_D051437 NONE alkaloid_31\NN\14727670 (r_amod) vinca_30\JJ\11567411 (r_conj) bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0 (l_acl) characterized_8\VBN\609683 (l_agent) by_9\IN\0 (l_pobj) insufficiency_11\NN\14462946
D001761_D013921 NONE bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0 (l_acl) characterized_8\VBN\609683 (l_conj) anemia_15\NN\14189204 (l_conj) thrombocytopenia_19\JJ\14189204
D002945_D000743 NONE cisplatin_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0 (l_acl) characterized_8\VBN\609683 (l_conj) anemia_15\NN\14189204
D014748_D002277 NONE alkaloid_31\NN\14727670 (r_amod) vinca_30\JJ\11567411 (r_conj) bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) carcinoma_3\NN\14239918
D002945_D001855 NONE cisplatin_30\VB\0 (r_amod) nephrotoxicity_31\NN\0 (l_conj) thrombocytopenia_36\NN\14189204 (l_prep) to_37\IN\0 (l_pobj) suppression_43\NN\13489037
D014748_D000743 NONE alkaloid_31\NN\14727670 (r_amod) vinca_30\JJ\11567411 (r_conj) bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0 (l_acl) characterized_8\VBN\609683 (l_conj) anemia_15\NN\14189204
D014748_D013921 NONE alkaloid_31\NN\14727670 (r_amod) vinca_30\JJ\11567411 (r_conj) bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0 (l_acl) characterized_8\VBN\609683 (l_conj) anemia_15\NN\14189204 (l_conj) thrombocytopenia_19\JJ\14189204
D001761_D051437 NONE bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0 (l_acl) characterized_8\VBN\609683 (l_agent) by_9\IN\0 (l_pobj) insufficiency_11\NN\14462946
D001761_D057049 NONE bleomycin_26\NNS\0 (r_conj) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0
D002945_D057049 NONE cisplatin_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) after_21\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) microangiopathy_6\NN\0
D002945_D000740 NONE cisplatin_30\VB\0 (r_amod) nephrotoxicity_31\NN\0 (l_conj) anemia_34\NN\14189204
11279304
D003630_D006333 CID dnr_16\NNP\0 (r_pobj) given_15\VBN\5892096 (r_acl) failure_14\NN\66216
D003630_D066126 NONE daunorubicin_36\NN\0 (r_pobj) with_34\IN\0 (r_prep) treated_33\VBN\2376958 (r_acl) leukemia_32\NN\14239918 (r_pobj) with_30\IN\0 (r_prep) patients_29\NNS\9898892 (r_pobj) in_28\IN\13603305 (r_prep) cardiotoxicity_27\NN\0
D003630_D066126 NONE dnr)-containing_38\NN\0 (r_compound) regimen_39\NNS\5898568 (r_appos) daunorubicin_36\NN\0 (r_pobj) with_34\IN\0 (r_prep) treated_33\VBN\2376958 (r_acl) leukemia_32\NN\14239918 (r_pobj) with_30\IN\0 (r_prep) patients_29\NNS\9898892 (r_pobj) in_28\IN\13603305 (r_prep) cardiotoxicity_27\NN\0
D018943_D015470 NONE anthracycline_24\NN\0 (r_advmod) induced_26\VBN\1627355 (r_amod) cardiotoxicity_27\NN\0 (l_prep) in_28\IN\13603305 (l_pobj) patients_29\NNS\9898892 (l_prep) with_30\IN\0 (l_pobj) leukemia_32\NN\14239918
D018943_D006331 NONE anthracycline_4\NN\0 (r_amod) therapy_5\NN\657604 (r_pobj) of_2\IN\0 (r_prep) cardiotoxicity_1\NN\0 (r_nsubj) highlights_6\VBZ\13809920 (l_dobj) need_8\NN\13920835 (l_acl) search_10\VB\407535 (l_prep) for_11\IN\0 (l_pobj) methods_12\NNS\5616786 (l_relcl) are_14\VBP\13600404 (l_acomp) sensitive_16\JJ\10488309 (l_conj) capable_18\JJ\0 (l_prep) of_19\IN\0 (l_pcomp) predicting_20\VBG\916909 (l_dobj) dysfunction_22\NN\14204950
D003630_D015470 NONE daunorubicin_36\NN\0 (r_pobj) with_34\IN\0 (r_prep) treated_33\VBN\2376958 (r_acl) leukemia_32\NN\14239918
D003630_D015470 NONE dnr)-containing_38\NN\0 (r_compound) regimen_39\NNS\5898568 (r_appos) daunorubicin_36\NN\0 (r_pobj) with_34\IN\0 (r_prep) treated_33\VBN\2376958 (r_acl) leukemia_32\NN\14239918
D003630_D015470 NONE dnr_9\NNP\0 (r_npadvmod) containing_11\VBG\2632940 (r_amod) regimen_12\NN\5898568 (r_pobj) with_7\IN\0 (r_prep) treated_6\VBN\2376958 (l_nsubjpass) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) leukemia_4\NN\14239918
D018943_D066126 NONE anthracycline_7\NN\0 (r_advmod) induced_9\VBN\1627355 (r_amod) cardiotoxicity_10\NN\0
D018943_D066126 NONE anthracyclines_0\NNS\0 (r_nsubj) are_1\VBP\13600404 (l_conj) cause_9\VBP\7323922 (l_dobj) cardiotoxicity_13\NN\0
D018943_D066126 NONE anthracycline_4\NN\0 (r_amod) therapy_5\NN\657604 (r_pobj) of_2\IN\0 (r_prep) cardiotoxicity_1\NN\0
D018943_D066126 NONE anthracycline_24\NN\0 (r_advmod) induced_26\VBN\1627355 (r_amod) cardiotoxicity_27\NN\0
D018943_D066126 NONE anthracycline_16\NN\0 (r_advmod) induced_18\VBN\1627355 (r_compound) cardiotoxicity_19\NN\0
20067456
D017367_D012735 NONE inhibitor_16\NN\20090 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) dysfunction_9\NN\14204950
D017367_D012735 NONE inhibitor_28\NN\20090 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (l_csubj) determine_1\VB\0 (l_dobj) safety_3\NN\13920835 (l_prep) of_6\IN\0 (l_pobj) bupropion_8\NN\0 (l_prep) on_15\IN\0 (l_pobj) dysfunction_18\NN\14204950
D017367_D012735 NONE inhibitor_28\NN\20090 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (l_csubj) determine_1\VB\0 (l_dobj) safety_3\NN\13920835 (l_prep) of_6\IN\0 (l_pobj) bupropion_8\NN\0 (l_prep) on_15\IN\0 (l_pobj) dysfunction_18\NN\14204950 (l_appos) sd_20\NN\0
D017367_D012735 NONE inhibitor_28\NN\20090 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (l_advcl) is_35\VBZ\0 (l_nsubj) sd_34\NN\0
D017367_D012735 NONE ssri_30\NNP\2718811 (r_appos) inhibitor_28\NN\20090 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (l_csubj) determine_1\VB\0 (l_dobj) safety_3\NN\13920835 (l_prep) of_6\IN\0 (l_pobj) bupropion_8\NN\0 (l_prep) on_15\IN\0 (l_pobj) dysfunction_18\NN\14204950
D017367_D012735 NONE ssri_30\NNP\2718811 (r_appos) inhibitor_28\NN\20090 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (l_csubj) determine_1\VB\0 (l_dobj) safety_3\NN\13920835 (l_prep) of_6\IN\0 (l_pobj) bupropion_8\NN\0 (l_prep) on_15\IN\0 (l_pobj) dysfunction_18\NN\14204950 (l_appos) sd_20\NN\0
D017367_D012735 NONE ssri_30\NNP\2718811 (r_appos) inhibitor_28\NN\20090 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (l_advcl) is_35\VBZ\0 (l_nsubj) sd_34\NN\0
D017367_D012735 NONE ssris_42\NNS\2718811 (r_pobj) of_41\IN\0 (r_prep) effect_40\NN\34213 (r_attr) is_35\VBZ\0 (r_advcl) induced_22\VBN\1627355 (l_csubj) determine_1\VB\0 (l_dobj) safety_3\NN\13920835 (l_prep) of_6\IN\0 (l_pobj) bupropion_8\NN\0 (l_prep) on_15\IN\0 (l_pobj) dysfunction_18\NN\14204950
D017367_D012735 NONE ssris_42\NNS\2718811 (r_pobj) of_41\IN\0 (r_prep) effect_40\NN\34213 (r_attr) is_35\VBZ\0 (r_advcl) induced_22\VBN\1627355 (l_csubj) determine_1\VB\0 (l_dobj) safety_3\NN\13920835 (l_prep) of_6\IN\0 (l_pobj) bupropion_8\NN\0 (l_prep) on_15\IN\0 (l_pobj) dysfunction_18\NN\14204950 (l_appos) sd_20\NN\0
D017367_D012735 NONE ssris_42\NNS\2718811 (r_pobj) of_41\IN\0 (r_prep) effect_40\NN\34213 (r_attr) is_35\VBZ\0 (l_nsubj) sd_34\NN\0
D017367_D012735 NONE ssri_21\NNP\2718811 (r_pobj) of_20\IN\0 (r_prep) type_19\NN\5839024 (r_appos) sd_17\NN\0
D017367_D012735 NONE ssris_10\NNS\2718811 (r_pobj) by_9\IN\0 (r_agent) induced_8\VBN\1627355 (r_acl) treatment_4\NN\654885 (l_prep) for_5\IN\0 (l_pobj) sd_7\NN\0
D016642_D012735 NONE bupropion_5\NN\0 (l_prep) on_6\IN\0 (l_pobj) dysfunction_9\NN\14204950
D016642_D012735 NONE bupropion_8\NN\0 (l_prep) on_15\IN\0 (l_pobj) dysfunction_18\NN\14204950
D016642_D012735 NONE bupropion_8\NN\0 (l_prep) on_15\IN\0 (l_pobj) dysfunction_18\NN\14204950 (l_appos) sd_20\NN\0
D016642_D012735 NONE bupropion_8\NN\0 (r_pobj) of_6\IN\0 (r_prep) safety_3\NN\13920835 (r_dobj) determine_1\VB\0 (r_csubj) induced_22\VBN\1627355 (l_advcl) is_35\VBZ\0 (l_nsubj) sd_34\NN\0
D016642_D012735 NONE bupropion_0\NN\0 (r_nsubj) is_1\VBZ\0 (l_attr) treatment_4\NN\654885 (l_prep) for_5\IN\0 (l_pobj) sd_7\NN\0
8231633
D015764_D012640 NONE bepridil_31\NN\0 (r_pcomp) with_30\IN\0 (r_prep) pronounced_29\VBN\0 (r_acomp) was_27\VBD\0 (l_ccomp) modified_8\VBN\109660 (l_conj) decreased_13\VBD\169651 (l_dobj) time_15\NN\7308889 (l_relcl) obtain_19\VB\2210855 (l_dobj) convulsions_23\NNS\14081375
D002045_D064420 NONE bupivacaine_6\NN\0 (r_npadvmod) induced_8\VBN\1627355 (r_amod) toxicity_9\NN\13576101
D002045_D064420 NONE bupivacaine_15\NN\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) toxicity_19\NN\13576101
D002045_D012640 CID bupivacaine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) activity_2\NN\30358 (r_nsubj) was_5\VBD\0 (r_auxpass) modified_8\VBN\109660 (l_conj) decreased_13\VBD\169651 (l_dobj) time_15\NN\7308889 (l_relcl) obtain_19\VB\2210855 (l_dobj) convulsions_23\NNS\14081375
D002045_D012640 CID bupivacaine_20\NN\0 (r_npadvmod) induced_22\VBN\1627355 (r_amod) convulsions_23\NNS\14081375
D002118_D012640 NONE calcium_10\NN\14625458 (r_compound) channel_11\NN\6251781 (r_compound) blockers_12\NNS\10101634 (r_nsubj) decreased_13\VBD\169651 (l_dobj) time_15\NN\7308889 (l_relcl) obtain_19\VB\2210855 (l_dobj) convulsions_23\NNS\14081375
D002118_D064420 NONE calcium_2\NN\14625458 (r_compound) channel_3\NN\6251781 (r_compound) blockers_4\NNS\10101634 (l_prep) on_5\IN\0 (l_pobj) toxicity_9\NN\13576101
D002118_D064420 NONE calcium_11\NN\14625458 (r_compound) channel_12\NN\6251781 (r_compound) blockers_13\NNS\10101634 (l_prep) on_14\IN\0 (l_pobj) toxicity_19\NN\13576101
2549018
D005473_D009771 NONE fluoxetine_3\NN\4169152 (r_dobj) receiving_2\VBG\2210855 (l_prep) for_4\IN\0 (l_pobj) treatment_6\NN\654885 (l_prep) of_7\IN\0 (l_pobj) disorder_10\NN\14034177
D005473_D017109 CID fluoxetine_0\NNP\4169152 (r_npadvmod) induced_2\VBN\1627355 (r_amod) akathisia_3\NN\0
D005473_D017109 CID fluoxetine_3\NN\4169152 (r_dobj) receiving_2\VBG\2210855 (r_acl) patients_1\NNS\9898892 (r_nsubj) developed_14\VBD\1753788 (l_dobj) akathisia_15\NN\0
D005473_D017109 CID fluoxetine_2\NN\4169152 (r_npadvmod) induced_4\VBN\1627355 (r_amod) symptoms_5\NNS\5823932 (r_nsubj) were_23\VBD\0 (l_acomp) indistinguishable_24\JJ\0 (l_prep) from_25\IN\0 (l_pobj) those_26\DT\0 (l_prep) of_27\IN\0 (l_pobj) akathisia_31\NN\0
D005473_D017109 CID fluoxetine_17\NN\4169152 (r_advmod) induced_19\VBN\1627355 (r_amod) akathisia_20\NN\0 (r_pobj) of_16\IN\0 (r_prep) symptoms_15\NNS\5823932 (r_nsubj) were_21\VBD\0 (r_ccomp) reported_12\VBD\831651 (l_nsubj) patients_1\NNS\9898892 (l_relcl) experienced_4\VBN\2108377 (l_dobj) akathisia_8\NN\0
D005473_D017109 CID fluoxetine_17\NN\4169152 (r_advmod) induced_19\VBN\1627355 (r_amod) akathisia_20\NN\0
D005473_D017109 CID fluoxetine_9\NN\4169152 (r_pobj) of_8\IN\0 (r_prep) effect_7\NN\34213 (r_attr) be_3\VB\14625458 (r_xcomp) appeared_1\VBD\2604760 (l_nsubj) akathisia_0\NNP\0
D005473_D017109 CID fluoxetine_4\NN\4169152 (r_advmod) induced_6\VBN\1627355 (r_amod) akathisia_7\NN\0
D005473_D017109 CID fluoxetine_4\NN\4169152 (r_advmod) induced_6\VBN\1627355 (r_amod) akathisia_7\NN\0 (r_nsubjpass) caused_10\VBN\1617192 (l_conj) be_36\VB\14625458 (l_nsubj) pathophysiology_21\NN\0 (l_prep) of_22\IN\0 (l_pobj) akathisia_26\NN\0
D005473_D017109 CID fluoxetine_23\NN\4169152 (r_advmod) induced_25\VBN\1627355 (r_amod) akathisia_26\NN\0 (r_pobj) of_22\IN\0 (r_prep) pathophysiology_21\NN\0 (r_nsubj) be_36\VB\14625458 (r_conj) caused_10\VBN\1617192 (l_nsubjpass) akathisia_7\NN\0
D005473_D017109 CID fluoxetine_23\NN\4169152 (r_advmod) induced_25\VBN\1627355 (r_amod) akathisia_26\NN\0
D000928_D017109 NONE antidepressant_29\NN\3740161 (r_npadvmod) induced_31\VBN\1627355 (r_amod) jitteriness_33\NN\7523905 (r_conj) akathisia_26\NN\0 (r_pobj) of_22\IN\0 (r_prep) pathophysiology_21\NN\0 (r_nsubj) be_36\VB\14625458 (r_conj) caused_10\VBN\1617192 (l_nsubjpass) akathisia_7\NN\0
D000928_D017109 NONE antidepressant_29\NN\3740161 (r_npadvmod) induced_31\VBN\1627355 (r_amod) jitteriness_33\NN\7523905 (r_conj) akathisia_26\NN\0
D011433_D017109 NONE propranolol_22\NN\0 (r_acl) antagonist_21\NN\7846 (r_pobj) with_16\IN\0 (r_prep) treatment_15\NN\654885 (r_pobj) to_14\IN\0 (r_prep) responded_12\VBD\2367363 (r_conj) appeared_1\VBD\2604760 (l_nsubj) akathisia_0\NNP\0
D005473_D001008 NONE fluoxetine_2\NN\4169152 (r_npadvmod) induced_4\VBN\1627355 (r_amod) symptoms_5\NNS\5823932 (l_prep) of_6\IN\0 (l_pobj) restlessness_7\NN\4773351 (l_conj) pacing_10\NN\15122011 (l_conj) movements_13\NNS\191142 (l_conj) anxiety_22\NN\14373582
D005473_D003865 NONE fluoxetine_3\NN\4169152 (r_dobj) receiving_2\VBG\2210855 (l_prep) for_4\IN\0 (l_pobj) treatment_6\NN\654885 (l_prep) of_7\IN\0 (l_pobj) disorder_10\NN\14034177 (l_conj) depression_13\NN\14373582
3997294
D000638_D013617 NONE amiodarone_11\NN\2715941 (l_prep) for_28\IN\0 (l_pobj) control_29\NN\5190804 (l_prep) of_30\IN\0 (l_pobj) tachyarrhythmias_32\NNS\0
D000638_D010490 CID amiodarone_9\NN\2715941 (r_compound) therapy_10\NN\657604 (r_pobj) during_8\IN\0 (r_prep) effusion_5\NN\6880249
D000638_D011014 CID amiodarone_14\NN\2715941 (r_compound) pneumonitis_15\NN\14336539
D000638_D011014 CID amiodarone_20\NN\2715941 (r_pobj) of_19\IN\0 (r_prep) withdrawal_18\NN\7206096 (r_dobj) indicates_7\VBZ\952524 (l_dobj) need_9\NN\13920835 (l_prep) for_10\IN\0 (l_pobj) diagnosis_12\NN\152018 (l_prep) of_13\IN\0 (l_pobj) pneumonitis_15\NN\14336539
D000638_D010996 CID amiodarone_9\NN\2715941 (r_compound) therapy_10\NN\657604 (r_pobj) during_8\IN\0 (r_prep) effusion_5\NN\6880249
D000638_D009422 NONE amiodarone_9\NN\2715941 (r_compound) therapy_10\NN\657604 (r_pobj) during_8\IN\0 (r_prep) effusion_5\NN\6880249 (l_conj) neuropathy_7\NN\14204950
D013256_D011014 NONE steroid_26\NN\14727670 (r_compound) therapy_27\NN\657604 (r_conj) prompt_23\JJ\7011209 (r_conj) withdrawal_18\NN\7206096 (r_dobj) indicates_7\VBZ\952524 (l_dobj) need_9\NN\13920835 (l_prep) for_10\IN\0 (l_pobj) diagnosis_12\NN\152018 (l_prep) of_13\IN\0 (l_pobj) pneumonitis_15\NN\14336539
D000638_D002318 NONE amiodarone_11\NN\2715941 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_nsubjpass) patient_1\NN\9898892 (l_prep) with_2\IN\0 (l_pobj) disease_4\NN\14061805
2265898
C009265_D012640 NONE levodopa_38\JJ\14604959 (r_compound) preparation_39\NN\407535 (r_dobj) receiving_34\VBG\2210855 (l_conj) had_43\VBD\0 (l_dobj) onset_45\NN\7325190 (l_prep) of_46\IN\0 (l_pobj) seizures_50\NNS\14081375
C009265_D001523 NONE levodopa_38\JJ\14604959 (r_compound) preparation_39\NN\407535 (r_dobj) receiving_34\VBG\2210855 (l_conj) had_43\VBD\0 (l_dobj) onset_45\NN\7325190 (l_prep) of_46\IN\0 (l_pobj) seizures_50\NNS\14081375 (l_nmod) hallucinosis_47\NN\14373582
C009265_D004827 CID carbidopa_6\NN\0 (l_nsubj) epilepsy_1\NN\14085708
C009265_D007676 NONE levodopa_38\JJ\14604959 (r_compound) preparation_39\NN\407535 (r_dobj) receiving_34\VBG\2210855 (l_ccomp) had_11\VBD\0 (l_dobj) failure_14\NN\66216
1147734
D011441_D006521 CID propylthiouracil_29\NN\14727670 (r_pobj) of_28\IN\0 (r_prep) administration_27\NN\1133281 (r_pobj) by_25\IN\0 (r_agent) caused_24\VBN\1617192 (r_acl) hepatitis_23\NN\14127211
D011441_D008107 NONE propylthiouracil_4\NN\14727670 (r_pobj) by_3\IN\0 (r_agent) caused_2\VBN\1617192 (r_acl) disease_1\NN\14061805
14659530
D012701_D008881 NONE serotonin_24\NN\14807737 (r_compound) release_25\NN\3748886 (r_pobj) with_22\IN\0 (r_prep) correlation_21\NN\13841213 (r_conj) concentration_18\NN\4916342 (r_appos) peptide_14\NN\14724264 (r_pobj) in_8\IN\13603305 (r_prep) increase_7\NN\13576355 (r_appos) attack_4\NN\955060 (l_compound) migraine_3\JJ\14326607
D012701_D008881 NONE serotonin_24\NN\14807737 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (r_dobj) investigate_8\VB\644583 (l_conj) attack_40\NN\955060 (l_compound) migraine_39\JJ\14326607
D012701_D008881 NONE 5-hydroxytriptamine_26\NN\0 (r_punct) ,_27\,\0 (r_punct) 5-ht_28\CD\0 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (r_dobj) investigate_8\VB\644583 (l_conj) attack_40\NN\955060 (l_compound) migraine_39\JJ\14326607
D012701_D008881 NONE 5-ht_28\CD\0 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (r_dobj) investigate_8\VB\644583 (l_conj) attack_40\NN\955060 (l_compound) migraine_39\JJ\14326607
D012701_D008881 NONE 5-ht_8\CD\0 (r_nummod) content_9\NN\7951464 (r_nsubj) tended_10\VBD\2604760 (l_xcomp) be_12\VB\14625458 (l_prep) in_14\IN\13603305 (l_pobj) subjects_15\NNS\6598915 (l_relcl) experienced_17\VBD\2108377 (l_dobj) attack_20\NN\955060 (l_compound) migraine_19\JJ\14326607
D012701_D008881 NONE serotonin_1\NN\14807737 (r_compound) content_2\NN\7951464 (r_nsubj) decreased_3\VBD\169651 (l_prep) after_8\IN\0 (l_pobj) nitroglycerin_9\NN\15015501 (l_prep) in_10\IN\13603305 (l_pobj) subjects_11\NNS\6598915 (l_prep) with_12\IN\0 (l_pobj) attack_15\NN\955060 (l_compound) migraine_14\JJ\14326607
D012701_D008881 NONE serotonin_1\NN\14807737 (r_compound) content_2\NN\7951464 (r_nsubj) decreased_3\VBD\169651 (l_conj) observed_21\VBN\2163746 (l_prep) in_22\IN\13603305 (l_pobj) patients_23\NNS\9898892 (l_prep) with_24\IN\0 (l_pobj) attack_26\NN\955060 (l_compound) migraine_25\JJ\14326607
D012701_D008881 NONE serotonin_3\NN\14807737 (r_compound) release_4\NN\3748886 (r_nsubj) provoke_9\VB\1617192 (l_dobj) migraine_10\NN\14326607
D009569_D008881 NONE no_0\RB\7204911 (r_intj) induced_2\VBN\1627355 (r_amod) attack_4\NN\955060 (l_compound) migraine_3\JJ\14326607
D015740_D008881 NONE peptide_14\NN\14724264 (r_pobj) in_8\IN\13603305 (r_prep) increase_7\NN\13576355 (r_appos) attack_4\NN\955060 (l_compound) migraine_3\JJ\14326607
D015740_D008881 NONE cgrp_16\NN\0 (r_nmod) concentration_18\NN\4916342 (r_appos) peptide_14\NN\14724264 (r_pobj) in_8\IN\13603305 (r_prep) increase_7\NN\13576355 (r_appos) attack_4\NN\955060 (l_compound) migraine_3\JJ\14326607
D015740_D008881 NONE peptide_17\NN\14724264 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (r_dobj) investigate_8\VB\644583 (l_conj) attack_40\NN\955060 (l_compound) migraine_39\JJ\14326607
D015740_D008881 NONE cgrp_19\NN\0 (r_nmod) concentration_21\NN\4916342 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (r_dobj) investigate_8\VB\644583 (l_conj) attack_40\NN\955060 (l_compound) migraine_39\JJ\14326607
D015740_D008881 NONE cgrp_1\NN\0 (r_compound) concentration_2\NN\4916342 (r_nsubj) increased_3\VBD\169651 (l_prep) during_8\IN\0 (l_pobj) attack_11\NN\955060 (l_compound) migraine_10\JJ\14326607
D015740_D008881 NONE cgrp_1\NN\0 (r_compound) concentration_2\NN\4916342 (r_nsubj) increased_3\VBD\169651 (l_conj) returned_13\VBD\1835496 (l_prep) after_16\IN\0 (l_pobj) cessation_18\NN\7365849 (l_prep) of_19\IN\0 (l_pobj) migraine_21\NN\14326607
D015740_D008881 NONE cgrp_3\NNP\0 (r_compound) concentrations_4\NNS\4916342 (r_nsubj) failed_5\VBD\0 (l_xcomp) change_7\VB\7283608 (l_prep) during_8\IN\0 (l_conj) in_12\IN\13603305 (l_pobj) subjects_14\NNS\6598915 (l_prep) with_15\IN\0 (l_pobj) attack_18\NN\955060 (l_compound) migraine_17\JJ\14326607
D015740_D008881 NONE cgrp_1\NNP\0 (r_compound) concentration_2\NN\4916342 (r_nsubj) was_3\VBD\0 (l_conj) platelet_7\NN\5432736 (l_ccomp) tended_10\VBD\2604760 (l_xcomp) be_12\VB\14625458 (l_prep) in_14\IN\13603305 (l_pobj) subjects_15\NNS\6598915 (l_relcl) experienced_17\VBD\2108377 (l_dobj) attack_20\NN\955060 (l_compound) migraine_19\JJ\14326607
D015740_D008881 NONE cgrp_7\NN\0 (r_compound) concentration_8\NN\4916342 (r_nsubj) correlates_9\VBZ\5857459 (l_prep) with_10\IN\0 (l_pobj) timing_12\NN\5044673 (l_prep) of_15\IN\0 (l_pobj) headache_18\NN\5829480 (l_compound) migraine_17\JJ\14326607
D015740_D008881 NONE cgrp_7\NN\0 (r_compound) concentration_8\NN\4916342 (r_nsubj) correlates_9\VBZ\5857459 (r_acl) fact_4\NN\5816287 (r_nsubj) suggests_19\VBZ\1010118 (l_dobj) relationship_22\NN\31921 (l_prep) between_23\IN\0 (l_pobj) cgrp_24\NN\0 (l_conj) migraine_26\NN\14326607
D015740_D008881 NONE cgrp_24\NN\0 (r_pobj) between_23\IN\0 (r_prep) relationship_22\NN\31921 (r_dobj) suggests_19\VBZ\1010118 (l_nsubj) fact_4\NN\5816287 (l_acl) correlates_9\VBZ\5857459 (l_prep) with_10\IN\0 (l_pobj) timing_12\NN\5044673 (l_prep) of_15\IN\0 (l_pobj) headache_18\NN\5829480 (l_compound) migraine_17\JJ\14326607
D015740_D008881 NONE cgrp_24\NN\0 (l_conj) migraine_26\NN\14326607
D015740_D008881 NONE cgrp_21\NN\0 (r_compound) release_22\NN\3748886 (r_conj) headache_17\NN\5829480 (r_dobj) counteract_15\VB\2367363 (l_ccomp) provoke_9\VB\1617192 (l_dobj) migraine_10\NN\14326607
D005996_D008881 NONE nitroglycerin_43\NN\15015501 (r_pobj) by_42\IN\0 (r_agent) provoked_41\VBN\1617192 (r_acl) attack_40\NN\955060 (l_compound) migraine_39\JJ\14326607
D005996_D008881 NONE nitroglycerin_16\NN\15015501 (r_compound) application_17\NN\947128 (r_pobj) after_14\IN\0 (r_conj) before_12\RB\0 (r_advmod) collected_2\VBN\2281093 (l_conj) min_23\NN\15154774 (l_prep) after_24\IN\0 (l_pobj) beginning_26\NN\7283608 (l_prep) of_27\IN\0 (l_pobj) attack_30\NN\955060 (l_compound) migraine_29\JJ\14326607
D005996_D008881 NONE nitroglycerin_9\NN\15015501 (l_prep) in_10\IN\13603305 (l_pobj) subjects_11\NNS\6598915 (l_prep) with_12\IN\0 (l_pobj) attack_15\NN\955060 (l_compound) migraine_14\JJ\14326607
D005996_D008881 NONE nitroglycerin_9\NN\15015501 (r_pobj) after_8\IN\0 (r_prep) decreased_3\VBD\169651 (l_conj) observed_21\VBN\2163746 (l_prep) in_22\IN\13603305 (l_pobj) patients_23\NNS\9898892 (l_prep) with_24\IN\0 (l_pobj) attack_26\NN\955060 (l_compound) migraine_25\JJ\14326607
D015740_D006261 NONE peptide_17\NN\14724264 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (l_prep) during_31\IN\0 (l_pobj) headache_34\NN\5829480
D015740_D006261 NONE cgrp_19\NN\0 (r_nmod) concentration_21\NN\4916342 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (l_prep) during_31\IN\0 (l_pobj) headache_34\NN\5829480
D015740_D006261 NONE cgrp_3\NNP\0 (r_compound) concentrations_4\NNS\4916342 (r_nsubj) failed_5\VBD\0 (l_xcomp) change_7\VB\7283608 (l_prep) during_8\IN\0 (l_pobj) headache_10\NN\5829480
D015740_D006261 NONE cgrp_7\NN\0 (r_compound) concentration_8\NN\4916342 (r_nsubj) correlates_9\VBZ\5857459 (l_prep) with_10\IN\0 (l_pobj) timing_12\NN\5044673 (l_prep) of_15\IN\0 (l_pobj) headache_18\NN\5829480
D015740_D006261 NONE cgrp_24\NN\0 (r_pobj) between_23\IN\0 (r_prep) relationship_22\NN\31921 (r_dobj) suggests_19\VBZ\1010118 (l_nsubj) fact_4\NN\5816287 (l_acl) correlates_9\VBZ\5857459 (l_prep) with_10\IN\0 (l_pobj) timing_12\NN\5044673 (l_prep) of_15\IN\0 (l_pobj) headache_18\NN\5829480
D015740_D006261 NONE cgrp_21\NN\0 (r_compound) release_22\NN\3748886 (r_conj) headache_17\NN\5829480
D012701_D006261 NONE serotonin_24\NN\14807737 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (l_prep) during_31\IN\0 (l_pobj) headache_34\NN\5829480
D012701_D006261 NONE 5-hydroxytriptamine_26\NN\0 (r_punct) ,_27\,\0 (r_punct) 5-ht_28\CD\0 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (l_prep) during_31\IN\0 (l_pobj) headache_34\NN\5829480
D012701_D006261 NONE 5-ht_28\CD\0 (r_nmod) content_30\NN\7951464 (r_pobj) in_10\IN\13603305 (r_prep) changes_9\NNS\7283608 (l_prep) during_31\IN\0 (l_pobj) headache_34\NN\5829480
D012701_D006261 NONE serotonin_3\NN\14807737 (r_compound) release_4\NN\3748886 (r_nsubj) provoke_9\VB\1617192 (r_ccomp) counteract_15\VB\2367363 (l_dobj) headache_17\NN\5829480
D005996_D006261 NONE nitroglycerin_43\NN\15015501 (r_pobj) by_42\IN\0 (r_agent) provoked_41\VBN\1617192 (r_acl) attack_40\NN\955060 (r_conj) investigate_8\VB\644583 (l_dobj) changes_9\NNS\7283608 (l_prep) during_31\IN\0 (l_pobj) headache_34\NN\5829480
9034419
C047426_D003865 NONE venlafaxine_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) overdose_10\NN\84738 (r_dobj) took_8\VBD\2367363 (l_nsubj) woman_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) depression_7\NN\14373582
C047426_D012640 CID venlafaxine_4\NNP\0 (r_amod) overdose_5\NN\84738 (r_pobj) from_2\IN\0 (r_prep) resulting_1\VBG\2633881 (r_acl) seizure_0\NN\14081375
C047426_D012640 CID venlafaxine_5\NNP\0 (r_pobj) of_3\IN\0 (r_prep) ingestion_2\NN\13440063 (r_pobj) after_0\IN\0 (r_prep) experienced_11\VBD\2108377 (l_dobj) seizure_15\NN\14081375
C047426_D012640 CID venlafaxine_11\NNP\0 (r_amod) overdose_12\NN\84738 (r_pobj) of_10\IN\0 (r_prep) case_9\NN\7283608 (l_relcl) resulted_14\VBD\2633881 (l_prep) in_15\IN\13603305 (l_pobj) seizure_18\NN\14081375
C047426_D012640 CID venlafaxine_1\NNP\0 (r_amod) overdose_2\NN\84738 (r_nsubj) resulted_6\VBD\2633881 (l_prep) in_7\IN\13603305 (l_pobj) episode_10\NN\7283608 (l_prep) of_11\IN\0 (l_pobj) seizure_13\NN\14081375
C047426_D062787 CID venlafaxine_4\NNP\0 (r_amod) overdose_5\NN\84738
C047426_D062787 CID venlafaxine_5\NNP\0 (r_amod) overdose_6\NN\84738
C047426_D062787 CID venlafaxine_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) overdose_10\NN\84738
C047426_D062787 CID venlafaxine_11\NNP\0 (r_amod) overdose_12\NN\84738
C047426_D062787 CID venlafaxine_1\NNP\0 (r_amod) overdose_2\NN\84738
18560792
D004298_D006349 NONE dopamine_33\NN\14807737 (r_compound) agonists_34\NNS\0 (r_pobj) to_29\IN\0 (r_prep) converted_28\VBN\126264 (r_advcl) is_22\VBZ\0 (r_ccomp) reveals_17\VBZ\2137132 (r_conj) treated_13\VBN\2376958 (r_acl) frequency_5\NN\15286249 (l_prep) of_6\IN\0 (l_pobj) regurgitation_9\NN\7406350
D010479_D006349 NONE pergolide_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_nsubj) disease_2\NN\14061805
D010479_D006349 NONE pergolide_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) treated_15\VBN\2376958 (r_acl) patients_7\NNS\9898892 (r_pobj) in_6\IN\13603305 (r_prep) reported_5\VBN\831651 (l_nsubjpass) abnormalities_2\NNS\14034177
D010479_D006349 NONE pergolide_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) role_10\NN\719494 (r_pobj) of_8\IN\0 (r_prep) suggestive_7\JJ\0 (r_amod) pattern_2\NN\5726345 (l_prep) of_3\IN\0 (l_pobj) regurgitation_5\NN\7406350
D010479_D006349 NONE pergolide_0\NNP\0 (r_nsubjpass) discontinued_2\VBN\0 (l_prep) in_3\IN\13603305 (l_pobj) patients_5\NNS\9898892 (l_prep) with_6\IN\0 (l_pobj) disease_9\NN\14061805
D010479_D006349 NONE pergolide_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) frequency_5\NN\15286249 (l_prep) of_6\IN\0 (l_pobj) regurgitation_9\NN\7406350
D004298_D010300 NONE dopamine_33\NN\14807737 (r_compound) agonists_34\NNS\0 (r_pobj) to_29\IN\0 (r_prep) converted_28\VBN\126264 (r_advcl) is_22\VBZ\0 (r_ccomp) reveals_17\VBZ\2137132 (r_conj) treated_13\VBN\2376958 (r_acl) frequency_5\NN\15286249 (l_prep) of_6\IN\0 (l_pobj) regurgitation_9\NN\7406350 (l_prep) in_10\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_compound) pd_11\NNP\14625458
D010479_D010300 NONE pergolide_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_nsubj) disease_2\NN\14061805 (l_prep) in_3\IN\13603305 (l_pobj) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) disease_8\NN\14061805
D010479_D010300 NONE pergolide_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) treated_15\VBN\2376958 (r_acl) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) disease_11\NN\14061805
D010479_D010300 NONE pergolide_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) treated_15\VBN\2376958 (r_acl) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) disease_11\NN\14061805 (l_appos) pd_13\NNP\14625458
D010479_D010300 NONE pergolide_9\NN\0 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (l_nsubj) patients_2\NNS\9898892 (l_compound) pd_1\NNP\14625458
D010479_D010300 NONE pergolide_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) frequency_5\NN\15286249 (l_prep) of_6\IN\0 (l_pobj) regurgitation_9\NN\7406350 (l_prep) in_10\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_compound) pd_11\NNP\14625458
D010479_D006333 NONE pergolide_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) role_10\NN\719494 (r_pobj) of_8\IN\0 (r_prep) suggestive_7\JJ\0 (r_amod) pattern_2\NN\5726345 (r_nsubjpass) observed_15\VBN\2163746 (l_dobj) patients_22\NNS\9898892 (l_prep) including_23\VBG\0 (l_pobj) two_24\CD\13741022 (l_prep) with_25\IN\0 (l_pobj) failure_27\NN\66216
D010479_D006333 NONE pergolide_0\NNP\0 (r_nsubjpass) discontinued_2\VBN\0 (l_advcl) resulting_11\VBG\2633881 (l_prep) in_12\IN\13603305 (l_pobj) grade_16\NN\7975026 (l_prep) at_20\IN\14622893 (l_pobj) transthoracic_23\NN\0 (l_conj) patients_28\NNS\9898892 (l_prep) with_29\IN\0 (l_pobj) failure_31\NN\66216
16181582
D014635_D004827 NONE valproate_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) encephalopathy_3\NN\14084880 (r_nsubj) is_4\VBZ\0 (l_attr) syndrome_7\NN\5870365 (l_relcl) manifest_10\VB\6479665 (l_prep) in_11\RP\13603305 (l_pobj) individuals_15\NNS\7347 (l_amod) epileptic_14\JJ\10595647
D014635_D001927 CID valproate_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) encephalopathy_3\NN\14084880
D014635_D001927 CID valproate_3\NN\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) encephalopathy_6\NN\14084880
869641
D015103_D001919 NONE dihydroxyphenylserine_21\NN\0 (r_conj) dopa_15\NNP\14601829 (r_pobj) by_12\IN\0 (r_agent) enhanced_11\VBN\227165 (l_nsubjpass) bradycardia_4\NN\14110674
D004298_D007022 NONE dopamine_3\NN\14807737 (r_compound) oxidase_7\NN\14732946 (r_compound) inhibitor_8\NN\20090 (r_nsubj) have_12\VB\7846 (l_dobj) effect_14\NN\34213 (l_prep) on_15\IN\0 (l_pobj) hypotension_17\NN\14057371
D005406_D001919 NONE fla-63_0\NN\0 (r_mark) have_12\VB\7846 (l_dobj) effect_14\NN\34213 (l_prep) on_15\IN\0 (l_pobj) hypotension_17\NN\14057371 (l_appos) effect_24\NN\34213 (l_amod) bradycardia_19\NN\14110674
D007980_D001919 NONE dopa_9\NN\14601829 (r_pobj) by_6\IN\0 (r_prep) mediation_0\NN\7148192 (l_prep) of_1\IN\0 (l_pobj) bradycardia_5\NNP\14110674
D007980_D001919 NONE dopa_15\NNP\14601829 (r_pobj) by_12\IN\0 (r_agent) enhanced_11\VBN\227165 (l_nsubjpass) bradycardia_4\NN\14110674
D007980_D001919 NONE dopa_28\NNP\14601829 (r_pobj) of_25\IN\0 (r_prep) effect_24\NN\34213 (l_amod) bradycardia_19\NN\14110674
D007980_D001919 NONE dopa_4\NNP\14601829 (r_nsubj) restored_5\VBD\1631072 (l_dobj) bradycardia_7\NN\14110674
D007980_D001919 NONE dopa_6\NNP\14601829 (r_nsubj) enhances_7\VBZ\227165 (l_dobj) bradycardia_9\NN\14110674
D004298_D001919 NONE dopamine_12\NN\14807737 (r_compound) formation_13\NN\7938773 (r_pobj) via_10\IN\0 (r_prep) mediation_0\NN\7148192 (l_prep) of_1\IN\0 (l_pobj) bradycardia_5\NNP\14110674
D004298_D001919 NONE dopamine_3\NN\14807737 (r_compound) oxidase_7\NN\14732946 (r_compound) inhibitor_8\NN\20090 (r_nsubj) have_12\VB\7846 (l_dobj) effect_14\NN\34213 (l_prep) on_15\IN\0 (l_pobj) hypotension_17\NN\14057371 (l_appos) effect_24\NN\34213 (l_amod) bradycardia_19\NN\14110674
D005406_D007022 NONE fla-63_0\NN\0 (r_mark) have_12\VB\7846 (l_dobj) effect_14\NN\34213 (l_prep) on_15\IN\0 (l_pobj) hypotension_17\NN\14057371
D009638_D001919 CID norepinephrine_8\NN\14807929 (r_pobj) by_6\IN\0 (r_agent) caused_5\VBN\1617192 (r_acl) bradycardia_4\NN\14110674
D009638_D001919 CID norepinephrine_35\NN\14807929 (r_pobj) to_34\IN\0 (r_prep) responses_33\NNS\11410625 (r_conj) rate_30\NN\13815152 (r_conj) pressure_27\NN\11419404 (r_pobj) on_25\IN\0 (r_prep) effect_24\NN\34213 (r_dobj) had_22\VBD\0 (r_conj) enhanced_11\VBN\227165 (l_nsubjpass) bradycardia_4\NN\14110674
D009638_D001919 CID norepinephrine_10\NN\14807929 (r_pobj) by_9\IN\0 (r_agent) caused_8\VBN\1617192 (r_acl) bradycardia_7\NN\14110674
D009638_D001919 CID norepinephrine_18\NN\14807929 (r_pobj) to_17\IN\0 (r_prep) bradycardia_16\NN\14110674
D007980_D007022 NONE dopa_28\NNP\14601829 (r_pobj) of_25\IN\0 (r_prep) effect_24\NN\34213 (r_appos) hypotension_17\NN\14057371
D006916_D001919 NONE 5-htp_0\NNP\0 (r_nsubj) decreased_6\VBD\169651 (l_conj) decreased_13\VBD\169651 (l_dobj) bradycardia_16\NN\14110674
7423039
D004317_D066126 CID adriamycin_3\JJ\0 (r_amod) cardiotoxicity_4\NN\0
D004317_D066126 CID adriamycin_4\NNS\0 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_amod) cardiotoxic_1\JJ\0
8386779
D010208_D007172 NONE papaverine_25\NN\3800001 (r_appos) drugs_21\NNS\14778436 (r_pobj) of_19\IN\0 (r_prep) combination_18\NN\7951464 (r_pobj) of_16\IN\0 (r_prep) ml._15\NN\0 (r_dobj) received_13\VBD\2210855 (l_nsubj) total_1\NN\3553 (l_prep) of_2\IN\0 (l_pobj) patients_5\NNS\9898892 (l_relcl) presented_7\VBD\2137132 (l_prep) with_11\IN\0 (l_pobj) impotence_12\NN\4723816
D017693_D007172 NONE bicarbonate_1\NN\14798450 (r_nsubj) alleviates_2\VBZ\205885 (l_advcl) induced_5\VBN\1627355 (l_agent) by_6\IN\0 (l_pobj) injections_8\NNS\320852 (l_prep) for_9\IN\0 (l_pobj) dysfunction_11\NN\14204950
D017693_D004414 NONE bicarbonate_1\NN\14798450 (r_nsubj) alleviates_2\VBZ\205885 (l_dobj) pain_4\NN\14299637
D017693_D004414 NONE bicarbonate_43\NN\14798450 (r_pobj) of_41\IN\0 (r_prep) addition_40\NN\3081021 (r_pobj) without_38\IN\0 (r_conj) with_36\IN\0 (r_prep) injections_35\NNS\320852 (r_pobj) following_33\VBG\8180190 (r_prep) comparing_27\VBG\635850 (r_acl) study_26\NN\635850 (r_dobj) performed_23\VBD\0 (l_prep) in_0\IN\13603305 (l_pobj) attempt_2\NN\407535 (l_acl) determine_4\VB\0 (l_ccomp) be_13\VB\14625458 (l_nsubj) pain_7\NN\14299637
D017693_D004414 NONE bicarbonate_43\NN\14798450 (r_pobj) of_41\IN\0 (r_prep) addition_40\NN\3081021 (r_pobj) without_38\IN\0 (r_conj) with_36\IN\0 (r_prep) injections_35\NNS\320852 (r_pobj) following_33\VBG\8180190 (r_prep) comparing_27\VBG\635850 (l_dobj) incidence_29\NN\13821570 (l_prep) of_30\IN\0 (l_pobj) pain_32\NN\14299637
D017693_D004414 NONE bicarbonate_6\NN\14798450 (r_pobj) without_4\IN\0 (r_prep) patients_3\NNS\9898892 (r_pobj) of_0\IN\0 (r_prep) complained_16\VBD\0 (l_prep) of_17\IN\0 (l_pobj) pain_19\NN\14299637
D017693_D004414 NONE bicarbonate_6\NN\14798450 (r_pobj) without_4\IN\0 (r_prep) patients_3\NNS\9898892 (r_pobj) of_0\IN\0 (r_prep) complained_16\VBD\0 (l_advcl) complained_40\VBD\0 (l_prep) of_41\IN\0 (l_pobj) pain_43\NN\14299637
D017693_D004414 NONE bicarbonate_39\NN\14798450 (r_dobj) received_37\VBD\2210855 (r_relcl) men_31\NNS\8208016 (r_pobj) of_28\IN\0 (r_prep) 1_27\CD\13741022 (r_nsubj) complained_40\VBD\0 (r_advcl) complained_16\VBD\0 (l_prep) of_17\IN\0 (l_pobj) pain_19\NN\14299637
D017693_D004414 NONE bicarbonate_39\NN\14798450 (r_dobj) received_37\VBD\2210855 (r_relcl) men_31\NNS\8208016 (r_pobj) of_28\IN\0 (r_prep) 1_27\CD\13741022 (r_nsubj) complained_40\VBD\0 (l_prep) of_41\IN\0 (l_pobj) pain_43\NN\14299637
11569530
C063968_D016171 NONE e4031_19\NNP\0 (r_conj) cisapride_17\NN\0 (r_conj) terodiline_15\NN\0 (r_conj) terfenadine_13\NN\0 (r_appos) investigated_11\VBN\644583 (l_nsubjpass) tdp_9\NNP\0
D020117_D016171 CID cisapride_17\NN\0 (r_conj) terodiline_15\NN\0 (r_conj) terfenadine_13\NN\0 (r_appos) investigated_11\VBN\644583 (l_nsubjpass) tdp_9\NNP\0
D020117_D016171 CID cisapride_14\JJ\0 (r_conj) terodiline_12\NN\0 (r_conj) terfenadine_10\NN\0 (r_appos) clinic_8\NN\8053905 (r_pobj) in_6\IN\13603305 (r_prep) shown_4\VBN\2137132 (l_dobj) tdp_5\NNP\0
D016593_D016171 CID terfenadine_19\NN\0 (r_appos) market_16\NN\407535 (r_pobj) from_14\IN\0 (r_prep) withdrawal_10\NN\7206096 (r_pobj) to_9\IN\0 (r_prep) led_8\VBN\3202760 (r_relcl) effect_5\NN\34213 (r_attr) is_1\VBZ\0 (l_nsubj) tdp_0\NNP\0
D016593_D016171 CID terfenadine_13\NN\0 (r_appos) investigated_11\VBN\644583 (l_nsubjpass) tdp_9\NNP\0
D016593_D016171 CID terfenadine_10\NN\0 (r_appos) clinic_8\NN\8053905 (r_pobj) in_6\IN\13603305 (r_prep) shown_4\VBN\2137132 (l_dobj) tdp_5\NNP\0
C010637_D016171 CID terodiline_21\NN\0 (r_conj) terfenadine_19\NN\0 (r_appos) market_16\NN\407535 (r_pobj) from_14\IN\0 (r_prep) withdrawal_10\NN\7206096 (r_pobj) to_9\IN\0 (r_prep) led_8\VBN\3202760 (r_relcl) effect_5\NN\34213 (r_attr) is_1\VBZ\0 (l_nsubj) tdp_0\NNP\0
C010637_D016171 CID terodiline_15\NN\0 (r_conj) terfenadine_13\NN\0 (r_appos) investigated_11\VBN\644583 (l_nsubjpass) tdp_9\NNP\0
C010637_D016171 CID terodiline_12\NN\0 (r_conj) terfenadine_10\NN\0 (r_appos) clinic_8\NN\8053905 (r_pobj) in_6\IN\13603305 (r_prep) shown_4\VBN\2137132 (l_dobj) tdp_5\NNP\0
6308277
D010433_D012640 CID pentylenetetrezol_30\NN\0 (r_pobj) of_29\IN\0 (r_prep) dose_28\NN\3740161 (r_dobj) alter_25\VB\0 (r_conj) modify_15\VB\109660 (l_dobj) seizures_17\NNS\14081375
D000082_D064420 NONE acetaminophen_5\NN\2707683 (r_pobj) by_4\IN\0 (r_prep) reduction_0\NN\351485 (l_prep) in_1\IN\13603305 (l_pobj) toxicity_3\NN\13576101
D000082_D064420 NONE acetaminophen_26\NN\2707683 (r_pobj) of_25\IN\0 (r_prep) presence_24\NN\13954253 (r_nsubj) reduced_33\VBD\441445 (l_dobj) toxicity_36\NN\13576101
D002110_D012640 CID caffeine_23\NN\14712692 (r_pobj) of_22\IN\0 (r_prep) administration_21\NN\1133281 (l_conj) onset_33\NN\7325190 (l_prep) of_34\IN\0 (l_pobj) convulsions_36\NNS\14081375
D002110_D012640 CID caffeine_23\NN\14712692 (r_pobj) of_22\IN\0 (r_prep) administration_21\NN\1133281 (r_pobj) between_19\IN\0 (r_prep) interval_18\NN\33615 (r_dobj) increased_16\VBD\169651 (l_conj) reduced_54\VBD\441445 (l_dobj) incidence_56\NN\13821570 (l_prep) of_57\IN\0 (l_pobj) seizures_59\NNS\14081375
D002110_D012640 CID caffeine_65\NN\14712692 (r_pobj) of_64\IN\0 (r_prep) presence_63\NN\13954253 (r_pobj) in_61\IN\13603305 (r_prep) produced_60\VBN\1617192 (r_acl) seizures_59\NNS\14081375 (r_pobj) of_57\IN\0 (r_prep) incidence_56\NN\13821570 (r_dobj) reduced_54\VBD\441445 (r_conj) increased_16\VBD\169651 (l_dobj) interval_18\NN\33615 (l_prep) between_19\IN\0 (l_pobj) administration_21\NN\1133281 (l_conj) onset_33\NN\7325190 (l_prep) of_34\IN\0 (l_pobj) convulsions_36\NNS\14081375
D002110_D012640 CID caffeine_65\NN\14712692 (r_pobj) of_64\IN\0 (r_prep) presence_63\NN\13954253 (r_pobj) in_61\IN\13603305 (r_prep) produced_60\VBN\1617192 (r_acl) seizures_59\NNS\14081375
D002110_D012640 CID caffeine_12\NN\14712692 (r_pobj) after_7\IN\0 (r_prep) frequency_1\NN\15286249 (l_prep) of_2\IN\0 (l_pobj) seizures_6\NNS\14081375
D002110_D012640 CID caffeine_4\NN\14712692 (r_pobj) of_3\IN\0 (r_prep) absence_2\NN\14449405 (r_pobj) in_0\IN\13603305 (r_prep) modify_15\VB\109660 (l_dobj) seizures_17\NNS\14081375
D002110_D064420 NONE caffeine_2\NN\14712692 (r_compound) toxicity_3\NN\13576101
D002110_D064420 NONE caffeine_11\NN\14712692 (r_pobj) of_10\IN\0 (r_prep) effects_9\NNS\13245626 (r_dobj) augment_6\VB\153263 (r_xcomp) reported_4\VBN\831651 (r_advcl) focused_18\VBN\628491 (l_prep) on_19\IN\0 (l_pobj) possibility_21\NN\5944958 (l_acl) reduced_33\VBD\441445 (l_dobj) toxicity_36\NN\13576101
D002110_D064420 NONE caffeine_38\NN\14712692 (r_pobj) of_37\IN\0 (r_prep) toxicity_36\NN\13576101
D000082_D012640 NONE acetaminophen_11\NN\2707683 (r_pobj) with_10\IN\0 (r_prep) pretreatment_9\NN\0 (r_nsubj) increased_16\VBD\169651 (l_dobj) interval_18\NN\33615 (l_prep) between_19\IN\0 (l_pobj) administration_21\NN\1133281 (l_conj) onset_33\NN\7325190 (l_prep) of_34\IN\0 (l_pobj) convulsions_36\NNS\14081375
D000082_D012640 NONE acetaminophen_11\NN\2707683 (r_pobj) with_10\IN\0 (r_prep) pretreatment_9\NN\0 (r_nsubj) increased_16\VBD\169651 (l_conj) reduced_54\VBD\441445 (l_dobj) incidence_56\NN\13821570 (l_prep) of_57\IN\0 (l_pobj) seizures_59\NNS\14081375
D000082_D012640 NONE acetaminophen_49\NN\2707683 (r_pobj) with_48\IN\0 (r_prep) pretreatment_47\NN\0 (r_conj) onset_33\NN\7325190 (l_prep) of_34\IN\0 (l_pobj) convulsions_36\NNS\14081375
D000082_D012640 NONE acetaminophen_49\NN\2707683 (r_pobj) with_48\IN\0 (r_prep) pretreatment_47\NN\0 (r_conj) onset_33\NN\7325190 (r_conj) administration_21\NN\1133281 (r_pobj) between_19\IN\0 (r_prep) interval_18\NN\33615 (r_dobj) increased_16\VBD\169651 (l_conj) reduced_54\VBD\441445 (l_dobj) incidence_56\NN\13821570 (l_prep) of_57\IN\0 (l_pobj) seizures_59\NNS\14081375
D000082_D012640 NONE acetaminophen_21\NN\2707683 (r_pobj) by_20\IN\0 (r_agent) reduced_14\VBN\441445 (l_nsubjpass) frequency_1\NN\15286249 (l_prep) of_2\IN\0 (l_pobj) seizures_6\NNS\14081375
D000082_D012640 NONE acetaminophen_6\FW\2707683 (r_nsubj) modify_15\VB\109660 (l_dobj) seizures_17\NNS\14081375
16574712
D018817_D003072 CID mdma_0\NN\3054098 (r_compound) users_2\NNS\7846 (r_nsubj) show_3\VBP\429048 (l_dobj) impairments_9\NNS\7296428 (l_acl) coupled_10\VBN\1295275 (l_prep) with_11\IN\0 (l_pobj) processes_17\NNS\407535
D018817_D008569 NONE mdma_12\NNP\3054098 (r_pobj) of_11\IN\0 (r_prep) users_10\NNS\7846 (r_pobj) in_9\IN\13603305 (r_prep) reported_8\VBN\831651 (l_nsubjpass) deficits_5\NNS\5113133
D018817_D008569 NONE 3,4-methylenedioxymethamphetamine_14\CD\0 (r_intj) mdma_12\NNP\3054098 (r_pobj) of_11\IN\0 (r_prep) users_10\NNS\7846 (r_pobj) in_9\IN\13603305 (r_prep) reported_8\VBN\831651 (l_nsubjpass) deficits_5\NNS\5113133
D018817_D008569 NONE ecstasy_16\NN\13985818 (r_appos) mdma_12\NNP\3054098 (r_pobj) of_11\IN\0 (r_prep) users_10\NNS\7846 (r_pobj) in_9\IN\13603305 (r_prep) reported_8\VBN\831651 (l_nsubjpass) deficits_5\NNS\5113133
6773726
D005996_D003920 NONE nitroglycerin_3\NN\15015501 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) compared_12\VBN\644583 (l_prep) in_13\IN\13603305 (l_pobj) subjects_16\NNS\6598915 (l_appos) subjects_20\NNS\6598915 (l_amod) diabetic_19\JJ\10595647
D005996_D003920 NONE nitroglycerin_3\NN\15015501 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) compared_12\VBN\644583 (l_prep) in_13\IN\13603305 (l_pobj) subjects_16\NNS\6598915 (l_appos) subjects_20\NNS\6598915 (l_conj) subjects_28\NNS\6598915 (l_amod) diabetic_27\JJ\10595647
D005996_D003920 NONE nitroglycerin_19\NN\15015501 (r_pobj) after_18\IN\0 (r_prep) decrease_13\NN\7296428 (r_conj) increase_7\NN\13576355 (r_pobj) of_5\IN\0 (r_prep) course_4\NN\883297 (r_nsubj) were_20\VBD\0 (l_acomp) similar_21\JJ\0 (l_prep) in_22\IN\13603305 (l_pobj) subjects_27\NNS\6598915 (l_amod) normal_24\JJ\5667196 (l_conj) diabetic_26\JJ\10595647
D005996_D003920 NONE nitroglycerin_19\NN\15015501 (r_pobj) after_18\IN\0 (r_prep) decrease_13\NN\7296428 (r_conj) increase_7\NN\13576355 (r_pobj) of_5\IN\0 (r_prep) course_4\NN\883297 (r_nsubj) were_20\VBD\0 (l_advcl) occurred_47\VBD\0 (l_prep) in_48\IN\13603305 (l_pobj) subjects_51\NNS\6598915 (l_amod) diabetic_50\JJ\10595647
D005996_D009422 NONE nitroglycerin_3\NN\15015501 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) compared_12\VBN\644583 (l_prep) in_13\IN\13603305 (l_pobj) subjects_16\NNS\6598915 (l_appos) subjects_20\NNS\6598915 (l_prep) without_21\IN\0 (l_pobj) neuropathy_23\NN\14204950
D005996_D009422 NONE nitroglycerin_3\NN\15015501 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) compared_12\VBN\644583 (l_prep) in_13\IN\13603305 (l_pobj) subjects_16\NNS\6598915 (l_appos) subjects_20\NNS\6598915 (l_conj) subjects_28\NNS\6598915 (l_prep) with_29\IN\0 (l_pobj) neuropathy_31\NN\14204950
D005996_D009422 NONE nitroglycerin_19\NN\15015501 (r_pobj) after_18\IN\0 (r_prep) decrease_13\NN\7296428 (r_conj) increase_7\NN\13576355 (r_pobj) of_5\IN\0 (r_prep) course_4\NN\883297 (r_nsubj) were_20\VBD\0 (l_acomp) similar_21\JJ\0 (l_prep) in_22\IN\13603305 (l_pobj) subjects_27\NNS\6598915 (l_prep) without_28\IN\0 (l_pobj) neuropathy_30\NN\14204950
D005996_D009422 NONE nitroglycerin_19\NN\15015501 (r_pobj) after_18\IN\0 (r_prep) decrease_13\NN\7296428 (r_conj) increase_7\NN\13576355 (r_pobj) of_5\IN\0 (r_prep) course_4\NN\883297 (r_nsubj) were_20\VBD\0 (l_advcl) occurred_47\VBD\0 (l_prep) in_48\IN\13603305 (l_pobj) subjects_51\NNS\6598915 (l_prep) with_52\IN\0 (l_pobj) neuropathy_54\NN\14204950
D005996_D007022 CID nitroglycerin_5\NN\15015501 (r_pobj) by_4\IN\0 (r_prep) hypotension_3\NN\14057371
D005996_D003929 NONE nitroglycerin_5\NN\15015501 (l_prep) in_6\IN\13603305 (l_pobj) neuropathy_9\NN\14204950
15130900
D003520_D001749 CID cyclophosphamide_12\NN\0 (r_pobj) to_11\IN\0 (r_prep) risks_8\NNS\14541044 (r_appos) granulomatosis_6\NN\0 (r_pobj) in_3\IN\13603305 (r_prep) cancer_2\NN\14239425
D003520_D001749 CID cyclophosphamide_16\NN\0 (r_pobj) to_15\IN\0 (r_prep) relation_14\NN\2137 (r_conj) assess_3\VB\5220461 (l_conj) characterise_5\VB\651991 (l_dobj) risk_7\NN\14541044 (l_prep) of_8\IN\0 (l_pobj) cancer_10\NN\14239425
D003520_D001749 CID cyclophosphamide_18\NN\0 (l_conj) cancer_21\NN\14239425
D003520_D001749 CID cyclophosphamide_12\NN\0 (r_pobj) in_11\IN\13603305 (r_prep) increment_10\NN\29677 (r_pobj) for_6\IN\0 (r_prep) doubled_5\VBD\247390 (l_nsubj) risk_1\NN\14541044 (l_prep) of_2\IN\0 (l_pobj) cancer_4\NN\14239425
D003520_D001749 CID cyclophosphamide_9\NN\0 (r_pobj) between_8\IN\0 (r_prep) relationship_7\NN\31921 (l_conj) risk_12\NN\14541044 (l_prep) of_13\IN\0 (l_pobj) cancer_15\NN\14239425
D003520_D014890 NONE cyclophosphamide_12\NN\0 (r_pobj) to_11\IN\0 (r_prep) risks_8\NNS\14541044 (r_appos) granulomatosis_6\NN\0
D003520_D014890 NONE cyclophosphamide_16\NN\0 (r_pobj) to_15\IN\0 (r_prep) relation_14\NN\2137 (l_prep) in_18\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_prep) with_20\IN\0 (l_pobj) granulomatosis_23\NN\0
D003520_D014890 NONE cyclophosphamide_9\NN\0 (r_pobj) between_8\IN\0 (r_prep) relationship_7\NN\31921 (l_conj) risk_12\NN\14541044 (l_conj) risks_19\NNS\14541044 (l_conj) possibility_28\NN\5944958 (l_prep) of_29\IN\0 (l_pobj) factors_31\NNS\7326557 (l_acl) operating_32\VBG\2439501 (l_prep) before_34\IN\0 (l_pobj) granulomatosis_37\NN\0
150790
D007538_D001523 NONE isoniazid_22\NN\2716205 (r_pobj) of_21\IN\0 (r_prep) administration_20\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) sleeping_15\VBG\14024882 (r_conj) irritability_12\NN\7552087
D011736_D002653 NONE pyridoxine_1\JJ\15090742 (r_advmod) dependent_3\JJ\9627906 (r_amod) disorder_5\NN\14034177
D007538_D012893 NONE isoniazid_22\NN\2716205 (r_pobj) of_21\IN\0 (r_prep) administration_20\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) sleeping_15\VBG\14024882 (l_dobj) difficulties_16\NNS\621627
D011736_D006948 NONE pyridoxine_3\NN\15090742 (r_pobj) of_2\IN\0 (r_prep) withdrawal_1\NN\7206096 (r_nsubjpass) associated_5\VBN\628491 (l_prep) with_6\IN\0 (l_pobj) return_7\NN\6479665 (l_prep) of_8\IN\0 (l_pobj) hyperkinesis_10\NN\0
D007538_D006948 CID isoniazid_22\NN\2716205 (r_pobj) of_21\IN\0 (r_prep) administration_20\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) sleeping_15\VBG\14024882 (r_conj) irritability_12\NN\7552087 (r_conj) hyperkinesis_10\NN\0
D007538_D002653 CID isoniazid_8\NN\2716205 (r_pobj) by_7\IN\0 (r_agent) unmasked_6\VBD\853195 (r_acl) disorder_5\NN\14034177
D007538_D002653 CID isoniazid_22\NN\2716205 (r_pobj) of_21\IN\0 (r_prep) administration_20\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) sleeping_15\VBG\14024882 (r_conj) irritability_12\NN\7552087 (r_conj) hyperkinesis_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) had_5\VBD\0 (l_dobj) deterioration_7\NN\14560612
3719553
D011241_D004342 NONE prednisone_3\NNP\2721538 (r_conj) diphenhydramine_1\NN\2720725 (r_nsubj) were_4\VBD\0 (l_prep) in_6\IN\13603305 (l_pcomp) preventing_7\VBG\0 (l_dobj) recurrence_9\NN\7342049 (l_prep) of_10\IN\0 (l_pobj) reaction_13\NN\13446390
D005472_D007674 NONE 5-fluorouracil_11\CD\0 (r_punct) reaction_2\NN\13446390 (r_nsubj) occurred_12\VBD\0 (l_prep) in_13\IN\13603305 (l_pobj) patient_15\NN\9898892 (l_prep) with_16\IN\0 (l_pobj) carcinoma_18\NN\14239918 (l_prep) of_19\IN\0 (l_pobj) cavity_22\NN\9304750 (l_conj) cirrhosis_24\NN\14116321 (l_conj) function_32\NN\13783581
D005472_D005355 NONE 5-fluorouracil_11\CD\0 (r_punct) reaction_2\NN\13446390 (r_nsubj) occurred_12\VBD\0 (l_prep) in_13\IN\13603305 (l_pobj) patient_15\NN\9898892 (l_prep) with_16\IN\0 (l_pobj) carcinoma_18\NN\14239918 (l_prep) of_19\IN\0 (l_pobj) cavity_22\NN\9304750 (l_conj) cirrhosis_24\NN\14116321
D005472_D000799 CID 5-fluorouracil_11\CD\0 (r_punct) reaction_2\NN\13446390 (l_acl) consisting_3\VBG\2603699 (l_prep) of_4\IN\0 (l_pobj) edema_6\NN\14315192
D005472_D009062 NONE 5-fluorouracil_11\CD\0 (r_punct) reaction_2\NN\13446390 (r_nsubj) occurred_12\VBD\0 (l_prep) in_13\IN\13603305 (l_pobj) patient_15\NN\9898892 (l_prep) with_16\IN\0 (l_pobj) carcinoma_18\NN\14239918 (l_prep) of_19\IN\0 (l_pobj) cavity_22\NN\9304750
D005472_D004342 NONE 5-fluorouracil_3\CD\0 (r_punct) infusion_4\NN\14589223 (r_pobj) to_2\IN\0 (r_prep) reaction_1\NN\13446390
D005472_D004342 NONE 5-fluorouracil_11\CD\0 (r_punct) reaction_2\NN\13446390
D002945_D005355 NONE cisplatin_27\NN\0 (r_advmod) induced_29\VBN\1627355 (r_amod) function_32\NN\13783581 (r_conj) cirrhosis_24\NN\14116321
D002945_D009062 NONE cisplatin_27\NN\0 (r_advmod) induced_29\VBN\1627355 (r_amod) function_32\NN\13783581 (r_conj) cirrhosis_24\NN\14116321 (r_conj) cavity_22\NN\9304750
D002945_D004342 NONE cisplatin_27\NN\0 (r_advmod) induced_29\VBN\1627355 (r_amod) function_32\NN\13783581 (r_conj) cirrhosis_24\NN\14116321 (r_conj) cavity_22\NN\9304750 (r_pobj) of_19\IN\0 (r_prep) carcinoma_18\NN\14239918 (r_pobj) with_16\IN\0 (r_prep) patient_15\NN\9898892 (r_pobj) in_13\IN\13603305 (r_prep) occurred_12\VBD\0 (l_nsubj) reaction_2\NN\13446390
D002945_D000799 NONE cisplatin_27\NN\0 (r_advmod) induced_29\VBN\1627355 (r_amod) function_32\NN\13783581 (r_conj) cirrhosis_24\NN\14116321 (r_conj) cavity_22\NN\9304750 (r_pobj) of_19\IN\0 (r_prep) carcinoma_18\NN\14239918 (r_pobj) with_16\IN\0 (r_prep) patient_15\NN\9898892 (r_pobj) in_13\IN\13603305 (r_prep) occurred_12\VBD\0 (l_nsubj) reaction_2\NN\13446390 (l_acl) consisting_3\VBG\2603699 (l_prep) of_4\IN\0 (l_pobj) edema_6\NN\14315192
D004155_D004342 NONE diphenhydramine_1\NN\2720725 (r_nsubj) were_4\VBD\0 (l_prep) in_6\IN\13603305 (l_pcomp) preventing_7\VBG\0 (l_dobj) recurrence_9\NN\7342049 (l_prep) of_10\IN\0 (l_pobj) reaction_13\NN\13446390
D002945_D007674 NONE cisplatin_27\NN\0 (r_advmod) induced_29\VBN\1627355 (r_amod) function_32\NN\13783581
12090760
D015215_D000740 CID azidothymidine_9\RB\0 (r_advmod) induced_11\VBN\1627355 (r_amod) anemia_12\NN\14189204
D015215_D000740 CID azidothymidine_0\NNP\0 (r_nsubjpass) reversed_8\VBN\109660 (l_nsubjpass) anemia_3\NN\14189204
D015215_D000740 CID azt)-induced_2\VBN\0 (r_compound) anemia_3\NN\14189204
15120741
D010862_D012640 CID pilocarpine_5\NN\14712692 (r_compound) injection_6\NN\320852 (r_nsubj) causes_7\VBZ\7323922 (l_dobj) se_11\NNP\14724645 (l_conj) development_16\NN\248977 (l_prep) of_17\IN\0 (l_pobj) seizures_19\NNS\14081375
D001640_D013226 NONE bicuculline_5\NN\0 (r_pobj) in_0\IN\13603305 (r_prep) resulted_21\VBD\2633881 (l_prep) in_22\IN\13603305 (l_pobj) spike_26\NN\7307895 (l_relcl) experience_41\VB\5984287 (l_dobj) se_42\NNP\14724645
D008274_D013226 NONE mg(2+)-free_1\JJ\0 (r_pobj) in_0\IN\13603305 (r_prep) resulted_21\VBD\2633881 (l_prep) in_22\IN\13603305 (l_pobj) spike_26\NN\7307895 (l_relcl) experience_41\VB\5984287 (l_dobj) se_42\NNP\14724645
D010862_D013226 CID pilocarpine_5\NN\14712692 (r_compound) injection_6\NN\320852 (r_nsubj) causes_7\VBZ\7323922 (l_dobj) se_11\NNP\14724645 (l_nmod) epilepticus_9\NN\0
D010862_D013226 CID pilocarpine_5\NN\14712692 (r_compound) injection_6\NN\320852 (r_nsubj) causes_7\VBZ\7323922 (l_dobj) se_11\NNP\14724645
D010862_D013226 CID pilocarpine_34\NN\14712692 (r_npadvmod) treated_36\VBN\2376958 (r_amod) mice_37\NNS\2329401 (r_conj) mice_32\NNS\2329401 (r_pobj) from_30\IN\0 (r_prep) cells_29\NNS\3080309 (r_pobj) in_27\IN\13603305 (r_prep) spike_26\NN\7307895 (l_relcl) experience_41\VB\5984287 (l_dobj) se_42\NNP\14724645
D018698_D013226 NONE glutamate_37\NN\15010703 (r_compound) receptor_38\NN\5225602 (r_compound) antagonists_39\NNS\7846 (r_pobj) by_35\IN\0 (r_agent) blocked_34\VBN\1476483 (r_relcl) duration_30\NN\15113229 (r_pobj) of_25\IN\0 (r_prep) afterdischarges_24\NNS\0 (r_conj) shifts_21\NNS\7446404 (r_pobj) by_18\IN\0 (r_prep) followed_11\VBD\1835496 (r_advcl) resulted_6\VBD\2633881 (l_prep) in_0\IN\13603305 (l_pobj) survivors_2\NNS\9630641 (l_compound) se_1\NNP\14724645
D018698_D013226 NONE glutamate_1\NN\15010703 (r_compound) photostimulation_2\NN\0 (r_nsubj) resulted_15\VBD\2633881 (l_prep) in_16\IN\13603305 (l_pobj) responses_18\NNS\11410625 (l_prep) of_19\IN\0 (l_pobj) duration_24\NN\15113229 (l_prep) in_25\IN\13603305 (l_pobj) slices_26\NNS\13285176 (l_prep) from_27\IN\0 (l_pobj) survivors_29\NNS\9630641 (l_compound) se_28\NNP\14724645
14765563
D011803_D003128 CID quinine_7\NN\2721948 (r_dobj) containing_6\VBG\2632940 (r_acl) products_5\NNS\3076708 (r_nsubj) produce_9\VB\7555863 (l_dobj) status_18\NN\24720 (l_conj) seizures_20\NNS\14081375 (l_conj) coma_23\NN\5678932
D011803_D012640 CID quinine_7\NN\2721948 (r_dobj) containing_6\VBG\2632940 (r_acl) products_5\NNS\3076708 (r_nsubj) produce_9\VB\7555863 (l_dobj) status_18\NN\24720 (l_conj) seizures_20\NNS\14081375
D011803_D002493 NONE quinine_7\NN\2721948 (r_dobj) containing_6\VBG\2632940 (r_acl) products_5\NNS\3076708 (r_nsubj) produce_9\VB\7555863 (l_dobj) complications_11\NNS\1073995
D011803_D020922 NONE quinine_23\NN\2721948 (r_nsubj) is_24\VBZ\0 (l_advcl) banned_8\VBD\2480923 (l_dobj) use_10\NN\407535 (l_prep) for_11\IN\0 (l_pobj) cramps_14\NNS\14299637
D011803_D003221 CID quinine_7\NN\2721948 (r_dobj) containing_6\VBG\2632940 (r_acl) products_5\NNS\3076708 (r_nsubj) produce_9\VB\7555863 (l_dobj) complications_11\NNS\1073995 (l_prep) including_13\VBG\0 (l_pobj) confusion_14\NN\13972797
10835440
D009553_D007022 CID nimodipine_2\NNP\0 (r_compound) trial_6\NN\786195 (r_nsubj) found_10\VBD\13279262 (l_dobj) correlation_12\NN\13841213 (l_prep) between_13\IN\0 (l_pobj) reduction_17\NN\351485 (l_prep) in_18\IN\13603305 (l_pobj) pressure_20\NN\11419404
D009553_D007022 CID nimodipine_14\NN\0 (r_npadvmod) induced_16\VBN\1627355 (r_amod) reduction_17\NN\351485 (l_prep) in_18\IN\13603305 (l_pobj) pressure_20\NN\11419404
D009553_D007022 CID nimodipine_0\NNP\0 (r_compound) treatment_1\NN\654885 (r_nsubj) resulted_2\VBD\2633881 (l_prep) in_3\IN\13603305 (l_pobj) reduction_7\NN\351485 (l_prep) in_8\IN\13603305 (l_pobj) bp_10\NNP\0
D009553_D002544 NONE nimodipine_34\NN\0 (r_parataxis) h_28\NN\14622893 (r_appos) receive_19\VB\2210855 (r_advcl) allocated_17\VBN\2228698 (l_nsubjpass) methods_0\NNS\5616786 (l_appos) patients_2\NNS\9898892 (l_prep) with_3\IN\0 (l_pobj) diagnosis_6\NN\152018 (l_prep) of_7\IN\0 (l_pobj) stroke_9\NN\556313
D009553_D002544 NONE nimodipine_49\NN\0 (r_conj) nimodipine_34\NN\0 (r_parataxis) h_28\NN\14622893 (r_appos) receive_19\VB\2210855 (r_advcl) allocated_17\VBN\2228698 (l_nsubjpass) methods_0\NNS\5616786 (l_appos) patients_2\NNS\9898892 (l_prep) with_3\IN\0 (l_pobj) diagnosis_6\NN\152018 (l_prep) of_7\IN\0 (l_pobj) stroke_9\NN\556313
D009553_D020521 NONE nimodipine_3\NN\0 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (l_prep) after_9\IN\0 (l_pobj) stroke_11\NN\556313
D009553_D020521 NONE nimodipine_2\NNP\0 (r_compound) trial_6\NN\786195 (l_compound) stroke_5\NNP\556313
D009553_D020521 NONE nimodipine_2\NNP\0 (r_compound) trial_6\NN\786195 (r_nsubj) found_10\VBD\13279262 (l_dobj) correlation_12\NN\13841213 (l_prep) between_13\IN\0 (l_pobj) reduction_17\NN\351485 (l_conj) outcome_27\NN\7291312 (l_prep) in_28\IN\13603305 (l_pobj) stroke_30\NN\556313
D009553_D020521 NONE nimodipine_14\NN\0 (r_npadvmod) induced_16\VBN\1627355 (r_amod) reduction_17\NN\351485 (r_pobj) between_13\IN\0 (r_prep) correlation_12\NN\13841213 (r_dobj) found_10\VBD\13279262 (l_nsubj) trial_6\NN\786195 (l_compound) stroke_5\NNP\556313
D009553_D020521 NONE nimodipine_14\NN\0 (r_npadvmod) induced_16\VBN\1627355 (r_amod) reduction_17\NN\351485 (l_conj) outcome_27\NN\7291312 (l_prep) in_28\IN\13603305 (l_pobj) stroke_30\NN\556313
D009553_D020521 NONE nimodipine_15\NN\0 (r_pobj) of_11\IN\0 (r_prep) administration_10\NN\1133281 (r_pobj) after_7\IN\0 (r_prep) worsening_6\VBG\13457378 (l_prep) after_16\IN\0 (l_pobj) stroke_18\NN\556313
18464113
D006514_D006509 CID antigen_14\NN\20090 (r_nmod) patients_20\NNS\9898892 (r_pobj) in_9\IN\13603305 (r_prep) reactivation_8\NN\0 (l_compound) virus_7\NN\9312843 (l_compound) b_6\NNP\1355326
D006514_D006509 CID hbsag_16\NNP\0 (r_nmod) patients_20\NNS\9898892 (r_pobj) in_9\IN\13603305 (r_prep) reactivation_8\NN\0 (l_compound) virus_7\NN\9312843 (l_compound) b_6\NNP\1355326
D019259_D056486 NONE lamivudine_3\NN\3834836 (r_compound) group_4\NN\2137 (r_pobj) in_0\IN\13603305 (r_prep) observed_8\VBN\2163746 (l_nsubjpass) hepatitis_6\NN\14127211
D006514_D009369 NONE antigen_14\NN\20090 (r_nmod) patients_20\NNS\9898892 (l_compound) cancer_19\NN\14239425
D006514_D009369 NONE hbsag_16\NNP\0 (r_nmod) patients_20\NNS\9898892 (l_compound) cancer_19\NN\14239425
D019259_D006509 NONE lamivudine_0\NNP\3834836 (l_prep) for_1\IN\0 (l_pobj) prevention_3\NN\1073995 (l_prep) of_4\IN\0 (l_pobj) reactivation_8\NN\0 (l_compound) virus_7\NN\9312843 (l_compound) b_6\NNP\1355326
D019259_D006509 NONE lamivudine_20\NN\3834836 (r_dobj) received_16\VBD\2210855 (l_nsubj) patients_5\NNS\9898892 (l_relcl) have_7\VBP\7846 (l_dobj) malignancies_11\NNS\14070360 (l_prep) with_12\IN\0 (l_pobj) infection_15\NN\14052046
D019259_D006509 NONE lamivudine_34\NN\3834836 (r_dobj) receive_33\VB\2210855 (r_relcl) group_29\NN\2137 (r_pobj) with_26\IN\0 (r_prep) compared_25\VBN\644583 (r_prep) received_16\VBD\2210855 (l_nsubj) patients_5\NNS\9898892 (l_relcl) have_7\VBP\7846 (l_dobj) malignancies_11\NNS\14070360 (l_prep) with_12\IN\0 (l_pobj) infection_15\NN\14052046
D019259_D019337 NONE lamivudine_20\NN\3834836 (r_dobj) received_16\VBD\2210855 (l_nsubj) patients_5\NNS\9898892 (l_relcl) have_7\VBP\7846 (l_dobj) malignancies_11\NNS\14070360
D019259_D019337 NONE lamivudine_34\NN\3834836 (r_dobj) receive_33\VB\2210855 (r_relcl) group_29\NN\2137 (r_pobj) with_26\IN\0 (r_prep) compared_25\VBN\644583 (r_prep) received_16\VBD\2210855 (l_nsubj) patients_5\NNS\9898892 (l_relcl) have_7\VBP\7846 (l_dobj) malignancies_11\NNS\14070360
D019259_D009369 NONE lamivudine_0\NNP\3834836 (l_prep) for_1\IN\0 (l_pobj) prevention_3\NN\1073995 (l_prep) of_4\IN\0 (l_pobj) reactivation_8\NN\0 (l_prep) in_9\IN\13603305 (l_pobj) patients_20\NNS\9898892 (l_compound) cancer_19\NN\14239425
D019259_D009369 NONE lamivudine_20\NN\3834836 (r_dobj) received_16\VBD\2210855 (l_nsubj) patients_5\NNS\9898892 (l_compound) cancer_4\NN\14239425
D019259_D009369 NONE lamivudine_34\NN\3834836 (r_dobj) receive_33\VB\2210855 (r_relcl) group_29\NN\2137 (r_pobj) with_26\IN\0 (r_prep) compared_25\VBN\644583 (r_prep) received_16\VBD\2210855 (l_nsubj) patients_5\NNS\9898892 (l_compound) cancer_4\NN\14239425
D019259_D009369 NONE lamivudine_5\NN\3834836 (r_nsubj) decreases_7\VBZ\7296428 (l_dobj) incidence_9\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) reactivation_12\NN\0 (l_conj) morbidity_15\NN\13826959 (l_prep) in_16\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_compound) cancer_17\NN\14239425
2924746
D005481_D015430 NONE hfde_21\NNP\0 (r_npadvmod) induced_23\VBN\1627355 (r_amod) seizures_24\NNS\14081375 (r_pobj) against_20\IN\0 (r_prep) protective_19\JJ\0 (r_acomp) was_17\VBD\0 (l_conj) was_26\VBD\0 (l_advcl) measured_30\VBN\697589 (l_agent) by_31\IN\0 (l_pobj) gain_33\NN\13576355
D005481_D012640 CID ether_4\NN\14840755 (r_pobj) by_2\IN\0 (r_prep) induced_1\VBN\1627355 (l_nsubj) seizures_0\NNS\14081375
D005481_D012640 CID ether_4\NN\14840755 (r_pobj) by_2\IN\0 (r_prep) induced_1\VBN\1627355 (l_conj) found_10\VBN\13279262 (l_xcomp) be_12\VB\14625458 (l_prep) than_21\IN\0 (l_pobj) seizures_22\NNS\14081375
D005481_D012640 CID hfde_6\NNP\0 (r_appos) ether_4\NN\14840755 (r_pobj) by_2\IN\0 (r_prep) induced_1\VBN\1627355 (l_nsubj) seizures_0\NNS\14081375
D005481_D012640 CID hfde_6\NNP\0 (r_appos) ether_4\NN\14840755 (r_pobj) by_2\IN\0 (r_prep) induced_1\VBN\1627355 (l_conj) found_10\VBN\13279262 (l_xcomp) be_12\VB\14625458 (l_prep) than_21\IN\0 (l_pobj) seizures_22\NNS\14081375
D005481_D012640 CID hfde_21\NNP\0 (r_npadvmod) induced_23\VBN\1627355 (r_amod) seizures_24\NNS\14081375
D002220_D015430 NONE cbz_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) was_17\VBD\0 (l_conj) was_26\VBD\0 (l_advcl) measured_30\VBN\697589 (l_agent) by_31\IN\0 (l_pobj) gain_33\NN\13576355
D002220_D012640 NONE cbz_20\NN\0 (r_pobj) by_19\IN\0 (r_prep) protection_18\NN\407535 (r_pobj) of_17\IN\0 (r_prep) measure_16\NN\168237 (r_attr) be_12\VB\14625458 (r_xcomp) found_10\VBN\13279262 (r_conj) induced_1\VBN\1627355 (l_nsubj) seizures_0\NNS\14081375
D002220_D012640 NONE cbz_20\NN\0 (r_pobj) by_19\IN\0 (r_prep) protection_18\NN\407535 (r_pobj) of_17\IN\0 (r_prep) measure_16\NN\168237 (r_attr) be_12\VB\14625458 (l_prep) than_21\IN\0 (l_pobj) seizures_22\NNS\14081375
D002220_D012640 NONE cbz_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) was_17\VBD\0 (l_acomp) protective_19\JJ\0 (l_prep) against_20\IN\0 (l_pobj) seizures_24\NNS\14081375
D005492_D064420 NONE folate_17\JJ\15090742 (r_compound) concentrations_18\NNS\4916342 (r_conj) plasma_14\NN\5398023 (r_pobj) on_13\IN\0 (r_prep) effect_12\NN\34213 (r_conj) toxicity_9\NN\13576101
D019946_D015430 NONE glycol_13\NN\14766364 (r_appos) vehicle_10\NN\3100490 (r_nsubjpass) found_22\VBN\13279262 (l_xcomp) exhibit_24\VB\6733939 (l_dobj) properties_26\NNS\32613 (l_prep) against_27\IN\0 (l_pobj) seizures_29\NNS\14081375 (l_conj) gain_33\NN\13576355
D019946_D012640 NONE glycol_13\NN\14766364 (r_appos) vehicle_10\NN\3100490 (r_nsubjpass) found_22\VBN\13279262 (l_xcomp) exhibit_24\VB\6733939 (l_dobj) properties_26\NNS\32613 (l_prep) against_27\IN\0 (l_pobj) seizures_29\NNS\14081375
D002220_D064420 NONE carbamazepine_1\NN\0 (r_compound) treatment_2\NN\654885 (l_appos) efficacy_7\NN\5199286 (l_conj) toxicity_9\NN\13576101
2224762
C027260_D009369 NONE 4'-0-tetrahydropyranyladriamycin_10\NNP\0 (r_dobj) bolus_9\NN\13899404 (r_appos) phase_1\NN\15113229 (r_nsubjpass) done_15\VBN\0 (l_prep) in_16\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) in_19\IN\13603305 (l_pobj) status_22\NN\24720 (l_prep) with_23\IN\0 (l_pobj) tumors_25\NNS\14234074
C027260_D009369 NONE pirarubicin_12\NNP\0 (r_appos) 4'-0-tetrahydropyranyladriamycin_10\NNP\0 (r_dobj) bolus_9\NN\13899404 (r_appos) phase_1\NN\15113229 (r_nsubjpass) done_15\VBN\0 (l_prep) in_16\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) in_19\IN\13603305 (l_pobj) status_22\NN\24720 (l_prep) with_23\IN\0 (l_pobj) tumors_25\NNS\14234074
10721819
D004294_D001919 CID domperidone_26\NN\0 (r_pobj) by_24\IN\0 (r_agent) reduced_23\VBN\441445 (r_relcl) effect_19\NN\34213 (r_npadvmod) reversed_13\VBN\109660 (l_prep) to_14\IN\0 (l_pobj) bradycardia_16\NNS\14110674
D001971_D007022 CID bromocriptine_5\NN\0 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hypotension_14\NN\14057371
D001971_D007022 CID bromocriptine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hypotension_3\NN\14057371
D007545_D007022 NONE isoproterenol_7\JJ\3740161 (r_compound) pretreatment_8\NN\0 (r_pobj) by_6\IN\0 (r_prep) unaffected_5\JJ\0 (r_acomp) was_4\VBD\0 (l_nsubj) hypotension_3\NN\14057371
D004298_D013610 NONE dopamine_27\NN\14807737 (r_compound) d2_28\NN\0 (r_compound) receptors_29\NNS\5225602 (r_pobj) at_25\IN\14622893 (r_prep) bradycardia_21\NN\14110674 (r_dobj) mask_19\VB\3122748 (r_conj) predominate_16\VB\0 (r_xcomp) appears_14\VBZ\2604760 (l_nsubj) tachycardia_11\NN\14110674
D007545_D006332 CID isoproterenol_0\JJ\3740161 (r_compound) pretreatment_1\NN\0 (r_nsubj) caused_5\VBD\1617192 (l_dobj) hypertrophy_7\NN\14365950
D007545_D001919 CID isoproterenol_7\JJ\3740161 (r_compound) pretreatment_8\NN\0 (r_pobj) by_6\IN\0 (r_prep) unaffected_5\JJ\0 (r_acomp) was_4\VBD\0 (l_advcl) reversed_13\VBN\109660 (l_prep) to_14\IN\0 (l_pobj) bradycardia_16\NNS\14110674
D007545_D001919 CID isoproterenol_5\JJ\3740161 (r_compound) pretreatment_6\NN\0 (r_nsubj) abolished_9\VBD\0 (l_conj) reversed_11\VBD\109660 (l_prep) to_16\IN\0 (l_pobj) bradycardia_17\NNP\14110674
D001971_D013610 CID bromocriptine_9\NN\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) tachycardia_12\NN\14110674
D001971_D013610 CID bromocriptine_5\NN\0 (r_npadvmod) induced_7\VBN\1627355 (r_amod) tachycardia_8\NN\14110674
D001971_D013610 CID bromocriptine_13\NN\0 (r_npadvmod) induced_15\VBN\1627355 (r_amod) tachycardia_16\NN\14110674
D001971_D013610 CID bromocriptine_5\NN\0 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hypotension_14\NN\14057371 (l_conj) tachycardia_16\NN\14110674
D001971_D013610 CID bromocriptine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hypotension_3\NN\14057371 (r_nsubj) was_4\VBD\0 (l_advcl) reversed_13\VBN\109660 (l_nsubjpass) tachycardia_11\NN\14110674
D001971_D013610 CID bromocriptine_12\NN\0 (r_npadvmod) induced_14\VBN\1627355 (r_amod) tachycardia_15\NN\14110674
D001971_D013610 CID bromocriptine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) tachycardia_11\NN\14110674
D001971_D001919 NONE bromocriptine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hypotension_3\NN\14057371 (r_nsubj) was_4\VBD\0 (l_advcl) reversed_13\VBN\109660 (l_prep) to_14\IN\0 (l_pobj) bradycardia_16\NNS\14110674
D001971_D001919 NONE bromocriptine_12\NN\0 (r_npadvmod) induced_14\VBN\1627355 (r_amod) tachycardia_15\NN\14110674 (r_dobj) reversed_11\VBD\109660 (l_prep) to_16\IN\0 (l_pobj) bradycardia_17\NNP\14110674
D001971_D001919 NONE bromocriptine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) tachycardia_11\NN\14110674 (r_nsubj) appears_14\VBZ\2604760 (l_xcomp) predominate_16\VB\0 (l_conj) mask_19\VB\3122748 (l_dobj) bradycardia_21\NN\14110674
D004294_D007022 NONE domperidone_26\NN\0 (r_pobj) by_24\IN\0 (r_agent) reduced_23\VBN\441445 (r_relcl) effect_19\NN\34213 (r_npadvmod) reversed_13\VBN\109660 (r_advcl) was_4\VBD\0 (l_nsubj) hypotension_3\NN\14057371
D004298_D001919 NONE dopamine_27\NN\14807737 (r_compound) d2_28\NN\0 (r_compound) receptors_29\NNS\5225602 (r_pobj) at_25\IN\14622893 (r_prep) bradycardia_21\NN\14110674
D007545_D013610 NONE isoproterenol_7\NN\3740161 (l_prep) on_8\IN\0 (l_pobj) tachycardia_12\NN\14110674
D007545_D013610 NONE isoproterenol_10\NN\3740161 (r_pobj) with_9\IN\0 (r_prep) pretreatment_8\NN\0 (r_nsubj) abolish_12\VB\0 (l_dobj) tachycardia_16\NN\14110674
D007545_D013610 NONE isoproterenol_7\JJ\3740161 (r_compound) pretreatment_8\NN\0 (r_pobj) by_6\IN\0 (r_prep) unaffected_5\JJ\0 (r_acomp) was_4\VBD\0 (l_advcl) reversed_13\VBN\109660 (l_nsubjpass) tachycardia_11\NN\14110674
D007545_D013610 NONE isoproterenol_5\JJ\3740161 (r_compound) pretreatment_6\NN\0 (r_nsubj) abolished_9\VBD\0 (l_conj) reversed_11\VBD\109660 (l_dobj) tachycardia_15\NN\14110674
D004294_D013610 NONE domperidone_26\NN\0 (r_pobj) by_24\IN\0 (r_agent) reduced_23\VBN\441445 (r_relcl) effect_19\NN\34213 (r_npadvmod) reversed_13\VBN\109660 (l_nsubjpass) tachycardia_11\NN\14110674
18754075
D019386_D005923 NONE alendronate_10\JJ\3740161 (r_nmod) administration_12\NN\1133281 (l_prep) in_13\IN\13603305 (l_pobj) patient_15\NN\9898892 (l_prep) with_16\IN\0 (l_pobj) glomerulosclerosis_19\NN\0
D019386_D011507 CID alendronate_10\JJ\3740161 (r_nmod) administration_12\NN\1133281 (r_pobj) after_6\IN\0 (r_prep) proteinuria_1\NN\14299637
D013256_D009404 NONE steroid_19\NN\14727670 (r_compound) therapy_20\NN\657604 (r_pobj) to_18\IN\0 (r_prep) responding_16\VBG\2367363 (l_nsubj) man_5\NN\9605289 (l_prep) with_6\IN\0 (l_pobj) syndrome_8\NN\5870365
D004164_D011507 NONE bisphosphonate_8\NN\0 (r_nmod) administration_12\NN\1133281 (r_pobj) after_6\IN\0 (r_prep) proteinuria_1\NN\14299637
D004164_D011507 NONE bisphosphonates_11\NNS\0 (r_nsubj) aggravate_13\VB\126264 (l_dobj) proteinuria_14\NN\14299637
D019386_D058186 CID alendronate_10\JJ\3740161 (r_nmod) administration_12\NN\1133281 (r_pobj) after_6\IN\0 (r_prep) proteinuria_1\NN\14299637 (l_conj) failure_5\NN\66216
D019386_D058186 CID sodium_9\NN\14625458 (r_nmod) administration_11\NN\1133281 (r_nsubj) increased_19\VBD\169651 (l_prep) with_25\IN\0 (l_pobj) failure_28\NN\66216
D004164_D058186 NONE bisphosphonate_8\NN\0 (r_nmod) administration_12\NN\1133281 (r_pobj) after_6\IN\0 (r_prep) proteinuria_1\NN\14299637 (l_conj) failure_5\NN\66216
D004164_D058186 NONE bisphosphonate_6\NN\0 (r_pobj) of_3\IN\0 (r_prep) days_2\NNS\15140892 (r_pobj) within_0\IN\0 (r_prep) increased_19\VBD\169651 (l_prep) with_25\IN\0 (l_pobj) failure_28\NN\66216
D004164_D058186 NONE bisphosphonates_11\NNS\0 (r_nsubj) aggravate_13\VB\126264 (l_dobj) proteinuria_14\NN\14299637 (l_conj) failure_18\NN\66216
D013256_D005923 NONE steroid_19\NN\14727670 (r_compound) therapy_20\NN\657604 (r_pobj) to_18\IN\0 (r_prep) responding_16\VBG\2367363 (l_nsubj) man_5\NN\9605289 (l_amod) due_9\IN\5174653 (l_pobj) glomerulosclerosis_13\NN\0
D004164_D005923 NONE bisphosphonate_8\NN\0 (r_nmod) administration_12\NN\1133281 (l_prep) in_13\IN\13603305 (l_pobj) patient_15\NN\9898892 (l_prep) with_16\IN\0 (l_pobj) glomerulosclerosis_19\NN\0
6747681
D002330_D005910 NONE bcnu_3\NNP\0 (r_compound) chemotherapy_4\NN\661091 (l_prep) for_5\IN\0 (l_pobj) treatment_6\NN\654885 (l_prep) of_7\IN\0 (l_pobj) gliomas_9\NNS\14236743
D002330_D005910 NONE bcnu_7\NNP\0 (r_nmod) 1,3-bis-(2-chloroethyl)-1-nitrosourea_9\NN\0 (r_pobj) of_6\IN\0 (r_prep) clearance_5\NN\5089947 (r_pobj) because_0\IN\0 (r_prep) provide_17\VB\2199590 (l_dobj) advantage_20\NN\5154517 (l_prep) over_21\IN\5867413 (l_pobj) administration_23\NN\1133281 (l_prep) for_24\IN\0 (l_pobj) treatment_26\NN\654885 (l_prep) of_27\IN\0 (l_pobj) gliomas_29\NNS\14236743
D002330_D005910 NONE 1,3-bis-(2-chloroethyl)-1-nitrosourea_9\NN\0 (r_pobj) of_6\IN\0 (r_prep) clearance_5\NN\5089947 (r_pobj) because_0\IN\0 (r_prep) provide_17\VB\2199590 (l_dobj) advantage_20\NN\5154517 (l_prep) over_21\IN\5867413 (l_pobj) administration_23\NN\1133281 (l_prep) for_24\IN\0 (l_pobj) treatment_26\NN\654885 (l_prep) of_27\IN\0 (l_pobj) gliomas_29\NNS\14236743
D000431_D014786 NONE ethanol_11\NN\14708720 (r_compound) diluent_12\NN\14778436 (r_pobj) of_9\IN\0 (r_prep) concentration_8\NN\4916342 (r_nsubjpass) lowered_14\VBN\1850315 (r_advcl) decreased_5\VBD\169651 (l_nsubj) frequency_1\NN\15286249 (l_prep) of_2\IN\0 (l_pobj) loss_4\NN\13252973
D002330_D001254 NONE bcnu_29\NNP\0 (r_compound) therapy_30\NN\657604 (r_pobj) of_25\IN\0 (r_prep) courses_24\NNS\883297 (r_dobj) received_20\VBD\2210855 (l_nsubj) patients_3\NNS\9898892 (l_prep) to_8\IN\0 (l_pobj) astrocytomas_10\NN\0
2522601
D002220_D051437 CID carbamazepine_2\NN\0 (r_pobj) to_1\IN\0 (r_prep) hypersensitivity_0\NN\14531772 (l_acl) presenting_3\VBG\2137132 (l_prep) with_4\IN\0 (l_pobj) reaction_7\NN\13446390 (l_conj) failure_15\NN\66216
D002220_D051437 CID carbamazepine_8\NN\0 (r_pobj) to_7\IN\0 (r_prep) hypersensitivity_6\NN\14531772 (r_nsubj) presented_9\VBN\2137132 (r_relcl) patient_3\NN\9898892 (l_conj) reaction_17\NN\13446390 (l_conj) eosinophilia_19\NN\14299637 (l_conj) hyponatremia_21\NN\14299637 (l_conj) failure_25\NN\66216
D002220_D004802 NONE carbamazepine_2\NN\0 (r_pobj) to_1\IN\0 (r_prep) hypersensitivity_0\NN\14531772 (l_acl) presenting_3\VBG\2137132 (l_prep) with_4\IN\0 (l_pobj) reaction_7\NN\13446390 (l_conj) eosinophilia_9\NN\14299637
D002220_D004802 NONE carbamazepine_8\NN\0 (r_pobj) to_7\IN\0 (r_prep) hypersensitivity_6\NN\14531772 (r_nsubj) presented_9\VBN\2137132 (r_relcl) patient_3\NN\9898892 (l_conj) reaction_17\NN\13446390 (l_conj) eosinophilia_19\NN\14299637
D002220_D004342 CID carbamazepine_2\NN\0 (r_pobj) to_1\IN\0 (r_prep) hypersensitivity_0\NN\14531772
D002220_D004342 CID carbamazepine_8\NN\0 (r_pobj) to_7\IN\0 (r_prep) hypersensitivity_6\NN\14531772
D002220_D007955 CID carbamazepine_2\NN\0 (r_pobj) to_1\IN\0 (r_prep) hypersensitivity_0\NN\14531772 (l_acl) presenting_3\VBG\2137132 (l_prep) with_4\IN\0 (l_pobj) reaction_7\NN\13446390
D002220_D007955 CID carbamazepine_8\NN\0 (r_pobj) to_7\IN\0 (r_prep) hypersensitivity_6\NN\14531772 (r_nsubj) presented_9\VBN\2137132 (r_relcl) patient_3\NN\9898892 (l_conj) reaction_17\NN\13446390
D002220_D007010 CID carbamazepine_8\NN\0 (r_pobj) to_7\IN\0 (r_prep) hypersensitivity_6\NN\14531772 (r_nsubj) presented_9\VBN\2137132 (r_relcl) patient_3\NN\9898892 (l_conj) reaction_17\NN\13446390 (l_conj) eosinophilia_19\NN\14299637 (l_conj) hyponatremia_21\NN\14299637
D002220_D003873 CID carbamazepine_2\NN\0 (r_pobj) to_1\IN\0 (r_prep) hypersensitivity_0\NN\14531772 (l_acl) presenting_3\VBG\2137132 (l_prep) with_4\IN\0 (l_pobj) reaction_7\NN\13446390 (l_conj) eosinophilia_9\NN\14299637 (l_conj) erythroderma_11\NN\14219661
D002220_D003873 CID carbamazepine_8\NN\0 (r_pobj) to_7\IN\0 (r_prep) hypersensitivity_6\NN\14531772 (r_nsubj) presented_9\VBN\2137132 (l_prep) with_10\IN\0 (l_pobj) erythroderma_12\NN\14219661
11426838
C050232_D064420 NONE tolylguanidine_22\NN\0 (r_nmod) dtg_24\NNP\0 (r_appos) antagonists_9\NNS\7846 (r_pobj) by_6\IN\0 (r_agent) provided_5\VBN\2199590 (r_acl) protection_4\NN\407535 (r_pobj) to_2\IN\0 (r_prep) contrast_1\NN\13854649 (r_pobj) in_0\IN\13603305 (r_prep) worsened_37\VBD\146138 (l_dobj) toxicity_40\NN\13576101
C050232_D064420 NONE dtg_24\NNP\0 (r_appos) antagonists_9\NNS\7846 (r_pobj) by_6\IN\0 (r_agent) provided_5\VBN\2199590 (r_acl) protection_4\NN\407535 (r_pobj) to_2\IN\0 (r_prep) contrast_1\NN\13854649 (r_pobj) in_0\IN\13603305 (r_prep) worsened_37\VBD\146138 (l_dobj) toxicity_40\NN\13576101
D003042_D064420 NONE cocaine_42\NN\3492717 (r_pobj) of_41\IN\0 (r_prep) toxicity_40\NN\13576101
C093337_D012640 NONE bd1063_12\NNP\0 (r_conj) bd1018_10\NN\0 (r_pobj) with_9\IN\0 (r_punct) attenuated_17\VBD\224901 (r_amod) convulsions_21\NNS\14081375
D009838_D012640 NONE oligodeoxynucleotide_23\NN\0 (r_appos) receptors_19\NNS\5225602 (r_pobj) of_17\IN\0 (r_prep) antagonism_16\NN\24720 (r_dobj) involved_15\VBD\2676054 (r_acl) ligands_14\NNS\20090 (r_pobj) of_11\IN\0 (r_prep) effects_10\NNS\13245626 (r_nsubjpass) shown_29\VBN\2137132 (l_xcomp) attenuate_32\VB\224901 (l_dobj) effects_38\NNS\13245626 (l_amod) convulsive_34\JJ\0
-1_D012640 NONE bd1018_10\NN\0 (r_pobj) with_9\IN\0 (r_punct) attenuated_17\VBD\224901 (r_amod) convulsions_21\NNS\14081375
-1_D012640 NONE lr132_15\NNS\0 (r_conj) bd1063_12\NNP\0 (r_conj) bd1018_10\NN\0 (r_pobj) with_9\IN\0 (r_punct) attenuated_17\VBD\224901 (r_amod) convulsions_21\NNS\14081375
D003042_D012640 CID cocaine_18\NN\3492717 (r_npadvmod) induced_20\VBN\1627355 (r_amod) convulsions_21\NNS\14081375
D003042_D012640 CID cocaine_9\NN\3492717 (r_compound) effects_10\NNS\13245626 (r_nsubjpass) shown_29\VBN\2137132 (l_xcomp) attenuate_32\VB\224901 (l_dobj) effects_38\NNS\13245626 (l_amod) convulsive_34\JJ\0
D003042_D012640 CID cocaine_40\NN\3492717 (r_pobj) of_39\IN\0 (r_prep) effects_38\NNS\13245626 (l_amod) convulsive_34\JJ\0
-1_D064420 NONE bd1031_32\NN\0 (r_conj) dtg_24\NNP\0 (r_appos) antagonists_9\NNS\7846 (r_pobj) by_6\IN\0 (r_agent) provided_5\VBN\2199590 (r_acl) protection_4\NN\407535 (r_pobj) to_2\IN\0 (r_prep) contrast_1\NN\13854649 (r_pobj) in_0\IN\13603305 (r_prep) worsened_37\VBD\146138 (l_dobj) toxicity_40\NN\13576101
-1_D064420 NONE 3r-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane_34\NN\0 (r_appos) bd1031_32\NN\0 (r_conj) dtg_24\NNP\0 (r_appos) antagonists_9\NNS\7846 (r_pobj) by_6\IN\0 (r_agent) provided_5\VBN\2199590 (r_acl) protection_4\NN\407535 (r_pobj) to_2\IN\0 (r_prep) contrast_1\NN\13854649 (r_pobj) in_0\IN\13603305 (r_prep) worsened_37\VBD\146138 (l_dobj) toxicity_40\NN\13576101
19957053
D004809_D002534 NONE ephedrine_3\JJ\14712692 (r_conj) phenylephrine_0\NNP\2682038 (r_nsubj) reduces_4\VBZ\441445 (l_dobj) oxygenation_7\NN\13518963
D004809_D007022 NONE ephedrine_3\JJ\14712692 (r_conj) phenylephrine_0\NNP\2682038 (r_nsubj) reduces_4\VBZ\441445 (l_dobj) oxygenation_7\NN\13518963 (l_prep) following_8\VBG\8180190 (l_dobj) hypotension_12\NN\14057371
D004809_D007022 NONE ephedrine_7\JJ\14712692 (r_conj) phenylephrine_5\NN\2682038 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_dobj) describe_1\VBP\1001294 (l_prep) following_16\VBG\8180190 (l_dobj) hypotension_20\NN\14057371
D004809_D007022 NONE ephedrine_18\JJ\14712692 (r_nsubj) maintains_19\VBZ\0 (r_advcl) has_10\VBZ\13888491 (l_nsubj) utilization_1\NN\407535 (l_acl) correct_5\VB\138508 (l_dobj) hypotension_6\NN\14057371
D010656_D007022 NONE phenylephrine_0\NNP\2682038 (r_nsubj) reduces_4\VBZ\441445 (l_dobj) oxygenation_7\NN\13518963 (l_prep) following_8\VBG\8180190 (l_dobj) hypotension_12\NN\14057371
D010656_D007022 NONE phenylephrine_5\NN\2682038 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_dobj) describe_1\VBP\1001294 (l_prep) following_16\VBG\8180190 (l_dobj) hypotension_20\NN\14057371
D010656_D007022 NONE phenylephrine_3\NN\2682038 (r_pobj) of_2\IN\0 (r_prep) utilization_1\NN\407535 (l_acl) correct_5\VB\138508 (l_dobj) hypotension_6\NN\14057371
D010656_D002534 CID phenylephrine_0\NNP\2682038 (r_nsubj) reduces_4\VBZ\441445 (l_dobj) oxygenation_7\NN\13518963
12684739
D004298_D019966 NONE dopamine_47\NN\14807737 (r_appos) accumbens_43\NNS\0 (r_oprd) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025
D004298_D019966 NONE da_49\NNP\10484858 (r_appos) dopamine_47\NN\14807737 (r_appos) accumbens_43\NNS\0 (r_oprd) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025
D003042_D005128 NONE cocaine_37\NN\3492717 (r_npadvmod) induced_39\VBN\1627355 (r_amod) increases_40\NNS\13576355 (r_pobj) on_36\IN\0 (r_prep) gvg_35\NNP\0 (r_pobj) of_29\IN\0 (r_prep) effects_28\NNS\13245626 (r_dobj) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025 (l_conj) risk_11\NN\14541044 (l_prep) of_12\IN\0 (l_pobj) defects_15\NNS\14462666
D003042_D005128 NONE cocaine_37\NN\3492717 (r_npadvmod) induced_39\VBN\1627355 (r_amod) increases_40\NNS\13576355 (r_pobj) on_36\IN\0 (r_prep) gvg_35\NNP\0 (r_pobj) of_29\IN\0 (r_prep) effects_28\NNS\13245626 (r_dobj) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025 (l_conj) risk_11\NN\14541044 (l_prep) of_12\IN\0 (l_pobj) defects_15\NNS\14462666 (l_appos) vfd_17\NNP\0
D004298_D005128 NONE dopamine_47\NN\14807737 (r_appos) accumbens_43\NNS\0 (r_oprd) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025 (l_conj) risk_11\NN\14541044 (l_prep) of_12\IN\0 (l_pobj) defects_15\NNS\14462666
D004298_D005128 NONE dopamine_47\NN\14807737 (r_appos) accumbens_43\NNS\0 (r_oprd) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025 (l_conj) risk_11\NN\14541044 (l_prep) of_12\IN\0 (l_pobj) defects_15\NNS\14462666 (l_appos) vfd_17\NNP\0
D004298_D005128 NONE da_49\NNP\10484858 (r_appos) dopamine_47\NN\14807737 (r_appos) accumbens_43\NNS\0 (r_oprd) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025 (l_conj) risk_11\NN\14541044 (l_prep) of_12\IN\0 (l_pobj) defects_15\NNS\14462666
D004298_D005128 NONE da_49\NNP\10484858 (r_appos) dopamine_47\NN\14807737 (r_appos) accumbens_43\NNS\0 (r_oprd) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025 (l_conj) risk_11\NN\14541044 (l_prep) of_12\IN\0 (l_pobj) defects_15\NNS\14462666 (l_appos) vfd_17\NNP\0
D020888_D005128 CID gvg_35\NNP\0 (r_pobj) of_29\IN\0 (r_prep) effects_28\NNS\13245626 (r_dobj) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025 (l_conj) risk_11\NN\14541044 (l_prep) of_12\IN\0 (l_pobj) defects_15\NNS\14462666
D020888_D005128 CID gvg_35\NNP\0 (r_pobj) of_29\IN\0 (r_prep) effects_28\NNS\13245626 (r_dobj) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025 (l_conj) risk_11\NN\14541044 (l_prep) of_12\IN\0 (l_pobj) defects_15\NNS\14462666 (l_appos) vfd_17\NNP\0
D020888_D019966 NONE gvg_35\NNP\0 (r_pobj) of_29\IN\0 (r_prep) effects_28\NNS\13245626 (r_dobj) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025
D003042_D019966 NONE cocaine_37\NN\3492717 (r_npadvmod) induced_39\VBN\1627355 (r_amod) increases_40\NNS\13576355 (r_pobj) on_36\IN\0 (r_prep) gvg_35\NNP\0 (r_pobj) of_29\IN\0 (r_prep) effects_28\NNS\13245626 (r_dobj) explored_26\VBD\789138 (l_prep) given_0\VBN\5892096 (l_pobj) success_3\NN\7283608 (l_prep) for_4\IN\0 (l_pcomp) treating_5\VBG\2376958 (l_dobj) abuse_7\NN\418025
17919553
C106791_D064420 NONE telithromycin_15\NNS\0 (r_nsubj) was_16\VBD\0 (l_prep) based_0\VBN\0 (l_prep) on_1\IN\0 (l_pobj) score_3\NN\5736149 (l_prep) on_6\IN\0 (l_pobj) scale_13\NN\7260623 (l_compound) probability_12\NN\33615 (l_compound) reaction_11\NN\13446390
C106791_D056486 CID telithromycin_6\NNS\0 (r_relcl) exposure_4\NN\5042871 (r_pobj) after_3\IN\0 (r_prep) attack_2\NN\955060 (l_compound) hepatitis_1\NNP\14127211
C106791_D056486 CID telithromycin_19\NNS\0 (r_compound) usage_20\NN\407535 (r_pobj) after_18\IN\0 (r_prep) occurred_17\VBD\0 (l_ccomp) suffered_3\VBN\2110220 (l_dobj) episode_6\NN\7283608 (l_prep) of_7\IN\0 (l_pobj) hepatitis_10\NN\14127211
C106791_D056486 CID telithromycin_15\NNS\0 (r_nsubj) was_16\VBD\0 (l_attr) cause_19\NN\7323922 (l_prep) of_20\IN\0 (l_pobj) hepatitis_22\NN\14127211
C106791_D056486 CID telithromycin_15\NNS\0 (r_nsubj) was_16\VBD\0 (l_conj) suggested_30\VBD\1010118 (l_dobj) hepatitis_35\NN\14127211
C106791_D056486 CID telithromycin_21\NNS\0 (r_dobj) prescribed_20\VBD\748282 (r_relcl) physician_18\NN\10305802 (r_pobj) to_15\IN\0 (r_prep) communicated_14\VBN\2231661 (r_advcl) avoided_7\VBN\0 (l_nsubjpass) recurrence_0\NN\7342049 (l_prep) of_1\IN\0 (l_pobj) attack_3\NN\955060 (l_compound) hepatitis_2\NN\14127211
C106791_D056486 CID telithromycin_14\NNS\0 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) case_4\NN\7283608 (l_prep) of_5\IN\0 (l_pobj) hepatitis_7\NN\14127211
7248170
D010634_D005355 NONE phenobarbitone_0\NNP\2792049 (r_npadvmod) induced_2\VBN\1627355 (r_amod) enlargement_3\NN\363260 (l_appos) relationship_12\NN\31921 (l_prep) to_13\TO\0 (l_pobj) cirrhosis_18\NN\14116321
D010634_D008103 CID phenobarbitone_60\NN\2792049 (r_npadvmod) primed_62\VBN\406243 (r_amod) rat_63\NN\2329401 (r_pobj) in_58\IN\13603305 (r_prep) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_nsubj) yield_1\NN\913705 (l_prep) of_2\IN\0 (l_pobj) cirrhosis_4\NN\14116321 (l_prep) of_5\IN\0 (l_pobj) liver_7\NN\5298729
D010634_D008103 CID phenobarbitone_88\NN\2792049 (r_npadvmod) induced_90\VBN\1627355 (r_amod) enlargement_91\NN\363260 (r_pobj) of_86\IN\0 (r_prep) peak_85\NN\13758296 (r_pobj) at_83\IN\14622893 (r_prep) giving_73\VBG\1085793 (r_pcomp) by_72\IN\0 (r_prep) increased_65\VBN\169651 (r_conj) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_nsubj) yield_1\NN\913705 (l_prep) of_2\IN\0 (l_pobj) cirrhosis_4\NN\14116321 (l_prep) of_5\IN\0 (l_pobj) liver_7\NN\5298729
D002251_D013163 NONE tetrachloride_55\NN\14818238 (r_advmod) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_conj) albumin_27\NN\14736972 (l_conj) splenomegaly_35\JJ\14366759
D002251_D013163 NONE tetrachloride_82\NN\14818238 (r_advmod) calibrating_77\VBG\296178 (r_dative) giving_73\VBG\1085793 (r_pcomp) by_72\IN\0 (r_prep) increased_65\VBN\169651 (r_conj) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_conj) albumin_27\NN\14736972 (l_conj) splenomegaly_35\JJ\14366759
D010634_D001201 NONE phenobarbitone_60\NN\2792049 (r_npadvmod) primed_62\VBN\406243 (r_amod) rat_63\NN\2329401 (r_pobj) in_58\IN\13603305 (r_prep) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950
D010634_D001201 NONE phenobarbitone_88\NN\2792049 (r_npadvmod) induced_90\VBN\1627355 (r_amod) enlargement_91\NN\363260 (r_pobj) of_86\IN\0 (r_prep) peak_85\NN\13758296 (r_pobj) at_83\IN\14622893 (r_prep) giving_73\VBG\1085793 (r_pcomp) by_72\IN\0 (r_prep) increased_65\VBN\169651 (r_conj) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950
D002251_D008103 CID tetrachloride_55\NN\14818238 (r_advmod) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_nsubj) yield_1\NN\913705 (l_prep) of_2\IN\0 (l_pobj) cirrhosis_4\NN\14116321 (l_prep) of_5\IN\0 (l_pobj) liver_7\NN\5298729
D002251_D008103 CID tetrachloride_82\NN\14818238 (r_advmod) calibrating_77\VBG\296178 (r_dative) giving_73\VBG\1085793 (r_pcomp) by_72\IN\0 (r_prep) increased_65\VBN\169651 (r_conj) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_nsubj) yield_1\NN\913705 (l_prep) of_2\IN\0 (l_pobj) cirrhosis_4\NN\14116321 (l_prep) of_5\IN\0 (l_pobj) liver_7\NN\5298729
D010634_D006529 CID phenobarbitone_0\NNP\2792049 (r_npadvmod) induced_2\VBN\1627355 (r_amod) enlargement_3\NN\363260 (l_prep) of_4\IN\0 (l_pobj) liver_6\NN\5298729
D010634_D006529 CID phenobarbitone_60\NN\2792049 (r_npadvmod) primed_62\VBN\406243 (r_amod) rat_63\NN\2329401 (r_pobj) in_58\IN\13603305 (r_prep) given_56\VBN\5892096 (l_conj) increased_65\VBN\169651 (l_prep) by_72\IN\0 (l_pcomp) giving_73\VBG\1085793 (l_prep) at_83\IN\14622893 (l_pobj) peak_85\NN\13758296 (l_prep) of_86\IN\0 (l_pobj) enlargement_91\NN\363260 (l_prep) of_92\IN\0 (l_pobj) liver_94\NN\5298729
D010634_D006529 CID phenobarbitone_88\NN\2792049 (r_npadvmod) induced_90\VBN\1627355 (r_amod) enlargement_91\NN\363260 (l_prep) of_92\IN\0 (l_pobj) liver_94\NN\5298729
D002251_D006529 NONE tetrachloride_15\NN\14818238 (r_advmod) induced_17\VBN\1627355 (r_amod) cirrhosis_18\NN\14116321 (r_pobj) to_13\TO\0 (r_prep) relationship_12\NN\31921 (r_appos) enlargement_3\NN\363260 (l_prep) of_4\IN\0 (l_pobj) liver_6\NN\5298729
D002251_D006529 NONE tetrachloride_55\NN\14818238 (r_advmod) given_56\VBN\5892096 (l_conj) increased_65\VBN\169651 (l_prep) by_72\IN\0 (l_pcomp) giving_73\VBG\1085793 (l_prep) at_83\IN\14622893 (l_pobj) peak_85\NN\13758296 (l_prep) of_86\IN\0 (l_pobj) enlargement_91\NN\363260 (l_prep) of_92\IN\0 (l_pobj) liver_94\NN\5298729
D002251_D006529 NONE tetrachloride_82\NN\14818238 (r_advmod) calibrating_77\VBG\296178 (r_dative) giving_73\VBG\1085793 (l_prep) at_83\IN\14622893 (l_pobj) peak_85\NN\13758296 (l_prep) of_86\IN\0 (l_pobj) enlargement_91\NN\363260 (l_prep) of_92\IN\0 (l_pobj) liver_94\NN\5298729
D010634_D001284 NONE phenobarbitone_60\NN\2792049 (r_npadvmod) primed_62\VBN\406243 (r_amod) rat_63\NN\2329401 (r_pobj) in_58\IN\13603305 (r_prep) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_conj) albumin_27\NN\14736972 (l_conj) splenomegaly_35\JJ\14366759 (l_conj) atrophy_44\NN\14299637
D010634_D001284 NONE phenobarbitone_88\NN\2792049 (r_npadvmod) induced_90\VBN\1627355 (r_amod) enlargement_91\NN\363260 (r_pobj) of_86\IN\0 (r_prep) peak_85\NN\13758296 (r_pobj) at_83\IN\14622893 (r_prep) giving_73\VBG\1085793 (r_pcomp) by_72\IN\0 (r_prep) increased_65\VBN\169651 (r_conj) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_conj) albumin_27\NN\14736972 (l_conj) splenomegaly_35\JJ\14366759 (l_conj) atrophy_44\NN\14299637
D002251_D001201 NONE tetrachloride_55\NN\14818238 (r_advmod) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950
D002251_D001201 NONE tetrachloride_82\NN\14818238 (r_advmod) calibrating_77\VBG\296178 (r_dative) giving_73\VBG\1085793 (r_pcomp) by_72\IN\0 (r_prep) increased_65\VBN\169651 (r_conj) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950
D010634_D013163 NONE phenobarbitone_60\NN\2792049 (r_npadvmod) primed_62\VBN\406243 (r_amod) rat_63\NN\2329401 (r_pobj) in_58\IN\13603305 (r_prep) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_conj) albumin_27\NN\14736972 (l_conj) splenomegaly_35\JJ\14366759
D010634_D013163 NONE phenobarbitone_88\NN\2792049 (r_npadvmod) induced_90\VBN\1627355 (r_amod) enlargement_91\NN\363260 (r_pobj) of_86\IN\0 (r_prep) peak_85\NN\13758296 (r_pobj) at_83\IN\14622893 (r_prep) giving_73\VBG\1085793 (r_pcomp) by_72\IN\0 (r_prep) increased_65\VBN\169651 (r_conj) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_conj) albumin_27\NN\14736972 (l_conj) splenomegaly_35\JJ\14366759
D002251_D005355 NONE tetrachloride_15\NN\14818238 (r_advmod) induced_17\VBN\1627355 (r_amod) cirrhosis_18\NN\14116321
D002251_D001284 NONE tetrachloride_55\NN\14818238 (r_advmod) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_conj) albumin_27\NN\14736972 (l_conj) splenomegaly_35\JJ\14366759 (l_conj) atrophy_44\NN\14299637
D002251_D001284 NONE tetrachloride_82\NN\14818238 (r_advmod) calibrating_77\VBG\296178 (r_dative) giving_73\VBG\1085793 (r_pcomp) by_72\IN\0 (r_prep) increased_65\VBN\169651 (r_conj) given_56\VBN\5892096 (l_nsubj) ascites_20\VBZ\14204950 (l_conj) albumin_27\NN\14736972 (l_conj) splenomegaly_35\JJ\14366759 (l_conj) atrophy_44\NN\14299637
17242861
D010862_D012640 NONE pilocarpine_4\NN\14712692 (r_npadvmod) induced_6\VBN\1627355 (r_amod) seizures_7\NNS\14081375
D010862_D012640 NONE pilocarpine_4\NN\14712692 (r_npadvmod) induced_6\VBN\1627355 (r_amod) seizures_7\NNS\14081375 (r_pobj) to_3\IN\0 (r_prep) susceptibility_2\NN\13920835 (r_pobj) for_1\IN\0 (r_prep) qtls_0\NNS\0 (r_nsubjpass) reported_19\VBN\831651 (l_conj) used_27\VBN\0 (l_xcomp) localize_29\VB\2694933 (l_dobj) genes_32\NNS\8459252 (l_compound) susceptibility_31\NN\13920835 (l_compound) seizure_30\NN\14081375
D010862_D012640 NONE pilocarpine_9\NN\14712692 (r_npadvmod) induced_11\VBN\1627355 (r_amod) seizures_12\NNS\14081375
D010862_D012640 NONE pilocarpine_23\NN\14712692 (r_npadvmod) induced_25\VBN\1627355 (r_amod) seizures_26\NNS\14081375
D010862_D004833 CID pilocarpine_4\NN\14712692 (r_npadvmod) induced_6\VBN\1627355 (r_amod) seizures_7\NNS\14081375 (l_appos) model_10\NN\5888929 (l_prep) of_11\IN\0 (l_pobj) epilepsy_14\NN\14085708
15278670
D004737_D012640 NONE enflurane_12\NN\3299929 (r_conj) sevoflurane_10\NN\0 (r_pobj) between_9\IN\0 (r_prep) threshold_8\NN\15265518 (l_amod) convulsive_7\JJ\0
D004737_D012640 NONE enflurane_14\NN\3299929 (r_conj) sevoflurane_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) concentrations_10\NNS\4916342 (r_nsubjpass) administered_16\VBN\2436349 (l_conj) decreased_23\VBD\169651 (l_nsubj) pressure_20\NN\11419404 (l_prep) at_21\IN\14622893 (l_pobj) convulsions_22\NNS\14081375
D004737_D012640 NONE enflurane_37\NN\3299929 (r_conj) %_33\NN\0 (r_pobj) in_31\IN\13603305 (r_conj) decreased_23\VBD\169651 (l_nsubj) pressure_20\NN\11419404 (l_prep) at_21\IN\14622893 (l_pobj) convulsions_22\NNS\14081375
D008012_D003866 NONE lidocaine_10\JJ\3681148 (r_compound) toxicity_11\NN\13576101 (r_pobj) of_9\IN\0 (r_prep) effect_8\NN\34213 (r_dobj) reduces_5\VBZ\441445 (l_conj) carries_13\VBZ\315986 (l_prep) due_16\IN\5174653 (l_pcomp) to_17\IN\0 (l_pobj) depression_19\NN\14373582
C009250_D064420 NONE sevoflurane_4\NN\0 (r_nsubj) reduces_5\VBZ\441445 (l_dobj) effect_8\NN\34213 (l_prep) of_9\IN\0 (l_pobj) toxicity_11\NN\13576101
C009250_D003866 NONE sevoflurane_4\NN\0 (r_nsubj) reduces_5\VBZ\441445 (l_conj) carries_13\VBZ\315986 (l_prep) due_16\IN\5174653 (l_pcomp) to_17\IN\0 (l_pobj) depression_19\NN\14373582
D008012_D012640 CID lidocaine_5\NN\3681148 (r_npadvmod) induced_7\VBN\1627355 (r_amod) convulsions_8\NNS\14081375
D008012_D012640 CID lidocaine_16\NN\3681148 (r_compound) infusion_17\NN\14589223 (r_pobj) with_15\IN\0 (r_prep) was_8\VBD\0 (l_nsubj) threshold_2\NN\15265518 (l_amod) convulsive_1\JJ\0
D008012_D012640 CID lidocaine_10\JJ\3681148 (r_compound) toxicity_11\NN\13576101 (r_pobj) of_9\IN\0 (r_prep) effect_8\NN\34213 (l_amod) convulsive_7\JJ\0
C009250_D012640 NONE sevoflurane_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) on_4\IN\0 (l_pobj) convulsions_8\NNS\14081375
C009250_D012640 NONE sevoflurane_3\NN\0 (l_prep) on_4\IN\0 (l_pobj) convulsions_8\NNS\14081375
C009250_D012640 NONE sevoflurane_40\NN\0 (r_pobj) of_39\IN\0 (r_prep) concentration_38\NN\4916342 (r_nsubj) was_41\VBD\0 (r_relcl) l(-1_31\NN\0 (r_pobj) to_26\IN\0 (r_prep) increasing_24\VBG\169651 (r_advcl) was_8\VBD\0 (l_nsubj) threshold_2\NN\15265518 (l_amod) convulsive_1\JJ\0
C009250_D012640 NONE sevoflurane_10\NN\0 (r_pobj) between_9\IN\0 (r_prep) threshold_8\NN\15265518 (l_amod) convulsive_7\JJ\0
C009250_D012640 NONE sevoflurane_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) concentrations_10\NNS\4916342 (r_nsubjpass) administered_16\VBN\2436349 (l_conj) decreased_23\VBD\169651 (l_nsubj) pressure_20\NN\11419404 (l_prep) at_21\IN\14622893 (l_pobj) convulsions_22\NNS\14081375
C009250_D012640 NONE sevoflurane_28\NN\0 (r_pobj) in_25\IN\13603305 (r_prep) decreased_23\VBD\169651 (l_nsubj) pressure_20\NN\11419404 (l_prep) at_21\IN\14622893 (l_pobj) convulsions_22\NNS\14081375
C009250_D012640 NONE sevoflurane_4\NN\0 (r_nsubj) reduces_5\VBZ\441445 (l_dobj) effect_8\NN\34213 (l_amod) convulsive_7\JJ\0
D001030_D012640 NONE apamin_0\NNP\0 (r_nsubj) had_5\VBD\0 (l_dobj) tendency_7\NN\6193203 (l_acl) decrease_9\VB\7296428 (l_dobj) threshold_12\NN\15265518 (l_amod) convulsive_11\JJ\0
D008012_D064420 NONE lidocaine_10\JJ\3681148 (r_compound) toxicity_11\NN\13576101
3856631
D001663_D052016 NONE bilirubin_10\NN\14756039 (r_amod) elevations_11\NNS\7445480 (r_conj) transaminase_8\NN\15077571 (l_appos) neutropenia_13\NN\14196405 (l_conj) mucositis_16\NN\0
D008727_D054198 NONE methotrexate_18\NNP\2722166 (r_compound) regimen_19\NN\5898568 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (l_nsubjpass) children_1\NNS\9622049 (l_prep) with_2\IN\0 (l_pobj) leukemia_5\NN\14239918
D008727_D054198 NONE methotrexate_28\NNP\2722166 (r_compound) concentrations_29\NNS\4916342 (r_dobj) maintain_26\VB\0 (r_conj) achieve_24\VB\2524171 (r_xcomp) designed_22\VBN\1631534 (r_relcl) regimen_19\NN\5898568 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (l_nsubjpass) children_1\NNS\9622049 (l_prep) with_2\IN\0 (l_pobj) leukemia_5\NN\14239918
D008727_D054198 NONE methotrexate_4\NN\2722166 (r_nsubj) is_5\VBZ\0 (l_attr) treatment_8\NN\654885 (l_prep) for_9\IN\0 (l_pobj) induction_11\NN\7450842 (l_prep) after_14\IN\0 (l_pobj) relapse_16\NN\66636 (l_prep) in_17\IN\13603305 (l_pobj) leukemia_20\NN\14239918
D001663_D064420 NONE bilirubin_10\NN\14756039 (r_amod) elevations_11\NNS\7445480 (r_conj) transaminase_8\NN\15077571 (r_attr) were_5\VBD\0 (l_nsubj) toxicities_3\NNS\13576101
D008727_D002493 NONE methotrexate_18\NNP\2722166 (r_compound) regimen_19\NN\5898568 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (l_nsubjpass) children_1\NNS\9622049 (l_relcl) developed_7\VBD\1753788 (l_dobj) disease_9\NN\14061805
D008727_D002493 NONE methotrexate_28\NNP\2722166 (r_compound) concentrations_29\NNS\4916342 (r_dobj) maintain_26\VB\0 (r_conj) achieve_24\VB\2524171 (r_xcomp) designed_22\VBN\1631534 (r_relcl) regimen_19\NN\5898568 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (l_nsubjpass) children_1\NNS\9622049 (l_relcl) developed_7\VBD\1753788 (l_dobj) disease_9\NN\14061805
D001663_D009503 NONE bilirubin_10\NN\14756039 (r_amod) elevations_11\NNS\7445480 (r_conj) transaminase_8\NN\15077571 (l_appos) neutropenia_13\NN\14196405
D008727_D008577 NONE methotrexate_10\NNP\2722166 (r_pobj) with_5\IN\0 (r_prep) leukemia_4\NN\14239918
15957009
D014236_D008569 NONE metrifonate_15\NN\0 (r_conj) ro4368554_2\NNP\0 (r_nsubj) reversed_24\VBD\109660 (l_dobj) deficits_26\NNS\5113133
D012701_D008569 NONE 5-ht(6_45\CD\0 (r_compound) antagonists_48\NNS\7846 (r_conj) involved_31\VBN\2676054 (r_ccomp) suggesting_25\VBG\1010118 (r_advcl) reversed_16\VBD\109660 (l_dobj) cholinergic_18\JJ\0 (l_conj) deficit_23\NN\5113133
D012601_D008569 CID scopolamine_29\NN\14712692 (r_pobj) by_28\IN\0 (r_agent) induced_27\VBN\1627355 (r_acl) deficits_26\NNS\5113133
C507242_D008569 NONE ro4368554_5\NN\0 (r_nsubj) restores_6\VBZ\1631072 (l_prep) in_9\IN\13603305 (l_pobj) models_13\NNS\5888929 (l_prep) of_14\IN\0 (l_pobj) deficiency_16\NN\14449126
C507242_D008569 NONE ro4368554_2\NNP\0 (r_nsubj) reversed_24\VBD\109660 (l_dobj) deficits_26\NNS\5113133
C507242_D008569 NONE ro4368554_4\NN\0 (r_nsubj) improve_7\VB\126264 (r_advcl) reversed_16\VBD\109660 (l_dobj) cholinergic_18\JJ\0 (l_conj) deficit_23\NN\5113133
C507242_D008569 NONE ro4368554_39\NN\0 (r_pobj) by_38\IN\0 (r_prep) facilitation_34\NN\13920835 (r_pobj) in_32\IN\13603305 (r_prep) involved_31\VBN\2676054 (r_ccomp) suggesting_25\VBG\1010118 (r_advcl) reversed_16\VBD\109660 (l_dobj) cholinergic_18\JJ\0 (l_conj) deficit_23\NN\5113133
D014364_D008569 NONE trp_31\NNP\0 (r_compound) depletion_32\NN\351638 (r_conj) scopolamine_29\NN\14712692 (r_pobj) by_28\IN\0 (r_agent) induced_27\VBN\1627355 (r_acl) deficits_26\NNS\5113133
15188772
D004837_D009202 NONE epinephrine_15\NN\14807929 (r_pobj) of_14\IN\0 (r_prep) mg_13\NN\13717155 (r_nsubj) developed_16\VBN\1753788 (l_dobj) markers_44\NNS\21939 (l_prep) of_45\IN\0 (l_pobj) necrosis_47\NN\11444117
D004837_D017682 CID epinephrine_15\NN\14807929 (r_pobj) of_14\IN\0 (r_prep) mg_13\NN\13717155 (r_nsubj) developed_16\VBN\1753788 (l_dobj) markers_44\NNS\21939 (l_amod) stunning_18\JJ\269140
D004837_D062787 NONE epinephrine_12\NN\14807929 (r_amod) overdose_13\NN\84738
D004837_D018487 NONE epinephrine_12\NN\14807929 (r_amod) overdose_13\NN\84738 (r_pobj) due_8\IN\5174653 (r_prep) dysfunction_7\NN\14204950
D004837_D018487 NONE epinephrine_15\NN\14807929 (r_pobj) of_14\IN\0 (r_prep) mg_13\NN\13717155 (r_nsubj) developed_16\VBN\1753788 (l_dobj) markers_44\NNS\21939 (l_amod) stunning_18\JJ\269140 (l_relcl) characterized_21\VBN\609683 (l_conj) left_32\VBD\8621598 (l_dobj) dysfunction_37\NN\14204950
D002395_D009202 NONE catecholamine_0\NN\5407119 (r_npadvmod) induced_2\VBN\1627355 (r_amod) cardiomyopathy_3\NN\14103288
D002395_D009202 NONE catecholamines_10\NNS\5407119 (r_pobj) of_8\IN\0 (r_prep) excess_7\NN\5119367 (r_pobj) due_4\IN\5174653 (r_prep) cardiomyopathy_3\NN\14103288
17615423
C413408_D012206 CID atazanavir_16\NNS\0 (r_conj) amiodarone_13\NN\2715941 (r_conj) simvastatin_11\NN\3676175 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) to_7\IN\0 (r_prep) secondary_6\JJ\8426461 (r_amod) failure_5\NN\66216 (r_conj) rhabdomyolysis_1\NN\0
C413408_D012206 CID atazanavir_14\NNS\0 (l_acl) resulting_15\VBG\2633881 (l_prep) in_16\IN\13603305 (l_pobj) rhabdomyolysis_17\NN\0
D019821_D015658 NONE simvastatin_0\NNP\3676175 (r_nmod) medications_11\NNS\3247620 (l_compound) virus_10\NN\9312843
C413408_D058186 CID atazanavir_16\NNS\0 (r_conj) amiodarone_13\NN\2715941 (r_conj) simvastatin_11\NN\3676175 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) to_7\IN\0 (r_prep) secondary_6\JJ\8426461 (r_amod) failure_5\NN\66216
C413408_D058186 CID atazanavir_14\NNS\0 (l_acl) resulting_15\VBG\2633881 (l_prep) in_16\IN\13603305 (l_pobj) rhabdomyolysis_17\NN\0 (l_conj) failure_21\NN\66216
D000638_D012206 CID amiodarone_13\NN\2715941 (r_conj) simvastatin_11\NN\3676175 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) to_7\IN\0 (r_prep) secondary_6\JJ\8426461 (r_amod) failure_5\NN\66216 (r_conj) rhabdomyolysis_1\NN\0
D000638_D012206 CID amiodarone_11\NN\2715941 (l_conj) atazanavir_14\NNS\0 (l_acl) resulting_15\VBG\2633881 (l_prep) in_16\IN\13603305 (l_pobj) rhabdomyolysis_17\NN\0
D000638_D058186 CID amiodarone_13\NN\2715941 (r_conj) simvastatin_11\NN\3676175 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) to_7\IN\0 (r_prep) secondary_6\JJ\8426461 (r_amod) failure_5\NN\66216
D000638_D058186 CID amiodarone_11\NN\2715941 (l_conj) atazanavir_14\NNS\0 (l_acl) resulting_15\VBG\2633881 (l_prep) in_16\IN\13603305 (l_pobj) rhabdomyolysis_17\NN\0 (l_conj) failure_21\NN\66216
D000638_D015658 NONE amiodarone_2\NN\2715941 (r_conj) simvastatin_0\NNP\3676175 (r_nmod) medications_11\NNS\3247620 (l_compound) virus_10\NN\9312843
D019821_D058186 CID simvastatin_11\NN\3676175 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) to_7\IN\0 (r_prep) secondary_6\JJ\8426461 (r_amod) failure_5\NN\66216
D019821_D058186 CID simvastatin_9\NN\3676175 (l_conj) amiodarone_11\NN\2715941 (l_conj) atazanavir_14\NNS\0 (l_acl) resulting_15\VBG\2633881 (l_prep) in_16\IN\13603305 (l_pobj) rhabdomyolysis_17\NN\0 (l_conj) failure_21\NN\66216
D019821_D012206 CID simvastatin_11\NN\3676175 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) to_7\IN\0 (r_prep) secondary_6\JJ\8426461 (r_amod) failure_5\NN\66216 (r_conj) rhabdomyolysis_1\NN\0
D019821_D012206 CID simvastatin_9\NN\3676175 (l_conj) amiodarone_11\NN\2715941 (l_conj) atazanavir_14\NNS\0 (l_acl) resulting_15\VBG\2633881 (l_prep) in_16\IN\13603305 (l_pobj) rhabdomyolysis_17\NN\0
D019821_D012206 CID simvastatin_14\NN\3676175 (r_amod) metabolism_15\NN\13526110 (r_dobj) inhibit_13\VBP\2510337 (r_relcl) drugs_11\NNS\14778436 (r_pobj) of_9\IN\0 (r_prep) presence_8\NN\13954253 (r_pobj) in_6\IN\13603305 (r_prep) increased_5\VBN\169651 (l_nsubjpass) risk_1\NN\14541044 (l_prep) of_2\IN\0 (l_pobj) rhabdomyolysis_3\NN\0
12584269
D016559_D007674 CID fk506_14\NNP\0 (r_nsubjpass) tolerated_19\VBN\802318 (r_advcl) demonstrated_3\VBD\2137132 (l_dobj) effect_7\NN\34213 (l_amod) nephrotoxic_6\JJ\0
D020123_D005355 NONE srl_3\NNP\0 (r_compound) combination_4\NN\7951464 (r_nsubj) showed_5\VBD\2137132 (l_dobj) degree_10\NN\4916342 (l_prep) of_11\IN\0 (l_pobj) fibrosis_12\NN\14204950
D016572_D007674 CID csa_9\NNP\0 (r_pobj) of_8\IN\0 (r_prep) effect_7\NN\34213 (l_amod) nephrotoxic_6\JJ\0
D020123_D007674 CID srl_5\NN\0 (r_nsubj) seems_6\VBZ\2604760 (r_conj) are_1\VBP\13600404 (l_acomp) nephrotoxic_2\JJ\0
D020123_D007674 CID srl_5\NN\0 (r_nsubj) seems_6\VBZ\2604760 (l_xcomp) act_8\VB\6479665 (l_advcl) displaying_10\VBG\2137132 (l_dobj) effects_14\NNS\13245626 (l_amod) nephrotoxic_13\JJ\0
D020123_D007674 CID srl_7\NN\0 (r_nsubjpass) combined_9\VBN\2630189 (l_prep) with_10\IN\0 (l_pobj) indications_14\NNS\33020 (l_prep) of_15\IN\0 (l_pobj) effect_19\NN\34213 (l_amod) nephrotoxic_18\JJ\0
D020123_D007674 CID srl_11\NNP\0 (r_conj) csa_9\NNP\0 (r_pobj) of_8\IN\0 (r_prep) effect_7\NN\34213 (l_amod) nephrotoxic_6\JJ\0
D020123_D007674 CID srl_16\NNP\0 (r_conj) fk506_14\NNP\0 (r_nsubjpass) tolerated_19\VBN\802318 (r_advcl) demonstrated_3\VBD\2137132 (l_dobj) effect_7\NN\34213 (l_amod) nephrotoxic_6\JJ\0
D016559_D005355 NONE fk506_1\NNP\0 (r_nmod) combination_4\NN\7951464 (r_nsubj) showed_5\VBD\2137132 (l_dobj) degree_10\NN\4916342 (l_prep) of_11\IN\0 (l_pobj) fibrosis_12\NN\14204950
14976857
D011405_D054092 NONE propafenone_26\NN\0 (r_compound) overdose_27\NN\84738 (r_pobj) by_24\IN\0 (r_agent) precipitated_23\VBN\1642924 (r_conj) occurred_9\VBD\0 (l_nsubj) shunt_1\NN\5248181 (l_prep) via_4\IN\0 (l_pobj) ovale_8\NN\0
D011405_D004437 NONE propafenone_9\NN\0 (r_compound) overdose_10\NN\84738 (l_prep) in_11\IN\13603305 (l_pobj) woman_14\NN\9605289 (l_prep) with_15\IN\0 (l_pobj) anomaly_18\NN\14501726
D011405_-1 NONE propafenone_9\NN\0 (r_compound) overdose_10\NN\84738 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (r_acl) syndrome_6\NN\5870365
D011405_D062787 NONE propafenone_9\NN\0 (r_compound) overdose_10\NN\84738
D011405_D062787 NONE propafenone_26\NN\0 (r_compound) overdose_27\NN\84738
11166519
D003042_D012640 CID cocaine_1\NN\3492717 (r_npadvmod) induced_3\VBN\1627355 (r_amod) seizures_4\NNS\14081375
D003042_D012640 CID cocaine_22\NN\3492717 (r_pobj) of_21\IN\0 (r_prep) injection_20\NN\320852 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) seizures_15\NNS\14081375
D003042_D012640 CID cocaine_14\NN\3492717 (r_npadvmod) induced_16\VBN\1627355 (r_amod) seizures_17\NNS\14081375
6209318
D008801_D014202 CID mexiletine_16\NN\2715941 (r_amod) group_17\NN\2137 (r_pobj) in_14\IN\13603305 (r_prep) frequent_13\JJ\2556126 (r_acomp) were_11\VBD\0 (l_nsubj) effects_3\NNS\13245626 (l_appos) tremor_6\JJ\345926
D008801_D012817 CID mexiletine_16\NN\2715941 (r_amod) group_17\NN\2137 (r_pobj) in_14\IN\13603305 (r_prep) frequent_13\JJ\2556126 (r_acomp) were_11\VBD\0 (l_nsubj) effects_3\NNS\13245626 (l_appos) tremor_6\JJ\345926 (l_conj) problems_9\NNS\14408086
D008801_D009203 NONE mexiletine_9\NN\2715941 (r_pobj) of_8\IN\0 (r_prep) form_7\NN\6286395 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubjpass) evaluated_16\VBN\670261 (l_prep) in_17\IN\13603305 (l_pobj) trial_23\NN\786195 (l_prep) in_24\IN\13603305 (l_pobj) patients_26\NNS\9898892 (l_prep) with_27\IN\0 (l_pobj) infarction_31\NN\14204950
D008801_D009203 NONE perlongets_13\NNP\0 (r_pobj) of_8\IN\0 (r_prep) form_7\NN\6286395 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubjpass) evaluated_16\VBN\670261 (l_prep) in_17\IN\13603305 (l_pobj) trial_23\NN\786195 (l_prep) in_24\IN\13603305 (l_pobj) patients_26\NNS\9898892 (l_prep) with_27\IN\0 (l_pobj) infarction_31\NN\14204950
D008801_D001145 NONE mexiletine_1\NN\2715941 (r_nmod) trial_6\NN\786195 (l_appos) report_9\NNP\6470073 (l_prep) on_10\IN\0 (l_pobj) arrhythmia_11\NN\14103288
D008801_D003643 NONE mexiletine_6\NN\2715941 (r_amod) group_7\NN\2137 (r_pobj) in_4\IN\13603305 (r_prep) deaths_3\NNS\7296428
20196116
D000995_D017114 CID antituberculosis_0\NNP\0 (r_nsubj) induced_3\VBN\1627355 (l_dobj) failure_6\NN\66216
D000995_D017114 CID antituberculosis_0\NN\0 (r_compound) therapy_1\NN\657604 (l_appos) failure_6\NN\66216
D000995_D017114 CID antituberculosis_0\NN\0 (r_compound) therapy_1\NN\657604 (l_appos) failure_6\NN\66216 (l_appos) alf_10\NNP\0
D000995_D017114 CID antituberculosis_0\NN\0 (r_compound) therapy_1\NN\657604 (r_nsubj) is_12\VBZ\0 (l_attr) alf_18\NNP\0
D001663_D001927 NONE bilirubin_11\NN\14756039 (l_appos) time_21\NN\7308889 (l_conj) encephalopathy_37\NN\14084880
20477932
D003042_D064420 NONE cocaine_6\NN\3492717 (r_compound) toxicity_7\NN\13576101
D003042_D064420 NONE cocaine_24\NN\3492717 (r_conj) brain_22\NN\5462674 (r_nmod) behaviour_27\NN\14006945 (r_pobj) in_20\IN\13603305 (r_prep) status_19\NN\24720 (r_pobj) between_17\IN\0 (r_prep) association_16\NN\8008335 (r_conj) increase_10\NN\13576355 (r_pobj) including_8\VBG\0 (r_prep) toxicity_7\NN\13576101
C052342_D008569 NONE topiramate_22\NN\0 (r_pobj) by_21\IN\0 (r_prep) prevention_20\NN\1073995 (r_conj) involvement_9\NN\1080366 (r_appos) memory_2\NN\5926676 (l_conj) learning_4\VBG\5701944 (l_dobj) impairments_5\NNS\7296428
D003042_D008569 CID cocaine_0\NN\3492717 (r_nsubj) causes_1\VBZ\7323922 (l_dobj) memory_2\NN\5926676 (l_conj) learning_4\VBG\5701944 (l_dobj) impairments_5\NNS\7296428
D003042_D007859 CID cocaine_0\NN\3492717 (r_nsubj) causes_1\VBZ\7323922 (l_dobj) memory_2\NN\5926676 (l_conj) learning_4\VBG\5701944 (l_dobj) impairments_5\NNS\7296428
C052342_D007859 NONE topiramate_22\NN\0 (r_pobj) by_21\IN\0 (r_prep) prevention_20\NN\1073995 (r_conj) involvement_9\NN\1080366 (r_appos) memory_2\NN\5926676 (l_conj) learning_4\VBG\5701944 (l_dobj) impairments_5\NNS\7296428
D003042_D019970 NONE cocaine_43\NN\3492717 (r_compound) administration_44\NN\1133281 (r_pobj) of_42\IN\0 (r_prep) model_41\NN\5888929 (r_pobj) in_38\IN\13603305 (r_prep) evaluated_37\VBN\670261 (l_nsubjpass) activity_2\NN\30358 (l_appos) stress_5\NN\7083732 (l_conj) synthase_10\NN\0 (l_conj) therapy_31\NN\657604 (l_prep) for_32\IN\0 (l_pobj) addiction_34\NN\14034177
D009569_D019970 NONE oxide_9\NN\14818238 (r_compound) synthase_10\NN\0 (l_conj) therapy_31\NN\657604 (l_prep) for_32\IN\0 (l_pobj) addiction_34\NN\14034177
C052342_D019970 NONE topiramate_26\NN\0 (r_pobj) of_25\IN\0 (r_prep) effect_24\NN\34213 (r_conj) learning_17\NN\5701944 (r_conj) activity_14\NN\30358 (r_conj) synthase_10\NN\0 (l_conj) therapy_31\NN\657604 (l_prep) for_32\IN\0 (l_pobj) addiction_34\NN\14034177
7265370
C020743_D053040 NONE dyazide_3\RB\0 (r_compound) therapy_4\NN\657604 (r_dobj) complicating_2\VBG\126264 (l_nsubj) nephrolithiasis_1\JJ\14115914
C020743_D053040 NONE triamterene_16\JJ\0 (r_compound) therapy_17\NN\657604 (r_pobj) of_13\IN\0 (r_prep) years_12\NNS\15144371 (r_pobj) after_10\IN\0 (r_prep) reported_6\VBN\831651 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) nephrolithiasis_4\NN\14115914
D014223_D053040 CID triamterene_0\JJ\0 (r_compound) nephrolithiasis_1\JJ\14115914
D014223_D053040 CID triamterene_3\JJ\0 (r_compound) nephrolithiasis_4\NN\14115914
D014223_D053040 CID triamterene_2\JJ\0 (r_compound) nephrolithiasis_3\NN\14115914
D014223_D006973 NONE triamterene_3\JJ\0 (r_compound) nephrolithiasis_4\NN\14115914 (r_pobj) of_2\IN\0 (r_prep) case_1\NN\7283608 (r_nsubjpass) reported_6\VBN\831651 (l_prep) after_10\IN\0 (l_pobj) years_12\NNS\15144371 (l_prep) for_18\IN\0 (l_pobj) hypertension_19\NN\14057371
C020743_D006973 NONE triamterene_16\JJ\0 (r_compound) therapy_17\NN\657604 (r_pobj) of_13\IN\0 (r_prep) years_12\NNS\15144371 (l_prep) for_18\IN\0 (l_pobj) hypertension_19\NN\14057371
424937
D008750_D056486 CID methyldopa_6\NN\2721160 (r_pobj) by_5\IN\0 (r_agent) induced_4\VBN\1627355 (l_nsubj) patterns_0\NNS\5726345 (l_prep) of_1\IN\0 (l_pobj) injury_3\NN\14052046
D008750_D056486 CID methyldopa_22\NN\2721160 (r_npadvmod) induced_24\VBN\1627355 (r_amod) hepatitis_25\NN\14127211
D008750_D056486 CID methyldopa_14\NN\2721160 (r_pobj) between_13\IN\0 (r_prep) relationship_12\NN\31921 (r_nsubjpass) proved_19\VBN\2604760 (l_prep) with_20\IN\0 (l_pobj) recurrence_22\NN\7342049 (l_prep) of_23\IN\0 (l_pobj) hepatitis_24\NN\14127211
D008750_D017114 NONE methyldopa_22\NN\2721160 (r_npadvmod) induced_24\VBN\1627355 (r_amod) hepatitis_25\NN\14127211 (r_pobj) of_21\IN\0 (r_prep) episode_20\NN\7283608 (r_pobj) after_17\IN\0 (r_prep) recommenced_14\VBN\348746 (r_advcl) developed_6\VBD\1753788 (l_dobj) hepatitis_8\NN\14127211
D008750_D017093 NONE methyldopa_17\NN\2721160 (r_dobj) taking_16\VBG\37396 (r_relcl) another_11\DT\0 (r_nsubj) showed_22\VBD\2137132 (r_conj) presented_5\VBN\2137132 (l_prep) in_6\IN\13603305 (l_pobj) failure_8\NN\66216
D008750_D008107 NONE methyldopa_7\NN\2721160 (r_pobj) to_6\IN\0 (r_prep) related_5\VBN\628491 (r_acl) disease_4\NN\14061805
D008750_D008107 NONE methyldopa_14\NN\2721160 (l_conj) dysfunction_17\NN\14204950
20470218
D008727_D056784 NONE methotrexate_32\NN\2722166 (r_compound) toxicity_33\NN\13576101 (r_conj) syndrome_6\NN\5870365 (l_compound) leukoencephalopathy_5\JJ\0
D008727_D020521 NONE methotrexate_32\NN\2722166 (r_compound) toxicity_33\NN\13576101 (r_conj) syndrome_6\NN\5870365 (l_conj) stroke_13\NN\556313
D008727_D064420 NONE methotrexate_32\NN\2722166 (r_compound) toxicity_33\NN\13576101
D008727_D004833 NONE methotrexate_32\NN\2722166 (r_compound) toxicity_33\NN\13576101 (r_conj) syndrome_6\NN\5870365 (l_conj) stroke_13\NN\556313 (l_conj) epilepsy_22\NN\14085708
D008727_D007177 NONE methotrexate_32\NN\2722166 (r_compound) toxicity_33\NN\13576101 (l_conj) syndrome_40\NN\5870365 (l_prep) of_41\IN\0 (l_pobj) secretion_45\NN\13526110
15572383
D004317_D011507 CID adriamycin_10\NNS\0 (r_pobj) by_9\IN\0 (r_agent) induced_8\VBN\1627355 (l_nsubjpass) proteinuria_6\NN\14299637
D004317_D011507 CID adriamycin_3\NNS\0 (l_pobj) proteinuria_7\NN\14299637
D004317_D011507 CID adriamycin_12\NNS\0 (r_advcl) correlated_4\VBD\2657219 (l_prep) with_5\IN\0 (l_pobj) rise_8\NN\7324673 (l_prep) in_9\IN\13603305 (l_pobj) proteinuria_10\NN\14299637
D004317_D009404 NONE adriamycin_3\NNS\0 (l_pobj) proteinuria_7\NN\14299637 (l_amod) nephrotic_5\JJ\0
D004317_D005923 NONE adriamycin_3\NNS\0 (l_pobj) proteinuria_7\NN\14299637 (l_conj) damage_11\NN\7296428 (l_conj) glomerulosclerosis_15\NN\0
D004317_D007674 NONE adriamycin_12\NNS\0 (r_advmod) induced_14\VBN\1627355 (r_amod) damage_16\NN\7296428
D004317_D007674 NONE adriamycin_23\NNS\0 (r_pobj) of_22\IN\0 (r_prep) injection_21\NN\320852 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) severity_13\NN\5036394 (l_prep) of_14\IN\0 (l_pobj) damage_16\NN\7296428
D004317_D007674 NONE adriamycin_3\NNS\0 (l_pobj) proteinuria_7\NN\14299637 (l_conj) damage_11\NN\7296428
D004317_D007674 NONE adriamycin_10\NNS\0 (r_advmod) induced_12\VBN\1627355 (r_amod) damage_14\NN\7296428
7582165
D000305_D004342 NONE corticosteroids_5\NNS\14745635 (r_pobj) to_4\IN\0 (r_prep) reactions_3\NNS\13446390
D010248_D004342 NONE paramethasone_3\NN\0 (r_pobj) from_2\IN\0 (r_prep) different_1\JJ\0 (r_amod) corticosteroids_0\NNS\14745635 (r_nsubj) produced_5\VBD\1617192 (l_dobj) reactions_7\NNS\13446390 (l_compound) hypersensitivity_6\NN\14531772
D010248_D004342 NONE paramethasone_16\NN\0 (r_pobj) by_15\IN\0 (r_agent) caused_14\VBN\1617192 (r_acl) allergy_13\NN\14533203
18208574
D006493_D013927 CID heparin_12\NN\2718259 (r_npadvmod) induced_14\VBN\1627355 (r_amod) thrombocytopenia_15\NN\14189204 (r_pobj) with_11\IN\0 (r_prep) patients_10\NNS\9898892 (r_pobj) in_9\IN\13603305 (r_prep) thrombosis_8\NN\14100769
D006493_D013927 CID heparin_12\NN\2718259 (r_npadvmod) induced_14\VBN\1627355 (r_amod) thrombocytopenia_15\NN\14189204 (l_appos) assay_20\NN\5733583 (l_prep) with_21\IN\0 (l_pobj) thrombosis_22\NN\14100769
D006493_D013927 CID heparin_33\JJ\2718259 (r_compound) concentration_34\NN\4916342 (r_pobj) of_30\IN\0 (r_prep) characteristics_29\NNS\5849040 (r_dobj) utilizes_26\VBZ\0 (l_advcl) correlate_1\VB\5857459 (l_dobj) density_3\NN\4941325 (l_prep) of_7\IN\0 (l_pobj) thrombocytopenia_15\NN\14189204 (l_appos) assay_20\NN\5733583 (l_prep) with_21\IN\0 (l_pobj) thrombosis_22\NN\14100769
D006493_D013921 CID heparin_12\NN\2718259 (r_npadvmod) induced_14\VBN\1627355 (r_amod) thrombocytopenia_15\NN\14189204
D006493_D013921 CID heparin_12\NN\2718259 (r_npadvmod) induced_14\VBN\1627355 (r_amod) thrombocytopenia_15\NN\14189204 (l_appos) assay_20\NN\5733583 (l_nmod) hit_17\NN\36762
D006493_D013921 CID heparin_33\JJ\2718259 (r_compound) concentration_34\NN\4916342 (r_pobj) of_30\IN\0 (r_prep) characteristics_29\NNS\5849040 (r_dobj) utilizes_26\VBZ\0 (l_advcl) correlate_1\VB\5857459 (l_dobj) density_3\NN\4941325 (l_prep) of_7\IN\0 (l_pobj) thrombocytopenia_15\NN\14189204
D006493_D013921 CID heparin_33\JJ\2718259 (r_compound) concentration_34\NN\4916342 (r_pobj) of_30\IN\0 (r_prep) characteristics_29\NNS\5849040 (r_dobj) utilizes_26\VBZ\0 (l_advcl) correlate_1\VB\5857459 (l_dobj) density_3\NN\4941325 (l_prep) of_7\IN\0 (l_pobj) thrombocytopenia_15\NN\14189204 (l_appos) assay_20\NN\5733583 (l_nmod) hit_17\NN\36762
D006493_D013921 CID heparin_21\NN\2718259 (r_pobj) to_20\IN\0 (r_prep) exposure_19\NN\5042871 (r_pobj) after_18\IN\0 (r_prep) patients_0\NNS\9898892 (l_prep) with_1\IN\0 (l_pobj) decrease_6\NN\7296428 (l_conj) thrombocytopenia_11\NNP\14189204
D006493_D013921 CID heparin_48\NN\2718259 (r_pobj) of_47\IN\0 (r_prep) concentration_46\NN\4916342 (r_pobj) with_44\IN\0 (r_prep) inhibition_43\NN\1068773 (r_dobj) had_24\VBD\0 (r_relcl) heparin_21\NN\2718259 (r_pobj) to_20\IN\0 (r_prep) exposure_19\NN\5042871 (r_pobj) after_18\IN\0 (r_prep) patients_0\NNS\9898892 (l_prep) with_1\IN\0 (l_pobj) decrease_6\NN\7296428 (l_conj) thrombocytopenia_11\NNP\14189204
19884587
D009582_D008850 CID nitrofurantoins_0\NNS\2716205 (r_nsubjpass) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) anophthalmia_4\NN\0 (l_conj) microphthalmos_6\NNS\0
D009582_D002971 CID nitrofurantoins_0\NNS\2716205 (r_nsubjpass) associated_2\VBN\628491 (l_appos) aor_8\NNP\0 (l_appos) aor_26\NNP\0 (l_conj) lip_58\NN\5301392
D009582_D002972 CID nitrofurantoins_0\NNS\2716205 (r_nsubjpass) associated_2\VBN\628491 (l_appos) aor_8\NNP\0 (l_appos) aor_26\NNP\0 (l_conj) lip_58\NN\5301392 (l_prep) with_59\IN\0 (l_pobj) palate_61\NN\8660339
D004917_D000014 NONE erythromycins_4\NNS\2716866 (r_conj) penicillins_2\NNS\2716866 (r_nsubjpass) associated_18\VBN\628491 (l_prep) with_19\IN\0 (l_pobj) defects_22\NNS\14462666
D009582_D000014 CID nitrofurantoins_2\NNS\2716205 (r_conj) sulfonamides_0\NNS\2716205 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) defects_8\NNS\14462666
D013449_D000014 CID sulfonamides_0\NNS\2716205 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) defects_8\NNS\14462666
D009582_D018636 CID nitrofurantoins_0\NNS\2716205 (r_nsubjpass) associated_2\VBN\628491 (l_appos) aor_8\NNP\0 (l_appos) syndrome_24\NN\5870365
D010406_D000014 NONE penicillins_2\NNS\2716866 (r_nsubjpass) associated_18\VBN\628491 (l_prep) with_19\IN\0 (l_pobj) defects_22\NNS\14462666
D009582_D006344 CID nitrofurantoins_0\NNS\2716205 (r_nsubjpass) associated_2\VBN\628491 (l_appos) aor_8\NNP\0 (l_appos) aor_26\NNP\0 (l_appos) defects_41\NNS\14462666
D009582_D000853 CID nitrofurantoins_0\NNS\2716205 (r_nsubjpass) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) anophthalmia_4\NN\0
D013449_D018636 CID sulfonamides_0\NNS\2716205 (r_nsubjpass) associated_2\VBN\628491 (r_ccomp) interval_17\NN\33615 (l_appos) syndrome_30\NN\5870365
D013449_D000757 CID sulfonamides_0\NNS\2716205 (r_nsubjpass) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) aor_9\NNP\0 (l_amod) anencephaly_4\NNS\14465048
D002511_D000014 NONE cephalosporins_7\NNS\2716866 (r_conj) erythromycins_4\NNS\2716866 (r_conj) penicillins_2\NNS\2716866 (r_nsubjpass) associated_18\VBN\628491 (l_prep) with_19\IN\0 (l_pobj) defects_22\NNS\14462666
17343925
D012906_D034381 CID smoking_3\NN\831191 (r_pobj) of_2\IN\0 (r_prep) influence_1\NN\5190804 (r_nsubjpass) estimated_13\VBN\637259 (l_advcl) associated_20\VBN\628491 (l_prep) with_21\IN\0 (l_pcomp) hearing_22\VBG\1184814 (l_dobj) loss_23\NN\13252973
D012906_D034381 CID smoking_16\NN\831191 (r_nsubjpass) associated_20\VBN\628491 (l_prep) with_21\IN\0 (l_pcomp) hearing_22\VBG\1184814 (l_dobj) loss_23\NN\13252973
8387218
D016049_D018149 CID didanosine_24\NN\2725367 (r_dobj) ceasing_23\VBG\0 (r_pcomp) on_22\IN\0 (r_prep) returned_19\VBN\1835496 (r_conj) require_16\VB\0 (r_conj) developed_2\VBD\1753788 (l_dobj) curves_5\VBZ\13863771
D015215_D015658 NONE zidovudine_17\NNP\3834836 (r_pobj) to_16\IN\0 (r_prep) intolerant_15\JJ\0 (r_amod) individuals_14\NNS\7347 (l_amod) positive_13\JJ\6321702
D015215_D015658 NONE azt_19\NNP\3834836 (r_appos) individuals_14\NNS\7347 (l_amod) positive_13\JJ\6321702
D015215_D064420 NONE zidovudine_17\NNP\3834836 (r_pobj) to_16\IN\0 (r_prep) intolerant_15\JJ\0 (r_amod) individuals_14\NNS\7347 (r_pobj) in_9\IN\13603305 (r_prep) didanosine_5\NN\2725367 (r_pobj) of_4\IN\0 (r_prep) use_1\NN\407535 (l_conj) toxicity_3\NN\13576101
D015215_D064420 NONE azt_19\NNP\3834836 (r_appos) individuals_14\NNS\7347 (r_pobj) in_9\IN\13603305 (r_prep) didanosine_5\NN\2725367 (r_pobj) of_4\IN\0 (r_prep) use_1\NN\407535 (l_conj) toxicity_3\NN\13576101
D016049_D003920 NONE didanosine_24\NN\2725367 (r_dobj) ceasing_23\VBG\0 (r_pcomp) on_22\IN\0 (r_prep) returned_19\VBN\1835496 (r_conj) require_16\VB\0 (r_conj) developed_2\VBD\1753788 (l_dobj) curves_5\VBZ\13863771 (l_amod) characteristic_6\JJ\5849040 (l_prep) of_7\IN\0 (l_pobj) diabetes_8\NNS\14075199
D016049_D064420 NONE didanosine_5\NN\2725367 (r_pobj) of_4\IN\0 (r_prep) use_1\NN\407535 (l_conj) toxicity_3\NN\13576101
D016049_D064420 NONE ddi_7\NN\2725367 (r_appos) didanosine_5\NN\2725367 (r_pobj) of_4\IN\0 (r_prep) use_1\NN\407535 (l_conj) toxicity_3\NN\13576101
D016049_D015658 NONE didanosine_5\NN\2725367 (l_prep) in_9\IN\13603305 (l_pobj) individuals_14\NNS\7347 (l_amod) positive_13\JJ\6321702
D016049_D015658 NONE ddi_7\NN\2725367 (r_appos) didanosine_5\NN\2725367 (l_prep) in_9\IN\13603305 (l_pobj) individuals_14\NNS\7347 (l_amod) positive_13\JJ\6321702
1639466
D004656_D006973 NONE enalapril_33\NN\2673637 (r_npadvmod) treated_35\VBN\2376958 (r_amod) 8)_39\CD\0 (r_appos) controls_27\NNS\5190804 (r_appos) groups_23\NNS\2137 (r_pobj) to_21\IN\0 (r_prep) assigned_20\VBN\2475922 (l_prep) after_2\IN\0 (l_pobj) clipping_3\VBG\6400510 (l_prep) of_4\IN\0 (l_pobj) artery_7\NN\5417975 (l_appos) rats_10\NNS\2329401 (l_amod) hypertensive_9\JJ\10405694
D004656_D006973 NONE enalapril_33\NN\2673637 (r_npadvmod) treated_35\VBN\2376958 (r_amod) 8)_39\CD\0 (r_appos) controls_27\NNS\5190804 (l_amod) hypertensive_26\JJ\10405694
D004656_D006973 NONE enalapril_25\NN\2673637 (r_npadvmod) treated_27\VBN\2376958 (r_amod) group_28\NN\2137 (r_pobj) in_23\IN\13603305 (r_prep) lower_22\JJR\2831724 (l_prep) compared_37\VBN\644583 (l_prep) with_38\IN\0 (l_pobj) controls_41\NNS\5190804 (l_amod) hypertensive_40\JJ\10405694
D002118_D000419 NONE calcium_8\NN\14625458 (r_compound) channel_9\NN\6251781 (l_appos) nitrendipine_11\NN\0 (l_conj) angiotensin_14\NN\4522421 (l_acl) converting_15\VBG\126264 (l_prep) on_19\IN\0 (l_pobj) pressure_21\NN\11419404 (l_conj) albuminuria_23\NN\14299637
D004656_D005921 NONE enalapril_14\JJ\2673637 (r_compound) treatment_15\NN\654885 (r_pobj) after_13\IN\0 (r_prep) change_12\VB\7283608 (l_nsubj) excretion_7\NN\13466586 (l_conj) glomerulosclerosis_9\NN\0
D009568_D005921 NONE nitrendipine_9\NN\0 (r_npadvmod) treated_11\VBN\2376958 (r_amod) group_12\NN\2137 (r_pobj) in_7\IN\13603305 (r_prep) increased_6\VBN\169651 (l_nsubjpass) index_3\NN\13850304 (l_compound) glomerulosclerosis_2\NN\0
D009568_D000419 CID nitrendipine_11\NN\0 (l_conj) angiotensin_14\NN\4522421 (l_acl) converting_15\VBG\126264 (l_prep) on_19\IN\0 (l_pobj) pressure_21\NN\11419404 (l_conj) albuminuria_23\NN\14299637
D009568_D000419 CID nitrendipine_5\NN\0 (r_npadvmod) treated_7\VBN\2376958 (r_amod) albuminuria_9\NN\14299637
D009568_D006978 NONE nitrendipine_7\NN\0 (l_prep) on_8\IN\0 (l_pobj) nephrosclerosis_9\NN\14113228 (l_prep) in_10\IN\13603305 (l_pobj) rats_11\NNS\2329401 (l_prep) with_12\IN\0 (l_pobj) hypertension_14\NN\14057371
D009568_D006978 NONE nitrendipine_11\NN\0 (r_appos) channel_9\NN\6251781 (r_pobj) with_6\IN\0 (r_prep) treatment_5\NN\654885 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_35\VBN\0 (l_prep) in_36\IN\13603305 (l_pobj) rats_37\NNS\2329401 (l_prep) with_38\IN\0 (l_pobj) kidney_41\NN\5333259 (l_appos) hypertension_46\NN\14057371
D000809_D000419 NONE angiotensin_14\NN\4522421 (l_acl) converting_15\VBG\126264 (l_prep) on_19\IN\0 (l_pobj) pressure_21\NN\11419404 (l_conj) albuminuria_23\NN\14299637
D009568_D009400 CID nitrendipine_7\NN\0 (l_prep) on_8\IN\0 (l_pobj) nephrosclerosis_9\NN\14113228
D002118_D009400 NONE calcium_4\NN\14625458 (r_compound) channel_5\NN\6251781 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_appos) nitrendipine_7\NN\0 (l_prep) on_8\IN\0 (l_pobj) nephrosclerosis_9\NN\14113228
D002118_D006978 NONE calcium_4\NN\14625458 (r_compound) channel_5\NN\6251781 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_appos) nitrendipine_7\NN\0 (l_prep) on_8\IN\0 (l_pobj) nephrosclerosis_9\NN\14113228 (l_prep) in_10\IN\13603305 (l_pobj) rats_11\NNS\2329401 (l_prep) with_12\IN\0 (l_pobj) hypertension_14\NN\14057371
D002118_D006978 NONE calcium_8\NN\14625458 (r_compound) channel_9\NN\6251781 (r_pobj) with_6\IN\0 (r_prep) treatment_5\NN\654885 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_35\VBN\0 (l_prep) in_36\IN\13603305 (l_pobj) rats_37\NNS\2329401 (l_prep) with_38\IN\0 (l_pobj) kidney_41\NN\5333259 (l_appos) hypertension_46\NN\14057371
D004656_D000419 NONE enalapril_18\NN\2673637 (r_dobj) converting_15\VBG\126264 (l_prep) on_19\IN\0 (l_pobj) pressure_21\NN\11419404 (l_conj) albuminuria_23\NN\14299637
D004656_D006978 NONE enalapril_18\NN\2673637 (r_dobj) converting_15\VBG\126264 (r_acl) angiotensin_14\NN\4522421 (r_conj) nitrendipine_11\NN\0 (r_appos) channel_9\NN\6251781 (r_pobj) with_6\IN\0 (r_prep) treatment_5\NN\654885 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_35\VBN\0 (l_prep) in_36\IN\13603305 (l_pobj) rats_37\NNS\2329401 (l_prep) with_38\IN\0 (l_pobj) kidney_41\NN\5333259 (l_appos) hypertension_46\NN\14057371
D009568_D006973 NONE nitrendipine_42\NN\0 (r_advmod) treated_44\VBN\2376958 (r_conj) 8)_39\CD\0 (r_appos) controls_27\NNS\5190804 (r_appos) groups_23\NNS\2137 (r_pobj) to_21\IN\0 (r_prep) assigned_20\VBN\2475922 (l_prep) after_2\IN\0 (l_pobj) clipping_3\VBG\6400510 (l_prep) of_4\IN\0 (l_pobj) artery_7\NN\5417975 (l_appos) rats_10\NNS\2329401 (l_amod) hypertensive_9\JJ\10405694
D009568_D006973 NONE nitrendipine_42\NN\0 (r_advmod) treated_44\VBN\2376958 (r_conj) 8)_39\CD\0 (r_appos) controls_27\NNS\5190804 (l_amod) hypertensive_26\JJ\10405694
D009568_D006973 NONE nitrendipine_5\NN\0 (r_npadvmod) treated_7\VBN\2376958 (r_amod) albuminuria_9\NN\14299637 (r_pobj) in_3\IN\13603305 (r_prep) increased_10\VBD\169651 (l_prep) compared_20\VBN\644583 (l_prep) with_21\IN\0 (l_pobj) hr_26\NN\15154774 (l_prep) in_27\IN\13603305 (l_pobj) controls_30\NNS\5190804 (l_amod) hypertensive_29\JJ\10405694
D009568_D006973 NONE nitrendipine_9\NN\0 (r_npadvmod) treated_11\VBN\2376958 (r_amod) group_12\NN\2137 (r_pobj) in_7\IN\13603305 (r_prep) increased_6\VBN\169651 (l_prep) compared_13\VBN\644583 (l_prep) with_14\IN\0 (l_pobj) controls_17\NNS\5190804 (l_amod) hypertensive_16\JJ\10405694
D009568_D006973 NONE nitrendipine_9\NN\0 (r_npadvmod) treated_11\VBN\2376958 (r_amod) group_12\NN\2137 (r_pobj) in_7\IN\13603305 (r_prep) was_5\VBD\0 (l_conj) lower_22\JJR\2831724 (l_prep) compared_37\VBN\644583 (l_prep) with_38\IN\0 (l_pobj) controls_41\NNS\5190804 (l_amod) hypertensive_40\JJ\10405694
D000809_D006978 NONE angiotensin_14\NN\4522421 (r_conj) nitrendipine_11\NN\0 (r_appos) channel_9\NN\6251781 (r_pobj) with_6\IN\0 (r_prep) treatment_5\NN\654885 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_35\VBN\0 (l_prep) in_36\IN\13603305 (l_pobj) rats_37\NNS\2329401 (l_prep) with_38\IN\0 (l_pobj) kidney_41\NN\5333259 (l_appos) hypertension_46\NN\14057371
16858720
D014859_D006470 NONE warfarin_1\JJ\2718259 (r_compound) drug_3\NN\14778436 (r_compound) interaction_4\NN\37396 (r_nsubj) contributed_7\VBN\126264 (l_prep) to_8\IN\0 (l_pobj) haemorrhage_10\NN\14285662
D014859_D006470 NONE warfarin_1\JJ\2718259 (r_compound) drug_3\NN\14778436 (r_compound) interaction_4\NN\37396 (r_nsubj) contributed_7\VBN\126264 (l_conj) considered_34\VBN\689344 (l_nsubjpass) complication_32\NN\1073995 (l_amod) bleeding_31\VBG\14285662
D014859_D006470 NONE warfarin_19\JJ\2718259 (r_compound) patients_20\NNS\9898892 (r_pobj) of_17\IN\0 (r_prep) %_15\NN\0 (r_pobj) in_11\IN\13603305 (r_prep) contributed_7\VBN\126264 (l_prep) to_8\IN\0 (l_pobj) haemorrhage_10\NN\14285662
D014859_D006470 NONE warfarin_19\JJ\2718259 (r_compound) patients_20\NNS\9898892 (r_pobj) of_17\IN\0 (r_prep) %_15\NN\0 (r_pobj) in_11\IN\13603305 (r_prep) contributed_7\VBN\126264 (l_conj) considered_34\VBN\689344 (l_nsubjpass) complication_32\NN\1073995 (l_amod) bleeding_31\VBG\14285662
D014859_D002543 CID warfarin_4\NN\2718259 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) haemorrhage_1\NN\14285662
D014859_D002543 CID warfarin_9\RB\2718259 (r_npadvmod) induced_11\VBN\1627355 (r_amod) haemorrhages_13\NNS\14285662
D014859_D002543 CID warfarin_16\JJ\2718259 (r_pobj) due_14\IN\5174653 (r_prep) evaluate_1\VB\670261 (l_dobj) frequency_3\NN\15286249 (l_prep) of_8\IN\0 (l_pobj) haemorrhages_13\NNS\14285662
D014859_D002543 CID warfarin_18\JJ\2718259 (r_compound) drug_20\NN\14778436 (r_compound) interactions_21\NNS\37396 (r_conj) warfarin_16\JJ\2718259 (r_pobj) due_14\IN\5174653 (r_prep) evaluate_1\VB\670261 (l_dobj) frequency_3\NN\15286249 (l_prep) of_8\IN\0 (l_pobj) haemorrhages_13\NNS\14285662
D014859_D002543 CID warfarin_8\JJ\2718259 (r_nmod) interactions_13\NNS\37396 (r_nsubj) caused_16\VBN\1617192 (l_dobj) haemorrhage_19\NN\14285662
D014859_D002543 CID warfarin_10\JJ\2718259 (r_compound) drug_12\NN\14778436 (r_conj) warfarin_8\JJ\2718259 (r_nmod) interactions_13\NNS\37396 (r_nsubj) caused_16\VBN\1617192 (l_dobj) haemorrhage_19\NN\14285662
D014859_D002543 CID warfarin_17\JJ\2718259 (r_compound) treatment_18\NN\654885 (r_pobj) to_16\IN\0 (r_prep) related_15\VBN\628491 (r_amod) as_14\IN\14622893 (r_prep) assessed_13\VBN\670261 (l_prep) among_0\IN\0 (l_pobj) patients_2\NNS\9898892 (l_prep) with_3\IN\0 (l_pobj) haemorrhage_5\NN\14285662
D014859_D002543 CID warfarin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) haemorrhages_4\NNS\14285662
D014859_D002543 CID warfarin_4\RB\2718259 (r_npadvmod) related_6\VBN\628491 (r_amod) haemorrhages_8\NNS\14285662
D014859_D002543 CID warfarin_26\NN\2718259 (r_pobj) with_25\IN\0 (r_prep) interact_24\VB\2367363 (r_xcomp) known_22\VBN\0 (r_acl) drugs_21\NNS\14778436 (r_dobj) prescribing_20\VBG\748282 (r_advcl) taken_18\VBN\2367363 (r_advcl) prevented_12\VBN\0 (l_nsubjpass) proportion_2\NN\13824815 (l_prep) of_3\IN\0 (l_pobj) haemorrhages_8\NNS\14285662
3173179
D002216_D006973 NONE captopril_13\NN\2673637 (r_pobj) of_12\IN\0 (r_prep) introduction_11\NN\235435 (l_conj) withdrawal_16\NN\7206096 (l_prep) in_19\IN\13603305 (l_pobj) woman_23\NN\9605289 (l_prep) with_24\IN\0 (l_pobj) hypertension_26\NN\14057371
D002216_D009203 NONE captopril_13\NN\2673637 (r_pobj) of_12\IN\0 (r_prep) introduction_11\NN\235435 (r_pobj) with_9\IN\0 (r_prep) coincided_8\VBD\2604477 (l_nsubj) infarction_7\NN\14204950
D014700_D009203 CID verapamil_0\NNP\2938514 (r_compound) withdrawal_1\NN\7206096 (l_prep) as_2\IN\14622893 (l_pobj) cause_5\NN\7323922 (l_prep) of_6\IN\0 (l_pobj) infarction_8\NN\14204950
D014700_D009203 CID verapamil_18\NN\2938514 (r_pobj) of_17\IN\0 (r_prep) withdrawal_16\NN\7206096 (r_conj) introduction_11\NN\235435 (r_pobj) with_9\IN\0 (r_prep) coincided_8\VBD\2604477 (l_nsubj) infarction_7\NN\14204950
D014700_D006973 NONE verapamil_0\NNP\2938514 (r_compound) withdrawal_1\NN\7206096 (l_prep) as_2\IN\14622893 (l_pobj) cause_5\NN\7323922 (l_prep) of_6\IN\0 (l_pobj) infarction_8\NN\14204950 (l_prep) in_9\IN\13603305 (l_pobj) woman_12\NN\9605289 (l_amod) hypertensive_11\JJ\10405694
D014700_D006973 NONE verapamil_18\NN\2938514 (r_pobj) of_17\IN\0 (r_prep) withdrawal_16\NN\7206096 (l_prep) in_19\IN\13603305 (l_pobj) woman_23\NN\9605289 (l_prep) with_24\IN\0 (l_pobj) hypertension_26\NN\14057371
12202650
D002211_D063806 NONE capsaicin_0\NN\15032661 (r_npadvmod) induced_2\VBN\1627355 (r_amod) pain_4\NN\14299637
D002211_D010146 CID capsaicin_0\NNS\15032661 (r_nsubjpass) injected_7\VBN\81072 (l_advcl) induce_13\VB\1627355 (l_dobj) pain_14\NN\14299637
1833784
D015647_D006948 NONE 38393_17\CD\0 (r_nummod) skf_16\NNP\0 (r_appos) agonist_15\NN\0 (r_nsubj) had_18\VBD\0 (r_advcl) pretreatment_0\NN\0 (l_prep) with_1\IN\0 (l_pobj) agonist_4\NN\0 (l_appos) hyperactivity_10\NN\14052403
-1_D006948 NONE phno_5\NNP\0 (r_npadvmod) enhanced_6\VBN\227165 (r_amod) hyperactivity_10\NN\14052403
C534628_D006948 NONE 23390_12\CD\0 (r_nummod) sch_11\NNP\0 (r_appos) antagonist_10\NN\7846 (r_pobj) by_6\IN\0 (r_agent) blocked_5\VBN\1476483 (l_nsubjpass) hyperactivity_3\NN\14052403
D004298_D006948 NONE dopamine_8\NN\14807737 (r_conj) d1_5\NN\0 (r_nmod) receptors_9\NNS\5225602 (r_pobj) of_4\IN\0 (r_prep) involvement_3\NN\1080366 (l_prep) in_10\IN\13603305 (l_pcomp) mediating_11\VBG\761713 (l_dobj) hyperactivity_15\NN\14052403
D009538_D006948 CID nicotine_12\NN\14712692 (r_npadvmod) induced_14\VBN\1627355 (r_amod) hyperactivity_15\NN\14052403
D009538_D006948 CID nicotine_0\NNP\14712692 (r_nsubj) caused_5\VBD\1617192 (l_dobj) increase_8\NN\13576355 (l_prep) in_9\IN\13603305 (l_pobj) activity_11\NN\30358
D009538_D006948 CID nicotine_0\NN\14712692 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hyperactivity_3\NN\14052403
D009538_D006948 CID nicotine_7\NN\14712692 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hyperactivity_10\NN\14052403
D009538_D006948 CID nicotine_5\NN\14712692 (r_compound) injection_6\NN\320852 (r_nsubj) induces_7\VBZ\1627355 (l_dobj) hyperactivity_10\NN\14052403
D020891_D006948 NONE raclopride_18\NN\0 (l_ccomp) blocked_5\VBN\1476483 (l_nsubjpass) hyperactivity_3\NN\14052403
D005476_D006948 NONE fluphenazine_23\NN\3713736 (r_conj) raclopride_18\NN\0 (l_ccomp) blocked_5\VBN\1476483 (l_nsubjpass) hyperactivity_3\NN\14052403
3371379
D014700_D020258 CID verapamil_0\NNP\2938514 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) neurotoxicity_4\NN\0
D014700_D020258 CID verapamil_11\NN\2938514 (r_pobj) with_10\IN\0 (r_prep) treatment_9\NN\654885 (r_pobj) after_7\IN\0 (r_prep) signs_3\NNS\6643763 (l_prep) of_4\IN\0 (l_pobj) neurotoxicity_6\NN\0
D002118_D020258 NONE calcium_19\NN\14625458 (r_compound) entry_20\NN\6502378 (r_compound) blocker_21\NN\10101634 (r_pobj) of_17\IN\0 (r_prep) discontinuation_16\NN\209943 (r_pobj) after_15\IN\0 (r_prep) recovery_14\NN\7357388 (r_dobj) showed_12\VBD\2137132 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) signs_3\NNS\6643763 (l_prep) of_4\IN\0 (l_pobj) neurotoxicity_6\NN\0
D002220_D020258 CID carbamazepine_3\NN\0 (r_compound) neurotoxicity_4\NN\0
D002220_D020258 CID carbamazepine_5\JJ\0 (r_compound) neurotoxicity_6\NN\0
20080419
D010862_D004827 CID pilocarpine_24\NN\14712692 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) model_19\NN\5888929 (l_prep) of_20\IN\0 (l_pobj) epilepsy_21\NN\14085708
16938416
C032109_D050197 NONE esters_38\NNS\14727670 (r_appos) therapy_33\NN\657604 (l_conj) atherosclerosis_42\NN\14108324
D004967_D050197 NONE estrogen_30\NN\14745635 (r_compound) testosterone_32\NN\14747587 (r_compound) therapy_33\NN\657604 (l_conj) atherosclerosis_42\NN\14108324
D013739_D050197 CID testosterone_3\NN\14747587 (r_nsubjpass) associated_5\VBN\628491 (l_prep) with_6\IN\0 (l_pobj) atherosclerosis_7\NN\14108324
D013739_D050197 CID testosterone_32\NN\14747587 (r_compound) therapy_33\NN\657604 (l_conj) atherosclerosis_42\NN\14108324
D013739_D050197 CID testosterone_7\NN\14747587 (r_compound) therapy_8\NN\657604 (r_nsubj) affect_11\VB\26192 (l_dobj) atherosclerosis_12\NN\14108324
D002784_D003920 NONE cholesterol_9\NN\15058310 (r_compound) level_10\NN\4916342 (r_conj) diabetes_7\NNS\14075199
D000431_D003920 NONE alcohol_17\NN\7881800 (r_compound) use_18\NN\407535 (r_conj) pressure_14\NN\11419404 (r_conj) level_10\NN\4916342 (r_conj) diabetes_7\NNS\14075199
17612891
D003024_D012559 NONE clozapine_16\NN\3713736 (r_pobj) of_15\IN\0 (r_prep) commencement_14\NN\15180528 (r_pobj) after_13\IN\0 (r_prep) developed_7\VBD\1753788 (l_nsubj) male_4\NN\15388 (l_prep) with_5\IN\0 (l_pobj) schizophrenia_6\NN\14398067
D003024_D009205 CID clozapine_4\NN\3713736 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) myocarditis_1\NN\14338942
D003024_D009205 CID clozapine_10\NN\3713736 (r_pobj) of_9\IN\0 (r_prep) commencement_8\NN\15180528 (r_pobj) with_6\IN\0 (r_prep) associated_5\VBN\628491 (r_acl) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) myocarditis_4\NN\14338942
D003024_D009205 CID clozapine_16\NN\3713736 (r_pobj) of_15\IN\0 (r_prep) commencement_14\NN\15180528 (r_pobj) after_13\IN\0 (r_prep) developed_7\VBD\1753788 (l_dobj) onset_10\NN\7325190 (l_prep) of_11\IN\0 (l_pobj) myocarditis_12\NN\14338942
D003024_D009205 CID clozapine_11\NN\3713736 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) with_7\IN\0 (r_prep) associated_6\VBN\628491 (r_acl) complication_5\NN\1073995 (r_attr) is_1\VBZ\0 (l_nsubj) myocarditis_0\NNP\14338942
D003024_D011618 NONE clozapine_2\NN\3713736 (r_pobj) considering_0\VBG\689344 (r_csubj) remains_3\VBZ\2684 (l_attr) standard_6\NN\13577171 (l_prep) in_7\IN\13603305 (l_pobj) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) psychosis_11\NN\14380140
12716030
D006493_D006470 NONE heparin_7\VBN\2718259 (r_nsubj) enhanced_8\VBD\227165 (l_dobj) volume_11\NN\33615 (l_prep) over_13\IN\5867413 (l_pobj) that_14\DT\0 (l_acl) seen_15\VBN\2106506 (l_prep) in_16\IN\13603305 (l_pobj) control_17\NN\5190804 (l_dobj) animals_19\NNS\4475 (l_conj) bleeding_22\NN\14285662
D006493_D002543 NONE heparin_7\VBN\2718259 (r_nsubj) enhanced_8\VBD\227165 (l_prep) in_0\IN\13603305 (l_pobj) induction_2\NN\7450842 (l_compound) ich_1\NNP\0
D006493_D002543 NONE heparin_7\VBN\2718259 (r_nsubj) enhanced_8\VBD\227165 (l_dobj) volume_11\NN\33615 (l_prep) over_13\IN\5867413 (l_pobj) that_14\DT\0 (l_acl) seen_15\VBN\2106506 (l_prep) in_16\IN\13603305 (l_pobj) control_17\NN\5190804 (l_dobj) animals_19\NNS\4475 (l_compound) ich_18\NNP\0
D006493_D006406 CID heparin_7\VBN\2718259 (r_nsubj) enhanced_8\VBD\227165 (l_dobj) volume_11\NN\33615 (l_compound) hematoma_10\NN\14317720
16274958
D017255_D055154 CID acitretin_3\NN\0 (r_conj) dysphonia_1\NN\14400677
D017255_D055154 CID acitretin_15\NN\0 (r_pobj) by_14\IN\0 (r_agent) treated_13\VBN\2376958 (r_advcl) report_1\VBP\6470073 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) woman_6\NN\9605289 (l_acl) complaining_7\VBG\0 (l_prep) of_8\IN\0 (l_pobj) dysphonia_9\NN\14400677
D017255_D055154 CID acitretin_10\NN\0 (r_advmod) induced_12\VBN\1627355 (r_amod) dysphonia_13\NN\14400677
19631624
D002188_D007859 NONE cannabis_12\NN\13112664 (r_compound) users_13\NNS\7846 (r_pobj) in_11\IN\13603305 (r_prep) hypoactivity_10\NN\0 (r_conj) hyperactivity_7\NN\14052403 (r_appos) deficits_0\NNS\5113133 (l_prep) in_1\IN\13603305 (l_pobj) learning_2\NN\5701944 (l_conj) memory_4\NN\5926676
D018817_D008569 CID ecstasy_5\NN\13985818 (r_compound) users_6\NNS\7846 (r_pobj) in_4\IN\13603305 (r_prep) deficits_3\NNS\5113133
D018817_D008569 CID ecstasy_6\NN\13985818 (r_compound) users_7\NNS\7846 (r_nsubj) display_8\VBP\6879180 (l_dobj) impairments_9\NNS\7296428 (l_prep) in_10\IN\13603305 (l_pobj) performance_14\NN\6619065 (l_nmod) learning_11\NN\5701944 (l_conj) memory_13\NN\5926676
D002188_D006948 NONE cannabis_12\NN\13112664 (r_compound) users_13\NNS\7846 (r_pobj) in_11\IN\13603305 (r_prep) hypoactivity_10\NN\0 (r_conj) hyperactivity_7\NN\14052403
D018817_D020258 NONE ecstasy_1\NN\13985818 (r_npadvmod) specific_3\JJ\5817396 (r_amod) effects_4\NNS\13245626 (r_nsubjpass) related_7\VBN\628491 (l_prep) to_8\IN\0 (l_pobj) vulnerability_10\NN\14540765 (l_prep) to_16\IN\0 (l_pobj) effects_19\NNS\13245626 (l_amod) neurotoxic_18\JJ\0
D018817_D020258 NONE ecstasy_21\NN\13985818 (r_pobj) of_20\IN\0 (r_prep) effects_19\NNS\13245626 (l_amod) neurotoxic_18\JJ\0
D018817_D006948 NONE ecstasy_13\NN\13985818 (r_npadvmod) specific_15\JJ\5817396 (r_amod) hyperactivity_16\NN\14052403
D002188_D008569 NONE cannabis_12\NN\13112664 (r_compound) users_13\NNS\7846 (r_pobj) in_11\IN\13603305 (r_prep) hypoactivity_10\NN\0 (r_conj) hyperactivity_7\NN\14052403 (r_appos) deficits_0\NNS\5113133 (l_prep) in_1\IN\13603305 (l_pobj) learning_2\NN\5701944 (l_conj) memory_4\NN\5926676
D018817_D007859 CID ecstasy_5\NN\13985818 (r_compound) users_6\NNS\7846 (r_pobj) in_4\IN\13603305 (r_prep) deficits_3\NNS\5113133
D018817_D007859 CID ecstasy_6\NN\13985818 (r_compound) users_7\NNS\7846 (r_nsubj) display_8\VBP\6879180 (l_dobj) impairments_9\NNS\7296428 (l_prep) in_10\IN\13603305 (l_pobj) performance_14\NN\6619065 (l_nmod) learning_11\NN\5701944 (l_conj) memory_13\NN\5926676
1732369
D004317_D009202 CID doxorubicin_0\NNP\2716866 (r_nsubj) is_1\VBZ\0 (l_attr) agent_6\NN\7347 (l_acl) known_7\VBN\0 (l_xcomp) cause_9\VB\7323922 (l_dobj) cardiomyopathy_13\NN\14103288
D004280_D006331 NONE dobutamine_21\NN\0 (r_compound) infusion_22\NN\14589223 (r_dobj) using_20\VBG\418025 (r_xcomp) performed_19\VBN\0 (l_advcl) develop_1\VB\1753788 (l_dobj) test_7\NN\5798043 (l_prep) for_8\IN\0 (l_pobj) damage_10\NN\7296428
D004317_D009369 NONE doxorubicin_13\NN\2716866 (r_npadvmod) treated_15\VBN\2376958 (r_amod) survivors_19\NNS\9630641 (l_prep) of_20\IN\0 (l_pobj) cancer_22\NN\14239425
D004317_D009369 NONE doxorubicin_13\NN\2716866 (r_pobj) due_11\IN\5174653 (r_amod) damage_10\NN\7296428 (r_pobj) for_8\IN\0 (r_prep) test_7\NN\5798043 (r_dobj) develop_1\VB\1753788 (r_advcl) performed_19\VBN\0 (l_xcomp) using_20\VBG\418025 (l_xcomp) differentiate_24\VB\618878 (l_dobj) survivors_29\NNS\9630641 (l_prep) of_30\IN\0 (l_pobj) cancer_32\NN\14239425
D004317_D009369 NONE doxorubicin_35\NN\2716866 (r_pobj) with_34\IN\0 (r_prep) treated_33\VBN\2376958 (r_acl) survivors_29\NNS\9630641 (l_prep) of_30\IN\0 (l_pobj) cancer_32\NN\14239425
D004317_D006331 NONE doxorubicin_13\NN\2716866 (r_pobj) due_11\IN\5174653 (r_amod) damage_10\NN\7296428
D004317_D006331 NONE doxorubicin_35\NN\2716866 (r_pobj) with_34\IN\0 (r_prep) treated_33\VBN\2376958 (r_acl) survivors_29\NNS\9630641 (r_dobj) differentiate_24\VB\618878 (r_xcomp) using_20\VBG\418025 (r_xcomp) performed_19\VBN\0 (l_advcl) develop_1\VB\1753788 (l_dobj) test_7\NN\5798043 (l_prep) for_8\IN\0 (l_pobj) damage_10\NN\7296428
D004280_D009369 NONE dobutamine_0\NNP\0 (r_nsubj) stress_1\VBP\7083732 (l_appos) indicator_6\NN\6636259 (l_prep) of_7\IN\0 (l_pobj) function_10\NN\13783581 (l_prep) in_11\IN\13603305 (l_pobj) survivors_19\NNS\9630641 (l_prep) of_20\IN\0 (l_pobj) cancer_22\NN\14239425
D004280_D009369 NONE dobutamine_21\NN\0 (r_compound) infusion_22\NN\14589223 (r_dobj) using_20\VBG\418025 (l_xcomp) differentiate_24\VB\618878 (l_dobj) survivors_29\NNS\9630641 (l_prep) of_30\IN\0 (l_pobj) cancer_32\NN\14239425
3629586
D002511_D006402 NONE cephalosporin_15\JJ\2716866 (r_amod) hematotoxicity_16\NN\0
D002511_D006402 NONE cephalosporin_0\JJ\2716866 (r_amod) antibiotics_1\NNS\2716205 (r_nsubj) cause_2\VBP\7323922 (l_dobj) variety_4\NN\7951464 (l_prep) of_5\IN\0 (l_pobj) disturbances_7\NNS\407535
D002511_D006402 NONE cephalosporin_4\NN\2716866 (r_pobj) with_2\IN\0 (r_prep) rechallenge_1\VB\0 (r_pobj) upon_0\IN\0 (r_prep) reproduced_10\VBN\1621555 (l_nsubjpass) syndrome_8\NN\5870365
D002511_D006402 NONE cephalosporin_20\NN\2716866 (r_advmod) induced_22\VBN\1627355 (r_amod) dyscrasias_24\NNS\14052046 (r_pobj) to_18\IN\0 (r_prep) similar_17\JJ\0 (r_amod) hematotoxicity_16\NN\0
D002511_D006402 NONE cephalosporin_20\NN\2716866 (r_advmod) induced_22\VBN\1627355 (r_amod) dyscrasias_24\NNS\14052046
D015790_D009503 CID cefonicid_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_nsubj) caused_16\VBD\1617192 (l_dobj) incidence_21\NN\13821570 (l_prep) of_22\IN\0 (l_pobj) anemia_23\NN\14189204 (l_conj) neutropenia_25\NN\14196405
C021341_D064420 NONE cefazedone_12\NN\0 (r_conj) cefonicid_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_nsubj) caused_16\VBD\1617192 (l_prep) in_0\IN\13603305 (l_pobj) studies_4\NNS\635850 (l_compound) toxicity_3\NN\13576101
D015790_D013921 CID cefonicid_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_nsubj) caused_16\VBD\1617192 (l_ccomp) thrombocytopenia_28\NN\14189204
C021341_D006402 NONE cefazedone_6\NN\0 (r_conj) cefonicid_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_appos) model_13\NN\5888929 (l_prep) of_14\IN\0 (l_pobj) hematotoxicity_16\NN\0
C021341_D006402 NONE cefazedone_29\NN\0 (r_conj) cefonicid_23\NN\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) of_16\IN\0 (r_prep) %_15\NN\0 (r_pobj) in_12\IN\13603305 (r_prep) occurred_11\VBD\0 (r_conj) was_3\VBD\0 (l_attr) compromising_6\NN\1035530 (l_prep) of_7\IN\0 (l_pobj) cytopenias_9\NNS\14189204
C021341_D006402 NONE cefazedone)-treated_20\VBN\0 (r_amod) dogs_21\NNS\2083346 (r_nsubj) showed_22\VBD\2137132 (l_ccomp) reproduced_10\VBN\1621555 (l_nsubjpass) syndrome_8\NN\5870365
C021341_D006402 NONE cefazedone_11\NN\0 (r_conj) cefonicid_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_nsubj) induce_15\VB\1627355 (l_dobj) hematotoxicity_16\NN\0
C021341_D006402 NONE cefazedone_11\NN\0 (r_conj) cefonicid_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_nsubj) induce_15\VB\1627355 (l_dobj) hematotoxicity_16\NN\0 (l_amod) similar_17\JJ\0 (l_prep) to_18\IN\0 (l_pobj) dyscrasias_24\NNS\14052046
D015790_D064420 NONE cefonicid_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_nsubj) caused_16\VBD\1617192 (l_prep) in_0\IN\13603305 (l_pobj) studies_4\NNS\635850 (l_compound) toxicity_3\NN\13576101
C021341_D009503 CID cefazedone_12\NN\0 (r_conj) cefonicid_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_nsubj) caused_16\VBD\1617192 (l_dobj) incidence_21\NN\13821570 (l_prep) of_22\IN\0 (l_pobj) anemia_23\NN\14189204 (l_conj) neutropenia_25\NN\14196405
C021341_D013921 CID cefazedone_12\NN\0 (r_conj) cefonicid_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_nsubj) caused_16\VBD\1617192 (l_ccomp) thrombocytopenia_28\NN\14189204
D015790_D006402 NONE cefonicid_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_appos) model_13\NN\5888929 (l_prep) of_14\IN\0 (l_pobj) hematotoxicity_16\NN\0
D015790_D006402 NONE cefonicid_23\NN\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) of_16\IN\0 (r_prep) %_15\NN\0 (r_pobj) in_12\IN\13603305 (r_prep) occurred_11\VBD\0 (r_conj) was_3\VBD\0 (l_attr) compromising_6\NN\1035530 (l_prep) of_7\IN\0 (l_pobj) cytopenias_9\NNS\14189204
D015790_D006402 NONE cefonicid_16\NN\0 (r_amod) dogs_21\NNS\2083346 (r_nsubj) showed_22\VBD\2137132 (l_ccomp) reproduced_10\VBN\1621555 (l_nsubjpass) syndrome_8\NN\5870365
D015790_D006402 NONE cefonicid_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_nsubj) induce_15\VB\1627355 (l_dobj) hematotoxicity_16\NN\0
D015790_D006402 NONE cefonicid_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_nsubj) induce_15\VB\1627355 (l_dobj) hematotoxicity_16\NN\0 (l_amod) similar_17\JJ\0 (l_prep) to_18\IN\0 (l_pobj) dyscrasias_24\NNS\14052046
D015790_D000740 CID cefonicid_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_nsubj) caused_16\VBD\1617192 (l_dobj) incidence_21\NN\13821570 (l_prep) of_22\IN\0 (l_pobj) anemia_23\NN\14189204
D015790_D000740 CID cefonicid_23\NN\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) of_16\IN\0 (r_prep) %_15\NN\0 (r_pobj) in_12\IN\13603305 (r_prep) occurred_11\VBD\0 (r_conj) was_3\VBD\0 (l_nsubj) anemia_2\NN\14189204
C021341_D000740 CID cefazedone_12\NN\0 (r_conj) cefonicid_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_nsubj) caused_16\VBD\1617192 (l_dobj) incidence_21\NN\13821570 (l_prep) of_22\IN\0 (l_pobj) anemia_23\NN\14189204
C021341_D000740 CID cefazedone_29\NN\0 (r_conj) cefonicid_23\NN\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) of_16\IN\0 (r_prep) %_15\NN\0 (r_pobj) in_12\IN\13603305 (r_prep) occurred_11\VBD\0 (r_conj) was_3\VBD\0 (l_nsubj) anemia_2\NN\14189204
14698717
D010672_D004827 NONE phenytoin_10\JJ\3550533 (r_compound) treatment_11\NN\654885 (l_prep) in_12\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_amod) epileptic_14\JJ\10595647
D010672_D011605 NONE phenytoin_6\NN\3550533 (r_pobj) with_5\IN\0 (r_prep) treatment_4\NN\654885 (r_pobj) due_2\IN\5174653 (r_amod) psychosis_1\NN\14380140
D010672_D011605 NONE phenytoin_10\JJ\3550533 (r_compound) treatment_11\NN\654885 (r_dobj) following_9\VBG\8180190 (r_acl) psychosis_8\NN\14380140
D010672_D011605 NONE phenytoin_10\JJ\3550533 (r_compound) treatment_11\NN\654885 (r_pobj) following_9\VBG\8180190 (r_prep) occur_8\VBP\0 (r_relcl) symptoms_6\NNS\5823932
D010672_D012640 NONE phenytoin_10\JJ\3550533 (r_compound) treatment_11\NN\654885 (r_pobj) following_9\VBG\8180190 (r_prep) occur_8\VBP\0 (r_relcl) symptoms_6\NNS\5823932 (r_nsubj) be_17\VB\14625458 (l_attr) result_20\NN\34213 (l_amod) unrelated_24\JJ\0 (l_prep) to_25\IN\0 (l_pobj) seizures_26\NNS\14081375
D010672_D014277 NONE phenytoin_10\JJ\3550533 (r_compound) treatment_11\NN\654885 (l_prep) for_12\IN\0 (l_pobj) neuralgia_14\NN\14322699
17931375
D006493_D003288 CID heparin_10\JJ\2718259 (r_compound) injection_11\NN\320852 (l_prep) on_12\IN\0 (l_pobj) bruising_13\VBG\69879
D006493_D003288 CID heparin_24\NN\2718259 (r_pobj) of_23\IN\0 (r_prep) injection_22\NN\320852 (r_pobj) of_19\IN\0 (r_prep) administration_18\NN\1133281 (r_pobj) following_16\VBG\8180190 (r_prep) effect_8\NN\34213 (l_prep) of_9\IN\0 (l_pobj) duration_11\NN\15113229 (l_prep) on_12\IN\0 (l_pobj) bruising_13\VBG\69879
D006493_D003288 CID heparin_13\NN\2718259 (r_pobj) of_12\IN\0 (r_prep) injection_11\NN\320852 (r_pobj) following_8\VBG\8180190 (r_prep) prevent_4\VB\0 (l_dobj) bruising_5\NN\69879
D006493_D003288 CID heparin_13\NN\2718259 (r_pobj) of_12\IN\0 (r_prep) injection_11\NN\320852 (r_pobj) following_8\VBG\8180190 (r_prep) prevent_4\VB\0 (r_acl) methods_2\NNS\5616786 (r_nsubjpass) studied_17\VBN\0 (r_advcl) documented_35\JJ\1000214 (l_nsubjpass) effect_22\NN\34213 (l_prep) of_23\IN\0 (l_pobj) duration_25\NN\15113229 (l_prep) on_26\IN\0 (l_pobj) occurrence_28\NN\29378 (l_prep) of_29\IN\0 (l_pobj) bruising_30\VBG\69879
D006493_D003288 CID heparin_6\NN\2718259 (r_pobj) on_4\IN\0 (r_prep) bruising_3\NN\69879
D006493_D003288 CID heparin_18\NN\2718259 (r_pobj) of_17\IN\0 (r_prep) administration_16\NN\1133281 (r_pobj) following_13\VBG\8180190 (r_prep) had_6\VBD\0 (l_dobj) effect_8\NN\34213 (l_prep) on_9\IN\0 (l_pobj) bruising_10\VBG\69879
D006493_D010146 CID heparin_10\JJ\2718259 (r_compound) injection_11\NN\320852 (l_prep) on_12\IN\0 (l_pobj) bruising_13\VBG\69879 (l_conj) pain_15\NN\14299637
D006493_D010146 CID heparin_24\NN\2718259 (r_pobj) of_23\IN\0 (r_prep) injection_22\NN\320852 (r_pobj) of_19\IN\0 (r_prep) administration_18\NN\1133281 (r_pobj) following_16\VBG\8180190 (r_prep) effect_8\NN\34213 (l_prep) of_9\IN\0 (l_pobj) duration_11\NN\15113229 (l_prep) on_12\IN\0 (l_pobj) bruising_13\VBG\69879 (l_conj) pain_15\NN\14299637
D006493_D010146 CID heparin_13\NN\2718259 (r_pobj) of_12\IN\0 (r_prep) injection_11\NN\320852 (r_pobj) following_8\VBG\8180190 (r_prep) prevent_4\VB\0 (l_dobj) bruising_5\NN\69879 (l_conj) pain_7\NN\14299637
D006493_D010146 CID heparin_13\NN\2718259 (r_pobj) of_12\IN\0 (r_prep) injection_11\NN\320852 (r_pobj) following_8\VBG\8180190 (r_prep) prevent_4\VB\0 (r_acl) methods_2\NNS\5616786 (r_nsubjpass) studied_17\VBN\0 (r_advcl) documented_35\JJ\1000214 (l_nsubjpass) effect_22\NN\34213 (l_prep) of_23\IN\0 (l_pobj) duration_25\NN\15113229 (l_prep) on_26\IN\0 (l_pobj) occurrence_28\NN\29378 (l_prep) of_29\IN\0 (l_pobj) bruising_30\VBG\69879 (l_conj) pain_32\NN\14299637
D006493_D010146 CID heparin_18\NN\2718259 (r_pobj) of_17\IN\0 (r_prep) administration_16\NN\1133281 (r_pobj) following_13\VBG\8180190 (r_prep) had_6\VBD\0 (l_dobj) effect_8\NN\34213 (l_prep) on_9\IN\0 (l_pobj) bruising_10\VBG\69879 (l_conj) pain_12\NN\14299637
2696505
D009599_D006973 NONE nitroprusside_31\NN\0 (r_pobj) of_30\IN\0 (r_prep) discontinuation_29\NN\209943 (r_pobj) after_28\IN\0 (r_prep) observed_24\VBN\2163746 (l_nsubjpass) hypertension_22\NN\14057371
D009599_D007022 CID nitroprusside_6\RB\0 (l_prep) for_7\IN\0 (l_pobj) hypotension_9\NN\14057371
D009599_D007022 CID nitroprusside_10\RB\0 (r_advmod) induced_12\VBN\1627355 (r_amod) hypotension_13\NN\14057371 (r_conj) hypotension_8\NN\14057371
D009599_D007022 CID nitroprusside_10\RB\0 (r_advmod) induced_12\VBN\1627355 (r_amod) hypotension_13\NN\14057371
D009599_D016534 CID nitroprusside_31\NN\0 (r_pobj) of_30\IN\0 (r_prep) discontinuation_29\NN\209943 (r_pobj) after_28\IN\0 (r_prep) observed_24\VBN\2163746 (l_ccomp) associated_3\VBN\628491 (l_advcl) increase_13\NN\13576355 (l_prep) in_14\IN\13603305 (l_pobj) rate_16\NN\13815152 (l_conj) output_19\NN\4007894
D007741_D007022 CID labetalol_4\NN\2721160 (l_conj) nitroprusside_6\RB\0 (l_prep) for_7\IN\0 (l_pobj) hypotension_9\NN\14057371
D007741_D007022 CID labetalol_5\RB\2721160 (r_npadvmod) induced_7\VBN\1627355 (r_amod) hypotension_8\NN\14057371
D007741_D007022 CID labetalol_5\RB\2721160 (r_npadvmod) induced_7\VBN\1627355 (r_amod) hypotension_8\NN\14057371 (l_conj) hypotension_13\NN\14057371
10579464
D003024_D002375 CID clozapine_2\NN\3713736 (r_conj) nra0160_0\NNP\0 (r_nsubj) induced_4\VBN\1627355 (l_dobj) catalepsy_5\NN\14023236
D008694_D006948 CID methamphetamine_8\NN\2704153 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (r_acl) hyperactivity_5\NN\14052403
D008694_D006948 CID map_10\NNP\4076846 (r_appos) methamphetamine_8\NN\2704153 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (r_acl) hyperactivity_5\NN\14052403
C121249_D006948 NONE nra0160_0\NNP\0 (r_nsubj) antagonized_3\VBN\1787955 (l_dobj) hyperactivity_5\NN\14052403
D003024_D006948 NONE clozapine_2\NN\3713736 (r_conj) nra0160_0\NNP\0 (r_nsubj) antagonized_3\VBN\1787955 (l_dobj) hyperactivity_5\NN\14052403
C121249_D002375 CID nra0160_0\NNP\0 (r_nsubj) induced_4\VBN\1627355 (l_dobj) catalepsy_5\NN\14023236
19356307
C032208_D003704 NONE alcohol_13\NN\7881800 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (l_compound) dementia_3\NN\14395018
D012601_D008569 CID scopolamine_12\NN\14712692 (r_pobj) by_11\IN\0 (r_agent) impaired_10\VBN\258857
D012601_D008569 CID scopolamine_12\NN\14712692 (r_pobj) by_11\IN\0 (r_agent) impaired_10\VBN\258857 (r_amod) memory_9\NN\5926676 (r_dobj) improve_8\VB\126264 (r_acl) ability_6\NN\4723816 (r_dobj) showed_4\VBD\2137132 (r_ccomp) relieved_20\VBD\205885 (l_dobj) deficit_22\NN\5113133 (l_prep) of_23\IN\0 (l_pobj) memory_25\NN\5926676
C032208_D008569 NONE alcohol_19\NN\7881800 (r_nsubj) relieved_20\VBD\205885 (l_ccomp) showed_4\VBD\2137132 (l_dobj) ability_6\NN\4723816 (l_acl) improve_8\VB\126264 (l_dobj) memory_9\NN\5926676 (l_amod) impaired_10\VBN\258857
C032208_D008569 NONE alcohol_19\NN\7881800 (r_nsubj) relieved_20\VBD\205885 (l_dobj) deficit_22\NN\5113133 (l_prep) of_23\IN\0 (l_pobj) memory_25\NN\5926676
D012601_D003704 NONE scopolamine_9\NN\14712692 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (l_nsubj) components_0\NNS\5867413 (l_prep) of_1\IN\0 (l_pobj) dementia_6\NN\14395018
C008281_D003704 NONE limonene_8\NN\15068635 (r_nmod) alcohol_13\NN\7881800 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (l_compound) dementia_3\NN\14395018
2273650
D012601_D000647 CID scopolamine_3\NN\14712692 (r_pobj) by_2\IN\0 (r_agent) produced_1\VBN\1617192 (r_acl) amnesia_0\NNP\5669934
D012601_D000647 CID scopolamine_5\NN\14712692 (r_nsubj) reversed_7\VBD\109660 (l_dobj) amnesia_12\NN\5669934
D012601_D000647 CID scopolamine_5\NN\14712692 (r_nsubj) reversed_7\VBD\109660 (l_conj) failed_23\VBD\0 (l_xcomp) reverse_25\VB\13854649 (l_dobj) amnesia_30\NN\5669934
D012601_D000647 CID scopolamine_9\NN\14712692 (r_npadvmod) induced_11\VBN\1627355 (r_amod) amnesia_12\NN\5669934
D012601_D000647 CID scopolamine_9\NN\14712692 (r_npadvmod) induced_11\VBN\1627355 (r_amod) amnesia_12\NN\5669934 (r_dobj) reversed_7\VBD\109660 (l_conj) failed_23\VBD\0 (l_xcomp) reverse_25\VB\13854649 (l_dobj) amnesia_30\NN\5669934
D009270_D000647 NONE naloxone_37\NN\3808977 (r_dobj) administered_36\VBN\2436349 (r_acl) retrieval_32\NN\13450862 (r_dobj) facilitated_29\VBD\2547586 (r_conj) reversed_7\VBN\109660 (l_nsubjpass) amnesia_0\NNP\5669934
D009020_D000647 NONE morphine_9\NN\2707683 (r_pobj) by_8\IN\0 (r_agent) reversed_7\VBN\109660 (l_nsubjpass) amnesia_0\NNP\5669934
D009020_D000647 NONE morphine_27\NN\2707683 (r_nsubj) facilitated_29\VBD\2547586 (r_conj) reversed_7\VBN\109660 (l_nsubjpass) amnesia_0\NNP\5669934
D003513_D000647 CID cycloheximide_5\NN\0 (r_conj) scopolamine_3\NN\14712692 (r_pobj) by_2\IN\0 (r_agent) produced_1\VBN\1617192 (r_acl) amnesia_0\NNP\5669934
D003513_D000647 CID cycloheximide_22\NN\0 (r_nsubj) failed_23\VBD\0 (r_conj) reversed_7\VBD\109660 (l_dobj) amnesia_12\NN\5669934
D003513_D000647 CID cycloheximide_22\NN\0 (r_nsubj) failed_23\VBD\0 (l_xcomp) reverse_25\VB\13854649 (l_dobj) amnesia_30\NN\5669934
D003513_D000647 CID cycloheximide_27\RB\0 (r_advmod) induced_29\VBN\1627355 (r_amod) amnesia_30\NN\5669934 (r_dobj) reverse_25\VB\13854649 (r_xcomp) failed_23\VBD\0 (r_conj) reversed_7\VBD\109660 (l_dobj) amnesia_12\NN\5669934
D003513_D000647 CID cycloheximide_27\RB\0 (r_advmod) induced_29\VBN\1627355 (r_amod) amnesia_30\NN\5669934
18217897
D013792_D009369 NONE thalidomide_0\NNP\4166841 (r_nsubj) limited_2\VBN\4019101 (l_prep) in_7\IN\13603305 (l_pobj) lymphomas_15\NNS\14239918 (l_appos) trial_20\NN\786195 (l_prep) of_21\IN\0 (l_pobj) cancer_23\NNP\14239425
D013792_D008228 NONE thalidomide_0\NNP\4166841 (r_nsubj) limited_2\VBN\4019101 (l_prep) in_7\IN\13603305 (l_pobj) lymphomas_15\NNS\14239918
D013792_D009101 NONE thalidomide_0\NNP\4166841 (r_nsubj) is_1\VBZ\0 (l_attr) agent_4\NN\7347 (l_prep) with_5\IN\0 (l_pobj) activity_7\NN\30358 (l_prep) in_8\IN\13603305 (l_pobj) myeloma_10\NN\14239425
C467567_D008223 NONE lenalidomide_31\NN\0 (r_appos) agent_29\NN\7347 (r_pobj) with_24\IN\0 (r_prep) reported_23\VBN\831651 (r_acl) level_22\NN\4916342 (r_pobj) with_18\IN\0 (r_prep) contrast_17\NN\13854649 (r_conj) demonstrate_4\VB\2137132 (l_dobj) rate_8\NN\13815152 (l_prep) in_13\IN\13603305 (l_pobj) lymphomas_15\NNS\14239918
D013792_D008223 NONE thalidomide_0\NNP\4166841 (r_nsubj) is_1\VBZ\0 (l_attr) agent_4\NN\7347 (l_prep) with_5\IN\0 (l_pobj) activity_7\NN\30358 (l_prep) in_8\IN\13603305 (l_pobj) myeloma_10\NN\14239425 (l_conj) lymphoma_14\NN\14239918 (l_conj) lymphoma_17\NN\14239918
D013792_D008223 NONE thalidomide_16\NN\4166841 (r_dobj) received_15\VBD\2210855 (l_nsubj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_pobj) lymphomas_14\NNS\14239918
D013792_D008223 NONE thalidomide_12\NN\4166841 (r_pobj) to_9\IN\0 (r_prep) rate_8\NN\13815152 (l_prep) in_13\IN\13603305 (l_pobj) lymphomas_15\NNS\14239918
D013792_D007938 NONE thalidomide_0\NNP\4166841 (r_nsubj) limited_2\VBN\4019101 (l_prep) in_7\IN\13603305 (l_pobj) lymphomas_15\NNS\14239918 (l_appos) trial_20\NN\786195 (l_prep) of_21\IN\0 (l_pobj) cancer_23\NNP\14239425 (l_conj) b._27\NNP\0 (l_compound) leukemia_25\NNP\14239918
D013792_D020522 NONE thalidomide_0\NNP\4166841 (r_nsubj) is_1\VBZ\0 (l_attr) agent_4\NN\7347 (l_prep) with_5\IN\0 (l_pobj) activity_7\NN\30358 (l_prep) in_8\IN\13603305 (l_pobj) myeloma_10\NN\14239425 (l_conj) lymphoma_14\NN\14239918
3070035
D002216_D051437 NONE captopril_2\NN\2673637 (r_npadvmod) induced_4\VBN\1627355 (r_amod) insufficiency_6\NN\14462946
D002216_D051437 NONE captopril_4\NN\2673637 (r_npadvmod) induced_6\VBN\1627355 (r_amod) failure_8\NN\66216
D002216_D058186 CID captopril_27\NN\2673637 (r_pobj) with_26\IN\0 (r_prep) treatment_25\NN\654885 (r_pobj) following_24\VBG\8180190 (r_prep) deterioration_20\NN\14560612 (l_prep) of_21\IN\0 (l_pobj) function_23\NN\13783581
D002216_D006978 NONE captopril_2\NN\2673637 (r_npadvmod) induced_4\VBN\1627355 (r_amod) insufficiency_6\NN\14462946 (r_pobj) of_1\IN\0 (r_prep) reversibility_0\NN\4733640 (l_prep) after_7\IN\0 (l_pobj) use_9\NN\407535 (l_prep) in_10\IN\13603305 (l_pobj) case_13\NN\7283608 (l_prep) of_14\IN\0 (l_pobj) hypertension_16\NN\14057371
D002216_D006973 NONE captopril_27\NN\2673637 (r_pobj) with_26\IN\0 (r_prep) treatment_25\NN\654885 (r_pobj) following_24\VBG\8180190 (r_prep) deterioration_20\NN\14560612 (r_dobj) developed_18\VBD\1753788 (r_relcl) kidney_15\NN\5333259 (r_pobj) to_12\IN\0 (r_prep) artery_11\NN\5417975 (r_pobj) with_7\IN\0 (r_prep) hypertension_6\NN\14057371
1987816
D008094_D011141 CID lithium_0\NN\14625458 (r_npadvmod) induced_2\VBN\1627355 (r_amod) polyuria_3\NN\14113228
4008111
D000638_D012848 CID amiodarone_0\NN\2715941 (r_npadvmod) induced_2\VBN\1627355 (r_amod) block_4\NN\21939
D000638_D012848 CID amiodarone_7\NN\2715941 (r_compound) administration_8\NN\1133281 (r_pobj) due_4\JJ\5174653 (r_prep) observed_1\VBD\2163746 (l_dobj) block_3\NN\21939
D000638_D012848 CID amiodarone_5\NN\2715941 (r_pobj) of_4\IN\0 (r_prep) dosage_3\NN\13576355 (r_pobj) in_1\IN\13603305 (r_prep) reduction_0\NN\351485 (r_nsubj) resulted_6\VBD\2633881 (l_prep) in_7\IN\13603305 (l_pobj) disappearance_9\NN\42757 (l_prep) of_10\IN\0 (l_pobj) block_13\NN\21939
D000638_D013617 NONE amiodarone_7\NN\2715941 (r_compound) administration_8\NN\1133281 (r_pobj) due_4\JJ\5174653 (r_prep) observed_1\VBD\2163746 (l_dobj) syndrome_24\NN\5870365 (l_conj) tachycardia_27\NN\14110674
D000638_D009202 NONE amiodarone_7\NN\2715941 (r_compound) administration_8\NN\1133281 (l_prep) in_9\IN\13603305 (l_pobj) boy_14\NN\9624168 (l_prep) with_15\IN\0 (l_pobj) cardiomyopathy_17\NN\14103288
D000638_D012804 NONE amiodarone_5\NN\2715941 (r_pobj) of_4\IN\0 (r_prep) dosage_3\NN\13576355 (r_pobj) in_1\IN\13603305 (r_prep) reduction_0\NN\351485 (r_nsubj) resulted_6\VBD\2633881 (l_prep) in_7\IN\13603305 (l_pobj) disappearance_9\NN\42757 (l_conj) persistence_16\NN\5053688 (l_prep) of_17\IN\0 (l_pobj) bradycardia_20\NNP\14110674
D000638_D014927 NONE amiodarone_7\NN\2715941 (r_compound) administration_8\NN\1133281 (r_pobj) due_4\JJ\5174653 (r_prep) observed_1\VBD\2163746 (l_dobj) syndrome_24\NN\5870365
3425586
D003622_D000743 CID dapsone_0\NN\2716205 (r_npadvmod) associated_2\VBN\628491 (r_amod) anemia_6\NN\14189204
D003622_D000743 CID dapsone_23\NN\2716205 (r_pobj) of_22\IN\0 (r_prep) dose_21\NN\3740161 (r_dobj) taking_19\VBG\37396 (r_advcl) developed_12\VBD\1753788 (l_dobj) anemia_17\NN\14189204
D003622_D000743 CID dapsone_21\NN\2716205 (r_nsubj) cause_24\VB\7323922 (l_dobj) anemia_26\NN\14189204
D003622_D007918 NONE dapsone_23\NN\2716205 (r_pobj) of_22\IN\0 (r_prep) dose_21\NN\3740161 (r_dobj) taking_19\VBG\37396 (r_advcl) developed_12\VBD\1753788 (l_nsubj) woman_2\NN\9605289 (l_conj) leprosy_11\NN\14127211
D003622_D006461 NONE dapsone_23\NN\2716205 (r_pobj) of_22\IN\0 (r_prep) dose_21\NN\3740161 (l_acl) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) hemolysis_35\NN\13509528
15338796
D000420_D008173 NONE salbutamol_19\NN\0 (r_pobj) of_18\IN\0 (r_prep) doses_17\NNS\3740161 (r_pobj) of_15\IN\0 (r_prep) administration_14\NN\1133281 (r_pobj) after_13\IN\0 (r_prep) disease_12\NN\14061805
D000420_D014202 CID salbutamol_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_compound) tremor_0\NNP\345926
D000420_D014202 CID salbutamol_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (l_compound) tremor_2\JJ\345926
D000420_D014202 CID salbutamol_19\NN\0 (r_pobj) of_18\IN\0 (r_prep) doses_17\NNS\3740161 (r_pobj) of_15\IN\0 (r_prep) administration_14\NN\1133281 (r_pobj) after_13\IN\0 (r_prep) disease_12\NN\14061805 (r_pobj) with_9\IN\0 (r_prep) patients_8\NNS\9898892 (r_pobj) in_6\IN\13603305 (r_prep) assessed_4\VBD\670261 (l_dobj) tremor_5\NN\345926
D000420_D014202 CID salbutamol_0\NNP\0 (r_nsubj) increased_2\VBD\169651 (l_dobj) severity_4\NN\5036394 (l_compound) tremor_3\NN\345926
3358181
D012312_D014693 CID ritodrine_6\JJ\0 (r_compound) therapy_7\NN\657604 (r_pobj) after_5\IN\0 (r_prep) section_4\NN\7020895 (r_pobj) during_2\IN\0 (r_prep) tachyarrhythmias_1\NNS\0
D010656_D007022 NONE phenylephrine_22\NN\2682038 (l_relcl) treat_24\VB\7570720 (l_dobj) patients_26\NNS\9898892 (l_amod) hypotensive_25\JJ\10405694
D012312_D002318 NONE ritodrine_15\NN\0 (r_pobj) of_14\IN\0 (r_prep) infusion_13\NN\14589223 (r_pobj) of_11\IN\0 (r_prep) cessation_10\NN\7365849 (r_pobj) after_9\IN\0 (r_prep) complications_7\NNS\1073995
D010656_D013610 NONE phenylephrine_22\NN\2682038 (l_relcl) treat_24\VB\7570720 (l_prep) with_27\IN\0 (l_pobj) tachycardia_28\NNS\14110674
D012312_D007752 NONE ritodrine_6\RB\0 (l_prep) for_7\IN\0 (l_pobj) labor_9\NN\7974025
D012312_D007752 NONE ritodrine_19\NN\0 (r_pobj) of_18\IN\0 (r_prep) effects_17\NNS\13245626 (r_pobj) between_13\IN\0 (r_prep) interactions_12\NNS\37396 (r_dobj) risk_11\VB\14541044 (l_nsubj) patients_4\NNS\9898892 (l_acl) receiving_5\VBG\2210855 (l_dobj) ritodrine_6\RB\0 (l_prep) for_7\IN\0 (l_pobj) labor_9\NN\7974025
19581773
D012254_D004172 NONE ribavirin_21\RB\2725367 (r_conj) alpha-2b_19\CD\0 (r_conj) ifn_17\NNP\0 (r_appos) interferon_15\NN\2725367 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) of_11\IN\0 (r_prep) weeks_10\NNS\15113229 (r_pobj) after_8\IN\0 (r_prep) diplopia_7\NN\14552802
D012254_D019698 NONE ribavirin_8\JJ\2725367 (r_conj) interferon_6\NN\2725367 (r_nmod) treatment_9\NN\654885 (l_prep) for_10\IN\0 (l_pobj) c._13\NNP\0
D012254_D019698 NONE ribavirin_21\RB\2725367 (r_conj) alpha-2b_19\CD\0 (r_conj) ifn_17\NNP\0 (r_appos) interferon_15\NN\2725367 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) of_11\IN\0 (r_prep) weeks_10\NNS\15113229 (r_pobj) after_8\IN\0 (r_prep) diplopia_7\NN\14552802 (l_prep) for_22\IN\0 (l_pobj) c_25\NNP\13714184
D012254_D019698 NONE ribavirin_21\RB\2725367 (r_conj) alpha-2b_19\CD\0 (r_conj) ifn_17\NNP\0 (r_appos) interferon_15\NN\2725367 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) of_11\IN\0 (r_prep) weeks_10\NNS\15113229 (r_pobj) after_8\IN\0 (r_prep) diplopia_7\NN\14552802 (l_prep) for_22\IN\0 (l_pobj) c_25\NNP\13714184 (l_appos) chc_27\NNP\0
D012254_D019698 NONE ribavirin_12\RB\2725367 (r_conj) alpha-2b_10\CD\0 (l_prep) for_13\IN\0 (l_pobj) chc_14\NNP\0
C417083_D004172 NONE alpha-2b_19\CD\0 (r_conj) ifn_17\NNP\0 (r_appos) interferon_15\NN\2725367 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) of_11\IN\0 (r_prep) weeks_10\NNS\15113229 (r_pobj) after_8\IN\0 (r_prep) diplopia_7\NN\14552802
C417083_D009157 CID interferon_6\NN\2725367 (r_nmod) treatment_9\NN\654885 (r_pobj) during_4\IN\0 (r_prep) development_0\NN\248977 (l_prep) of_1\IN\0 (l_pobj) myasthenia_3\NN\14187378
C417083_D009157 CID alpha-2b_10\CD\0 (r_pobj) of_7\IN\0 (r_prep) therapy_6\NN\657604 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) myasthenia_2\NN\14187378
C417083_D009157 CID ifn_35\NNP\0 (r_compound) therapy_36\NN\657604 (r_pobj) of_34\IN\0 (r_prep) complications_33\NNS\1073995 (r_pobj) of_29\IN\0 (r_prep) review_28\NN\5733583 (r_pobj) with_26\IN\0 (r_prep) present_23\VBP\28270 (l_ccomp) reported_18\VBN\831651 (l_nsubjpass) myasthenia_2\NN\14187378
C417083_D019698 NONE interferon_6\NN\2725367 (r_nmod) treatment_9\NN\654885 (l_prep) for_10\IN\0 (l_pobj) c._13\NNP\0
C417083_D019698 NONE alpha-2b_19\CD\0 (r_conj) ifn_17\NNP\0 (r_appos) interferon_15\NN\2725367 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) of_11\IN\0 (r_prep) weeks_10\NNS\15113229 (r_pobj) after_8\IN\0 (r_prep) diplopia_7\NN\14552802 (l_prep) for_22\IN\0 (l_pobj) c_25\NNP\13714184
C417083_D019698 NONE alpha-2b_19\CD\0 (r_conj) ifn_17\NNP\0 (r_appos) interferon_15\NN\2725367 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) of_11\IN\0 (r_prep) weeks_10\NNS\15113229 (r_pobj) after_8\IN\0 (r_prep) diplopia_7\NN\14552802 (l_prep) for_22\IN\0 (l_pobj) c_25\NNP\13714184 (l_appos) chc_27\NNP\0
C417083_D019698 NONE alpha-2b_10\CD\0 (l_prep) for_13\IN\0 (l_pobj) chc_14\NNP\0
C417083_D019698 NONE ifn_35\NNP\0 (r_compound) therapy_36\NN\657604 (r_pobj) of_34\IN\0 (r_prep) complications_33\NNS\1073995 (r_pobj) of_29\IN\0 (r_prep) review_28\NN\5733583 (r_pobj) with_26\IN\0 (r_prep) present_23\VBP\28270 (l_ccomp) reported_18\VBN\831651 (l_nsubjpass) myasthenia_2\NN\14187378 (l_acl) associated_3\VBN\628491 (l_prep) with_4\IN\0 (l_pobj) therapy_6\NN\657604 (l_prep) of_7\IN\0 (l_pobj) alpha-2b_10\CD\0 (l_prep) for_13\IN\0 (l_pobj) chc_14\NNP\0
D012254_D009157 CID ribavirin_8\JJ\2725367 (r_conj) interferon_6\NN\2725367 (r_nmod) treatment_9\NN\654885 (r_pobj) during_4\IN\0 (r_prep) development_0\NN\248977 (l_prep) of_1\IN\0 (l_pobj) myasthenia_3\NN\14187378
D012254_D009157 CID ribavirin_12\RB\2725367 (r_conj) alpha-2b_10\CD\0 (r_pobj) of_7\IN\0 (r_prep) therapy_6\NN\657604 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) myasthenia_2\NN\14187378
9088814
D000527_D007022 CID e1-induced_5\JJ\0 (r_amod) hypotension_6\NN\14057371
D000527_D007022 CID e1_5\NN\0 (l_appos) hypotension_8\NN\14057371
D000527_D007022 CID pge1)-induced_7\JJ\0 (r_amod) hypotension_8\NN\14057371
D000527_D007022 CID pge1_10\NNP\0 (r_pobj) with_9\IN\0 (r_prep) induced_8\VBN\1627355 (l_nsubjpass) hypotension_1\NN\14057371
D000527_D007022 CID pge1-induced_13\JJ\0 (r_amod) hypotension_14\NN\14057371
D003911_D020141 NONE dextran_23\NN\0 (r_amod) solution_24\NN\14586258 (r_pobj) of_22\IN\0 (r_prep) amount_21\NN\13329641 (r_pobj) with_18\IN\0 (r_prep) replacing_16\VBG\196485 (r_conj) withdrawing_9\VBG\1835496 (r_pcomp) by_8\IN\0 (r_prep) produced_7\VBN\1617192 (l_nsubjpass) haemodilution_0\NN\0
D001663_D007022 NONE bilirubin_68\NN\14756039 (r_conj) ldh_65\NNP\0 (r_conj) sgpt_63\NNP\0 (r_appos) sgot_61\NNP\0 (r_nsubj) showed_69\VBD\2137132 (r_conj) showed_23\VBD\2137132 (l_prep) after_42\IN\0 (l_pobj) start_44\NN\7290905 (l_prep) of_45\IN\0 (l_pobj) hypotension_46\NN\14057371
D000527_D008107 CID pge1-induced_13\JJ\0 (r_amod) hypotension_14\NN\14057371 (r_pobj) of_12\IN\0 (r_prep) min_11\NN\15154774 (r_pobj) of_7\IN\0 (r_prep) combination_6\NN\7951464 (r_nsubj) cause_19\VB\7323922 (l_dobj) impairment_20\NN\7296428 (l_prep) of_21\IN\0 (l_pobj) function_23\NN\13783581
D000527_D020141 NONE e1-induced_5\JJ\0 (r_amod) hypotension_6\NN\14057371 (l_conj) haemodilution_8\NN\0
D000527_D020141 NONE e1_5\NN\0 (l_appos) hypotension_8\NN\14057371 (l_conj) haemodilution_10\NN\0
D000527_D020141 NONE pge1)-induced_7\JJ\0 (r_amod) hypotension_8\NN\14057371 (l_conj) haemodilution_10\NN\0
D000527_D020141 NONE pge1-induced_13\JJ\0 (r_amod) hypotension_14\NN\14057371 (l_conj) haemodilution_17\NN\0
18726058
D010208_D003389 NONE papaverine_13\NN\3800001 (r_pobj) with_11\IN\0 (r_prep) cases_10\NNS\7283608 (r_pobj) in_7\IN\13603305 (r_prep) described_6\VBN\1001294 (l_nsubjpass) dysfunction_3\NN\14204950
D010208_D003389 NONE papaverine_8\NN\3800001 (r_pobj) from_7\IN\0 (r_prep) deficits_6\NNS\5113133
D010208_D020301 NONE hydrochloride_1\NN\14817592 (r_nsubj) is_2\VBZ\0 (l_attr) vasodilator_7\NN\3198383 (l_acl) used_8\VBD\0 (l_xcomp) manage_10\VB\2524171 (l_dobj) vasospasm_11\NN\0
D010208_D020301 NONE papaverine_18\NN\3800001 (r_dobj) received_16\VBD\2210855 (l_prep) for_19\IN\0 (l_pobj) vasospasm_20\NN\0
D010208_D020301 NONE papaverine_1\NN\3800001 (r_nsubjpass) used_3\VBN\0 (l_prep) as_4\IN\14622893 (l_pobj) action_8\NN\30358 (l_acl) manage_10\VB\2524171 (l_dobj) vasospasm_11\NN\0
D010208_D020301 NONE papaverine_1\NN\3800001 (l_prep) for_2\IN\0 (l_pobj) treatment_4\NN\654885 (l_prep) of_5\IN\0 (l_pobj) vasospasm_6\NN\0
17639754
D064704_D006470 CID levofloxacin_20\JJ\0 (r_conj) warfarin_18\NN\2718259 (r_pobj) between_17\IN\0 (r_prep) interaction_16\NN\37396 (r_pobj) of_14\IN\0 (r_prep) result_13\NN\34213 (r_attr) be_11\VB\14625458 (r_xcomp) appear_9\VBP\2604760 (r_relcl) complications_7\NNS\1073995 (l_compound) bleeding_6\NN\14285662
D014859_D006470 CID warfarin_18\NN\2718259 (r_pobj) between_17\IN\0 (r_prep) interaction_16\NN\37396 (r_pobj) of_14\IN\0 (r_prep) result_13\NN\34213 (r_attr) be_11\VB\14625458 (r_xcomp) appear_9\VBP\2604760 (r_relcl) complications_7\NNS\1073995 (l_compound) bleeding_6\NN\14285662
19473225
D000596_D010523 NONE acid_24\NN\14818238 (r_compound) glutamine_25\NN\14601829 (r_conj) glutamate_18\NN\15010703 (r_nsubjpass) claimed_27\VBN\1011725 (r_advcl) is_3\VBZ\0 (l_nsubj) neuropathy_2\NN\14204950
D000596_D020258 NONE acid_24\NN\14818238 (r_compound) glutamine_25\NN\14601829 (r_conj) glutamate_18\NN\15010703 (r_nsubjpass) claimed_27\VBN\1011725 (l_xcomp) ameliorate_29\VB\126264 (l_dobj) neurotoxicity_31\NN\0
D018698_D010523 NONE glutamate_3\NN\15010703 (r_compound) supplementation_4\NN\5108947 (r_nsubj) failed_5\VBD\0 (l_xcomp) protect_7\VB\1127795 (l_prep) against_8\IN\0 (l_pobj) neurotoxicity_10\NN\0
D018698_D010523 NONE glutamate_18\NN\15010703 (r_nsubjpass) claimed_27\VBN\1011725 (r_advcl) is_3\VBZ\0 (l_nsubj) neuropathy_2\NN\14204950
D018698_D010523 NONE glutamine_25\NN\14601829 (r_conj) glutamate_18\NN\15010703 (r_nsubjpass) claimed_27\VBN\1011725 (r_advcl) is_3\VBZ\0 (l_nsubj) neuropathy_2\NN\14204950
D018698_D010523 NONE glutamate_9\NN\15010703 (r_compound) supplementation_10\NN\5108947 (l_prep) for_11\IN\0 (l_pcomp) preventing_12\VBG\0 (l_dobj) neuropathy_17\NN\14204950
D018698_D010523 NONE glutamate_8\NN\15010703 (r_compound) supplementation_9\NN\5108947 (r_nsubj) fails_14\VBZ\0 (l_xcomp) protect_16\VB\1127795 (l_prep) against_17\IN\0 (l_pobj) neurotoxicity_19\NN\0
D018698_D020258 NONE glutamate_18\NN\15010703 (r_nsubjpass) claimed_27\VBN\1011725 (l_xcomp) ameliorate_29\VB\126264 (l_dobj) neurotoxicity_31\NN\0
D018698_D020258 NONE glutamine_25\NN\14601829 (r_conj) glutamate_18\NN\15010703 (r_nsubjpass) claimed_27\VBN\1011725 (l_xcomp) ameliorate_29\VB\126264 (l_dobj) neurotoxicity_31\NN\0
D018698_D010051 NONE glutamate_26\NN\15010703 (r_pobj) by_25\IN\0 (r_agent) supplemented_24\VBN\182406 (l_ccomp) were_6\VBD\0 (l_nsubj) patients_5\NNS\9898892 (l_compound) cancer_4\NN\14239425
D017239_D010051 NONE pac_16\NNP\8324514 (r_npadvmod) containing_18\VBG\2632940 (r_amod) regimen_19\NN\5898568 (r_pobj) of_13\IN\0 (r_prep) cycles_12\NNS\15269513 (r_pobj) following_10\VBG\8180190 (r_prep) analysis_9\NN\633864 (r_pobj) for_8\IN\0 (r_prep) available_7\JJ\0 (r_acomp) were_6\VBD\0 (l_nsubj) patients_5\NNS\9898892 (l_compound) cancer_4\NN\14239425
D017239_D020258 NONE paclitaxel_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) chemotherapy_10\NN\661091 (r_pobj) for_9\IN\0 (r_prep) factor_8\NN\7326557 (r_attr) is_3\VBZ\0 (l_advcl) claimed_27\VBN\1011725 (l_xcomp) ameliorate_29\VB\126264 (l_dobj) neurotoxicity_31\NN\0
D017239_D020258 NONE pac_14\NNP\8324514 (r_appos) chemotherapy_10\NN\661091 (r_pobj) for_9\IN\0 (r_prep) factor_8\NN\7326557 (r_attr) is_3\VBZ\0 (l_advcl) claimed_27\VBN\1011725 (l_xcomp) ameliorate_29\VB\126264 (l_dobj) neurotoxicity_31\NN\0
D017239_D020258 NONE pac_30\NNP\8324514 (r_compound) neurotoxicity_31\NN\0
D017239_D010523 CID paclitaxel_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) neurotoxicity_10\NN\0
D017239_D010523 CID paclitaxel_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) chemotherapy_10\NN\661091 (r_pobj) for_9\IN\0 (r_prep) factor_8\NN\7326557 (r_attr) is_3\VBZ\0 (l_nsubj) neuropathy_2\NN\14204950
D017239_D010523 CID pac_14\NNP\8324514 (r_appos) chemotherapy_10\NN\661091 (r_pobj) for_9\IN\0 (r_prep) factor_8\NN\7326557 (r_attr) is_3\VBZ\0 (l_nsubj) neuropathy_2\NN\14204950
D017239_D010523 CID pac_30\NNP\8324514 (r_compound) neurotoxicity_31\NN\0 (r_dobj) ameliorate_29\VB\126264 (r_xcomp) claimed_27\VBN\1011725 (r_advcl) is_3\VBZ\0 (l_nsubj) neuropathy_2\NN\14204950
D017239_D010523 CID pac_13\NNP\8324514 (r_npadvmod) induced_15\VBN\1627355 (r_amod) neuropathy_17\NN\14204950
D017239_D010523 CID pac_21\NNP\8324514 (r_pobj) of_20\IN\0 (r_prep) neurotoxicity_19\NN\0
435349
D013390_D005207 CID suxamethonium_0\JJ\0 (r_compound) rate_2\NN\13815152 (l_conj) observed_4\JJ\2163746 (l_dobj) fasciculations_5\NNS\14361664
D013390_D013746 NONE sch_20\NNP\0 (r_nsubjpass) exceeded_24\VBN\0 (r_advcl) was_7\VBD\0 (l_attr) response_10\NN\11410625 (l_prep) to_11\IN\0 (l_pobj) stimulation_13\NN\242808 (l_compound) tetanic_12\JJ\0
3827439
D000666_D058186 CID amphotericin_6\JJ\2716866 (r_pobj) from_5\IN\0 (r_prep) failure_4\NN\66216
D000666_D058186 CID b_18\NNP\1355326 (r_pobj) of_16\IN\0 (r_prep) administration_15\NN\1133281 (r_dobj) following_13\VBG\8180190 (r_acl) failure_11\NN\66216
D000666_D058186 CID amphotericin_3\JJ\2716866 (r_advmod) propose_1\VBP\1010118 (l_conj) activate_15\VB\1641914 (l_advcl) contributing_20\VBG\126264 (l_prep) to_21\IN\0 (l_pobj) failure_24\NN\66216
D000666_D005355 NONE b_18\NNP\1355326 (r_pobj) of_16\IN\0 (r_prep) administration_15\NN\1133281 (r_dobj) following_13\VBG\8180190 (r_acl) failure_11\NN\66216 (r_dobj) developed_8\VBD\1753788 (l_nsubj) patient_1\NN\9898892 (l_prep) with_2\IN\0 (l_pobj) cirrhosis_4\NN\14116321
D000666_D013174 NONE b_18\NNP\1355326 (r_pobj) of_16\IN\0 (r_prep) administration_15\NN\1133281 (r_dobj) following_13\VBG\8180190 (r_acl) failure_11\NN\66216 (r_dobj) developed_8\VBD\1753788 (l_nsubj) patient_1\NN\9898892 (l_conj) disseminated_6\VBN\954608 (l_dobj) sporotrichosis_7\NN\14176895
20667451
D003474_D003072 NONE curcumin_0\NN\0 (r_nsubj) ameliorates_1\VBZ\126264 (l_dobj) dysfunction_3\NN\14204950
D003474_D003072 NONE curcumin_14\NN\0 (r_compound) administration_15\NN\1133281 (r_pobj) of_12\IN\0 (r_prep) effect_11\NN\34213 (l_prep) on_16\IN\0 (l_pobj) impairment_23\NN\7296428
D003474_D003072 NONE curcumin_1\NN\0 (r_compound) administration_2\NN\1133281 (r_nsubj) prevented_3\VBD\0 (l_dobj) impairment_6\NN\7296428
D003474_D003072 NONE curcumin_4\NN\0 (r_nsubj) has_5\VBZ\13888491 (l_dobj) effect_7\NN\34213 (l_prep) in_8\IN\13603305 (l_pcomp) mitigating_9\VBG\894738 (l_dobj) deterioration_11\NN\14560612 (l_prep) of_12\IN\0 (l_pobj) functions_14\NNS\13783581
D003474_D003072 NONE curcumin_4\NN\0 (r_nsubjpass) considered_7\VBN\689344 (l_advcl) phenobarbitone_16\NN\2792049 (l_prep) in_20\IN\13603305 (l_pcomp) preventing_21\VBG\0 (l_dobj) impairment_23\NN\7296428
D002220_D003072 CID carbamazepine_10\NN\0 (r_conj) phenobarbitone_8\NN\2792049 (r_pobj) in_7\IN\13603305 (r_prep) damage_6\NN\7296428 (r_conj) dysfunction_3\NN\14204950
D002220_D003072 CID carbamazepine_6\NN\0 (r_conj) phenobarbitone_4\NN\2792049 (r_conj) drugs_2\NNS\14778436 (r_nsubj) are_7\VBP\13600404 (l_acomp) known_9\JJ\0 (l_xcomp) cause_11\VB\7323922 (l_dobj) impairment_13\NN\7296428
D002220_D003072 CID carbamazepine_19\NN\0 (r_npadvmod) induced_21\VBN\1627355 (r_conj) phenobarbitone-_17\JJ\0 (r_nmod) impairment_23\NN\7296428
D002220_D003072 CID carbamazepine_5\NN\0 (r_conj) phenobarbitone_3\NN\2792049 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) caused_8\VBD\1617192 (l_dobj) impairment_11\NN\7296428 (l_prep) of_12\IN\0 (l_pobj) learning_13\NN\5701944 (l_conj) memory_15\NN\5926676
D002220_D003072 CID carbamazepine_24\NN\0 (r_conj) phenobarbitone_22\NN\2792049 (r_pobj) with_21\IN\0 (r_prep) treated_20\VBN\2376958 (r_acl) rats_19\NNS\2329401 (r_pobj) in_18\IN\13603305 (r_prep) damage_17\NN\7296428 (r_conj) functions_14\NNS\13783581
D002220_D003072 CID carbamazepine_18\NN\0 (r_compound) therapy_19\NN\657604 (r_conj) phenobarbitone_16\NN\2792049 (l_prep) in_20\IN\13603305 (l_pcomp) preventing_21\VBG\0 (l_dobj) impairment_23\NN\7296428
D010634_D003072 CID phenobarbitone_8\NN\2792049 (r_pobj) in_7\IN\13603305 (r_prep) damage_6\NN\7296428 (r_conj) dysfunction_3\NN\14204950
D010634_D003072 CID phenobarbitone_4\NN\2792049 (r_conj) drugs_2\NNS\14778436 (r_nsubj) are_7\VBP\13600404 (l_acomp) known_9\JJ\0 (l_xcomp) cause_11\VB\7323922 (l_dobj) impairment_13\NN\7296428
D010634_D003072 CID phenobarbitone-_17\JJ\0 (r_nmod) impairment_23\NN\7296428
D010634_D003072 CID phenobarbitone_3\NN\2792049 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) caused_8\VBD\1617192 (l_dobj) impairment_11\NN\7296428 (l_prep) of_12\IN\0 (l_pobj) learning_13\NN\5701944 (l_conj) memory_15\NN\5926676
D010634_D003072 CID phenobarbitone_22\NN\2792049 (r_pobj) with_21\IN\0 (r_prep) treated_20\VBN\2376958 (r_acl) rats_19\NNS\2329401 (r_pobj) in_18\IN\13603305 (r_prep) damage_17\NN\7296428 (r_conj) functions_14\NNS\13783581
D010634_D003072 CID phenobarbitone_16\NN\2792049 (l_prep) in_20\IN\13603305 (l_pcomp) preventing_21\VBG\0 (l_dobj) impairment_23\NN\7296428
12907309
C121465_D005334 NONE mpep_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) action_1\NN\30358 (r_nsubjpass) associated_17\VBN\628491 (l_prep) with_18\IN\0 (l_pobj) decrease_20\NN\7296428 (l_prep) in_21\IN\13603305 (l_pobj) outflow_23\NN\7407777 (l_conj) inhibition_25\NN\1068773 (l_prep) of_26\IN\0 (l_pobj) hyperthermia_27\NN\14034177
C121465_D005334 NONE mpep_3\NNP\0 (r_pobj) by_2\IN\0 (r_agent) rendered_1\VBN\120316 (r_acl) neuroprotection_0\NNP\0 (r_nsubjpass) associated_6\VBN\628491 (l_conj) with_29\IN\0 (l_pobj) decrease_31\NN\7296428 (l_prep) in_32\IN\13603305 (l_pobj) hyperthermia_33\NN\14034177
C121465_D020258 NONE mpep_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) action_1\NN\30358 (l_prep) in_10\IN\13603305 (l_pobj) neurotoxicity_15\NN\0
D008694_D020258 NONE methamphetamine_11\NN\2704153 (r_npadvmod) induced_13\VBN\1627355 (r_amod) neurotoxicity_15\NN\0
D008694_D064420 NONE methamphetamine_18\NN\2704153 (r_npadvmod) induced_20\VBN\1627355 (r_amod) toxicity_21\NN\13576101
C121465_D064420 NONE mpep_12\NNP\0 (r_pobj) by_11\IN\0 (r_prep) blockade_8\NN\952963 (r_nsubj) protect_14\VB\1127795 (l_dobj) neurones_16\NNS\0 (l_prep) against_17\IN\0 (l_pobj) toxicity_21\NN\13576101
D004298_D005334 NONE dopamine_22\NN\14807737 (r_compound) outflow_23\NN\7407777 (l_conj) inhibition_25\NN\1068773 (l_prep) of_26\IN\0 (l_pobj) hyperthermia_27\NN\14034177
D004298_D005334 NONE dopamine_15\NN\14807737 (r_compound) efflux_16\NN\13482330 (r_pobj) of_10\IN\0 (r_prep) reduction_9\NN\351485 (r_pobj) with_7\IN\0 (r_prep) associated_6\VBN\628491 (l_conj) with_29\IN\0 (l_pobj) decrease_31\NN\7296428 (l_prep) in_32\IN\13603305 (l_pobj) hyperthermia_33\NN\14034177
D004298_D020258 NONE dopamine_22\NN\14807737 (r_compound) outflow_23\NN\7407777 (r_pobj) in_21\IN\13603305 (r_prep) decrease_20\NN\7296428 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (l_nsubjpass) action_1\NN\30358 (l_prep) in_10\IN\13603305 (l_pobj) neurotoxicity_15\NN\0
D008694_D005334 CID methamphetamine_11\NN\2704153 (r_npadvmod) induced_13\VBN\1627355 (r_amod) neurotoxicity_15\NN\0 (r_pobj) in_10\IN\13603305 (r_prep) action_1\NN\30358 (r_nsubjpass) associated_17\VBN\628491 (l_prep) with_18\IN\0 (l_pobj) decrease_20\NN\7296428 (l_prep) in_21\IN\13603305 (l_pobj) outflow_23\NN\7407777 (l_conj) inhibition_25\NN\1068773 (l_prep) of_26\IN\0 (l_pobj) hyperthermia_27\NN\14034177
D008694_D005334 CID methamphetamine_12\NN\2704153 (r_npadvmod) induced_14\VBN\1627355 (r_amod) efflux_16\NN\13482330 (r_pobj) of_10\IN\0 (r_prep) reduction_9\NN\351485 (r_pobj) with_7\IN\0 (r_prep) associated_6\VBN\628491 (l_conj) with_29\IN\0 (l_pobj) decrease_31\NN\7296428 (l_prep) in_32\IN\13603305 (l_pobj) hyperthermia_33\NN\14034177
11391224
D003042_D006974 NONE cocaine_23\NN\3492717 (r_npadvmod) related_25\VBN\628491 (r_amod) failure_28\NN\66216 (r_conj) glomerulonephritis_20\NN\14113798 (r_conj) nephritis_17\NN\14113228 (r_conj) nephritis_12\NN\14113228 (r_dobj) lupus_11\NN\14219661 (r_conj) included_2\VBD\0 (l_dobj) cases_3\NNS\7283608 (l_prep) of_4\IN\0 (l_pobj) hypertension_6\NN\14057371
D003042_D058186 CID cocaine_23\NN\3492717 (r_npadvmod) related_25\VBN\628491 (r_amod) failure_28\NN\66216
D003042_D011695 NONE cocaine_23\NN\3492717 (r_npadvmod) related_25\VBN\628491 (r_amod) failure_28\NN\66216 (r_conj) glomerulonephritis_20\NN\14113798 (r_conj) nephritis_17\NN\14113228
D003042_D008181 NONE cocaine_23\NN\3492717 (r_npadvmod) related_25\VBN\628491 (r_amod) failure_28\NN\66216 (r_conj) glomerulonephritis_20\NN\14113798 (r_conj) nephritis_17\NN\14113228 (r_conj) nephritis_12\NN\14113228
D003042_D005921 NONE cocaine_23\NN\3492717 (r_npadvmod) related_25\VBN\628491 (r_amod) failure_28\NN\66216 (r_conj) glomerulonephritis_20\NN\14113798
D003042_D057049 NONE cocaine_23\NN\3492717 (r_npadvmod) related_25\VBN\628491 (r_amod) failure_28\NN\66216 (r_conj) glomerulonephritis_20\NN\14113798 (r_conj) nephritis_17\NN\14113228 (r_conj) nephritis_12\NN\14113228 (r_dobj) lupus_11\NN\14219661 (l_nsubj) microangiopathy_9\NN\0
14596845
D013395_D006948 CID sucrose_6\NN\14836642 (r_dobj) experienced_4\VBN\2108377 (r_relcl) animals_1\NNS\4475 (r_nsubj) were_9\VBD\0 (l_acomp) hyperactive_10\JJ\0
D013395_D006948 CID sucrose_25\NN\14836642 (r_appos) groups_19\NNS\2137 (r_pobj) with_16\IN\0 (r_prep) compared_15\VBN\644583 (r_prep) were_9\VBD\0 (l_acomp) hyperactive_10\JJ\0
D013395_D006948 CID sucrose_50\NN\14836642 (r_conj) amphetamine_44\NN\3248958 (r_pobj) with_43\IN\0 (r_prep) chow_42\NN\7971582 (r_appos) groups_19\NNS\2137 (r_pobj) with_16\IN\0 (r_prep) compared_15\VBN\644583 (r_prep) were_9\VBD\0 (l_acomp) hyperactive_10\JJ\0
D000661_D006948 CID amphetamine_15\NN\3248958 (r_pobj) of_14\IN\0 (r_prep) dose_13\NN\3740161 (r_pobj) to_10\IN\0 (r_prep) sensitization_9\NN\14531772
D000661_D006948 CID amphetamine_24\NN\3248958 (r_pobj) of_23\IN\0 (r_prep) dose_22\NN\3740161 (r_pobj) to_19\IN\0 (r_prep) show_14\VB\429048 (l_dobj) sensitization_18\NN\14531772
D000661_D006948 CID amphetamine_14\NN\3248958 (r_pobj) to_13\IN\0 (r_prep) response_12\NN\11410625 (r_pobj) in_11\IN\13603305 (r_prep) were_9\VBD\0 (l_acomp) hyperactive_10\JJ\0
D000661_D006948 CID amphetamine_30\NN\3248958 (r_compound) injection_31\NN\320852 (r_pobj) by_29\IN\0 (r_agent) followed_28\VBN\1835496 (r_acl) sucrose_25\NN\14836642 (r_appos) groups_19\NNS\2137 (r_pobj) with_16\IN\0 (r_prep) compared_15\VBN\644583 (r_prep) were_9\VBD\0 (l_acomp) hyperactive_10\JJ\0
D000661_D006948 CID amphetamine_37\NN\3248958 (r_compound) injection_38\NN\320852 (r_pobj) by_36\IN\0 (r_agent) followed_35\VBN\1835496 (r_acl) chow_34\NN\7971582 (r_appos) groups_19\NNS\2137 (r_pobj) with_16\IN\0 (r_prep) compared_15\VBN\644583 (r_prep) were_9\VBD\0 (l_acomp) hyperactive_10\JJ\0
D000661_D006948 CID amphetamine_44\NN\3248958 (r_pobj) with_43\IN\0 (r_prep) chow_42\NN\7971582 (r_appos) groups_19\NNS\2137 (r_pobj) with_16\IN\0 (r_prep) compared_15\VBN\644583 (r_prep) were_9\VBD\0 (l_acomp) hyperactive_10\JJ\0
D000661_D019966 NONE amphetamine_15\NN\3248958 (r_pobj) of_14\IN\0 (r_prep) dose_13\NN\3740161 (r_pobj) to_10\IN\0 (r_prep) sensitization_9\NN\14531772 (r_dobj) causes_5\VBZ\7323922 (l_nsubj) diet_1\NN\7560652 (l_acl) promoting_2\VBG\2556126 (l_dobj) dependency_4\NN\24720
19445921
C066201_D009203 NONE a_5\NN\13649268 (l_prep) on_6\IN\0 (l_pobj) infarction_11\NN\14204950
C066201_D009203 NONE a_13\NN\13649268 (r_pobj) of_10\IN\0 (r_prep) potential_9\NN\14481929 (l_prep) on_14\IN\0 (l_pobj) infarction_19\NN\14204950
C066201_D009203 NONE a_9\DT\13649268 (r_appos) salvianolic_7\JJ\0 (r_nsubj) has_13\VBZ\13888491 (l_dobj) effect_17\NN\34213 (l_prep) against_18\IN\0 (l_pobj) infarction_23\NN\14204950
D000244_D012131 NONE adp_13\NNP\14964590 (r_nmod) o_15\NNP\14622893 (r_conj) ratio_11\NN\13815152 (r_pobj) by_7\IN\0 (r_agent) characterized_6\VBN\609683 (r_acl) dysfunction_5\NN\14204950
D007545_D009203 CID isoproterenol_7\NN\3740161 (r_npadvmod) induced_9\VBN\1627355 (r_amod) infarction_11\NN\14204950
D007545_D009203 CID isoproterenol_15\NN\3740161 (r_npadvmod) induced_17\VBN\1627355 (r_amod) infarction_19\NN\14204950
D007545_D009203 CID isoproterenol_19\NN\3740161 (r_npadvmod) induced_21\VBN\1627355 (r_amod) infarction_23\NN\14204950
D007545_D012131 NONE isoproterenol_19\NN\3740161 (r_npadvmod) treated_21\VBN\2376958 (r_amod) rats_22\NNS\2329401 (r_pobj) in_18\IN\13603305 (r_prep) observed_17\VBN\2163746 (l_nsubjpass) dysfunction_5\NN\14204950
C066201_D006331 NONE a_4\NN\13649268 (r_appos) administration_0\NN\1133281 (l_conj) dysfunction_17\NN\14204950
D007545_D006331 NONE isoproterenol_13\NN\3740161 (r_npadvmod) induced_15\VBN\1627355 (r_amod) dysfunction_17\NN\14204950
D007545_D009202 NONE isoproterenol_13\NN\3740161 (r_npadvmod) induced_15\VBN\1627355 (r_amod) dysfunction_17\NN\14204950 (l_conj) injury_20\NN\14052046
D007545_D009202 NONE isoproterenol_8\NN\3740161 (r_npadvmod) induced_10\VBN\1627355 (r_amod) damage_12\NN\7296428
C066201_D009202 NONE a_4\NN\13649268 (r_appos) administration_0\NN\1133281 (l_conj) dysfunction_17\NN\14204950 (l_conj) injury_20\NN\14052046
C066201_D009202 NONE a_6\NN\13649268 (r_pobj) of_3\IN\0 (r_prep) role_2\NN\719494 (l_prep) against_7\IN\0 (l_pobj) damage_12\NN\7296428
7930386
D002997_D012893 CID clomipramine_0\NNP\4482543 (r_npadvmod) induced_2\VBN\1627355 (r_amod) disturbance_4\NN\407535
D002997_D012893 CID clomipramine_15\NN\4482543 (r_compound) administration_16\NN\1133281 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_conj) examine_6\VB\0 (l_dobj) role_8\NN\719494 (l_prep) of_9\IN\0 (l_pobj) disturbance_11\NN\407535
9587734
D013390_D006947 CID suxamethonium_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) use_19\NN\407535 (r_pobj) following_17\VBG\8180190 (r_prep) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) arrest_8\NN\88481 (l_conj) death_11\NN\7296428 (l_prep) as_12\IN\14622893 (l_pobj) result_14\NN\34213 (l_prep) of_15\IN\0 (l_pobj) hyperkalaemia_16\NN\0
D013390_D006947 CID suxamethonium_35\NN\0 (r_pobj) of_34\IN\0 (r_prep) administration_33\NN\1133281 (r_pobj) following_31\VBG\8180190 (r_prep) signs_15\NNS\6643763 (l_prep) of_16\IN\0 (l_conj) of_21\IN\0 (l_pobj) any_22\DT\0 (l_prep) of_23\IN\0 (l_pobj) conditions_28\NNS\14512817 (l_prep) for_29\IN\0 (l_pobj) hyperkalaemia_30\NN\0
D013390_D001919 CID suxamethonium_5\NN\0 (l_appos) arrest_10\NN\88481 (l_amod) bradycardia_7\NN\14110674
D013390_D004342 CID suxamethonium_11\NN\0 (r_pobj) to_10\IN\0 (r_prep) hypersensitivity_9\NN\14531772
D013390_D003643 NONE suxamethonium_0\NN\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) arrest_4\NN\88481 (l_conj) death_6\NN\7296428
D013390_D003643 NONE suxamethonium_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) use_19\NN\407535 (r_pobj) following_17\VBG\8180190 (r_prep) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) arrest_8\NN\88481 (l_conj) death_11\NN\7296428
D013390_D003643 NONE suxamethonium_11\NN\0 (r_pobj) to_10\IN\0 (r_prep) hypersensitivity_9\NN\14531772 (r_pobj) by_8\IN\0 (r_agent) caused_7\VBN\1617192 (l_nsubjpass) death_5\NN\7296428
D013390_D006323 CID suxamethonium_0\NN\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) arrest_4\NN\88481
D013390_D006323 CID suxamethonium_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) use_19\NN\407535 (r_pobj) following_17\VBG\8180190 (r_prep) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) arrest_8\NN\88481
D013390_D006323 CID suxamethonium_5\NN\0 (l_appos) arrest_10\NN\88481
11752354
D004967_D009203 NONE estrogen_38\NN\14745635 (r_pobj) of_37\IN\0 (r_prep) dose_36\NN\3740161 (r_dep) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950
D004967_D009203 NONE estrogen_38\NN\14745635 (r_pobj) of_37\IN\0 (r_prep) dose_36\NN\3740161 (r_dep) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950 (l_prep) between_82\IN\0 (l_pobj) 1990_83\CD\0 (l_conj) women_89\NNS\9605289 (l_relcl) had_93\VBN\0 (l_dobj) infarction_96\NN\14204950
D017135_D009203 NONE desogestrel_19\NN\0 (r_appos) generation_15\NN\7942152 (r_nmod) contraceptives_33\NNS\3183080 (r_pobj) in_12\IN\13603305 (r_prep) included_11\VBN\0 (r_acl) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950
D017135_D009203 NONE desogestrel_19\NN\0 (r_appos) generation_15\NN\7942152 (r_nmod) contraceptives_33\NNS\3183080 (r_pobj) in_12\IN\13603305 (r_prep) included_11\VBN\0 (r_acl) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950 (l_prep) between_82\IN\0 (l_pobj) 1990_83\CD\0 (l_conj) women_89\NNS\9605289 (l_relcl) had_93\VBN\0 (l_dobj) infarction_96\NN\14204950
D003276_D009203 CID contraceptives_1\NNS\3183080 (l_conj) risk_4\NN\14541044 (l_prep) of_5\IN\0 (l_pobj) infarction_7\NN\14204950
D003276_D009203 CID contraceptives_7\NNS\3183080 (r_pobj) of_5\IN\0 (r_prep) use_4\NN\407535 (l_conj) risk_10\NN\14541044 (l_prep) of_11\IN\0 (l_pobj) infarction_13\NN\14204950
D003276_D009203 CID contraceptives_33\NNS\3183080 (r_pobj) in_12\IN\13603305 (r_prep) included_11\VBN\0 (r_acl) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950
D003276_D009203 CID contraceptives_33\NNS\3183080 (r_pobj) in_12\IN\13603305 (r_prep) included_11\VBN\0 (r_acl) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950 (l_prep) between_82\IN\0 (l_pobj) 1990_83\CD\0 (l_conj) women_89\NNS\9605289 (l_relcl) had_93\VBN\0 (l_dobj) infarction_96\NN\14204950
D003276_D009203 CID contraceptive_39\NN\3183080 (r_pobj) of_36\IN\0 (r_prep) type_35\NN\5839024 (r_dobj) used_33\VBD\0 (r_relcl) women_31\NNS\9605289 (r_pobj) among_30\IN\0 (r_prep) infarction_29\NN\14204950
D003276_D009203 CID contraceptives_5\NNS\3183080 (r_dobj) used_3\VBD\0 (r_relcl) women_1\NNS\9605289 (r_pobj) among_0\IN\0 (r_prep) was_10\VBD\0 (r_ccomp) increased_53\VBN\169651 (l_nsubjpass) risk_48\NN\14541044 (l_prep) of_49\IN\0 (l_pobj) infarction_51\NN\14204950
D003276_D009203 CID contraceptives_62\NNS\3183080 (r_dobj) used_57\VBD\0 (r_relcl) women_55\NNS\9605289 (r_pobj) among_54\IN\0 (r_prep) increased_53\VBN\169651 (l_nsubjpass) risk_48\NN\14541044 (l_prep) of_49\IN\0 (l_pobj) infarction_51\NN\14204950
D003276_D009203 CID contraceptives_12\NNS\3183080 (r_dobj) used_10\VBD\0 (r_relcl) women_8\NNS\9605289 (r_pobj) among_7\IN\0 (r_prep) similar_6\JJ\0 (r_acomp) was_5\VBD\0 (l_nsubj) risk_1\NN\14541044 (l_prep) of_2\IN\0 (l_pobj) infarction_4\NN\14204950
C033273_D009203 NONE gestodene_21\NN\0 (r_conj) desogestrel_19\NN\0 (r_appos) generation_15\NN\7942152 (r_nmod) contraceptives_33\NNS\3183080 (r_pobj) in_12\IN\13603305 (r_prep) included_11\VBN\0 (r_acl) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950
C033273_D009203 NONE gestodene_21\NN\0 (r_conj) desogestrel_19\NN\0 (r_appos) generation_15\NN\7942152 (r_nmod) contraceptives_33\NNS\3183080 (r_pobj) in_12\IN\13603305 (r_prep) included_11\VBN\0 (r_acl) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950 (l_prep) between_82\IN\0 (l_pobj) 1990_83\CD\0 (l_conj) women_89\NNS\9605289 (l_relcl) had_93\VBN\0 (l_dobj) infarction_96\NN\14204950
D011372_D009203 NONE progestagen_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950
D011372_D009203 NONE progestagen_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950 (l_prep) between_82\IN\0 (l_pobj) 1990_83\CD\0 (l_conj) women_89\NNS\9605289 (l_relcl) had_93\VBN\0 (l_dobj) infarction_96\NN\14204950
D016912_D009203 NONE levonorgestrel_30\JJ\0 (r_conj) desogestrel_19\NN\0 (r_appos) generation_15\NN\7942152 (r_nmod) contraceptives_33\NNS\3183080 (r_pobj) in_12\IN\13603305 (r_prep) included_11\VBN\0 (r_acl) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950
D016912_D009203 NONE levonorgestrel_30\JJ\0 (r_conj) desogestrel_19\NN\0 (r_appos) generation_15\NN\7942152 (r_nmod) contraceptives_33\NNS\3183080 (r_pobj) in_12\IN\13603305 (r_prep) included_11\VBN\0 (r_acl) type_8\NN\5839024 (r_pobj) to_6\IN\0 (r_prep) according_5\VBG\2657219 (r_prep) investigated_1\VBD\644583 (l_conj) identified_64\VBD\699815 (l_conj) enrolled_66\VBD\2471690 (l_dobj) women_68\NNS\9605289 (l_relcl) had_77\VBN\0 (l_dobj) infarction_81\NN\14204950 (l_prep) between_82\IN\0 (l_pobj) 1990_83\CD\0 (l_conj) women_89\NNS\9605289 (l_relcl) had_93\VBN\0 (l_dobj) infarction_96\NN\14204950
7444978
D013307_D004409 CID streptomycin_48\NNS\2716866 (r_pobj) to_47\IN\0 (r_prep) sensitive_46\JJ\10488309 (r_acomp) is_44\VBZ\0 (r_ccomp) indicating_40\VBG\952524 (r_advcl) occurred_23\VBD\0 (l_ccomp) occurred_4\VBD\0 (l_nsubj) movements_1\NNS\191142
D013307_D004409 CID streptomycin_48\NNS\2716866 (l_prep) than_49\IN\0 (l_pobj) site_51\NN\8673395 (l_amod) responsible_57\JJ\0 (l_prep) for_58\IN\0 (l_pobj) dyskinesias_60\NNS\14084880
D013307_D003638 CID streptomycin_48\NNS\2716866 (r_pobj) to_47\IN\0 (r_prep) sensitive_46\JJ\10488309 (r_acomp) is_44\VBZ\0 (r_ccomp) indicating_40\VBG\952524 (r_advcl) occurred_23\VBD\0 (l_ccomp) occurred_4\VBD\0 (l_nsubj) movements_1\NNS\191142 (l_conj) deafness_3\NN\14550797
D013307_D020258 NONE streptomycin_11\NNS\2716866 (r_pobj) of_10\IN\0 (r_prep) effects_9\NNS\13245626 (l_amod) neurotoxic_8\JJ\0
18544179
D005283_D009325 NONE fentanyl_1\NN\2707683 (r_dobj) omitting_0\VBG\471711 (r_csubj) reduces_2\VBZ\441445 (l_dobj) nausea_3\NN\14299637
D005283_D009325 NONE fentanyl_2\NN\2707683 (r_pobj) of_1\IN\0 (r_prep) omission_0\NN\70965 (r_nsubj) reduce_5\VB\441445 (l_conj) reduce_17\VB\441445 (l_conj) moderate_23\JJ\9605289 (l_prep) to_24\TO\0 (l_pobj) nausea_26\NN\14299637
D005283_D009325 NONE fentanyl_37\NN\2707683 (r_nmod) dexamethasone_41\NN\2721538 (r_pobj) with_36\IN\0 (r_prep) %_35\NN\0 (r_conj) %_32\NN\0 (r_pobj) from_30\IN\0 (r_prep) discharge_29\NN\7283608 (r_pobj) to_28\IN\0 (r_prep) prior_27\RB\10675876 (r_advmod) reduce_17\VB\441445 (l_conj) moderate_23\JJ\9605289 (l_prep) to_24\TO\0 (l_pobj) nausea_26\NN\14299637
D005283_D009325 NONE fentanyl_39\NN\2707683 (r_compound) dexamethasone_41\NN\2721538 (r_pobj) with_36\IN\0 (r_prep) %_35\NN\0 (r_conj) %_32\NN\0 (r_pobj) from_30\IN\0 (r_prep) discharge_29\NN\7283608 (r_pobj) to_28\IN\0 (r_prep) prior_27\RB\10675876 (r_advmod) reduce_17\VB\441445 (l_conj) moderate_23\JJ\9605289 (l_prep) to_24\TO\0 (l_pobj) nausea_26\NN\14299637
D005283_D009325 NONE fentanyl_3\NN\2707683 (r_compound) groups_4\NNS\2137 (r_dobj) combining_0\VBG\7373277 (r_csubj) revealed_5\VBD\2137132 (l_advcl) reducing_15\VBG\13447361 (l_dobj) nausea_17\NN\14299637 (l_conj) vomiting_19\NN\116687 (l_conj) nausea_21\NN\14299637
D005283_D009325 NONE fentanyl_3\NN\2707683 (r_compound) groups_4\NNS\2137 (r_dobj) combining_0\VBG\7373277 (r_csubj) revealed_5\VBD\2137132 (l_advcl) decreased_57\VBN\169651 (l_nsubjpass) nausea_50\NN\14299637
C009250_D007022 NONE sevoflurane_9\NN\0 (r_npadvmod) sparing_11\VBG\2725714 (r_amod) effect_12\NN\34213 (r_dobj) had_7\VBD\0 (l_conj) depression_16\NN\14373582 (l_conj) hypotension_18\NN\14057371
C009250_D010146 NONE sevoflurane_12\NN\0 (r_pobj) after_11\IN\0 (r_prep) reduces_2\VBZ\441445 (l_prep) without_7\IN\0 (l_pcomp) increasing_8\VBG\169651 (l_dobj) pain_9\NN\14299637
C009250_D010146 NONE sevoflurane_23\NN\0 (r_compound) anaesthesia_24\NN\14034177 (r_pobj) after_22\IN\0 (r_prep) h_21\NN\14622893 (r_pobj) in_17\IN\13603305 (r_prep) examined_5\VBD\0 (l_dobj) incidence_7\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) nausea_12\NN\14299637 (l_conj) vomiting_14\NN\116687 (l_conj) pain_16\NN\14299637
D003907_D014839 NONE dexamethasone_41\NN\2721538 (r_pobj) with_36\IN\0 (r_prep) %_35\NN\0 (r_conj) %_32\NN\0 (r_pobj) from_30\IN\0 (r_prep) discharge_29\NN\7283608 (r_pobj) to_28\IN\0 (r_prep) prior_27\RB\10675876 (r_advmod) reduce_17\VB\441445 (l_dobj) incidence_19\NN\13821570 (l_prep) of_20\IN\0 (l_pobj) vomiting_21\NN\116687
C009250_D001919 NONE sevoflurane_9\NN\0 (r_npadvmod) sparing_11\VBG\2725714 (r_amod) effect_12\NN\34213 (r_dobj) had_7\VBD\0 (l_conj) depression_16\NN\14373582 (l_conj) hypotension_18\NN\14057371 (l_conj) bradycardia_20\NN\14110674
C009250_D020250 NONE sevoflurane_9\NN\0 (r_pobj) with_8\IN\0 (r_prep) advantages_1\NNS\5154517 (r_pobj) despite_0\IN\7501545 (r_prep) occurs_15\VBZ\0 (l_nsubj) nausea_12\NN\14299637 (l_conj) vomiting_14\NN\116687
C009250_D020250 NONE sevoflurane_23\NN\0 (r_compound) anaesthesia_24\NN\14034177 (r_pobj) after_22\IN\0 (r_prep) h_21\NN\14622893 (r_pobj) in_17\IN\13603305 (r_prep) examined_5\VBD\0 (l_dobj) incidence_7\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) nausea_12\NN\14299637 (l_conj) vomiting_14\NN\116687
C009250_D020250 NONE sevoflurane_31\NN\0 (r_relcl) supplement_29\NN\6365467 (r_attr) be_23\VB\14625458 (r_xcomp) appears_21\VBZ\2604760 (l_advcl) exacerbated_2\VBD\126264 (l_dobj) nausea_4\NN\14299637 (l_conj) vomiting_6\VBG\116687
C009250_D010149 NONE sevoflurane_31\NN\0 (r_relcl) supplement_29\NN\6365467 (r_attr) be_23\VB\14625458 (r_xcomp) appears_21\VBZ\2604760 (l_advcl) exacerbated_2\VBD\126264 (l_dobj) nausea_4\NN\14299637 (l_conj) vomiting_6\VBG\116687 (l_prep) without_7\IN\0 (l_pobj) improvement_9\NN\7359599 (l_prep) in_10\IN\13603305 (l_pobj) pain_12\NN\14299637
C009250_D014839 NONE sevoflurane_12\NN\0 (r_pobj) after_11\IN\0 (r_prep) reduces_2\VBZ\441445 (l_dobj) nausea_3\NN\14299637 (l_conj) vomiting_5\NN\116687
C009250_D009325 NONE sevoflurane_12\NN\0 (r_pobj) after_11\IN\0 (r_prep) reduces_2\VBZ\441445 (l_dobj) nausea_3\NN\14299637
D003907_D009325 NONE dexamethasone_41\NN\2721538 (r_pobj) with_36\IN\0 (r_prep) %_35\NN\0 (r_conj) %_32\NN\0 (r_pobj) from_30\IN\0 (r_prep) discharge_29\NN\7283608 (r_pobj) to_28\IN\0 (r_prep) prior_27\RB\10675876 (r_advmod) reduce_17\VB\441445 (l_conj) moderate_23\JJ\9605289 (l_prep) to_24\TO\0 (l_pobj) nausea_26\NN\14299637
D003907_D020250 NONE dexamethasone_41\NN\2721538 (r_pobj) with_36\IN\0 (r_prep) %_35\NN\0 (r_conj) %_32\NN\0 (r_pobj) from_30\IN\0 (r_prep) discharge_29\NN\7283608 (r_pobj) to_28\IN\0 (r_prep) prior_27\RB\10675876 (r_advmod) reduce_17\VB\441445 (r_conj) reduce_5\VB\441445 (l_dobj) incidence_8\NN\13821570 (l_prep) of_9\IN\0 (l_pobj) nausea_11\NN\14299637 (l_conj) vomiting_13\NN\116687
D003907_D020250 NONE dexamethasone_0\NNP\2721538 (r_nsubj) had_1\VBD\0 (l_dobj) effect_4\NN\34213 (l_prep) on_5\IN\0 (l_pobj) incidence_7\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) nausea_12\NN\14299637 (l_conj) vomiting_14\NN\116687
D005283_D014839 NONE fentanyl_1\NN\2707683 (r_dobj) omitting_0\VBG\471711 (r_csubj) reduces_2\VBZ\441445 (l_dobj) nausea_3\NN\14299637 (l_conj) vomiting_5\NN\116687
D005283_D014839 NONE fentanyl_2\NN\2707683 (r_pobj) of_1\IN\0 (r_prep) omission_0\NN\70965 (r_nsubj) reduce_5\VB\441445 (l_conj) reduce_17\VB\441445 (l_dobj) incidence_19\NN\13821570 (l_prep) of_20\IN\0 (l_pobj) vomiting_21\NN\116687
D005283_D014839 NONE fentanyl_37\NN\2707683 (r_nmod) dexamethasone_41\NN\2721538 (r_pobj) with_36\IN\0 (r_prep) %_35\NN\0 (r_conj) %_32\NN\0 (r_pobj) from_30\IN\0 (r_prep) discharge_29\NN\7283608 (r_pobj) to_28\IN\0 (r_prep) prior_27\RB\10675876 (r_advmod) reduce_17\VB\441445 (l_dobj) incidence_19\NN\13821570 (l_prep) of_20\IN\0 (l_pobj) vomiting_21\NN\116687
D005283_D014839 NONE fentanyl_39\NN\2707683 (r_compound) dexamethasone_41\NN\2721538 (r_pobj) with_36\IN\0 (r_prep) %_35\NN\0 (r_conj) %_32\NN\0 (r_pobj) from_30\IN\0 (r_prep) discharge_29\NN\7283608 (r_pobj) to_28\IN\0 (r_prep) prior_27\RB\10675876 (r_advmod) reduce_17\VB\441445 (l_dobj) incidence_19\NN\13821570 (l_prep) of_20\IN\0 (l_pobj) vomiting_21\NN\116687
D005283_D012131 CID fentanyl_0\NNP\2707683 (r_nsubj) reduce_2\VB\441445 (l_conj) had_7\VBD\0 (l_conj) depression_16\NN\14373582
D005283_D020250 CID fentanyl_2\NN\2707683 (r_pobj) of_1\IN\0 (r_prep) omission_0\NN\70965 (r_nsubj) reduce_5\VB\441445 (l_dobj) incidence_8\NN\13821570 (l_prep) of_9\IN\0 (l_pobj) nausea_11\NN\14299637 (l_conj) vomiting_13\NN\116687
D005283_D020250 CID fentanyl_37\NN\2707683 (r_nmod) dexamethasone_41\NN\2721538 (r_pobj) with_36\IN\0 (r_prep) %_35\NN\0 (r_conj) %_32\NN\0 (r_pobj) from_30\IN\0 (r_prep) discharge_29\NN\7283608 (r_pobj) to_28\IN\0 (r_prep) prior_27\RB\10675876 (r_advmod) reduce_17\VB\441445 (r_conj) reduce_5\VB\441445 (l_dobj) incidence_8\NN\13821570 (l_prep) of_9\IN\0 (l_pobj) nausea_11\NN\14299637 (l_conj) vomiting_13\NN\116687
D005283_D020250 CID fentanyl_39\NN\2707683 (r_compound) dexamethasone_41\NN\2721538 (r_pobj) with_36\IN\0 (r_prep) %_35\NN\0 (r_conj) %_32\NN\0 (r_pobj) from_30\IN\0 (r_prep) discharge_29\NN\7283608 (r_pobj) to_28\IN\0 (r_prep) prior_27\RB\10675876 (r_advmod) reduce_17\VB\441445 (r_conj) reduce_5\VB\441445 (l_dobj) incidence_8\NN\13821570 (l_prep) of_9\IN\0 (l_pobj) nausea_11\NN\14299637 (l_conj) vomiting_13\NN\116687
D005283_D020250 CID fentanyl_3\NN\2707683 (r_compound) groups_4\NNS\2137 (r_dobj) combining_0\VBG\7373277 (r_csubj) revealed_5\VBD\2137132 (l_advcl) reducing_15\VBG\13447361 (l_dobj) nausea_17\NN\14299637 (l_conj) vomiting_19\NN\116687
D005283_D020250 CID fentanyl_1\NN\2707683 (r_nsubj) exacerbated_2\VBD\126264 (l_dobj) nausea_4\NN\14299637 (l_conj) vomiting_6\VBG\116687
D005283_D001919 CID fentanyl_0\NNP\2707683 (r_nsubj) reduce_2\VB\441445 (l_conj) had_7\VBD\0 (l_conj) depression_16\NN\14373582 (l_conj) hypotension_18\NN\14057371 (l_conj) bradycardia_20\NN\14110674
D005283_D010146 NONE fentanyl_1\NN\2707683 (r_dobj) omitting_0\VBG\471711 (r_csubj) reduces_2\VBZ\441445 (l_prep) without_7\IN\0 (l_pcomp) increasing_8\VBG\169651 (l_dobj) pain_9\NN\14299637
D005283_D010146 NONE fentanyl_11\NN\2707683 (r_pobj) of_10\IN\0 (r_prep) omission_9\NN\70965 (r_pobj) by_7\IN\0 (r_prep) unaffected_6\JJ\0 (r_acomp) were_5\VBD\0 (l_nsubj) severity_1\NN\5036394 (l_compound) pain_0\NN\14299637
D005283_D010149 NONE fentanyl_1\NN\2707683 (r_nsubj) exacerbated_2\VBD\126264 (l_dobj) nausea_4\NN\14299637 (l_conj) vomiting_6\VBG\116687 (l_prep) without_7\IN\0 (l_pobj) improvement_9\NN\7359599 (l_prep) in_10\IN\13603305 (l_pobj) pain_12\NN\14299637
D005283_D007022 CID fentanyl_0\NNP\2707683 (r_nsubj) reduce_2\VB\441445 (l_conj) had_7\VBD\0 (l_conj) depression_16\NN\14373582 (l_conj) hypotension_18\NN\14057371
C009250_D012131 NONE sevoflurane_9\NN\0 (r_npadvmod) sparing_11\VBG\2725714 (r_amod) effect_12\NN\34213 (r_dobj) had_7\VBD\0 (l_conj) depression_16\NN\14373582
17241784
D019821_D009135 CID statin_12\NN\3740161 (r_compound) therapy_13\NN\657604 (r_pobj) with_11\IN\0 (r_prep) associated_10\VBD\628491 (r_acl) myopathy_1\NNS\14204950
D019821_D009135 CID statins_0\NNS\3740161 (r_nsubj) cause_2\VB\7323922 (l_ccomp) myopathy_5\NN\14204950
D019821_D009135 CID statins_9\NNS\3740161 (r_nsubj) induce_11\VB\1627355 (l_dobj) myopathy_13\NN\14204950
D019821_D009135 CID statins_4\NNS\3740161 (r_nsubj) initiate_6\VB\9632274 (l_dobj) myopathy_11\NN\14204950
D019821_D009135 CID statins_13\NNS\3740161 (r_pobj) by_12\IN\0 (r_prep) induction_11\NN\7450842 (r_dobj) involve_9\VB\2676054 (r_conj) is_5\VBZ\0 (l_nsubj) mechanism_1\NN\13446390 (l_prep) of_2\IN\0 (l_pobj) myopathy_4\NN\14204950
D019821_-1 NONE statins_0\NNS\3740161 (r_nsubj) cause_2\VB\7323922 (l_ccomp) myopathy_5\NN\14204950 (l_conj) hyperckaemia_7\NN\0
19308880
D014635_D003221 CID acid_10\NN\14818238 (r_pobj) with_8\IN\0 (r_prep) reaction_7\NN\13446390 (r_appos) confusion_0\NN\13972797
D014635_D003221 CID acid_10\NN\14818238 (r_pobj) with_8\IN\0 (r_prep) observed_7\VBD\2163746 (r_acl) reaction_5\NN\13446390 (r_attr) is_1\VBZ\0 (l_nsubj) confusion_0\NN\13972797
D014635_D003221 CID acid_17\NN\14818238 (r_pobj) with_15\IN\0 (r_prep) reported_12\VBN\831651 (r_acl) confusion_11\NN\13972797
D014635_D003221 CID acid_9\NN\14818238 (r_pobj) with_7\IN\0 (r_prep) reported_6\VBN\831651 (l_nsubjpass) cases_2\NNS\7283608 (l_prep) of_3\IN\0 (l_pobj) confusion_4\NN\13972797
D014635_D003221 CID acid_10\NN\14818238 (r_compound) exposure_11\NN\5042871 (r_pobj) following_8\VBG\8180190 (r_prep) weeks_7\NNS\15113229 (r_pobj) during_3\IN\0 (r_prep) occurred_2\VBD\0 (l_nsubj) confusion_0\NN\13972797
D014635_D003221 CID acid_7\NN\14818238 (r_pobj) with_5\IN\0 (r_prep) confusion_4\NN\13972797
18182964
D003000_D006970 NONE clonidine_4\NN\2721160 (r_pobj) on_3\IN\0 (r_prep) was_1\VBD\0 (l_nsubj) drowsiness_0\NN\14015731
D003000_D006970 NONE clonidine_2\NN\2721160 (r_dobj) prescribing_1\VBG\748282 (r_acl) physicians_0\NNS\10305802 (r_nsubj) monitor_4\VB\10676877 (l_conj) advise_8\VB\813978 (l_dobj) patients_9\NNS\9898892 (l_prep) about_10\IN\0 (l_pobj) likelihood_13\NN\4756172 (l_prep) of_14\IN\0 (l_pobj) drowsiness_16\NN\14015731
D003000_D001919 CID clonidine_10\NN\2721160 (r_pobj) with_9\IN\0 (r_prep) treated_8\VBN\2376958 (r_acl) subjects_7\NNS\6598915 (r_pobj) in_6\IN\13603305 (r_prep) incidents_3\NNS\7283608 (l_prep) of_4\IN\0 (l_pobj) bradycardia_5\NN\14110674
D003000_D001919 CID clonidine_17\NN\2721160 (r_pobj) with_16\IN\0 (r_prep) treated_15\VBN\2376958 (r_acl) those_13\DT\0 (r_pobj) with_12\IN\0 (r_prep) compared_11\VBN\644583 (r_prep) treated_8\VBN\2376958 (r_acl) subjects_7\NNS\6598915 (r_pobj) in_6\IN\13603305 (r_prep) incidents_3\NNS\7283608 (l_prep) of_4\IN\0 (l_pobj) bradycardia_5\NN\14110674
D003000_D001919 CID clonidine_2\NN\2721160 (r_dobj) prescribing_1\VBG\748282 (r_acl) physicians_0\NNS\10305802 (r_nsubj) monitor_4\VB\10676877 (l_prep) for_5\IN\0 (l_pobj) bradycardia_6\NN\14110674
D008774_D001289 NONE methylphenidate_12\NN\4320126 (l_prep) with_15\IN\0 (l_pobj) disorder_21\NN\14034177
D008774_D001289 NONE methylphenidate_12\NN\4320126 (l_prep) with_15\IN\0 (l_pobj) disorder_21\NN\14034177 (l_appos) adhd_23\NNP\14304060
D008774_D001289 NONE methylphenidate_25\NN\4320126 (r_conj) clonidine_18\NN\2721160 (r_xcomp) assigned_16\VBN\2475922 (l_nsubjpass) children_11\NNS\9622049 (l_prep) with_12\IN\0 (l_pobj) adhd_13\NNP\14304060
D008774_D001289 NONE methylphenidate_34\NN\4320126 (r_conj) clonidine_32\NN\2721160 (r_conj) methylphenidate_25\NN\4320126 (r_conj) clonidine_18\NN\2721160 (r_xcomp) assigned_16\VBN\2475922 (l_nsubjpass) children_11\NNS\9622049 (l_prep) with_12\IN\0 (l_pobj) adhd_13\NNP\14304060
D008774_D001289 NONE methylphenidate_6\NN\4320126 (r_pobj) with_5\IN\0 (r_conj) used_2\VBN\0 (r_acl) clonidine_0\NNP\2721160 (r_nsubj) appears_8\VBZ\2604760 (l_conj) tolerated_12\VBN\802318 (l_prep) in_13\IN\13603305 (l_pobj) adhd_15\NNP\14304060
D003000_D001289 NONE clonidine_0\NNP\2721160 (l_prep) for_1\IN\0 (l_pobj) disorder_7\NN\14034177
D003000_D001289 NONE clonidine_7\NN\2721160 (r_pobj) of_6\IN\0 (r_prep) safety_3\NN\13920835 (r_dobj) examine_1\VB\0 (r_csubj) used_8\VBN\0 (l_conj) with_11\IN\0 (l_pobj) methylphenidate_12\NN\4320126 (l_prep) with_15\IN\0 (l_pobj) disorder_21\NN\14034177
D003000_D001289 NONE clonidine_7\NN\2721160 (r_pobj) of_6\IN\0 (r_prep) safety_3\NN\13920835 (r_dobj) examine_1\VB\0 (r_csubj) used_8\VBN\0 (l_conj) with_11\IN\0 (l_pobj) methylphenidate_12\NN\4320126 (l_prep) with_15\IN\0 (l_pobj) disorder_21\NN\14034177 (l_appos) adhd_23\NNP\14304060
D003000_D001289 NONE clonidine_18\NN\2721160 (r_xcomp) assigned_16\VBN\2475922 (l_nsubjpass) children_11\NNS\9622049 (l_prep) with_12\IN\0 (l_pobj) adhd_13\NNP\14304060
D003000_D001289 NONE clonidine_32\NN\2721160 (r_conj) methylphenidate_25\NN\4320126 (r_conj) clonidine_18\NN\2721160 (r_xcomp) assigned_16\VBN\2475922 (l_nsubjpass) children_11\NNS\9622049 (l_prep) with_12\IN\0 (l_pobj) adhd_13\NNP\14304060
D003000_D001289 NONE clonidine_0\NNP\2721160 (r_nsubj) appears_8\VBZ\2604760 (l_conj) tolerated_12\VBN\802318 (l_prep) in_13\IN\13603305 (l_pobj) adhd_15\NNP\14304060
20528871
C104457_D006402 CID arag_8\NNP\0 (r_pobj) than_7\IN\0 (r_prep) combination_6\NN\7951464 (r_pobj) for_4\IN\0 (r_prep) greater_3\JJR\0 (r_acomp) was_2\VBD\0 (l_nsubj) toxicity_1\NN\13576101
D005047_D015458 NONE etoposide_5\RB\0 (r_conj) nelarabine_3\NN\0 (l_prep) in_9\IN\13603305 (l_pobj) leukaemia_18\NN\14239918 (l_conj) lymphoma_20\NN\14239918
D005047_D015458 NONE etoposide_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) d_12\SYM\15089472 (r_pobj) with_10\IN\0 (r_prep) arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
D005047_D015458 NONE vp_16\NNP\0 (r_appos) d_12\SYM\15089472 (r_pobj) with_10\IN\0 (r_prep) arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
D005047_D016399 NONE etoposide_5\RB\0 (r_conj) nelarabine_3\NN\0 (l_prep) in_9\IN\13603305 (l_pobj) leukaemia_18\NN\14239918 (l_conj) lymphoma_20\NN\14239918
D005047_D016399 NONE etoposide_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) d_12\SYM\15089472 (r_pobj) with_10\IN\0 (r_prep) arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
D005047_D016399 NONE vp_16\NNP\0 (r_appos) d_12\SYM\15089472 (r_pobj) with_10\IN\0 (r_prep) arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
C104457_D015458 NONE nelarabine_3\NN\0 (l_prep) in_9\IN\13603305 (l_pobj) leukaemia_18\NN\14239918 (l_conj) lymphoma_20\NN\14239918
C104457_D015458 NONE nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
C104457_D015458 NONE arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
D003520_D015458 NONE cyclophosphamide_8\NN\0 (r_conj) etoposide_5\RB\0 (r_conj) nelarabine_3\NN\0 (l_prep) in_9\IN\13603305 (l_pobj) leukaemia_18\NN\14239918 (l_conj) lymphoma_20\NN\14239918
D003520_D015458 NONE cyclophosphamide_19\NN\0 (r_conj) vp_16\NNP\0 (r_appos) d_12\SYM\15089472 (r_pobj) with_10\IN\0 (r_prep) arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
D003520_D015458 NONE cpm_21\NNP\0 (r_appos) vp_16\NNP\0 (r_appos) d_12\SYM\15089472 (r_pobj) with_10\IN\0 (r_prep) arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
C104457_D016399 NONE nelarabine_3\NN\0 (l_prep) in_9\IN\13603305 (l_pobj) leukaemia_18\NN\14239918 (l_conj) lymphoma_20\NN\14239918
C104457_D016399 NONE nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
C104457_D016399 NONE arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
D003520_D016399 NONE cyclophosphamide_8\NN\0 (r_conj) etoposide_5\RB\0 (r_conj) nelarabine_3\NN\0 (l_prep) in_9\IN\13603305 (l_pobj) leukaemia_18\NN\14239918 (l_conj) lymphoma_20\NN\14239918
D003520_D016399 NONE cyclophosphamide_19\NN\0 (r_conj) vp_16\NNP\0 (r_appos) d_12\SYM\15089472 (r_pobj) with_10\IN\0 (r_prep) arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
D003520_D016399 NONE cpm_21\NNP\0 (r_appos) vp_16\NNP\0 (r_appos) d_12\SYM\15089472 (r_pobj) with_10\IN\0 (r_prep) arag_8\NNP\0 (r_appos) nelarabine_6\JJ\0 (r_pobj) of_5\IN\0 (r_prep) d_4\SYM\15089472 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) used_28\VBN\0 (l_prep) in_32\IN\13603305 (l_pobj) children_34\NNS\9622049 (l_prep) with_35\IN\0 (l_pobj) leukaemia_42\NN\14239918 (l_conj) lymphoma_44\NN\14239918
D005047_D009422 NONE etoposide_14\NN\0 (r_pobj) with_13\IN\0 (r_prep) synchrony_12\NN\13844690 (r_pobj) in_11\IN\13603305 (r_prep) therapy_10\NN\657604 (r_pobj) as_8\IN\14622893 (r_prep) giving_6\VBG\1085793 (r_pcomp) of_5\IN\0 (r_prep) safety_4\NN\13920835 (r_dobj) supports_2\VBZ\407535 (l_advcl) monitored_24\VBN\2169352 (l_nsubjpass) toxicity_20\NN\13576101
D003520_D009422 NONE cyclophosphamide_16\NN\0 (r_conj) etoposide_14\NN\0 (r_pobj) with_13\IN\0 (r_prep) synchrony_12\NN\13844690 (r_pobj) in_11\IN\13603305 (r_prep) therapy_10\NN\657604 (r_pobj) as_8\IN\14622893 (r_prep) giving_6\VBG\1085793 (r_pcomp) of_5\IN\0 (r_prep) safety_4\NN\13920835 (r_dobj) supports_2\VBZ\407535 (l_advcl) monitored_24\VBN\2169352 (l_nsubjpass) toxicity_20\NN\13576101
C104457_D009422 CID arag_8\NNP\0 (r_pobj) to_6\IN\0 (r_prep) attributable_5\JJ\0 (r_amod) effects_4\NNS\13245626 (r_nsubj) included_9\VBD\0 (l_dobj) neuropathy_17\NN\14204950
C104457_D009422 CID arag_7\NN\0 (r_dobj) giving_6\VBG\1085793 (r_pcomp) of_5\IN\0 (r_prep) safety_4\NN\13920835 (r_dobj) supports_2\VBZ\407535 (l_advcl) monitored_24\VBN\2169352 (l_nsubjpass) toxicity_20\NN\13576101
C104457_D059352 CID arag_8\NNP\0 (r_pobj) to_6\IN\0 (r_prep) attributable_5\JJ\0 (r_amod) effects_4\NNS\13245626 (r_nsubj) included_9\VBD\0 (l_dobj) neuropathy_17\NN\14204950 (l_conj) pain_20\NN\14299637
10704919
D017665_D006461 NONE hydroxyl_32\NN\14621446 (r_dobj) inactivated_30\VBN\1097743 (r_parataxis) prevented_6\VBN\0 (l_nsubjpass) effect_2\NN\34213 (l_amod) hemolytic_1\JJ\0
D017665_D006461 NONE hydroxyl_32\NN\14621446 (r_dobj) inactivated_30\VBN\1097743 (r_parataxis) prevented_6\VBN\0 (l_advcl) indicating_34\VBG\952524 (l_ccomp) related_42\VBN\628491 (l_nsubjpass) hemolysis_39\NN\13509528
D013629_D006461 CID tamoxifen_6\NN\2714883 (r_pobj) by_5\IN\0 (r_agent) induced_4\VBN\1627355 (l_nsubj) hemolysis_0\NNP\13509528
D013629_D006461 CID tam_0\NNP\2954340 (r_nsubj) induces_1\VBZ\1627355 (l_dobj) hemolysis_2\NN\13509528
D013629_D006461 CID tam_13\NNP\2954340 (r_nsubj) induces_14\VBZ\1627355 (r_conj) is_4\VBZ\0 (l_nsubj) extension_1\NN\15272029 (l_prep) of_2\IN\0 (l_pobj) hemolysis_3\NN\13509528
D013629_D006461 CID tam_13\NNP\2954340 (r_nsubj) induces_14\VBZ\1627355 (l_dobj) hemolysis_16\NN\13509528
D013629_D006461 CID tam_4\NNP\2954340 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (l_amod) hemolytic_1\JJ\0
D013629_D006461 CID tam_4\NNP\2954340 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (r_nsubjpass) prevented_6\VBN\0 (l_advcl) indicating_34\VBG\952524 (l_ccomp) related_42\VBN\628491 (l_nsubjpass) hemolysis_39\NN\13509528
D013629_D006461 CID tam_36\NNP\2954340 (r_npadvmod) induced_38\VBN\1627355 (r_amod) hemolysis_39\NN\13509528 (r_nsubjpass) related_42\VBN\628491 (r_ccomp) indicating_34\VBG\952524 (r_advcl) prevented_6\VBN\0 (l_nsubjpass) effect_2\NN\34213 (l_amod) hemolytic_1\JJ\0
D013629_D006461 CID tam_36\NNP\2954340 (r_npadvmod) induced_38\VBN\1627355 (r_amod) hemolysis_39\NN\13509528
D013629_D006461 CID tam_17\NNP\2954340 (r_npadvmod) induced_19\VBN\1627355 (r_amod) hemolysis_20\NN\13509528
D013629_D006461 CID tam_3\NNP\2954340 (r_pobj) by_2\IN\0 (r_agent) caused_1\VBN\1617192 (r_acl) hemolysis_0\NNP\13509528
D013629_D006461 CID tam_3\NNP\2954340 (r_pobj) by_2\IN\0 (r_agent) caused_1\VBN\1617192 (r_acl) hemolysis_0\NNP\13509528 (r_nsubjpass) preceded_6\VBN\0 (l_prep) excluding_18\VBG\471711 (l_pobj) mechanism_24\NN\13446390 (l_prep) of_25\IN\0 (l_pobj) hemolysis_26\NN\13509528
D013629_D006461 CID tam_15\NNP\2954340 (r_compound) incorporation_16\NN\1237415 (r_pobj) to_12\IN\0 (r_prep) related_11\VBN\628491 (l_nsubjpass) protection_5\NN\407535 (l_prep) from_6\IN\0 (l_pobj) hemolysis_7\NN\13509528
D013629_D006461 CID tam_2\NNP\2954340 (r_npadvmod) induced_4\VBN\1627355 (r_amod) results_6\NNS\34213 (l_compound) hemolysis_5\NN\13509528
D013629_D001943 NONE tamoxifen_0\NNP\2714883 (r_nsubj) induces_18\VBZ\1627355 (l_nsubj) drug_7\NN\14778436 (l_acl) prescribed_10\VBN\748282 (l_prep) in_11\IN\13603305 (l_pobj) chemotherapy_13\NN\661091 (l_prep) of_14\IN\0 (l_pobj) cancer_16\NN\14239425
D013629_D001943 NONE tam_2\NNP\2954340 (r_appos) tamoxifen_0\NNP\2714883 (r_nsubj) induces_18\VBZ\1627355 (l_nsubj) drug_7\NN\14778436 (l_acl) prescribed_10\VBN\748282 (l_prep) in_11\IN\13603305 (l_pobj) chemotherapy_13\NN\661091 (l_prep) of_14\IN\0 (l_pobj) cancer_16\NN\14239425
D011188_D006461 NONE k(+_11\NNP\0 (r_pobj) of_10\IN\0 (r_prep) leakage_9\NN\7407777 (r_pobj) by_7\IN\0 (r_agent) preceded_6\VBN\0 (l_nsubjpass) hemolysis_0\NNP\13509528
D011188_D006461 NONE k(+_11\NNP\0 (r_pobj) of_10\IN\0 (r_prep) leakage_9\NN\7407777 (r_pobj) by_7\IN\0 (r_agent) preceded_6\VBN\0 (l_prep) excluding_18\VBG\471711 (l_pobj) mechanism_24\NN\13446390 (l_prep) of_25\IN\0 (l_pobj) hemolysis_26\NN\13509528
D013629_D000743 CID tamoxifen_0\NNP\2714883 (r_nsubj) induces_18\VBZ\1627355 (l_dobj) changes_19\NNS\7283608 (l_prep) in_20\IN\13603305 (l_pobj) shape_23\NN\5062748 (l_prep) of_24\IN\0 (l_pobj) erythrocytes_25\NNS\5449268 (l_conj) anemia_28\NN\14189204
D013629_D000743 CID tam_2\NNP\2954340 (r_appos) tamoxifen_0\NNP\2714883 (r_nsubj) induces_18\VBZ\1627355 (l_dobj) changes_19\NNS\7283608 (l_prep) in_20\IN\13603305 (l_pobj) shape_23\NN\5062748 (l_prep) of_24\IN\0 (l_pobj) erythrocytes_25\NNS\5449268 (l_conj) anemia_28\NN\14189204
D013629_D000743 CID tam_6\NNP\2954340 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (r_dobj) evaluates_2\VBZ\670261 (l_advcl) attempting_12\VBG\2367363 (l_xcomp) identify_14\VB\699815 (l_dobj) mechanisms_17\NNS\13446390 (l_prep) on_18\IN\0 (l_pobj) anemia_23\NN\14189204
D013629_D000743 CID tam_19\NNP\2954340 (r_npadvmod) induced_21\VBN\1627355 (r_amod) anemia_23\NN\14189204
D013629_D000743 CID tam_13\NNP\2954340 (r_pobj) by_12\IN\0 (r_agent) promoted_11\VBN\2556126 (r_acl) stability_10\NN\4777852 (r_dobj) decreased_8\VBD\169651 (l_conj) resulting_15\VBG\2633881 (l_prep) in_16\IN\13603305 (l_pobj) anemia_18\NN\14189204
D010100_D006461 NONE oxygen_7\NN\14622893 (r_compound) consumption_8\NN\13440063 (r_pobj) of_6\IN\0 (r_prep) absence_5\NN\14449405 (r_pobj) by_4\IN\0 (r_agent) evidenced_3\VBN\1015244 (l_conj) determined_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) parallel_15\NN\4743605 (l_prep) with_16\IN\0 (l_pobj) hemolysis_20\NN\13509528
D024502_D006461 NONE tocopherol_13\NN\14724645 (r_pobj) of_10\IN\0 (r_prep) concentrations_9\NNS\4916342 (r_pobj) by_7\IN\0 (r_agent) prevented_6\VBN\0 (l_nsubjpass) effect_2\NN\34213 (l_amod) hemolytic_1\JJ\0
D024502_D006461 NONE tocopherol_13\NN\14724645 (r_pobj) of_10\IN\0 (r_prep) concentrations_9\NNS\4916342 (r_pobj) by_7\IN\0 (r_agent) prevented_6\VBN\0 (l_advcl) indicating_34\VBG\952524 (l_ccomp) related_42\VBN\628491 (l_nsubjpass) hemolysis_39\NN\13509528
D024502_D006461 NONE t_17\NNP\14999913 (r_appos) tocopherol_13\NN\14724645 (r_pobj) of_10\IN\0 (r_prep) concentrations_9\NNS\4916342 (r_pobj) by_7\IN\0 (r_agent) prevented_6\VBN\0 (l_nsubjpass) effect_2\NN\34213 (l_amod) hemolytic_1\JJ\0
D024502_D006461 NONE t_17\NNP\14999913 (r_appos) tocopherol_13\NN\14724645 (r_pobj) of_10\IN\0 (r_prep) concentrations_9\NNS\4916342 (r_pobj) by_7\IN\0 (r_agent) prevented_6\VBN\0 (l_advcl) indicating_34\VBG\952524 (l_ccomp) related_42\VBN\628491 (l_nsubjpass) hemolysis_39\NN\13509528
D024502_D006461 NONE acetate_23\NN\15010703 (r_conj) concentrations_9\NNS\4916342 (r_pobj) by_7\IN\0 (r_agent) prevented_6\VBN\0 (l_nsubjpass) effect_2\NN\34213 (l_amod) hemolytic_1\JJ\0
D024502_D006461 NONE acetate_23\NN\15010703 (r_conj) concentrations_9\NNS\4916342 (r_pobj) by_7\IN\0 (r_agent) prevented_6\VBN\0 (l_advcl) indicating_34\VBG\952524 (l_ccomp) related_42\VBN\628491 (l_nsubjpass) hemolysis_39\NN\13509528
D024502_D006461 NONE tac_27\NNS\0 (r_appos) acetate_23\NN\15010703 (r_conj) concentrations_9\NNS\4916342 (r_pobj) by_7\IN\0 (r_agent) prevented_6\VBN\0 (l_nsubjpass) effect_2\NN\34213 (l_amod) hemolytic_1\JJ\0
D024502_D006461 NONE tac_27\NNS\0 (r_appos) acetate_23\NN\15010703 (r_conj) concentrations_9\NNS\4916342 (r_pobj) by_7\IN\0 (r_agent) prevented_6\VBN\0 (l_advcl) indicating_34\VBG\952524 (l_ccomp) related_42\VBN\628491 (l_nsubjpass) hemolysis_39\NN\13509528
D024505_D006461 NONE tocopherols_9\NNS\14724645 (r_pobj) by_8\IN\0 (r_prep) protection_5\NN\407535 (l_prep) from_6\IN\0 (l_pobj) hemolysis_7\NN\13509528
10683478
D001058_D006948 CID apomorphine_5\NN\3786417 (r_npadvmod) induced_7\VBN\1627355 (r_amod) hyperactivity_8\NN\14052403
D004298_D007035 NONE dopamine_28\NN\14807737 (r_relcl) changes_26\NNS\7283608 (r_dobj) produce_24\VB\7555863 (r_conj) induce_19\VB\1627355 (l_dobj) hypothermia_20\NN\14034177
D001058_D007035 CID apomorphine_0\NNP\3786417 (r_nsubjpass) selected_8\VBN\697589 (l_dobj) ability_17\NN\4723816 (l_acl) induce_19\VB\1627355 (l_dobj) hypothermia_20\NN\14034177
D001058_D007035 CID apomorphine_11\NN\3786417 (l_prep) as_13\IN\14622893 (l_pobj) hypothermia_17\NN\14034177
D018491_D007035 NONE agonist_5\NN\0 (r_appos) apomorphine_0\NNP\3786417 (r_nsubjpass) selected_8\VBN\697589 (l_dobj) ability_17\NN\4723816 (l_acl) induce_19\VB\1627355 (l_dobj) hypothermia_20\NN\14034177
12041669
D000961_D000741 NONE globulin_1\NN\14736972 (l_prep) in_2\IN\13603305 (l_pobj) treatment_4\NN\654885 (l_prep) of_5\IN\0 (l_pobj) anemia_12\NN\14189204
D000961_D000741 NONE globulin_5\NN\14736972 (r_compound) therapy_6\NN\657604 (r_dobj) received_3\VBD\2210855 (l_prep) for_7\IN\0 (l_pobj) anemia_9\NN\14189204
D000961_D000741 NONE globulin_3\NN\14736972 (r_dobj) use_0\NN\407535 (r_nsubj) be_5\VB\14625458 (l_attr) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) anemia_16\NN\14189204
D010396_D000741 CID penicillamine_8\NN\3740161 (r_npadvmod) induced_10\VBN\1627355 (r_amod) anemia_12\NN\14189204
D010396_D000741 CID penicillamine_14\NN\3740161 (r_compound) therapy_15\NN\657604 (r_nsubjpass) described_17\VBN\1001294 (l_nsubjpass) patient_1\NN\9898892 (l_relcl) received_3\VBD\2210855 (l_prep) for_7\IN\0 (l_pobj) anemia_9\NN\14189204
D010396_D000741 CID penicillamine_12\NN\3740161 (r_npadvmod) induced_14\VBN\1627355 (r_amod) anemia_16\NN\14189204
12536034
D020888_D004832 CID vigabatrin_15\NN\0 (r_conj) carbamazepine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) administration_11\NN\1133281 (r_pobj) after_10\IN\0 (r_prep) present_2\VBP\28270 (l_dobj) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) epilepsy_9\NN\14085708
D005680_D004832 NONE acid_4\NN\14818238 (r_npadvmod) transmitted_6\VBN\2232190 (r_amod) circuitry_8\NN\3278248 (r_compound) accounts_9\VBZ\6647206 (l_prep) for_10\IN\0 (l_pobj) part_13\NN\31921 (l_prep) of_14\IN\0 (l_pobj) neurophysiology_17\NN\6081833 (l_prep) of_18\IN\0 (l_pobj) epilepsy_21\NN\14085708
D002220_D004832 CID carbamazepine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) administration_11\NN\1133281 (r_pobj) after_10\IN\0 (r_prep) present_2\VBP\28270 (l_dobj) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) epilepsy_9\NN\14085708
10365197
D003042_D019970 NONE cocaine_1\NN\3492717 (r_npadvmod) dependent_3\JJ\9627906 (r_amod) outpatients_4\NNS\10405694 (l_prep) with_5\IN\0 (l_pobj) disorder_10\NN\14034177 (l_appos) cimd_12\NNP\0
D003042_D019970 NONE cocaine_6\NN\3492717 (r_npadvmod) induced_8\VBN\1627355 (r_amod) disorder_10\NN\14034177 (l_appos) cimd_12\NNP\0
D003042_D001523 NONE cocaine_0\NN\3492717 (r_npadvmod) induced_2\VBN\1627355 (r_amod) disorder_4\NN\14034177 (l_appos) rates_7\NNS\13308999 (l_conj) symptoms_10\NNS\5823932 (l_amod) psychiatric_9\JJ\0
D003042_D001523 NONE cocaine_14\NN\3492717 (r_npadvmod) dependent_16\JJ\9627906 (r_amod) sample_17\NN\5820620 (r_pobj) in_11\IN\13603305 (r_prep) rates_7\NNS\13308999 (l_conj) symptoms_10\NNS\5823932 (l_amod) psychiatric_9\JJ\0
D003042_D001523 NONE cocaine_1\NN\3492717 (r_npadvmod) dependent_3\JJ\9627906 (r_amod) outpatients_4\NNS\10405694 (r_nsubjpass) compared_24\VBN\644583 (l_prep) on_25\IN\0 (l_pobj) measures_26\NNS\168237 (l_prep) of_27\IN\0 (l_pobj) symptoms_29\NNS\5823932 (l_amod) psychiatric_28\JJ\0
D003042_D001523 NONE cocaine_6\NN\3492717 (r_npadvmod) induced_8\VBN\1627355 (r_amod) disorder_10\NN\14034177 (r_pobj) with_5\IN\0 (r_prep) outpatients_4\NNS\10405694 (r_nsubjpass) compared_24\VBN\644583 (l_prep) on_25\IN\0 (l_pobj) measures_26\NNS\168237 (l_prep) of_27\IN\0 (l_pobj) symptoms_29\NNS\5823932 (l_amod) psychiatric_28\JJ\0
D003042_D019964 CID cocaine_0\NN\3492717 (r_npadvmod) induced_2\VBN\1627355 (r_amod) disorder_4\NN\14034177
D003042_D019964 CID cocaine_14\NN\3492717 (r_npadvmod) dependent_16\JJ\9627906 (r_amod) sample_17\NN\5820620 (r_pobj) in_11\IN\13603305 (r_prep) rates_7\NNS\13308999 (r_appos) disorder_4\NN\14034177
D003042_D019964 CID cocaine_1\NN\3492717 (r_npadvmod) dependent_3\JJ\9627906 (r_amod) outpatients_4\NNS\10405694 (l_prep) with_5\IN\0 (l_pobj) disorder_10\NN\14034177
D003042_D019964 CID cocaine_1\NN\3492717 (r_npadvmod) dependent_3\JJ\9627906 (r_amod) outpatients_4\NNS\10405694 (l_conj) disorders_17\NNS\14034177
D003042_D019964 CID cocaine_1\NN\3492717 (r_npadvmod) dependent_3\JJ\9627906 (r_amod) outpatients_4\NNS\10405694 (l_conj) disorders_17\NNS\14034177 (l_conj) disorder_22\NN\14034177
D003042_D019964 CID cocaine_6\NN\3492717 (r_npadvmod) induced_8\VBN\1627355 (r_amod) disorder_10\NN\14034177
D003042_D019964 CID cocaine_6\NN\3492717 (r_npadvmod) induced_8\VBN\1627355 (r_amod) disorder_10\NN\14034177 (r_pobj) with_5\IN\0 (r_prep) outpatients_4\NNS\10405694 (l_conj) disorders_17\NNS\14034177
D003042_D019964 CID cocaine_6\NN\3492717 (r_npadvmod) induced_8\VBN\1627355 (r_amod) disorder_10\NN\14034177 (r_pobj) with_5\IN\0 (r_prep) outpatients_4\NNS\10405694 (l_conj) disorders_17\NNS\14034177 (l_conj) disorder_22\NN\14034177
16160878
D014579_D001919 NONE ii_8\NNP\13741022 (r_pobj) of_5\IN\0 (r_prep) injection_4\NN\320852 (r_nsubj) causes_9\NNS\7323922 (l_dobj) hypertension_10\NN\14057371 (l_conj) bradycardia_12\NN\14110674
D003345_D010409 NONE corticosterone_35\NN\14752057 (r_compound) level_36\NN\4916342 (r_conj) had_12\VBD\0 (l_dobj) erection_25\NN\14037619
D014579_D006973 NONE ii_8\NNP\13741022 (r_pobj) of_5\IN\0 (r_prep) injection_4\NN\320852 (r_nsubj) causes_9\NNS\7323922 (l_dobj) hypertension_10\NN\14057371
D001058_D010409 CID apomorphine_21\NN\3786417 (r_npadvmod) induced_23\VBN\1627355 (r_amod) erection_25\NN\14037619
D014579_D001523 NONE ii_6\NNP\13741022 (r_nsubjpass) involved_9\VBN\2676054 (l_prep) in_10\IN\13603305 (l_pobj) aspects_12\NNS\5849789 (l_prep) of_13\IN\0 (l_pobj) disorders_15\NNS\14034177
D014579_D010409 NONE ii_11\NNP\13741022 (r_pobj) of_8\IN\0 (r_prep) administration_7\NN\1133281 (r_nsubj) had_12\VBD\0 (l_dobj) erection_25\NN\14037619
2385256
D008274_D009157 CID magnesium_6\NN\14625458 (r_compound) administration_7\NN\1133281 (r_pobj) after_5\IN\0 (r_prep) weakness_4\NN\14462666 (r_pobj) as_3\IN\14622893 (r_prep) presenting_2\VBG\2137132 (r_acl) gravis_1\NN\0
D008274_D009157 CID magnesium_3\NN\14625458 (r_compound) administration_4\NN\1133281 (r_pobj) after_2\IN\0 (r_prep) paralysis_1\NN\14557898 (r_nsubjpass) described_7\VBN\1001294 (l_prep) in_8\IN\13603305 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) gravis_13\NN\0
D008274_D009468 NONE magnesium_17\NN\14625458 (r_compound) administration_18\NN\1133281 (r_pobj) after_15\IN\0 (r_prep) became_12\VBD\146138 (r_relcl) disease_10\NN\14061805
D008274_D011782 NONE magnesium_17\NN\14625458 (r_compound) administration_18\NN\1133281 (r_pobj) after_15\IN\0 (r_prep) became_12\VBD\146138 (l_acomp) quadriplegic_14\JJ\10158756
D008274_D010243 NONE magnesium_3\NN\14625458 (r_compound) administration_4\NN\1133281 (r_pobj) after_2\IN\0 (r_prep) paralysis_1\NN\14557898
D008274_D020511 NONE magnesium_10\NN\14625458 (r_pobj) of_9\IN\0 (r_prep) effects_8\NNS\13245626 (r_pobj) to_5\IN\0 (r_prep) sensitive_4\JJ\10488309 (r_acomp) are_2\VBP\13600404 (r_relcl) patients_0\NNS\9898892 (r_nsubjpass) suspected_13\VBN\916909 (l_prep) of_14\IN\0 (l_pcomp) having_15\VBG\0 (l_dobj) disorder_18\NN\14034177 (l_prep) of_19\IN\0 (l_pobj) transmission_21\NN\121166
D008274_D011225 NONE magnesium_17\NN\14625458 (r_compound) administration_18\NN\1133281 (l_prep) for_19\IN\0 (l_pobj) preeclampsia_20\NN\14191037
3076126
D009525_D009135 CID niacin_35\NN\15090742 (r_conj) gemfibrozil_33\NN\3740161 (r_conj) cyclosporin_31\NN\0 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_acl) patients_27\NNS\9898892 (r_pobj) in_26\IN\13603305 (r_prep) reported_21\VBN\831651 (r_conj) associated_2\VBN\628491 (r_acl) myopathy_0\NNP\14204950
D015248_D009135 CID gemfibrozil_33\NN\3740161 (r_conj) cyclosporin_31\NN\0 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_acl) patients_27\NNS\9898892 (r_pobj) in_26\IN\13603305 (r_prep) reported_21\VBN\831651 (r_conj) associated_2\VBN\628491 (r_acl) myopathy_0\NNP\14204950
D009525_D009212 NONE niacin_35\NN\15090742 (r_conj) gemfibrozil_33\NN\3740161 (r_conj) cyclosporin_31\NN\0 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_acl) patients_27\NNS\9898892 (r_pobj) in_26\IN\13603305 (r_prep) reported_21\VBN\831651 (r_conj) associated_2\VBN\628491 (l_prep) in_3\IN\13603305 (l_pobj) cases_5\NNS\7283608 (l_prep) with_6\IN\0 (l_pobj) myoglobinuria_7\NNS\14299637
D016572_D009212 NONE cyclosporin_31\NN\0 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_acl) patients_27\NNS\9898892 (r_pobj) in_26\IN\13603305 (r_prep) reported_21\VBN\831651 (r_conj) associated_2\VBN\628491 (l_prep) in_3\IN\13603305 (l_pobj) cases_5\NNS\7283608 (l_prep) with_6\IN\0 (l_pobj) myoglobinuria_7\NNS\14299637
D008148_D009135 NONE lovastatin_23\NN\3676175 (r_pobj) with_22\IN\0 (r_prep) reported_21\VBN\831651 (r_conj) associated_2\VBN\628491 (r_acl) myopathy_0\NNP\14204950
D009525_D051437 NONE niacin_35\NN\15090742 (r_conj) gemfibrozil_33\NN\3740161 (r_conj) cyclosporin_31\NN\0 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_acl) patients_27\NNS\9898892 (r_pobj) in_26\IN\13603305 (r_prep) reported_21\VBN\831651 (l_prep) in_10\IN\13603305 (l_pobj) cases_12\NNS\7283608 (l_prep) with_13\IN\0 (l_pobj) failure_16\NN\66216
D008148_D051437 CID lovastatin_23\NN\3676175 (r_pobj) with_22\IN\0 (r_prep) reported_21\VBN\831651 (l_prep) in_10\IN\13603305 (l_pobj) cases_12\NNS\7283608 (l_prep) with_13\IN\0 (l_pobj) failure_16\NN\66216
D008148_D009212 CID lovastatin_23\NN\3676175 (r_pobj) with_22\IN\0 (r_prep) reported_21\VBN\831651 (r_conj) associated_2\VBN\628491 (l_prep) in_3\IN\13603305 (l_pobj) cases_5\NNS\7283608 (l_prep) with_6\IN\0 (l_pobj) myoglobinuria_7\NNS\14299637
D015248_D051437 NONE gemfibrozil_33\NN\3740161 (r_conj) cyclosporin_31\NN\0 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_acl) patients_27\NNS\9898892 (r_pobj) in_26\IN\13603305 (r_prep) reported_21\VBN\831651 (l_prep) in_10\IN\13603305 (l_pobj) cases_12\NNS\7283608 (l_prep) with_13\IN\0 (l_pobj) failure_16\NN\66216
D016572_D009135 CID cyclosporin_31\NN\0 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_acl) patients_27\NNS\9898892 (r_pobj) in_26\IN\13603305 (r_prep) reported_21\VBN\831651 (r_conj) associated_2\VBN\628491 (r_acl) myopathy_0\NNP\14204950
D016572_D051437 NONE cyclosporin_31\NN\0 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_acl) patients_27\NNS\9898892 (r_pobj) in_26\IN\13603305 (r_prep) reported_21\VBN\831651 (l_prep) in_10\IN\13603305 (l_pobj) cases_12\NNS\7283608 (l_prep) with_13\IN\0 (l_pobj) failure_16\NN\66216
D015248_D009212 NONE gemfibrozil_33\NN\3740161 (r_conj) cyclosporin_31\NN\0 (r_pobj) with_30\IN\0 (r_prep) treated_29\VBN\2376958 (r_acl) patients_27\NNS\9898892 (r_pobj) in_26\IN\13603305 (r_prep) reported_21\VBN\831651 (r_conj) associated_2\VBN\628491 (l_prep) in_3\IN\13603305 (l_pobj) cases_5\NNS\7283608 (l_prep) with_6\IN\0 (l_pobj) myoglobinuria_7\NNS\14299637
1592014
D003042_D020521 NONE cocaine_8\NN\3492717 (r_pobj) of_7\IN\0 (r_prep) t1/2_5\NN\0 (r_appos) life_3\NN\13954253 (r_nsubj) is_9\VBZ\0 (l_conj) occur_29\VB\0 (l_nsubj) some_14\DT\0 (l_prep) of_15\IN\0 (l_pobj) consequences_17\NNS\34213 (l_prep) of_18\IN\0 (l_pobj) use_20\NN\407535 (l_prep) as_23\IN\14622893 (l_pobj) seizures_24\NNS\14081375 (l_conj) strokes_26\NNS\556313
C005618_D012640 CID benzoylecgonine_6\NN\0 (r_pobj) by_2\IN\0 (r_agent) induced_1\VBN\1627355 (l_nsubj) seizures_0\NNS\14081375
C005618_D012640 CID benzoylecgonine_11\NN\0 (r_appos) metabolite_7\NN\20090 (r_pobj) of_4\IN\0 (r_prep) potential_3\NN\14481929 (r_dobj) evaluated_1\VBD\670261 (l_advcl) cause_17\VB\7323922 (l_dobj) seizures_18\NNS\14081375
C005618_D012640 CID be_13\VB\14625458 (r_appos) metabolite_7\NN\20090 (r_pobj) of_4\IN\0 (r_prep) potential_3\NN\14481929 (r_dobj) evaluated_1\VBD\670261 (l_advcl) cause_17\VB\7323922 (l_dobj) seizures_18\NNS\14081375
C005618_D012640 CID be_0\VB\14625458 (r_advmod) induced_2\VBN\1627355 (r_amod) seizures_3\NNS\14081375
C005618_D012640 CID be_23\NNP\14625458 (r_pobj) by_22\IN\0 (r_agent) induced_21\VBN\1627355 (r_acl) those_20\DT\0 (r_nsubj) were_24\VBD\0 (l_advcl) characterized_7\VBN\609683 (l_nsubjpass) seizures_4\NNS\14081375
C005618_D012640 CID be_0\VB\14625458 (r_advmod) injected_2\VBN\81072 (r_amod) rats_3\NNS\2329401 (l_relcl) have_7\VB\7846 (l_dobj) seizures_8\NNS\14081375
C005618_D012640 CID be_0\VB\14625458 (r_advmod) injected_2\VBN\81072 (r_amod) rats_3\NNS\2329401 (r_nsubj) had_9\VBD\0 (l_prep) without_19\IN\0 (l_pobj) seizures_20\NNS\14081375
C005618_D012640 CID be_5\VB\14625458 (r_advmod) induced_7\VBN\1627355 (r_conj) cocaine-_3\NN\0 (r_nmod) seizures_8\NNS\14081375
C005618_D012640 CID be_5\VB\14625458 (r_advmod) induced_7\VBN\1627355 (r_conj) cocaine-_3\NN\0 (r_nmod) seizures_8\NNS\14081375 (r_nsubj) differ_9\VBP\0 (r_relcl) finding_1\NN\43195 (r_nsubj) suggests_13\VBZ\1010118 (l_dobj) mechanism_17\NN\13446390 (l_prep) for_18\IN\0 (l_pobj) seizures_22\NNS\14081375
C005618_D012640 CID be_32\VB\14625458 (r_conj) emphasizes_24\VBZ\943837 (r_conj) suggests_13\VBZ\1010118 (l_nsubj) finding_1\NN\43195 (l_relcl) differ_9\VBP\0 (l_nsubj) seizures_8\NNS\14081375
C005618_D012640 CID be_32\VB\14625458 (r_conj) emphasizes_24\VBZ\943837 (r_conj) suggests_13\VBZ\1010118 (l_dobj) mechanism_17\NN\13446390 (l_prep) for_18\IN\0 (l_pobj) seizures_22\NNS\14081375
D003042_D003643 NONE cocaine_1\NN\3492717 (r_npadvmod) induced_3\VBN\1627355 (r_amod) seizures_4\NNS\14081375 (r_nsubjpass) characterized_7\VBN\609683 (l_conj) resulted_16\VBD\2633881 (l_prep) in_17\IN\13603305 (l_pobj) death_18\NN\7296428
D003042_D003643 NONE cocaine_1\NN\3492717 (r_npadvmod) induced_3\VBN\1627355 (r_amod) seizures_4\NNS\14081375 (r_nsubjpass) characterized_7\VBN\609683 (r_advcl) were_24\VBD\0 (l_conj) resulted_36\VBD\2633881 (l_prep) in_37\IN\13603305 (l_pobj) death_38\NN\7296428
C005618_D003643 NONE be_23\NNP\14625458 (r_pobj) by_22\IN\0 (r_agent) induced_21\VBN\1627355 (r_acl) those_20\DT\0 (r_nsubj) were_24\VBD\0 (l_advcl) characterized_7\VBN\609683 (l_conj) resulted_16\VBD\2633881 (l_prep) in_17\IN\13603305 (l_pobj) death_18\NN\7296428
C005618_D003643 NONE be_23\NNP\14625458 (r_pobj) by_22\IN\0 (r_agent) induced_21\VBN\1627355 (r_acl) those_20\DT\0 (r_nsubj) were_24\VBD\0 (l_conj) resulted_36\VBD\2633881 (l_prep) in_37\IN\13603305 (l_pobj) death_38\NN\7296428
D003042_D012640 CID cocaine_4\NN\3492717 (r_compound) metabolite_5\NN\20090 (r_amod) benzoylecgonine_6\NN\0 (r_pobj) by_2\IN\0 (r_agent) induced_1\VBN\1627355 (l_nsubj) seizures_0\NNS\14081375
D003042_D012640 CID cocaine_8\NN\3492717 (r_pobj) of_7\IN\0 (r_prep) t1/2_5\NN\0 (r_appos) life_3\NN\13954253 (r_nsubj) is_9\VBZ\0 (l_conj) occur_29\VB\0 (l_nsubj) some_14\DT\0 (l_prep) of_15\IN\0 (l_pobj) consequences_17\NNS\34213 (l_prep) of_18\IN\0 (l_pobj) use_20\NN\407535 (l_prep) as_23\IN\14622893 (l_pobj) seizures_24\NNS\14081375
D003042_D012640 CID cocaine_9\NN\3492717 (r_pobj) of_8\IN\0 (r_prep) metabolite_7\NN\20090 (r_pobj) of_4\IN\0 (r_prep) potential_3\NN\14481929 (r_dobj) evaluated_1\VBD\670261 (l_advcl) cause_17\VB\7323922 (l_dobj) seizures_18\NNS\14081375
D003042_D012640 CID cocaine_19\NN\3492717 (r_pobj) of_18\IN\0 (r_prep) amounts_17\NNS\13329641 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_acl) those_13\DT\0 (r_pobj) than_12\IN\0 (r_prep) latencies_11\NNS\15269513 (r_dobj) had_8\VBD\0 (r_conj) occurred_4\VBD\0 (l_nsubj) seizures_3\NNS\14081375
D003042_D012640 CID cocaine_1\NN\3492717 (r_npadvmod) induced_3\VBN\1627355 (r_amod) seizures_4\NNS\14081375
D003042_D012640 CID cocaine_15\NN\3492717 (r_npadvmod) injected_17\VBN\81072 (r_amod) animals_18\NNS\4475 (r_pobj) than_14\IN\0 (r_prep) activity_13\NN\30358 (r_dobj) had_9\VBD\0 (l_nsubj) rats_3\NNS\2329401 (l_relcl) have_7\VB\7846 (l_dobj) seizures_8\NNS\14081375
D003042_D012640 CID cocaine_15\NN\3492717 (r_npadvmod) injected_17\VBN\81072 (r_amod) animals_18\NNS\4475 (r_pobj) than_14\IN\0 (r_prep) activity_13\NN\30358 (r_dobj) had_9\VBD\0 (l_prep) without_19\IN\0 (l_pobj) seizures_20\NNS\14081375
D003042_D012640 CID cocaine-_3\NN\0 (r_nmod) seizures_8\NNS\14081375
D003042_D012640 CID cocaine-_3\NN\0 (r_nmod) seizures_8\NNS\14081375 (r_nsubj) differ_9\VBP\0 (r_relcl) finding_1\NN\43195 (r_nsubj) suggests_13\VBZ\1010118 (l_dobj) mechanism_17\NN\13446390 (l_prep) for_18\IN\0 (l_pobj) seizures_22\NNS\14081375
D003042_D012640 CID cocaine_19\NN\3492717 (r_npadvmod) induced_21\VBN\1627355 (r_amod) seizures_22\NNS\14081375 (r_pobj) for_18\IN\0 (r_prep) mechanism_17\NN\13446390 (r_dobj) suggests_13\VBZ\1010118 (l_nsubj) finding_1\NN\43195 (l_relcl) differ_9\VBP\0 (l_nsubj) seizures_8\NNS\14081375
D003042_D012640 CID cocaine_19\NN\3492717 (r_npadvmod) induced_21\VBN\1627355 (r_amod) seizures_22\NNS\14081375
D003042_D012640 CID cocaine_29\NN\3492717 (r_compound) metabolite_30\NN\20090 (r_pobj) of_27\IN\0 (r_prep) importance_26\NN\5138488 (r_dobj) emphasizes_24\VBZ\943837 (r_conj) suggests_13\VBZ\1010118 (l_nsubj) finding_1\NN\43195 (l_relcl) differ_9\VBP\0 (l_nsubj) seizures_8\NNS\14081375
D003042_D012640 CID cocaine_29\NN\3492717 (r_compound) metabolite_30\NN\20090 (r_pobj) of_27\IN\0 (r_prep) importance_26\NN\5138488 (r_dobj) emphasizes_24\VBZ\943837 (r_conj) suggests_13\VBZ\1010118 (l_dobj) mechanism_17\NN\13446390 (l_prep) for_18\IN\0 (l_pobj) seizures_22\NNS\14081375
1867351
D015767_D008288 NONE mefloquine_10\NN\2721948 (r_pobj) with_9\IN\0 (r_prep) treatment_8\NN\654885 (r_conj) prophylaxis_6\NN\1077350 (l_compound) malaria_5\NN\14178913
21029050
D013390_D001049 CID succinylcholine_9\NN\3800001 (r_pobj) after_8\IN\0 (r_prep) mutations_2\NNS\4475 (l_prep) in_3\IN\13603305 (l_pobj) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) apnea_7\NN\14299637
D013390_D001049 CID succinylcholine_11\NN\3800001 (r_pobj) of_10\IN\0 (r_prep) action_9\NN\30358 (r_pobj) of_8\IN\0 (r_prep) duration_7\NN\15113229 (r_pobj) with_4\IN\0 (r_prep) patients_3\NNS\9898892 (r_pobj) of_1\IN\0 (r_prep) eleven_0\CD\13745420 (r_nsubj) had_12\VBD\0 (l_advcl) indicating_17\VBG\952524 (l_ccomp) is_20\VBZ\0 (l_attr) reason_23\NN\9178821 (l_prep) for_24\IN\0 (l_pobj) period_27\NN\13575869 (l_prep) of_28\IN\0 (l_pobj) apnea_29\NN\14299637
322550
D009599_D007022 CID nitroprusside_8\RB\0 (r_advmod) induced_10\VBN\1627355 (r_amod) hypotension_11\NN\14057371
D009599_D007022 CID nitroprusside_1\JJ\0 (r_amod) infusion_2\NN\14589223 (r_nsubj) produced_3\VBD\1617192 (l_dobj) decrease_6\NN\7296428 (l_prep) in_7\IN\13603305 (l_pobj) pressure_10\NN\11419404
D009599_D007022 CID nitroprusside_0\NNP\0 (r_nsubj) caused_1\VBD\1617192 (l_dobj) decreases_3\NNS\7296428 (l_prep) in_4\IN\13603305 (l_pobj) pressure_7\NN\11419404
D009599_D007022 NONE nitroprusside_1\JJ\0 (r_amod) levels_4\NNS\4916342 (r_pobj) during_0\IN\0 (r_prep) alter_10\VB\0 (l_conj) produce_31\VBP\7555863 (l_dobj) decreases_33\NNS\7296428 (l_prep) in_34\IN\13603305 (l_pobj) pressure_37\NN\11419404 (l_conj) output_40\NN\4007894
D014867_D002303 NONE h2o_22\NNP\14618834 (r_punct) levels_16\NNS\4916342 (r_conj) alter_10\VB\0 (l_conj) produce_31\VBP\7555863 (l_dobj) decreases_33\NNS\7296428 (l_prep) in_34\IN\13603305 (l_pobj) pressure_37\NN\11419404 (l_conj) output_40\NN\4007894
D014867_D007022 NONE h2o_22\NNP\14618834 (r_punct) levels_16\NNS\4916342 (r_conj) alter_10\VB\0 (l_conj) produce_31\VBP\7555863 (l_dobj) decreases_33\NNS\7296428 (l_prep) in_34\IN\13603305 (l_pobj) pressure_37\NN\11419404 (l_conj) output_40\NN\4007894
D009599_D002303 NONE nitroprusside_1\JJ\0 (r_amod) infusion_2\NN\14589223 (r_nsubj) produced_3\VBD\1617192 (l_conj) increased_13\VBN\169651 (l_conj) decreased_17\VBD\169651 (l_dobj) output_19\NN\4007894
D009599_D002303 NONE nitroprusside_1\JJ\0 (r_amod) levels_4\NNS\4916342 (r_pobj) during_0\IN\0 (r_prep) alter_10\VB\0 (l_conj) produce_31\VBP\7555863 (l_dobj) decreases_33\NNS\7296428 (l_prep) in_34\IN\13603305 (l_pobj) pressure_37\NN\11419404 (l_conj) output_40\NN\4007894
3031535
D006220_D002375 CID haloperidol_28\NN\3713736 (r_pobj) by_27\IN\0 (r_agent) induced_26\VBN\1627355 (r_advcl) are_22\VBP\13600404 (r_advcl) have_6\VBP\7846 (l_dobj) role_9\NN\719494 (l_prep) in_10\IN\13603305 (l_pobj) manifestation_12\NN\7321772 (l_prep) of_13\IN\0 (l_pobj) catalepsy_14\NN\14023236
D006220_D002375 CID haloperidol_28\NN\3713736 (r_pobj) by_27\IN\0 (r_agent) induced_26\VBN\1627355 (r_advcl) are_22\VBP\13600404 (l_prep) in_24\IN\13603305 (l_pobj) catalepsy_25\NN\14023236
D013759_D002375 CID 9-tetrahydrocannabinol_7\NN\0 (r_pobj) by_5\IN\0 (r_agent) induced_4\VBN\1627355 (l_nsubj) involvement_1\NN\1080366 (l_prep) in_2\IN\13603305 (l_pobj) catalepsy_3\NN\14023236
D013759_D002375 CID thc_17\NNP\4017137 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_acl) manifestation_12\NN\7321772 (l_prep) of_13\IN\0 (l_pobj) catalepsy_14\NN\14023236
D013759_D002375 CID thc_17\NNP\4017137 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_acl) manifestation_12\NN\7321772 (r_pobj) in_10\IN\13603305 (r_prep) role_9\NN\719494 (r_dobj) have_6\VBP\7846 (l_advcl) are_22\VBP\13600404 (l_prep) in_24\IN\13603305 (l_pobj) catalepsy_25\NN\14023236
9284778
D017402_D008107 NONE chlorofluorocarbons_14\NNS\14871968 (r_pobj) of_13\IN\0 (r_prep) substitutes_12\NNS\5695554 (r_pobj) as_8\IN\14622893 (r_prep) used_7\VBN\0 (r_acl) hydrochlorofluorocarbons_6\NNS\14603497 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) epidemic_0\NN\7435273 (l_prep) of_1\IN\0 (l_pobj) disease_3\NN\14061805
D006221_D056486 NONE 1-bromo-1-chloro-2,2,2-trifluoroethane_9\CD\0 (r_pobj) as_8\IN\14622893 (r_prep) way_7\NN\4916342 (r_pobj) in_4\IN\13603305 (r_prep) metabolised_3\VBN\0 (l_advcl) form_14\VB\6286395 (l_dobj) intermediates_18\NNS\14806838 (l_relcl) implicated_23\VBN\2677097 (l_prep) in_24\IN\13603305 (l_pobj) hepatotoxicity_26\NN\0
D006221_D056486 NONE halothane_11\NN\3570838 (r_appos) 1-bromo-1-chloro-2,2,2-trifluoroethane_9\CD\0 (r_pobj) as_8\IN\14622893 (r_prep) way_7\NN\4916342 (r_pobj) in_4\IN\13603305 (r_prep) metabolised_3\VBN\0 (l_advcl) form_14\VB\6286395 (l_dobj) intermediates_18\NNS\14806838 (l_relcl) implicated_23\VBN\2677097 (l_prep) in_24\IN\13603305 (l_pobj) hepatotoxicity_26\NN\0
D006221_D056486 NONE halothane_28\NN\3570838 (r_pobj) of_27\IN\0 (r_prep) hepatotoxicity_26\NN\0
C072959_D008107 CID 1-chloro-1,2,2,2-tetrafluoroethane_27\NN\0 (r_conj) hcfc_23\NNP\14603497 (r_appos) 1,1-dichloro-2,2,2-trifluoroethane_21\CD\0 (r_pobj) of_20\IN\0 (r_prep) mixture_19\NN\19613 (r_pobj) to_17\IN\0 (r_prep) exposure_16\NN\5042871 (r_dobj) repeated_14\VBN\952524 (r_relcl) workers_10\NNS\7846 (r_pobj) in_7\IN\13603305 (r_prep) epidemic_3\NN\7435273 (l_prep) of_4\IN\0 (l_pobj) disease_6\NN\14061805
C072959_D008107 CID 124_30\CD\0 (r_nummod) hcfc_29\NNP\14603497 (r_appos) hcfc_23\NNP\14603497 (r_appos) 1,1-dichloro-2,2,2-trifluoroethane_21\CD\0 (r_pobj) of_20\IN\0 (r_prep) mixture_19\NN\19613 (r_pobj) to_17\IN\0 (r_prep) exposure_16\NN\5042871 (r_dobj) repeated_14\VBN\952524 (r_relcl) workers_10\NNS\7846 (r_pobj) in_7\IN\13603305 (r_prep) epidemic_3\NN\7435273 (l_prep) of_4\IN\0 (l_pobj) disease_6\NN\14061805
C072959_D008107 CID 124_8\CD\0 (r_conj) hcfcs_5\NNS\14603497 (r_nsubj) result_10\VB\34213 (l_prep) in_11\IN\13603305 (l_pobj) disease_14\NN\14061805
D014269_D056486 NONE trifluoroacetyl_16\NNS\0 (r_compound) halide_17\NN\15010703 (r_compound) intermediates_18\NNS\14806838 (l_relcl) implicated_23\VBN\2677097 (l_prep) in_24\IN\13603305 (l_pobj) hepatotoxicity_26\NN\0
D014269_D056486 NONE trifluoroacetyl_17\NN\0 (r_npadvmod) altered_19\VBN\0 (r_amod) proteins_21\NNS\14944888 (r_nsubjpass) involved_23\VBN\2676054 (r_ccomp) suggest_15\VBP\1010118 (l_advcl) known_11\VBN\0 (l_nsubjpass) mechanism_3\NN\13446390 (l_prep) of_4\IN\0 (l_pobj) hepatotoxicity_5\NN\0
C067411_D056486 NONE 124_9\CD\0 (r_conj) hcfcs_6\NNS\14603497 (r_pobj) to_5\IN\0 (r_prep) exposure_1\NN\5042871 (r_nsubj) result_11\VB\34213 (l_prep) in_12\IN\13603305 (l_pobj) injury_15\NN\14052046
C072959_D056486 NONE 124_9\CD\0 (r_conj) hcfcs_6\NNS\14603497 (r_pobj) to_5\IN\0 (r_prep) exposure_1\NN\5042871 (r_nsubj) result_11\VB\34213 (l_prep) in_12\IN\13603305 (l_pobj) injury_15\NN\14052046
-1_D008107 NONE hydrochlorofluorocarbons_6\NNS\14603497 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) epidemic_0\NN\7435273 (l_prep) of_1\IN\0 (l_pobj) disease_3\NN\14061805
D010126_D008107 NONE ozone_9\NN\14877585 (r_npadvmod) sparing_11\VBG\2725714 (r_amod) substitutes_12\NNS\5695554 (r_pobj) as_8\IN\14622893 (r_prep) used_7\VBN\0 (r_acl) hydrochlorofluorocarbons_6\NNS\14603497 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) epidemic_0\NN\7435273 (l_prep) of_1\IN\0 (l_pobj) disease_3\NN\14061805
C067411_D008107 CID 1,1-dichloro-2,2,2-trifluoroethane_21\CD\0 (r_pobj) of_20\IN\0 (r_prep) mixture_19\NN\19613 (r_pobj) to_17\IN\0 (r_prep) exposure_16\NN\5042871 (r_dobj) repeated_14\VBN\952524 (r_relcl) workers_10\NNS\7846 (r_pobj) in_7\IN\13603305 (r_prep) epidemic_3\NN\7435273 (l_prep) of_4\IN\0 (l_pobj) disease_6\NN\14061805
C067411_D008107 CID 123_24\CD\0 (r_nummod) hcfc_23\NNP\14603497 (r_appos) 1,1-dichloro-2,2,2-trifluoroethane_21\CD\0 (r_pobj) of_20\IN\0 (r_prep) mixture_19\NN\19613 (r_pobj) to_17\IN\0 (r_prep) exposure_16\NN\5042871 (r_dobj) repeated_14\VBN\952524 (r_relcl) workers_10\NNS\7846 (r_pobj) in_7\IN\13603305 (r_prep) epidemic_3\NN\7435273 (l_prep) of_4\IN\0 (l_pobj) disease_6\NN\14061805
C067411_D008107 CID 124_8\CD\0 (r_conj) hcfcs_5\NNS\14603497 (r_nsubj) result_10\VB\34213 (l_prep) in_11\IN\13603305 (l_pobj) disease_14\NN\14061805
8752018
D008094_D001714 NONE lithium_0\NN\14625458 (r_nsubj) remains_1\VBZ\2684 (l_attr) treatment_6\NN\654885 (l_prep) for_7\IN\0 (l_pobj) treatment_12\NN\654885 (l_prep) of_13\IN\0 (l_pobj) disorder_15\NN\14034177
D008094_D001714 NONE lithium_10\NN\14625458 (r_pobj) from_9\IN\0 (r_prep) switching_6\VBG\191142 (l_dobj) patients_8\NNS\9898892 (l_amod) bipolar_7\JJ\0
D008094_D001714 NONE lithium_8\NN\14625458 (r_pobj) of_7\IN\0 (r_prep) substitution_6\NN\7337390 (r_nsubj) was_18\VBD\0 (l_acomp) helpful_20\JJ\0 (l_prep) in_21\IN\13603305 (l_pcomp) reducing_22\VBG\13447361 (l_dobj) cognitive_24\JJ\0 (l_acl) attributed_31\VBN\670261 (l_prep) to_32\IN\0 (l_pobj) lithium_33\NN\14625458 (l_prep) in_34\IN\13603305 (l_pobj) patients_37\NNS\9898892 (l_amod) bipolar_36\JJ\0
D008094_D001714 NONE lithium_33\NN\14625458 (l_prep) in_34\IN\13603305 (l_pobj) patients_37\NNS\9898892 (l_amod) bipolar_36\JJ\0
D008094_D001714 NONE lithium_12\NN\14625458 (l_prep) in_13\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_amod) bipolar_14\JJ\0
D008094_D011141 NONE lithium_15\NN\14625458 (r_pobj) of_14\IN\0 (r_prep) effects_13\NNS\13245626 (l_prep) as_18\IN\14622893 (l_pobj) polyuria_19\NN\14113228
D008094_D011141 NONE lithium_25\NN\14625458 (r_compound) effects_27\NNS\13245626 (r_nsubj) remain_40\VBP\2604760 (l_advcl) written_4\VBN\1697816 (l_prep) about_5\IN\0 (l_pobj) management_7\NN\1123598 (l_prep) of_8\IN\0 (l_pobj) effects_13\NNS\13245626 (l_prep) as_18\IN\14622893 (l_pobj) polyuria_19\NN\14113228
D014635_D003072 NONE sodium_13\NN\14625458 (r_dobj) divalproex_12\NN\0 (r_advcl) reduced_7\VBN\441445 (r_acl) deficits_6\NNS\5113133
D014635_D003072 NONE sodium_13\NN\14625458 (r_dobj) divalproex_12\NN\0 (l_xcomp) alleviate_15\VB\205885 (l_dobj) impairments_20\NNS\7296428
D014635_D003072 NONE sodium_17\NN\14625458 (r_pobj) with_15\IN\0 (r_prep) substitution_6\NN\7337390 (r_nsubj) was_18\VBD\0 (l_acomp) helpful_20\JJ\0 (l_prep) in_21\IN\13603305 (l_pcomp) reducing_22\VBG\13447361 (l_dobj) cognitive_24\JJ\0 (l_conj) motivational_26\JJ\0 (l_conj) deficits_30\NNS\5113133
D014635_D003072 NONE sodium_6\NN\14625458 (r_nsubj) was_7\VBD\0 (l_attr) alternative_10\NN\5788149 (l_prep) to_11\IN\0 (l_pobj) lithium_12\NN\14625458 (l_prep) in_13\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_acl) experiencing_16\VBG\2108377 (l_dobj) deficits_18\NNS\5113133
D014635_D003072 NONE sodium_6\NN\14625458 (r_nsubj) was_7\VBD\0 (l_attr) alternative_10\NN\5788149 (l_prep) to_11\IN\0 (l_pobj) lithium_12\NN\14625458 (l_prep) in_13\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_acl) experiencing_16\VBG\2108377 (l_dobj) deficits_18\NNS\5113133 (l_conj) loss_20\NN\13252973 (l_prep) of_21\IN\0 (l_pobj) creativity_22\NN\5616246
D014635_D003072 NONE sodium_6\NN\14625458 (r_nsubj) was_7\VBD\0 (l_attr) alternative_10\NN\5788149 (l_prep) to_11\IN\0 (l_pobj) lithium_12\NN\14625458 (l_prep) in_13\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_acl) experiencing_16\VBG\2108377 (l_dobj) deficits_18\NNS\5113133 (l_conj) loss_20\NN\13252973 (l_prep) of_21\IN\0 (l_pobj) creativity_22\NN\5616246 (l_conj) impairments_26\NNS\7296428
D014635_D001714 NONE sodium_13\NN\14625458 (r_dobj) divalproex_12\NN\0 (r_advcl) switching_6\VBG\191142 (l_dobj) patients_8\NNS\9898892 (l_amod) bipolar_7\JJ\0
D014635_D001714 NONE sodium_17\NN\14625458 (r_pobj) with_15\IN\0 (r_prep) substitution_6\NN\7337390 (r_nsubj) was_18\VBD\0 (l_acomp) helpful_20\JJ\0 (l_prep) in_21\IN\13603305 (l_pcomp) reducing_22\VBG\13447361 (l_dobj) cognitive_24\JJ\0 (l_acl) attributed_31\VBN\670261 (l_prep) to_32\IN\0 (l_pobj) lithium_33\NN\14625458 (l_prep) in_34\IN\13603305 (l_pobj) patients_37\NNS\9898892 (l_amod) bipolar_36\JJ\0
D014635_D001714 NONE sodium_6\NN\14625458 (r_nsubj) was_7\VBD\0 (l_attr) alternative_10\NN\5788149 (l_prep) to_11\IN\0 (l_pobj) lithium_12\NN\14625458 (l_prep) in_13\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_amod) bipolar_14\JJ\0
D008094_D003072 CID lithium_0\NN\14625458 (r_npadvmod) associated_2\VBN\628491 (r_amod) deficits_6\NNS\5113133
D008094_D003072 CID lithium_15\NN\14625458 (r_pobj) of_14\IN\0 (r_prep) effects_13\NNS\13245626 (r_pobj) of_8\IN\0 (r_prep) management_7\NN\1123598 (r_pobj) about_5\IN\0 (r_prep) written_4\VBN\1697816 (r_advcl) remain_40\VBP\2604760 (l_nsubj) effects_27\NNS\13245626 (l_prep) as_29\IN\14622893 (l_pobj) deficits_31\NNS\5113133
D008094_D003072 CID lithium_15\NN\14625458 (r_pobj) of_14\IN\0 (r_prep) effects_13\NNS\13245626 (r_pobj) of_8\IN\0 (r_prep) management_7\NN\1123598 (r_pobj) about_5\IN\0 (r_prep) written_4\VBN\1697816 (r_advcl) remain_40\VBP\2604760 (l_nsubj) effects_27\NNS\13245626 (l_prep) as_29\IN\14622893 (l_pobj) deficits_31\NNS\5113133 (l_conj) loss_33\NN\13252973 (l_prep) of_34\IN\0 (l_pobj) creativity_35\NN\5616246
D008094_D003072 CID lithium_15\NN\14625458 (r_pobj) of_14\IN\0 (r_prep) effects_13\NNS\13245626 (r_pobj) of_8\IN\0 (r_prep) management_7\NN\1123598 (r_pobj) about_5\IN\0 (r_prep) written_4\VBN\1697816 (r_advcl) remain_40\VBP\2604760 (l_nsubj) effects_27\NNS\13245626 (l_prep) as_29\IN\14622893 (l_pobj) deficits_31\NNS\5113133 (l_conj) loss_33\NN\13252973 (l_conj) impairments_39\NNS\7296428
D008094_D003072 CID lithium_25\NN\14625458 (r_compound) effects_27\NNS\13245626 (l_prep) as_29\IN\14622893 (l_pobj) deficits_31\NNS\5113133
D008094_D003072 CID lithium_25\NN\14625458 (r_compound) effects_27\NNS\13245626 (l_prep) as_29\IN\14622893 (l_pobj) deficits_31\NNS\5113133 (l_conj) loss_33\NN\13252973 (l_prep) of_34\IN\0 (l_pobj) creativity_35\NN\5616246
D008094_D003072 CID lithium_25\NN\14625458 (r_compound) effects_27\NNS\13245626 (l_prep) as_29\IN\14622893 (l_pobj) deficits_31\NNS\5113133 (l_conj) loss_33\NN\13252973 (l_conj) impairments_39\NNS\7296428
D008094_D003072 CID lithium_10\NN\14625458 (r_pobj) from_9\IN\0 (r_prep) switching_6\VBG\191142 (l_advcl) divalproex_12\NN\0 (l_xcomp) alleviate_15\VB\205885 (l_dobj) impairments_20\NNS\7296428
D008094_D003072 CID lithium_8\NN\14625458 (r_pobj) of_7\IN\0 (r_prep) substitution_6\NN\7337390 (r_nsubj) was_18\VBD\0 (l_acomp) helpful_20\JJ\0 (l_prep) in_21\IN\13603305 (l_pcomp) reducing_22\VBG\13447361 (l_dobj) cognitive_24\JJ\0 (l_conj) motivational_26\JJ\0 (l_conj) deficits_30\NNS\5113133
D008094_D003072 CID lithium_33\NN\14625458 (r_pobj) to_32\IN\0 (r_prep) attributed_31\VBN\670261 (r_acl) cognitive_24\JJ\0 (l_conj) motivational_26\JJ\0 (l_conj) deficits_30\NNS\5113133
D008094_D003072 CID lithium_12\NN\14625458 (l_prep) in_13\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_acl) experiencing_16\VBG\2108377 (l_dobj) deficits_18\NNS\5113133
D008094_D003072 CID lithium_12\NN\14625458 (l_prep) in_13\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_acl) experiencing_16\VBG\2108377 (l_dobj) deficits_18\NNS\5113133 (l_conj) loss_20\NN\13252973 (l_prep) of_21\IN\0 (l_pobj) creativity_22\NN\5616246
D008094_D003072 CID lithium_12\NN\14625458 (l_prep) in_13\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_acl) experiencing_16\VBG\2108377 (l_dobj) deficits_18\NNS\5113133 (l_conj) loss_20\NN\13252973 (l_prep) of_21\IN\0 (l_pobj) creativity_22\NN\5616246 (l_conj) impairments_26\NNS\7296428
D008094_D014202 NONE lithium_15\NN\14625458 (r_pobj) of_14\IN\0 (r_prep) effects_13\NNS\13245626 (l_prep) as_18\IN\14622893 (l_pobj) polyuria_19\NN\14113228 (l_conj) tremor_21\NN\345926
D008094_D014202 NONE lithium_25\NN\14625458 (r_compound) effects_27\NNS\13245626 (r_nsubj) remain_40\VBP\2604760 (l_advcl) written_4\VBN\1697816 (l_prep) about_5\IN\0 (l_pobj) management_7\NN\1123598 (l_prep) of_8\IN\0 (l_pobj) effects_13\NNS\13245626 (l_prep) as_18\IN\14622893 (l_pobj) polyuria_19\NN\14113228 (l_conj) tremor_21\NN\345926
7516729
D014700_D001919 CID verapamil_6\NN\2938514 (r_pobj) by_5\IN\0 (r_agent) induced_4\VBN\1627355 (r_acl) bradycardia_3\NNS\14110674
6727060
D008787_D005767 NONE metoclopramide_23\RB\0 (r_dobj) took_22\VBD\2367363 (l_prep) for_24\IN\0 (l_pobj) disorder_26\NN\14034177
D008787_D004409 CID metoclopramide_7\NN\0 (r_pobj) by_6\IN\0 (r_agent) caused_5\VBN\1617192 (r_acl) dyskinesia_4\JJ\14084880
D008787_D004409 CID metoclopramide_23\RB\0 (r_dobj) took_22\VBD\2367363 (r_advcl) appeared_3\VBD\2604760 (l_nsubj) movements_2\NNS\191142
D008787_D004409 CID metoclopramide_2\JJ\0 (r_compound) administration_3\NN\1133281 (r_nsubjpass) discontinued_5\VBN\0 (r_advcl) improved_11\VBD\126264 (l_nsubj) movements_9\NNS\191142
983936
D006854_D009202 NONE hydrocortisone_8\NN\14751417 (l_prep) on_9\IN\0 (l_pobj) injury_14\NN\14052046
D001241_D009202 NONE acid_3\NN\14818238 (l_conj) dipyridamole_5\NN\0 (l_conj) hydrocortisone_8\NN\14751417 (l_prep) on_9\IN\0 (l_pobj) injury_14\NN\14052046
D004837_D009203 NONE epinephrine_9\NN\14807929 (r_amod) infusion_10\NN\14589223 (r_appos) injury_7\NN\14052046 (r_dobj) producing_4\VBG\1617192 (r_pcomp) for_3\IN\0 (r_prep) model_2\NN\5888929 (r_nsubjpass) developed_14\VBN\1753788 (l_advcl) study_16\VB\635850 (l_dobj) effects_19\NNS\13245626 (l_prep) of_20\IN\0 (l_pobj) agents_21\NNS\7347 (l_relcl) alter_26\VB\0 (l_dobj) evolution_28\NN\29677 (l_prep) of_29\IN\0 (l_pobj) infarction_32\NN\14204950
D004837_D009202 CID epinephrine_10\NN\14807929 (r_npadvmod) induced_12\VBN\1627355 (r_amod) injury_14\NN\14052046
D004837_D009202 CID epinephrine_9\NN\14807929 (r_amod) infusion_10\NN\14589223 (r_appos) injury_7\NN\14052046
D004176_D009202 NONE dipyridamole_5\NN\0 (l_conj) hydrocortisone_8\NN\14751417 (l_prep) on_9\IN\0 (l_pobj) injury_14\NN\14052046
11431197
D011899_D009395 CID ranitidine_0\NNP\14778019 (r_npadvmod) induced_2\VBN\1627355 (r_amod) nephritis_5\NN\14113228
D011899_D009395 CID ranitidine_5\NN\14778019 (r_npadvmod) induced_7\VBN\1627355 (r_amod) nephritis_10\NN\14113228
12757899
D012834_D013226 NONE silver_3\NN\14821043 (r_npadvmod) stained_5\VBN\283090 (r_amod) ca3_6\NN\0 (r_pobj) of_2\IN\0 (r_prep) extent_1\NN\13939892 (r_nsubjpass) evaluated_12\VBN\670261 (l_prep) after_15\IN\0 (l_pobj) se_16\NNP\14724645
D008094_D013226 CID lithium_17\NN\14625458 (r_compound) pilocarpine_19\NN\14712692 (r_npadvmod) induced_21\VBN\1627355 (r_amod) se_22\NNP\14724645
D004958_D001930 NONE estradiol_0\NN\14749794 (r_nsubj) reduces_1\VBZ\441445 (l_dobj) injury_6\NN\14052046
D004958_D013226 NONE estradiol_7\NN\14749794 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (l_conj) rats_14\NNS\2329401 (l_acl) subjected_15\VBN\137313 (l_prep) to_16\IN\0 (l_pobj) se_22\NNP\14724645
D007608_D013226 NONE acid_10\NN\14818238 (r_npadvmod) induced_12\VBN\1627355 (r_amod) status_13\NN\24720 (l_appos) se_16\NNP\14724645 (l_amod) epilepticus_14\NN\0
D007608_D013226 NONE acid_10\NN\14818238 (r_npadvmod) induced_12\VBN\1627355 (r_amod) status_13\NN\24720 (l_appos) se_16\NNP\14724645
D004958_D012640 NONE estradiol_0\NN\14749794 (r_nsubj) reduces_1\VBZ\441445 (l_dobj) injury_6\NN\14052046 (l_amod) induced_4\VBN\1627355 (l_npadvmod) seizure_2\NN\14081375
D004958_D012640 NONE estradiol_7\NN\14749794 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (l_prep) on_8\IN\0 (l_pobj) threshold_10\NN\15265518 (l_compound) seizure_9\NN\14081375
D007608_D001930 NONE acid_10\NN\14818238 (r_npadvmod) induced_12\VBN\1627355 (r_amod) status_13\NN\24720 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (r_advcl) protect_1\VBP\1127795 (l_dobj) rats_3\NNS\2329401 (l_prep) from_4\IN\0 (l_pobj) injury_6\NN\14052046
D010862_D013226 CID pilocarpine_19\NN\14712692 (r_npadvmod) induced_21\VBN\1627355 (r_amod) se_22\NNP\14724645
8073369
D009538_D002543 CID nicotine_30\NN\14712692 (r_nmod) chicks_34\NNS\1791625 (r_pobj) in_28\IN\13603305 (r_prep) occurred_27\VBD\0 (l_nsubj) hemorrhage_26\NN\14285662
C007112_D001176 CID coniine_2\NN\0 (r_nsubj) failed_4\VBN\0 (l_xcomp) produce_6\VB\7555863 (l_dobj) arthrogryposis_7\NN\0
C007112_D001176 CID coniine_15\RB\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) arthrogryposis_18\NN\0
D009538_D009140 NONE nicotine_7\NN\14712692 (r_compound) sulfate_8\NN\15010703 (r_conj) coniine_5\NN\0 (r_pobj) by_3\IN\0 (r_agent) caused_2\VBN\1617192 (r_acl) deformations_1\NNS\7420770
D009538_D009140 NONE nicotine_7\NN\14712692 (r_compound) sulfate_8\NN\15010703 (r_conj) coniine_5\NN\0 (r_pobj) by_3\IN\0 (r_agent) caused_2\VBN\1617192 (r_acl) deformations_1\NNS\7420770 (r_nsubj) were_9\VBD\0 (l_attr) flexion_11\NN\14034177 (l_prep) of_14\IN\0 (l_pobj) toes_18\NNS\5566097
C007112_D009140 NONE coniine_5\NN\0 (r_pobj) by_3\IN\0 (r_agent) caused_2\VBN\1617192 (r_acl) deformations_1\NNS\7420770
C007112_D009140 NONE coniine_5\NN\0 (r_pobj) by_3\IN\0 (r_agent) caused_2\VBN\1617192 (r_acl) deformations_1\NNS\7420770 (r_nsubj) were_9\VBD\0 (l_attr) flexion_11\NN\14034177 (l_prep) of_14\IN\0 (l_pobj) toes_18\NNS\5566097
15863244
D010894_D006345 NONE piroxicam_23\NN\3828465 (r_nmod) inhibitor_31\NN\20090 (r_pobj) to_22\IN\0 (r_prep) exposed_21\VBN\2110927 (r_acl) fetuses_20\NNS\1471682 (r_pobj) for_18\IN\0 (r_prep) performed_17\VBN\0 (l_nsubjpass) analysis_3\NN\633864 (l_prep) for_4\IN\0 (l_pobj) defects_15\NNS\14462666
D010894_D009139 CID piroxicam_24\NN\3828465 (r_pobj) of_23\IN\0 (r_prep) dose_22\NN\3740161 (r_pobj) with_19\IN\0 (r_prep) treated_18\VBN\2376958 (r_acl) rats_17\NNS\2329401 (r_pobj) in_16\IN\13603305 (r_prep) found_15\VBN\13279262 (l_nsubjpass) toxicity_1\NN\13576101 (l_appos) retardation_5\NN\7296428 (l_conj) increase_8\NN\13576355 (l_prep) of_9\IN\0 (l_pobj) variations_13\NNS\7296428
D010894_D064420 NONE piroxicam_19\NN\3828465 (r_compound) study_20\NN\635850 (r_conj) dfu_17\NNP\0 (r_appos) inhibitors_11\NNS\20090 (r_pobj) of_4\IN\0 (r_prep) toxicity_3\NN\13576101
D010894_D064420 NONE piroxicam_17\NN\3828465 (r_pobj) of_11\IN\0 (r_prep) toxicity_10\NN\13576101
D010894_D064420 NONE piroxicam_24\NN\3828465 (r_pobj) of_23\IN\0 (r_prep) dose_22\NN\3740161 (r_pobj) with_19\IN\0 (r_prep) treated_18\VBN\2376958 (r_acl) rats_17\NNS\2329401 (r_pobj) in_16\IN\13603305 (r_prep) found_15\VBN\13279262 (l_nsubjpass) toxicity_1\NN\13576101
C106876_D064420 NONE dfu_17\NNP\0 (r_appos) inhibitors_11\NNS\20090 (r_pobj) of_4\IN\0 (r_prep) toxicity_3\NN\13576101
C106876_D064420 NONE dfu_22\NNP\0 (r_conj) toxicity_10\NN\13576101
C106876_D064420 NONE phenyl-2(5h)-furanon_26\XX\0 (l_ccomp) was_5\VBD\0 (l_xcomp) evaluate_7\VB\670261 (l_dobj) toxicity_10\NN\13576101
C106876_D064420 NONE dfu_10\NNP\0 (r_nmod) toxicity_12\NN\13576101
D010894_D009436 NONE piroxicam_23\NN\3828465 (r_nmod) inhibitor_31\NN\20090 (r_pobj) to_22\IN\0 (r_prep) exposed_21\VBN\2110927 (r_acl) fetuses_20\NNS\1471682 (r_pobj) for_18\IN\0 (r_prep) performed_17\VBN\0 (l_nsubjpass) analysis_3\NN\633864 (l_prep) for_4\IN\0 (l_pobj) defects_15\NNS\14462666
D010894_D005317 CID piroxicam_24\NN\3828465 (r_pobj) of_23\IN\0 (r_prep) dose_22\NN\3740161 (r_pobj) with_19\IN\0 (r_prep) treated_18\VBN\2376958 (r_acl) rats_17\NNS\2329401 (r_pobj) in_16\IN\13603305 (r_prep) found_15\VBN\13279262 (l_nsubjpass) toxicity_1\NN\13576101 (l_appos) retardation_5\NN\7296428
9495837
D012601_D000647 CID scopolamine_18\NN\14712692 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) amnesia_15\NN\5669934
D004025_D000647 CID dicyclomine_26\NN\0 (r_conj) kg-1_22\NNP\0 (r_appos) scopolamine_18\NN\14712692 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) amnesia_15\NN\5669934
D000109_D000647 NONE acetylcholine_73\NN\14807558 (r_amod) levels_75\NNS\4916342 (r_pobj) in_72\IN\13603305 (r_prep) increase_71\NN\13576355 (r_pobj) through_69\IN\0 (r_prep) /-)-pg-9_68\NFP\0 (r_punct) shown_44\VBN\2137132 (l_dobj) ratio_48\NN\13815152 (l_relcl) be_53\VB\14625458 (l_acomp) responsible_54\JJ\0 (l_prep) for_55\IN\0 (l_pobj) antinociception_57\NN\0 (l_conj) effect_63\NN\34213 (l_amod) amnesic_62\JJ\10158756
C087567_D000647 NONE /-)-pg-9_2\.\0 (r_nsubj) was_11\VBD\0 (l_acomp) able_12\JJ\0 (l_xcomp) prevent_14\VB\0 (l_dobj) amnesia_15\NN\5669934
C087567_D000647 NONE /-)-pg-9_5\NFP\0 (r_conj) of_2\IN\0 (r_prep) profiles_1\NNS\6999802 (r_nsubj) shown_44\VBN\2137132 (l_dobj) ratio_48\NN\13815152 (l_relcl) be_53\VB\14625458 (l_acomp) responsible_54\JJ\0 (l_prep) for_55\IN\0 (l_pobj) antinociception_57\NN\0 (l_conj) effect_63\NN\34213 (l_amod) amnesic_62\JJ\10158756
C087567_D000647 NONE /-)-pg-9_68\NFP\0 (r_punct) shown_44\VBN\2137132 (l_dobj) ratio_48\NN\13815152 (l_relcl) be_53\VB\14625458 (l_acomp) responsible_54\JJ\0 (l_prep) for_55\IN\0 (l_pobj) antinociception_57\NN\0 (l_conj) effect_63\NN\34213 (l_amod) amnesic_62\JJ\10158756
11875660
D001374_D009436 NONE 5-azacytidine_6\NN\0 (r_pobj) by_5\IN\0 (r_agent) induced_4\VBN\1627355 (r_acl) exencephaly_3\NNS\0
17532790
D001971_D010300 NONE bromocriptine_36\NN\0 (r_conj) dopa_34\NNP\14601829 (r_appos) changes_8\NNS\7283608 (l_acl) occurring_9\VBG\0 (l_prep) at_10\IN\14622893 (l_pobj) level_13\NN\4916342 (l_acl) obtained_17\VBN\2210855 (l_prep) from_18\IN\0 (l_pobj) model_25\NN\5888929 (l_prep) of_26\IN\0 (l_pobj) pd_27\NNP\14625458
D007980_D004409 CID dopa_12\NNP\14601829 (r_npadvmod) induced_14\VBN\1627355 (r_amod) dyskinesia_15\NN\14084880
D007980_D004409 CID dopa_2\NNP\14601829 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesia_5\NN\14084880
D007980_D004409 CID dopa_2\NNP\14601829 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesia_5\NN\14084880 (l_appos) lid_7\NNP\5313679
D007980_D004409 CID dopa_31\NNP\14601829 (r_pobj) with_28\IN\0 (r_prep) treatment_27\NN\654885 (r_pobj) after_24\IN\0 (r_prep) arise_15\VBP\2623529 (r_relcl) complications_13\NNS\1073995 (r_pobj) among_10\IN\0 (r_prep) is_9\VBZ\0 (l_nsubj) dyskinesia_5\NN\14084880
D007980_D004409 CID dopa_31\NNP\14601829 (r_pobj) with_28\IN\0 (r_prep) treatment_27\NN\654885 (r_pobj) after_24\IN\0 (r_prep) arise_15\VBP\2623529 (r_relcl) complications_13\NNS\1073995 (r_pobj) among_10\IN\0 (r_prep) is_9\VBZ\0 (l_nsubj) dyskinesia_5\NN\14084880 (l_appos) lid_7\NNP\5313679
D007980_D004409 CID dopa_5\NNP\14601829 (r_pobj) with_2\IN\0 (r_prep) treated_1\VBD\2376958 (l_conj) allocated_7\VBN\2228698 (l_prep) to_8\IN\0 (l_pobj) groups_10\NNS\2137 (l_acl) based_11\VBN\0 (l_prep) on_12\IN\0 (l_pobj) presence_14\NN\13954253 (l_conj) absence_16\NN\14449405 (l_prep) of_17\IN\0 (l_pobj) lid_18\NNP\5313679
D016627_D010300 NONE 6-hydroxydopamine_21\CD\0 (r_compound) lesion_23\NN\14204950 (r_compound) rat_24\NN\2329401 (r_compound) model_25\NN\5888929 (l_prep) of_26\IN\0 (l_pobj) pd_27\NNP\14625458
D007980_D010300 NONE dopa_2\NNP\14601829 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesia_5\NN\14084880 (r_nsubj) is_9\VBZ\0 (l_prep) among_10\IN\0 (l_pobj) complications_13\NNS\1073995 (l_relcl) arise_15\VBP\2623529 (l_prep) in_16\IN\13603305 (l_pobj) patients_23\NNS\9898892 (l_nmod) disease_19\NN\14061805
D007980_D010300 NONE dopa_2\NNP\14601829 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesia_5\NN\14084880 (r_nsubj) is_9\VBZ\0 (l_prep) among_10\IN\0 (l_pobj) complications_13\NNS\1073995 (l_relcl) arise_15\VBP\2623529 (l_prep) in_16\IN\13603305 (l_pobj) patients_23\NNS\9898892 (l_nmod) pd_21\NNP\14625458
D007980_D010300 NONE dopa_31\NNP\14601829 (r_pobj) with_28\IN\0 (r_prep) treatment_27\NN\654885 (r_pobj) after_24\IN\0 (r_prep) arise_15\VBP\2623529 (l_prep) in_16\IN\13603305 (l_pobj) patients_23\NNS\9898892 (l_nmod) disease_19\NN\14061805
D007980_D010300 NONE dopa_31\NNP\14601829 (r_pobj) with_28\IN\0 (r_prep) treatment_27\NN\654885 (r_pobj) after_24\IN\0 (r_prep) arise_15\VBP\2623529 (l_prep) in_16\IN\13603305 (l_pobj) patients_23\NNS\9898892 (l_nmod) pd_21\NNP\14625458
D007980_D010300 NONE dopa_34\NNP\14601829 (r_appos) changes_8\NNS\7283608 (l_acl) occurring_9\VBG\0 (l_prep) at_10\IN\14622893 (l_pobj) level_13\NN\4916342 (l_acl) obtained_17\VBN\2210855 (l_prep) from_18\IN\0 (l_pobj) model_25\NN\5888929 (l_prep) of_26\IN\0 (l_pobj) pd_27\NNP\14625458
11198499
C023754_D007022 CID tizanidine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) initiation_3\NN\7450842 (r_dobj) following_1\VBG\8180190 (r_acl) hypotension_0\NN\14057371
C023754_D007022 CID tizanidine_29\NN\0 (r_pobj) of_28\IN\0 (r_prep) addition_27\NN\3081021 (r_pobj) following_25\VBG\8180190 (r_prep) developed_23\VBD\1753788 (l_dobj) hypotension_24\NN\14057371
D017706_D006973 NONE lisinopril_11\NN\2673637 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) boy_7\NN\9624168 (r_dobj) present_2\VBP\28270 (l_advcl) control_20\VB\5190804 (l_dobj) hypertension_21\NN\14057371
D000809_D009128 NONE angiotensin_14\NN\4522421 (r_appos) lisinopril_11\NN\2673637 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) boy_7\NN\9624168 (r_dobj) present_2\VBP\28270 (l_advcl) control_20\VB\5190804 (l_dobj) hypertension_21\NN\14057371 (l_relcl) developed_23\VBD\1753788 (l_prep) following_25\VBG\8180190 (l_pobj) addition_27\NN\3081021 (l_prep) for_35\IN\0 (l_pobj) treatment_37\NN\654885 (l_prep) of_38\IN\0 (l_pobj) spasticity_39\NN\4770535
C023754_D006973 NONE tizanidine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) initiation_3\NN\7450842 (l_prep) in_6\IN\13603305 (l_pobj) patient_8\NN\9898892 (l_acl) treated_9\VBN\2376958 (l_prep) with_10\IN\0 (l_pobj) angiotensin_12\NN\4522421 (l_acl) converting_13\VBG\126264 (l_prep) for_16\IN\0 (l_pobj) hypertension_18\NN\14057371
C023754_D006973 NONE tizanidine_29\NN\0 (r_pobj) of_28\IN\0 (r_prep) addition_27\NN\3081021 (r_pobj) following_25\VBG\8180190 (r_prep) developed_23\VBD\1753788 (r_relcl) hypertension_21\NN\14057371
C023754_D006973 NONE tizanidine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) interaction_2\NN\37396 (r_nsubjpass) kept_11\VBN\0 (l_advcl) prescribing_15\VBG\748282 (l_xcomp) treat_18\VB\7570720 (l_dobj) hypertension_20\NN\14057371
D000809_D006973 NONE angiotensin_12\NN\4522421 (l_acl) converting_13\VBG\126264 (l_prep) for_16\IN\0 (l_pobj) hypertension_18\NN\14057371
D000809_D006973 NONE angiotensin_14\NN\4522421 (r_appos) lisinopril_11\NN\2673637 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) boy_7\NN\9624168 (r_dobj) present_2\VBP\28270 (l_advcl) control_20\VB\5190804 (l_dobj) hypertension_21\NN\14057371
C023754_D009128 NONE tizanidine_29\NN\0 (r_pobj) of_28\IN\0 (r_prep) addition_27\NN\3081021 (l_prep) for_35\IN\0 (l_pobj) treatment_37\NN\654885 (l_prep) of_38\IN\0 (l_pobj) spasticity_39\NN\4770535
C023754_D009128 NONE tizanidine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) interaction_2\NN\37396 (r_nsubjpass) kept_11\VBN\0 (l_advcl) prescribing_15\VBG\748282 (l_xcomp) treat_18\VB\7570720 (l_dobj) hypertension_20\NN\14057371 (l_conj) spasticity_22\NN\4770535
D017706_D009128 NONE lisinopril_11\NN\2673637 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) boy_7\NN\9624168 (r_dobj) present_2\VBP\28270 (l_advcl) control_20\VB\5190804 (l_dobj) hypertension_21\NN\14057371 (l_relcl) developed_23\VBD\1753788 (l_prep) following_25\VBG\8180190 (l_pobj) addition_27\NN\3081021 (l_prep) for_35\IN\0 (l_pobj) treatment_37\NN\654885 (l_prep) of_38\IN\0 (l_pobj) spasticity_39\NN\4770535
D000809_D007022 NONE angiotensin_12\NN\4522421 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) patient_8\NN\9898892 (r_pobj) in_6\IN\13603305 (r_prep) initiation_3\NN\7450842 (r_dobj) following_1\VBG\8180190 (r_acl) hypotension_0\NN\14057371
D000809_D007022 NONE angiotensin_4\NN\4522421 (r_pobj) with_3\IN\0 (r_prep) treated_2\VBN\2376958 (r_csubj) have_9\VB\7846 (l_dobj) ability_12\NN\4723816 (l_acl) respond_14\VB\2367363 (l_prep) to_15\IN\0 (l_pobj) hypotension_16\NN\14057371
D000809_D007022 NONE angiotensin_14\NN\4522421 (r_appos) lisinopril_11\NN\2673637 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) boy_7\NN\9624168 (r_dobj) present_2\VBP\28270 (l_advcl) control_20\VB\5190804 (l_dobj) hypertension_21\NN\14057371 (l_relcl) developed_23\VBD\1753788 (l_dobj) hypotension_24\NN\14057371
D017706_D007022 CID lisinopril_11\NN\2673637 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) boy_7\NN\9624168 (r_dobj) present_2\VBP\28270 (l_advcl) control_20\VB\5190804 (l_dobj) hypertension_21\NN\14057371 (l_relcl) developed_23\VBD\1753788 (l_dobj) hypotension_24\NN\14057371
8423889
D000928_D009069 NONE antidepressant_20\JJ\3740161 (r_amod) fluoxetine_21\NN\4169152 (r_pobj) to_18\IN\0 (r_prep) exposure_17\NN\5042871 (r_pobj) after_16\IN\0 (r_prep) amount_4\NN\13329641 (l_prep) of_5\IN\0 (l_pobj) disability_7\NN\14547369
D004298_D010300 NONE dopamine_6\NN\14807737 (r_npadvmod) antagonistic_8\JJ\0 (r_amod) capacity_9\NN\5202497 (l_prep) in_12\IN\13603305 (l_pobj) patients_16\NNS\9898892 (l_compound) disease_15\NN\14061805
D005473_D009069 CID fluoxetine_5\NN\4169152 (r_amod) medication_6\NN\3247620 (r_pobj) after_4\IN\0 (r_prep) increase_0\NNP\13576355 (l_prep) of_1\IN\0 (l_pobj) disability_3\NN\14547369
D005473_D009069 CID fluoxetine_21\NN\4169152 (r_pobj) to_18\IN\0 (r_prep) exposure_17\NN\5042871 (r_pobj) after_16\IN\0 (r_prep) amount_4\NN\13329641 (l_prep) of_5\IN\0 (l_pobj) disability_7\NN\14547369
D005473_D010300 NONE fluoxetine_21\NN\4169152 (r_pobj) to_18\IN\0 (r_prep) exposure_17\NN\5042871 (r_pobj) after_16\IN\0 (r_prep) amount_4\NN\13329641 (l_prep) in_8\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) disease_15\NN\14061805
D005473_D010300 NONE fluoxetine_11\NN\4169152 (r_pobj) of_10\IN\0 (r_prep) capacity_9\NN\5202497 (l_prep) in_12\IN\13603305 (l_pobj) patients_16\NNS\9898892 (l_compound) disease_15\NN\14061805
D000928_D010300 NONE antidepressant_20\JJ\3740161 (r_amod) fluoxetine_21\NN\4169152 (r_pobj) to_18\IN\0 (r_prep) exposure_17\NN\5042871 (r_pobj) after_16\IN\0 (r_prep) amount_4\NN\13329641 (l_prep) in_8\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) disease_15\NN\14061805
1420741
D016572_D003424 NONE cyclosporin_16\NN\0 (r_pobj) to_15\IN\0 (r_prep) similar_14\JJ\0 (r_amod) properties_13\NNS\32613 (r_pobj) with_11\IN\0 (r_prep) antibiotic_10\NN\2716205 (r_appos) treatment_0\NN\654885 (l_prep) of_1\IN\0 (l_pobj) disease_4\NN\14061805
D005672_D015212 NONE acid_13\NN\14818238 (r_pobj) of_11\IN\0 (r_prep) use_10\NN\407535 (l_prep) at_14\IN\14622893 (l_pobj) level_17\NN\4916342 (l_prep) in_18\IN\13603305 (l_pobj) disease_21\NN\14061805
D005672_D003424 NONE acid_7\NN\14818238 (r_pobj) with_5\IN\0 (r_prep) disease_4\NN\14061805
D005672_D003424 NONE acid_28\NN\14818238 (r_compound) treatment_29\NN\654885 (r_pobj) of_26\IN\0 (r_prep) tolerability_25\NN\0 (r_conj) pharmacodynamics_23\NNS\0 (r_dobj) estimate_21\VB\5802185 (r_advcl) undertaken_19\VBN\1641914 (l_prep) because_0\IN\0 (l_pobj) need_3\NN\13920835 (l_prep) for_4\IN\0 (l_pobj) development_6\NN\248977 (l_prep) of_7\IN\0 (l_pobj) treatments_9\NNS\654885 (l_prep) for_10\IN\0 (l_pobj) disease_13\NN\14061805
D005672_D003424 NONE acid_9\NN\14818238 (r_nsubj) be_11\VB\14625458 (l_prep) in_14\IN\13603305 (l_pobj) patients_21\NNS\9898892 (l_compound) disease_20\NN\14061805
18703024
D006220_D002375 CID haloperidol_3\NN\3713736 (r_npadvmod) induced_5\VBN\1627355 (r_amod) catalepsy_6\NN\14023236
D016291_D002375 NONE mk-801-induced_8\JJ\0 (r_compound) locomotion_9\NN\4773351 (r_conj) catalepsy_6\NN\14023236
11679859
D011346_D017109 CID prochlorperazine_3\NN\2719750 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) affect_12\VB\26192 (l_dobj) incidence_14\NN\13821570 (l_prep) of_15\IN\0 (l_pobj) akathisia_16\NN\0
D011346_D017109 CID prochlorperazine_12\NN\2719750 (r_pobj) of_10\IN\0 (r_prep) administration_9\NN\1133281 (r_pobj) after_8\IN\0 (r_prep) akathisia_7\NN\0
D011346_D017109 CID prochlorperazine_10\NN\2719750 (r_nsubjpass) administered_12\VBN\2436349 (r_advcl) reduction_3\NN\351485 (l_prep) in_4\IN\13603305 (l_pobj) incidence_6\NN\13821570 (l_prep) of_7\IN\0 (l_pobj) akathisia_8\NN\0
D011346_D014839 NONE prochlorperazine_8\NN\2719750 (l_prep) for_9\IN\0 (l_pobj) headache_10\NN\5829480 (l_conj) nausea_12\NN\14299637 (l_conj) vomiting_15\NN\116687
D011346_D009325 NONE prochlorperazine_8\NN\2719750 (l_prep) for_9\IN\0 (l_pobj) headache_10\NN\5829480 (l_conj) nausea_12\NN\14299637
D011346_D009325 NONE prochlorperazine_3\NN\2719750 (r_pobj) of_2\IN\0 (r_prep) efficacy_1\NN\5199286 (l_prep) in_4\IN\13603305 (l_pobj) treatment_6\NN\654885 (l_prep) of_7\IN\0 (l_pobj) headache_8\NN\5829480 (l_conj) nausea_10\NN\14299637
D011346_D006261 NONE prochlorperazine_8\NN\2719750 (l_prep) for_9\IN\0 (l_pobj) headache_10\NN\5829480
D011346_D006261 NONE prochlorperazine_3\NN\2719750 (r_pobj) of_2\IN\0 (r_prep) efficacy_1\NN\5199286 (l_prep) in_4\IN\13603305 (l_pobj) treatment_6\NN\654885 (l_prep) of_7\IN\0 (l_pobj) headache_8\NN\5829480
3828020
D010665_D002544 CID phenylpropanolamine_8\NN\2682038 (r_pobj) of_7\IN\0 (r_prep) dose_6\NN\3740161 (r_pobj) with_2\IN\0 (r_prep) infarction_1\NN\14204950
D010665_D002544 CID ppa_20\NNP\0 (r_pobj) of_19\IN\0 (r_prep) dose_18\NN\3740161 (r_dobj) taking_14\VBG\37396 (r_pcomp) after_13\IN\0 (r_prep) suffered_9\VBD\2110220 (l_dobj) infarction_12\NN\14204950
2396046
D010634_D006528 NONE phenobarbital_35\NN\2792049 (r_dobj) containing_34\VBG\2632940 (r_acl) diet_33\NN\7560652 (r_dobj) fed_30\VBD\10373801 (r_conj) fed_10\VBD\10373801 (l_nsubj) nodules_3\NNS\5264913 (l_conj) carcinomas_6\NNS\14239918
D010634_D006528 NONE phenobarbital_35\NN\2792049 (r_dobj) containing_34\VBG\2632940 (r_acl) diet_33\NN\7560652 (r_dobj) fed_30\VBD\10373801 (r_conj) fed_10\VBD\10373801 (l_advcl) developed_26\VBN\1753788 (l_nsubj) nodule_21\NN\5264913 (l_conj) carcinoma_25\NN\14239918
D010634_D006528 NONE phenobarbital_39\RB\2792049 (r_npadvmod) containing_41\VBG\2632940 (r_amod) diet_45\NN\7560652 (r_dobj) fed_37\VBD\10373801 (r_conj) was_9\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_conj) of_6\IN\0 (l_pobj) carcinomas_8\NNS\14239918
D002794_D006528 CID choline_13\NN\15090742 (r_npadvmod) supplemented_15\VBN\182406 (r_amod) diet_16\NN\7560652 (r_dobj) fed_10\VBD\10373801 (l_nsubj) nodules_3\NNS\5264913 (l_conj) carcinomas_6\NNS\14239918
D002794_D006528 CID choline_13\NN\15090742 (r_npadvmod) supplemented_15\VBN\182406 (r_amod) diet_16\NN\7560652 (r_dobj) fed_10\VBD\10373801 (l_advcl) developed_26\VBN\1753788 (l_nsubj) nodule_21\NN\5264913 (l_conj) carcinoma_25\NN\14239918
D002794_D006528 CID choline_23\NN\15090742 (r_npadvmod) devoid_25\JJ\0 (r_amod) diet_26\NN\7560652 (r_dobj) fed_20\VBD\10373801 (r_conj) was_9\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_conj) of_6\IN\0 (l_pobj) carcinomas_8\NNS\14239918
D002794_D006528 CID choline_42\NN\15090742 (r_npadvmod) devoid_44\JJ\0 (r_amod) diet_45\NN\7560652 (r_dobj) fed_37\VBD\10373801 (r_conj) was_9\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_conj) of_6\IN\0 (l_pobj) carcinomas_8\NNS\14239918
9698967
D008619_D019954 NONE mepivacaine_43\NN\0 (r_amod) mg_45\NN\13717155 (r_pobj) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_acl) accompanied_6\VBN\0 (l_agent) by_7\IN\0 (l_pobj) fibrillation_9\NN\14361664 (l_conj) agitation_11\NN\14373582 (l_conj) shouts_14\NNS\7109847
D004837_D004387 NONE adrenaline_47\NN\14807929 (r_dobj) containing_46\VBG\2632940 (r_pcomp) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (l_prep) for_51\IN\0 (l_pobj) correction_52\NN\248977 (l_prep) of_53\IN\0 (l_pobj) contracture_56\NN\369802
D008619_D004387 NONE mepivacaine_43\NN\0 (r_amod) mg_45\NN\13717155 (r_pobj) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (l_prep) for_51\IN\0 (l_pobj) correction_52\NN\248977 (l_prep) of_53\IN\0 (l_pobj) contracture_56\NN\369802
D008619_D011595 NONE mepivacaine_43\NN\0 (r_amod) mg_45\NN\13717155 (r_pobj) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_acl) accompanied_6\VBN\0 (l_agent) by_7\IN\0 (l_pobj) fibrillation_9\NN\14361664 (l_conj) agitation_11\NN\14373582
D008619_D006973 CID mepivacaine_43\NN\0 (r_amod) mg_45\NN\13717155 (r_pobj) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_prep) in_2\IN\13603305 (l_pobj) pressure_4\NN\11419404
D004837_D014474 NONE adrenaline_47\NN\14807929 (r_dobj) containing_46\VBG\2632940 (r_pcomp) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_acl) accompanied_6\VBN\0 (l_agent) by_7\IN\0 (l_pobj) fibrillation_9\NN\14361664 (l_conj) agitation_11\NN\14373582 (l_conj) shouts_14\NNS\7109847 (l_prep) of_17\IN\0 (l_pobj) consciousness_18\NN\5669934
D004837_D019954 NONE adrenaline_47\NN\14807929 (r_dobj) containing_46\VBG\2632940 (r_pcomp) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_acl) accompanied_6\VBN\0 (l_agent) by_7\IN\0 (l_pobj) fibrillation_9\NN\14361664 (l_conj) agitation_11\NN\14373582 (l_conj) shouts_14\NNS\7109847
D008619_D001281 CID mepivacaine_43\NN\0 (r_amod) mg_45\NN\13717155 (r_pobj) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_acl) accompanied_6\VBN\0 (l_agent) by_7\IN\0 (l_pobj) fibrillation_9\NN\14361664
D008619_D014474 NONE mepivacaine_43\NN\0 (r_amod) mg_45\NN\13717155 (r_pobj) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_acl) accompanied_6\VBN\0 (l_agent) by_7\IN\0 (l_pobj) fibrillation_9\NN\14361664 (l_conj) agitation_11\NN\14373582 (l_conj) shouts_14\NNS\7109847 (l_prep) of_17\IN\0 (l_pobj) consciousness_18\NN\5669934
D004837_D006973 CID adrenaline_47\NN\14807929 (r_dobj) containing_46\VBG\2632940 (r_pcomp) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_prep) in_2\IN\13603305 (l_pobj) pressure_4\NN\11419404
D004837_D011595 NONE adrenaline_47\NN\14807929 (r_dobj) containing_46\VBG\2632940 (r_pcomp) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_acl) accompanied_6\VBN\0 (l_agent) by_7\IN\0 (l_pobj) fibrillation_9\NN\14361664 (l_conj) agitation_11\NN\14373582
D004837_D001281 CID adrenaline_47\NN\14807929 (r_dobj) containing_46\VBG\2632940 (r_pcomp) with_42\IN\0 (r_prep) block_41\NN\21939 (r_pobj) of_39\IN\0 (r_prep) performance_38\NN\6619065 (r_pobj) after_37\IN\0 (r_prep) min_36\NN\15154774 (r_appos) group_28\NN\2137 (r_appos) observed_21\VBN\2163746 (l_nsubjpass) increase_1\NN\13576355 (l_acl) accompanied_6\VBN\0 (l_agent) by_7\IN\0 (l_pobj) fibrillation_9\NN\14361664
1616457
D010424_D000647 CID pentobarbital_7\NN\2792049 (r_pobj) by_6\IN\0 (r_agent) caused_5\VBN\1617192 (r_acl) amnesia_4\NN\5669934
D010424_D000647 CID pentobarbital_15\NN\2792049 (r_nmod) ip_20\NNP\5999797 (r_pobj) by_14\IN\0 (r_agent) produced_13\VBN\1617192 (r_acl) amnesia_12\NN\5669934
12589964
D004317_D009202 CID doxorubicin_14\NN\2716866 (r_npadvmod) induced_16\VBN\1627355 (r_amod) rats_18\NNS\2329401 (r_pobj) in_13\IN\13603305 (r_prep) damage_12\NN\7296428
D004317_D009202 CID doxorubicin_14\NN\2716866 (r_npadvmod) induced_16\VBN\1627355 (r_amod) rats_18\NNS\2329401 (l_amod) cardiomyopathy_17\NN\14103288
D004317_D009202 CID doxorubicin_20\NN\2716866 (r_pobj) of_19\IN\0 (r_prep) model_18\NN\5888929 (r_pobj) in_15\IN\13603305 (r_prep) damage_14\NN\7296428
D004317_D009202 CID doxorubicin_20\NN\2716866 (r_pobj) of_19\IN\0 (r_prep) model_18\NN\5888929 (l_appos) cardiomyopathy_23\NN\14103288
D004317_D009202 CID dox)-induced_22\VBN\0 (r_amod) cardiomyopathy_23\NN\14103288 (r_appos) model_18\NN\5888929 (r_pobj) in_15\IN\13603305 (r_prep) damage_14\NN\7296428
D004317_D009202 CID dox)-induced_22\VBN\0 (r_amod) cardiomyopathy_23\NN\14103288
D004317_D009202 CID dox_6\NNP\0 (r_pobj) after_5\IN\0 (r_prep) markers_1\NNS\21939 (r_pobj) among_0\IN\0 (r_prep) showed_11\VBD\2137132 (l_dobj) ability_14\NN\4723816 (l_acl) detect_16\VB\2163746 (l_dobj) damage_18\NN\7296428
D004317_D066126 NONE dox_13\NNP\0 (r_pobj) after_12\IN\0 (r_prep) amount_7\NN\13329641 (r_pobj) between_5\IN\0 (r_prep) discrepancy_4\NN\4748836 (r_attr) was_2\VBD\0 (r_advcl) is_33\VBZ\0 (l_acomp) likely_34\JJ\0 (l_ccomp) indicates_41\VBZ\952524 (l_conj) be_55\VB\14625458 (l_attr) marker_58\NN\21939 (l_prep) for_59\IN\0 (l_pobj) prediction_61\NN\5772356 (l_prep) of_62\IN\0 (l_pobj) cardiotoxicity_65\NN\0
D004317_D066126 NONE dox_40\NNP\0 (r_nsubj) indicates_41\VBZ\952524 (l_conj) be_55\VB\14625458 (l_attr) marker_58\NN\21939 (l_prep) for_59\IN\0 (l_pobj) prediction_61\NN\5772356 (l_prep) of_62\IN\0 (l_pobj) cardiotoxicity_65\NN\0
D004317_D005355 NONE dox_8\NNP\0 (r_pobj) given_7\VBN\5892096 (r_prep) rats_6\NNS\2329401 (r_pobj) from_4\IN\0 (r_prep) hearts_3\NNS\496167 (r_pobj) of_2\IN\0 (r_prep) evaluation_1\NN\874067 (r_nsubj) revealed_9\VBD\2137132 (l_dobj) degrees_12\NNS\4916342 (l_prep) of_13\IN\0 (l_pobj) fibrosis_17\NN\14204950
D004317_D064420 NONE dox_3\NNP\0 (r_compound) rats_4\NNS\2329401 (r_pobj) of_1\IN\0 (r_prep) eighteen_0\CD\13745420 (r_nsubj) died_5\VBD\146138 (l_prep) of_7\IN\0 (l_pobj) toxicity_9\NN\13576101
D004317_D006331 NONE doxorubicin_20\NN\2716866 (r_pobj) of_19\IN\0 (r_prep) model_18\NN\5888929 (r_pobj) in_15\IN\13603305 (r_prep) damage_14\NN\7296428 (r_pobj) of_12\IN\0 (r_prep) diagnosis_11\NN\152018 (r_pobj) for_9\IN\0 (r_prep) investigated_1\VBD\644583 (l_conj) examined_27\VBD\0 (l_dobj) relationship_29\NN\31921 (l_prep) with_35\IN\0 (l_pobj) development_37\NN\248977 (l_prep) of_38\IN\0 (l_pobj) disorders_40\NNS\14034177
D004317_D006331 NONE dox)-induced_22\VBN\0 (r_amod) cardiomyopathy_23\NN\14103288 (r_appos) model_18\NN\5888929 (r_pobj) in_15\IN\13603305 (r_prep) damage_14\NN\7296428 (r_pobj) of_12\IN\0 (r_prep) diagnosis_11\NN\152018 (r_pobj) for_9\IN\0 (r_prep) investigated_1\VBD\644583 (l_conj) examined_27\VBD\0 (l_dobj) relationship_29\NN\31921 (l_prep) with_35\IN\0 (l_pobj) development_37\NN\248977 (l_prep) of_38\IN\0 (l_pobj) disorders_40\NNS\14034177
D004317_D017202 NONE dox_6\NNP\0 (r_pobj) after_5\IN\0 (r_prep) markers_1\NNS\21939 (l_prep) of_2\IN\0 (l_pobj) injury_4\NN\14052046
11379838
D000928_D001714 CID antidepressant_0\NNP\3740161 (r_npadvmod) induced_2\VBN\1627355 (r_amod) mania_3\NN\9180259
D000928_D001714 CID antidepressant_0\NNP\3740161 (r_npadvmod) induced_2\VBN\1627355 (r_amod) mania_3\NN\9180259 (l_prep) in_4\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_amod) bipolar_5\JJ\0
D000928_D001714 CID antidepressants_10\NNS\3740161 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (r_acl) mania_7\NN\9180259
D000928_D001714 CID antidepressants_10\NNS\3740161 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (r_acl) mania_7\NN\9180259 (r_pobj) to_6\IN\0 (r_prep) switching_5\VBG\191142 (r_pcomp) of_4\IN\0 (r_prep) risks_3\NNS\14541044 (r_pobj) about_1\IN\0 (r_prep) concerns_0\NNS\5682950 (r_nsubj) continue_11\VBP\2367363 (l_xcomp) interfere_13\VB\2451370 (l_prep) with_14\IN\0 (l_pobj) establishment_16\NN\235435 (l_prep) of_17\IN\0 (l_pobj) paradigm_21\NN\13803782 (l_prep) for_22\IN\0 (l_pobj) depression_24\NN\14373582
D000928_D001714 CID antidepressant_43\NN\3740161 (r_amod) therapy_44\NN\657604 (r_pobj) of_42\IN\0 (r_prep) type_41\NN\5839024 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0
D000928_D001714 CID antidepressant_43\NN\3740161 (r_amod) therapy_44\NN\657604 (r_pobj) of_42\IN\0 (r_prep) type_41\NN\5839024 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0 (l_conj) hypomanic_6\JJ\0
D000928_D001714 CID antidepressant_43\NN\3740161 (r_amod) therapy_44\NN\657604 (r_pobj) of_42\IN\0 (r_prep) type_41\NN\5839024 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893
D000928_D001714 CID antidepressant_43\NN\3740161 (r_amod) therapy_44\NN\657604 (r_pobj) of_42\IN\0 (r_prep) type_41\NN\5839024 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893 (l_prep) vs._30\IN\0 (l_pobj) ii_32\NNP\13741022
D000928_D001714 CID antidepressant_43\NN\3740161 (r_amod) therapy_44\NN\657604 (r_pobj) of_42\IN\0 (r_prep) type_41\NN\5839024 (r_appos) episodes_39\NNS\7283608 (l_amod) manic_38\JJ\0
D000928_D001714 CID antidepressant_50\NN\3740161 (r_amod) drugs_51\NNS\14778436 (r_pobj) vs._49\IN\0 (r_prep) therapy_48\NN\657604 (r_dobj) used_45\VBN\0 (r_acl) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0
D000928_D001714 CID antidepressant_50\NN\3740161 (r_amod) drugs_51\NNS\14778436 (r_pobj) vs._49\IN\0 (r_prep) therapy_48\NN\657604 (r_dobj) used_45\VBN\0 (r_acl) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0 (l_conj) hypomanic_6\JJ\0
D000928_D001714 CID antidepressant_50\NN\3740161 (r_amod) drugs_51\NNS\14778436 (r_pobj) vs._49\IN\0 (r_prep) therapy_48\NN\657604 (r_dobj) used_45\VBN\0 (r_acl) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893
D000928_D001714 CID antidepressant_50\NN\3740161 (r_amod) drugs_51\NNS\14778436 (r_pobj) vs._49\IN\0 (r_prep) therapy_48\NN\657604 (r_dobj) used_45\VBN\0 (r_acl) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893 (l_prep) vs._30\IN\0 (l_pobj) ii_32\NNP\13741022
D000928_D001714 CID antidepressant_50\NN\3740161 (r_amod) drugs_51\NNS\14778436 (r_pobj) vs._49\IN\0 (r_prep) therapy_48\NN\657604 (r_dobj) used_45\VBN\0 (r_acl) episodes_39\NNS\7283608 (l_amod) manic_38\JJ\0
D008094_D001714 NONE lithium_73\NN\14625458 (r_appos) stabilizers_71\NNS\14806838 (r_pobj) of_69\IN\0 (r_prep) type_68\NN\5839024 (r_conj) use_66\NN\407535 (r_conj) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0
D008094_D001714 NONE lithium_73\NN\14625458 (r_appos) stabilizers_71\NNS\14806838 (r_pobj) of_69\IN\0 (r_prep) type_68\NN\5839024 (r_conj) use_66\NN\407535 (r_conj) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0 (l_conj) hypomanic_6\JJ\0
D008094_D001714 NONE lithium_73\NN\14625458 (r_appos) stabilizers_71\NNS\14806838 (r_pobj) of_69\IN\0 (r_prep) type_68\NN\5839024 (r_conj) use_66\NN\407535 (r_conj) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893
D008094_D001714 NONE lithium_73\NN\14625458 (r_appos) stabilizers_71\NNS\14806838 (r_pobj) of_69\IN\0 (r_prep) type_68\NN\5839024 (r_conj) use_66\NN\407535 (r_conj) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893 (l_prep) vs._30\IN\0 (l_pobj) ii_32\NNP\13741022
D008094_D001714 NONE lithium_73\NN\14625458 (r_appos) stabilizers_71\NNS\14806838 (r_pobj) of_69\IN\0 (r_prep) type_68\NN\5839024 (r_conj) use_66\NN\407535 (r_conj) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (l_amod) manic_38\JJ\0
D017367_D001714 CID inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0
D017367_D001714 CID inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0 (l_conj) hypomanic_6\JJ\0
D017367_D001714 CID inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893
D017367_D001714 CID inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893 (l_prep) vs._30\IN\0 (l_pobj) ii_32\NNP\13741022
D017367_D001714 CID inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (l_amod) manic_38\JJ\0
D017367_D001714 CID ssris_62\NNPS\2718811 (r_appos) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0
D017367_D001714 CID ssris_62\NNPS\2718811 (r_appos) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (r_pobj) with_10\IN\0 (r_prep) compared_9\VBN\644583 (l_nsubjpass) patients_0\NNS\9898892 (l_relcl) experienced_2\VBD\2108377 (l_dobj) switch_7\NN\3096960 (l_amod) manic_4\JJ\0 (l_conj) hypomanic_6\JJ\0
D017367_D001714 CID ssris_62\NNPS\2718811 (r_appos) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893
D017367_D001714 CID ssris_62\NNPS\2718811 (r_appos) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (r_pobj) of_36\IN\0 (r_prep) number_35\NN\5107765 (r_appos) those_11\DT\0 (l_relcl) did_13\VBD\0 (l_prep) on_15\IN\0 (l_pobj) variables_17\NNS\2452 (l_prep) including_18\VBG\0 (l_pobj) age_19\NN\4916342 (l_conj) sex_21\NN\13440063 (l_conj) diagnosis_23\NN\152018 (l_appos) iv_27\NNP\13741022 (l_appos) i_29\PRP\14622893 (l_prep) vs._30\IN\0 (l_pobj) ii_32\NNP\13741022
D017367_D001714 CID ssris_62\NNPS\2718811 (r_appos) inhibitors_60\NNS\20090 (r_appos) episodes_39\NNS\7283608 (l_amod) manic_38\JJ\0
D017367_D001714 CID ssris_29\NNS\2718811 (r_pobj) with_28\IN\0 (r_prep) treated_27\VBN\2376958 (r_acl) patients_26\NNS\9898892 (r_pobj) of_25\IN\0 (r_prep) subgroup_24\NN\31264 (r_pobj) of_22\IN\0 (r_prep) %_21\NN\0 (r_pobj) in_19\IN\13603305 (r_prep) experienced_42\JJ\2108377 (r_parataxis) patients_11\NNS\9898892 (r_pobj) of_9\IN\0 (r_prep) %_8\NN\0 (r_pobj) in_6\IN\13603305 (r_prep) occurred_5\VBD\0 (l_nsubj) switches_0\NNS\3096960 (l_prep) to_1\IN\0 (l_pobj) hypomania_2\NN\0
D017367_D001714 CID ssris_29\NNS\2718811 (r_pobj) with_28\IN\0 (r_prep) treated_27\VBN\2376958 (r_acl) patients_26\NNS\9898892 (r_pobj) of_25\IN\0 (r_prep) subgroup_24\NN\31264 (r_pobj) of_22\IN\0 (r_prep) %_21\NN\0 (r_pobj) in_19\IN\13603305 (r_prep) experienced_42\JJ\2108377 (r_parataxis) patients_11\NNS\9898892 (r_pobj) of_9\IN\0 (r_prep) %_8\NN\0 (r_pobj) in_6\IN\13603305 (r_prep) occurred_5\VBD\0 (l_nsubj) switches_0\NNS\3096960 (l_prep) to_1\IN\0 (l_pobj) hypomania_2\NN\0 (l_conj) mania_4\NN\9180259
D017367_D001714 CID ssris_29\NNS\2718811 (r_pobj) with_28\IN\0 (r_prep) treated_27\VBN\2376958 (r_acl) patients_26\NNS\9898892 (r_pobj) of_25\IN\0 (r_prep) subgroup_24\NN\31264 (r_pobj) of_22\IN\0 (r_prep) %_21\NN\0 (r_pobj) in_19\IN\13603305 (r_prep) experienced_42\JJ\2108377 (l_dobj) episodes_44\NNS\7283608 (l_amod) manic_43\JJ\0
D017367_D001714 CID ssris_29\NNS\2718811 (r_pobj) with_28\IN\0 (r_prep) treated_27\VBN\2376958 (r_acl) patients_26\NNS\9898892 (r_pobj) of_25\IN\0 (r_prep) subgroup_24\NN\31264 (r_pobj) of_22\IN\0 (r_prep) %_21\NN\0 (r_pobj) in_19\IN\13603305 (r_prep) experienced_42\JJ\2108377 (r_parataxis) patients_11\NNS\9898892 (r_pobj) of_9\IN\0 (r_prep) %_8\NN\0 (r_pobj) in_6\IN\13603305 (r_prep) occurred_5\VBD\0 (l_npadvmod) episodes_56\NNS\7283608 (l_amod) hypomanic_55\JJ\0
11206082
D005680_D012640 NONE gaba(a_24\NNP\0 (r_nmod) ligands_27\NNS\20090 (r_pobj) of_22\IN\0 (r_prep) effects_21\NNS\13245626 (r_pobj) to_18\IN\0 (r_prep) sensitive_17\JJ\10488309 (r_acomp) are_14\VBP\13600404 (l_nsubj) lines_2\NNS\8426461 (l_acl) selected_3\VBN\697589 (l_prep) for_4\IN\0 (l_pobj) sensitivities_6\NNS\5651971 (l_prep) to_7\IN\0 (l_pobj) seizures_13\NNS\14081375
D005680_D012640 NONE gaba(a_44\NNP\0 (r_nmod) site_48\NN\8673395 (r_pobj) of_42\IN\0 (r_prep) agonist_41\NN\0 (r_appos) carboline-3-carboxylate_32\NN\0 (r_pobj) of_28\IN\0 (r_prep) injection_27\NN\320852 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) seizures_21\NNS\14081375
D001569_D012640 NONE benzodiazepine_47\NN\3771443 (r_amod) site_48\NN\8673395 (r_pobj) of_42\IN\0 (r_prep) agonist_41\NN\0 (r_appos) carboline-3-carboxylate_32\NN\0 (r_pobj) of_28\IN\0 (r_prep) injection_27\NN\320852 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) seizures_21\NNS\14081375
C036150_D012640 CID carboline_10\NN\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) seizures_13\NNS\14081375
C036150_D012640 CID carboline-3-carboxylate_32\NN\0 (r_pobj) of_28\IN\0 (r_prep) injection_27\NN\320852 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) seizures_21\NNS\14081375
C036150_D012640 CID ccm_36\NNP\0 (r_appos) carboline-3-carboxylate_32\NN\0 (r_pobj) of_28\IN\0 (r_prep) injection_27\NN\320852 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) seizures_21\NNS\14081375
D010852_D012640 CID picrotoxin-_25\NN\0 (r_amod) seizures_30\NNS\14081375
D010433_D012640 CID pentylenetetrazol_27\NN\3740161 (r_npadvmod) induced_29\VBN\1627355 (r_conj) picrotoxin-_25\NN\0 (r_amod) seizures_30\NNS\14081375
D003975_D012640 NONE diazepam_2\NN\2830852 (r_npadvmod) induced_4\VBN\1627355 (r_amod) anxiolysis_5\NN\0 (r_dobj) measured_1\VBD\697589 (l_dobj) sedation_17\NN\14034177 (l_prep) by_18\IN\0 (l_pcomp) recording_19\VBG\6791372 (l_dobj) states_22\NNS\8491826 (l_conj) seizures_30\NNS\14081375
D003975_D012640 NONE diazepam_14\NN\2830852 (r_npadvmod) induced_16\VBN\1627355 (r_amod) sedation_17\NN\14034177 (l_prep) by_18\IN\0 (l_pcomp) recording_19\VBG\6791372 (l_dobj) states_22\NNS\8491826 (l_conj) seizures_30\NNS\14081375
18951540
D007980_D004409 CID levodopa_5\NN\14604959 (r_npadvmod) induced_7\VBN\1627355 (r_amod) dyskinesias_8\NNS\14084880
D007980_D010300 NONE levodopa_5\NN\14604959 (r_npadvmod) induced_7\VBN\1627355 (r_amod) dyskinesias_8\NNS\14084880 (l_prep) in_9\IN\13603305 (l_pobj) disease_12\NN\14061805
17879945
D019438_D050197 CID ritonavir_5\VBZ\4013993 (r_compound) treatment_6\NN\654885 (r_nsubj) increases_7\VBZ\13576355 (l_dobj) formation_10\NN\7938773 (l_compound) lesion_9\NN\14204950
4027862
D003891_D003693 CID desipramine_0\NN\4482543 (r_npadvmod) induced_2\VBN\1627355 (r_amod) delirium_3\NN\14391660
D003891_D003693 CID desipramine_7\NNP\4482543 (r_nsubj) developed_8\VBD\1753788 (l_dobj) delirium_10\NN\14391660
7862923
D002220_D019965 NONE carbamazepine_0\NNP\0 (r_nsubjpass) switched_2\VBN\138508 (l_prep) among_8\IN\0 (l_pobj) patients_19\NNS\9898892 (l_amod) psychotic_18\JJ\10595647
D002220_D012559 NONE carbamazepine_0\NNP\0 (r_nsubjpass) switched_2\VBN\138508 (l_prep) among_8\IN\0 (l_pobj) patients_19\NNS\9898892 (l_amod) schizophrenic_15\JJ\10490141
D003024_D019965 NONE clozapine_26\NN\3713736 (r_conj) chlorpromazine_24\NN\3713736 (r_conj) haloperidol_22\NN\3713736 (r_dobj) using_20\VBG\418025 (r_acl) patients_19\NNS\9898892 (l_amod) psychotic_18\JJ\10595647
D002746_D012559 NONE chlorpromazine_24\NN\3713736 (r_conj) haloperidol_22\NN\3713736 (r_dobj) using_20\VBG\418025 (r_acl) patients_19\NNS\9898892 (l_amod) schizophrenic_15\JJ\10490141
C036006_D012559 NONE oxcarbazepine_7\NN\0 (r_pobj) to_3\IN\0 (r_prep) switched_2\VBN\138508 (l_prep) among_8\IN\0 (l_pobj) patients_19\NNS\9898892 (l_amod) schizophrenic_15\JJ\10490141
D006220_D019965 NONE haloperidol_22\NN\3713736 (r_dobj) using_20\VBG\418025 (r_acl) patients_19\NNS\9898892 (l_amod) psychotic_18\JJ\10595647
D002746_D019965 NONE chlorpromazine_24\NN\3713736 (r_conj) haloperidol_22\NN\3713736 (r_dobj) using_20\VBG\418025 (r_acl) patients_19\NNS\9898892 (l_amod) psychotic_18\JJ\10595647
C036006_D019965 NONE oxcarbazepine_7\NN\0 (r_pobj) to_3\IN\0 (r_prep) switched_2\VBN\138508 (l_prep) among_8\IN\0 (l_pobj) patients_19\NNS\9898892 (l_amod) psychotic_18\JJ\10595647
D003024_D012559 NONE clozapine_26\NN\3713736 (r_conj) chlorpromazine_24\NN\3713736 (r_conj) haloperidol_22\NN\3713736 (r_dobj) using_20\VBG\418025 (r_acl) patients_19\NNS\9898892 (l_amod) schizophrenic_15\JJ\10490141
D006220_D012559 NONE haloperidol_22\NN\3713736 (r_dobj) using_20\VBG\418025 (r_acl) patients_19\NNS\9898892 (l_amod) schizophrenic_15\JJ\10490141
18221780
D016202_D010146 NONE nmda_3\NNP\0 (r_compound) enhancement_5\NN\248977 (r_pobj) in_2\IN\13603305 (r_prep) differences_1\NNS\4723816 (l_prep) in_9\IN\13603305 (l_pobj) model_12\NN\5888929 (l_prep) of_13\IN\0 (l_pobj) pain_15\NN\14299637
D016202_D010146 NONE nmda_9\NNP\0 (r_compound) antagonists_10\NNS\7846 (r_pobj) between_8\IN\0 (r_prep) interaction_7\NN\37396 (l_prep) in_13\IN\13603305 (l_pobj) model_17\NN\5888929 (l_compound) pain_16\NN\14299637
D002211_D059787 NONE capsaicin_11\NN\15032661 (r_compound) model_12\NN\5888929 (r_pobj) in_9\IN\13603305 (r_prep) differences_1\NNS\4723816 (l_appos) comparisons_17\NNS\635850 (l_prep) to_18\IN\0 (l_pobj) models_20\NNS\5888929 (l_prep) of_21\IN\0 (l_pobj) pain_23\NN\14299637
D009020_D059787 NONE morphine_7\NN\2707683 (r_compound) antihyperalgesia_8\NN\0 (r_pobj) of_6\IN\0 (r_prep) enhancement_5\NN\248977 (r_pobj) in_2\IN\13603305 (r_prep) differences_1\NNS\4723816 (l_appos) comparisons_17\NNS\635850 (l_prep) to_18\IN\0 (l_pobj) models_20\NNS\5888929 (l_prep) of_21\IN\0 (l_pobj) pain_23\NN\14299637
D009020_D059787 NONE morphine_21\NN\2707683 (r_pobj) of_20\IN\0 (r_prep) effects_19\NNS\13245626 (r_dobj) enhance_16\VBP\227165 (l_prep) in_0\IN\13603305 (l_pobj) models_3\NNS\5888929 (l_compound) pain_2\NN\14299637
D009020_D059787 NONE morphine_2\NN\2707683 (r_compound) antinociception_3\NN\0 (r_pobj) of_1\IN\0 (r_prep) enhancement_0\NN\248977 (r_nsubjpass) seen_7\VBN\2106506 (l_prep) in_8\IN\13603305 (l_pobj) males_10\NNS\15388 (l_prep) in_13\IN\13603305 (l_pobj) models_17\NNS\5888929 (l_compound) pain_16\NN\14299637
D009020_D059787 NONE morphine_12\NN\2707683 (r_conj) antagonists_10\NNS\7846 (r_pobj) between_8\IN\0 (r_prep) interaction_7\NN\37396 (l_prep) in_13\IN\13603305 (l_pobj) model_17\NN\5888929 (l_relcl) distinguished_21\VBN\618878 (l_prep) from_22\IN\0 (l_pobj) those_23\DT\0 (l_acl) observed_24\VBN\2163746 (l_prep) in_25\IN\13603305 (l_pobj) models_28\NNS\5888929 (l_compound) pain_27\NN\14299637
D003915_D059787 NONE dextromethorphan_5\NNP\0 (r_pobj) by_4\IN\0 (r_prep) enhancement_0\NN\248977 (r_nsubjpass) seen_7\VBN\2106506 (l_prep) in_8\IN\13603305 (l_pobj) males_10\NNS\15388 (l_prep) in_13\IN\13603305 (l_pobj) models_17\NNS\5888929 (l_compound) pain_16\NN\14299637
D002211_D010146 NONE capsaicin_11\NN\15032661 (r_compound) model_12\NN\5888929 (l_prep) of_13\IN\0 (l_pobj) pain_15\NN\14299637
D002211_D006930 CID capsaicin_11\NN\15032661 (r_pobj) of_10\IN\0 (r_prep) administration_9\NN\1133281 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (l_nsubjpass) hyperalgesia_5\NN\0
D016202_D059787 NONE nmda_3\NNP\0 (r_compound) enhancement_5\NN\248977 (r_pobj) in_2\IN\13603305 (r_prep) differences_1\NNS\4723816 (l_appos) comparisons_17\NNS\635850 (l_prep) to_18\IN\0 (l_pobj) models_20\NNS\5888929 (l_prep) of_21\IN\0 (l_pobj) pain_23\NN\14299637
D016202_D059787 NONE aspartate_11\NNP\0 (r_nmod) antagonists_15\NNS\7846 (r_nsubj) enhance_16\VBP\227165 (l_prep) in_0\IN\13603305 (l_pobj) models_3\NNS\5888929 (l_compound) pain_2\NN\14299637
D016202_D059787 NONE nmda_13\NNP\0 (r_nmod) antagonists_15\NNS\7846 (r_nsubj) enhance_16\VBP\227165 (l_prep) in_0\IN\13603305 (l_pobj) models_3\NNS\5888929 (l_compound) pain_2\NN\14299637
D016202_D059787 NONE nmda_9\NNP\0 (r_compound) antagonists_10\NNS\7846 (r_pobj) between_8\IN\0 (r_prep) interaction_7\NN\37396 (l_prep) in_13\IN\13603305 (l_pobj) model_17\NN\5888929 (l_relcl) distinguished_21\VBN\618878 (l_prep) from_22\IN\0 (l_pobj) those_23\DT\0 (l_acl) observed_24\VBN\2163746 (l_prep) in_25\IN\13603305 (l_pobj) models_28\NNS\5888929 (l_compound) pain_27\NN\14299637
D009020_D010146 NONE morphine_7\NN\2707683 (r_compound) antihyperalgesia_8\NN\0 (r_pobj) of_6\IN\0 (r_prep) enhancement_5\NN\248977 (r_pobj) in_2\IN\13603305 (r_prep) differences_1\NNS\4723816 (l_prep) in_9\IN\13603305 (l_pobj) model_12\NN\5888929 (l_prep) of_13\IN\0 (l_pobj) pain_15\NN\14299637
D009020_D010146 NONE morphine_12\NN\2707683 (r_conj) antagonists_10\NNS\7846 (r_pobj) between_8\IN\0 (r_prep) interaction_7\NN\37396 (l_prep) in_13\IN\13603305 (l_pobj) model_17\NN\5888929 (l_compound) pain_16\NN\14299637
17261653
D003000_D001919 CID clonidine_0\NNP\2721160 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) bradycardia_3\NN\14110674
7858459
C007744_D020258 NONE fluorocitrate_16\NN\0 (r_conj) fluoroacetate_14\NN\0 (r_pobj) by_13\IN\0 (r_prep) blockade_12\NN\952963 (r_pobj) to_8\IN\0 (r_prep) due_7\JJ\5174653 (r_acomp) be_6\VB\14625458 (l_nsubj) pathogenesis_1\NN\13533470 (l_prep) of_2\IN\0 (l_pobj) neurotoxicity_4\NN\0
D002955_D020258 NONE acid_2\NN\14818238 (r_nsubj) was_3\VBD\0 (r_advcl) suspected_21\VBN\916909 (l_nsubjpass) neurotoxicity_12\NN\0
D005472_D009369 NONE 5-fluorouracil_3\CD\0 (r_punct) folinic_5\JJ\0 (r_amod) therapy_8\NN\657604 (r_nsubj) become_11\VBN\146138 (l_attr) regimen_14\NN\5898568 (l_prep) for_15\IN\0 (l_pobj) cancers_17\NNS\14239425
D005472_D003128 CID 5-fluorouracil_35\CD\0 (r_punct) of_34\IN\0 (r_prep) dose_29\NN\3740161 (r_nmod) infusion_39\NN\14589223 (r_pobj) during_26\IN\0 (r_prep) lasting_21\VBG\2704349 (r_advcl) lapsed_15\VBD\124442 (l_prep) into_16\IN\0 (l_pobj) coma_19\NN\5678932
D005472_D003221 CID 5-fluorouracil_10\CD\0 (r_punct) of_9\IN\0 (r_prep) infusion_8\NN\14589223 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (l_nsubj) confusion_1\NN\13972797
D005472_D003221 CID 5-fluorouracil_35\CD\0 (r_punct) of_34\IN\0 (r_prep) dose_29\NN\3740161 (r_nmod) infusion_39\NN\14589223 (r_pobj) during_26\IN\0 (r_prep) lasting_21\VBG\2704349 (r_advcl) lapsed_15\VBD\124442 (r_conj) developed_1\VBD\1753788 (l_dobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) confusion_7\NN\13972797
D005472_D003221 CID 5-fluorouracil_35\CD\0 (r_punct) of_34\IN\0 (r_prep) dose_29\NN\3740161 (r_nmod) infusion_39\NN\14589223 (r_pobj) during_26\IN\0 (r_prep) lasting_21\VBG\2704349 (r_advcl) lapsed_15\VBD\124442 (r_conj) developed_1\VBD\1753788 (l_dobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) confusion_7\NN\13972797 (l_conj) disorientation_9\NN\5896733
D002955_D009369 NONE acid_6\NN\14818238 (r_compound) infusion_7\NN\14589223 (r_compound) therapy_8\NN\657604 (r_nsubj) become_11\VBN\146138 (l_attr) regimen_14\NN\5898568 (l_prep) for_15\IN\0 (l_pobj) cancers_17\NNS\14239425
D002955_D003128 CID acid_38\NN\14818238 (r_compound) infusion_39\NN\14589223 (r_pobj) during_26\IN\0 (r_prep) lasting_21\VBG\2704349 (r_advcl) lapsed_15\VBD\124442 (l_prep) into_16\IN\0 (l_pobj) coma_19\NN\5678932
D005463_D020258 NONE fluoroacetate_14\NN\0 (r_pobj) by_13\IN\0 (r_prep) blockade_12\NN\952963 (r_pobj) to_8\IN\0 (r_prep) due_7\JJ\5174653 (r_acomp) be_6\VB\14625458 (l_nsubj) pathogenesis_1\NN\13533470 (l_prep) of_2\IN\0 (l_pobj) neurotoxicity_4\NN\0
D013831_D020258 NONE thiamine_18\NN\15090742 (r_compound) deficiency_19\NN\14449126 (r_conj) blockade_12\NN\952963 (r_pobj) to_8\IN\0 (r_prep) due_7\JJ\5174653 (r_acomp) be_6\VB\14625458 (l_nsubj) pathogenesis_1\NN\13533470 (l_prep) of_2\IN\0 (l_pobj) neurotoxicity_4\NN\0
D005472_D020258 NONE 5-fluorouracil_18\CD\0 (r_punct) suspected_21\VBN\916909 (l_nsubjpass) neurotoxicity_12\NN\0
D005472_D020258 NONE 5-fluorouracil_3\CD\0 (r_punct) neurotoxicity_4\NN\0
D002945_D013274 NONE cisplatinum_11\NN\0 (l_appos) hours_24\NNS\15118228 (l_conj) acid_28\NN\14818238 (l_prep) for_29\IN\0 (l_pobj) adenocarcinoma_33\NN\14242337
D002955_D001523 NONE acid_38\NN\14818238 (r_compound) infusion_39\NN\14589223 (r_pobj) during_26\IN\0 (r_prep) lasting_21\VBG\2704349 (r_advcl) lapsed_15\VBD\124442 (r_conj) developed_1\VBD\1753788 (l_dobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) confusion_7\NN\13972797 (l_conj) disorientation_9\NN\5896733 (l_conj) irritability_11\NN\7552087
D002955_D003221 CID acid_13\NN\14818238 (r_conj) infusion_8\NN\14589223 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (l_nsubj) confusion_1\NN\13972797
D002955_D003221 CID acid_38\NN\14818238 (r_compound) infusion_39\NN\14589223 (r_pobj) during_26\IN\0 (r_prep) lasting_21\VBG\2704349 (r_advcl) lapsed_15\VBD\124442 (r_conj) developed_1\VBD\1753788 (l_dobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) confusion_7\NN\13972797
D002955_D003221 CID acid_38\NN\14818238 (r_compound) infusion_39\NN\14589223 (r_pobj) during_26\IN\0 (r_prep) lasting_21\VBG\2704349 (r_advcl) lapsed_15\VBD\124442 (r_conj) developed_1\VBD\1753788 (l_dobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) confusion_7\NN\13972797 (l_conj) disorientation_9\NN\5896733
D005047_D013274 NONE etoposide_13\NN\0 (r_conj) cisplatinum_11\NN\0 (l_appos) hours_24\NNS\15118228 (l_conj) acid_28\NN\14818238 (l_prep) for_29\IN\0 (l_pobj) adenocarcinoma_33\NN\14242337
D002955_D013274 NONE acid_28\NN\14818238 (l_prep) for_29\IN\0 (l_pobj) adenocarcinoma_33\NN\14242337
C007419_D020258 NONE dihydrouracil_22\VBN\0 (r_compound) dehydrogenase_23\NN\0 (r_compound) deficiency_24\NN\14449126 (r_conj) deficiency_19\NN\14449126 (r_conj) blockade_12\NN\952963 (r_pobj) to_8\IN\0 (r_prep) due_7\JJ\5174653 (r_acomp) be_6\VB\14625458 (l_nsubj) pathogenesis_1\NN\13533470 (l_prep) of_2\IN\0 (l_pobj) neurotoxicity_4\NN\0
D005472_D013274 NONE 5-fluorouracil_18\CD\0 (r_punct) m2/24_23\NN\0 (r_compound) hours_24\NNS\15118228 (l_conj) acid_28\NN\14818238 (l_prep) for_29\IN\0 (l_pobj) adenocarcinoma_33\NN\14242337
D005472_D001523 NONE 5-fluorouracil_35\CD\0 (r_punct) of_34\IN\0 (r_prep) dose_29\NN\3740161 (r_nmod) infusion_39\NN\14589223 (r_pobj) during_26\IN\0 (r_prep) lasting_21\VBG\2704349 (r_advcl) lapsed_15\VBD\124442 (r_conj) developed_1\VBD\1753788 (l_dobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) confusion_7\NN\13972797 (l_conj) disorientation_9\NN\5896733 (l_conj) irritability_11\NN\7552087
2234245
D003676_D064420 NONE desferrioxamine_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) doses_8\NNS\3740161 (r_dobj) receiving_5\VBG\2210855 (r_acl) patients_4\NNS\9898892 (r_pobj) in_3\IN\13603305 (r_prep) appeared_2\VBD\2604760 (l_nsubj) toxicity_1\NN\13576101
D003676_D014786 NONE desferrioxamine_8\NN\0 (r_dobj) receiving_7\VBG\2210855 (r_acl) patients_6\NNS\9898892 (r_pobj) in_4\IN\13603305 (r_prep) toxicity_3\NN\13576101
D003676_D014786 NONE desferrioxamine_10\NN\0 (r_dobj) receiving_9\VBG\2210855 (r_acl) patients_8\NNS\9898892 (r_pobj) during_0\IN\0 (r_prep) monitored_25\VBN\2169352 (l_prep) for_26\IN\0 (l_pobj) detection_27\NN\5708432 (l_prep) of_28\IN\0 (l_pobj) toxicity_30\NN\13576101
D003676_D014786 NONE desferrioxamine_15\NN\0 (r_dobj) receiving_14\VBG\2210855 (r_acl) patients_13\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) complication_10\NN\1073995 (r_attr) is_6\VBZ\0 (l_nsubj) toxicity_5\NN\13576101
D003676_D034381 NONE desferrioxamine_0\NNP\0 (r_compound) withdrawal_1\NN\7206096 (r_nsubj) resulted_2\VBD\2633881 (l_conj) reversal_22\NN\199130 (l_prep) of_23\IN\0 (l_pcomp) hearing_24\NN\1184814 (l_dobj) loss_25\NN\13252973
D003676_D006311 NONE desferrioxamine_8\NN\0 (r_dobj) receiving_7\VBG\2210855 (r_acl) patients_6\NNS\9898892 (r_pobj) in_4\IN\13603305 (r_prep) toxicity_3\NN\13576101
D003676_D006311 NONE desferrioxamine_10\NN\0 (r_dobj) receiving_9\VBG\2210855 (r_acl) patients_8\NNS\9898892 (r_pobj) during_0\IN\0 (r_prep) monitored_25\VBN\2169352 (l_prep) for_26\IN\0 (l_pobj) detection_27\NN\5708432 (l_prep) of_28\IN\0 (l_pobj) toxicity_30\NN\13576101
D003676_D006311 NONE desferrioxamine_15\NN\0 (r_dobj) receiving_14\VBG\2210855 (r_acl) patients_13\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) complication_10\NN\1073995 (r_attr) is_6\VBZ\0 (l_nsubj) toxicity_5\NN\13576101
-1_D064420 NONE aluminium_19\NN\14625458 (r_conj) ferritin_17\NN\14728724 (r_nmod) levels_21\NNS\4916342 (r_pobj) of_16\IN\0 (r_prep) normalization_15\NN\1123598 (r_pobj) with_13\IN\0 (r_prep) coincided_12\VBD\2604477 (r_conj) appeared_2\VBD\2604760 (l_nsubj) toxicity_1\NN\13576101
17437408
D010862_D012640 CID pilocarpine_11\NN\14712692 (r_npadvmod) induced_13\VBN\1627355 (r_amod) seizures_14\NNS\14081375
18020536
D001569_D004244 CID bzds_4\NNP\0 (r_nmod) rds_6\NNS\0 (r_pobj) of_3\IN\0 (r_prep) use_2\NN\407535 (r_nsubjpass) associated_8\VBN\628491 (l_prep) with_9\IN\0 (l_pobj) dizziness_10\NN\14299637
D001569_D005221 CID bzds_4\NNP\0 (r_nmod) rds_6\NNS\0 (r_pobj) of_3\IN\0 (r_prep) use_2\NN\407535 (r_nsubjpass) associated_8\VBN\628491 (l_npadvmod) inability_12\NN\23271 (l_acl) sleep_14\VB\14034177 (l_prep) after_15\IN\0 (l_pcomp) awaking_16\VBG\146138 (l_prep) at_17\IN\14622893 (l_pobj) night_18\NN\15113229 (l_conj) tiredness_20\NN\14015731
D001569_D003866 CID bzds_4\NNP\0 (r_nmod) rds_6\NNS\0 (r_pobj) of_3\IN\0 (r_prep) use_2\NN\407535 (r_nsubjpass) associated_8\VBN\628491 (l_npadvmod) inability_12\NN\23271 (l_acl) sleep_14\VB\14034177 (l_prep) after_15\IN\0 (l_conj) with_31\IN\0 (l_pobj) symptoms_34\NNS\5823932
D001569_D007319 CID bzds_4\NNP\0 (r_nmod) rds_6\NNS\0 (r_pobj) of_3\IN\0 (r_prep) use_2\NN\407535 (r_nsubjpass) associated_8\VBN\628491 (l_npadvmod) inability_12\NN\23271 (l_acl) sleep_14\VB\14034177
9625142
D001663_D000744 NONE bilirubin_21\NN\14756039 (r_pobj) in_19\IN\13603305 (r_prep) increase_18\NN\13576355 (l_conj) decrease_24\NN\7296428 (l_prep) in_25\IN\13603305 (l_pobj) concentration_27\NN\4916342 (l_acl) caused_28\VBN\1617192 (l_agent) by_29\IN\0 (l_pobj) anemia_33\NN\14189204
D047090_D000744 NONE lactam_11\NN\0 (r_compound) antibiotic_12\NN\2716205 (r_dobj) withholding_8\VBG\360757 (r_pcomp) after_7\IN\0 (r_prep) returned_4\VBD\1835496 (r_advcl) was_15\VBD\0 (l_attr) increase_18\NN\13576355 (l_conj) decrease_24\NN\7296428 (l_prep) in_25\IN\13603305 (l_pobj) concentration_27\NN\4916342 (l_acl) caused_28\VBN\1617192 (l_agent) by_29\IN\0 (l_pobj) anemia_33\NN\14189204
D002443_D000744 CID ceftriaxone_11\NN\2996840 (r_pobj) by_10\IN\0 (r_prep) induced_9\VBN\1627355 (l_nsubj) hepatitis_1\NNP\14127211 (l_appos) anemia_5\NN\14189204
D002443_-1 NONE ceftriaxone_11\NN\2996840 (r_pobj) by_10\IN\0 (r_prep) induced_9\VBN\1627355 (l_nsubj) hepatitis_1\NNP\14127211 (l_appos) anemia_5\NN\14189204 (l_conj) erythroblastocytopenia_8\NN\0
D002443_D056486 CID ceftriaxone_11\NN\2996840 (r_pobj) by_10\IN\0 (r_prep) induced_9\VBN\1627355 (l_nsubj) hepatitis_1\NNP\14127211
D002443_D056486 CID ceftriaxone_12\NN\2996840 (r_dobj) ingesting_10\VBG\0 (r_pcomp) after_9\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) hepatitis_7\NN\14127211
D001663_-1 NONE bilirubin_21\NN\14756039 (r_pobj) in_19\IN\13603305 (r_prep) increase_18\NN\13576355 (l_conj) decrease_24\NN\7296428 (l_prep) in_25\IN\13603305 (l_pobj) concentration_27\NN\4916342 (l_acl) caused_28\VBN\1617192 (l_agent) by_29\IN\0 (l_pobj) anemia_33\NN\14189204 (l_conj) erythroblastocytopenia_35\NN\0
D047090_-1 NONE lactam_11\NN\0 (r_compound) antibiotic_12\NN\2716205 (r_dobj) withholding_8\VBG\360757 (r_pcomp) after_7\IN\0 (r_prep) returned_4\VBD\1835496 (r_advcl) was_15\VBD\0 (l_attr) increase_18\NN\13576355 (l_conj) decrease_24\NN\7296428 (l_prep) in_25\IN\13603305 (l_pobj) concentration_27\NN\4916342 (l_acl) caused_28\VBN\1617192 (l_agent) by_29\IN\0 (l_pobj) anemia_33\NN\14189204 (l_conj) erythroblastocytopenia_35\NN\0
16403073
D007654_D016171 CID ketoconazole_0\NNP\0 (r_nsubj) induced_1\VBD\1627355 (l_dobj) pointes_4\FW\831651
D007654_D016171 CID ketoconazole_24\RB\0 (r_dobj) taking_23\VBG\37396 (r_pcomp) after_22\IN\0 (r_prep) torsades_16\NNS\0 (l_dobj) pointes_18\FW\831651
D007654_D016171 CID ketoconazole_24\RB\0 (r_dobj) taking_23\VBG\37396 (r_pcomp) after_22\IN\0 (r_prep) torsades_16\NNS\0 (l_dobj) pointes_18\FW\831651 (l_appos) tdp_20\NN\0
D007654_D016171 CID ketoconazole_13\RB\0 (r_nsubj) prolong_16\VB\317700 (l_conj) induce_20\VB\1627355 (l_dobj) tdp._21\NN\0
D007654_D008133 CID ketoconazole_24\RB\0 (r_dobj) taking_23\VBG\37396 (r_pcomp) after_22\IN\0 (r_prep) torsades_16\NNS\0 (r_conj) developed_9\VBD\1753788 (l_dobj) interval_14\NN\33615
D007654_D008133 CID ketoconazole_5\JJ\0 (r_nsubjpass) administered_7\VBN\2436349 (l_prep) to_8\IN\0 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) factors_12\NNS\7326557 (l_prep) for_13\IN\0 (l_pobj) syndrome_17\NN\5870365
D007654_D009181 NONE ketoconazole_24\RB\0 (r_dobj) taking_23\VBG\37396 (l_prep) for_25\IN\0 (l_pobj) treatment_26\NN\654885 (l_prep) of_27\IN\0 (l_pobj) infection_29\NN\14052046
D007654_D003324 NONE ketoconazole_24\RB\0 (r_dobj) taking_23\VBG\37396 (r_pcomp) after_22\IN\0 (r_prep) torsades_16\NNS\0 (r_conj) developed_9\VBD\1753788 (r_relcl) woman_3\NN\9605289 (l_prep) with_4\IN\0 (l_pobj) disease_7\NN\14061805
3341566
D009599_D007022 CID nitroprusside_10\RB\0 (r_advmod) induced_12\VBN\1627355 (r_amod) hypotension_13\NN\14057371
D009599_D007022 CID snp_21\NNP\11493266 (r_compound) group_22\NN\2137 (r_pobj) in_19\IN\13603305 (r_prep) that_18\DT\0 (r_pobj) with_17\IN\0 (r_prep) compared_16\VBN\644583 (r_prep) higher_15\RBR\0 (r_acomp) was_8\VBD\0 (l_prep) during_0\IN\0 (l_pobj) hypotension_4\NN\14057371
D009599_D007022 CID snp_7\NNP\11493266 (r_compound) groups_8\NNS\2137 (r_pobj) in_3\IN\13603305 (r_prep) hg_2\NNP\14625458 (l_prep) during_12\IN\0 (l_pobj) hypotension_13\NN\14057371
D009599_D006470 NONE nitroprusside_10\RB\0 (r_advmod) induced_12\VBN\1627355 (r_amod) hypotension_13\NN\14057371 (r_pobj) during_8\IN\0 (r_prep) than_7\IN\0 (r_prep) is_3\VBZ\0 (l_prep) during_5\IN\0 (l_pobj) hemorrhage_6\NN\14285662
D009599_D006470 NONE nitroprusside_28\NN\0 (r_advcl) decreased_4\VBN\169651 (l_prep) for_9\IN\0 (l_pobj) minutes_11\NNS\6502378 (l_prep) by_13\IN\0 (l_pobj) hemorrhage_14\NN\14285662
D009599_D006470 NONE nitroprusside_28\NN\0 (r_advcl) decreased_4\VBN\169651 (l_prep) for_9\IN\0 (l_pobj) minutes_11\NNS\6502378 (l_prep) by_13\IN\0 (l_pobj) hemorrhage_14\NN\14285662 (l_appos) hem_16\NNP\3264542
D009599_D006470 NONE snp_30\NNP\11493266 (r_dep) n_32\CC\14622893 (r_npadvmod) nitroprusside_28\NN\0 (r_advcl) decreased_4\VBN\169651 (l_prep) for_9\IN\0 (l_pobj) minutes_11\NNS\6502378 (l_prep) by_13\IN\0 (l_pobj) hemorrhage_14\NN\14285662
D009599_D006470 NONE snp_30\NNP\11493266 (r_dep) n_32\CC\14622893 (r_npadvmod) nitroprusside_28\NN\0 (r_advcl) decreased_4\VBN\169651 (l_prep) for_9\IN\0 (l_pobj) minutes_11\NNS\6502378 (l_prep) by_13\IN\0 (l_pobj) hemorrhage_14\NN\14285662 (l_appos) hem_16\NNP\3264542
D009599_D006470 NONE snp_21\NNP\11493266 (r_compound) group_22\NN\2137 (r_pobj) in_19\IN\13603305 (r_prep) that_18\DT\0 (r_pobj) with_17\IN\0 (r_prep) compared_16\VBN\644583 (r_prep) higher_15\RBR\0 (r_acomp) was_8\VBD\0 (l_prep) during_0\IN\0 (l_pobj) hypotension_4\NN\14057371 (l_amod) induced_3\VBN\1627355 (l_npadvmod) hem_1\NNP\3264542
D009599_D006470 NONE snp_17\NNP\11493266 (r_compound) group_18\NN\2137 (r_pobj) in_15\IN\13603305 (r_prep) hg_14\NNP\14625458 (r_appos) mm_13\NN\13649268 (r_pobj) with_9\IN\0 (r_prep) compared_8\VBN\644583 (r_prep) hg_2\NNP\14625458 (l_prep) in_3\IN\13603305 (l_pobj) group_6\NN\2137 (l_compound) hem_5\NNP\3264542
D009599_D006470 NONE snp_7\NNP\11493266 (r_compound) groups_8\NNS\2137 (l_nmod) hem_5\NNP\3264542
15009014
D001285_D006940 NONE atropine_16\NN\14712692 (r_pobj) by_10\IN\0 (r_agent) abolished_9\VBN\0 (l_nsubjpass) increases_2\NNS\13576355 (l_prep) in_3\IN\13603305 (l_pobj) flow_6\NN\7311115
D002211_D006940 CID capsaicin_0\NNS\15032661 (r_nsubj) applied_7\VBN\0 (l_conj) induced_13\VBN\1627355 (l_dobj) increases_14\NNS\13576355 (l_prep) in_15\IN\13603305 (l_pobj) flow_20\NN\7311115
19058010
D007545_D009203 CID isoproterenol_9\JJ\3740161 (r_pobj) in_8\IN\13603305 (r_prep) combination_7\NN\7951464 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (r_nsubj) induced_10\VBN\1627355 (l_dobj) infarction_12\NN\14204950
D007545_D009203 CID isoproterenol_37\NN\3740161 (r_pobj) in_36\IN\13603305 (r_prep) bound_34\VBN\13863771 (r_acl) effects_9\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_xcomp) aimed_4\VBN\1987160 (l_parataxis) iso)-induced_39\VBN\0 (l_dobj) infarction_41\NN\14204950
D007545_D009203 CID iso)-induced_39\VBN\0 (l_dobj) infarction_41\NN\14204950
D007545_D009203 CID iso_14\NN\0 (r_pobj) during_13\IN\0 (r_prep) effect_6\NN\34213 (r_dobj) indicate_2\VBP\952524 (l_ccomp) induced_15\VBN\1627355 (l_dobj) infarction_17\NN\14204950
D010936_D009203 NONE tea_3\NN\7881800 (r_nmod) combination_7\NN\7951464 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (r_nsubj) induced_10\VBN\1627355 (l_dobj) infarction_12\NN\14204950
D010936_D009203 NONE tea_12\NN\7881800 (r_pobj) of_10\IN\0 (r_prep) effects_9\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_xcomp) aimed_4\VBN\1987160 (l_parataxis) iso)-induced_39\VBN\0 (l_dobj) infarction_41\NN\14204950
D010936_D009203 NONE tea_9\NN\7881800 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (r_dobj) indicate_2\VBP\952524 (l_ccomp) induced_15\VBN\1627355 (l_dobj) infarction_17\NN\14204950
D014810_D009203 NONE e_6\NN\14724645 (r_conj) tea_3\NN\7881800 (r_nmod) combination_7\NN\7951464 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (r_nsubj) induced_10\VBN\1627355 (l_dobj) infarction_12\NN\14204950
D014810_D009203 NONE e_15\NN\14724645 (r_conj) tea_12\NN\7881800 (r_pobj) of_10\IN\0 (r_prep) effects_9\NNS\13245626 (r_dobj) investigate_6\VB\644583 (r_xcomp) aimed_4\VBN\1987160 (l_parataxis) iso)-induced_39\VBN\0 (l_dobj) infarction_41\NN\14204950
D014810_D009203 NONE e_12\NN\14724645 (r_conj) tea_9\NN\7881800 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (r_dobj) indicate_2\VBP\952524 (l_ccomp) induced_15\VBN\1627355 (l_dobj) infarction_17\NN\14204950
2096243
C017367_D019965 CID carmofur_0\NN\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) disorders_5\NNS\14034177
C017367_D019965 CID carmofur_19\NN\0 (r_npadvmod) induced_21\VBN\1627355 (r_amod) leukoencephalopathy_22\NN\0 (r_pobj) of_18\IN\0 (r_prep) onset_17\NN\7325190 (r_pobj) after_15\IN\0 (r_prep) period_14\NN\13575869 (r_pobj) in_11\IN\13603305 (r_prep) female_10\NN\15388 (r_pobj) in_5\IN\13603305 (r_prep) observed_4\VBN\2163746 (l_nsubjpass) disorder_2\NN\14034177
C017367_D056784 CID carmofur_19\NN\0 (r_npadvmod) induced_21\VBN\1627355 (r_amod) leukoencephalopathy_22\NN\0
C017367_D056784 CID carmofur_2\NN\0 (r_npadvmod) induced_4\VBN\1627355 (r_amod) leukoencephalopathy_5\JJ\0
C017367_D010554 NONE carmofur_2\NN\0 (r_npadvmod) induced_4\VBN\1627355 (r_amod) leukoencephalopathy_5\JJ\0 (r_nsubj) result_8\VB\34213 (l_prep) in_9\IN\13603305 (l_pobj) syndrome_12\NN\5870365
3676049
D007530_D007022 CID isoflurane_6\RB\3570838 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hypotension_9\NN\14057371
D007530_D007022 CID isoflurane_12\RB\3570838 (r_npadvmod) induced_14\VBN\1627355 (r_amod) hypotension_15\NN\14057371
D007530_D007022 CID isoflurane_19\NN\3570838 (r_pobj) of_18\IN\0 (r_prep) dose_17\NN\3740161 (r_dobj) increasing_15\VBG\169651 (r_pcomp) by_14\IN\0 (r_prep) induced_13\VBN\1627355 (l_nsubjpass) hypotension_1\NN\14057371
D008628_D007022 NONE hg_11\NNP\14625458 (r_pobj) of_6\IN\0 (r_prep) map_5\NNP\4076846 (r_pobj) to_2\IN\0 (r_prep) hypotension_1\NN\14057371
D014978_D013345 NONE xenon-133_24\.\0 (r_punct) measured_4\VBN\697589 (l_prep) after_9\IN\0 (l_pobj) haemorrhage_12\NN\14285662
D010100_D007022 NONE oxygen_8\NN\14622893 (r_pobj) for_7\IN\0 (r_prep) rate_6\NN\13815152 (r_conj) flow_2\NN\7311115 (r_nsubjpass) measured_10\VBN\697589 (l_prep) during_11\IN\0 (l_pobj) hypotension_15\NN\14057371
D007530_D002532 NONE isoflurane_6\RB\3570838 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hypotension_9\NN\14057371 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_acl) subjected_12\VBN\137313 (l_prep) for_15\IN\0 (l_pobj) aneurysms_17\NNS\14057371
D007530_D002532 NONE isoflurane_12\RB\3570838 (r_npadvmod) induced_14\VBN\1627355 (r_amod) hypotension_15\NN\14057371 (l_prep) in_16\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_acl) subjected_19\VBN\137313 (l_prep) to_20\IN\0 (l_pobj) craniotomy_21\NN\671351 (l_prep) for_22\IN\0 (l_pobj) clipping_23\NN\6400510 (l_prep) of_24\IN\0 (l_pobj) aneurysm_27\NN\14057371
D007530_D000783 NONE isoflurane_7\JJ\3570838 (r_amod) concentration_8\NN\4916342 (r_nsubjpass) reduced_10\VBN\441445 (l_prep) after_0\IN\0 (l_pobj) clipping_2\NN\6400510 (l_prep) of_3\IN\0 (l_pobj) aneurysm_5\NN\14057371
D010100_D002532 NONE oxygen_8\NN\14622893 (r_pobj) for_7\IN\0 (r_prep) rate_6\NN\13815152 (r_conj) flow_2\NN\7311115 (r_nsubjpass) measured_10\VBN\697589 (l_prep) during_11\IN\0 (l_pobj) hypotension_15\NN\14057371 (l_prep) in_16\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_acl) subjected_19\VBN\137313 (l_prep) to_20\IN\0 (l_pobj) craniotomy_21\NN\671351 (l_prep) for_22\IN\0 (l_pobj) clipping_23\NN\6400510 (l_prep) of_24\IN\0 (l_pobj) aneurysm_27\NN\14057371
10706004
D011188_D003866 NONE k)-atpase_28\NNP\0 (r_pobj) of_23\IN\0 (r_prep) properties_22\NNS\32613 (r_pobj) of_19\IN\0 (r_prep) consequence_18\NN\34213 (r_pobj) as_16\IN\14622893 (r_prep) accompanied_9\VBN\0 (l_agent) by_10\IN\0 (l_pobj) na+-extrusion_12\NN\0 (l_amod) depressed_11\JJ\1819147
D009569_D003866 NONE no_2\JJ\7204911 (r_compound) synthase_4\NN\0 (r_pobj) of_1\IN\0 (r_prep) inhibition_0\NN\1068773 (r_nsubj) induced_5\VBD\1627355 (l_dobj) hypertension_8\NN\14057371 (l_acl) accompanied_9\VBN\0 (l_agent) by_10\IN\0 (l_pobj) na+-extrusion_12\NN\0 (l_amod) depressed_11\JJ\1819147
D019331_D006973 NONE ester_49\NN\14727670 (r_appos) kg_40\NNS\13717155 (r_pobj) with_36\IN\0 (r_prep) inhibition_35\NN\1068773 (r_pobj) by_31\IN\0 (r_prep) rats_30\NNS\2329401 (r_pobj) in_29\IN\13603305 (r_prep) induced_28\VBN\1627355 (r_advcl) studied_14\VBD\0 (l_dobj) response_16\NN\11410625 (l_prep) of_17\IN\0 (l_pobj) k)-atpase_22\NNP\0 (l_prep) to_23\IN\0 (l_pobj) hypertension_27\NN\14057371
D019331_D006973 NONE name_53\NNP\6284225 (r_appos) ester_49\NN\14727670 (r_appos) kg_40\NNS\13717155 (r_pobj) with_36\IN\0 (r_prep) inhibition_35\NN\1068773 (r_pobj) by_31\IN\0 (r_prep) rats_30\NNS\2329401 (r_pobj) in_29\IN\13603305 (r_prep) induced_28\VBN\1627355 (r_advcl) studied_14\VBD\0 (l_dobj) response_16\NN\11410625 (l_prep) of_17\IN\0 (l_pobj) k)-atpase_22\NNP\0 (l_prep) to_23\IN\0 (l_pobj) hypertension_27\NN\14057371
D012964_D003866 NONE na+-extrusion_12\NN\0 (l_amod) depressed_11\JJ\1819147
D012964_D003866 NONE na+-binding_21\NN\0 (r_compound) properties_22\NNS\32613 (r_pobj) of_19\IN\0 (r_prep) consequence_18\NN\34213 (r_pobj) as_16\IN\14622893 (r_prep) accompanied_9\VBN\0 (l_agent) by_10\IN\0 (l_pobj) na+-extrusion_12\NN\0 (l_amod) depressed_11\JJ\1819147
D012964_D003866 NONE na_26\UH\14625458 (r_nmod) k)-atpase_28\NNP\0 (r_pobj) of_23\IN\0 (r_prep) properties_22\NNS\32613 (r_pobj) of_19\IN\0 (r_prep) consequence_18\NN\34213 (r_pobj) as_16\IN\14622893 (r_prep) accompanied_9\VBN\0 (l_agent) by_10\IN\0 (l_pobj) na+-extrusion_12\NN\0 (l_amod) depressed_11\JJ\1819147
D009569_D006973 CID oxide_17\NN\14818238 (r_npadvmod) deficient_18\JJ\0 (r_amod) hypertension_19\NN\14057371
D009569_D006973 CID no_2\DT\7204911 (r_det) synthesis_3\NN\13446390 (r_pobj) of_1\IN\0 (r_prep) inhibition_0\NN\1068773 (r_nsubj) induces_4\VBZ\1627355 (l_dobj) hypertension_6\NN\14057371
D009569_D006973 CID no_24\JJ\7204911 (r_npadvmod) deficient_26\JJ\0 (r_amod) hypertension_27\NN\14057371
D009569_D006973 CID no_32\JJ\7204911 (r_compound) synthase_34\NN\0 (r_compound) inhibition_35\NN\1068773 (r_pobj) by_31\IN\0 (r_prep) rats_30\NNS\2329401 (r_pobj) in_29\IN\13603305 (r_prep) induced_28\VBN\1627355 (r_advcl) studied_14\VBD\0 (l_dobj) response_16\NN\11410625 (l_prep) of_17\IN\0 (l_pobj) k)-atpase_22\NNP\0 (l_prep) to_23\IN\0 (l_pobj) hypertension_27\NN\14057371
D009569_D006973 CID no_2\JJ\7204911 (r_compound) synthase_4\NN\0 (r_pobj) of_1\IN\0 (r_prep) inhibition_0\NN\1068773 (r_nsubj) induced_5\VBD\1627355 (l_dobj) hypertension_8\NN\14057371
D000255_D006973 NONE atp_4\NNP\14964590 (r_conj) sodium_2\NN\14625458 (r_nmod) affinities_5\NNS\11426530 (r_pobj) of_1\IN\0 (r_prep) changes_0\NNS\7283608 (l_prep) during_13\IN\0 (l_conj) after_15\IN\0 (l_pobj) hypertension_19\NN\14057371
D000255_D006973 NONE atp_20\NNP\14964590 (r_npadvmod) binding_22\VBG\4688246 (r_amod) site_23\NN\8673395 (r_pobj) of_18\IN\0 (r_prep) affinity_17\NN\11426530 (r_pobj) due_14\IN\5174653 (r_prep) increased_12\VBD\169651 (r_parataxis) activity_6\NN\30358 (l_prep) after_0\IN\0 (l_pobj) recovery_1\NN\7357388 (l_prep) from_2\IN\0 (l_pobj) hypertension_3\NN\14057371
D000255_D006973 NONE atp_33\NNP\14964590 (r_pobj) for_32\IN\0 (r_prep) value_31\NN\5856066 (r_pobj) from_27\IN\0 (r_prep) revealed_26\VBN\2137132 (r_advcl) activity_6\NN\30358 (l_prep) after_0\IN\0 (l_pobj) recovery_1\NN\7357388 (l_prep) from_2\IN\0 (l_pobj) hypertension_3\NN\14057371
D012964_D006973 NONE sodium_2\NN\14625458 (r_nmod) affinities_5\NNS\11426530 (r_pobj) of_1\IN\0 (r_prep) changes_0\NNS\7283608 (l_prep) during_13\IN\0 (l_conj) after_15\IN\0 (l_pobj) hypertension_19\NN\14057371
D012964_D006973 NONE na_10\UH\14625458 (r_nmod) k)-atpase_12\NNP\0 (r_pobj) of_6\IN\0 (r_prep) affinities_5\NNS\11426530 (r_pobj) of_1\IN\0 (r_prep) changes_0\NNS\7283608 (l_prep) during_13\IN\0 (l_conj) after_15\IN\0 (l_pobj) hypertension_19\NN\14057371
D012964_D006973 NONE sodium_9\NN\14625458 (r_compound) level_10\NN\4916342 (r_pobj) of_7\IN\0 (r_prep) elevation_6\NN\7445480 (r_nsubjpass) documented_12\VBN\1000214 (l_prep) in_0\IN\13603305 (l_pobj) models_2\NNS\5888929 (l_prep) of_3\IN\0 (l_pobj) hypertension_4\NN\14057371
D012964_D006973 NONE na+_11\NNP\0 (r_pobj) of_10\IN\0 (r_prep) transport_9\NN\3575240 (r_pobj) in_7\IN\13603305 (r_prep) disturbances_6\NNS\407535 (r_pobj) of_5\IN\0 (r_prep) basis_4\NN\13790712 (r_dobj) assess_1\VB\5220461 (r_advcl) studied_14\VBD\0 (l_dobj) response_16\NN\11410625 (l_prep) of_17\IN\0 (l_pobj) k)-atpase_22\NNP\0 (l_prep) to_23\IN\0 (l_pobj) hypertension_27\NN\14057371
D012964_D006973 NONE na_20\UH\14625458 (r_nmod) k)-atpase_22\NNP\0 (l_prep) to_23\IN\0 (l_pobj) hypertension_27\NN\14057371
D012964_D006973 NONE na_9\NNP\14625458 (r_npadvmod) increased_12\VBD\169651 (r_parataxis) activity_6\NN\30358 (l_prep) after_0\IN\0 (l_pobj) recovery_1\NN\7357388 (l_prep) from_2\IN\0 (l_pobj) hypertension_3\NN\14057371
D012964_D006973 NONE na+-extrusion_12\NN\0 (r_pobj) by_10\IN\0 (r_agent) accompanied_9\VBN\0 (r_acl) hypertension_8\NN\14057371
D012964_D006973 NONE na+-binding_21\NN\0 (r_compound) properties_22\NNS\32613 (r_pobj) of_19\IN\0 (r_prep) consequence_18\NN\34213 (r_pobj) as_16\IN\14622893 (r_prep) accompanied_9\VBN\0 (r_acl) hypertension_8\NN\14057371
D012964_D006973 NONE na_26\UH\14625458 (r_nmod) k)-atpase_28\NNP\0 (r_pobj) of_23\IN\0 (r_prep) properties_22\NNS\32613 (r_pobj) of_19\IN\0 (r_prep) consequence_18\NN\34213 (r_pobj) as_16\IN\14622893 (r_prep) accompanied_9\VBN\0 (r_acl) hypertension_8\NN\14057371
D011188_D006973 NONE k)-atpase_12\NNP\0 (r_pobj) of_6\IN\0 (r_prep) affinities_5\NNS\11426530 (r_pobj) of_1\IN\0 (r_prep) changes_0\NNS\7283608 (l_prep) during_13\IN\0 (l_conj) after_15\IN\0 (l_pobj) hypertension_19\NN\14057371
D011188_D006973 NONE k)-atpase_22\NNP\0 (l_prep) to_23\IN\0 (l_pobj) hypertension_27\NN\14057371
D011188_D006973 NONE k)-atpase_11\NNP\0 (r_nsubj) increased_12\VBD\169651 (r_parataxis) activity_6\NN\30358 (l_prep) after_0\IN\0 (l_pobj) recovery_1\NN\7357388 (l_prep) from_2\IN\0 (l_pobj) hypertension_3\NN\14057371
D011188_D006973 NONE k)-atpase_28\NNP\0 (r_pobj) of_23\IN\0 (r_prep) properties_22\NNS\32613 (r_pobj) of_19\IN\0 (r_prep) consequence_18\NN\34213 (r_pobj) as_16\IN\14622893 (r_prep) accompanied_9\VBN\0 (r_acl) hypertension_8\NN\14057371
10737864
D003000_D001919 CID clonidine_14\NN\2721160 (r_pobj) given_12\VBN\5892096 (r_prep) induces_15\VBZ\1627355 (l_dobj) withdrawal_17\NN\7206096 (l_conj) bradycardia_19\NNP\14110674
D003000_D001919 CID clonidine_24\NN\2721160 (r_poss) effects_27\NNS\13245626 (r_nsubj) mirror_35\VB\4069276 (r_ccomp) hypothesized_22\VBD\719734 (l_ccomp) exhibits_5\VBZ\6733939 (l_conj) induces_15\VBZ\1627355 (l_dobj) withdrawal_17\NN\7206096 (l_conj) bradycardia_19\NNP\14110674
D003000_D001919 CID clonidine_19\NN\2721160 (r_npadvmod) induced_21\VBN\1627355 (r_amod) bradycardia_22\NN\14110674
12617329
D014508_D007674 NONE urea_10\NN\14727670 (r_conj) creatinine_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) concentrations_6\NNS\4916342 (r_dobj) measuring_4\VBG\407535 (r_pcomp) by_3\IN\0 (r_prep) assessed_2\VBN\670261 (l_nsubjpass) nephrotoxicity_0\NN\0
D006170_D007674 NONE arabic_6\JJ\6986894 (r_pobj) with_4\IN\0 (r_prep) treatment_3\NN\654885 (l_prep) on_7\IN\0 (l_pobj) nephrotoxicity_9\NN\0
D006170_D007674 NONE arabic_14\JJ\6986894 (r_pobj) with_12\IN\0 (r_prep) rats_11\NNS\2329401 (r_pobj) of_10\IN\0 (r_prep) treatment_9\NN\654885 (l_prep) on_15\IN\0 (l_pobj) failure_18\NN\66216 (l_acl) induced_19\VBN\1627355 (l_agent) by_20\IN\0 (l_pobj) nephrotoxicity_25\NN\0
D006170_D007674 NONE arabic_6\JJ\6986894 (r_amod) treatment_7\NN\654885 (r_nsubj) induced_9\VBN\1627355 (l_dobj) amelioration_12\NN\248977 (l_prep) of_13\IN\0 (l_pobj) some_14\DT\0 (l_prep) of_15\IN\0 (l_pobj) indices_20\NNS\13850304 (l_prep) of_21\IN\0 (l_pobj) nephrotoxicity_23\NN\0
D005839_D007683 NONE gm_1\NNP\13717155 (r_npadvmod) induced_3\VBN\1627355 (r_amod) necrosis_6\NN\11444117
D005839_D007683 NONE gm_16\NNP\13717155 (r_dobj) given_15\VBN\5892096 (r_acl) rats_14\NNS\2329401 (r_pobj) in_13\IN\13603305 (r_prep) severe_12\JJ\0 (r_acomp) be_9\VB\14625458 (r_xcomp) appeared_7\VBD\2604760 (l_nsubj) necrosis_6\NN\11444117
D005839_D007683 NONE gm_25\NNP\13717155 (r_pobj) given_24\VBN\5892096 (r_acl) those_23\DT\0 (r_pobj) in_22\IN\13603305 (r_prep) than_21\IN\0 (r_prep) given_15\VBN\5892096 (r_acl) rats_14\NNS\2329401 (r_pobj) in_13\IN\13603305 (r_prep) severe_12\JJ\0 (r_acomp) be_9\VB\14625458 (r_xcomp) appeared_7\VBD\2604760 (l_nsubj) necrosis_6\NN\11444117
D005839_D007674 NONE gentamicin_8\NN\2716866 (r_amod) nephrotoxicity_9\NN\0
D005839_D007674 NONE gentamicin_21\NN\2716866 (r_nmod) nephrotoxicity_25\NN\0
D005839_D007674 NONE gm_23\NNP\13717155 (r_nmod) nephrotoxicity_25\NN\0
D005839_D007674 NONE gm_22\NNP\13717155 (r_compound) nephrotoxicity_23\NN\0
D006170_D058186 CID arabic_14\JJ\6986894 (r_pobj) with_12\IN\0 (r_prep) rats_11\NNS\2329401 (r_pobj) of_10\IN\0 (r_prep) treatment_9\NN\654885 (l_prep) on_15\IN\0 (l_pobj) failure_18\NN\66216
D005839_D058186 CID gentamicin_21\NN\2716866 (r_nmod) nephrotoxicity_25\NN\0 (r_pobj) by_20\IN\0 (r_agent) induced_19\VBN\1627355 (r_acl) failure_18\NN\66216
D005839_D058186 CID gm_23\NNP\13717155 (r_nmod) nephrotoxicity_25\NN\0 (r_pobj) by_20\IN\0 (r_agent) induced_19\VBN\1627355 (r_acl) failure_18\NN\66216
D006170_D007683 NONE arabic_20\JJ\6986894 (r_pobj) with_18\IN\0 (r_prep) given_15\VBN\5892096 (r_acl) rats_14\NNS\2329401 (r_pobj) in_13\IN\13603305 (r_prep) severe_12\JJ\0 (r_acomp) be_9\VB\14625458 (r_xcomp) appeared_7\VBD\2604760 (l_nsubj) necrosis_6\NN\11444117
D003404_D007674 NONE creatinine_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) concentrations_6\NNS\4916342 (r_dobj) measuring_4\VBG\407535 (r_pcomp) by_3\IN\0 (r_prep) assessed_2\VBN\670261 (l_nsubjpass) nephrotoxicity_0\NN\0
D005978_D007674 NONE glutathione_16\NN\0 (r_conj) measuring_4\VBG\407535 (r_pcomp) by_3\IN\0 (r_prep) assessed_2\VBN\670261 (l_nsubjpass) nephrotoxicity_0\NN\0
D005978_D007674 NONE gsh_18\NNP\0 (r_appos) glutathione_16\NN\0 (r_conj) measuring_4\VBG\407535 (r_pcomp) by_3\IN\0 (r_prep) assessed_2\VBN\670261 (l_nsubjpass) nephrotoxicity_0\NN\0
6466532
D006024_D001919 NONE glycopyrrolate_3\NN\0 (l_prep) in_6\IN\13603305 (l_pobj) prevention_8\NN\1073995 (l_prep) of_9\IN\0 (l_pobj) bradycardia_10\NN\14110674
D006024_D001919 NONE glycopyrrolate_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_pobj) of_2\IN\0 (r_prep) effectiveness_1\NN\5190804 (l_acl) prevent_27\VB\0 (l_dobj) arrhythmia_28\NN\14103288 (l_conj) bradycardia_30\NNP\14110674
D001285_D001919 NONE atropine_5\NN\14712692 (r_conj) glycopyrrolate_3\NN\0 (l_prep) in_6\IN\13603305 (l_pobj) prevention_8\NN\1073995 (l_prep) of_9\IN\0 (l_pobj) bradycardia_10\NN\14110674
D001285_D001919 NONE atropine_12\NN\14712692 (r_conj) kg-1_10\NNS\0 (r_dobj) glycopyrrolate_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_pobj) of_2\IN\0 (r_prep) effectiveness_1\NN\5190804 (l_acl) prevent_27\VB\0 (l_dobj) arrhythmia_28\NN\14103288 (l_conj) bradycardia_30\NNP\14110674
D013390_D001145 NONE suxamethonium_17\NN\0 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_pobj) following_13\VBG\8180190 (r_prep) bradycardia_10\NN\14110674 (l_conj) arrhythmias_12\NNS\14103288
D013390_D001145 NONE suxamethonium_35\NN\0 (r_pobj) of_34\IN\0 (r_prep) doses_33\NNS\3740161 (r_pobj) following_31\VBG\8180190 (r_prep) prevent_27\VB\0 (l_dobj) arrhythmia_28\NN\14103288
D013390_D001919 CID suxamethonium_17\NN\0 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_pobj) following_13\VBG\8180190 (r_prep) bradycardia_10\NN\14110674
D013390_D001919 CID suxamethonium_35\NN\0 (r_pobj) of_34\IN\0 (r_prep) doses_33\NNS\3740161 (r_pobj) following_31\VBG\8180190 (r_prep) prevent_27\VB\0 (l_dobj) arrhythmia_28\NN\14103288 (l_conj) bradycardia_30\NNP\14110674
D001285_D001145 NONE atropine_5\NN\14712692 (r_conj) glycopyrrolate_3\NN\0 (l_prep) in_6\IN\13603305 (l_pobj) prevention_8\NN\1073995 (l_prep) of_9\IN\0 (l_pobj) bradycardia_10\NN\14110674 (l_conj) arrhythmias_12\NNS\14103288
D001285_D001145 NONE atropine_12\NN\14712692 (r_conj) kg-1_10\NNS\0 (r_dobj) glycopyrrolate_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_pobj) of_2\IN\0 (r_prep) effectiveness_1\NN\5190804 (l_acl) prevent_27\VB\0 (l_dobj) arrhythmia_28\NN\14103288
D006024_D001145 NONE glycopyrrolate_3\NN\0 (l_prep) in_6\IN\13603305 (l_pobj) prevention_8\NN\1073995 (l_prep) of_9\IN\0 (l_pobj) bradycardia_10\NN\14110674 (l_conj) arrhythmias_12\NNS\14103288
D006024_D001145 NONE glycopyrrolate_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_pobj) of_2\IN\0 (r_prep) effectiveness_1\NN\5190804 (l_acl) prevent_27\VB\0 (l_dobj) arrhythmia_28\NN\14103288
9199746
D014640_D013290 NONE vancomycin_14\NNP\2716866 (l_prep) for_15\IN\0 (l_pobj) endophthalmitis_20\NN\0
D000583_D064420 NONE amikacin_4\RB\0 (l_nsubj) toxicity_1\NN\13576101
D000617_D009877 NONE aminoglycosides_2\NNS\0 (r_nsubj) improved_5\VBN\126264 (l_dobj) prognosis_7\NN\6748969 (l_prep) in_8\IN\13603305 (l_pobj) endophthalmitis_9\NN\0
D019793_D013684 NONE fluorescein_1\NN\14598383 (r_amod) angiography_2\NN\904623 (r_nsubj) confirmed_3\VBD\0 (l_dobj) closure_6\NN\280853 (l_conj) telangiectasis_8\NN\0
D000583_D013290 NONE amikacin_6\JJ\0 (r_prep) presumed_5\VBN\719734 (l_prep) following_9\VBG\8180190 (l_pobj) treatment_10\NN\654885 (l_prep) with_11\IN\0 (l_pobj) amikacin_12\JJ\0 (l_conj) vancomycin_14\NNP\2716866 (l_prep) for_15\IN\0 (l_pobj) endophthalmitis_20\NN\0
D000583_D013290 NONE amikacin_12\JJ\0 (l_conj) vancomycin_14\NNP\2716866 (l_prep) for_15\IN\0 (l_pobj) endophthalmitis_20\NN\0
D000617_D007238 NONE aminoglycosides_2\NNS\0 (r_nsubj) improved_5\VBN\126264 (r_advcl) impair_14\VB\258857 (l_nsubj) infarction_12\NN\14204950
D000583_D012164 CID amikacin_6\JJ\0 (l_pobj) toxicity_8\NN\13576101
D000583_D012164 CID amikacin_12\JJ\0 (r_pobj) with_11\IN\0 (r_prep) treatment_10\NN\654885 (r_pobj) following_9\VBG\8180190 (r_prep) presumed_5\VBN\719734 (l_prep) amikacin_6\JJ\0 (l_pobj) toxicity_8\NN\13576101
D014640_D012164 NONE vancomycin_14\NNP\2716866 (r_conj) amikacin_12\JJ\0 (r_pobj) with_11\IN\0 (r_prep) treatment_10\NN\654885 (r_pobj) following_9\VBG\8180190 (r_prep) presumed_5\VBN\719734 (l_prep) amikacin_6\JJ\0 (l_pobj) toxicity_8\NN\13576101
17175308
D020123_D007674 NONE srl_13\NNP\0 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (l_prep) due_18\IN\5174653 (l_pobj) nephropathy_22\NN\14573196 (l_advmod) can_24\VB\3094503
D020123_D011507 CID sirolimus_4\VB\0 (r_pobj) to_3\TO\0 (r_prep) conversion_2\NN\7359599 (r_pobj) after_1\IN\0 (r_prep) proteinuria_0\NNP\14299637
D020123_D011507 CID sirolimus_11\NN\0 (r_compound) therapy_12\NN\657604 (r_pobj) of_10\IN\0 (r_prep) consequence_9\NN\34213 (r_pobj) as_7\IN\14622893 (r_prep) reported_6\VBN\831651 (l_nsubjpass) proteinuria_3\NN\14299637
D020123_D011507 CID srl_18\NN\0 (r_compound) conversion_19\NN\7359599 (r_pobj) after_17\IN\0 (r_prep) displayed_14\VBD\2137132 (l_dobj) proteinuria_16\NN\14299637
D020123_D011507 CID srl_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) use_6\NN\407535 (r_pobj) after_4\IN\0 (r_prep) was_2\VBD\0 (l_nsubj) proteinuria_1\NN\14299637
D020123_D051436 NONE srl_13\NNP\0 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (l_prep) due_18\IN\5174653 (l_pobj) nephropathy_22\NN\14573196
3750012
D010396_D001172 NONE penicillamine_4\NN\3740161 (l_conj) therapy_7\NN\657604 (l_prep) for_8\IN\0 (l_pobj) arthritis_10\NN\14171682
D010396_D001172 NONE penicillamine_16\NN\3740161 (l_conj) therapy_19\NN\657604 (l_prep) for_20\IN\0 (l_pobj) arthritis_22\NN\14171682
D002738_D001172 NONE chloroquine_6\NN\2721948 (r_amod) therapy_7\NN\657604 (l_prep) for_8\IN\0 (l_pobj) arthritis_10\NN\14171682
D002738_D001172 NONE chloroquine_18\NN\2721948 (r_compound) therapy_19\NN\657604 (l_prep) for_20\IN\0 (l_pobj) arthritis_22\NN\14171682
D002738_D009157 CID chloroquine_6\NN\2721948 (r_amod) therapy_7\NN\657604 (r_conj) penicillamine_4\NN\3740161 (r_pobj) by_3\IN\0 (r_agent) caused_2\VBN\1617192 (r_acl) gravis_1\NN\0
D002738_D009157 CID chloroquine_18\NN\2721948 (r_compound) therapy_19\NN\657604 (r_conj) penicillamine_16\NN\3740161 (r_pobj) after_15\IN\0 (r_prep) had_7\VBD\0 (l_dobj) gravis_14\NN\0
D010396_D009157 CID penicillamine_4\NN\3740161 (r_pobj) by_3\IN\0 (r_agent) caused_2\VBN\1617192 (r_acl) gravis_1\NN\0
D010396_D009157 CID penicillamine_16\NN\3740161 (r_pobj) after_15\IN\0 (r_prep) had_7\VBD\0 (l_dobj) gravis_14\NN\0
18186898
D019259_D009135 CID lamivudine_24\NN\3834836 (r_pobj) by_23\IN\0 (r_agent) augmented_22\VBN\153263 (r_conj) triggered_18\VBN\1641914 (r_relcl) dysfunction_15\NN\14204950 (r_pobj) from_13\IN\0 (r_prep) resulted_12\VBN\2633881 (l_nsubj) dysfunction_7\NN\14204950 (l_conj) myopathy_9\NNS\14204950
D016559_D000138 NONE tacrolimus_1\NN\0 (r_nsubjpass) suspected_3\VBN\916909 (l_xcomp) be_5\VB\14625458 (l_attr) cause_7\NN\7323922 (l_prep) of_8\IN\0 (l_pobj) acidosis_14\NN\14204950
D016559_D000138 NONE tacrolimus_1\NN\0 (r_nsubjpass) suspected_3\VBN\916909 (l_conj) replaced_17\VBN\1631072 (l_agent) by_18\IN\0 (l_pobj) sirolimus_19\NN\0 (l_conj) acidosis_21\NN\14204950
D020123_D000138 NONE sirolimus_19\NN\0 (r_pobj) by_18\IN\0 (r_agent) replaced_17\VBN\1631072 (r_conj) suspected_3\VBN\916909 (l_xcomp) be_5\VB\14625458 (l_attr) cause_7\NN\7323922 (l_prep) of_8\IN\0 (l_pobj) acidosis_14\NN\14204950
D020123_D000138 NONE sirolimus_19\NN\0 (l_conj) acidosis_21\NN\14204950
D019259_D005198 CID lamivudine_24\NN\3834836 (r_pobj) by_23\IN\0 (r_agent) augmented_22\VBN\153263 (r_conj) triggered_18\VBN\1641914 (r_relcl) dysfunction_15\NN\14204950 (r_pobj) from_13\IN\0 (r_prep) resulted_12\VBN\2633881 (l_nsubj) dysfunction_7\NN\14204950
D016559_D009135 CID tacrolimus_20\NN\0 (r_pobj) by_19\IN\0 (r_agent) triggered_18\VBN\1641914 (r_relcl) dysfunction_15\NN\14204950 (r_pobj) from_13\IN\0 (r_prep) resulted_12\VBN\2633881 (l_nsubj) dysfunction_7\NN\14204950 (l_conj) myopathy_9\NNS\14204950
D019259_D028361 NONE lamivudine_24\NN\3834836 (r_pobj) by_23\IN\0 (r_agent) augmented_22\VBN\153263 (r_conj) triggered_18\VBN\1641914 (r_relcl) dysfunction_15\NN\14204950
D016559_D028361 NONE tacrolimus_20\NN\0 (r_pobj) by_19\IN\0 (r_agent) triggered_18\VBN\1641914 (r_relcl) dysfunction_15\NN\14204950
D016559_D005198 CID tacrolimus_20\NN\0 (r_pobj) by_19\IN\0 (r_agent) triggered_18\VBN\1641914 (r_relcl) dysfunction_15\NN\14204950 (r_pobj) from_13\IN\0 (r_prep) resulted_12\VBN\2633881 (l_nsubj) dysfunction_7\NN\14204950
D019259_D006509 NONE lamivudine_0\NNP\3834836 (r_nsubjpass) added_2\VBN\156601 (l_prep) because_3\IN\0 (l_pobj) infection_9\NN\14052046
12084448
D007069_D009207 CID ifosfamide_27\NN\0 (r_pobj) of_26\IN\0 (r_prep) infusion_25\NN\14589223 (r_pobj) after_23\IN\0 (r_prep) disabling_14\VBG\126264 (l_dobj) myoclonus_16\NN\14360459
D007069_D009207 CID ifosfamide_12\JJ\0 (r_pobj) of_11\IN\0 (r_prep) infusion_10\NN\14589223 (r_pobj) during_9\IN\0 (r_prep) presence_6\NN\13954253 (r_nsubj) suggest_31\VBP\1010118 (l_ccomp) associated_36\VBN\628491 (l_nsubjpass) myoclonus_34\NN\14360459
D007069_D009207 CID ifx_41\NNP\0 (r_pobj) of_40\IN\0 (r_prep) use_39\NN\407535 (r_pobj) with_37\IN\0 (r_prep) associated_36\VBN\628491 (l_nsubjpass) myoclonus_34\NN\14360459
D007069_D001927 CID ifosfamide_0\NNP\0 (r_compound) encephalopathy_1\NN\14084880
D007069_D010954 NONE ifosfamide_27\NN\0 (r_pobj) of_26\IN\0 (r_prep) infusion_25\NN\14589223 (l_prep) for_28\IN\0 (l_pobj) plasmacytoma_29\NN\14235200
D007069_D020820 NONE ifosfamide_0\NNP\0 (r_compound) encephalopathy_1\NN\14084880 (l_acl) presenting_2\VBG\2137132 (l_prep) with_3\IN\0 (l_pobj) asterixis_4\NNS\0
D007069_D020820 NONE ifosfamide_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubjpass) discontinued_5\VBN\0 (l_conj) resolved_12\VBD\352826 (l_nsubj) asterixis_11\NNS\0
D007069_D020820 NONE ifosfamide_12\JJ\0 (r_pobj) of_11\IN\0 (r_prep) infusion_10\NN\14589223 (r_pobj) during_9\IN\0 (r_prep) presence_6\NN\13954253 (l_prep) of_7\IN\0 (l_pobj) asterixis_8\NNS\0
D007069_D020820 NONE ifx_41\NNP\0 (r_pobj) of_40\IN\0 (r_prep) use_39\NN\407535 (r_pobj) with_37\IN\0 (r_prep) associated_36\VBN\628491 (r_ccomp) suggest_31\VBP\1010118 (l_nsubj) presence_6\NN\13954253 (l_prep) of_7\IN\0 (l_pobj) asterixis_8\NNS\0
15458908
D020849_D005705 NONE raloxifene_0\NNP\0 (r_nsubj) increase_3\VB\13576355 (l_dep) disease_20\NN\14061805
D020849_D005705 NONE raloxifene_0\NNP\0 (r_nsubjpass) associated_2\VBN\628491 (l_conj) was_13\VBD\0 (l_attr) risk_16\NN\14541044 (l_prep) for_17\IN\0 (l_pobj) cataracts_18\NNS\14252864 (l_conj) disease_21\NN\14061805
D020849_D054556 CID raloxifene_11\NN\0 (r_nsubjpass) associated_13\VBN\628491 (l_prep) with_14\IN\0 (l_pobj) risk_17\NN\14541044 (l_prep) for_18\IN\0 (l_pobj) thromboembolism_20\NN\14100769
D020849_D054556 CID raloxifene_0\NNP\0 (r_nsubjpass) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) risk_6\NN\14541044 (l_prep) for_7\IN\0 (l_pobj) thromboembolism_9\NN\14100769
D020849_D004714 NONE raloxifene_0\NNP\0 (r_nsubj) increase_3\VB\13576355 (l_dep) disease_20\NN\14061805 (l_appos) ci_27\NNP\13635336 (l_appos) hyperplasia_34\NN\14365950
D020849_D004714 NONE raloxifene_0\NNP\0 (r_nsubjpass) associated_2\VBN\628491 (l_conj) was_13\VBD\0 (l_attr) risk_16\NN\14541044 (l_prep) for_17\IN\0 (l_pobj) cataracts_18\NNS\14252864 (l_conj) disease_21\NN\14061805 (l_conj) hyperplasia_24\NN\14365950
D020849_D002386 NONE raloxifene_0\NNP\0 (r_nsubj) increase_3\VB\13576355 (l_dobj) risk_4\NN\14541044 (l_prep) for_5\IN\0 (l_pobj) cataracts_6\NNS\14252864
D020849_D002386 NONE raloxifene_0\NNP\0 (r_nsubjpass) associated_2\VBN\628491 (l_conj) was_13\VBD\0 (l_attr) risk_16\NN\14541044 (l_prep) for_17\IN\0 (l_pobj) cataracts_18\NNS\14252864
D020849_D010024 NONE raloxifene_4\NNP\0 (r_compound) evaluation_5\NNP\874067 (r_pobj) of_3\IN\0 (r_prep) outcomes_2\NNPS\7291312 (r_nsubj) enrolled_17\VBD\2471690 (l_prep) with_21\IN\0 (l_pobj) osteoporosis_22\NN\14204950
D020849_D016889 NONE raloxifene_0\NNP\0 (r_nsubj) increase_3\VB\13576355 (l_dep) disease_20\NN\14061805 (l_appos) ci_27\NNP\13635336 (l_appos) hyperplasia_34\NN\14365950 (l_appos) %_40\NN\0 (l_conj) cancer_49\NN\14239425
D020849_D016889 NONE raloxifene_0\NNP\0 (r_nsubjpass) associated_2\VBN\628491 (l_conj) was_13\VBD\0 (l_attr) risk_16\NN\14541044 (l_prep) for_17\IN\0 (l_pobj) cataracts_18\NNS\14252864 (l_conj) disease_21\NN\14061805 (l_conj) hyperplasia_24\NN\14365950 (l_conj) cancer_28\NN\14239425
17491223
D017256_D017202 NONE sestamibi_46\NNP\0 (r_nmod) emission_50\NN\44455 (r_dobj) using_43\VBG\418025 (r_conj) detecting_36\VBG\635012 (l_dobj) ischemia_41\NN\14195315
D004280_D017202 CID dobutamine_14\NN\0 (r_npadvmod) induced_16\VBN\1627355 (r_amod) ischemia_18\NN\14195315
D004280_D017202 CID dobutamine_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) ischemia_12\NN\14195315
D004280_D017202 CID dobutamine_37\NN\0 (r_npadvmod) induced_39\VBN\1627355 (r_amod) ischemia_41\NN\14195315
D017256_D007511 NONE sestamibi_46\NNP\0 (r_nmod) emission_50\NN\44455 (r_dobj) using_43\VBG\418025 (r_conj) detecting_36\VBG\635012 (r_pcomp) for_35\IN\0 (r_prep) assess_3\VB\5220461 (l_conj) computed_51\VBD\632627 (l_advcl) assess_60\VB\5220461 (l_dobj) presence_62\NN\13954253 (l_prep) of_65\IN\0 (l_pobj) ischemia_66\NN\14195315
D004280_D007511 NONE dobutamine_37\NN\0 (r_npadvmod) induced_39\VBN\1627355 (r_amod) ischemia_41\NN\14195315 (r_dobj) detecting_36\VBG\635012 (r_pcomp) for_35\IN\0 (r_prep) assess_3\VB\5220461 (l_conj) computed_51\VBD\632627 (l_advcl) assess_60\VB\5220461 (l_dobj) presence_62\NN\13954253 (l_prep) of_65\IN\0 (l_pobj) ischemia_66\NN\14195315
10091617
D012642_D010300 NONE selegiline_0\NNP\0 (r_advmod) induced_2\VBN\1627355 (l_dobj) hypotension_4\NN\14057371 (l_prep) in_5\IN\13603305 (l_pobj) disease_8\NN\14061805
D012642_D010300 NONE selegiline_30\NN\0 (r_dobj) receive_27\VB\2210855 (r_xcomp) randomized_25\VBN\278117 (r_acl) mortality_15\NN\5054863 (r_dobj) found_12\VBD\13279262 (l_nsubj) trial_11\NN\786195 (l_nmod) group_7\NNP\2137 (l_compound) disease_5\NNP\14061805
D012642_D010300 NONE selegiline_30\NN\0 (r_dobj) receive_27\VB\2210855 (r_xcomp) randomized_25\VBN\278117 (r_acl) mortality_15\NN\5054863 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) disease_21\NN\14061805
D012642_D010300 NONE selegiline_30\NN\0 (r_dobj) receive_27\VB\2210855 (r_xcomp) randomized_25\VBN\278117 (r_acl) mortality_15\NN\5054863 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) disease_21\NN\14061805 (l_appos) pd_23\NNP\14625458
D012642_D010300 NONE selegiline_17\RB\0 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (l_compound) pd_14\NNP\14625458
D012642_D010300 NONE selegiline_18\NN\0 (r_pobj) on_17\IN\0 (r_prep) marked_10\VBN\1296462 (l_prep) in_11\IN\13603305 (l_pobj) patients_16\NNS\9898892 (l_compound) pd_15\NNP\14625458
D007980_D007024 NONE dopa_11\NNP\14601829 (r_conj) therapy_5\NN\657604 (r_nsubjpass) associated_13\VBN\628491 (l_prep) with_14\IN\0 (l_pobj) hypotension_18\NN\14057371
D007980_D007024 NONE dopa_13\NNP\14601829 (r_pobj) with_10\IN\0 (r_prep) combination_9\NN\7951464 (r_pobj) in_8\IN\13603305 (r_prep) selegiline_7\NN\0 (r_nsubjpass) associated_15\VBN\628491 (l_prep) with_16\IN\0 (l_pobj) hypotension_19\NN\14057371
D012642_D007024 CID selegiline_0\NNP\0 (r_advmod) induced_2\VBN\1627355 (l_dobj) hypotension_4\NN\14057371
D012642_D007024 CID selegiline_7\NN\0 (r_pobj) with_6\IN\0 (r_prep) therapy_5\NN\657604 (r_nsubjpass) associated_13\VBN\628491 (l_prep) with_14\IN\0 (l_pobj) hypotension_18\NN\14057371
D012642_D007024 CID selegiline_25\NN\0 (r_pobj) of_24\IN\0 (r_prep) withdrawal_23\NN\7206096 (r_pobj) by_22\IN\0 (r_agent) abolished_21\VBN\0 (r_relcl) hypotension_18\NN\14057371
D012642_D007024 CID selegiline_29\NN\0 (r_dobj) stopping_28\VBG\3323703 (l_prep) in_30\IN\13603305 (l_pobj) expectation_32\NN\5941423 (l_acl) shed_36\VB\3859280 (l_prep) on_38\IN\0 (l_pobj) mechanisms_40\NNS\13446390 (l_relcl) causes_45\VBZ\7323922 (l_dobj) hypotension_47\NN\14057371
D012642_D007024 CID selegiline_18\NN\0 (r_pobj) on_17\IN\0 (r_prep) marked_10\VBN\1296462 (r_relcl) hypotension_7\NN\14057371
D012642_D007024 CID selegiline_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) withdrawal_7\NN\7206096 (r_pobj) after_6\IN\0 (r_prep) ameliorated_3\VBN\126264 (l_nsubjpass) hypotension_1\NN\14057371
D012642_D007024 CID selegiline_1\NN\0 (r_dobj) stopping_0\VBG\3323703 (r_csubj) reduced_4\VBD\441445 (l_dobj) pressures_11\NNS\11419404
D012642_D007024 CID selegiline_7\NN\0 (r_nsubjpass) associated_15\VBN\628491 (l_prep) with_16\IN\0 (l_pobj) hypotension_19\NN\14057371
D007980_D010300 NONE dopa_36\NN\14601829 (r_nsubj) compared_37\VBN\644583 (r_conj) found_12\VBD\13279262 (l_nsubj) trial_11\NN\786195 (l_nmod) group_7\NNP\2137 (l_compound) disease_5\NNP\14061805
D007980_D010300 NONE dopa_36\NN\14601829 (r_nsubj) compared_37\VBN\644583 (r_conj) found_12\VBD\13279262 (l_dobj) mortality_15\NN\5054863 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) disease_21\NN\14061805
D007980_D010300 NONE dopa_36\NN\14601829 (r_nsubj) compared_37\VBN\644583 (r_conj) found_12\VBD\13279262 (l_dobj) mortality_15\NN\5054863 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) disease_21\NN\14061805 (l_appos) pd_23\NNP\14625458
D007980_D010300 NONE dopa_43\NN\14601829 (r_dobj) taking_40\VBG\37396 (r_acl) those_39\DT\0 (r_pobj) with_38\IN\0 (r_prep) compared_37\VBN\644583 (r_conj) found_12\VBD\13279262 (l_nsubj) trial_11\NN\786195 (l_nmod) group_7\NNP\2137 (l_compound) disease_5\NNP\14061805
D007980_D010300 NONE dopa_43\NN\14601829 (r_dobj) taking_40\VBG\37396 (r_acl) those_39\DT\0 (r_pobj) with_38\IN\0 (r_prep) compared_37\VBN\644583 (r_conj) found_12\VBD\13279262 (l_dobj) mortality_15\NN\5054863 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) disease_21\NN\14061805
D007980_D010300 NONE dopa_43\NN\14601829 (r_dobj) taking_40\VBG\37396 (r_acl) those_39\DT\0 (r_pobj) with_38\IN\0 (r_prep) compared_37\VBN\644583 (r_conj) found_12\VBD\13279262 (l_dobj) mortality_15\NN\5054863 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) disease_21\NN\14061805 (l_appos) pd_23\NNP\14625458
2951327
D005996_D007022 CID nitroglycerin_103\NN\15015501 (r_conj) hydralazine_101\NN\2721160 (r_pobj) by_100\IN\0 (r_agent) induced_99\VBN\1627355 (r_acl) hypotension_98\NN\14057371
D009638_D007022 NONE norepinephrine_76\NN\14807929 (r_amod) rate_78\NN\13815152 (r_pobj) of_74\IN\0 (r_prep) augmentation_73\NN\7356676 (r_conj) tachycardia_70\NN\14110674 (r_conj) +/-_45\NN\0 (r_appos) was_29\VBD\0 (l_conj) observed_90\VBN\2163746 (l_advcl) is_93\VBZ\0 (l_prep) in_94\IN\13603305 (l_pobj) contrast_95\NN\13854649 (l_prep) to_96\IN\0 (l_pobj) hypotension_98\NN\14057371
D005996_D013610 NONE nitroglycerin_103\NN\15015501 (r_conj) hydralazine_101\NN\2721160 (r_pobj) by_100\IN\0 (r_agent) induced_99\VBN\1627355 (r_acl) hypotension_98\NN\14057371 (r_pobj) to_96\IN\0 (r_prep) contrast_95\NN\13854649 (r_pobj) in_94\IN\13603305 (r_prep) is_93\VBZ\0 (r_advcl) observed_90\VBN\2163746 (r_conj) was_29\VBD\0 (l_appos) +/-_45\NN\0 (l_conj) tachycardia_70\NN\14110674
D006830_D013610 NONE hydralazine_101\NN\2721160 (r_pobj) by_100\IN\0 (r_agent) induced_99\VBN\1627355 (r_acl) hypotension_98\NN\14057371 (r_pobj) to_96\IN\0 (r_prep) contrast_95\NN\13854649 (r_pobj) in_94\IN\13603305 (r_prep) is_93\VBZ\0 (r_advcl) observed_90\VBN\2163746 (r_conj) was_29\VBD\0 (l_appos) +/-_45\NN\0 (l_conj) tachycardia_70\NN\14110674
D009638_D013610 NONE norepinephrine_76\NN\14807929 (r_amod) rate_78\NN\13815152 (r_pobj) of_74\IN\0 (r_prep) augmentation_73\NN\7356676 (r_conj) tachycardia_70\NN\14110674
D006830_D007022 CID hydralazine_101\NN\2721160 (r_pobj) by_100\IN\0 (r_agent) induced_99\VBN\1627355 (r_acl) hypotension_98\NN\14057371
19657887
D000431_D004417 CID alcohol_9\NN\7881800 (r_pobj) of_8\IN\0 (r_prep) ingestion_7\NN\13440063 (r_pobj) after_5\IN\0 (r_prep) hour_4\NN\15154774 (r_pobj) in_0\IN\13603305 (r_prep) developed_12\VBD\1753788 (l_dobj) malaise_13\NN\14446652 (l_prep) with_14\IN\0 (l_pobj) flushing_15\NN\281101 (l_prep) of_16\IN\0 (l_pobj) face_18\NN\5225090 (l_conj) tachycardia_20\NN\14110674 (l_conj) dyspnea_23\NN\14299637
D000431_D013610 CID alcohol_9\NN\7881800 (r_pobj) of_8\IN\0 (r_prep) ingestion_7\NN\13440063 (r_pobj) after_5\IN\0 (r_prep) hour_4\NN\15154774 (r_pobj) in_0\IN\13603305 (r_prep) developed_12\VBD\1753788 (l_dobj) malaise_13\NN\14446652 (l_prep) with_14\IN\0 (l_pobj) flushing_15\NN\281101 (l_prep) of_16\IN\0 (l_pobj) face_18\NN\5225090 (l_conj) tachycardia_20\NN\14110674
D000431_D005483 CID alcohol_9\NN\7881800 (r_pobj) of_8\IN\0 (r_prep) ingestion_7\NN\13440063 (r_pobj) after_5\IN\0 (r_prep) hour_4\NN\15154774 (r_pobj) in_0\IN\13603305 (r_prep) developed_12\VBD\1753788 (l_dobj) malaise_13\NN\14446652 (l_prep) with_14\IN\0 (l_pobj) flushing_15\NN\281101 (l_prep) of_16\IN\0 (l_pobj) face_18\NN\5225090
D004221_D013610 NONE disulfiram_7\NN\3740161 (r_npadvmod) like_9\JJ\5839024 (r_amod) syndrome_10\NN\5870365 (l_prep) with_11\IN\0 (l_pcomp) flushing_12\NN\281101 (l_conj) tachycardia_14\NN\14110674
D004221_D005483 NONE disulfiram_7\NN\3740161 (r_npadvmod) like_9\JJ\5839024 (r_amod) syndrome_10\NN\5870365 (l_prep) with_11\IN\0 (l_pcomp) flushing_12\NN\281101
D004221_D007022 NONE disulfiram_7\NN\3740161 (r_npadvmod) like_9\JJ\5839024 (r_amod) syndrome_10\NN\5870365 (l_prep) with_11\IN\0 (l_pcomp) flushing_12\NN\281101 (l_conj) tachycardia_14\NN\14110674 (l_conj) hypotension_18\NN\14057371
2071257
D012601_D000647 NONE scopolamine_13\NN\14712692 (r_pobj) by_12\IN\0 (r_agent) caused_11\VBN\1617192 (r_acl) amnesia_10\NN\5669934
D005997_D008569 NONE glycerylphosphorylcholine_15\NN\0 (r_pobj) of_10\IN\0 (r_prep) effects_9\NNS\13245626 (l_prep) on_23\IN\0 (l_pobj) impairment_25\NN\7296428
D005997_D008569 NONE gfc_21\NNP\0 (r_appos) glycerylphosphorylcholine_15\NN\0 (r_pobj) of_10\IN\0 (r_prep) effects_9\NNS\13245626 (l_prep) on_23\IN\0 (l_pobj) impairment_25\NN\7296428
D012601_D008569 CID scopolamine_28\NN\14712692 (r_pobj) by_27\IN\0 (r_agent) induced_26\VBN\1627355 (r_acl) impairment_25\NN\7296428
D012601_D008569 CID scopolamine_20\NN\14712692 (r_pobj) by_19\IN\0 (r_agent) induced_18\VBN\1627355 (r_acl) impairment_13\NN\7296428 (l_prep) of_14\IN\0 (l_pobj) attention_15\NN\5701944 (l_conj) memory_17\NN\5926676
D005997_D000647 NONE phosphorylcholine_8\NN\0 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (l_prep) on_9\IN\0 (l_pobj) amnesia_10\NN\5669934
2375138
D008874_D006323 CID midazolam_2\RB\2830852 (r_npadvmod) associated_4\VBN\628491 (r_amod) arrest_6\NN\88481
D008874_D006323 CID midazolam_17\NN\2830852 (r_pobj) of_16\IN\0 (r_prep) administration_15\NN\1133281 (r_pobj) with_13\IN\0 (r_prep) associated_12\VBN\628491 (r_acl) case_6\NN\7283608 (l_prep) of_7\IN\0 (l_pobj) arrest_9\NN\88481
D008874_D003643 NONE midazolam_2\RB\2830852 (r_npadvmod) associated_4\VBN\628491 (r_amod) arrest_6\NN\88481 (l_conj) death_8\NN\7296428
D008874_D003643 NONE midazolam_17\NN\2830852 (r_pobj) of_16\IN\0 (r_prep) administration_15\NN\1133281 (r_pobj) with_13\IN\0 (r_prep) associated_12\VBN\628491 (r_acl) case_6\NN\7283608 (l_prep) of_7\IN\0 (l_pobj) arrest_9\NN\88481 (l_conj) death_11\NN\7296428
1436384
C070935_D020258 NONE ly274614_13\NNP\0 (r_pobj) by_12\IN\0 (r_prep) rodents_11\NNS\1886756 (r_pobj) in_10\IN\13603305 (r_prep) neurons_9\NNS\5430628 (r_pobj) toward_6\IN\0 (r_prep) neurotoxicity_5\NN\0
C070935_D020258 NONE ly274614_23\NNP\0 (r_nsubj) is_24\VBZ\0 (r_conj) involves_18\VBZ\2676054 (l_nsubj) effect_8\NN\34213 (l_amod) neurotoxic_7\JJ\0
D000661_D020258 CID amphetamine_2\NN\3248958 (r_npadvmod) induced_4\VBN\1627355 (r_amod) neurotoxicity_5\NN\0
D000661_D020258 CID amphetamine_10\NN\3248958 (r_nmod) compounds_13\NNS\5869584 (r_pobj) of_9\IN\0 (r_prep) effect_8\NN\34213 (l_amod) neurotoxic_7\JJ\0
D000596_D020258 NONE acid_18\NN\14818238 (r_compound) antagonist_19\NN\7846 (r_appos) ly274614_13\NNP\0 (r_pobj) by_12\IN\0 (r_prep) rodents_11\NNS\1886756 (r_pobj) in_10\IN\13603305 (r_prep) neurons_9\NNS\5430628 (r_pobj) toward_6\IN\0 (r_prep) neurotoxicity_5\NN\0
D004298_D020258 NONE dopamine_8\NN\14807737 (r_compound) neurons_9\NNS\5430628 (r_pobj) toward_6\IN\0 (r_prep) neurotoxicity_5\NN\0
D004298_D020258 NONE dopamine_16\NN\14807737 (r_compound) neurons_17\NNS\5430628 (r_pobj) toward_14\IN\0 (r_prep) compounds_13\NNS\5869584 (r_pobj) of_9\IN\0 (r_prep) effect_8\NN\34213 (l_amod) neurotoxic_7\JJ\0
D016202_D020258 NONE nmda_19\NNP\0 (r_compound) receptors_20\NNS\5225602 (r_dobj) involves_18\VBZ\2676054 (l_nsubj) effect_8\NN\34213 (l_amod) neurotoxic_7\JJ\0
D016202_D020258 NONE nmda_26\NNP\0 (r_compound) antagonist_28\NN\7846 (r_attr) is_24\VBZ\0 (r_conj) involves_18\VBZ\2676054 (l_nsubj) effect_8\NN\34213 (l_amod) neurotoxic_7\JJ\0
12443032
D003042_D002637 CID cocaine_0\NN\3492717 (r_nsubj) related_1\VBN\628491 (l_dobj) pain_3\NN\14299637
D003042_D002637 CID cocaine_6\NN\3492717 (r_pobj) of_5\IN\0 (r_prep) tendency_4\NN\6193203 (l_acl) produce_8\VB\7555863 (l_dobj) pain_10\NN\14299637
D003042_D002637 CID cocaine_6\NN\3492717 (r_pobj) of_5\IN\0 (r_prep) tendency_4\NN\6193203 (r_nsubj) ought_11\MD\0 (l_xcomp) be_13\VB\14625458 (l_advcl) faced_22\VBN\2439281 (l_prep) with_23\IN\0 (l_pobj) victim_26\NN\9630641 (l_prep) of_27\IN\0 (l_pobj) pain_29\NN\14299637
D003042_D002637 CID cocaine_7\NN\3492717 (r_compound) use_8\NN\407535 (r_pobj) to_6\IN\0 (r_prep) related_5\VBN\628491 (r_acl) mechanism_1\NN\13446390 (l_prep) of_2\IN\0 (l_pobj) pain_4\NN\14299637
11135224
D017239_D002289 NONE paclitaxel_0\NNP\0 (l_conj) cisplatin_2\NN\0 (l_conj) chemotherapy_7\NN\661091 (l_prep) within_8\IN\0 (l_pobj) approach_12\NN\940842 (l_prep) in_13\IN\13603305 (l_pobj) carcinoma_18\NN\14239918
D017239_D002289 NONE paclitaxel_18\NN\0 (r_pobj) of_16\IN\0 (r_prep) toxicity_15\NN\13576101 (r_conj) rate_12\NN\13815152 (r_conj) feasibility_9\NN\5152150 (r_dobj) determine_7\VB\0 (l_xcomp) treat_26\VB\7570720 (l_dobj) nsclc_28\NN\0
D017239_D002289 NONE paclitaxel_30\NN\0 (r_pobj) of_29\IN\0 (r_prep) combination_28\NN\7951464 (r_pobj) with_26\IN\0 (r_prep) treated_25\VBN\2376958 (l_nsubjpass) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) nsclc_11\NNP\0
D017239_D002289 NONE paclitaxel_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) tolerated_11\VBN\802318 (l_conj) shows_13\VBZ\429048 (l_prep) in_16\IN\13603305 (l_pobj) nsclc_18\NNP\0
C056507_D064420 NONE gemcitabine_23\NN\0 (r_compound) combination_24\NN\7951464 (r_conj) paclitaxel_18\NN\0 (r_pobj) of_16\IN\0 (r_prep) toxicity_15\NN\13576101
D002945_D002289 NONE cisplatin_2\NN\0 (l_conj) chemotherapy_7\NN\661091 (l_prep) within_8\IN\0 (l_pobj) approach_12\NN\940842 (l_prep) in_13\IN\13603305 (l_pobj) carcinoma_18\NN\14239918
D002945_D002289 NONE cisplatin_0\NN\0 (r_npadvmod) based_2\VBN\0 (r_amod) combinations_4\NNS\7951464 (r_nsubj) improve_5\VBP\126264 (l_dobj) quality_6\NN\24264 (l_prep) in_11\IN\13603305 (l_pobj) carcinoma_16\NN\14239918
D002945_D002289 NONE cisplatin_0\NN\0 (r_npadvmod) based_2\VBN\0 (r_amod) combinations_4\NNS\7951464 (r_nsubj) improve_5\VBP\126264 (l_dobj) quality_6\NN\24264 (l_prep) in_11\IN\13603305 (l_pobj) carcinoma_16\NN\14239918 (l_appos) nsclc_18\NNP\0
D002945_D002289 NONE cisplatin_20\NN\0 (r_conj) paclitaxel_18\NN\0 (r_pobj) of_16\IN\0 (r_prep) toxicity_15\NN\13576101 (r_conj) rate_12\NN\13815152 (r_conj) feasibility_9\NN\5152150 (r_dobj) determine_7\VB\0 (l_xcomp) treat_26\VB\7570720 (l_dobj) nsclc_28\NN\0
D002945_D002289 NONE cisplatin_47\NN\0 (r_conj) treated_25\VBN\2376958 (l_nsubjpass) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) nsclc_11\NNP\0
D002945_D002289 NONE cisplatin_5\NN\0 (r_conj) paclitaxel_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubjpass) tolerated_11\VBN\802318 (l_conj) shows_13\VBZ\429048 (l_prep) in_16\IN\13603305 (l_pobj) nsclc_18\NNP\0
D017239_D064420 NONE paclitaxel_18\NN\0 (r_pobj) of_16\IN\0 (r_prep) toxicity_15\NN\13576101
D002945_D064420 NONE cisplatin_20\NN\0 (r_conj) paclitaxel_18\NN\0 (r_pobj) of_16\IN\0 (r_prep) toxicity_15\NN\13576101
C056507_D002289 NONE gemcitabine_5\NN\0 (r_compound) combination_6\NN\7951464 (r_compound) chemotherapy_7\NN\661091 (l_prep) within_8\IN\0 (l_pobj) approach_12\NN\940842 (l_prep) in_13\IN\13603305 (l_pobj) carcinoma_18\NN\14239918
C056507_D002289 NONE gemcitabine_23\NN\0 (r_compound) combination_24\NN\7951464 (r_conj) paclitaxel_18\NN\0 (r_pobj) of_16\IN\0 (r_prep) toxicity_15\NN\13576101 (r_conj) rate_12\NN\13815152 (r_conj) feasibility_9\NN\5152150 (r_dobj) determine_7\VB\0 (l_xcomp) treat_26\VB\7570720 (l_dobj) nsclc_28\NN\0
C056507_D002289 NONE gemcitabine_65\NN\0 (r_conj) treated_25\VBN\2376958 (l_nsubjpass) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) nsclc_11\NNP\0
C056507_D002289 NONE gemcitabine_8\NN\0 (r_conj) combination_1\NN\7951464 (r_nsubjpass) tolerated_11\VBN\802318 (l_conj) shows_13\VBZ\429048 (l_prep) in_16\IN\13603305 (l_pobj) nsclc_18\NNP\0
3403780
D000082_D017093 NONE paracetamol_0\NN\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) coma_3\NN\5678932 (l_appos) acidosis_6\NN\14204950 (l_conj) failure_11\NN\66216
D000082_D003128 NONE paracetamol_0\NN\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) coma_3\NN\5678932
D000082_D058186 CID paracetamol_13\JJ\0 (r_compound) ingestion_14\NN\13440063 (r_pobj) following_12\VBG\8180190 (r_prep) failure_8\NN\66216 (l_conj) failure_11\NN\66216
D000082_D058186 NONE paracetamol_0\NN\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) coma_3\NN\5678932 (l_appos) acidosis_6\NN\14204950 (l_conj) failure_11\NN\66216
D000082_D000138 CID paracetamol_0\NN\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) coma_3\NN\5678932 (l_appos) acidosis_6\NN\14204950
D000082_D000138 CID paracetamol_13\JJ\0 (r_compound) ingestion_14\NN\13440063 (r_pobj) following_12\VBG\8180190 (r_prep) failure_8\NN\66216 (r_nsubjpass) presented_16\VBN\2137132 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) acidosis_4\NN\14204950
D000082_D017114 CID paracetamol_13\JJ\0 (r_compound) ingestion_14\NN\13440063 (r_pobj) following_12\VBG\8180190 (r_prep) failure_8\NN\66216 (l_conj) failure_11\NN\66216
2632720
D006854_D006973 NONE cortisol_8\NN\14751417 (r_compound) levels_9\NNS\4916342 (r_nsubjpass) achieved_12\VBN\2524171 (l_conj) demonstrated_22\VBD\2137132 (l_dobj) hypertension_23\NN\14057371
D007654_D003480 NONE ketoconazole_16\JJ\0 (r_pobj) with_15\IN\0 (r_prep) basis_14\NN\13790712 (r_pobj) on_9\IN\0 (r_prep) treated_8\VBN\2376958 (l_nsubj) patients_3\NNS\9898892 (l_prep) with_4\IN\0 (l_pobj) syndrome_7\NN\5870365
D007654_D006973 CID ketoconazole_7\JJ\0 (r_compound) treatment_8\NN\654885 (r_pobj) of_5\IN\0 (r_prep) complication_4\NN\1073995 (r_pobj) as_2\IN\14622893 (r_prep) hypertension_1\NN\14057371
D007654_D006973 CID ketoconazole_16\JJ\0 (r_pobj) with_15\IN\0 (r_prep) basis_14\NN\13790712 (r_pobj) on_9\IN\0 (r_prep) treated_8\VBN\2376958 (l_advcl) developed_17\VBN\1753788 (l_dobj) hypertension_19\NN\14057371
D007654_D006973 CID ketoconazole_14\JJ\0 (r_compound) therapy_15\NN\657604 (r_dobj) following_13\VBG\8180190 (r_prep) achieved_12\VBN\2524171 (l_conj) demonstrated_22\VBD\2137132 (l_dobj) hypertension_23\NN\14057371
D007654_D006973 CID ketoconazole_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) doses_10\NNS\3740161 (r_pobj) with_8\IN\0 (r_prep) treatment_7\NN\654885 (r_nsubj) induce_14\VB\1627355 (l_dobj) blockade_16\NN\952963 (l_acl) leading_17\VBG\4339291 (l_prep) to_18\IN\0 (l_pobj) hypertension_22\NN\14057371
17042910
C065179_D006973 NONE atorvastatin_5\NN\3676175 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (l_prep) in_6\IN\13603305 (l_pobj) hypertension_10\NN\14057371
C065179_D006973 NONE atorvastatin_0\NNP\3676175 (r_nsubj) possesses_4\VBZ\8209687 (l_dobj) properties_6\NNS\32613 (l_relcl) reported_10\VBN\831651 (l_xcomp) improve_12\VB\126264 (l_prep) through_15\IN\0 (l_pobj) availability_17\NN\4718563 (l_prep) of_18\IN\0 (l_pobj) production_23\NN\30358 (l_prep) in_24\IN\13603305 (l_pobj) forms_26\NNS\6286395 (l_prep) of_27\IN\0 (l_pobj) hypertension_28\NN\14057371
C065179_D006973 NONE ato_2\NNP\0 (r_appos) atorvastatin_0\NNP\3676175 (r_nsubj) possesses_4\VBZ\8209687 (l_dobj) properties_6\NNS\32613 (l_relcl) reported_10\VBN\831651 (l_xcomp) improve_12\VB\126264 (l_prep) through_15\IN\0 (l_pobj) availability_17\NN\4718563 (l_prep) of_18\IN\0 (l_pobj) production_23\NN\30358 (l_prep) in_24\IN\13603305 (l_pobj) forms_26\NNS\6286395 (l_prep) of_27\IN\0 (l_pobj) hypertension_28\NN\14057371
D013481_D006973 NONE superoxide_19\NN\14971519 (r_advmod) increased_18\VBN\169651 (r_conj) characterized_5\VBN\609683 (l_nsubjpass) hypertension_3\NN\14057371
D013481_D006973 NONE o2-_21\NNPS\0 (r_nmod) production_23\NN\30358 (r_appos) dexamethasone_0\NNP\2721538 (l_parataxis) characterized_5\VBN\609683 (l_nsubjpass) hypertension_3\NN\14057371
D013481_D006973 NONE o2-_22\JJ\0 (r_compound) production_23\NN\30358 (l_prep) in_24\IN\13603305 (l_pobj) forms_26\NNS\6286395 (l_prep) of_27\IN\0 (l_pobj) hypertension_28\NN\14057371
D003907_D006973 CID dexamethasone_7\NN\2721538 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hypertension_10\NN\14057371
D003907_D006973 CID dexamethasone_0\NNP\2721538 (l_parataxis) characterized_5\VBN\609683 (l_nsubjpass) hypertension_3\NN\14057371
D003907_D006973 CID dex)-induced_2\JJ\0 (r_amod) hypertension_3\NN\14057371
D009569_D006973 NONE oxide_12\NN\14818238 (r_nmod) deficiency_16\NN\14449126 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) dysfunction_8\NN\14204950 (r_pobj) by_6\IN\0 (r_agent) characterized_5\VBN\609683 (l_nsubjpass) hypertension_3\NN\14057371
D009569_D006973 NONE no_14\NNP\7204911 (r_intj) deficiency_16\NN\14449126 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) dysfunction_8\NN\14204950 (r_pobj) by_6\IN\0 (r_agent) characterized_5\VBN\609683 (l_nsubjpass) hypertension_3\NN\14057371
D009569_D006973 NONE no_19\DT\7204911 (r_amod) production_23\NN\30358 (l_prep) in_24\IN\13603305 (l_pobj) forms_26\NNS\6286395 (l_prep) of_27\IN\0 (l_pobj) hypertension_28\NN\14057371
3780846
D006220_D009127 CID haloperidol_7\NN\3713736 (r_nsubjpass) used_14\VBN\0 (l_prep) in_15\IN\13603305 (l_pobj) order_16\NN\7168131 (l_acl) block_18\VB\21939 (l_conj) estimate_24\VB\5802185 (l_dobj) degree_27\NN\4916342 (l_prep) of_28\IN\0 (l_pobj) tolerance_30\NN\5032565 (l_prep) to_31\IN\0 (l_pobj) rigidity_33\NN\5023233
D006220_D009127 CID haloperidol_0\NNP\3713736 (r_nsubj) enhanced_1\VBD\227165 (l_dobj) rigidity_3\NN\5023233
D009020_D009127 CID morphine_14\NN\2707683 (r_pobj) by_13\IN\0 (r_agent) produced_12\VBN\1617192 (r_acl) rigidity_11\NN\5023233
D009020_D009127 CID morphine_10\NN\2707683 (r_pobj) by_9\IN\0 (r_agent) produced_8\VBN\1617192 (r_acl) rigidity_7\NN\5023233
D009020_D009127 CID morphine_9\NN\2707683 (r_pobj) of_8\IN\0 (r_prep) dose_7\NN\3740161 (r_dobj) given_4\VBN\5892096 (r_csubj) showed_15\VBD\2137132 (l_dobj) rigidity_18\NN\5023233
D009020_D009127 CID morphine_6\NN\2707683 (r_pobj) with_5\IN\0 (r_prep) treated_1\VBD\2376958 (l_conj) showed_27\VBD\2137132 (l_dobj) rigidity_29\NN\5023233
D009020_D009127 CID morphine_35\NN\2707683 (r_pobj) of_34\IN\0 (r_prep) dose_33\NN\3740161 (r_pobj) after_30\IN\0 (r_prep) showed_27\VBD\2137132 (l_dobj) rigidity_29\NN\5023233
D009020_D009127 CID morphine_16\NN\2707683 (r_pobj) of_15\IN\0 (r_prep) action_14\NN\30358 (r_pobj) to_12\IN\0 (r_prep) due_11\JJ\5174653 (r_acomp) be_10\VB\14625458 (r_xcomp) assumed_8\VBN\719734 (r_relcl) rigidity_4\NN\5023233
D009020_D018476 CID morphine_6\NN\2707683 (r_pobj) with_5\IN\0 (r_prep) treated_1\VBD\2376958 (l_conj) showed_27\VBD\2137132 (l_prep) after_30\IN\0 (l_pobj) dose_33\NN\3740161 (l_relcl) was_37\VBD\0 (l_conj) were_46\VBD\0 (l_acomp) akinetic_47\JJ\0
D009020_D018476 CID morphine_35\NN\2707683 (r_pobj) of_34\IN\0 (r_prep) dose_33\NN\3740161 (l_relcl) was_37\VBD\0 (l_conj) were_46\VBD\0 (l_acomp) akinetic_47\JJ\0
3693336
D014229_D003866 NONE triazolam_0\NNP\2830852 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) episodes_4\NNS\7283608 (l_prep) in_8\IN\13603305 (l_pobj) patient_11\NN\9898892 (l_amod) depressed_10\JJ\1819147
D014229_D003866 NONE triazolam_3\NN\2830852 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) induced_5\VBD\1627355 (l_dobj) episodes_7\NNS\7283608 (l_prep) in_10\IN\13603305 (l_pobj) woman_14\NN\9605289 (l_amod) depressed_12\JJ\1819147
D014229_D001714 CID triazolam_0\NNP\2830852 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) episodes_4\NNS\7283608 (l_prep) of_5\IN\0 (l_pobj) mania_7\NN\9180259
D014229_D001714 CID triazolam_3\NN\2830852 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) induced_5\VBD\1627355 (l_dobj) episodes_7\NNS\7283608 (l_prep) of_8\IN\0 (l_pobj) mania_9\NN\9180259
D014229_D001714 CID triazolam_10\NN\2830852 (r_pobj) of_9\IN\0 (r_prep) action_8\NN\30358 (r_pobj) of_7\IN\0 (r_prep) duration_6\NN\15113229 (r_pobj) with_4\IN\0 (r_prep) coincident_3\JJ\0 (r_acomp) was_2\VBD\0 (l_nsubj) excitement_1\NN\7527352 (l_amod) manic_0\JJ\0
12523465
C022189_D006212 CID zonisamide_4\NN\0 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) hallucinations_1\NNS\14376855
C022189_D006212 CID zonisamide_29\NN\0 (r_amod) treatment_30\NN\654885 (r_pobj) after_28\IN\0 (r_prep) altered_25\VBD\0 (r_conj) experienced_20\VBD\2108377 (r_relcl) patients_18\NNS\9898892 (r_dobj) describe_16\VBP\1001294 (l_advcl) reported_6\VBN\831651 (l_nsubjpass) hallucinations_2\NNS\14376855
C022189_D006212 CID zonisamide_29\NN\0 (r_amod) treatment_30\NN\654885 (r_pobj) after_28\IN\0 (r_prep) altered_25\VBD\0 (r_conj) experienced_20\VBD\2108377 (l_dobj) hallucinations_23\NNS\14376855
C022189_D012640 NONE zonisamide_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) drug_7\NN\14778436 (l_acl) used_8\VBN\0 (l_xcomp) treat_10\VB\7570720 (l_dobj) types_12\NNS\5839024 (l_prep) of_13\IN\0 (l_pobj) seizures_14\NNS\14081375
15649445
D012110_D004409 CID reserpine_1\NN\2721160 (r_nsubj) change_6\VBP\7283608 (l_conj) elicit_12\VBP\1617192 (l_dobj) dyskinesia_14\NN\14084880
D012110_D004409 CID reserpine-_0\NNP\0 (l_conj) dyskinesia_6\NN\14084880
D012110_D004409 CID reserpine-_0\NNP\0 (r_nsubj) are_7\VBP\13600404 (l_attr) models_10\NNS\5888929 (l_prep) of_11\IN\0 (l_pobj) dyskinesia_13\JJ\14084880
D012110_D004409 CID reserpine-_0\NNP\0 (r_nsubj) are_7\VBP\13600404 (l_attr) models_10\NNS\5888929 (l_prep) of_11\IN\0 (l_pobj) dyskinesia_13\JJ\14084880 (l_appos) td_15\NN\0
D012110_D004409 CID reserpine_12\NN\2721160 (r_pobj) by_10\IN\0 (r_prep) induced_7\VBD\1627355 (l_dobj) dyskinesia_9\NN\14084880
D018698_D004409 NONE glutamate_9\NN\15010703 (r_compound) uptake_10\NN\13440063 (r_dobj) change_6\VBP\7283608 (l_conj) elicit_12\VBP\1617192 (l_dobj) dyskinesia_14\NN\14084880
D018698_D004409 NONE glutamate_5\NN\15010703 (r_compound) uptake_6\NN\13440063 (r_pobj) in_4\IN\13603305 (r_prep) decrease_3\NN\7296428 (r_nsubj) correlates_7\VBZ\5857459 (l_prep) with_9\IN\0 (l_pobj) increase_11\NN\13576355 (l_prep) in_12\IN\13603305 (l_pobj) incidence_14\NN\13821570 (l_prep) of_15\IN\0 (l_pobj) diskinesia_17\NN\0
D006220_D004409 CID haloperidol_4\NN\3713736 (r_compound) change_6\VBP\7283608 (l_conj) elicit_12\VBP\1617192 (l_dobj) dyskinesia_14\NN\14084880
D006220_D004409 CID haloperidol_2\NN\3713736 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesia_6\NN\14084880
D006220_D004409 CID haloperidol_2\NN\3713736 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesia_6\NN\14084880 (r_conj) reserpine-_0\NNP\0 (r_nsubj) are_7\VBP\13600404 (l_attr) models_10\NNS\5888929 (l_prep) of_11\IN\0 (l_pobj) dyskinesia_13\JJ\14084880
D006220_D004409 CID haloperidol_2\NN\3713736 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesia_6\NN\14084880 (r_conj) reserpine-_0\NNP\0 (r_nsubj) are_7\VBP\13600404 (l_attr) models_10\NNS\5888929 (l_prep) of_11\IN\0 (l_pobj) dyskinesia_13\JJ\14084880 (l_appos) td_15\NN\0
D006220_D004409 CID haloperidol_15\NN\3713736 (r_compound) administration_16\NN\1133281 (r_conj) reserpine_12\NN\2721160 (r_pobj) by_10\IN\0 (r_prep) induced_7\VBD\1627355 (l_dobj) dyskinesia_9\NN\14084880
18631865
D020123_D051436 NONE rapamycin_16\NNS\0 (r_nmod) inhibitors_20\NNS\20090 (r_pobj) of_15\IN\0 (r_prep) target_14\NN\7258332 (r_pobj) to_12\IN\0 (r_prep) conversion_8\NN\7359599 (l_prep) in_25\IN\13603305 (l_pobj) recipients_28\NNS\9764201 (l_prep) with_29\IN\0 (l_pobj) nephropathy_32\NN\14573196
D020123_D051436 NONE sirolimus_23\NN\0 (r_appos) inhibitors_20\NNS\20090 (r_pobj) of_15\IN\0 (r_prep) target_14\NN\7258332 (r_pobj) to_12\IN\0 (r_prep) conversion_8\NN\7359599 (l_prep) in_25\IN\13603305 (l_pobj) recipients_28\NNS\9764201 (l_prep) with_29\IN\0 (l_pobj) nephropathy_32\NN\14573196
D020123_D011507 CID sirolimus_5\NN\0 (r_pobj) to_4\IN\0 (r_prep) due_3\JJ\5174653 (r_acomp) was_2\VBD\0 (l_nsubj) proteinuria_1\NN\14299637
D020123_D011507 CID sirolimus_5\NN\0 (r_pobj) to_4\IN\0 (r_prep) due_3\JJ\5174653 (r_acomp) was_2\VBD\0 (r_csubj) remained_14\VBD\2604760 (l_advcl) observed_22\VBN\2163746 (l_nsubjpass) proteinuria_19\NN\14299637
D020123_D011507 CID sirolimus_24\NN\0 (r_compound) therapy_25\NN\657604 (r_pobj) during_23\IN\0 (r_prep) observed_22\VBN\2163746 (r_advcl) remained_14\VBD\2604760 (l_csubj) was_2\VBD\0 (l_nsubj) proteinuria_1\NN\14299637
D020123_D011507 CID sirolimus_24\NN\0 (r_compound) therapy_25\NN\657604 (r_pobj) during_23\IN\0 (r_prep) observed_22\VBN\2163746 (l_nsubjpass) proteinuria_19\NN\14299637
D020123_D011507 CID sirolimus_34\NN\0 (r_nmod) novo_36\NNP\0 (r_dobj) received_33\VBD\2210855 (r_relcl) patients_31\NNS\9898892 (r_pobj) in_30\IN\13603305 (r_conj) in_26\IN\13603305 (r_prep) observed_22\VBN\2163746 (r_advcl) remained_14\VBD\2604760 (l_csubj) was_2\VBD\0 (l_nsubj) proteinuria_1\NN\14299637
D020123_D011507 CID sirolimus_34\NN\0 (r_nmod) novo_36\NNP\0 (r_dobj) received_33\VBD\2210855 (r_relcl) patients_31\NNS\9898892 (r_pobj) in_30\IN\13603305 (r_conj) in_26\IN\13603305 (r_prep) observed_22\VBN\2163746 (l_nsubjpass) proteinuria_19\NN\14299637
1085609
D007538_D012640 CID isoniazid_6\NN\2716205 (r_amod) therapy_7\NN\657604 (r_pobj) due_4\IN\5174653 (r_amod) convulsions_3\NNS\14081375
D007538_D012640 CID isoniazid_6\NN\2716205 (r_pobj) on_5\IN\0 (r_prep) infant_4\NN\9918248 (r_nsubjpass) admitted_18\VBN\822367 (l_prep) after_19\IN\0 (l_pobj) days_21\NNS\15140892 (l_prep) of_22\IN\0 (l_pobj) fits_24\NNS\7518132
D007538_D012640 CID isoniazid_19\NN\2716205 (r_relcl) aetiology_13\NN\7326557 (r_dobj) suggesting_11\VBG\1010118 (r_advcl) ceased_2\VBD\0 (l_nsubj) fits_1\NNS\7518132
D011736_D012640 NONE pyridoxine_1\NN\15090742 (r_nmod) convulsions_3\NNS\14081375
D011736_D012640 NONE pyridoxine_9\NN\15090742 (r_dobj) administering_7\VBG\2436349 (r_pcomp) of_6\IN\0 (r_prep) hours_5\NNS\15118228 (r_pobj) within_3\IN\0 (r_prep) ceased_2\VBD\0 (l_nsubj) fits_1\NNS\7518132
D011736_D012640 NONE pyridoxine_15\JJ\15090742 (r_compound) deficiency_16\NN\14449126 (r_pobj) of_14\IN\0 (r_prep) aetiology_13\NN\7326557 (r_dobj) suggesting_11\VBG\1010118 (r_advcl) ceased_2\VBD\0 (l_nsubj) fits_1\NNS\7518132
D007538_D014376 NONE isoniazid_6\NN\2716205 (r_pobj) on_5\IN\0 (r_prep) infant_4\NN\9918248 (l_prep) because_13\IN\0 (l_pobj) tuberculosis_16\NN\14127211
891050
D004176_D001002 NONE dipyridamole_6\NN\0 (r_conj) heparin_4\JJ\2718259 (r_pobj) with_3\IN\0 (r_prep) treated_2\VBN\2376958 (l_conj) rose_20\VBD\13112664 (l_conj) stopped_37\VBN\0 (l_prep) after_28\IN\0 (l_pobj) onset_30\NN\7325190 (l_prep) of_31\IN\0 (l_pobj) anuria_32\NN\14061805
D003276_D006463 CID contraceptives_17\NNS\3183080 (r_dobj) taking_15\VBG\37396 (r_acl) woman_14\NN\9605289 (r_pobj) in_12\IN\13603305 (r_prep) syndrome_8\NN\5870365
D003276_D006463 CID contraceptives_17\NNS\3183080 (r_dobj) taking_15\VBG\37396 (r_acl) woman_14\NN\9605289 (r_pobj) in_12\IN\13603305 (r_prep) syndrome_8\NN\5870365 (l_appos) hus_10\NNP\0
D006493_D001002 NONE heparin_4\JJ\2718259 (r_pobj) with_3\IN\0 (r_prep) treated_2\VBN\2376958 (l_conj) rose_20\VBD\13112664 (l_conj) stopped_37\VBN\0 (l_prep) after_28\IN\0 (l_pobj) onset_30\NN\7325190 (l_prep) of_31\IN\0 (l_pobj) anuria_32\NN\14061805
7199841
C004616_D010243 CID ce_11\NN\14625458 (r_nmod) %_15\NN\0 (r_pobj) of_8\IN\0 (r_prep) injection_7\NN\320852 (r_dobj) received_5\VBD\2210855 (r_relcl) animals_3\NNS\4475 (r_pobj) of_0\IN\0 (r_prep) paralysis_21\NN\14557898
D002045_D010243 NONE bupivacaine_6\NN\0 (r_dobj) received_5\VBD\2210855 (r_relcl) animals_3\NNS\4475 (r_pobj) of_1\IN\0 (r_prep) none_0\NN\15228378 (r_nsubj) titrated_14\VBN\489837 (l_prep) to_15\IN\0 (l_pobj) paralysis_23\NN\14557898
C004616_D013118 CID ce_12\NNP\14625458 (r_dobj) received_9\VBD\2210855 (r_relcl) animals_7\NNS\4475 (r_pobj) of_5\IN\0 (r_prep) cords_4\NNS\4489008 (r_pobj) of_0\IN\0 (r_prep) 13_14\CD\13745420 (r_nsubj) showed_15\VBD\2137132 (l_dobj) necrosis_17\NN\11444117
11256525
D000588_D001002 NONE amine_26\NN\14951377 (r_conj) furosemide_24\NN\3214670 (r_nmod) infusion_27\NN\14589223 (r_pobj) despite_20\IN\7501545 (r_prep) lasted_17\VBD\2704349 (r_relcl) anuria_14\NN\14061805
D019808_D006331 NONE losartan_5\NN\0 (l_compound) dysfunction_4\NN\14204950
D000809_D012078 NONE angiotensin_24\NN\4522421 (r_compound) system_25\NN\3575240 (r_pobj) of_20\IN\0 (r_prep) activation_19\NN\13561719 (r_pobj) in_16\IN\13603305 (r_prep) resulted_15\VBD\2633881 (l_nsubj) stenosis_6\NN\14204950
D019808_D001002 CID losartan_4\NN\0 (r_amod) administration_5\NN\1133281 (r_dobj) following_3\VBG\8180190 (r_prep) anuria_2\NN\14061805
D019808_D001002 CID losartan_27\NN\0 (r_amod) administration_28\NN\1133281 (r_pobj) after_26\IN\0 (r_prep) developed_20\VBD\1753788 (l_dobj) episodes_22\NNS\7283608 (l_prep) of_23\IN\0 (l_pobj) anuria_25\NN\14061805
D019808_D001002 CID losartan_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) mg_7\NN\13717155 (r_pobj) of_5\IN\0 (r_prep) dose_4\NN\3740161 (r_nsubj) resulted_10\VBD\2633881 (l_prep) in_11\IN\13603305 (l_pobj) anuria_14\NN\14061805
D019808_D001002 CID losartan_7\NN\0 (r_nsubjpass) prescribed_9\VBN\748282 (l_conj) developed_22\VBD\1753788 (l_dobj) episode_25\NN\7283608 (l_prep) of_26\IN\0 (l_pobj) anuria_28\NN\14061805
D019808_D014652 NONE losartan_12\NN\0 (r_nsubj) cause_14\VB\7323922 (l_dobj) complications_17\NNS\1073995 (l_prep) in_18\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_prep) with_20\IN\0 (l_pobj) disease_22\NN\14061805
D005665_D001002 NONE furosemide_24\NN\3214670 (r_nmod) infusion_27\NN\14589223 (r_pobj) despite_20\IN\7501545 (r_prep) lasted_17\VBD\2704349 (r_relcl) anuria_14\NN\14061805
D019808_D051436 NONE losartan_27\NN\0 (r_amod) administration_28\NN\1133281 (r_pobj) after_26\IN\0 (r_prep) developed_20\VBD\1753788 (r_relcl) kidney_14\NN\5333259 (l_conj) insufficiency_18\NN\14462946
D000809_D006333 NONE angiotensin_24\NN\4522421 (r_compound) system_25\NN\3575240 (r_pobj) of_20\IN\0 (r_prep) activation_19\NN\13561719 (r_pobj) in_16\IN\13603305 (r_prep) resulted_15\VBD\2633881 (l_nsubj) stenosis_6\NN\14204950 (l_acl) combined_7\VBN\2630189 (l_prep) with_8\IN\0 (l_pobj) failure_10\NN\66216
D000804_D014652 NONE ii_9\NNP\13741022 (r_compound) antagonist_11\NN\7846 (r_compound) losartan_12\NN\0 (r_nsubj) cause_14\VB\7323922 (l_dobj) complications_17\NNS\1073995 (l_prep) in_18\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_prep) with_20\IN\0 (l_pobj) disease_22\NN\14061805
D019808_D006973 NONE losartan_27\NN\0 (r_amod) administration_28\NN\1133281 (r_pobj) after_26\IN\0 (r_prep) developed_20\VBD\1753788 (r_relcl) kidney_14\NN\5333259 (r_pobj) with_11\IN\0 (r_prep) man_10\NN\9605289 (l_amod) hypertensive_9\JJ\10405694
3412544
D010615_D014516 NONE phenacetin_22\JJ\2707683 (r_pobj) of_20\IN\0 (r_prep) consumption_19\NN\13440063 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) pelvis_12\NN\5578911 (l_conj) ureter_14\NN\5250659 (l_conj) bladder_16\NN\5515670
D010615_D014516 NONE phenacetin_13\NN\2707683 (r_pobj) of_12\IN\0 (r_prep) consumption_11\NN\13440063 (l_relcl) increased_17\VBD\169651 (l_conj) for_30\IN\0 (l_pobj) cancer_32\NN\14239425
D010615_D007680 CID phenacetin_13\NN\2707683 (r_pobj) of_12\IN\0 (r_prep) consumption_11\NN\13440063 (l_relcl) increased_17\VBD\169651 (l_dobj) risk_19\NN\14541044 (l_prep) for_20\IN\0 (l_pobj) cancer_21\NN\14239425 (l_prep) of_22\IN\0 (l_pobj) pelvis_25\NN\5578911 (l_conj) bladder_27\NN\5515670
D010615_D007680 NONE phenacetin_22\JJ\2707683 (r_pobj) of_20\IN\0 (r_prep) consumption_19\NN\13440063 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) pelvis_12\NN\5578911 (l_conj) ureter_14\NN\5250659 (l_conj) bladder_16\NN\5515670
D000082_D007681 NONE paracetamol_1\JJ\0 (r_nsubj) cause_2\VB\7323922 (l_dobj) cancer_4\NN\14239425 (l_conj) necrosis_8\NN\11444117
D000082_D007681 NONE paracetamol_24\NNP\0 (r_conj) phenacetin_22\JJ\2707683 (r_pobj) of_20\IN\0 (r_prep) consumption_19\NN\13440063 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) pelvis_12\NN\5578911 (r_pobj) of_9\IN\0 (r_prep) necrosis_6\NN\11444117
D000082_D007681 NONE paracetamol_12\JJ\0 (r_compound) consumption_13\NN\13440063 (r_pobj) from_11\IN\0 (r_prep) risk_10\NN\14541044 (l_prep) for_14\IN\0 (l_pobj) necrosis_17\NN\11444117
D000082_D001749 NONE paracetamol_24\NNP\0 (r_conj) phenacetin_22\JJ\2707683 (r_pobj) of_20\IN\0 (r_prep) consumption_19\NN\13440063 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) pelvis_12\NN\5578911 (l_conj) ureter_14\NN\5250659 (l_conj) bladder_16\NN\5515670
D000082_D014516 NONE paracetamol_24\NNP\0 (r_conj) phenacetin_22\JJ\2707683 (r_pobj) of_20\IN\0 (r_prep) consumption_19\NN\13440063 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) pelvis_12\NN\5578911 (l_conj) ureter_14\NN\5250659 (l_conj) bladder_16\NN\5515670
D000082_D014516 NONE paracetamol_12\JJ\0 (r_compound) consumption_13\NN\13440063 (r_pobj) from_11\IN\0 (r_prep) risk_10\NN\14541044 (r_dobj) substantiate_7\VB\0 (r_xcomp) unable_5\JJ\0 (r_acomp) were_4\VBD\0 (l_advcl) was_25\VBD\0 (l_attr) suggestion_27\NN\5833840 (l_prep) of_28\IN\0 (l_pobj) association_30\NN\8008335 (l_prep) with_31\IN\0 (l_pobj) cancer_32\NN\14239425 (l_prep) of_33\IN\0 (l_pobj) ureter_35\NN\5250659
D000082_D014523 NONE paracetamol_1\JJ\0 (r_nsubj) cause_2\VB\7323922 (l_dobj) cancer_4\NN\14239425
D000082_D007680 NONE paracetamol_24\NNP\0 (r_conj) phenacetin_22\JJ\2707683 (r_pobj) of_20\IN\0 (r_prep) consumption_19\NN\13440063 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) pelvis_12\NN\5578911 (l_conj) ureter_14\NN\5250659 (l_conj) bladder_16\NN\5515670
D000082_D009369 NONE paracetamol_12\JJ\0 (r_compound) consumption_13\NN\13440063 (r_pobj) from_11\IN\0 (r_prep) risk_10\NN\14541044 (l_conj) any_19\DT\0 (l_prep) of_20\IN\0 (l_pobj) cancers_22\NNS\14239425
D010615_D007681 CID phenacetin_22\JJ\2707683 (r_pobj) of_20\IN\0 (r_prep) consumption_19\NN\13440063 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) pelvis_12\NN\5578911 (r_pobj) of_9\IN\0 (r_prep) necrosis_6\NN\11444117
D010615_D007681 CID phenacetin_13\NN\2707683 (r_pobj) of_12\IN\0 (r_prep) consumption_11\NN\13440063 (r_pobj) by_10\IN\0 (r_agent) increased_7\VBN\169651 (l_nsubjpass) risk_1\NN\14541044 (l_prep) of_2\IN\0 (l_pobj) necrosis_5\NN\11444117
D010615_D001749 CID phenacetin_13\NN\2707683 (r_pobj) of_12\IN\0 (r_prep) consumption_11\NN\13440063 (l_relcl) increased_17\VBD\169651 (l_dobj) risk_19\NN\14541044 (l_prep) for_20\IN\0 (l_pobj) cancer_21\NN\14239425 (l_prep) of_22\IN\0 (l_pobj) pelvis_25\NN\5578911 (l_conj) bladder_27\NN\5515670
D010615_D001749 NONE phenacetin_22\JJ\2707683 (r_pobj) of_20\IN\0 (r_prep) consumption_19\NN\13440063 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) pelvis_12\NN\5578911 (l_conj) ureter_14\NN\5250659 (l_conj) bladder_16\NN\5515670
9862868
D004997_D002780 CID estradiol_9\NNP\14749794 (r_nmod) treatment_13\NN\654885 (r_nmod) cholestasis_16\NN\14052403 (r_dobj) used_1\VBD\0 (l_dobj) models_3\NNS\5888929 (l_prep) of_4\IN\0 (l_pobj) cholestasis_6\NN\14052403
D004997_D002780 CID ee_11\NNP\6125041 (r_nmod) treatment_13\NN\654885 (r_nmod) cholestasis_16\NN\14052403 (r_dobj) used_1\VBD\0 (l_dobj) models_3\NNS\5888929 (l_prep) of_4\IN\0 (l_pobj) cholestasis_6\NN\14052403
D004997_D001651 NONE estradiol_9\NNP\14749794 (r_nmod) treatment_13\NN\654885 (r_nmod) cholestasis_16\NN\14052403
D004997_D001651 NONE ee_11\NNP\6125041 (r_nmod) treatment_13\NN\654885 (r_nmod) cholestasis_16\NN\14052403
2008831
D008755_D000787 NONE methylergonovine_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) studied_8\VBN\0 (l_prep) without_25\IN\0 (l_pobj) angina_26\NN\14171682 (l_appos) pectoris_27\NN\0
D008755_D013035 NONE methylergonovine_19\NN\0 (r_pobj) of_18\IN\0 (r_prep) dose_17\NN\3740161 (r_pobj) of_13\IN\0 (r_prep) injection_12\NN\320852 (r_dobj) use_9\VBP\407535 (r_relcl) tests_6\NNS\5798043 (l_compound) spasm_4\NN\14299637
D008755_D000788 NONE methylergonovine_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (l_prep) in_7\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_conj) without_11\IN\0 (l_pobj) angina_13\NN\14171682
D008755_D000788 NONE methylergonovine_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) studied_8\VBN\0 (l_prep) in_9\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) angina_14\NN\14171682
D008755_D000788 NONE methylergonovine_19\NN\0 (r_pobj) of_18\IN\0 (r_prep) dose_17\NN\3740161 (r_pobj) of_13\IN\0 (r_prep) injection_12\NN\320852 (r_dobj) use_9\VBP\407535 (r_relcl) tests_6\NNS\5798043 (r_nsubj) have_21\VBP\7846 (l_dobj) sensitivity_24\NN\5651971 (l_prep) in_25\IN\13603305 (l_pobj) angina_27\NN\14171682
D008755_D002637 NONE methylergonovine_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) studied_8\VBN\0 (l_prep) in_9\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) angina_14\NN\14171682 (l_conj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) pain_21\NN\14299637
17020434
D001241_D020521 NONE aspirin_24\NN\2707683 (r_nsubj) reduces_26\VBZ\441445 (r_conj) reduces_13\VBZ\441445 (l_dobj) risk_15\NN\14541044 (l_prep) of_16\IN\0 (l_pobj) stroke_17\NN\556313
D001241_D020521 NONE aspirin_12\NN\2707683 (l_prep) in_13\IN\13603305 (l_pcomp) preventing_14\VBG\0 (l_dobj) strokes_15\NNS\556313
D014812_D004617 NONE k_16\NNP\13608598 (r_compound) drugs_18\NNS\14778436 (r_pobj) as_14\IN\14622893 (r_prep) efficient_13\JJ\0 (l_prep) in_19\IN\13603305 (l_pobj) prevention_21\NN\1073995 (l_prep) of_22\IN\0 (l_pobj) events_24\NNS\23100
C081309_D004617 NONE irbesartan_10\NNP\0 (r_pobj) with_9\IN\0 (r_prep) trial_8\NN\786195 (r_nsubj) demonstrated_19\VBN\2137132 (l_ccomp) is_22\VBZ\0 (l_acomp) superior_23\JJ\9623038 (l_xcomp) platelet_25\NN\5432736 (l_prep) in_32\IN\13603305 (l_pobj) events_37\NNS\23100
C479958_D001281 NONE idraparinux_0\NNP\0 (r_nsubjpass) evaluated_9\VBN\670261 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) fibrillation_14\NN\14361664
D000809_D001281 NONE angiotensin_0\NN\4522421 (r_npadvmod) converting_2\VBG\126264 (r_amod) inhibitors_4\NNS\20090 (r_nsubj) hold_12\VBP\812274 (l_dobj) promise_13\NN\6684383 (l_prep) in_14\IN\13603305 (l_pobj) fibrillation_16\NN\14361664
D000804_D020257 NONE ii_7\CD\13741022 (r_nummod) drugs_11\NNS\14778436 (r_conj) inhibitors_4\NNS\20090 (r_nsubj) hold_12\VBP\812274 (l_dobj) promise_13\NN\6684383 (l_prep) in_14\IN\13603305 (l_pobj) fibrillation_16\NN\14361664 (l_prep) through_17\IN\0 (l_pobj) remodelling_19\NN\0
D014859_D004617 NONE warfarin_21\NN\2718259 (r_nsubj) is_22\VBZ\0 (l_acomp) superior_23\JJ\9623038 (l_xcomp) platelet_25\NN\5432736 (l_prep) in_32\IN\13603305 (l_pobj) events_37\NNS\23100
C426686_D004617 NONE ximelagatran_0\NN\0 (r_nsubjpass) found_9\VBN\13279262 (l_xcomp) be_11\VB\14625458 (l_acomp) efficient_13\JJ\0 (l_prep) in_19\IN\13603305 (l_pobj) prevention_21\NN\1073995 (l_prep) of_22\IN\0 (l_pobj) events_24\NNS\23100
D000804_D001281 NONE ii_7\CD\13741022 (r_nummod) drugs_11\NNS\14778436 (r_conj) inhibitors_4\NNS\20090 (r_nsubj) hold_12\VBP\812274 (l_dobj) promise_13\NN\6684383 (l_prep) in_14\IN\13603305 (l_pobj) fibrillation_16\NN\14361664
D014859_D001281 NONE warfarin_21\NN\2718259 (r_nsubj) is_22\VBZ\0 (r_ccomp) demonstrated_19\VBN\2137132 (l_nsubj) trial_8\NN\786195 (l_compound) clopidogrel_7\NNP\0 (l_compound) fibrillation_6\NNP\14361664
C055162_D004617 NONE clopidogrel_7\NNP\0 (r_compound) trial_8\NN\786195 (r_nsubj) demonstrated_19\VBN\2137132 (l_ccomp) is_22\VBZ\0 (l_acomp) superior_23\JJ\9623038 (l_xcomp) platelet_25\NN\5432736 (l_prep) in_32\IN\13603305 (l_pobj) events_37\NNS\23100
C055162_D004617 NONE clopidogrel_28\JJ\0 (r_dobj) platelet_25\NN\5432736 (l_prep) in_32\IN\13603305 (l_pobj) events_37\NNS\23100
D001241_D001281 NONE aspirin_30\NN\2707683 (r_conj) clopidogrel_28\JJ\0 (r_dobj) platelet_25\NN\5432736 (r_xcomp) superior_23\JJ\9623038 (r_acomp) is_22\VBZ\0 (r_ccomp) demonstrated_19\VBN\2137132 (l_nsubj) trial_8\NN\786195 (l_compound) clopidogrel_7\NNP\0 (l_compound) fibrillation_6\NNP\14361664
D014812_D056486 NONE k_16\NNP\13608598 (r_compound) drugs_18\NNS\14778436 (r_pobj) as_14\IN\14622893 (r_prep) efficient_13\JJ\0 (r_acomp) be_11\VB\14625458 (r_xcomp) found_9\VBN\13279262 (l_conj) withdrawn_30\VBN\1835496 (l_prep) because_31\IN\0 (l_pobj) tests_36\NNS\5798043 (l_compound) function_35\NN\13783581
C426686_D056486 CID ximelagatran_0\NN\0 (r_nsubjpass) found_9\VBN\13279262 (l_conj) withdrawn_30\VBN\1835496 (l_prep) because_31\IN\0 (l_pobj) tests_36\NNS\5798043 (l_compound) function_35\NN\13783581
C055162_D001281 NONE clopidogrel_7\NNP\0 (l_compound) fibrillation_6\NNP\14361664
C055162_D001281 NONE clopidogrel_28\JJ\0 (r_dobj) platelet_25\NN\5432736 (r_xcomp) superior_23\JJ\9623038 (r_acomp) is_22\VBZ\0 (r_ccomp) demonstrated_19\VBN\2137132 (l_nsubj) trial_8\NN\786195 (l_compound) clopidogrel_7\NNP\0 (l_compound) fibrillation_6\NNP\14361664
C081309_D001281 NONE irbesartan_10\NNP\0 (r_pobj) with_9\IN\0 (r_prep) trial_8\NN\786195 (l_compound) clopidogrel_7\NNP\0 (l_compound) fibrillation_6\NNP\14361664
D000809_D020257 NONE angiotensin_0\NN\4522421 (r_npadvmod) converting_2\VBG\126264 (r_amod) inhibitors_4\NNS\20090 (r_nsubj) hold_12\VBP\812274 (l_dobj) promise_13\NN\6684383 (l_prep) in_14\IN\13603305 (l_pobj) fibrillation_16\NN\14361664 (l_prep) through_17\IN\0 (l_pobj) remodelling_19\NN\0
D001241_D004617 NONE aspirin_30\NN\2707683 (r_conj) clopidogrel_28\JJ\0 (r_dobj) platelet_25\NN\5432736 (l_prep) in_32\IN\13603305 (l_pobj) events_37\NNS\23100
D014859_D020521 NONE warfarin_12\NN\2718259 (r_nsubj) reduces_13\VBZ\441445 (l_dobj) risk_15\NN\14541044 (l_prep) of_16\IN\0 (l_pobj) stroke_17\NN\556313
D014859_D020521 NONE warfarin_8\VB\2718259 (r_nsubj) is_9\VBZ\0 (l_acomp) superior_10\JJ\9623038 (l_prep) to_11\IN\0 (l_pobj) aspirin_12\NN\2707683 (l_prep) in_13\IN\13603305 (l_pcomp) preventing_14\VBG\0 (l_dobj) strokes_15\NNS\556313
11745184
D004999_D001943 NONE wr-2721_7\NNP\0 (r_nmod) amifostine_9\NN\0 (r_pobj) of_4\IN\0 (r_prep) trial_3\NN\786195 (l_prep) for_11\IN\0 (l_pobj) carcinoma_14\NN\14239918
D004999_D001943 NONE amifostine_9\NN\0 (r_pobj) of_4\IN\0 (r_prep) trial_3\NN\786195 (l_prep) for_11\IN\0 (l_pobj) carcinoma_14\NN\14239918
D004999_D001943 NONE amifostine_10\NN\0 (r_conj) cisplatin_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) combination_6\NN\7951464 (r_pobj) of_4\IN\0 (r_prep) study_3\NN\635850 (r_nsubjpass) conducted_12\VBN\2436349 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) carcinoma_19\NN\14239918
D002945_D020258 NONE cisplatin_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) observed_8\VBN\2163746 (r_advcl) limited_31\VBN\4019101 (l_nsubj) toxicities_16\NNS\13576101 (l_acl) associated_17\VBN\628491 (l_prep) with_18\IN\0 (l_pcomp) cisplatin_19\NN\0 (l_preconj) nephrotoxicity_23\NN\0 (l_conj) ototoxicity_25\NN\0 (l_conj) neurotoxicity_28\NN\0
D002945_D020258 NONE cisplatin_19\NN\0 (l_preconj) nephrotoxicity_23\NN\0 (l_conj) ototoxicity_25\NN\0 (l_conj) neurotoxicity_28\NN\0
D002945_D001943 NONE cisplatin_5\NN\0 (r_nmod) amifostine_9\NN\0 (r_pobj) of_4\IN\0 (r_prep) trial_3\NN\786195 (l_prep) for_11\IN\0 (l_pobj) carcinoma_14\NN\14239918
D002945_D001943 NONE cisplatin_0\NNP\0 (r_nsubj) has_1\VBZ\13888491 (l_advcl) used_6\VBN\0 (l_prep) as_7\IN\14622893 (l_pobj) treatment_13\NN\654885 (l_prep) of_14\IN\0 (l_pobj) carcinoma_17\NN\14239918
D002945_D001943 NONE cisplatin_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) observed_8\VBN\2163746 (r_advcl) limited_31\VBN\4019101 (l_dobj) use_33\NN\407535 (l_prep) as_34\IN\14622893 (l_pobj) treatment_36\NN\654885 (l_prep) for_37\IN\0 (l_pobj) carcinoma_39\NN\14239918
D002945_D001943 NONE cisplatin_19\NN\0 (r_pcomp) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) toxicities_16\NNS\13576101 (r_nsubj) limited_31\VBN\4019101 (l_dobj) use_33\NN\407535 (l_prep) as_34\IN\14622893 (l_pobj) treatment_36\NN\654885 (l_prep) for_37\IN\0 (l_pobj) carcinoma_39\NN\14239918
D002945_D001943 NONE cisplatin_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) combination_6\NN\7951464 (r_pobj) of_4\IN\0 (r_prep) study_3\NN\635850 (r_nsubjpass) conducted_12\VBN\2436349 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) carcinoma_19\NN\14239918
D002945_D006311 CID cisplatin_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) observed_8\VBN\2163746 (r_advcl) limited_31\VBN\4019101 (l_nsubj) toxicities_16\NNS\13576101 (l_acl) associated_17\VBN\628491 (l_prep) with_18\IN\0 (l_pcomp) cisplatin_19\NN\0 (l_preconj) nephrotoxicity_23\NN\0 (l_conj) ototoxicity_25\NN\0
D002945_D006311 CID cisplatin_19\NN\0 (l_preconj) nephrotoxicity_23\NN\0 (l_conj) ototoxicity_25\NN\0
D002945_D006311 CID cisplatin_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) trials_1\NNS\786195 (r_nsubj) suggested_7\VBD\1010118 (l_ccomp) reduced_24\VBN\441445 (l_nsubjpass) incidence_10\NN\13821570 (l_prep) of_13\IN\0 (l_pobj) nephrotoxicity_17\NN\0 (l_conj) ototoxicity_19\NN\0
D002945_D006311 CID cisplatin_14\NN\0 (r_advmod) induced_16\VBN\1627355 (r_amod) nephrotoxicity_17\NN\0 (l_conj) ototoxicity_19\NN\0
D004999_D006311 NONE amifostine_5\NN\0 (r_conj) cisplatin_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) trials_1\NNS\786195 (r_nsubj) suggested_7\VBD\1010118 (l_ccomp) reduced_24\VBN\441445 (l_nsubjpass) incidence_10\NN\13821570 (l_prep) of_13\IN\0 (l_pobj) nephrotoxicity_17\NN\0 (l_conj) ototoxicity_19\NN\0
D004999_D009369 NONE amifostine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) addition_16\NN\3081021 (r_pobj) with_14\IN\0 (r_prep) observed_13\VBN\2163746 (l_nsubjpass) effect_5\NN\34213 (l_amod) protective_4\JJ\0 (l_npadvmod) tumor_2\NN\14234074
D004999_D064420 NONE amifostine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) addition_16\NN\3081021 (r_pobj) with_14\IN\0 (r_prep) observed_13\VBN\2163746 (l_nsubjpass) effect_5\NN\34213 (l_conj) reduced_7\VBN\441445 (l_dobj) toxicity_8\NN\13576101
D002945_D064420 NONE cisplatin_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) observed_8\VBN\2163746 (r_advcl) limited_31\VBN\4019101 (l_nsubj) toxicities_16\NNS\13576101
D002945_D064420 NONE cisplatin_19\NN\0 (r_pcomp) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) toxicities_16\NNS\13576101
D002945_D064420 NONE cisplatin_20\VB\0 (r_acl) amifostine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) addition_16\NN\3081021 (r_pobj) with_14\IN\0 (r_prep) observed_13\VBN\2163746 (l_nsubjpass) effect_5\NN\34213 (l_conj) reduced_7\VBN\441445 (l_dobj) toxicity_8\NN\13576101
D002945_D009422 CID cisplatin_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) trials_1\NNS\786195 (r_nsubj) suggested_7\VBD\1010118 (l_ccomp) reduced_24\VBN\441445 (l_nsubjpass) incidence_10\NN\13821570 (l_prep) of_13\IN\0 (l_pobj) nephrotoxicity_17\NN\0 (l_conj) ototoxicity_19\NN\0 (l_conj) neuropathy_22\NN\14204950
D002945_D009422 CID cisplatin_14\NN\0 (r_advmod) induced_16\VBN\1627355 (r_amod) nephrotoxicity_17\NN\0 (l_conj) ototoxicity_19\NN\0 (l_conj) neuropathy_22\NN\14204950
D004999_D007674 NONE amifostine_5\NN\0 (r_conj) cisplatin_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) trials_1\NNS\786195 (r_nsubj) suggested_7\VBD\1010118 (l_ccomp) reduced_24\VBN\441445 (l_nsubjpass) incidence_10\NN\13821570 (l_prep) of_13\IN\0 (l_pobj) nephrotoxicity_17\NN\0
D004999_D009422 NONE amifostine_5\NN\0 (r_conj) cisplatin_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) trials_1\NNS\786195 (r_nsubj) suggested_7\VBD\1010118 (l_ccomp) reduced_24\VBN\441445 (l_nsubjpass) incidence_10\NN\13821570 (l_prep) of_13\IN\0 (l_pobj) nephrotoxicity_17\NN\0 (l_conj) ototoxicity_19\NN\0 (l_conj) neuropathy_22\NN\14204950
D002945_D007674 CID cisplatin_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) observed_8\VBN\2163746 (r_advcl) limited_31\VBN\4019101 (l_nsubj) toxicities_16\NNS\13576101 (l_acl) associated_17\VBN\628491 (l_prep) with_18\IN\0 (l_pcomp) cisplatin_19\NN\0 (l_preconj) nephrotoxicity_23\NN\0
D002945_D007674 CID cisplatin_19\NN\0 (l_preconj) nephrotoxicity_23\NN\0
D002945_D007674 CID cisplatin_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) trials_1\NNS\786195 (r_nsubj) suggested_7\VBD\1010118 (l_ccomp) reduced_24\VBN\441445 (l_nsubjpass) incidence_10\NN\13821570 (l_prep) of_13\IN\0 (l_pobj) nephrotoxicity_17\NN\0
D002945_D007674 CID cisplatin_14\NN\0 (r_advmod) induced_16\VBN\1627355 (r_amod) nephrotoxicity_17\NN\0
D002945_D009369 NONE cisplatin_20\VB\0 (r_acl) amifostine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) addition_16\NN\3081021 (r_pobj) with_14\IN\0 (r_prep) observed_13\VBN\2163746 (l_nsubjpass) effect_5\NN\34213 (l_amod) protective_4\JJ\0 (l_npadvmod) tumor_2\NN\14234074
8410052
D010862_D002544 CID pilocarpine_10\NN\14712692 (r_npadvmod) induced_12\VBN\1627355 (r_amod) status_13\NN\24720 (r_pobj) by_8\IN\0 (r_agent) evoked_7\VBN\1617192 (l_nsubjpass) infarcts_0\NNS\14204950 (l_prep) in_1\IN\13603305 (l_pobj) reticulata_5\NNS\0
D010862_D013226 CID pilocarpine_10\NN\14712692 (r_npadvmod) induced_12\VBN\1627355 (r_amod) status_13\NN\24720 (r_pobj) by_8\IN\0 (r_agent) evoked_7\VBN\1617192 (l_advmod) epilepticus_14\NN\0
D019344_D001480 NONE lactate_10\NN\14850483 (r_pobj) of_9\IN\0 (r_prep) infusion_8\NN\14589223 (r_pobj) by_7\IN\0 (r_agent) produced_6\VBN\1617192 (l_nsubjpass) injury_1\NN\14052046 (l_prep) in_2\IN\13603305 (l_pobj) cortex_4\NN\5462674
14657095
D000666_D006333 CID b_20\NNP\1355326 (r_pobj) with_18\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) failure_12\NN\66216
D000666_D006333 CID amb_22\NNP\0 (r_appos) b_20\NNP\1355326 (r_pobj) with_18\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) failure_12\NN\66216
D000666_D006333 CID amb._12\NN\0 (r_pobj) for_11\IN\0 (r_prep) substituted_10\VBN\126264 (r_advcl) resolved_6\VBD\352826 (r_acl) abnormalities_2\NNS\14034177 (l_conj) failure_5\NN\66216
D000666_D064420 NONE amb._12\NN\0 (r_pobj) of_11\IN\0 (r_prep) toxicity_10\NN\13576101
C101425_D006333 NONE posaconazole_8\NN\0 (r_nsubjpass) substituted_10\VBN\126264 (r_advcl) resolved_6\VBD\352826 (r_acl) abnormalities_2\NNS\14034177 (l_conj) failure_5\NN\66216
D000666_D003047 NONE b_20\NNP\1355326 (r_pobj) with_18\IN\0 (r_prep) developed_5\VBD\1753788 (l_prep) for_24\IN\0 (l_pobj) coccidioidomycosis_26\NN\14176895
D000666_D003047 NONE amb_22\NNP\0 (r_appos) b_20\NNP\1355326 (r_pobj) with_18\IN\0 (r_prep) developed_5\VBD\1753788 (l_prep) for_24\IN\0 (l_pobj) coccidioidomycosis_26\NN\14176895
D000666_D002311 CID b_6\NNP\1355326 (r_compound) therapy_7\NN\657604 (r_pobj) to_4\IN\0 (r_prep) related_3\VBN\628491 (r_acl) cardiomyopathy_2\NN\14103288
D000666_D002311 CID b_20\NNP\1355326 (r_pobj) with_18\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) failure_12\NN\66216 (l_amod) cardiomyopathy_7\NN\14103288
D000666_D002311 CID amb_22\NNP\0 (r_appos) b_20\NNP\1355326 (r_pobj) with_18\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) failure_12\NN\66216 (l_amod) cardiomyopathy_7\NN\14103288
2334618
D009020_D013610 NONE morphine_26\NN\2707683 (r_compound) infusion_27\NN\14589223 (r_compound) group_28\NN\2137 (r_pobj) in_24\IN\13603305 (r_prep) beats_17\NNS\8289449 (r_conj) tachyarrhythmias_7\NNS\0
D009020_D018879 CID morphine_26\NN\2707683 (r_compound) infusion_27\NN\14589223 (r_compound) group_28\NN\2137 (r_pobj) in_24\IN\13603305 (r_prep) beats_17\NNS\8289449
D002045_D001049 NONE bupivacaine_34\NN\0 (r_pobj) of_31\IN\0 (r_prep) infusion_30\NN\14589223 (r_dobj) receiving_26\VBG\2210855 (r_acl) patients_25\NNS\9898892 (r_conj) patients_10\NNS\9898892 (r_pobj) between_8\IN\0 (r_prep) compared_7\VBN\644583 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) apnoea_5\NN\0
D009020_D001049 NONE morphine_17\NN\2707683 (r_pobj) of_16\IN\0 (r_prep) infusion_15\NN\14589223 (r_dobj) receiving_11\VBG\2210855 (r_acl) patients_10\NNS\9898892 (r_pobj) between_8\IN\0 (r_prep) compared_7\VBN\644583 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) apnoea_5\NN\0
D009020_D020181 CID morphine_25\NN\2707683 (r_compound) infusion_26\NN\14589223 (r_dobj) had_23\VBD\0 (r_relcl) patients_21\NNS\9898892 (r_pobj) in_20\IN\13603305 (r_prep) occurred_17\VBD\0 (l_nsubj) obstructive_1\JJ\0 (l_appos) p_3\NN\14622893 (l_conj) apnoea_10\NN\0
D009020_D020182 CID morphine_25\NN\2707683 (r_compound) infusion_26\NN\14589223 (r_dobj) had_23\VBD\0 (r_relcl) patients_21\NNS\9898892 (r_pobj) in_20\IN\13603305 (r_prep) occurred_17\VBD\0 (l_nsubj) obstructive_1\JJ\0 (l_appos) p_3\NN\14622893 (l_conj) apnoea_10\NN\0
8437969
D002927_D007938 NONE cimetidine_27\NN\14778019 (r_dobj) receiving_23\VBG\2210855 (r_advcl) recurrent_14\JJ\0 (r_appos) man_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) leukemia_6\NN\14239918
D002927_D001145 NONE cimetidine_6\NN\14778019 (r_compound) administration_7\NN\1133281 (r_pobj) to_5\IN\0 (r_prep) related_4\VBN\628491 (l_nsubjpass) arrhythmias_1\NNS\14103288
D011899_D001145 NONE ranitidine_18\NN\14778019 (r_compound) treatment_19\NN\654885 (r_pobj) during_17\IN\0 (r_prep) recur_16\VB\339934 (r_conj) disappeared_9\VBD\0 (l_ccomp) related_4\VBN\628491 (l_nsubjpass) arrhythmias_1\NNS\14103288
D002927_D054138 CID cimetidine_7\NN\14778019 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) arrest_1\NN\88481
D002927_D054138 CID cimetidine_27\NN\14778019 (r_dobj) receiving_23\VBG\2210855 (r_advcl) recurrent_14\JJ\0 (l_appos) episodes_17\NNS\7283608 (l_prep) of_18\IN\0 (l_pobj) arrest_21\NN\88481
D002927_D054138 CID cimetidine_14\NN\14778019 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) arrest_8\NN\88481
D002927_D001919 CID cimetidine_7\NN\14778019 (r_pobj) of_6\IN\0 (r_prep) infusions_5\NNS\14589223 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubjpass) associated_10\VBN\628491 (l_prep) with_11\IN\0 (l_pobj) development_13\NN\248977 (l_prep) of_14\IN\0 (l_pobj) bradyarrhythmias_15\NNS\0
D002927_D006331 NONE cimetidine_27\NN\14778019 (r_dobj) receiving_23\VBG\2210855 (r_advcl) recurrent_14\JJ\0 (r_appos) man_4\NN\9605289 (l_conj) history_9\NN\15120823 (l_prep) of_10\IN\0 (l_pobj) disease_12\NN\14061805
2870085
C047847_D002637 NONE flestolol_6\NN\0 (r_compound) infusion_7\NN\14589223 (r_nsubjpass) found_9\VBN\13279262 (l_xcomp) be_11\VB\14625458 (l_acomp) safe_12\JJ\4340750 (l_conj) effective_14\JJ\0 (l_prep) in_15\IN\13603305 (l_pcomp) controlling_16\VBG\0 (l_dobj) pain_18\NN\14299637
C047847_D013610 NONE flestolol_0\NNP\0 (r_nsubj) produced_1\VBD\1617192 (l_dobj) attenuation_6\NN\7427337 (l_prep) of_7\IN\0 (l_pobj) tachycardia_11\NN\14110674
D007545_D013610 CID isoproterenol_8\NN\3740161 (r_npadvmod) induced_10\VBN\1627355 (r_amod) tachycardia_11\NN\14110674
C047847_D013617 NONE flestolol_0\NNP\0 (r_nsubj) reduced_2\VBD\441445 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) tachyarrhythmia_9\NN\0
C047847_D000789 NONE flestolol_6\NN\0 (r_compound) infusion_7\NN\14589223 (r_nsubjpass) found_9\VBN\13279262 (l_prep) in_0\IN\13603305 (l_pobj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) angina_4\NN\14171682
7053303
D002927_D003704 CID cimetidine_10\NN\14778019 (r_pobj) due_8\IN\5174653 (r_amod) case_4\NN\7283608 (l_prep) of_5\IN\0 (l_pobj) dementia_6\NN\14395018
D002927_D003704 CID cimetidine_40\JJ\14778019 (r_compound) levels_41\NNS\4916342 (r_dobj) had_39\VBD\0 (r_relcl) disease_37\NN\14061805 (r_pobj) without_33\IN\0 (r_prep) patients_32\NNS\9898892 (r_pobj) of_30\IN\0 (r_prep) group_29\NN\2137 (r_pobj) in_27\IN\13603305 (r_prep) cimetidine_10\NN\14778019 (r_pobj) due_8\IN\5174653 (r_amod) case_4\NN\7283608 (l_prep) of_5\IN\0 (l_pobj) dementia_6\NN\14395018
D002927_D003704 CID cimetidine_3\NN\14778019 (r_compound) levels_4\NNS\4916342 (r_nsubj) induce_9\VB\1627355 (l_dobj) dementia_10\NN\14395018
D002927_D008107 NONE cimetidine_10\NN\14778019 (l_prep) in_27\IN\13603305 (l_pobj) group_29\NN\2137 (l_prep) of_30\IN\0 (l_pobj) patients_32\NNS\9898892 (l_prep) without_33\IN\0 (l_pobj) disease_37\NN\14061805
D002927_D008107 NONE cimetidine_40\JJ\14778019 (r_compound) levels_41\NNS\4916342 (r_dobj) had_39\VBD\0 (r_relcl) disease_37\NN\14061805
D002927_D007674 NONE cimetidine_10\NN\14778019 (l_prep) in_27\IN\13603305 (l_pobj) group_29\NN\2137 (l_prep) of_30\IN\0 (l_pobj) patients_32\NNS\9898892 (l_prep) without_33\IN\0 (l_pobj) disease_37\NN\14061805
D002927_D007674 NONE cimetidine_40\JJ\14778019 (r_compound) levels_41\NNS\4916342 (r_dobj) had_39\VBD\0 (r_relcl) disease_37\NN\14061805
12921865
D005680_D012640 NONE acid_21\NN\14818238 (l_appos) receptor_26\NN\5225602 (l_prep) against_27\IN\0 (l_pobj) increase_29\NN\13576355 (l_prep) in_30\IN\13603305 (l_pobj) sensitivity_31\NN\5651971 (l_prep) to_32\IN\0 (l_pobj) effects_35\NNS\13245626 (l_prep) of_36\IN\0 (l_pobj) cocaine_37\NN\3492717 (l_acl) engendered_38\VBN\1645601 (l_agent) by_39\IN\0 (l_pobj) administration_42\NN\1133281 (l_appos) kindling_45\NN\15101361 (l_compound) seizure_44\NN\14081375
D005680_D012640 NONE gaba(a_23\NNP\0 (r_appos) acid_21\NN\14818238 (l_appos) receptor_26\NN\5225602 (l_prep) against_27\IN\0 (l_pobj) increase_29\NN\13576355 (l_prep) in_30\IN\13603305 (l_pobj) sensitivity_31\NN\5651971 (l_prep) to_32\IN\0 (l_pobj) effects_35\NNS\13245626 (l_prep) of_36\IN\0 (l_pobj) cocaine_37\NN\3492717 (l_acl) engendered_38\VBN\1645601 (l_agent) by_39\IN\0 (l_pobj) administration_42\NN\1133281 (l_appos) kindling_45\NN\15101361 (l_compound) seizure_44\NN\14081375
D005680_D012640 NONE gaba(a_4\NN\0 (r_nmod) modulators_6\NNS\0 (r_pobj) of_1\IN\0 (r_prep) all_0\DT\0 (r_nsubj) suppressed_7\VBD\2510337 (l_dobj) expression_9\NN\4679549 (l_prep) of_10\IN\0 (l_pobj) seizures_12\NNS\14081375
D013256_D001523 NONE steroids_1\NNS\14727670 (r_nsubj) demonstrate_2\VBP\2137132 (l_dobj) actions_4\NNS\30358 (l_relcl) have_6\VBP\7846 (l_dobj) relevance_7\NN\13791389 (l_prep) for_8\IN\0 (l_pobj) host_10\NN\9605289 (l_prep) of_11\IN\0 (l_pobj) disorders_15\NNS\14034177
D011280_D012640 NONE allopregnanolone_0\NN\0 (r_nsubjpass) tested_34\VBN\670261 (l_prep) for_35\IN\0 (l_pobj) ability_37\NN\4723816 (l_acl) suppress_39\VB\2510337 (l_dobj) expression_41\NN\4679549 (l_appos) effect_44\NN\34213 (l_conj) development_47\NN\248977 (l_prep) of_52\IN\0 (l_pobj) seizures_56\NNS\14081375
D011280_D012640 NONE pregnan-20-one_6\NNP\0 (r_advmod) 3alpha_2\CD\0 (r_appos) allopregnanolone_0\NN\0 (r_nsubjpass) tested_34\VBN\670261 (l_prep) for_35\IN\0 (l_pobj) ability_37\NN\4723816 (l_acl) suppress_39\VB\2510337 (l_dobj) expression_41\NN\4679549 (l_appos) effect_44\NN\34213 (l_conj) development_47\NN\248977 (l_prep) of_52\IN\0 (l_pobj) seizures_56\NNS\14081375
D011280_D012640 NONE pregnanolone_9\NN\0 (r_appos) allopregnanolone_0\NN\0 (r_nsubjpass) tested_34\VBN\670261 (l_prep) for_35\IN\0 (l_pobj) ability_37\NN\4723816 (l_acl) suppress_39\VB\2510337 (l_dobj) expression_41\NN\4679549 (l_appos) effect_44\NN\34213 (l_conj) development_47\NN\248977 (l_prep) of_52\IN\0 (l_pobj) seizures_56\NNS\14081375
D011280_D012640 NONE pregnan-20-one_15\NNP\0 (r_parataxis) pregnanolone_9\NN\0 (r_appos) allopregnanolone_0\NN\0 (r_nsubjpass) tested_34\VBN\670261 (l_prep) for_35\IN\0 (l_pobj) ability_37\NN\4723816 (l_acl) suppress_39\VB\2510337 (l_dobj) expression_41\NN\4679549 (l_appos) effect_44\NN\34213 (l_conj) development_47\NN\248977 (l_prep) of_52\IN\0 (l_pobj) seizures_56\NNS\14081375
D011280_D012640 NONE allopregnanolone_24\NN\0 (r_pobj) of_23\IN\0 (r_prep) derivative_22\NN\5802185 (r_appos) ganaxolone_18\NN\0 (r_conj) pregnanolone_9\NN\0 (r_appos) allopregnanolone_0\NN\0 (r_nsubjpass) tested_34\VBN\670261 (l_prep) for_35\IN\0 (l_pobj) ability_37\NN\4723816 (l_acl) suppress_39\VB\2510337 (l_dobj) expression_41\NN\4679549 (l_appos) effect_44\NN\34213 (l_conj) development_47\NN\248977 (l_prep) of_52\IN\0 (l_pobj) seizures_56\NNS\14081375
D011280_D012640 NONE allopregnanolone_16\NN\0 (r_nsubj) inhibited_19\VBD\2510337 (r_advcl) suppressed_7\VBD\2510337 (l_dobj) expression_9\NN\4679549 (l_prep) of_10\IN\0 (l_pobj) seizures_12\NNS\14081375
C105051_D012640 NONE ganaxolone_18\NN\0 (r_conj) pregnanolone_9\NN\0 (r_appos) allopregnanolone_0\NN\0 (r_nsubjpass) tested_34\VBN\670261 (l_prep) for_35\IN\0 (l_pobj) ability_37\NN\4723816 (l_acl) suppress_39\VB\2510337 (l_dobj) expression_41\NN\4679549 (l_appos) effect_44\NN\34213 (l_conj) development_47\NN\248977 (l_prep) of_52\IN\0 (l_pobj) seizures_56\NNS\14081375
C105051_D012640 NONE pregnan-20-one_31\NNP\0 (r_appos) 3alpha_25\CD\0 (r_appos) allopregnanolone_24\NN\0 (r_pobj) of_23\IN\0 (r_prep) derivative_22\NN\5802185 (r_appos) ganaxolone_18\NN\0 (r_conj) pregnanolone_9\NN\0 (r_appos) allopregnanolone_0\NN\0 (r_nsubjpass) tested_34\VBN\670261 (l_prep) for_35\IN\0 (l_pobj) ability_37\NN\4723816 (l_acl) suppress_39\VB\2510337 (l_dobj) expression_41\NN\4679549 (l_appos) effect_44\NN\34213 (l_conj) development_47\NN\248977 (l_prep) of_52\IN\0 (l_pobj) seizures_56\NNS\14081375
C105051_D012640 NONE ganaxolone_18\NN\0 (r_conj) allopregnanolone_16\NN\0 (r_nsubj) inhibited_19\VBD\2510337 (r_advcl) suppressed_7\VBD\2510337 (l_dobj) expression_9\NN\4679549 (l_prep) of_10\IN\0 (l_pobj) seizures_12\NNS\14081375
D013256_D009422 NONE steroids_1\NNS\14727670 (r_nsubj) demonstrate_2\VBP\2137132 (l_dobj) actions_4\NNS\30358 (l_relcl) have_6\VBP\7846 (l_dobj) relevance_7\NN\13791389 (l_prep) for_8\IN\0 (l_pobj) host_10\NN\9605289 (l_prep) of_11\IN\0 (l_pobj) disorders_15\NNS\14034177
D013256_D012640 NONE steroids_4\NNS\14727670 (l_prep) against_5\IN\0 (l_pobj) seizures_9\NNS\14081375
D013256_D012640 NONE steroid_13\NN\14727670 (l_relcl) modulate_16\VBP\1724459 (l_dobj) acid_21\NN\14818238 (l_appos) receptor_26\NN\5225602 (l_prep) against_27\IN\0 (l_pobj) increase_29\NN\13576355 (l_prep) in_30\IN\13603305 (l_pobj) sensitivity_31\NN\5651971 (l_prep) to_32\IN\0 (l_pobj) effects_35\NNS\13245626 (l_prep) of_36\IN\0 (l_pobj) cocaine_37\NN\3492717 (l_acl) engendered_38\VBN\1645601 (l_agent) by_39\IN\0 (l_pobj) administration_42\NN\1133281 (l_appos) kindling_45\NN\15101361 (l_compound) seizure_44\NN\14081375
D003042_D012640 CID cocaine_6\NN\3492717 (r_compound) seizures_9\NNS\14081375
D003042_D012640 CID cocaine_37\NN\3492717 (l_acl) engendered_38\VBN\1645601 (l_agent) by_39\IN\0 (l_pobj) administration_42\NN\1133281 (l_appos) kindling_45\NN\15101361 (l_compound) seizure_44\NN\14081375
D003042_D012640 CID cocaine_41\NN\3492717 (r_compound) administration_42\NN\1133281 (l_appos) kindling_45\NN\15101361 (l_compound) seizure_44\NN\14081375
D003042_D012640 CID cocaine_53\NN\3492717 (r_npadvmod) kindled_55\VBN\2764245 (r_amod) seizures_56\NNS\14081375
D003042_D012640 CID cocaine_10\NN\3492717 (r_pobj) of_7\IN\0 (r_prep) administration_6\NN\1133281 (r_pobj) by_4\IN\0 (r_agent) induced_3\VBN\1627355 (l_csubjpass) kindled_0\VBN\2764245 (l_dobj) seizures_1\NNS\14081375
16904497
D014221_D011128 NONE triamcinolone_16\NN\14751417 (r_pobj) of_15\IN\0 (r_prep) injection_14\NN\320852 (r_pobj) by_12\IN\0 (r_agent) caused_11\VBN\1617192 (r_acl) report_5\NN\6470073 (l_prep) of_6\IN\0 (l_pobj) syndrome_9\NN\5870365
D002045_D011128 CID bupivacaine_18\NN\0 (r_conj) triamcinolone_16\NN\14751417 (r_pobj) of_15\IN\0 (r_prep) injection_14\NN\320852 (r_pobj) by_12\IN\0 (r_agent) caused_11\VBN\1617192 (r_acl) report_5\NN\6470073 (l_prep) of_6\IN\0 (l_pobj) syndrome_9\NN\5870365
D013256_D010146 NONE steroid_16\NN\14727670 (r_compound) injection_17\NN\320852 (r_pobj) for_14\IN\0 (r_prep) scheduled_13\VBN\704690 (l_nsubjpass) woman_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) pain_11\NN\14299637
D013256_D011128 NONE steroid_5\NN\14727670 (r_compound) injection_6\NN\320852 (r_pobj) after_3\IN\0 (r_prep) syndrome_2\NN\5870365
D013256_D009422 NONE steroid_10\NN\14727670 (r_compound) injections_11\NNS\320852 (r_pobj) after_8\IN\0 (r_prep) vigilance_4\NN\5650579 (l_prep) for_5\IN\0 (l_pobj) deterioration_7\NN\14560612
D013256_D011843 NONE steroid_11\NN\14727670 (r_compound) injections_12\NNS\320852 (r_conj) therapy_8\NN\657604 (r_attr) are_6\VBP\13600404 (l_nsubj) methods_2\NNS\5616786 (l_prep) of_3\IN\0 (l_pobj) radiculopathy_5\NN\0
D013256_D017116 NONE steroid_16\NN\14727670 (r_compound) injection_17\NN\320852 (r_pobj) for_14\IN\0 (r_prep) scheduled_13\VBN\704690 (l_nsubjpass) woman_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) pain_11\NN\14299637
12596116
D015282_D000860 NONE octreotide_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) hypoxemia_3\NN\0
D015282_D006976 CID octreotide_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) hypoxemia_3\NN\0 (l_conj) hypertension_6\NN\14057371
D015282_D006976 CID octreotide_10\NN\0 (r_advmod) developed_2\VBD\1753788 (l_nsubj) hypertension_1\NN\14057371
D015282_D005402 NONE octreotide_10\NN\0 (r_advmod) developed_2\VBD\1753788 (l_advcl) enhance_13\VB\227165 (l_dobj) resolution_14\NN\6470073 (l_prep) of_15\IN\0 (l_pobj) fistula_17\NN\14253124
16337777
D010862_D004833 CID pilocarpine_49\NN\14712692 (r_amod) model_50\NN\5888929 (l_prep) of_51\IN\0 (l_pobj) epilepsy_54\NN\14085708
D010862_D013226 NONE pilocarpine_49\NN\14712692 (r_amod) model_50\NN\5888929 (r_pobj) of_47\IN\0 (r_prep) phase_46\NN\15113229 (r_pobj) in_43\IN\13603305 (r_prep) provoke_18\VB\1617192 (r_xcomp) sufficient_16\JJ\0 (r_acomp) be_15\VB\14625458 (l_nsubj) generation_8\NN\7942152 (l_prep) during_11\IN\0 (l_pobj) epilepticus_13\NN\0
D010862_D004827 NONE pilocarpine_12\NN\14712692 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) model_7\NN\5888929 (l_prep) of_8\IN\0 (l_pobj) epilepsy_9\NN\14085708
18503483
D016559_D020968 CID tacrolimus_2\NN\0 (r_npadvmod) associated_4\VBN\628491 (r_amod) neuritis_6\NN\14336539
C107135_D020968 NONE everolimus_10\NN\0 (r_pobj) to_9\TO\0 (r_prep) conversion_8\NN\7359599 (r_pobj) after_7\IN\0 (r_prep) recovery_0\NN\7357388 (l_prep) of_1\IN\0 (l_pobj) neuritis_6\NN\14336539
11334364
D000082_D066126 NONE acetaminophen_13\RB\2707683 (r_advmod) induced_15\VBN\1627355 (r_amod) nephrotoxicity_16\NN\0 (l_conj) toxicity_22\NN\13576101 (l_conj) cardiotoxicity_27\NN\0
D000082_D066126 NONE acetaminophen_16\RB\2707683 (r_advmod) prevent_15\VB\0 (l_dobj) toxicity_25\NN\13576101 (l_conj) doxorubicin_28\NN\2716866 (l_dobj) cardiotoxicity_31\NN\0
D000082_D066126 NONE aap)-induced_18\VBN\0 (r_compound) nephrotoxicity_19\NN\0 (r_nmod) toxicity_25\NN\13576101 (l_conj) doxorubicin_28\NN\2716866 (l_dobj) cardiotoxicity_31\NN\0
D000638_D066126 NONE amiodarone_18\NN\2715941 (r_npadvmod) induced_20\VBN\1627355 (r_amod) toxicity_22\NN\13576101 (l_conj) cardiotoxicity_27\NN\0
D000638_D066126 NONE amiodarone_21\NN\2715941 (r_appos) nephrotoxicity_19\NN\0 (r_nmod) toxicity_25\NN\13576101 (l_conj) doxorubicin_28\NN\2716866 (l_dobj) cardiotoxicity_31\NN\0
D000638_D066126 NONE ami)-induced_23\JJ\0 (r_amod) toxicity_25\NN\13576101 (l_conj) doxorubicin_28\NN\2716866 (l_dobj) cardiotoxicity_31\NN\0
D000638_D007674 NONE amiodarone_18\NN\2715941 (r_npadvmod) induced_20\VBN\1627355 (r_amod) toxicity_22\NN\13576101 (r_conj) nephrotoxicity_16\NN\0
D000638_D007674 NONE amiodarone_21\NN\2715941 (r_appos) nephrotoxicity_19\NN\0
D000638_D007674 NONE ami)-induced_23\JJ\0 (r_amod) toxicity_25\NN\13576101 (l_nmod) nephrotoxicity_19\NN\0
C511402_D009336 NONE extract_35\NN\14589223 (r_pobj) by_28\IN\0 (r_prep) cardiotoxicity_27\NN\0 (r_conj) toxicity_22\NN\13576101 (r_conj) nephrotoxicity_16\NN\0 (r_pobj) during_12\IN\0 (r_prep) deaths_11\NNS\7296428 (l_amod) apoptotic_7\JJ\0 (l_conj) necrotic_9\JJ\0
C511402_D009336 NONE gspe_31\NNP\0 (r_pobj) by_30\IN\0 (r_agent) blocked_29\VBN\1476483 (r_relcl) necrosis_20\NN\11444117
C511402_D008171 NONE extract_35\NN\14589223 (r_pobj) by_28\IN\0 (r_prep) cardiotoxicity_27\NN\0 (r_conj) toxicity_22\NN\13576101
C511402_D008171 NONE extract_10\NN\14589223 (r_pobj) of_5\IN\0 (r_prep) ability_4\NN\4723816 (l_acl) prevent_15\VB\0 (l_dobj) toxicity_25\NN\13576101
C511402_D008171 NONE gspe_12\NNP\0 (r_appos) extract_10\NN\14589223 (r_pobj) of_5\IN\0 (r_prep) ability_4\NN\4723816 (l_acl) prevent_15\VB\0 (l_dobj) toxicity_25\NN\13576101
D000082_D007674 CID acetaminophen_13\RB\2707683 (r_advmod) induced_15\VBN\1627355 (r_amod) nephrotoxicity_16\NN\0
D000082_D007674 CID acetaminophen_16\RB\2707683 (r_advmod) prevent_15\VB\0 (l_dobj) toxicity_25\NN\13576101 (l_nmod) nephrotoxicity_19\NN\0
D000082_D007674 CID aap)-induced_18\VBN\0 (r_compound) nephrotoxicity_19\NN\0
D000638_D009336 CID amiodarone_18\NN\2715941 (r_npadvmod) induced_20\VBN\1627355 (r_amod) toxicity_22\NN\13576101 (r_conj) nephrotoxicity_16\NN\0 (r_pobj) during_12\IN\0 (r_prep) deaths_11\NNS\7296428 (l_amod) apoptotic_7\JJ\0 (l_conj) necrotic_9\JJ\0
D000638_D009336 CID ami_11\NNP\0 (r_conj) aap_9\NNP\0 (r_appos) drugs_4\NNS\14778436 (r_nsubj) induced_14\VBD\1627355 (l_prep) in_17\IN\13603305 (l_pobj) addition_18\NN\3081021 (l_prep) to_19\IN\0 (l_pobj) necrosis_20\NN\11444117
C511402_D017695 NONE gspe_30\NNP\0 (r_compound) preexposure_31\NN\0 (r_pobj) of_29\IN\0 (r_prep) absence_28\NN\14449405 (r_pobj) in_26\IN\13603305 (r_prep) variety_17\NN\7951464 (r_pobj) with_15\IN\0 (r_prep) damage_14\NN\7296428
D000638_D008171 CID amiodarone_18\NN\2715941 (r_npadvmod) induced_20\VBN\1627355 (r_amod) toxicity_22\NN\13576101
D000638_D008171 CID amiodarone_21\NN\2715941 (r_appos) nephrotoxicity_19\NN\0 (r_nmod) toxicity_25\NN\13576101
D000638_D008171 CID ami)-induced_23\JJ\0 (r_amod) toxicity_25\NN\13576101
D004317_D007674 NONE doxorubicin_24\NN\2716866 (r_npadvmod) induced_26\VBN\1627355 (r_amod) cardiotoxicity_27\NN\0 (r_conj) toxicity_22\NN\13576101 (r_conj) nephrotoxicity_16\NN\0
D004317_D007674 NONE doxorubicin_28\NN\2716866 (r_conj) toxicity_25\NN\13576101 (l_nmod) nephrotoxicity_19\NN\0
D004317_D007674 NONE dox)-induced_30\JJ\0 (r_amod) cardiotoxicity_31\NN\0 (r_dobj) doxorubicin_28\NN\2716866 (r_conj) toxicity_25\NN\13576101 (l_nmod) nephrotoxicity_19\NN\0
D000082_D009336 CID acetaminophen_13\RB\2707683 (r_advmod) induced_15\VBN\1627355 (r_amod) nephrotoxicity_16\NN\0 (r_pobj) during_12\IN\0 (r_prep) deaths_11\NNS\7296428 (l_amod) apoptotic_7\JJ\0 (l_conj) necrotic_9\JJ\0
D000082_D009336 CID aap_9\NNP\0 (r_appos) drugs_4\NNS\14778436 (r_nsubj) induced_14\VBD\1627355 (l_prep) in_17\IN\13603305 (l_pobj) addition_18\NN\3081021 (l_prep) to_19\IN\0 (l_pobj) necrosis_20\NN\11444117
C511402_D007674 NONE extract_35\NN\14589223 (r_pobj) by_28\IN\0 (r_prep) cardiotoxicity_27\NN\0 (r_conj) toxicity_22\NN\13576101 (r_conj) nephrotoxicity_16\NN\0
C511402_D007674 NONE extract_10\NN\14589223 (r_pobj) of_5\IN\0 (r_prep) ability_4\NN\4723816 (l_acl) prevent_15\VB\0 (l_dobj) toxicity_25\NN\13576101 (l_nmod) nephrotoxicity_19\NN\0
C511402_D007674 NONE gspe_12\NNP\0 (r_appos) extract_10\NN\14589223 (r_pobj) of_5\IN\0 (r_prep) ability_4\NN\4723816 (l_acl) prevent_15\VB\0 (l_dobj) toxicity_25\NN\13576101 (l_nmod) nephrotoxicity_19\NN\0
D004317_D008171 NONE doxorubicin_24\NN\2716866 (r_npadvmod) induced_26\VBN\1627355 (r_amod) cardiotoxicity_27\NN\0 (r_conj) toxicity_22\NN\13576101
D004317_D008171 NONE doxorubicin_28\NN\2716866 (r_conj) toxicity_25\NN\13576101
D004317_D008171 NONE dox)-induced_30\JJ\0 (r_amod) cardiotoxicity_31\NN\0 (r_dobj) doxorubicin_28\NN\2716866 (r_conj) toxicity_25\NN\13576101
D000082_D008171 NONE acetaminophen_13\RB\2707683 (r_advmod) induced_15\VBN\1627355 (r_amod) nephrotoxicity_16\NN\0 (l_conj) toxicity_22\NN\13576101
D000082_D008171 NONE acetaminophen_16\RB\2707683 (r_advmod) prevent_15\VB\0 (l_dobj) toxicity_25\NN\13576101
D000082_D008171 NONE aap)-induced_18\VBN\0 (r_compound) nephrotoxicity_19\NN\0 (r_nmod) toxicity_25\NN\13576101
D004317_D009336 CID doxorubicin_24\NN\2716866 (r_npadvmod) induced_26\VBN\1627355 (r_amod) cardiotoxicity_27\NN\0 (r_conj) toxicity_22\NN\13576101 (r_conj) nephrotoxicity_16\NN\0 (r_pobj) during_12\IN\0 (r_prep) deaths_11\NNS\7296428 (l_amod) apoptotic_7\JJ\0 (l_conj) necrotic_9\JJ\0
D004317_D009336 CID dox_13\NNP\0 (r_conj) ami_11\NNP\0 (r_conj) aap_9\NNP\0 (r_appos) drugs_4\NNS\14778436 (r_nsubj) induced_14\VBD\1627355 (l_prep) in_17\IN\13603305 (l_pobj) addition_18\NN\3081021 (l_prep) to_19\IN\0 (l_pobj) necrosis_20\NN\11444117
C511402_D066126 NONE extract_35\NN\14589223 (r_pobj) by_28\IN\0 (r_prep) cardiotoxicity_27\NN\0
C511402_D066126 NONE extract_10\NN\14589223 (r_pobj) of_5\IN\0 (r_prep) ability_4\NN\4723816 (l_acl) prevent_15\VB\0 (l_dobj) toxicity_25\NN\13576101 (l_conj) doxorubicin_28\NN\2716866 (l_dobj) cardiotoxicity_31\NN\0
C511402_D066126 NONE gspe_12\NNP\0 (r_appos) extract_10\NN\14589223 (r_pobj) of_5\IN\0 (r_prep) ability_4\NN\4723816 (l_acl) prevent_15\VB\0 (l_dobj) toxicity_25\NN\13576101 (l_conj) doxorubicin_28\NN\2716866 (l_dobj) cardiotoxicity_31\NN\0
D004317_D066126 CID doxorubicin_24\NN\2716866 (r_npadvmod) induced_26\VBN\1627355 (r_amod) cardiotoxicity_27\NN\0
D004317_D066126 CID doxorubicin_28\NN\2716866 (l_dobj) cardiotoxicity_31\NN\0
D004317_D066126 CID dox)-induced_30\JJ\0 (r_amod) cardiotoxicity_31\NN\0
19346865
D008795_D007239 NONE metronidazole_4\NN\2723292 (r_dobj) taking_3\VBG\37396 (l_advcl) treat_23\VB\7570720 (l_dobj) infection_25\NN\14052046
D008795_D001927 CID metronidazole_5\NN\2723292 (r_npadvmod) induced_7\VBN\1627355 (r_amod) encephalopathy_8\NN\14084880 (r_pobj) in_4\IN\13603305 (r_prep) lesion_3\NN\14204950
D008795_D001927 CID metronidazole_5\NN\2723292 (r_npadvmod) induced_7\VBN\1627355 (r_amod) encephalopathy_8\NN\14084880
D008795_D001927 CID metronidazole_9\NN\2723292 (r_npadvmod) induced_11\VBN\1627355 (r_amod) encephalopathy_12\NN\14084880 (r_pobj) in_8\IN\13603305 (r_prep) lesions_7\NNS\14204950
D008795_D001927 CID metronidazole_9\NN\2723292 (r_npadvmod) induced_11\VBN\1627355 (r_amod) encephalopathy_12\NN\14084880
D008795_D001927 CID metronidazole_20\NN\2723292 (r_npadvmod) induced_22\VBN\1627355 (r_amod) encephalopathy_23\NN\14084880
D008795_D001927 CID metronidazole_11\NN\2723292 (r_npadvmod) induced_13\VBN\1627355 (r_amod) encephalopathy_14\NN\14084880 (r_pobj) for_10\IN\0 (r_prep) characteristic_9\NN\5849040 (r_pobj) as_7\IN\14622893 (r_prep) considered_6\VBN\689344 (l_nsubjpass) lesions_3\NNS\14204950
D008795_D001927 CID metronidazole_11\NN\2723292 (r_npadvmod) induced_13\VBN\1627355 (r_amod) encephalopathy_14\NN\14084880
3970039
D003520_D002277 CID cyclophosphamide_0\NNP\0 (r_compound) therapy_1\NN\657604 (r_nsubj) increases_2\VBZ\13576355 (l_dobj) risk_4\NN\14541044 (l_prep) of_5\IN\0 (l_pobj) carcinoma_6\NN\14239918 (l_prep) of_7\IN\0 (l_pobj) bladder_9\NN\5515670
D000477_D015470 CID agents_4\NNS\7347 (r_pobj) with_2\IN\0 (r_prep) treated_1\VBN\2376958 (r_csubj) have_5\VBP\7846 (l_dobj) risk_8\NN\14541044 (l_prep) of_9\IN\0 (l_pobj) development_10\NN\248977 (l_prep) of_11\IN\0 (l_pobj) leukemia_14\NN\14239918
D000477_D015470 CID agents_19\NNS\7347 (r_nsubjpass) associated_23\VBN\628491 (r_conj) have_5\VBP\7846 (l_dobj) risk_8\NN\14541044 (l_prep) of_9\IN\0 (l_pobj) development_10\NN\248977 (l_prep) of_11\IN\0 (l_pobj) leukemia_14\NN\14239918
D000477_D009369 NONE agents_31\NNS\7347 (r_appos) drugs_27\NNS\14778436 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_nsubjpass) reserved_41\VBN\2213690 (r_conj) collected_14\VBN\2281093 (l_nsubjpass) data_0\NNS\7951464 (l_prep) on_1\IN\0 (l_pobj) risk_5\NN\14541044 (l_prep) of_6\IN\0 (l_pobj) malignancy_7\NN\14070360
D003520_D001172 NONE cyclophosphamide_17\NN\0 (r_conj) azathioprine_15\NN\3740161 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) studies_7\NNS\635850 (l_prep) of_8\IN\0 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) arthritis_12\NN\14171682
D000477_D001172 NONE agents_31\NNS\7347 (r_appos) drugs_27\NNS\14778436 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_nsubjpass) reserved_41\VBN\2213690 (r_conj) collected_14\VBN\2281093 (l_nsubjpass) data_0\NNS\7951464 (l_prep) on_1\IN\0 (l_pobj) risk_5\NN\14541044 (l_prep) of_6\IN\0 (l_pobj) malignancy_7\NN\14070360 (l_prep) in_8\IN\13603305 (l_pobj) arthritis_10\NN\14171682
D000477_D001172 NONE agents_31\NNS\7347 (r_appos) drugs_27\NNS\14778436 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (l_prep) in_33\IN\13603305 (l_pobj) treatment_35\NN\654885 (l_prep) of_36\IN\0 (l_pobj) arthritis_38\NN\14171682
D003520_D009369 NONE cyclophosphamide_17\NN\0 (r_conj) azathioprine_15\NN\3740161 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) studies_7\NNS\635850 (r_attr) been_2\VBN\0 (l_conj) increased_29\VBN\169651 (l_nsubjpass) incidence_20\NN\13821570 (l_prep) of_21\IN\0 (l_pobj) most_22\JJS\0 (l_prep) of_23\IN\0 (l_pobj) cancers_26\NNS\14239425
D003520_D001749 CID cyclophosphamide_0\NNP\0 (r_compound) therapy_1\NN\657604 (r_nsubj) increases_2\VBZ\13576355 (l_dobj) risk_4\NN\14541044 (l_prep) of_5\IN\0 (l_pobj) carcinoma_6\NN\14239918 (l_prep) of_7\IN\0 (l_pobj) bladder_9\NN\5515670
D000477_D008228 CID agents_4\NNS\7347 (r_pobj) with_2\IN\0 (r_prep) treated_1\VBN\2376958 (r_csubj) have_5\VBP\7846 (l_conj) associated_23\VBN\628491 (l_prep) with_24\IN\0 (l_pobj) development_26\NN\248977 (l_prep) of_27\IN\0 (l_pobj) lymphoma_32\NN\14239918
D000477_D008228 CID agents_19\NNS\7347 (r_nsubjpass) associated_23\VBN\628491 (l_prep) with_24\IN\0 (l_pobj) development_26\NN\248977 (l_prep) of_27\IN\0 (l_pobj) lymphoma_32\NN\14239918
D001379_D009369 NONE azathioprine_15\NN\3740161 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) studies_7\NNS\635850 (r_attr) been_2\VBN\0 (l_conj) increased_29\VBN\169651 (l_nsubjpass) incidence_20\NN\13821570 (l_prep) of_21\IN\0 (l_pobj) most_22\JJS\0 (l_prep) of_23\IN\0 (l_pobj) cancers_26\NNS\14239425
D001379_D001172 NONE azathioprine_15\NN\3740161 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) studies_7\NNS\635850 (l_prep) of_8\IN\0 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) arthritis_12\NN\14171682
D001379_D008228 CID azathioprine_21\NN\3740161 (r_conj) agents_19\NNS\7347 (r_nsubjpass) associated_23\VBN\628491 (l_prep) with_24\IN\0 (l_pobj) development_26\NN\248977 (l_prep) of_27\IN\0 (l_pobj) lymphoma_32\NN\14239918
D001379_D015470 NONE azathioprine_21\NN\3740161 (r_conj) agents_19\NNS\7347 (r_nsubjpass) associated_23\VBN\628491 (r_conj) have_5\VBP\7846 (l_dobj) risk_8\NN\14541044 (l_prep) of_9\IN\0 (l_pobj) development_10\NN\248977 (l_prep) of_11\IN\0 (l_pobj) leukemia_14\NN\14239918
2266990
D008454_D001068 CID mazindol_4\NN\0 (r_pobj) to_3\IN\0 (r_prep) attributable_2\JJ\0 (r_amod) effects_1\NNS\13245626 (r_nsubj) included_5\VBN\0 (l_dobj) appetite_7\NN\7485475
D008454_D001068 CID mazindol_35\NN\0 (r_amod) dosage_36\NN\13576355 (r_nsubjpass) reduced_38\VBN\441445 (l_ccomp) included_5\VBN\0 (l_dobj) appetite_7\NN\7485475
D008454_D020388 NONE mazindol_7\NN\0 (l_prep) in_8\IN\13603305 (l_pobj) dystrophy_10\NN\14151139
D008454_D020388 NONE mazindol_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) trial_5\NN\786195 (r_dobj) conducted_1\VBD\2436349 (l_prep) in_16\IN\13603305 (l_pobj) boys_18\NNS\9624168 (l_prep) with_19\IN\0 (l_pobj) dystrophy_21\NN\14151139
D008454_D020388 NONE mazindol_0\JJ\0 (r_compound) doses_1\NNS\3740161 (r_nsubj) slow_3\VBP\151689 (l_dobj) progression_5\NN\8457976 (l_prep) of_6\IN\0 (l_pobj) weakness_7\NN\14462666 (l_prep) in_8\IN\13603305 (l_pobj) dystrophy_10\NN\14151139
D008454_D014987 CID mazindol_4\NN\0 (r_pobj) to_3\IN\0 (r_prep) attributable_2\JJ\0 (r_amod) effects_1\NNS\13245626 (r_nsubj) included_5\VBN\0 (l_dobj) appetite_7\NN\7485475 (l_appos) mouth_14\NN\5610008
D008454_D014987 CID mazindol_35\NN\0 (r_amod) dosage_36\NN\13576355 (r_nsubjpass) reduced_38\VBN\441445 (l_ccomp) included_5\VBN\0 (l_dobj) appetite_7\NN\7485475 (l_appos) mouth_14\NN\5610008
D008454_D018908 NONE mazindol_0\JJ\0 (r_compound) doses_1\NNS\3740161 (r_nsubj) slow_3\VBP\151689 (l_dobj) progression_5\NN\8457976 (l_prep) of_6\IN\0 (l_pobj) weakness_7\NN\14462666
D008454_D012817 CID mazindol_4\NN\0 (r_pobj) to_3\IN\0 (r_prep) attributable_2\JJ\0 (r_amod) effects_1\NNS\13245626 (r_nsubj) included_5\VBN\0 (l_dobj) appetite_7\NN\7485475 (l_appos) change_21\NN\7283608 (l_conj) symptoms_29\NNS\5823932
D008454_D012817 CID mazindol_35\NN\0 (r_amod) dosage_36\NN\13576355 (r_nsubjpass) reduced_38\VBN\441445 (l_ccomp) included_5\VBN\0 (l_dobj) appetite_7\NN\7485475 (l_appos) change_21\NN\7283608 (l_conj) symptoms_29\NNS\5823932
6861444
D009638_D006973 CID noradrenaline_3\NN\14807929 (r_pobj) of_2\IN\0 (r_prep) infusion_1\NN\14589223 (r_nsubj) caused_4\VBD\1617192 (l_dobj) hypertension_5\NN\14057371
D009638_D006973 CID noradrenaline_8\NN\14807929 (r_amod) infusion_9\NN\14589223 (r_pobj) after_5\IN\0 (r_prep) hypertension_4\NN\14057371
D009638_D006973 CID noradrenaline_18\NN\14807929 (r_dobj) circulating_17\VBG\1835496 (r_pcomp) of_16\IN\0 (r_prep) levels_15\NNS\4916342 (r_pobj) by_12\IN\0 (r_agent) produced_11\VBN\1617192 (l_nsubjpass) hypertension_4\NN\14057371
137340
D010830_D006948 NONE physostigmine_12\NN\14712692 (r_pobj) by_11\IN\0 (r_agent) attenuated_10\VBN\224901 (r_conj) potentiated_6\VBN\229605 (l_nsubjpass) hyperactivity_4\NN\14052403
D012701_D006948 NONE serotonin_22\NN\14807737 (r_compound) depletor_23\NN\0 (r_nsubj) caused_25\VBD\1617192 (l_dobj) change_28\NN\7283608 (l_prep) in_29\IN\13603305 (l_pobj) hyperactivity_31\NN\14052403
D009388_D006948 NONE neostigmine_6\NN\2718084 (r_conj) methscopolamine_4\NN\0 (r_nsubj) had_18\VBD\0 (l_dobj) effect_20\NN\34213 (l_prep) on_21\IN\0 (l_pobj) hyperactivity_23\NN\14052403
D012601_D006948 CID scopolamine_8\NN\14712692 (r_pobj) by_7\IN\0 (r_agent) potentiated_6\VBN\229605 (l_nsubjpass) hyperactivity_4\NN\14052403
D010134_D006948 NONE chlorophenylalamine_9\NN\0 (r_pobj) with_6\IN\0 (r_prep) pretreatment_5\NN\0 (r_nsubj) caused_25\VBD\1617192 (l_dobj) change_28\NN\7283608 (l_prep) in_29\IN\13603305 (l_pobj) hyperactivity_31\NN\14052403
D019832_D006948 NONE methscopolamine_4\NN\0 (r_nsubj) had_18\VBD\0 (l_dobj) effect_20\NN\34213 (l_prep) on_21\IN\0 (l_pobj) hyperactivity_23\NN\14052403
D009020_D006948 CID morphine_5\NN\2707683 (r_npadvmod) induced_7\VBN\1627355 (r_amod) increase_8\NN\13576355 (l_prep) in_9\IN\13603305 (l_pobj) activity_11\NN\30358
D009020_D006948 CID morphine_7\NN\2707683 (r_npadvmod) induced_9\VBN\1627355 (r_amod) increase_10\NN\13576355 (l_prep) in_11\IN\13603305 (l_pobj) activity_13\NN\30358
D009020_D006948 CID morphine_7\NN\2707683 (r_compound) hc1_9\NNP\0 (r_pobj) of_6\IN\0 (r_prep) mg/kg_5\NN\0 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) produced_10\VBD\1617192 (l_dobj) increase_13\NN\13576355 (l_prep) in_14\IN\13603305 (l_pobj) activity_16\NN\30358
D009020_D006948 CID morphine_1\NN\2707683 (r_npadvmod) induced_3\VBN\1627355 (r_amod) hyperactivity_4\NN\14052403
D009020_D006948 CID morphine_26\NN\2707683 (r_pobj) by_25\IN\0 (r_agent) produced_24\VBN\1617192 (r_acl) hyperactivity_23\NN\14052403
227508
D008750_D007022 CID methyldopa_8\NN\2721160 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (l_amod) hypotensive_1\JJ\10405694
D003000_D006973 NONE clonidine_17\NN\2721160 (r_pobj) by_15\IN\0 (r_agent) produced_14\VBN\1617192 (r_acl) pressure_10\NN\11419404 (r_pobj) in_8\IN\13603305 (r_prep) decrease_7\NN\7296428 (r_dobj) rats_5\NNS\2329401 (l_amod) hypertensive_4\JJ\10405694
D003000_D006973 NONE clonidine_7\NN\2721160 (r_preconj) in_0\IN\13603305 (l_pobj) membranes_2\NNS\4188643 (l_prep) from_3\IN\0 (l_pobj) rats_6\NNS\2329401 (l_amod) hypertensive_5\JJ\10405694
D003000_D006973 NONE clonidine_42\NN\2721160 (r_npadvmod) suppressible_44\NN\0 (r_amod) binding_45\NN\4688246 (r_dobj) influence_41\VB\5190804 (r_conj) influence_18\VB\5190804 (l_prep) in_0\IN\13603305 (l_pobj) membranes_2\NNS\4188643 (l_prep) from_3\IN\0 (l_pobj) rats_6\NNS\2329401 (l_amod) hypertensive_5\JJ\10405694
-1_D006973 NONE nalozone_31\NN\0 (r_pobj) by_30\IN\0 (r_agent) reversed_29\VBN\109660 (r_conj) inhibited_27\VBN\2510337 (r_conj) rats_5\NNS\2329401 (l_amod) hypertensive_4\JJ\10405694
-1_D006973 NONE 3h]-naloxone_23\CD\0 (r_pobj) of_21\IN\0 (r_prep) binding_20\NN\4688246 (r_dobj) influence_18\VB\5190804 (l_prep) in_0\IN\13603305 (l_pobj) membranes_2\NNS\4188643 (l_prep) from_3\IN\0 (l_pobj) rats_6\NNS\2329401 (l_amod) hypertensive_5\JJ\10405694
-1_D006973 NONE 3h]-dihydroergocryptine_48\CD\0 (r_nummod) nm_51\NNP\13649268 (r_pobj) of_46\IN\0 (r_prep) binding_45\NN\4688246 (r_dobj) influence_41\VB\5190804 (r_conj) influence_18\VB\5190804 (l_prep) in_0\IN\13603305 (l_pobj) membranes_2\NNS\4188643 (l_prep) from_3\IN\0 (l_pobj) rats_6\NNS\2329401 (l_amod) hypertensive_5\JJ\10405694
D009270_D006973 NONE naloxone_30\NN\3808977 (r_nsubj) influence_41\VB\5190804 (r_conj) influence_18\VB\5190804 (l_prep) in_0\IN\13603305 (l_pobj) membranes_2\NNS\4188643 (l_prep) from_3\IN\0 (l_pobj) rats_6\NNS\2329401 (l_amod) hypertensive_5\JJ\10405694
D009270_D007022 NONE naloxone_14\NN\3808977 (r_pobj) by_13\IN\0 (r_agent) reversed_12\VBN\109660 (l_nsubjpass) effect_2\NN\34213 (l_amod) hypotensive_1\JJ\10405694
16680561
C476217_D006261 CID cinacalcet_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) receiving_12\VBG\2210855 (r_pcomp) than_10\IN\0 (r_prep) alone_9\RB\0 (r_amod) events_4\NNS\23100 (r_dobj) reported_2\VBD\831651 (r_ccomp) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637 (l_conj) headache_31\NN\5829480
C476217_D006261 CID cinacalcet_43\NN\0 (r_conj) desipramine_41\NN\4482543 (r_pobj) with_39\IN\0 (r_prep) treated_38\VBN\2376958 (r_acl) patients_37\NNS\9898892 (r_pobj) for_36\IN\0 (r_prep) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637 (l_conj) headache_31\NN\5829480
C476217_D009325 CID cinacalcet_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) receiving_12\VBG\2210855 (r_pcomp) than_10\IN\0 (r_prep) alone_9\RB\0 (r_amod) events_4\NNS\23100 (r_dobj) reported_2\VBD\831651 (r_ccomp) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637
C476217_D009325 CID cinacalcet_43\NN\0 (r_conj) desipramine_41\NN\4482543 (r_pobj) with_39\IN\0 (r_prep) treated_38\VBN\2376958 (r_acl) patients_37\NNS\9898892 (r_pobj) for_36\IN\0 (r_prep) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637
D003891_D006261 CID desipramine_8\NN\4482543 (r_pobj) with_7\IN\0 (r_prep) treatment_6\NN\654885 (r_dobj) following_5\VBG\8180190 (r_acl) events_4\NNS\23100 (r_dobj) reported_2\VBD\831651 (r_ccomp) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637 (l_conj) headache_31\NN\5829480
D003891_D006261 CID desipramine_13\NN\4482543 (r_dobj) receiving_12\VBG\2210855 (r_pcomp) than_10\IN\0 (r_prep) alone_9\RB\0 (r_amod) events_4\NNS\23100 (r_dobj) reported_2\VBD\831651 (r_ccomp) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637 (l_conj) headache_31\NN\5829480
D003891_D006261 CID desipramine_41\NN\4482543 (r_pobj) with_39\IN\0 (r_prep) treated_38\VBN\2376958 (r_acl) patients_37\NNS\9898892 (r_pobj) for_36\IN\0 (r_prep) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637 (l_conj) headache_31\NN\5829480
D003891_D009325 CID desipramine_8\NN\4482543 (r_pobj) with_7\IN\0 (r_prep) treatment_6\NN\654885 (r_dobj) following_5\VBG\8180190 (r_acl) events_4\NNS\23100 (r_dobj) reported_2\VBD\831651 (r_ccomp) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637
D003891_D009325 CID desipramine_13\NN\4482543 (r_dobj) receiving_12\VBG\2210855 (r_pcomp) than_10\IN\0 (r_prep) alone_9\RB\0 (r_amod) events_4\NNS\23100 (r_dobj) reported_2\VBD\831651 (r_ccomp) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637
D003891_D009325 CID desipramine_41\NN\4482543 (r_pobj) with_39\IN\0 (r_prep) treated_38\VBN\2376958 (r_acl) patients_37\NNS\9898892 (r_pobj) for_36\IN\0 (r_prep) reported_35\VBN\831651 (l_nsubjpass) nausea_29\NN\14299637
7881871
D011692_D011507 CID aminonucleoside_12\NN\0 (r_nmod) nephropathy_15\NN\14573196 (r_pobj) of_9\IN\0 (r_prep) pathogenesis_8\NN\13533470 (r_pobj) in_6\IN\13603305 (r_prep) implicated_5\VBN\2677097 (l_prep) with_17\IN\0 (l_pcomp) reducing_20\VBG\13447361 (l_dobj) proteinuria_22\NN\14299637
D011692_D011507 CID pan)-induced_14\JJ\0 (r_amod) nephropathy_15\NN\14573196 (r_pobj) of_9\IN\0 (r_prep) pathogenesis_8\NN\13533470 (r_pobj) in_6\IN\13603305 (r_prep) implicated_5\VBN\2677097 (l_prep) with_17\IN\0 (l_pcomp) reducing_20\VBG\13447361 (l_dobj) proteinuria_22\NN\14299637
D011692_D011507 CID pan_14\NNP\3101986 (r_compound) nephropathy_15\NN\14573196 (r_pobj) in_13\IN\13603305 (r_prep) injury_12\NN\14052046
D010100_D011507 NONE oxygen_1\NN\14622893 (r_compound) species_2\NNS\7992450 (r_nsubjpass) implicated_5\VBN\2677097 (l_prep) with_17\IN\0 (l_pcomp) reducing_20\VBG\13447361 (l_dobj) proteinuria_22\NN\14299637
D010100_D007674 NONE oxygen_1\NN\14622893 (r_compound) species_2\NNS\7992450 (r_nsubjpass) implicated_5\VBN\2677097 (l_prep) in_6\IN\13603305 (l_pobj) pathogenesis_8\NN\13533470 (l_prep) of_9\IN\0 (l_pobj) nephropathy_15\NN\14573196
D011692_D007674 CID aminonucleoside_7\NN\0 (r_advmod) induced_9\VBN\1627355 (r_amod) nephropathy_10\NN\14573196
D011692_D007674 CID aminonucleoside_12\NN\0 (r_nmod) nephropathy_15\NN\14573196
D011692_D007674 CID pan)-induced_14\JJ\0 (r_amod) nephropathy_15\NN\14573196
D011692_D007674 CID pan_14\NNP\3101986 (r_compound) nephropathy_15\NN\14573196
6666578
D010396_D001018 CID penicillamine_2\NN\3740161 (r_compound) induced_4\VBN\1627355 (l_advmod) angiopathy_5\NN\14204950
9249847
D014700_D013611 CID verapamil_7\NN\2938514 (r_nmod) ablation_10\NN\671351 (r_pobj) after_6\IN\0 (r_prep) induced_1\VBD\1627355 (l_dobj) tachycardia_5\NN\14110674
D014700_D013611 CID verapamil_10\NN\2938514 (r_nmod) block_14\NN\21939 (r_pobj) after_9\IN\0 (r_prep) beats_8\NNS\8289449 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) qrs_0\UH\0 (r_nsubj) established_22\VBD\2426171 (l_dobj) attack_25\NN\955060 (l_compound) avrt_24\NN\0
D014700_D002311 NONE verapamil_7\NN\2938514 (r_nmod) ablation_10\NN\671351 (l_conj) cardiomyopathy_24\NN\14103288
D014700_D014927 NONE verapamil_7\NN\2938514 (r_nmod) ablation_10\NN\671351 (l_prep) in_11\IN\13603305 (l_pobj) patient_13\NN\9898892 (l_prep) with_14\IN\0 (l_pobj) syndrome_20\NN\5870365
3107448
D005905_D003924 NONE glyburide_18\NN\2719105 (r_amod) therapy_19\NN\657604 (r_pobj) of_17\IN\0 (r_prep) initiation_16\NN\7450842 (r_pobj) after_15\IN\0 (r_prep) developed_7\VBD\1753788 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) mellitus_6\NN\0
D005905_D056486 CID glyburide_0\NN\2719105 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hepatitis_3\NN\14127211
D005905_D056486 CID glyburide_1\NN\2719105 (r_pobj) for_0\IN\0 (r_prep) exist_15\VBP\0 (l_nsubj) reports_12\NNS\6470073 (l_prep) of_13\IN\0 (l_pobj) hepatotoxicity_14\NN\0
D005905_D056486 CID glyburide_18\NN\2719105 (r_amod) therapy_19\NN\657604 (r_pobj) of_17\IN\0 (r_prep) initiation_16\NN\7450842 (r_pobj) after_15\IN\0 (r_prep) developed_7\VBD\1753788 (l_dobj) syndrome_13\NN\5870365
D005905_D056486 CID glyburide_0\NNP\2719105 (r_nsubj) produce_2\VB\7555863 (l_dobj) illness_8\NN\14052046
D013453_D056486 NONE sulfonylureas_14\NNS\2719105 (r_pobj) with_13\IN\0 (r_prep) reported_10\VBN\831651 (l_nsubjpass) hepatotoxicity_3\NN\0
D013453_D056486 NONE sulfonylurea_7\NN\2719105 (r_nsubj) exist_15\VBP\0 (l_nsubj) reports_12\NNS\6470073 (l_prep) of_13\IN\0 (l_pobj) hepatotoxicity_14\NN\0
6387529
D003975_D000379 NONE diazepam_3\NN\2830852 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_conj) propranolol_5\NN\0 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) disorder_10\NN\14034177 (l_conj) agoraphobia_12\NNP\14381416
D003975_D000379 NONE diazepam_6\NN\2830852 (r_pobj) of_5\IN\0 (r_prep) doses_4\NNS\3740161 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubj) propranolol_27\NN\0 (r_advcl) investigated_58\VBN\644583 (l_nsubjpass) dose_37\NN\3740161 (l_prep) on_47\IN\0 (l_pobj) performance_49\NN\6619065 (l_prep) of_50\IN\0 (l_pobj) patients_51\NNS\9898892 (l_prep) with_52\IN\0 (l_pobj) disorders_54\NNS\14034177 (l_conj) agoraphobia_56\NNP\14381416
D011433_D000379 NONE propranolol_5\NN\0 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) disorder_10\NN\14034177 (l_conj) agoraphobia_12\NNP\14381416
D011433_D000379 NONE propranolol_27\NN\0 (r_advcl) investigated_58\VBN\644583 (l_nsubjpass) dose_37\NN\3740161 (l_prep) on_47\IN\0 (l_pobj) performance_49\NN\6619065 (l_prep) of_50\IN\0 (l_pobj) patients_51\NNS\9898892 (l_prep) with_52\IN\0 (l_pobj) disorders_54\NNS\14034177 (l_conj) agoraphobia_56\NNP\14381416
D003975_D008569 CID diazepam_12\NN\2830852 (r_pobj) for_11\IN\0 (r_prep) greater_10\JJR\0 (r_acomp) was_9\VBD\0 (r_conj) impaired_2\VBD\258857 (l_dobj) recall_5\NN\7185325
D003975_D016584 NONE diazepam_3\NN\2830852 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_conj) propranolol_5\NN\0 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) disorder_10\NN\14034177
D003975_D016584 NONE diazepam_6\NN\2830852 (r_pobj) of_5\IN\0 (r_prep) doses_4\NNS\3740161 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubj) propranolol_27\NN\0 (r_advcl) investigated_58\VBN\644583 (l_nsubjpass) dose_37\NN\3740161 (l_prep) on_47\IN\0 (l_pobj) performance_49\NN\6619065 (l_prep) of_50\IN\0 (l_pobj) patients_51\NNS\9898892 (l_prep) with_52\IN\0 (l_pobj) disorders_54\NNS\14034177
D011433_D008569 CID propranolol_14\NN\0 (r_advcl) diazepam_12\NN\2830852 (r_pobj) for_11\IN\0 (r_prep) greater_10\JJR\0 (r_acomp) was_9\VBD\0 (r_conj) impaired_2\VBD\258857 (l_dobj) recall_5\NN\7185325
D011433_D016584 NONE propranolol_5\NN\0 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) disorder_10\NN\14034177
D011433_D016584 NONE propranolol_27\NN\0 (r_advcl) investigated_58\VBN\644583 (l_nsubjpass) dose_37\NN\3740161 (l_prep) on_47\IN\0 (l_pobj) performance_49\NN\6619065 (l_prep) of_50\IN\0 (l_pobj) patients_51\NNS\9898892 (l_prep) with_52\IN\0 (l_pobj) disorders_54\NNS\14034177
18083142
D004298_D001008 NONE dopamine_9\NN\14807737 (r_compound) knockout_13\NN\10787470 (r_pobj) of_8\IN\0 (r_prep) performance_7\NN\6619065 (r_dobj) evaluated_5\VBD\670261 (l_advcl) examine_36\VB\0 (l_dobj) contribution_38\NN\786195 (l_prep) of_39\IN\0 (l_pobj) signaling_41\NN\33020 (l_prep) to_42\IN\0 (l_pobj) anxiety_46\NN\14373582
D004298_D001008 NONE dopamine_17\NN\14807737 (r_nmod) hydroxylase_20\NN\0 (r_nmod) inhibitor_24\NN\20090 (r_appos) administration_12\NN\1133281 (r_pobj) following_11\VBG\8180190 (r_prep) attenuated_6\VBN\224901 (l_nsubjpass) anxiety_3\NN\14373582
D015016_D001008 NONE yohimbine_48\NN\0 (r_appos) antagonist_47\NN\7846 (r_conj) prazosin_42\NN\2698769 (r_nsubj) had_49\VBD\0 (r_advcl) pretreatment_10\NN\0 (l_prep) with_11\IN\0 (l_pobj) antagonist_17\NN\7846 (l_acl) propranolol_18\NN\0 (l_dobj) behavior_26\NN\407535 (l_amod) like_25\JJ\5839024 (l_npadvmod) anxiety_23\NN\14373582
D011433_D001008 NONE propranolol_18\NN\0 (l_dobj) behavior_26\NN\407535 (l_amod) like_25\JJ\5839024 (l_npadvmod) anxiety_23\NN\14373582
D003042_D001008 CID cocaine_12\NN\3492717 (r_npadvmod) induced_14\VBN\1627355 (r_amod) anxiety_15\NN\14373582
D003042_D001008 CID cocaine_4\NN\3492717 (r_poss) effects_7\NNS\13245626 (r_nsubjpass) studied_10\VBN\0 (r_advcl) paid_17\VBN\2199590 (l_dative) to_18\IN\0 (l_pobj) states_22\NNS\8491826 (l_acl) induced_23\VBN\1627355 (l_agent) by_24\IN\0 (l_pobj) cocaine_25\NN\3492717 (l_prep) as_28\IN\14622893 (l_pobj) anxiety_29\NN\14373582
D003042_D001008 CID cocaine_25\NN\3492717 (l_prep) as_28\IN\14622893 (l_pobj) anxiety_29\NN\14373582
D003042_D001008 CID cocaine_43\NN\3492717 (r_npadvmod) induced_45\VBN\1627355 (r_amod) anxiety_46\NN\14373582
D003042_D001008 CID cocaine_4\NN\3492717 (r_nsubj) increased_8\VBN\169651 (l_dobj) behavior_12\NN\407535 (l_amod) like_11\JJ\5839024 (l_npadvmod) anxiety_9\NN\14373582
D003042_D001008 CID cocaine_0\NN\3492717 (r_npadvmod) induced_2\VBN\1627355 (r_amod) anxiety_3\NN\14373582
D003042_D001008 CID cocaine_20\NN\3492717 (r_npadvmod) induced_22\VBN\1627355 (r_amod) behavior_26\NN\407535 (l_amod) like_25\JJ\5839024 (l_npadvmod) anxiety_23\NN\14373582
D003042_D001008 CID cocaine_14\NN\3492717 (r_npadvmod) induced_16\VBN\1627355 (r_amod) anxiety_17\NN\14373582
D011224_D001008 NONE prazosin_42\NN\2698769 (r_nsubj) had_49\VBD\0 (r_advcl) pretreatment_10\NN\0 (l_prep) with_11\IN\0 (l_pobj) antagonist_17\NN\7846 (l_acl) propranolol_18\NN\0 (l_dobj) behavior_26\NN\407535 (l_amod) like_25\JJ\5839024 (l_npadvmod) anxiety_23\NN\14373582
D009638_D001008 NONE norepinephrine_0\NN\14807929 (r_compound) signaling_1\VBG\33020 (r_nsubj) is_7\VBZ\0 (l_acomp) critical_8\JJ\0 (l_prep) for_9\IN\0 (l_pobj) expression_10\NN\4679549 (l_prep) of_11\IN\0 (l_pobj) anxiety_15\NN\14373582
D009638_D001008 NONE norepinephrine_22\NN\14807929 (r_dobj) lack_21\VBP\14449126 (r_relcl) mice_18\NNS\2329401 (r_appos) knockout_13\NN\10787470 (r_pobj) of_8\IN\0 (r_prep) performance_7\NN\6619065 (r_dobj) evaluated_5\VBD\670261 (l_advcl) examine_36\VB\0 (l_dobj) contribution_38\NN\786195 (l_prep) of_39\IN\0 (l_pobj) signaling_41\NN\33020 (l_prep) to_42\IN\0 (l_pobj) anxiety_46\NN\14373582
D009638_D001008 NONE ne_24\NNP\14622893 (r_appos) norepinephrine_22\NN\14807929 (r_dobj) lack_21\VBP\14449126 (r_relcl) mice_18\NNS\2329401 (r_appos) knockout_13\NN\10787470 (r_pobj) of_8\IN\0 (r_prep) performance_7\NN\6619065 (r_dobj) evaluated_5\VBD\670261 (l_advcl) examine_36\VB\0 (l_dobj) contribution_38\NN\786195 (l_prep) of_39\IN\0 (l_pobj) signaling_41\NN\33020 (l_prep) to_42\IN\0 (l_pobj) anxiety_46\NN\14373582
D004221_D001008 NONE disulfiram_14\NN\3740161 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) following_11\VBG\8180190 (r_prep) attenuated_6\VBN\224901 (l_nsubjpass) anxiety_3\NN\14373582
3173180
D008795_D006463 CID metronidazole_7\NN\2723292 (r_pobj) with_6\IN\0 (r_prep) treatment_5\NN\654885 (r_pobj) after_4\IN\0 (r_prep) syndrome_3\NN\5870365
D008795_D006463 CID metronidazole_19\NN\2723292 (r_pobj) with_18\IN\0 (r_prep) treatment_17\NN\654885 (r_pobj) after_16\IN\0 (r_prep) developed_10\VBD\1753788 (l_dobj) syndrome_15\NN\5870365
D008795_D006463 CID metronidazole_4\NN\2723292 (r_pobj) of_3\IN\0 (r_prep) involvement_2\NN\1080366 (l_prep) in_5\IN\13603305 (l_pobj) aetiology_7\NN\7326557 (l_prep) of_8\IN\0 (l_pobj) syndrome_13\NN\5870365
D008795_D006463 CID metronidazole_4\NN\2723292 (r_pobj) of_3\IN\0 (r_prep) involvement_2\NN\1080366 (r_nsubjpass) established_16\VBN\2426171 (r_advcl) suggest_43\VBP\1010118 (l_nsubj) action_20\NN\30358 (l_conj) evidence_33\NN\5816287 (l_prep) of_34\IN\0 (l_pobj) changes_36\NNS\7283608 (l_prep) in_37\IN\13603305 (l_pobj) syndrome_42\NN\5870365
D008795_D006463 CID metronidazole_4\NN\2723292 (r_pobj) of_3\IN\0 (r_prep) involvement_2\NN\1080366 (r_nsubjpass) established_16\VBN\2426171 (r_advcl) suggest_43\VBP\1010118 (l_dobj) link_46\NN\13792579 (l_prep) between_47\IN\0 (l_pobj) treatment_49\NN\654885 (l_conj) cases_52\NNS\7283608 (l_prep) of_53\IN\0 (l_pobj) syndrome_58\NN\5870365
D008795_D006463 CID metronidazole_48\NN\2723292 (r_amod) treatment_49\NN\654885 (r_pobj) between_47\IN\0 (r_prep) link_46\NN\13792579 (r_dobj) suggest_43\VBP\1010118 (l_advcl) established_16\VBN\2426171 (l_nsubjpass) involvement_2\NN\1080366 (l_prep) in_5\IN\13603305 (l_pobj) aetiology_7\NN\7326557 (l_prep) of_8\IN\0 (l_pobj) syndrome_13\NN\5870365
D008795_D006463 CID metronidazole_48\NN\2723292 (r_amod) treatment_49\NN\654885 (r_pobj) between_47\IN\0 (r_prep) link_46\NN\13792579 (r_dobj) suggest_43\VBP\1010118 (l_nsubj) action_20\NN\30358 (l_conj) evidence_33\NN\5816287 (l_prep) of_34\IN\0 (l_pobj) changes_36\NNS\7283608 (l_prep) in_37\IN\13603305 (l_pobj) syndrome_42\NN\5870365
D008795_D006463 CID metronidazole_48\NN\2723292 (r_amod) treatment_49\NN\654885 (l_conj) cases_52\NNS\7283608 (l_prep) of_53\IN\0 (l_pobj) syndrome_58\NN\5870365
2578334
D001564_D011230 CID benzo[a]-pyrene_53\NN\0 (r_appos) carcinogens_51\NNS\20090 (r_pobj) by_48\IN\0 (r_agent) induced_47\VBN\1627355 (r_acl) phase_43\NN\15113229 (r_pobj) during_41\IN\0 (r_prep) given_38\VBN\5892096 (l_nsubjpass) 5-azc_24\CD\0 (l_advcl) test_1\VB\5798043 (l_dobj) validity_3\NN\4782878 (l_prep) of_4\IN\0 (l_pobj) hypothesis_6\NN\7162194 (l_acl) plays_11\VBZ\7007684 (l_prep) in_15\IN\13603305 (l_pobj) initiation_17\NN\7450842 (l_prep) of_18\IN\0 (l_pobj) process_20\NN\407535
D008770_D011230 CID nitrosourea_65\NN\0 (r_appos) carcinogens_51\NNS\20090 (r_pobj) by_48\IN\0 (r_agent) induced_47\VBN\1627355 (r_acl) phase_43\NN\15113229 (r_pobj) during_41\IN\0 (r_prep) given_38\VBN\5892096 (l_nsubjpass) 5-azc_24\CD\0 (l_advcl) test_1\VB\5798043 (l_dobj) validity_3\NN\4782878 (l_prep) of_4\IN\0 (l_pobj) hypothesis_6\NN\7162194 (l_acl) plays_11\VBZ\7007684 (l_prep) in_15\IN\13603305 (l_pobj) initiation_17\NN\7450842 (l_prep) of_18\IN\0 (l_pobj) process_20\NN\407535
D019813_D011230 CID 1,2-dimethylhydrazine_71\CD\0 (r_conj) 60_67\CD\13745420 (r_appos) nitrosourea_65\NN\0 (r_appos) carcinogens_51\NNS\20090 (r_pobj) by_48\IN\0 (r_agent) induced_47\VBN\1627355 (r_acl) phase_43\NN\15113229 (r_pobj) during_41\IN\0 (r_prep) given_38\VBN\5892096 (l_nsubjpass) 5-azc_24\CD\0 (l_advcl) test_1\VB\5798043 (l_dobj) validity_3\NN\4782878 (l_prep) of_4\IN\0 (l_pobj) hypothesis_6\NN\7162194 (l_acl) plays_11\VBZ\7007684 (l_prep) in_15\IN\13603305 (l_pobj) initiation_17\NN\7450842 (l_prep) of_18\IN\0 (l_pobj) process_20\NN\407535
D019813_D011230 CID 1,2-dmh_73\NNP\0 (r_appos) nitrosourea_65\NN\0 (r_appos) carcinogens_51\NNS\20090 (r_pobj) by_48\IN\0 (r_agent) induced_47\VBN\1627355 (r_acl) phase_43\NN\15113229 (r_pobj) during_41\IN\0 (r_prep) given_38\VBN\5892096 (l_nsubjpass) 5-azc_24\CD\0 (l_advcl) test_1\VB\5798043 (l_dobj) validity_3\NN\4782878 (l_prep) of_4\IN\0 (l_pobj) hypothesis_6\NN\7162194 (l_acl) plays_11\VBZ\7007684 (l_prep) in_15\IN\13603305 (l_pobj) initiation_17\NN\7450842 (l_prep) of_18\IN\0 (l_pobj) process_20\NN\407535
D001374_D011230 CID 5-azacytidine_0\RB\0 (r_nsubj) potentiates_1\VBZ\229605 (l_dobj) initiation_2\NN\7450842 (l_acl) induced_3\VBN\1627355 (l_agent) by_4\IN\0 (l_pobj) carcinogens_5\NNS\20090
D001374_D011230 CID 5-azacytidine_22\JJ\0 (r_punct) 5-azc_24\CD\0 (l_advcl) test_1\VB\5798043 (l_dobj) validity_3\NN\4782878 (l_prep) of_4\IN\0 (l_pobj) hypothesis_6\NN\7162194 (l_acl) plays_11\VBZ\7007684 (l_prep) in_15\IN\13603305 (l_pobj) initiation_17\NN\7450842 (l_prep) of_18\IN\0 (l_pobj) process_20\NN\407535
D001374_D011230 CID 5-azc_24\CD\0 (l_advcl) test_1\VB\5798043 (l_dobj) validity_3\NN\4782878 (l_prep) of_4\IN\0 (l_pobj) hypothesis_6\NN\7162194 (l_acl) plays_11\VBZ\7007684 (l_prep) in_15\IN\13603305 (l_pobj) initiation_17\NN\7450842 (l_prep) of_18\IN\0 (l_pobj) process_20\NN\407535
8669433
D010615_D007676 CID phenacetin_16\NN\2707683 (r_pobj) with_15\IN\0 (r_prep) comparison_14\NN\635850 (r_appos) use_1\NN\407535 (l_prep) as_4\IN\14622893 (l_pobj) factor_7\NN\7326557 (l_prep) for_8\IN\0 (l_pobj) failure_11\NN\66216
D010615_D007676 CID phenacetin_14\NN\2707683 (r_pobj) of_13\IN\0 (r_prep) use_12\NN\407535 (r_nsubjpass) associated_16\VBN\628491 (l_prep) with_17\IN\0 (l_pobj) development_19\NN\248977 (l_prep) of_20\IN\0 (l_pobj) failure_23\NN\66216
D010615_D007676 CID phenacetin_14\NN\2707683 (r_pobj) of_13\IN\0 (r_prep) use_12\NN\407535 (r_nsubjpass) associated_16\VBN\628491 (l_prep) with_17\IN\0 (l_pobj) development_19\NN\248977 (l_prep) of_20\IN\0 (l_pobj) failure_23\NN\66216 (l_conj) disease_29\NN\14061805
D010615_D007676 CID phenacetin_14\NN\2707683 (r_pobj) of_13\IN\0 (r_prep) use_12\NN\407535 (r_nsubjpass) associated_16\VBN\628491 (l_prep) with_17\IN\0 (l_pobj) development_19\NN\248977 (l_prep) of_20\IN\0 (l_pobj) failure_23\NN\66216 (l_conj) disease_29\NN\14061805 (l_appos) esrd_31\NNP\0
D010615_D007676 CID phenacetin_5\NN\2707683 (r_nsubj) contribute_9\VB\126264 (l_prep) to_10\IN\0 (l_pobj) burden_12\NN\5832264 (l_prep) of_13\IN\0 (l_pobj) esrd_14\NNP\0
D000082_D007676 NONE acetaminophen_3\NN\2707683 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (l_prep) as_4\IN\14622893 (l_pobj) factor_7\NN\7326557 (l_prep) for_8\IN\0 (l_pobj) failure_11\NN\66216
D000082_D007676 NONE acetaminophen_27\NN\2707683 (r_pobj) of_26\IN\0 (r_prep) use_25\NN\407535 (r_nsubjpass) associated_30\VBN\628491 (l_prep) with_31\IN\0 (l_pobj) failure_34\NN\66216
D000082_D007676 NONE acetaminophen_27\NN\2707683 (r_pobj) of_26\IN\0 (r_prep) use_25\NN\407535 (r_nsubjpass) associated_30\VBN\628491 (l_prep) with_31\IN\0 (l_pobj) failure_34\NN\66216 (l_conj) esrd_36\NNP\0
D000082_D007676 NONE acetaminophen_7\RB\2707683 (r_conj) phenacetin_5\NN\2707683 (r_nsubj) contribute_9\VB\126264 (l_prep) to_10\IN\0 (l_pobj) burden_12\NN\5832264 (l_prep) of_13\IN\0 (l_pobj) esrd_14\NNP\0
D000082_D007676 NONE acetaminophen_6\NN\2707683 (r_pobj) of_5\IN\0 (r_prep) use_4\NN\407535 (r_nsubj) increases_8\VBZ\13576355 (l_dobj) risk_10\NN\14541044 (l_prep) of_11\IN\0 (l_pobj) esrd_12\NNP\0
8741744
D009538_D009069 NONE nicotine_29\NN\14712692 (r_pobj) by_28\IN\0 (r_agent) caused_27\VBN\1617192 (r_acl) hypoactivity_26\NN\0
D009538_D009069 NONE nicotine_48\NN\14712692 (r_npadvmod) induced_50\VBN\1627355 (r_amod) hyperactivity_51\NN\14052403 (r_dobj) enhanced_39\VBD\227165 (r_advcl) blunted_14\VBD\224901 (l_dobj) hypoactivity_26\NN\0
D009538_D006948 CID nicotine_29\NN\14712692 (r_pobj) by_28\IN\0 (r_agent) caused_27\VBN\1617192 (r_acl) hypoactivity_26\NN\0 (r_dobj) blunted_14\VBD\224901 (l_advcl) enhanced_39\VBD\227165 (l_dobj) hyperactivity_51\NN\14052403
D009538_D006948 CID nicotine_48\NN\14712692 (r_npadvmod) induced_50\VBN\1627355 (r_amod) hyperactivity_51\NN\14052403
2894766
D012460_D002305 CID sulfasalazine_29\NN\0 (r_compound) therapy_30\NN\657604 (r_dobj) receiving_25\VBG\2210855 (r_relcl) man_21\NN\9605289 (r_pobj) in_16\IN\13603305 (r_prep) developed_15\VBN\1753788 (r_acl) autoantibodies_14\NNS\15027189 (r_conj) evidence_7\NN\5816287 (l_prep) of_8\IN\0 (l_pobj) tamponade_10\NN\14507951
D012460_D008180 CID sulfasalazine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) erythematosus_4\NN\0
D012460_D008180 CID sulfasalazine_7\RB\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) lupus_10\NN\14219661
D012460_D008180 CID sulfasalazine_3\NN\0 (r_dobj) use_2\VBP\407535 (r_relcl) physicians_0\NNS\10305802 (r_nsubj) be_12\VB\14625458 (l_acomp) aware_13\JJ\0 (l_prep) of_14\IN\0 (l_pobj) signs_16\NNS\6643763 (l_prep) of_17\IN\0 (l_pobj) syndrome_22\NN\5870365
D012460_D008180 CID sulfasalazine_18\NN\0 (r_npadvmod) induced_20\VBN\1627355 (r_amod) syndrome_22\NN\5870365
D012460_D012700 NONE sulfasalazine_7\RB\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) lupus_10\NN\14219661 (l_relcl) manifested_13\VBD\1015244 (l_prep) with_14\IN\0 (l_pobj) serositis_15\NN\0
D012460_D003093 NONE sulfasalazine_29\NN\0 (r_compound) therapy_30\NN\657604 (r_dobj) receiving_25\VBG\2210855 (l_prep) for_31\IN\0 (l_pobj) colitis_34\NN\14336539
D012460_D011014 CID sulfasalazine_29\NN\0 (r_compound) therapy_30\NN\657604 (r_dobj) receiving_25\VBG\2210855 (r_relcl) man_21\NN\9605289 (r_pobj) in_16\IN\13603305 (r_prep) developed_15\VBN\1753788 (r_acl) autoantibodies_14\NNS\15027189 (r_conj) evidence_7\NN\5816287 (r_appos) effusions_4\NNS\6880249 (l_dep) pneumonitis_0\NNP\14336539
D012460_D010996 CID sulfasalazine_29\NN\0 (r_compound) therapy_30\NN\657604 (r_dobj) receiving_25\VBG\2210855 (r_relcl) man_21\NN\9605289 (r_pobj) in_16\IN\13603305 (r_prep) developed_15\VBN\1753788 (r_acl) autoantibodies_14\NNS\15027189 (r_conj) evidence_7\NN\5816287 (r_appos) effusions_4\NNS\6880249
D012460_D015212 NONE sulfasalazine_3\NN\0 (r_dobj) use_2\VBP\407535 (l_xcomp) treat_5\VB\7570720 (l_dobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) disease_10\NN\14061805
D012460_D015212 NONE sulfasalazine_18\NN\0 (r_npadvmod) induced_20\VBN\1627355 (r_amod) syndrome_22\NN\5870365 (r_pobj) of_17\IN\0 (r_prep) signs_16\NNS\6643763 (r_pobj) of_14\IN\0 (r_prep) aware_13\JJ\0 (r_acomp) be_12\VB\14625458 (l_nsubj) physicians_0\NNS\10305802 (l_relcl) use_2\VBP\407535 (l_xcomp) treat_5\VB\7570720 (l_dobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) disease_10\NN\14061805
19729346
D010098_D010146 NONE oxycodone_18\NN\0 (r_pobj) of_14\IN\0 (r_prep) dose_13\NN\3740161 (r_pobj) of_9\IN\0 (r_prep) effects_8\NNS\13245626 (r_dobj) measured_2\VBD\697589 (l_dobj) adults_39\NNS\7846 (l_relcl) suffering_43\VBG\14322699 (l_prep) from_44\IN\0 (l_pobj) pain_49\NN\14299637
D010098_D059350 NONE oxycodone_30\NN\0 (r_pobj) of_26\IN\0 (r_prep) dose_25\NN\3740161 (r_pobj) to_22\IN\0 (r_prep) response_21\NN\11410625 (r_pobj) in_20\IN\13603305 (r_prep) changes_19\NNS\7283608 (r_dobj) suffering_11\VBG\14322699 (l_prep) from_12\IN\0 (l_pobj) pain_14\NN\14299637
14513889
D007654_D009422 NONE ketoconazole_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) sequelae_4\NNS\14501726
20633755
D013390_D001049 CID suxamethonium_0\NNS\0 (r_nsubj) induced_1\VBD\1627355 (l_dobj) apnea_3\NN\14299637
D013390_D001049 CID suxamethonium_0\JJ\0 (r_nsubj) causes_1\VBZ\7323922 (l_dobj) apnea_3\NN\14299637
D009943_D001049 CID poisons_17\NNS\20090 (r_pobj) by_12\IN\0 (r_agent) deactivated_11\VBN\1097743 (r_relcl) patients_5\NNS\9898892 (r_pobj) in_4\IN\13603305 (r_prep) apnea_3\NN\14299637
D009943_D001049 CID compound_14\NN\5869584 (r_pobj) by_12\IN\0 (r_prep) attempt_11\NN\407535 (r_pobj) about_9\IN\0 (r_prep) information_8\NN\6598915 (r_nsubjpass) concealed_16\VBN\0 (r_advcl) ensued_5\VBD\2633881 (l_nsubj) apnea_1\NN\14299637
8319760
D000804_D009404 NONE ii_43\NNP\13741022 (r_compound) antagonist_45\NN\7846 (r_appos) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365
D000804_D011507 NONE ii_43\NNP\13741022 (r_compound) antagonist_45\NN\7846 (r_appos) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637
D001806_D009404 NONE urea_17\NN\14727670 (r_pobj) in_14\IN\13603305 (r_prep) increase_13\NN\13576355 (r_conj) hypercholesterolemia_11\NN\14299637 (r_conj) hypoalbuminemia_9\NN\0 (r_conj) proteinuria_7\NN\14299637 (r_pobj) as_6\IN\14622893 (r_prep) syndromes_4\NNS\5870365
D019808_D009401 NONE 753_1\CD\0 (r_nummod) dup_0\NN\0 (r_nsubj) prevents_2\VBZ\0 (l_dobj) development_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) nephrosis_10\NN\14304060
D000804_D006937 NONE ii_43\NNP\13741022 (r_compound) antagonist_45\NN\7846 (r_appos) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637 (l_conj) hypoalbuminemia_9\NN\0 (l_conj) hypercholesterolemia_11\NN\14299637
D011692_D009401 NONE aminonucleoside_7\NN\0 (r_advmod) induced_9\VBN\1627355 (r_amod) nephrosis_10\NN\14304060
D011692_D009401 NONE aminonucleoside_17\NN\0 (r_advmod) induced_19\VBN\1627355 (r_amod) nephrosis_20\NN\14304060
D011692_D009404 CID aminonucleoside_26\NN\0 (r_advmod) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365
D019808_D006937 NONE 753_35\CD\0 (r_nummod) dup_34\NN\0 (r_nmod) losartan_37\NN\0 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) by_30\IN\0 (r_agent) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637 (l_conj) hypoalbuminemia_9\NN\0 (l_conj) hypercholesterolemia_11\NN\14299637
D019808_D006937 NONE losartan_37\NN\0 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) by_30\IN\0 (r_agent) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637 (l_conj) hypoalbuminemia_9\NN\0 (l_conj) hypercholesterolemia_11\NN\14299637
D019808_D011507 NONE 753_35\CD\0 (r_nummod) dup_34\NN\0 (r_nmod) losartan_37\NN\0 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) by_30\IN\0 (r_agent) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637
D019808_D011507 NONE losartan_37\NN\0 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) by_30\IN\0 (r_agent) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637
D011692_D006937 CID aminonucleoside_26\NN\0 (r_advmod) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637 (l_conj) hypoalbuminemia_9\NN\0 (l_conj) hypercholesterolemia_11\NN\14299637
D019808_D034141 NONE 753_35\CD\0 (r_nummod) dup_34\NN\0 (r_nmod) losartan_37\NN\0 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) by_30\IN\0 (r_agent) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637 (l_conj) hypoalbuminemia_9\NN\0
D019808_D034141 NONE losartan_37\NN\0 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) by_30\IN\0 (r_agent) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637 (l_conj) hypoalbuminemia_9\NN\0
D001806_D011507 NONE urea_17\NN\14727670 (r_pobj) in_14\IN\13603305 (r_prep) increase_13\NN\13576355 (r_conj) hypercholesterolemia_11\NN\14299637 (r_conj) hypoalbuminemia_9\NN\0 (r_conj) proteinuria_7\NN\14299637
D000809_D009401 NONE angiotensin_10\NN\4522421 (r_compound) system_11\NN\3575240 (l_prep) in_12\IN\13603305 (l_pobj) development_14\NN\248977 (l_prep) of_15\IN\0 (l_pobj) nephrosis_20\NN\14304060
D001806_D034141 NONE urea_17\NN\14727670 (r_pobj) in_14\IN\13603305 (r_prep) increase_13\NN\13576355 (r_conj) hypercholesterolemia_11\NN\14299637 (r_conj) hypoalbuminemia_9\NN\0
D000804_D034141 NONE ii_43\NNP\13741022 (r_compound) antagonist_45\NN\7846 (r_appos) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637 (l_conj) hypoalbuminemia_9\NN\0
D011692_D011507 CID aminonucleoside_26\NN\0 (r_advmod) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637
D011692_D034141 CID aminonucleoside_26\NN\0 (r_advmod) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365 (l_prep) as_6\IN\14622893 (l_pobj) proteinuria_7\NN\14299637 (l_conj) hypoalbuminemia_9\NN\0
D019808_D009404 NONE 753_35\CD\0 (r_nummod) dup_34\NN\0 (r_nmod) losartan_37\NN\0 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) by_30\IN\0 (r_agent) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365
D019808_D009404 NONE losartan_37\NN\0 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) by_30\IN\0 (r_agent) inhibited_29\VBN\2510337 (l_ccomp) induced_19\VBN\1627355 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) syndromes_4\NNS\5870365
D001806_D006937 NONE urea_17\NN\14727670 (r_pobj) in_14\IN\13603305 (r_prep) increase_13\NN\13576355 (r_conj) hypercholesterolemia_11\NN\14299637
11147747
D018490_D014549 CID antidepressants_1\NNS\3740161 (l_conj) incontinence_4\NN\13473097
D018490_D014549 CID antidepressants_8\NNS\3740161 (r_pobj) to_6\IN\0 (r_prep) secondary_5\JJ\8426461 (r_amod) incontinence_4\NN\13473097
D020280_D014549 CID sertraline_22\NN\4169152 (r_conj) paroxetine_20\NN\0 (r_pobj) to_14\IN\0 (r_prep) developed_11\VBD\1753788 (l_dobj) secondary_13\JJ\8426461 (l_compound) incontinence_12\NN\13473097
C047426_D014549 CID venlafaxine_10\NN\0 (r_dobj) taking_9\VBG\37396 (r_advcl) experienced_6\VBD\2108377 (l_dobj) incontinence_7\NN\13473097
C047426_D014549 CID venlafaxine_35\NNP\0 (r_pobj) on_34\IN\0 (r_prep) developed_30\VBD\1753788 (r_relcl) third_28\NN\13732295 (r_conj) paroxetine_20\NN\0 (r_pobj) to_14\IN\0 (r_prep) developed_11\VBD\1753788 (l_dobj) secondary_13\JJ\8426461 (l_compound) incontinence_12\NN\13473097
D017374_D014549 CID paroxetine_20\NN\0 (r_pobj) to_14\IN\0 (r_prep) developed_11\VBD\1753788 (l_dobj) secondary_13\JJ\8426461 (l_compound) incontinence_12\NN\13473097
D016651_D014549 CID carbonate_12\NN\15010703 (r_dobj) taking_10\VBG\37396 (r_relcl) cases_5\NNS\7283608 (r_pobj) of_2\IN\0 (r_prep) 2_1\CD\13741022 (r_pobj) in_0\IN\13603305 (r_prep) contributed_23\VBN\126264 (l_prep) to_24\IN\0 (l_pobj) incontinence_26\NN\13473097
D012701_D014549 NONE serotonin_17\NN\14807737 (r_compound) paroxetine_20\NN\0 (r_pobj) to_14\IN\0 (r_prep) developed_11\VBD\1753788 (l_dobj) secondary_13\JJ\8426461 (l_compound) incontinence_12\NN\13473097
20882060
D009496_D002375 NONE neurotensin_3\NN\0 (l_prep) on_4\IN\0 (l_pobj) catalepsy_9\NN\14023236
D009496_D002375 NONE neurotensin_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) infusions_1\NNS\14589223 (r_nsubj) reversed_8\VBD\109660 (l_dobj) catalepsy_13\NN\14023236
D006220_D002375 CID haloperidol_5\NN\3713736 (r_npadvmod) induced_7\VBN\1627355 (r_amod) catalepsy_9\NN\14023236
D006220_D002375 CID haloperidol_9\NN\3713736 (r_npadvmod) induced_11\VBN\1627355 (r_amod) catalepsy_13\NN\14023236
D006220_D010302 NONE haloperidol_12\NN\3713736 (r_npadvmod) induced_14\VBN\1627355 (r_amod) symptoms_16\NNS\5823932
D009496_D010302 NONE neurotensin_10\NN\0 (l_prep) on_11\IN\0 (l_pobj) symptoms_16\NNS\5823932
3496378
D014217_D056486 CID troleandomycin_3\NN\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) hepatitis_7\NN\14127211
D014217_D056486 CID troleandomycin_9\NN\0 (r_npadvmod) induced_11\VBN\1627355 (r_relcl) patient_6\NN\9898892 (r_pobj) of_4\IN\0 (r_prep) case_3\NN\7283608 (r_dobj) report_1\VBP\6470073 (l_ccomp) followed_14\VBN\1835496 (l_nsubjpass) hepatitis_12\NN\14127211
D014217_D056486 CID troleandomycin_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hepatitis_12\NN\14127211
D014217_D002779 CID troleandomycin_3\NN\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) hepatitis_7\NN\14127211 (r_pobj) after_2\IN\0 (r_prep) cholestasis_1\NN\14052403
D014217_D002779 CID troleandomycin_9\NN\0 (r_npadvmod) induced_11\VBN\1627355 (r_relcl) patient_6\NN\9898892 (r_pobj) of_4\IN\0 (r_prep) case_3\NN\7283608 (r_dobj) report_1\VBP\6470073 (l_ccomp) followed_14\VBN\1835496 (l_agent) by_15\IN\0 (l_pobj) cholestasis_18\NN\14052403
D014217_D002779 CID troleandomycin_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hepatitis_12\NN\14127211 (r_dobj) follow_7\VB\1835496 (l_nsubj) cholestasis_5\NN\14052403
D014217_D007565 CID troleandomycin_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_pobj) after_2\IN\0 (r_prep) occurred_1\VBD\0 (l_nsubj) jaundice_0\NN\14299637
D014217_D004802 CID troleandomycin_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_pobj) after_2\IN\0 (r_prep) occurred_1\VBD\0 (l_conj) associated_11\VBN\628491 (l_prep) with_12\IN\0 (l_pobj) hypereosinophilia_13\NNS\0
16005948
D003042_D064420 NONE cocaine_3\NN\3492717 (r_compound) toxicity_4\NN\13576101
-1_D064420 NONE gnc92h2_12\NNP\0 (r_pobj) of_11\IN\0 (r_prep) dose_10\NN\3740161 (r_pobj) with_7\IN\0 (r_prep) observed_6\VBN\2163746 (l_nsubjpass) blockade_1\NN\952963 (l_prep) of_2\IN\0 (l_pobj) toxicity_4\NN\13576101
-1_D003643 NONE gnc92h2_12\NNP\0 (r_pobj) of_11\IN\0 (r_prep) dose_10\NN\3740161 (l_appos) seizures_28\NNS\14081375 (l_prt) up_29\IN\153263 (l_prep) to_30\TO\0 (l_pobj) %_32\NN\0 (l_conj) death_34\NN\7296428
-1_D003643 NONE gnc92h2_2\NNP\0 (r_nsubj) prevented_3\VBD\0 (l_dobj) death_4\NN\7296428
D003042_D062787 NONE cocaine_4\NN\3492717 (r_pobj) of_3\IN\0 (r_prep) use_2\NN\407535 (r_nsubj) continues_5\VBZ\2367363 (l_prep) in_6\IN\13603305 (l_pobj) proportions_8\NNS\13824815 (l_conj) treatment_10\NN\654885 (l_prep) for_11\IN\0 (l_pobj) overdose_13\NN\84738
D003042_D003643 NONE cocaine_3\NN\3492717 (r_compound) toxicity_4\NN\13576101 (r_pobj) of_2\IN\0 (r_prep) blockade_1\NN\952963 (r_nsubjpass) observed_6\VBN\2163746 (l_prep) with_7\IN\0 (l_pobj) dose_10\NN\3740161 (l_appos) seizures_28\NNS\14081375 (l_prt) up_29\IN\153263 (l_prep) to_30\TO\0 (l_pobj) %_32\NN\0 (l_conj) death_34\NN\7296428
D003042_D003643 NONE cocaine_8\NN\3492717 (r_compound) injection_9\NN\320852 (r_dobj) prevented_3\VBD\0 (l_dobj) death_4\NN\7296428
-1_D062787 NONE gnc92h2_6\NNP\0 (r_pobj) of_1\IN\0 (r_prep) evaluation_0\NN\874067 (l_prep) as_7\IN\14622893 (l_pobj) immunotherapy_9\NN\661091 (l_prep) for_10\IN\0 (l_pobj) overdose_12\NN\84738
-1_D062787 NONE gnc92h2_7\NNP\0 (r_pobj) of_3\IN\0 (r_prep) potential_2\NN\14481929 (r_nsubjpass) examined_9\VBN\0 (l_advcl) using_10\VBG\418025 (l_dobj) model_12\NN\5888929 (l_prep) of_13\IN\0 (l_pobj) overdose_15\NN\84738
-1_D062787 NONE gnc92h2_7\NNP\0 (r_pobj) of_6\IN\0 (r_prep) potential_5\NN\14481929 (l_prep) as_8\IN\14622893 (l_pobj) tool_11\NN\3563967 (l_prep) against_12\IN\0 (l_pobj) overdose_14\NN\84738
-1_D012640 NONE gnc92h2_12\NNP\0 (r_pobj) of_11\IN\0 (r_prep) dose_10\NN\3740161 (l_appos) seizures_28\NNS\14081375
D003042_D012640 CID cocaine_3\NN\3492717 (r_compound) toxicity_4\NN\13576101 (r_pobj) of_2\IN\0 (r_prep) blockade_1\NN\952963 (r_nsubjpass) observed_6\VBN\2163746 (l_prep) with_7\IN\0 (l_pobj) dose_10\NN\3740161 (l_appos) seizures_28\NNS\14081375
11897407
D007545_D009203 CID isoproterenol_6\NN\3740161 (r_npadvmod) induced_8\VBN\1627355 (r_amod) infarction_10\NN\14204950
D007545_D009203 CID isoproterenol_22\NN\3740161 (r_npadvmod) induced_24\VBN\1627355 (r_amod) infarction_27\NN\14204950
C067171_D009203 NONE glucarate_2\NN\0 (l_prep) for_3\IN\0 (l_pobj) detection_4\NN\5708432 (l_prep) of_5\IN\0 (l_pobj) infarction_10\NN\14204950
C067171_D009203 NONE glucarate_2\NN\0 (r_nsubj) was_3\VBD\0 (l_conj) used_14\VBN\0 (l_xcomp) study_16\VB\635850 (l_dobj) biodistribution_18\NN\0 (l_prep) in_19\IN\13603305 (l_pobj) rats_20\NNS\2329401 (l_prep) with_21\IN\0 (l_pobj) infarction_27\NN\14204950
D005937_D007238 NONE acid_9\NN\14818238 (r_pobj) on_7\IN\0 (r_prep) based_6\VBN\0 (r_acl) radiopharmaceutical_5\NN\3920989 (l_amod) avid_4\JJ\0 (l_npadvmod) infarct_2\NN\14204950
D007545_D007238 NONE isoproterenol_18\NN\3740161 (r_pobj) with_17\IN\0 (r_prep) obtained_16\VBN\2210855 (r_conj) implies_7\VBZ\943837 (l_nsubj) model_2\NN\5888929 (l_acl) used_3\VBN\0 (l_xcomp) produce_5\VB\7555863 (l_dobj) infarction_6\NN\14204950
D007545_D007238 NONE isoproterenol_12\JJ\3740161 (r_compound) administration_13\NN\1133281 (r_pobj) after_11\IN\0 (r_prep) h_10\NN\14622893 (r_npadvmod) developed_6\VBD\1753788 (l_dobj) infarct_8\NN\14204950
567256
D004054_D000230 NONE diethylstilbestrol_25\NN\14749794 (r_pobj) with_24\IN\0 (r_prep) liver_23\NN\5298729
D004054_D008113 CID diethylstilbestrol_6\NN\14749794 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) liver_3\NN\5298729
D004054_D008113 CID diethylstilbestrol_25\NN\14749794 (r_pobj) with_24\IN\0 (r_prep) liver_23\NN\5298729 (r_pobj) of_21\IN\0 (r_prep) adenocarcinoma_20\NN\14242337 (r_pobj) for_15\IN\0 (r_prep) treated_14\VBN\2376958 (r_relcl) man_10\NN\9605289 (r_pobj) in_5\IN\13603305 (r_prep) occurred_4\VBD\0 (l_nsubj) angiosarcoma_0\NNP\14239425 (l_prep) of_1\IN\0 (l_pobj) liver_3\NN\5298729
D004054_D008113 NONE diethylstilbestrol_25\NN\14749794 (r_pobj) with_24\IN\0 (r_prep) liver_23\NN\5298729
D004054_D006394 CID diethylstilbestrol_6\NN\14749794 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) liver_3\NN\5298729
D004054_D006394 CID diethylstilbestrol_25\NN\14749794 (r_pobj) with_24\IN\0 (r_prep) liver_23\NN\5298729 (r_pobj) of_21\IN\0 (r_prep) adenocarcinoma_20\NN\14242337 (r_pobj) for_15\IN\0 (r_prep) treated_14\VBN\2376958 (r_relcl) man_10\NN\9605289 (r_pobj) in_5\IN\13603305 (r_prep) occurred_4\VBD\0 (l_nsubj) angiosarcoma_0\NNP\14239425 (l_prep) of_1\IN\0 (l_pobj) liver_3\NN\5298729
15515654
D003676_D034381 NONE dfo_5\NNP\0 (r_poss) role_8\NN\719494 (l_prep) in_9\IN\13603305 (l_pobj) development_11\NN\248977 (l_prep) of_12\IN\0 (l_pobj) impairment_14\NN\7296428
D003676_D006311 NONE dfo_6\NNP\0 (r_pobj) than_5\IN\0 (r_prep) other_4\JJ\0 (r_amod) factor_2\NN\7326557 (l_compound) ototoxic_1\JJ\0
D003676_D006319 CID dfo_6\NNP\0 (r_compound) reduction_7\NN\351485 (r_pobj) to_5\IN\0 (r_prep) submitted_4\VBN\1952898 (l_nsubjpass) subjects_0\NNS\6598915 (l_prep) with_1\IN\0 (l_pobj) snhl_2\NNP\0
18162529
D004967_D006966 NONE estrogen_20\NN\14745635 (r_npadvmod) induced_22\VBN\1627355 (r_amod) surge_24\NN\7405893 (r_conj) secretion_17\NN\13526110 (r_appos) parameters_9\NNS\5858936 (r_dobj) inhibited_6\VBD\2510337 (l_nsubj) hyperprolactinemia_5\NN\0
D013469_D006966 CID sulpiride_7\NN\0 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) hyperprolactinemia_1\NN\0
D012313_D006966 NONE acid_5\NN\14818238 (r_compound) levels_6\NNS\4916342 (l_conj) signaling_9\NN\33020 (l_conj) inhibition_13\NN\1068773 (l_amod) hyperprolactinemic_12\JJ\0
D004298_D006966 NONE dopamine_5\NN\14807737 (r_compound) antagonist_6\NN\7846 (r_compound) sulpiride_7\NN\0 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) hyperprolactinemia_1\NN\0
D013256_D006966 NONE steroid_14\NN\14727670 (r_npadvmod) dependent_16\JJ\9627906 (r_amod) manner_17\NN\4916342 (r_pobj) in_12\IN\13603305 (r_prep) inhibited_8\VBN\2510337 (l_agent) by_9\IN\0 (l_pobj) hyperprolactinemia_11\NN\0
D004958_D006966 NONE estradiol_22\NN\14749794 (r_pobj) on_21\IN\0 (r_prep) dependent_20\JJ\9627906 (r_acomp) are_19\VBP\13600404 (l_nsubj) levels_6\NNS\4916342 (l_conj) signaling_9\NN\33020 (l_conj) inhibition_13\NN\1068773 (l_amod) hyperprolactinemic_12\JJ\0
D004958_D006966 NONE estradiol_30\NN\14749794 (r_pobj) of_29\IN\0 (r_prep) levels_28\NNS\4916342 (r_pobj) of_25\IN\0 (r_prep) presence_24\NN\13954253 (r_pobj) in_22\IN\13603305 (r_conj) caused_8\VBD\1617192 (l_nsubj) hyperprolactinemia_1\NN\0
11587867
D014750_-1 NONE vincristine_28\NN\3917455 (r_pobj) to_27\IN\0 (r_prep) exposed_26\VBN\2110927 (r_acl) areas_25\NNS\8630985 (r_pobj) in_24\IN\13603305 (r_prep) transformation_23\NN\7296428
D014750_D054198 NONE vincristine_9\NN\3917455 (r_compound) instillation_10\NN\320852 (l_prep) in_11\IN\13603305 (l_pobj) girl_15\NN\10787470 (l_prep) with_16\IN\0 (l_pobj) leucemia_20\NN\0
D014750_D054198 NONE vincristine_9\NN\3917455 (r_compound) instillation_10\NN\320852 (l_prep) in_11\IN\13603305 (l_pobj) girl_15\NN\10787470 (l_prep) with_16\IN\0 (l_pobj) leucemia_20\NN\0 (l_conj) man_25\NN\9605289 (l_prep) with_26\IN\0 (l_pobj) lymphoma_28\NN\14239918
D014750_D009410 CID vincristine_28\NN\3917455 (r_pobj) to_27\IN\0 (r_prep) exposed_26\VBN\2110927 (r_acl) areas_25\NNS\8630985 (r_pobj) in_24\IN\13603305 (r_prep) transformation_23\NN\7296428 (r_conj) degeneration_14\NN\29677 (l_prep) of_15\IN\0 (l_pobj) myelin_16\NN\14864360 (l_conj) axons_18\NNS\5464104
D014750_D003711 CID vincristine_28\NN\3917455 (r_pobj) to_27\IN\0 (r_prep) exposed_26\VBN\2110927 (r_acl) areas_25\NNS\8630985 (r_pobj) in_24\IN\13603305 (r_prep) transformation_23\NN\7296428 (r_conj) degeneration_14\NN\29677 (l_prep) of_15\IN\0 (l_pobj) myelin_16\NN\14864360 (l_conj) axons_18\NNS\5464104
D014750_D001927 NONE vincristin_6\NN\0 (r_compound) administration_7\NN\1133281 (r_pobj) due_2\IN\5174653 (r_prep) myeloencephalopathy_1\NN\0
2312209
D007548_D009336 NONE dinitrate_22\NN\0 (r_pobj) of_20\IN\0 (r_prep) administration_19\NN\1133281 (r_pobj) following_17\VBG\8180190 (r_prep) suffered_8\VBD\2110220 (l_nsubj) necrosis_7\NN\11444117
D007548_D009203 CID dinitrate_7\NN\0 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_dobj) following_2\VBG\8180190 (r_prep) infarction_1\NN\14204950
D007548_D009203 CID dinitrate_22\NN\0 (r_pobj) of_20\IN\0 (r_prep) administration_19\NN\1133281 (r_pobj) following_17\VBG\8180190 (r_prep) suffered_8\VBD\2110220 (l_dobj) infarction_12\NN\14204950
6229975
D013999_D007238 NONE timolol_17\NN\2832168 (r_compound) group_18\NN\2137 (r_pobj) in_15\IN\13603305 (r_prep) remained_13\VBD\2604760 (r_conj) increased_7\VBD\169651 (l_punct) ,_4\,\0 (l_punct) infarction_3\NN\14204950
D013999_D009203 NONE timolol_8\NN\2832168 (r_compound) treatment_9\NN\654885 (l_prep) after_10\IN\0 (l_pobj) infarction_12\NN\14204950
D013999_D009203 NONE timolol_6\NN\2832168 (r_compound) treatment_7\NN\654885 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) after_11\IN\0 (l_pobj) infarction_13\NN\14204950
D013999_D009203 NONE timolol_33\NN\2832168 (r_conj) evaluated_15\VBN\670261 (l_nsubjpass) effect_1\NN\34213 (l_prep) after_11\IN\0 (l_pobj) infarction_13\NN\14204950
D013999_D001919 NONE timolol_6\NN\2832168 (r_npadvmod) induced_8\VBN\1627355 (r_amod) bradycardia_9\NN\14110674
10901305
D007649_D004204 NONE ketamine_7\NN\3054098 (l_prep) to_8\IN\0 (l_pobj) manipulation_9\NN\157081 (l_prep) of_10\IN\0 (l_pobj) fracture_12\NN\14285662 (l_conj) dislocation_14\NN\7367812
D007649_D050723 NONE ketamine_0\NN\3054098 (l_dobj) sedation_1\NN\14034177 (l_prep) for_2\IN\0 (l_pobj) reduction_4\NN\351485 (l_prep) of_5\IN\0 (l_pobj) fractures_8\NNS\14285662
D007649_D050723 NONE ketamine_14\NN\3054098 (l_prep) for_15\IN\0 (l_pobj) sedation_16\NN\14034177 (l_prep) in_17\IN\13603305 (l_pobj) treatment_19\NN\654885 (l_prep) of_20\IN\0 (l_pobj) fractures_23\NNS\14285662
D007649_D050723 NONE ketamine_7\NN\3054098 (l_prep) to_8\IN\0 (l_pobj) manipulation_9\NN\157081 (l_prep) of_10\IN\0 (l_pobj) fracture_12\NN\14285662
D007649_D050723 NONE ketamine_0\NNP\3054098 (r_nsubj) provided_7\VBD\2199590 (l_dobj) sedation_9\NN\14034177 (l_acl) facilitate_12\VB\2547586 (l_dobj) reduction_14\NN\351485 (l_prep) of_15\IN\0 (l_pobj) fractures_18\NNS\14285662
7988234
D017706_D000799 CID lisinopril_6\NN\2673637 (r_compound) therapy_7\NN\657604 (r_pobj) to_5\IN\0 (r_prep) history_1\NN\15120823 (l_prep) of_2\IN\0 (l_pobj) angioedema_3\NN\14316714
D008790_D000799 CID metoprolol_6\NN\2832168 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_dobj) following_1\VBG\8180190 (r_prep) angioedema_0\NNP\14316714
D008790_D000799 CID metoprolol_12\NN\2832168 (r_nsubjpass) given_14\VBN\5892096 (l_advcl) resulting_16\VBG\2633881 (l_prep) in_17\IN\13603305 (l_pobj) angioedema_19\NN\14316714
D013256_D000799 NONE steroids_7\NNS\14727670 (r_pobj) with_5\IN\0 (r_prep) resolved_2\VBD\352826 (l_nsubj) angioedema_1\NN\14316714
D004155_D000799 NONE diphenhydramine_9\NN\2720725 (r_conj) steroids_7\NNS\14727670 (r_pobj) with_5\IN\0 (r_prep) resolved_2\VBD\352826 (l_nsubj) angioedema_1\NN\14316714
2054792
D004317_D009369 NONE adriamycin_2\NNS\0 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (l_acl) combined_3\VBN\2630189 (l_prep) on_8\IN\0 (l_pobj) tumor_9\NN\14234074
D004317_D005334 NONE adriamycin_2\NNS\0 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (l_acl) combined_3\VBN\2630189 (l_prep) with_4\IN\0 (l_pobj) hyperthermia_7\NN\14034177
D004317_D005334 NONE adriamycin_3\NNP\0 (r_npadvmod) mediated_5\VBN\761713 (r_amod) activity_7\NN\30358 (l_conj) toxicities_11\NNS\13576101 (l_prep) by_12\IN\0 (l_pobj) hyperthermia_15\NN\14034177
D004317_D005334 NONE adriamycin_13\NNP\0 (r_npadvmod) mediated_15\VBN\761713 (r_amod) activity_17\NN\30358 (r_dobj) enhanced_11\VBD\227165 (l_nsubj) hyperthermia_2\NN\14034177
D004317_D005334 NONE adriamycin_7\NNP\0 (r_npadvmod) mediated_9\VBN\761713 (r_amod) effect_11\NN\34213 (r_dobj) enhances_6\VBZ\227165 (l_nsubj) hyperthermia_5\NN\14034177
D004317_D064420 NONE adriamycin_3\NNP\0 (r_npadvmod) mediated_5\VBN\761713 (r_amod) activity_7\NN\30358 (l_conj) toxicities_11\NNS\13576101
D004317_D064420 NONE adriamycin_7\NNP\0 (r_npadvmod) mediated_9\VBN\761713 (r_amod) effect_11\NN\34213 (r_dobj) enhances_6\VBZ\227165 (r_advcl) increased_18\VBN\169651 (l_nsubjpass) toxicity_15\NN\13576101
20621845
D002122_D014652 NONE chloride_18\NN\14818238 (l_appos) injury_22\NN\14052046
D002122_D014652 NONE cacl(2))-induced_20\VBN\0 (r_amod) injury_22\NN\14052046
D002122_D017545 CID cacl2-induced_14\VBN\0 (r_amod) aneurysm_17\NN\14057371
D002122_D017545 CID chloride_18\NN\14818238 (r_pobj) by_16\IN\0 (r_prep) establish_5\VB\2426171 (l_dobj) model_8\NN\5888929 (l_prep) of_9\IN\0 (l_pobj) aneurysm_12\NN\14057371
D002122_D017545 CID chloride_18\NN\14818238 (r_pobj) by_16\IN\0 (r_prep) establish_5\VB\2426171 (l_dobj) model_8\NN\5888929 (l_prep) of_9\IN\0 (l_pobj) aneurysm_12\NN\14057371 (l_appos) taa_14\NNP\0
D002122_D017545 CID chloride_18\NN\14818238 (r_pobj) by_16\IN\0 (r_prep) establish_5\VB\2426171 (r_xcomp) designed_3\VBN\1631534 (l_conj) metalloproteinases_39\NNS\0 (l_conj) inhibitors_46\NNS\20090 (l_prep) in_50\IN\13603305 (l_pobj) formation_52\NN\7938773 (l_compound) taa_51\NNP\0
D002122_D017545 CID cacl(2))-induced_20\VBN\0 (r_amod) injury_22\NN\14052046 (r_appos) chloride_18\NN\14818238 (r_pobj) by_16\IN\0 (r_prep) establish_5\VB\2426171 (l_dobj) model_8\NN\5888929 (l_prep) of_9\IN\0 (l_pobj) aneurysm_12\NN\14057371
D002122_D017545 CID cacl(2))-induced_20\VBN\0 (r_amod) injury_22\NN\14052046 (r_appos) chloride_18\NN\14818238 (r_pobj) by_16\IN\0 (r_prep) establish_5\VB\2426171 (l_dobj) model_8\NN\5888929 (l_prep) of_9\IN\0 (l_pobj) aneurysm_12\NN\14057371 (l_appos) taa_14\NNP\0
D002122_D017545 CID cacl(2))-induced_20\VBN\0 (r_amod) injury_22\NN\14052046 (r_appos) chloride_18\NN\14818238 (r_pobj) by_16\IN\0 (r_prep) establish_5\VB\2426171 (r_xcomp) designed_3\VBN\1631534 (l_conj) metalloproteinases_39\NNS\0 (l_conj) inhibitors_46\NNS\20090 (l_prep) in_50\IN\13603305 (l_pobj) formation_52\NN\7938773 (l_compound) taa_51\NNP\0
D002122_D017545 CID )_9\-RRB-\0 (r_punct) establishes_2\VBZ\2426171 (l_dobj) model_5\NN\5888929 (l_compound) taa_4\NNP\0
1835291
D009241_D029424 NONE bromide_5\NN\14904359 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_prep) in_8\IN\13603305 (l_pobj) disease_12\NN\14061805
D009241_D029424 NONE bromide_9\NN\14904359 (r_compound) aerosol_10\NN\11439690 (r_pobj) of_7\IN\0 (r_prep) dose_6\NN\3740161 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubjpass) compared_37\VBN\644583 (l_prep) in_38\IN\13603305 (l_pobj) study_48\NN\635850 (l_prep) in_49\IN\13603305 (l_pobj) patients_51\NNS\9898892 (l_prep) with_52\IN\0 (l_pobj) disease_58\NN\14061805
D009241_D029424 NONE ipratropium_4\NN\0 (r_nsubj) is_5\VBZ\0 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) obstruction_18\NN\4341686
D013806_D029424 NONE theophylline_7\NN\2905612 (r_conj) bromide_5\NN\14904359 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_prep) in_8\IN\13603305 (l_pobj) disease_12\NN\14061805
D013806_D029424 NONE theophylline_19\NN\2905612 (r_amod) tablets_20\NNS\4233405 (r_conj) aerosol_10\NN\11439690 (r_pobj) of_7\IN\0 (r_prep) dose_6\NN\3740161 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubjpass) compared_37\VBN\644583 (l_prep) in_38\IN\13603305 (l_pobj) study_48\NN\635850 (l_prep) in_49\IN\13603305 (l_pobj) patients_51\NNS\9898892 (l_prep) with_52\IN\0 (l_pobj) disease_58\NN\14061805
D013806_D029424 NONE theophylline_12\NN\2905612 (r_pobj) than_10\IN\0 (r_prep) bronchodilator_9\NN\3740161 (r_attr) is_5\VBZ\0 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) obstruction_18\NN\4341686
D013806_D005767 CID theophylline_9\JJ\2905612 (r_amod) use_10\NN\407535 (r_pobj) after_8\IN\0 (r_prep) experienced_7\VBN\2108377 (r_acl) those_6\DT\0 (r_nsubj) involve_12\VB\2676054 (l_dobj) systems_17\NNS\3575240
D013806_D002318 CID theophylline_9\JJ\2905612 (r_amod) use_10\NN\407535 (r_pobj) after_8\IN\0 (r_prep) experienced_7\VBN\2108377 (r_acl) those_6\DT\0 (r_nsubj) involve_12\VB\2676054 (l_dobj) systems_17\NNS\3575240
347884
D006220_D019967 NONE haloperidol_6\NN\3713736 (r_pobj) with_5\IN\0 (r_prep) study_4\NN\635850 (r_pobj) in_0\IN\13603305 (r_prep) found_11\VBN\13279262 (l_xcomp) be_13\VB\14625458 (l_acomp) effective_15\JJ\0 (l_prep) in_16\IN\13603305 (l_pobj) treatment_18\NN\654885 (l_prep) of_19\IN\0 (l_pobj) syndromes_21\NNS\5870365 (l_acl) belonging_22\VBG\7526757 (l_prep) to_24\IN\0 (l_pobj) group_27\NN\2137
2445283
D012254_D000740 CID ribavirin_7\NN\2725367 (r_nsubj) has_8\VBZ\13888491 (l_conj) managed_31\VBN\2524171 (l_nsubjpass) anemia_20\NN\14189204
D012254_D006478 NONE ribavirin_5\NN\2725367 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_conj) tolerance_0\NN\5032565 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) fever_11\NN\14299637
D012254_D006478 NONE ribavirin_5\NN\2725367 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_conj) tolerance_0\NN\5032565 (r_nsubjpass) studied_7\VBN\0 (l_prep) in_8\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) fever_14\NN\14299637
D012254_D006478 NONE ribavirin_5\NN\2725367 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_conj) tolerance_0\NN\5032565 (r_nsubjpass) studied_7\VBN\0 (l_prep) in_8\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) fever_14\NN\14299637 (l_appos) ahf_16\NNP\0
D012254_D006478 NONE ribavirin_7\NN\2725367 (r_nsubj) has_8\VBZ\13888491 (l_dobj) effect_11\NN\34213 (l_prep) in_12\IN\13603305 (l_pobj) cases_14\NNS\7283608 (l_prep) of_15\IN\0 (l_pobj) ahf_16\NNP\0
D012254_D006478 NONE ribavirin_5\RB\2725367 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (l_prep) during_6\IN\0 (l_pobj) days_9\NNS\15140892 (l_prep) of_10\IN\0 (l_pobj) ahf_11\NNP\0
D012254_D014766 NONE ribavirin_2\RB\2725367 (r_pobj) of_1\IN\0 (r_prep) administration_0\NN\1133281 (r_nsubj) resulted_3\VBD\2633881 (l_prep) in_4\IN\13603305 (l_pobj) neutralization_6\NN\231567 (l_prep) of_7\IN\0 (l_pobj) viremia_8\NN\14204950
17854040
D012964_D006509 NONE na_9\TO\14625458 (r_aux) ve_10\VB\0 (l_dobj) virus_13\NN\9312843 (l_appos) patients_18\NNS\9898892 (l_amod) infected_17\JJ\2316868
D012964_D006509 NONE na_9\TO\14625458 (r_aux) ve_10\VB\0 (l_dobj) virus_13\NN\9312843 (l_appos) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_conj) without_21\IN\0 (l_pobj) implications_27\NNS\5774614 (l_conj) patients_40\NNS\9898892 (l_amod) infected_37\VBN\2316868
D012964_D006509 NONE na_21\NN\14625458 (r_aux) ve_22\VB\0 (r_acl) study_4\NN\635850 (l_acl) investigate_6\VB\644583 (l_dobj) virus_12\NN\9312843 (l_compound) b_11\NN\1355326
D012964_D006509 NONE na_21\TO\14625458 (r_aux) ve_22\VB\0 (l_dobj) patients_29\NNS\9898892 (l_amod) infected_28\VBN\2316868
D012964_D015658 NONE na_9\TO\14625458 (r_aux) ve_10\VB\0 (l_dobj) virus_13\NN\9312843 (l_appos) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_conj) without_21\IN\0 (l_pobj) implications_27\NNS\5774614 (l_punct) :_26\:\0 (l_punct) infection_25\NN\14052046
D012964_D015658 NONE na_9\TO\14625458 (r_aux) ve_10\VB\0 (l_dobj) virus_13\NN\9312843 (l_appos) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_conj) without_21\IN\0 (l_pobj) implications_27\NNS\5774614 (l_conj) patients_40\NNS\9898892 (l_amod) infected_37\VBN\2316868
D012964_D015658 NONE na_21\NN\14625458 (r_aux) ve_22\VB\0 (r_acl) study_4\NN\635850 (r_attr) was_1\VBD\0 (l_punct) ._41\.\0 (l_punct) in_37\IN\13603305 (l_punct) infection_36\NN\14052046
D012964_D015658 NONE na_21\TO\14625458 (r_aux) ve_22\VB\0 (l_dobj) patients_29\NNS\9898892 (l_amod) infected_28\VBN\2316868
D019259_D015658 NONE lamivudine_3\NN\3834836 (r_compound) resistance_5\NN\37396 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) mutations_0\NNS\4475 (r_nsubj) ve_10\VB\0 (l_dobj) virus_13\NN\9312843 (l_appos) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_conj) without_21\IN\0 (l_pobj) implications_27\NNS\5774614 (l_punct) :_26\:\0 (l_punct) infection_25\NN\14052046
D019259_D015658 NONE lamivudine_3\NN\3834836 (r_compound) resistance_5\NN\37396 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) mutations_0\NNS\4475 (r_nsubj) ve_10\VB\0 (l_dobj) virus_13\NN\9312843 (l_appos) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_conj) without_21\IN\0 (l_pobj) implications_27\NNS\5774614 (l_conj) patients_40\NNS\9898892 (l_amod) infected_37\VBN\2316868
D019259_D015658 NONE lamivudine_7\JJ\3834836 (r_npadvmod) resistant_9\JJ\0 (r_amod) virus_12\NN\9312843 (r_dobj) investigate_6\VB\644583 (r_acl) study_4\NN\635850 (r_attr) was_1\VBD\0 (l_punct) ._41\.\0 (l_punct) in_37\IN\13603305 (l_punct) infection_36\NN\14052046
D019259_D015658 NONE lamivudine_19\NN\3834836 (r_compound) na_21\NN\14625458 (r_aux) ve_22\VB\0 (r_acl) study_4\NN\635850 (r_attr) was_1\VBD\0 (l_punct) ._41\.\0 (l_punct) in_37\IN\13603305 (l_punct) infection_36\NN\14052046
D019259_D015658 NONE lamivudine_1\NN\3834836 (r_npadvmod) resistant_3\JJ\0 (r_amod) strains_4\NNS\7358060 (r_nsubjpass) detected_6\VBN\2163746 (l_conj) patients_28\NNS\9898892 (l_amod) infected_27\VBN\2316868
D019259_D015658 NONE lamivudine_14\NN\3834836 (r_npadvmod) resistant_16\JJ\0 (r_amod) strains_17\NNS\7358060 (l_prep) in_18\IN\13603305 (l_pcomp) ve_22\VB\0 (l_dobj) patients_29\NNS\9898892 (l_amod) infected_28\VBN\2316868
D019259_D015658 NONE lamivudine_22\NN\3834836 (r_npadvmod) containing_24\VBG\2632940 (r_advcl) emergence_16\NN\7290905 (r_pobj) in_14\IN\13603305 (r_prep) result_13\VB\34213 (l_conj) applied_38\VBN\0 (l_advcl) is_45\VBZ\0 (l_acomp) likely_46\JJ\0 (l_xcomp) have_48\VB\7846 (l_dobj) implications_50\NNS\5774614 (l_prep) in_51\IN\13603305 (l_pobj) management_53\NN\1123598 (l_prep) of_54\IN\0 (l_pobj) patients_61\NNS\9898892 (l_amod) infected_60\VBN\2316868
D019259_D006509 NONE lamivudine_3\NN\3834836 (r_compound) resistance_5\NN\37396 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) mutations_0\NNS\4475 (r_nsubj) ve_10\VB\0 (l_dobj) virus_13\NN\9312843 (l_appos) patients_18\NNS\9898892 (l_amod) infected_17\JJ\2316868
D019259_D006509 NONE lamivudine_3\NN\3834836 (r_compound) resistance_5\NN\37396 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) mutations_0\NNS\4475 (r_nsubj) ve_10\VB\0 (l_dobj) virus_13\NN\9312843 (l_appos) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_conj) without_21\IN\0 (l_pobj) implications_27\NNS\5774614 (l_conj) patients_40\NNS\9898892 (l_amod) infected_37\VBN\2316868
D019259_D006509 NONE lamivudine_7\JJ\3834836 (r_npadvmod) resistant_9\JJ\0 (r_amod) virus_12\NN\9312843 (l_compound) b_11\NN\1355326
D019259_D006509 NONE lamivudine_19\NN\3834836 (r_compound) na_21\NN\14625458 (r_aux) ve_22\VB\0 (r_acl) study_4\NN\635850 (l_acl) investigate_6\VB\644583 (l_dobj) virus_12\NN\9312843 (l_compound) b_11\NN\1355326
D019259_D006509 NONE lamivudine_1\NN\3834836 (r_npadvmod) resistant_3\JJ\0 (r_amod) strains_4\NNS\7358060 (r_nsubjpass) detected_6\VBN\2163746 (l_prep) in_7\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_compound) b_16\NNP\1355326
D019259_D006509 NONE lamivudine_1\NN\3834836 (r_npadvmod) resistant_3\JJ\0 (r_amod) strains_4\NNS\7358060 (r_nsubjpass) detected_6\VBN\2163746 (l_conj) patients_28\NNS\9898892 (l_amod) infected_27\VBN\2316868
D019259_D006509 NONE lamivudine_14\NN\3834836 (r_npadvmod) resistant_16\JJ\0 (r_amod) strains_17\NNS\7358060 (l_prep) in_18\IN\13603305 (l_pcomp) ve_22\VB\0 (l_dobj) patients_29\NNS\9898892 (l_amod) infected_28\VBN\2316868
D019259_D006509 NONE lamivudine_22\NN\3834836 (r_npadvmod) containing_24\VBG\2632940 (r_advcl) emergence_16\NN\7290905 (r_pobj) in_14\IN\13603305 (r_prep) result_13\VB\34213 (l_conj) applied_38\VBN\0 (l_advcl) is_45\VBZ\0 (l_acomp) likely_46\JJ\0 (l_xcomp) have_48\VB\7846 (l_dobj) implications_50\NNS\5774614 (l_prep) in_51\IN\13603305 (l_pobj) management_53\NN\1123598 (l_prep) of_54\IN\0 (l_pobj) patients_61\NNS\9898892 (l_amod) infected_60\VBN\2316868
7468724
D013726_D007752 NONE terbutaline_4\JJ\0 (r_compound) treatment_5\NN\654885 (l_prep) for_6\IN\0 (l_pobj) labor_8\NN\7974025
D013726_D007752 NONE terbutaline_11\NN\0 (l_prep) for_12\IN\0 (l_pobj) labor_14\NN\7974025
D013726_D002318 CID terbutaline_4\JJ\0 (r_compound) treatment_5\NN\654885 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) complications_1\NNS\1073995
D013726_D002318 CID terbutaline_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) patients_8\NNS\9898892 (r_pobj) in_4\IN\13603305 (r_prep) occurred_3\VBD\0 (l_nsubj) complications_2\NNS\1073995
7269015
D003520_D003556 NONE cyclophosphamide_13\NN\0 (r_npadvmod) induced_15\VBN\1627355 (r_conj) radiation_11\NN\11452218 (r_nmod) cystitis_16\NN\14566129 (r_conj) cystitis_8\NN\14566129
D003520_D003556 NONE cyclophosphamide_13\NN\0 (r_npadvmod) induced_15\VBN\1627355 (r_conj) radiation_11\NN\11452218 (r_nmod) cystitis_16\NN\14566129
D002066_D006470 CID busulfan_0\NNS\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) cystitis_4\NN\14566129
D002066_D006470 CID busulfan_4\NNS\0 (r_npadvmod) induced_6\VBN\1627355 (r_amod) cystitis_8\NN\14566129
D002066_D002277 NONE busulfan_7\NNS\0 (r_pobj) of_6\IN\0 (r_prep) tendency_5\NN\6193203 (r_pobj) of_2\IN\0 (r_prep) view_1\NN\6208021 (r_pobj) in_0\IN\13603305 (l_advcl) induce_9\VB\1627355 (l_dobj) atypia_11\NN\0 (l_conj) carcinoma_13\NN\14239918
D002066_D003556 CID busulfan_0\NNS\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) cystitis_4\NN\14566129
D002066_D003556 CID busulfan_4\NNS\0 (r_npadvmod) induced_6\VBN\1627355 (r_amod) cystitis_8\NN\14566129
D002066_D003556 CID busulfan_7\NNS\0 (r_amod) cystitis_8\NN\14566129
D002066_D003556 CID busulfan_7\NNS\0 (r_amod) cystitis_8\NN\14566129 (l_conj) cystitis_16\NN\14566129
15899738
D003401_D001281 CID creatine_5\NN\14601829 (r_compound) supplementation_7\NN\5108947 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) fibrillation_2\NN\14361664
D003401_D001145 NONE creatine_5\NN\14601829 (l_prep) to_6\IN\0 (l_pobj) development_8\NN\248977 (l_prep) of_9\IN\0 (l_pobj) arrhythmia_10\NN\14103288
12615818
D017373_D011085 NONE acetate_1\NN\15010703 (r_nsubjpass) licensed_12\VBN\803325 (l_conj) is_26\VBZ\0 (l_attr) option_30\NN\6480506 (l_prep) for_31\IN\0 (l_pobj) syndrome_34\NN\5870365
D017373_D011085 NONE acetate_1\NN\15010703 (r_nsubjpass) licensed_12\VBN\803325 (l_conj) is_26\VBZ\0 (l_attr) option_30\NN\6480506 (l_prep) for_31\IN\0 (l_pobj) syndrome_34\NN\5870365 (l_appos) pcos_36\NNP\0
D017373_D011085 NONE cpa_7\NNP\9761403 (r_nmod) ee_9\NNP\6125041 (r_appos) estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_conj) is_26\VBZ\0 (l_attr) option_30\NN\6480506 (l_prep) for_31\IN\0 (l_pobj) syndrome_34\NN\5870365
D017373_D011085 NONE cpa_7\NNP\9761403 (r_nmod) ee_9\NNP\6125041 (r_appos) estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_conj) is_26\VBZ\0 (l_attr) option_30\NN\6480506 (l_prep) for_31\IN\0 (l_pobj) syndrome_34\NN\5870365 (l_appos) pcos_36\NNP\0
D017373_D011085 NONE cpa_42\NNP\9761403 (r_nmod) ee_44\NNP\6125041 (r_pobj) with_41\IN\0 (r_prep) associated_40\VBN\628491 (r_acl) vte_39\NNP\0 (r_pobj) of_38\IN\0 (r_prep) risk_37\NN\14541044 (r_dobj) estimate_35\VB\5802185 (r_advcl) conducted_7\VBD\2436349 (l_npadvmod) years_27\NNS\15144371 (l_prep) with_28\IN\0 (l_pobj) acne_29\NN\14171682 (l_conj) hirsutism_31\NN\4683453 (l_conj) pcos_33\NNP\0
D017373_D011085 NONE cpa_13\NNP\9761403 (r_nmod) ee_15\NNP\6125041 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (l_prep) in_16\IN\13603305 (l_pobj) women_17\NNS\9605289 (l_prep) with_18\IN\0 (l_pobj) acne_19\NN\14171682 (l_conj) hirsutism_21\NN\4683453 (l_conj) pcos_23\NNP\0
D003276_D054556 NONE contraceptives_23\NNS\3183080 (r_pobj) with_19\IN\0 (r_prep) compared_18\VBN\644583 (r_prep) demonstrated_3\VBN\2137132 (l_dobj) risk_6\NN\14541044 (l_prep) of_7\IN\0 (l_pobj) thromboembolism_9\NN\14100769
D003276_D054556 NONE contraceptives_23\NNS\3183080 (r_pobj) with_19\IN\0 (r_prep) compared_18\VBN\644583 (r_prep) demonstrated_3\VBN\2137132 (l_dobj) risk_6\NN\14541044 (l_prep) of_7\IN\0 (l_pobj) thromboembolism_9\NN\14100769 (l_appos) vte_11\NNP\0
D004997_D006628 NONE estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_prep) for_16\IN\0 (l_pobj) treatment_18\NN\654885 (l_prep) of_19\IN\0 (l_pobj) women_20\NNS\9605289 (l_prep) with_21\IN\0 (l_pobj) acne_22\NN\14171682 (l_conj) hirsutism_24\NN\4683453
D004997_D006628 NONE ee_9\NNP\6125041 (r_appos) estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_prep) for_16\IN\0 (l_pobj) treatment_18\NN\654885 (l_prep) of_19\IN\0 (l_pobj) women_20\NNS\9605289 (l_prep) with_21\IN\0 (l_pobj) acne_22\NN\14171682 (l_conj) hirsutism_24\NN\4683453
D004997_D006628 NONE ee_44\NNP\6125041 (r_pobj) with_41\IN\0 (r_prep) associated_40\VBN\628491 (r_acl) vte_39\NNP\0 (r_pobj) of_38\IN\0 (r_prep) risk_37\NN\14541044 (r_dobj) estimate_35\VB\5802185 (r_advcl) conducted_7\VBD\2436349 (l_npadvmod) years_27\NNS\15144371 (l_prep) with_28\IN\0 (l_pobj) acne_29\NN\14171682 (l_conj) hirsutism_31\NN\4683453
D004997_D006628 NONE ee_15\NNP\6125041 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (l_prep) in_16\IN\13603305 (l_pobj) women_17\NNS\9605289 (l_prep) with_18\IN\0 (l_pobj) acne_19\NN\14171682 (l_conj) hirsutism_21\NN\4683453
D017373_D000152 NONE acetate_1\NN\15010703 (r_nsubjpass) licensed_12\VBN\803325 (l_prep) for_16\IN\0 (l_pobj) treatment_18\NN\654885 (l_prep) of_19\IN\0 (l_pobj) women_20\NNS\9605289 (l_prep) with_21\IN\0 (l_pobj) acne_22\NN\14171682
D017373_D000152 NONE cpa_7\NNP\9761403 (r_nmod) ee_9\NNP\6125041 (r_appos) estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_prep) for_16\IN\0 (l_pobj) treatment_18\NN\654885 (l_prep) of_19\IN\0 (l_pobj) women_20\NNS\9605289 (l_prep) with_21\IN\0 (l_pobj) acne_22\NN\14171682
D017373_D000152 NONE cpa_42\NNP\9761403 (r_nmod) ee_44\NNP\6125041 (r_pobj) with_41\IN\0 (r_prep) associated_40\VBN\628491 (r_acl) vte_39\NNP\0 (r_pobj) of_38\IN\0 (r_prep) risk_37\NN\14541044 (r_dobj) estimate_35\VB\5802185 (r_advcl) conducted_7\VBD\2436349 (l_npadvmod) years_27\NNS\15144371 (l_prep) with_28\IN\0 (l_pobj) acne_29\NN\14171682
D017373_D000152 NONE cpa_13\NNP\9761403 (r_nmod) ee_15\NNP\6125041 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (l_prep) in_16\IN\13603305 (l_pobj) women_17\NNS\9605289 (l_prep) with_18\IN\0 (l_pobj) acne_19\NN\14171682
D017373_D006628 NONE acetate_1\NN\15010703 (r_nsubjpass) licensed_12\VBN\803325 (l_prep) for_16\IN\0 (l_pobj) treatment_18\NN\654885 (l_prep) of_19\IN\0 (l_pobj) women_20\NNS\9605289 (l_prep) with_21\IN\0 (l_pobj) acne_22\NN\14171682 (l_conj) hirsutism_24\NN\4683453
D017373_D006628 NONE cpa_7\NNP\9761403 (r_nmod) ee_9\NNP\6125041 (r_appos) estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_prep) for_16\IN\0 (l_pobj) treatment_18\NN\654885 (l_prep) of_19\IN\0 (l_pobj) women_20\NNS\9605289 (l_prep) with_21\IN\0 (l_pobj) acne_22\NN\14171682 (l_conj) hirsutism_24\NN\4683453
D017373_D006628 NONE cpa_42\NNP\9761403 (r_nmod) ee_44\NNP\6125041 (r_pobj) with_41\IN\0 (r_prep) associated_40\VBN\628491 (r_acl) vte_39\NNP\0 (r_pobj) of_38\IN\0 (r_prep) risk_37\NN\14541044 (r_dobj) estimate_35\VB\5802185 (r_advcl) conducted_7\VBD\2436349 (l_npadvmod) years_27\NNS\15144371 (l_prep) with_28\IN\0 (l_pobj) acne_29\NN\14171682 (l_conj) hirsutism_31\NN\4683453
D017373_D006628 NONE cpa_13\NNP\9761403 (r_nmod) ee_15\NNP\6125041 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (l_prep) in_16\IN\13603305 (l_pobj) women_17\NNS\9605289 (l_prep) with_18\IN\0 (l_pobj) acne_19\NN\14171682 (l_conj) hirsutism_21\NN\4683453
D004997_D054556 CID estradiol_14\NN\14749794 (r_appos) risk_1\NN\14541044 (l_prep) of_2\IN\0 (l_pobj) thromboembolism_4\NN\14100769
D004997_D054556 CID ee_17\NNP\6125041 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (r_acl) thromboembolism_9\NN\14100769
D004997_D054556 CID ee_17\NNP\6125041 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (r_acl) thromboembolism_9\NN\14100769 (l_appos) vte_11\NNP\0
D004997_D054556 CID ee_44\NNP\6125041 (r_pobj) with_41\IN\0 (r_prep) associated_40\VBN\628491 (r_acl) vte_39\NNP\0
D004997_D054556 CID ee_15\NNP\6125041 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (r_acl) risk_5\NN\14541044 (l_prep) of_6\IN\0 (l_pobj) vte_7\NNP\0
D004997_D011085 NONE estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_conj) is_26\VBZ\0 (l_attr) option_30\NN\6480506 (l_prep) for_31\IN\0 (l_pobj) syndrome_34\NN\5870365
D004997_D011085 NONE estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_conj) is_26\VBZ\0 (l_attr) option_30\NN\6480506 (l_prep) for_31\IN\0 (l_pobj) syndrome_34\NN\5870365 (l_appos) pcos_36\NNP\0
D004997_D011085 NONE ee_9\NNP\6125041 (r_appos) estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_conj) is_26\VBZ\0 (l_attr) option_30\NN\6480506 (l_prep) for_31\IN\0 (l_pobj) syndrome_34\NN\5870365
D004997_D011085 NONE ee_9\NNP\6125041 (r_appos) estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_conj) is_26\VBZ\0 (l_attr) option_30\NN\6480506 (l_prep) for_31\IN\0 (l_pobj) syndrome_34\NN\5870365 (l_appos) pcos_36\NNP\0
D004997_D011085 NONE ee_44\NNP\6125041 (r_pobj) with_41\IN\0 (r_prep) associated_40\VBN\628491 (r_acl) vte_39\NNP\0 (r_pobj) of_38\IN\0 (r_prep) risk_37\NN\14541044 (r_dobj) estimate_35\VB\5802185 (r_advcl) conducted_7\VBD\2436349 (l_npadvmod) years_27\NNS\15144371 (l_prep) with_28\IN\0 (l_pobj) acne_29\NN\14171682 (l_conj) hirsutism_31\NN\4683453 (l_conj) pcos_33\NNP\0
D004997_D011085 NONE ee_15\NNP\6125041 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (l_prep) in_16\IN\13603305 (l_pobj) women_17\NNS\9605289 (l_prep) with_18\IN\0 (l_pobj) acne_19\NN\14171682 (l_conj) hirsutism_21\NN\4683453 (l_conj) pcos_23\NNP\0
D017373_D054556 CID acetate_9\NN\15010703 (r_oprd) prescribed_7\VBD\748282 (r_acl) women_6\NNS\9605289 (r_pobj) in_5\IN\13603305 (r_prep) thromboembolism_4\NN\14100769
D017373_D054556 CID cpa_15\NNP\9761403 (r_nmod) ee_17\NNP\6125041 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (r_acl) thromboembolism_9\NN\14100769
D017373_D054556 CID cpa_15\NNP\9761403 (r_nmod) ee_17\NNP\6125041 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (r_acl) thromboembolism_9\NN\14100769 (l_appos) vte_11\NNP\0
D017373_D054556 CID cpa_42\NNP\9761403 (r_nmod) ee_44\NNP\6125041 (r_pobj) with_41\IN\0 (r_prep) associated_40\VBN\628491 (r_acl) vte_39\NNP\0
D017373_D054556 CID cpa_13\NNP\9761403 (r_nmod) ee_15\NNP\6125041 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (r_acl) risk_5\NN\14541044 (l_prep) of_6\IN\0 (l_pobj) vte_7\NNP\0
D004997_D000152 NONE estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_prep) for_16\IN\0 (l_pobj) treatment_18\NN\654885 (l_prep) of_19\IN\0 (l_pobj) women_20\NNS\9605289 (l_prep) with_21\IN\0 (l_pobj) acne_22\NN\14171682
D004997_D000152 NONE ee_9\NNP\6125041 (r_appos) estradiol_5\NN\14749794 (r_nsubjpass) licensed_12\VBN\803325 (l_prep) for_16\IN\0 (l_pobj) treatment_18\NN\654885 (l_prep) of_19\IN\0 (l_pobj) women_20\NNS\9605289 (l_prep) with_21\IN\0 (l_pobj) acne_22\NN\14171682
D004997_D000152 NONE ee_44\NNP\6125041 (r_pobj) with_41\IN\0 (r_prep) associated_40\VBN\628491 (r_acl) vte_39\NNP\0 (r_pobj) of_38\IN\0 (r_prep) risk_37\NN\14541044 (r_dobj) estimate_35\VB\5802185 (r_advcl) conducted_7\VBD\2436349 (l_npadvmod) years_27\NNS\15144371 (l_prep) with_28\IN\0 (l_pobj) acne_29\NN\14171682
D004997_D000152 NONE ee_15\NNP\6125041 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (l_prep) in_16\IN\13603305 (l_pobj) women_17\NNS\9605289 (l_prep) with_18\IN\0 (l_pobj) acne_19\NN\14171682
12483326
D002945_D009916 NONE cisplatin_11\NN\0 (r_pcomp) than_10\IN\0 (r_prep) effects_9\NNS\13245626 (r_dobj) have_6\VB\7846 (r_xcomp) said_4\VBN\940384 (l_ccomp) known_20\JJ\0 (l_auxpass) are_18\VBP\13600404 (l_nsubj) toxicity_17\NN\13576101
D002945_D005128 NONE cisplatin_11\NN\0 (r_pcomp) than_10\IN\0 (r_prep) effects_9\NNS\13245626 (r_dobj) have_6\VB\7846 (r_xcomp) said_4\VBN\940384 (l_ccomp) known_20\JJ\0 (l_auxpass) are_18\VBP\13600404 (l_nsubj) toxicity_17\NN\13576101
D016190_D005909 NONE carboplatin_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) injection_7\NN\320852 (l_prep) for_10\IN\0 (l_pobj) glioblastomas_12\NNS\14236743
D016190_D005909 NONE carboplatin_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) injection_8\NN\320852 (l_prep) for_11\IN\0 (l_pobj) glioblastomas_13\NNS\14236743
D016190_D005128 NONE carboplatin_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) injection_7\NN\320852 (r_pobj) after_5\IN\0 (r_prep) toxicity_4\NN\13576101
D016190_D005128 NONE carboplatin_2\NN\0 (r_nsubjpass) said_4\VBN\940384 (l_ccomp) known_20\JJ\0 (l_auxpass) are_18\VBP\13600404 (l_nsubj) toxicity_17\NN\13576101
D016190_D005128 NONE carboplatin_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) injection_14\NN\320852 (r_pobj) after_12\IN\0 (r_prep) experienced_3\VBD\2108377 (l_dobj) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) toxicity_11\NN\13576101
D016190_D005128 NONE carboplatin_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) injection_3\NN\320852 (r_dobj) performing_1\VBG\407535 (r_advcl) be_9\VB\14625458 (l_acomp) aware_10\JJ\0 (l_prep) of_11\IN\0 (l_pobj) toxicity_16\NN\13576101
D016190_D009916 NONE carboplatin_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) injection_7\NN\320852 (r_pobj) after_5\IN\0 (r_prep) toxicity_4\NN\13576101
D016190_D009916 NONE carboplatin_2\NN\0 (r_nsubjpass) said_4\VBN\940384 (l_ccomp) known_20\JJ\0 (l_auxpass) are_18\VBP\13600404 (l_nsubj) toxicity_17\NN\13576101
D016190_D009916 NONE carboplatin_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) injection_14\NN\320852 (r_pobj) after_12\IN\0 (r_prep) experienced_3\VBD\2108377 (l_dobj) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) toxicity_11\NN\13576101
D016190_D064420 NONE carboplatin_7\NN\0 (r_amod) toxicity_8\NN\13576101
7292072
D003891_D017180 CID desipramine_4\JJ\4482543 (r_amod) toxicity_5\NN\13576101 (r_pobj) in_3\IN\13603305 (r_prep) tachycardia_2\NN\14110674
D003891_D017180 CID desipramine_10\NN\4482543 (r_amod) toxicity_11\NN\13576101 (r_pobj) by_9\IN\0 (r_agent) induced_8\VBN\1627355 (r_acl) tachycardia_7\NN\14110674
D003891_D064420 NONE desipramine_4\JJ\4482543 (r_amod) toxicity_5\NN\13576101
D003891_D064420 NONE desipramine_10\NN\4482543 (r_amod) toxicity_11\NN\13576101
9401499
D013988_D000741 CID ticlopidine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) anemia_4\NN\14189204
D013988_D000741 CID ticlopidine_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) anemia_12\NN\14189204
D013988_D000741 CID ticlopidine_2\NN\0 (r_npadvmod) induced_4\VBN\1627355 (r_amod) anemia_6\NN\14189204
D013988_D000380 CID ticlopidine_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) initiation_7\NN\7450842 (r_pobj) after_6\IN\0 (r_prep) occurred_1\VBD\0 (l_nsubj) agranulocytosis_0\NN\14189204
9195768
D018170_D010292 CID sumatriptan_7\NN\0 (r_pobj) of_5\IN\0 (r_prep) use_4\NN\407535 (r_dobj) following_2\VBG\8180190 (r_prep) sensations_1\NNS\5708432
17147461
D000804_D011507 NONE ii_52\CD\13741022 (r_compound) blockers_54\NNS\10101634 (r_conj) inhibitors_49\NNS\20090 (r_pobj) of_44\IN\0 (r_prep) use_43\NN\407535 (r_conj) monitoring_36\NN\879759 (l_prep) of_37\IN\0 (l_pobj) proteinuria_38\NN\14299637
D000804_D011507 NONE ii_52\CD\13741022 (r_compound) blockers_54\NNS\10101634 (r_conj) inhibitors_49\NNS\20090 (r_pobj) of_44\IN\0 (r_prep) use_43\NN\407535 (r_conj) monitoring_36\NN\879759 (l_advcl) occurs_57\VBZ\0 (l_nsubj) proteinuria_56\NN\14299637
D000809_D011507 NONE angiotensin_45\NN\4522421 (r_npadvmod) converting_47\VBG\126264 (r_amod) inhibitors_49\NNS\20090 (r_pobj) of_44\IN\0 (r_prep) use_43\NN\407535 (r_conj) monitoring_36\NN\879759 (l_prep) of_37\IN\0 (l_pobj) proteinuria_38\NN\14299637
D000809_D011507 NONE angiotensin_45\NN\4522421 (r_npadvmod) converting_47\VBG\126264 (r_amod) inhibitors_49\NNS\20090 (r_pobj) of_44\IN\0 (r_prep) use_43\NN\407535 (r_conj) monitoring_36\NN\879759 (l_advcl) occurs_57\VBZ\0 (l_nsubj) proteinuria_56\NN\14299637
D020123_D011507 CID sirolimus_0\NNP\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) proteinuria_3\NN\14299637
D020123_D011507 CID sirolimus_11\NN\0 (r_nsubjpass) associated_13\VBN\628491 (l_prep) with_14\IN\0 (l_pobj) proteinuria_15\NN\14299637
D020123_D011507 CID sirolimus_3\NN\0 (r_npadvmod) associated_5\VBN\628491 (r_amod) proteinuria_6\NN\14299637
D020123_D011507 CID sirolimus_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) effects_19\NNS\13245626 (r_pobj) of_16\IN\0 (r_prep) knowledge_15\NN\23100 (r_pobj) by_14\IN\0 (r_agent) minimised_13\VBN\831651 (l_dep) use_27\NN\407535 (l_appos) monitoring_36\NN\879759 (l_prep) of_37\IN\0 (l_pobj) proteinuria_38\NN\14299637
D020123_D011507 CID sirolimus_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) effects_19\NNS\13245626 (r_pobj) of_16\IN\0 (r_prep) knowledge_15\NN\23100 (r_pobj) by_14\IN\0 (r_agent) minimised_13\VBN\831651 (l_dep) use_27\NN\407535 (l_appos) monitoring_36\NN\879759 (l_advcl) occurs_57\VBZ\0 (l_nsubj) proteinuria_56\NN\14299637
D020123_D011507 CID sirolimus_29\NN\0 (r_pobj) of_28\IN\0 (r_prep) use_27\NN\407535 (l_appos) monitoring_36\NN\879759 (l_prep) of_37\IN\0 (l_pobj) proteinuria_38\NN\14299637
D020123_D011507 CID sirolimus_29\NN\0 (r_pobj) of_28\IN\0 (r_prep) use_27\NN\407535 (l_appos) monitoring_36\NN\879759 (l_advcl) occurs_57\VBZ\0 (l_nsubj) proteinuria_56\NN\14299637
D020123_D058186 NONE sirolimus_11\NN\0 (r_nsubjpass) associated_13\VBN\628491 (l_prep) with_14\IN\0 (l_pobj) proteinuria_15\NN\14299637 (l_conj) dysfunction_19\NN\14204950
D020123_D058186 NONE sirolimus_6\NN\0 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) dysfunction_3\NN\14204950
D020123_D007674 CID sirolimus_0\NNP\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) proteinuria_3\NN\14299637 (l_conj) dysfunction_6\NN\14204950
D020123_D007674 CID sirolimus_0\NNP\0 (r_nsubj) represents_1\VBZ\2664769 (l_dobj) advance_5\NN\7311115 (l_prep) in_6\IN\13603305 (l_pobj) prevention_8\NN\1073995 (l_prep) of_9\IN\0 (l_pobj) rejection_13\NN\30358 (l_conj) nephropathy_17\NN\14573196
D020123_D007674 CID sirolimus_1\NN\0 (r_nsubj) share_4\VB\13329641 (r_advcl) designated_18\VBN\0 (l_oprd) drug_24\NN\14778436 (l_amod) nephrotoxic_23\JJ\0
12464714
D004878_D006970 NONE ergotamine_19\NNP\14712692 (r_nmod) caffeine_21\NN\14712692 (r_conj) rizatriptan_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) >_7\XX\0 (r_appos) events_4\NNS\23100 (l_appos) nausea_34\NN\14299637 (l_conj) somnolence_42\NN\14015731
D004878_D004244 NONE ergotamine_19\NNP\14712692 (r_nmod) caffeine_21\NN\14712692 (r_conj) rizatriptan_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) >_7\XX\0 (r_appos) events_4\NNS\23100 (r_nsubj) were_25\VBD\0 (l_attr) dizziness_26\NN\14299637
D002110_D008881 NONE caffeine_13\NN\14712692 (l_prep) in_14\IN\13603305 (l_pobj) migraine_15\NN\14326607
D002110_D008881 NONE caffeine_22\NN\14712692 (r_appos) ergotamine_18\NN\14712692 (r_pobj) to_16\IN\0 (r_prep) tablet_15\NN\4233405 (r_amod) rizatriptan_12\JJ\0 (r_pobj) for_10\IN\0 (r_prep) preference_9\NN\7497473 (r_dobj) assessed_7\VBD\670261 (l_prep) in_26\IN\13603305 (l_pobj) patients_28\NNS\9898892 (l_acl) treating_29\VBG\2376958 (l_dobj) attack_33\NN\955060 (l_compound) migraine_32\JJ\14326607
C093622_D010146 NONE rizatriptan_12\NN\0 (r_pobj) after_11\IN\0 (r_prep) h_10\NN\14622893 (r_npadvmod) were_6\VBD\0 (l_acomp) free_8\JJ\7942152 (l_npadvmod) pain_7\NN\14299637
C093622_D010146 NONE rizatriptan_31\JJ\0 (r_nsubj) being_32\VBG\24720 (r_advcl) were_6\VBD\0 (l_acomp) free_8\JJ\7942152 (l_npadvmod) pain_7\NN\14299637
C093622_D010146 NONE rizatriptan_6\NN\0 (r_dobj) taking_5\VBG\37396 (r_acl) patients_4\NNS\9898892 (r_pobj) of_3\IN\0 (r_prep) %_2\NN\0 (r_nsubj) were_7\VBD\0 (l_acomp) free_9\JJ\7942152 (l_npadvmod) pain_8\NN\14299637
C093622_D004244 CID rizatriptan_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) >_7\XX\0 (r_appos) events_4\NNS\23100 (r_nsubj) were_25\VBD\0 (l_attr) dizziness_26\NN\14299637
D002110_D012001 NONE caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637 (l_conj) vomiting_17\VBG\116687 (l_conj) phonophobia_19\NNS\14382238
C093622_D012001 NONE rizatriptan_0\NNP\0 (r_nsubj) was_1\VBD\0 (l_acomp) superior_3\JJ\9623038 (l_prep) to_4\IN\0 (l_pobj) caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637 (l_conj) vomiting_17\VBG\116687 (l_conj) phonophobia_19\NNS\14382238
D002110_D014839 NONE caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637 (l_conj) vomiting_17\VBG\116687
D002110_D004244 NONE caffeine_21\NN\14712692 (r_conj) rizatriptan_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) >_7\XX\0 (r_appos) events_4\NNS\23100 (r_nsubj) were_25\VBD\0 (l_attr) dizziness_26\NN\14299637
D012701_D008881 NONE 5-ht(1b/1d_4\CD\0 (r_nummod) receptor_6\NN\5225602 (r_compound) agonist_7\NN\0 (l_prep) with_8\IN\0 (l_pobj) absorption_11\NN\13558490 (l_conj) onset_14\NN\7325190 (l_prep) in_17\IN\13603305 (l_pobj) treatment_20\NN\654885 (l_prep) of_21\IN\0 (l_pobj) migraine_22\NN\14326607
D004878_D014839 NONE ergotamine_5\NN\14712692 (r_nmod) caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637 (l_conj) vomiting_17\VBG\116687
C093622_D006261 NONE rizatriptan_19\JJ\0 (r_dobj) preferring_18\VBG\1777210 (r_acl) patients_17\NNS\9898892 (r_pobj) of_16\IN\0 (r_prep) %_15\NN\0 (r_pobj) by_13\IN\0 (r_agent) cited_12\VBN\730052 (r_acl) reason_8\NN\9178821 (r_attr) was_4\VBD\0 (l_nsubj) relief_1\NN\7492516 (l_prep) of_2\IN\0 (l_pobj) headache_3\NN\5829480
D004878_D008881 NONE ergotamine_11\NN\14712692 (r_nmod) caffeine_13\NN\14712692 (l_prep) in_14\IN\13603305 (l_pobj) migraine_15\NN\14326607
D004878_D008881 NONE ergotamine_18\NN\14712692 (r_pobj) to_16\IN\0 (r_prep) tablet_15\NN\4233405 (r_amod) rizatriptan_12\JJ\0 (r_pobj) for_10\IN\0 (r_prep) preference_9\NN\7497473 (r_dobj) assessed_7\VBD\670261 (l_prep) in_26\IN\13603305 (l_pobj) patients_28\NNS\9898892 (l_acl) treating_29\VBG\2376958 (l_dobj) attack_33\NN\955060 (l_compound) migraine_32\JJ\14326607
C093622_D009325 CID rizatriptan_0\NNP\0 (r_nsubj) was_1\VBD\0 (l_acomp) superior_3\JJ\9623038 (l_prep) to_4\IN\0 (l_pobj) caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637
C093622_D009325 CID rizatriptan_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) >_7\XX\0 (r_appos) events_4\NNS\23100 (l_appos) nausea_34\NN\14299637
C093622_D020795 NONE rizatriptan_0\NNP\0 (r_nsubj) was_1\VBD\0 (l_acomp) superior_3\JJ\9623038 (l_prep) to_4\IN\0 (l_pobj) caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637 (l_conj) vomiting_17\VBG\116687 (l_conj) phonophobia_19\NNS\14382238 (l_conj) photophobia_21\NNS\14382238
D002110_D009325 NONE caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637
D002110_D009325 NONE caffeine_21\NN\14712692 (r_conj) rizatriptan_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) >_7\XX\0 (r_appos) events_4\NNS\23100 (l_appos) nausea_34\NN\14299637
D004878_D012001 NONE ergotamine_5\NN\14712692 (r_nmod) caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637 (l_conj) vomiting_17\VBG\116687 (l_conj) phonophobia_19\NNS\14382238
D002110_D020795 NONE caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637 (l_conj) vomiting_17\VBG\116687 (l_conj) phonophobia_19\NNS\14382238 (l_conj) photophobia_21\NNS\14382238
D004878_D020795 NONE ergotamine_5\NN\14712692 (r_nmod) caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637 (l_conj) vomiting_17\VBG\116687 (l_conj) phonophobia_19\NNS\14382238 (l_conj) photophobia_21\NNS\14382238
C093622_D006970 NONE rizatriptan_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) >_7\XX\0 (r_appos) events_4\NNS\23100 (l_appos) nausea_34\NN\14299637 (l_conj) somnolence_42\NN\14015731
D004878_D009325 NONE ergotamine_5\NN\14712692 (r_nmod) caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637
D004878_D009325 NONE ergotamine_19\NNP\14712692 (r_nmod) caffeine_21\NN\14712692 (r_conj) rizatriptan_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) >_7\XX\0 (r_appos) events_4\NNS\23100 (l_appos) nausea_34\NN\14299637
C093622_D014839 NONE rizatriptan_0\NNP\0 (r_nsubj) was_1\VBD\0 (l_acomp) superior_3\JJ\9623038 (l_prep) to_4\IN\0 (l_pobj) caffeine_7\NN\14712692 (l_prep) in_8\IN\13603305 (l_pobj) proportions_10\NNS\13824815 (l_prep) of_11\IN\0 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) nausea_15\NN\14299637 (l_conj) vomiting_17\VBG\116687
D002110_D010146 NONE caffeine_22\NN\14712692 (r_pobj) with_19\IN\0 (r_prep) treated_18\VBN\2376958 (r_acl) %_17\NN\0 (r_pobj) with_15\IN\0 (r_prep) compared_14\VBN\644583 (r_prep) were_6\VBD\0 (l_acomp) free_8\JJ\7942152 (l_npadvmod) pain_7\NN\14299637
D002110_D010146 NONE caffeine_35\NN\14712692 (r_pobj) on_32\IN\0 (r_prep) patients_31\NNS\9898892 (r_pobj) of_30\IN\0 (r_prep) %_29\NN\0 (r_pobj) to_27\IN\0 (r_prep) compared_26\VBN\644583 (r_prep) were_7\VBD\0 (l_acomp) free_9\JJ\7942152 (l_npadvmod) pain_8\NN\14299637
D002110_D006261 NONE caffeine_29\NN\14712692 (r_dobj) preferred_26\VBD\1777210 (r_relcl) patients_24\NNS\9898892 (r_pobj) of_23\IN\0 (r_prep) %_22\NN\0 (r_conj) rizatriptan_19\JJ\0 (r_dobj) preferring_18\VBG\1777210 (r_acl) patients_17\NNS\9898892 (r_pobj) of_16\IN\0 (r_prep) %_15\NN\0 (r_pobj) by_13\IN\0 (r_agent) cited_12\VBN\730052 (r_acl) reason_8\NN\9178821 (r_attr) was_4\VBD\0 (l_nsubj) relief_1\NN\7492516 (l_prep) of_2\IN\0 (l_pobj) headache_3\NN\5829480
C093622_D008881 NONE rizatriptan_7\JJ\0 (r_pobj) for_6\IN\0 (r_prep) preference_5\NN\7497473 (r_conj) efficacy_3\NN\5199286 (r_pobj) of_2\IN\0 (r_prep) comparison_1\NN\635850 (l_conj) caffeine_13\NN\14712692 (l_prep) in_14\IN\13603305 (l_pobj) migraine_15\NN\14326607
C093622_D008881 NONE rizatriptan_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) agonist_7\NN\0 (l_prep) with_8\IN\0 (l_pobj) absorption_11\NN\13558490 (l_conj) onset_14\NN\7325190 (l_prep) in_17\IN\13603305 (l_pobj) treatment_20\NN\654885 (l_prep) of_21\IN\0 (l_pobj) migraine_22\NN\14326607
C093622_D008881 NONE rizatriptan_12\JJ\0 (r_pobj) for_10\IN\0 (r_prep) preference_9\NN\7497473 (r_dobj) assessed_7\VBD\670261 (l_prep) in_26\IN\13603305 (l_pobj) patients_28\NNS\9898892 (l_acl) treating_29\VBG\2376958 (l_dobj) attack_33\NN\955060 (l_compound) migraine_32\JJ\14326607
D004878_D010146 NONE ergotamine_20\NN\14712692 (r_nmod) caffeine_22\NN\14712692 (r_pobj) with_19\IN\0 (r_prep) treated_18\VBN\2376958 (r_acl) %_17\NN\0 (r_pobj) with_15\IN\0 (r_prep) compared_14\VBN\644583 (r_prep) were_6\VBD\0 (l_acomp) free_8\JJ\7942152 (l_npadvmod) pain_7\NN\14299637
D004878_D010146 NONE ergotamine_33\NNP\14712692 (r_nmod) caffeine_35\NN\14712692 (r_pobj) on_32\IN\0 (r_prep) patients_31\NNS\9898892 (r_pobj) of_30\IN\0 (r_prep) %_29\NN\0 (r_pobj) to_27\IN\0 (r_prep) compared_26\VBN\644583 (r_prep) were_7\VBD\0 (l_acomp) free_9\JJ\7942152 (l_npadvmod) pain_8\NN\14299637
D004878_D006261 NONE ergotamine_27\NN\14712692 (r_nmod) caffeine_29\NN\14712692 (r_dobj) preferred_26\VBD\1777210 (r_relcl) patients_24\NNS\9898892 (r_pobj) of_23\IN\0 (r_prep) %_22\NN\0 (r_conj) rizatriptan_19\JJ\0 (r_dobj) preferring_18\VBG\1777210 (r_acl) patients_17\NNS\9898892 (r_pobj) of_16\IN\0 (r_prep) %_15\NN\0 (r_pobj) by_13\IN\0 (r_agent) cited_12\VBN\730052 (r_acl) reason_8\NN\9178821 (r_attr) was_4\VBD\0 (l_nsubj) relief_1\NN\7492516 (l_prep) of_2\IN\0 (l_pobj) headache_3\NN\5829480
D002110_D006970 NONE caffeine_21\NN\14712692 (r_conj) rizatriptan_17\NN\0 (r_pobj) after_16\IN\0 (r_prep) >_7\XX\0 (r_appos) events_4\NNS\23100 (l_appos) nausea_34\NN\14299637 (l_conj) somnolence_42\NN\14015731
18619688
D004317_D003643 NONE adriamycin_0\NNP\0 (r_advmod) induced_2\VBN\1627355 (r_amod) death_5\NN\7296428
D004317_D003643 NONE adriamycin_17\NNS\0 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_advcl) plays_3\VBZ\7007684 (l_nsubj) death_2\NN\7296428
C025946_D006333 NONE 3-methyladenine_2\LS\0 (r_appos) methods_0\NNS\5616786 (r_nsubjpass) used_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) model_18\NN\5888929 (l_compound) failure_17\NN\66216
C025946_D006333 NONE 3ma_4\VBN\0 (r_appos) 3-methyladenine_2\LS\0 (r_appos) methods_0\NNS\5616786 (r_nsubjpass) used_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) model_18\NN\5888929 (l_compound) failure_17\NN\66216
D004317_D006333 CID adriamycin_0\NNP\0 (r_advmod) induced_2\VBN\1627355 (r_amod) death_5\NN\7296428 (r_nsubj) plays_6\VBZ\7007684 (l_prep) in_10\IN\13603305 (l_pobj) model_13\NN\5888929 (l_prep) of_14\IN\0 (l_pobj) failure_16\NN\66216
D004317_D006333 CID adriamycin_7\NNS\0 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (r_acl) failure_4\NN\66216
D004317_D006333 CID adriamycin_20\NNS\0 (r_pobj) by_19\IN\0 (r_agent) induced_18\VBN\1627355 (r_acl) progression_14\NN\8457976 (l_prep) of_15\IN\0 (l_pobj) failure_17\NN\66216
D004317_D006333 CID adriamycin_20\NNS\0 (r_pobj) by_19\IN\0 (r_agent) induced_18\VBN\1627355 (r_acl) progression_14\NN\8457976 (r_pobj) in_12\IN\13603305 (r_prep) involved_11\VBN\2676054 (r_ccomp) investigate_7\VB\644583 (l_advcl) develop_26\VB\1753788 (l_dobj) strategy_30\NN\5902545 (l_prep) for_31\IN\0 (l_pobj) failure_33\NN\66216
D004317_D006333 CID adriamycin_23\NNS\0 (r_pobj) by_22\IN\0 (r_agent) induced_21\VBN\1627355 (r_acl) model_18\NN\5888929 (l_compound) failure_17\NN\66216
D004317_D006333 CID adriamycin_17\NNS\0 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_advcl) plays_3\VBZ\7007684 (l_prep) in_7\IN\13603305 (l_pobj) pathogenesis_9\NN\13533470 (l_prep) of_10\IN\0 (l_pobj) failure_12\NN\66216
D004317_D006333 CID adriamycin_13\NNS\0 (r_pobj) by_12\IN\0 (r_agent) caused_11\VBN\1617192 (r_acl) failure_10\NN\66216
11250767
D011441_D005921 CID propylthiouracil_13\NN\14727670 (l_relcl) developed_25\VBD\1753788 (l_nsubj) syndrome_17\NN\5870365 (l_prep) of_18\IN\0 (l_pobj) pericarditis_19\NN\14338942 (l_conj) fever_21\NN\14299637 (l_conj) glomerulonephritis_24\NN\14113798
D011441_D010493 CID propylthiouracil_0\NNP\14727670 (r_npadvmod) induced_2\VBN\1627355 (r_amod) vasculitis_11\NN\14336539 (l_prep) in_12\IN\13603305 (l_pobj) conjunction_13\NN\5048123 (l_prep) with_14\IN\0 (l_pobj) pericarditis_15\NN\14338942
D011441_D010493 CID propylthiouracil_5\NN\14727670 (r_npadvmod) induced_7\VBN\1627355 (r_amod) vasculitis_8\NN\14336539 (l_acl) manifesting_9\VBG\1015244 (l_prep) with_10\IN\0 (l_pobj) pericarditis_11\NN\14338942
D011441_D010493 CID propylthiouracil_13\NN\14727670 (l_relcl) developed_25\VBD\1753788 (l_nsubj) syndrome_17\NN\5870365 (l_prep) of_18\IN\0 (l_pobj) pericarditis_19\NN\14338942
D011441_D010493 CID uracil_20\NN\14964590 (r_compound) therapy_21\NN\657604 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) vasculitis_16\NN\14336539 (r_pobj) in_9\IN\13603305 (r_prep) reports_6\NNS\6470073 (l_prep) of_7\IN\0 (l_pobj) pericarditis_8\NN\14338942
D011441_D010493 CID uracil_14\NN\14964590 (r_compound) therapy_15\NN\657604 (r_appos) propylthio-_13\VB\0 (r_pobj) to_12\IN\0 (r_prep) attributable_11\JJ\0 (r_amod) manifestation_5\NN\7321772 (r_attr) be_2\VB\14625458 (l_nsubj) pericarditis_0\NNP\14338942
D011441_D006980 NONE propylthiouracil_13\NN\14727670 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (r_acl) report_5\NN\6470073 (l_prep) of_6\IN\0 (l_pobj) woman_8\NN\9605289 (l_prep) with_9\IN\0 (l_pobj) hyperthyroidism_10\NN\14059928
D011441_D014657 NONE propylthiouracil_0\NNP\14727670 (r_npadvmod) induced_2\VBN\1627355 (r_amod) vasculitis_11\NN\14336539
D011441_D014657 NONE propylthiouracil_5\NN\14727670 (r_npadvmod) induced_7\VBN\1627355 (r_amod) vasculitis_8\NN\14336539
D011441_D014657 NONE uracil_20\NN\14964590 (r_compound) therapy_21\NN\657604 (r_pobj) with_18\IN\0 (r_prep) associated_17\VBN\628491 (r_acl) vasculitis_16\NN\14336539
D011441_D014657 NONE uracil_14\NN\14964590 (r_compound) therapy_15\NN\657604 (r_appos) propylthio-_13\VB\0 (r_pobj) to_12\IN\0 (r_prep) attributable_11\JJ\0 (r_amod) manifestation_5\NN\7321772 (l_prep) of_6\IN\0 (l_pobj) vasculitis_10\NN\14336539
D011441_D005334 CID propylthiouracil_13\NN\14727670 (l_relcl) developed_25\VBD\1753788 (l_nsubj) syndrome_17\NN\5870365 (l_prep) of_18\IN\0 (l_pobj) pericarditis_19\NN\14338942 (l_conj) fever_21\NN\14299637
11706060
D019344_D000163 NONE lactate_8\NN\14850483 (r_dobj) elevates_6\VBZ\2391803 (l_prep) in_9\IN\13603305 (l_pobj) mice_12\NNS\2329401 (l_compound) aids_11\NNP\13974317
D019344_D000163 NONE lactate_18\NN\14850483 (l_prep) in_22\IN\13603305 (l_pobj) aids_23\NNP\13974317
D019344_D000163 NONE la_20\NNP\14625458 (r_appos) lactate_18\NN\14850483 (l_prep) in_22\IN\13603305 (l_pobj) aids_23\NNP\13974317
D019344_D000163 NONE la_10\NNP\14625458 (l_prep) in_11\IN\13603305 (l_pobj) mice_14\NNS\2329401 (l_compound) transgenic_13\JJ\0 (l_compound) aids_12\NNP\13974317
D019259_D000163 NONE lamivudine_43\NN\3834836 (r_pobj) of_40\IN\0 (r_prep) combination_39\NN\7951464 (r_pobj) with_36\IN\0 (r_prep) treated_35\VBN\2376958 (l_nsubjpass) mice_15\NNS\2329401 (l_compound) aids_14\NNP\13974317
D019344_D009202 NONE lactate_8\NN\14850483 (r_dobj) elevates_6\VBZ\2391803 (r_conj) causes_3\VBZ\7323922 (l_advmod) cardiomyopathy_4\NN\14103288
D019344_D009202 NONE lactate_18\NN\14850483 (r_pobj) in_15\IN\13603305 (r_conj) in_9\IN\13603305 (l_pobj) cm_12\NNP\13649268 (l_amod) cardiomyopathy_10\NN\14103288
D019344_D009202 NONE lactate_18\NN\14850483 (r_pobj) in_15\IN\13603305 (r_conj) in_9\IN\13603305 (l_pobj) cm_12\NNP\13649268
D019344_D009202 NONE la_20\NNP\14625458 (r_appos) lactate_18\NN\14850483 (r_pobj) in_15\IN\13603305 (r_conj) in_9\IN\13603305 (l_pobj) cm_12\NNP\13649268 (l_amod) cardiomyopathy_10\NN\14103288
D019344_D009202 NONE la_20\NNP\14625458 (r_appos) lactate_18\NN\14850483 (r_pobj) in_15\IN\13603305 (r_conj) in_9\IN\13603305 (l_pobj) cm_12\NNP\13649268
D019344_D009202 NONE la_41\NNP\14625458 (r_pobj) of_39\IN\0 (r_prep) determination_38\NN\43195 (r_conj) underwent_7\VBD\109660 (l_dobj) echocardiography_8\RB\177127 (l_appos) quantitation_10\NN\0 (l_prep) of_11\IN\0 (l_pobj) abundance_12\NN\5108740 (l_prep) of_13\IN\0 (l_pobj) markers_15\NNS\21939 (l_prep) of_16\IN\0 (l_pobj) cm_17\NNP\13649268
D019344_D009202 NONE la_10\NNP\14625458 (r_pobj) with_8\IN\0 (r_prep) cm_7\NNP\13649268
D019344_D028361 NONE lactate_18\NN\14850483 (r_pobj) in_15\IN\13603305 (r_conj) in_9\IN\13603305 (r_prep) implicated_8\VBN\2677097 (l_prep) through_24\IN\0 (l_pobj) mechanisms_25\NNS\13446390 (l_prep) of_26\IN\0 (l_pobj) dysfunction_28\NN\14204950
D019344_D028361 NONE la_20\NNP\14625458 (r_appos) lactate_18\NN\14850483 (r_pobj) in_15\IN\13603305 (r_conj) in_9\IN\13603305 (r_prep) implicated_8\VBN\2677097 (l_prep) through_24\IN\0 (l_pobj) mechanisms_25\NNS\13446390 (l_prep) of_26\IN\0 (l_pobj) dysfunction_28\NN\14204950
D019469_D000163 NONE indinavir_46\NNS\4013993 (r_conj) lamivudine_43\NN\3834836 (r_pobj) of_40\IN\0 (r_prep) combination_39\NN\7951464 (r_pobj) with_36\IN\0 (r_prep) treated_35\VBN\2376958 (l_nsubjpass) mice_15\NNS\2329401 (l_compound) aids_14\NNP\13974317
D002118_D009202 NONE calcium_30\NN\14625458 (r_compound) atpase_31\NNP\0 (r_conj) encoding_21\VBG\614489 (r_parataxis) quantitation_10\NN\0 (l_prep) of_11\IN\0 (l_pobj) abundance_12\NN\5108740 (l_prep) of_13\IN\0 (l_pobj) markers_15\NNS\21939 (l_prep) of_16\IN\0 (l_pobj) cm_17\NNP\13649268
D015215_D000163 NONE zidovudine_41\NN\3834836 (r_nmod) lamivudine_43\NN\3834836 (r_pobj) of_40\IN\0 (r_prep) combination_39\NN\7951464 (r_pobj) with_36\IN\0 (r_prep) treated_35\VBN\2376958 (l_nsubjpass) mice_15\NNS\2329401 (l_compound) aids_14\NNP\13974317
9100294
D020748_D018376 CID 5967_14\CD\0 (r_prep) 40_12\CD\13745420 (r_nummod) ro_11\NNP\6894544 (r_appos) blocker_9\NN\10101634 (r_nsubj) induced_16\VBD\1627355 (l_dobj) alterations_18\NNS\7283608
D009543_D018376 CID nifedipine_29\NN\2938514 (r_conj) verapamil_27\NN\2938514 (r_pobj) for_26\IN\0 (r_prep) significant_24\JJ\0 (r_acomp) was_22\VBD\0 (r_conj) observed_7\VBN\2163746 (l_nsubjpass) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) malformations_5\NNS\14213199
D002118_D018376 NONE calcium_7\NN\14625458 (r_compound) channel_8\NN\6251781 (r_compound) blockers_9\NNS\10101634 (r_pobj) to_6\IN\0 (r_prep) exposed_5\VBN\2110927 (r_acl) alterations_1\NNS\7283608
D002118_D018376 NONE calcium_7\NN\14625458 (r_compound) channel_8\NN\6251781 (r_compound) blocker_9\NN\10101634 (r_nsubj) induced_16\VBD\1627355 (l_dobj) alterations_18\NNS\7283608
D002118_D018376 NONE calcium_10\NN\14625458 (r_compound) channel_11\NN\6251781 (r_compound) blockers_12\NNS\10101634 (r_nsubj) induce_15\VBP\1627355 (l_dobj) malformations_17\NNS\14213199
D002118_D018376 NONE calcium_7\NN\14625458 (r_compound) channel_8\NN\6251781 (r_compound) blockers_9\NNS\10101634 (r_pobj) of_5\IN\0 (r_prep) one_4\CD\13741022 (r_dobj) administered_3\VBN\2436349 (l_prep) during_10\IN\0 (l_pobj) period_12\NN\13575869 (l_prep) of_13\IN\0 (l_pobj) morphogenesis_15\NN\13489037 (l_conj) offspring_18\NN\10235549 (l_acl) examined_19\VBD\0 (l_prep) on_20\IN\0 (l_pobj) day_21\NN\15154774 (l_prep) of_23\IN\0 (l_pobj) gestation_24\NN\15116532 (l_prep) for_25\IN\0 (l_pobj) malformations_27\NNS\14213199
D002118_D018376 NONE calcium_15\NN\14625458 (r_compound) channel_16\NN\6251781 (r_compound) blockers_17\NNS\10101634 (r_pobj) of_12\IN\0 (r_prep) each_11\DT\0 (r_pobj) to_10\IN\0 (r_prep) exposure_9\NN\5042871 (r_pobj) after_8\IN\0 (r_prep) observed_7\VBN\2163746 (l_nsubjpass) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) malformations_5\NNS\14213199
D014700_D018376 CID verapamil_27\NN\2938514 (r_pobj) for_26\IN\0 (r_prep) significant_24\JJ\0 (r_acomp) was_22\VBD\0 (r_conj) observed_7\VBN\2163746 (l_nsubjpass) incidence_2\NN\13821570 (l_prep) of_3\IN\0 (l_pobj) malformations_5\NNS\14213199
16867021
C052075_D006948 NONE thp_6\NNP\0 (r_nmod) time_16\NN\7308889 (r_npadvmod) traveled_19\VBD\0 (l_prep) on_0\IN\0 (l_pobj) hyperactivity_4\NN\14052403
C052075_D006948 NONE thp_0\NNP\0 (r_nsubj) exhibited_1\VBD\2632167 (l_dobj) profile_6\NN\6999802 (l_prep) by_7\IN\0 (l_pcomp) potentiating_8\VBG\229605 (l_conj) reducing_14\VBG\13447361 (l_dobj) hyperactivity_18\NN\14052403
C052075_D002375 CID thioperamide_13\JJ\0 (r_conj) microg_9\NN\0 (r_parataxis) methylhistamine_3\NN\0 (r_nsubj) cause_27\VB\7323922 (l_dobj) catalepsy_28\NN\14023236
C052075_D002375 CID thp_15\NNP\0 (r_appos) thioperamide_13\JJ\0 (r_conj) microg_9\NN\0 (r_parataxis) methylhistamine_3\NN\0 (r_nsubj) cause_27\VB\7323922 (l_dobj) catalepsy_28\NN\14023236
C052075_D002375 CID thp_0\NNP\0 (r_nsubj) exhibited_1\VBD\2632167 (l_dobj) profile_6\NN\6999802 (l_prep) by_7\IN\0 (l_pcomp) potentiating_8\VBG\229605 (l_dobj) catalepsy_12\NN\14023236
D001058_D006948 NONE apomorphine_21\NN\3786417 (r_dobj) reducing_20\VBG\13447361 (r_conj) reducing_14\VBG\13447361 (l_dobj) hyperactivity_18\NN\14052403
D000661_D006948 CID amphetamine_1\NN\3248958 (r_npadvmod) induced_3\VBN\1627355 (r_amod) hyperactivity_4\NN\14052403
D000661_D006948 CID amphetamine_15\NN\3248958 (r_npadvmod) induced_17\VBN\1627355 (r_amod) hyperactivity_18\NN\14052403
D006220_D006948 NONE haloperidol_9\NN\3713736 (r_npadvmod) induced_11\VBN\1627355 (r_amod) catalepsy_12\NN\14023236 (r_dobj) potentiating_8\VBG\229605 (l_conj) reducing_14\VBG\13447361 (l_dobj) hyperactivity_18\NN\14052403
D001058_D002375 NONE apomorphine_19\NN\3786417 (r_npadvmod) induced_21\VBN\1627355 (r_amod) behavior_23\NN\407535 (r_dobj) study_6\VB\635850 (l_dobj) effect_8\NN\34213 (l_prep) of_9\IN\0 (l_pobj) ligands_12\NNS\20090 (l_prep) on_13\IN\0 (l_pobj) catalepsy_17\NN\14023236
D001058_D002375 NONE apomorphine_12\NN\3786417 (r_nsubjpass) used_26\VBN\0 (r_advcl) induced_2\VBN\1627355 (l_nsubjpass) catalepsy_0\NNP\14023236
D001058_D002375 NONE apomorphine_21\NN\3786417 (r_dobj) reducing_20\VBG\13447361 (r_conj) reducing_14\VBG\13447361 (r_conj) potentiating_8\VBG\229605 (l_dobj) catalepsy_12\NN\14023236
D006220_D002375 CID haloperidol_4\NN\3713736 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (l_nsubjpass) catalepsy_0\NNP\14023236
D006220_D002375 CID haloperidol_4\NN\3713736 (r_pobj) to_3\IN\0 (r_prep) prior_2\RB\10675876 (r_advmod) resulted_5\VBD\2633881 (l_prep) in_6\IN\13603305 (l_pobj) increase_11\NN\13576355 (l_prep) in_12\IN\13603305 (l_pobj) catalepsy_14\NN\14023236
D006220_D002375 CID haloperidol_9\NN\3713736 (r_npadvmod) induced_11\VBN\1627355 (r_amod) catalepsy_12\NN\14023236
D000661_D002375 NONE amphetamine_25\NN\3248958 (r_npadvmod) induced_27\VBN\1627355 (r_amod) activities_29\NNS\30358 (r_conj) behavior_23\NN\407535 (r_dobj) study_6\VB\635850 (l_dobj) effect_8\NN\34213 (l_prep) of_9\IN\0 (l_pobj) ligands_12\NNS\20090 (l_prep) on_13\IN\0 (l_pobj) catalepsy_17\NN\14023236
D000661_D002375 NONE amphetamine_19\NN\3248958 (r_conj) apomorphine_12\NN\3786417 (r_nsubjpass) used_26\VBN\0 (r_advcl) induced_2\VBN\1627355 (l_nsubjpass) catalepsy_0\NNP\14023236
D000661_D002375 NONE amphetamine_15\NN\3248958 (r_npadvmod) induced_17\VBN\1627355 (r_amod) hyperactivity_18\NN\14052403 (r_dobj) reducing_14\VBG\13447361 (r_conj) potentiating_8\VBG\229605 (l_dobj) catalepsy_12\NN\14023236
D006632_D002375 NONE histamine_10\NN\14739004 (r_nmod) ligands_12\NNS\20090 (l_prep) on_13\IN\0 (l_pobj) catalepsy_17\NN\14023236
C069357_D002375 NONE methylhistamine_3\NN\0 (r_nsubj) cause_27\VB\7323922 (l_dobj) catalepsy_28\NN\14023236
C069357_D002375 NONE ramh_5\NNP\0 (r_appos) methylhistamine_3\NN\0 (r_nsubj) cause_27\VB\7323922 (l_dobj) catalepsy_28\NN\14023236
19269743
D002211_D010146 CID capsaicin_9\NN\15032661 (r_npadvmod) induced_11\VBN\1627355 (r_amod) pain_12\NN\14299637
D002211_D010146 CID capsaicin_21\NN\15032661 (r_pobj) of_20\IN\0 (r_prep) doses_19\NNS\3740161 (r_pobj) of_17\IN\0 (r_prep) injections_16\NNS\320852 (r_dobj) received_14\VBD\2210855 (l_prep) in_0\IN\13603305 (l_pobj) order_1\NN\7168131 (l_acl) address_3\VB\6355894 (l_dobj) memory_8\NN\5926676 (l_compound) pain_7\NN\14299637
D002211_D010146 CID capsaicin_11\NN\15032661 (r_compound) doses_12\NNS\3740161 (r_pobj) across_10\IN\0 (r_prep) discriminate_5\VB\650353 (l_dobj) magnitude_7\NN\4916342 (l_compound) pain_6\NN\14299637
84204
D002927_D008107 NONE cimetidine_19\FW\14778019 (r_conj) dysfunction_8\NN\14204950
D002927_D003221 CID cimetidine_7\NN\14778019 (r_npadvmod) associated_9\VBN\628491 (r_amod) confusion_11\NN\13972797
D002927_D003221 CID cimetidine_3\NN\14778019 (r_npadvmod) associated_5\VBN\628491 (r_amod) confusion_7\NN\13972797
D002927_D051437 NONE cimetidine_19\FW\14778019 (r_conj) dysfunction_8\NN\14204950
11027905
D016202_D009437 NONE aspartate_13\NNP\0 (r_nmod) antagonists_17\NNS\7846 (r_nsubj) be_24\VB\14625458 (l_acomp) effective_25\JJ\0 (l_prep) in_26\IN\13603305 (l_pcomp) improving_27\VBG\126264 (l_dobj) analgesia_29\NN\14034177 (l_prep) in_30\IN\13603305 (l_pobj) syndromes_33\NNS\5870365 (l_prep) as_36\IN\14622893 (l_pobj) pain_38\NN\14299637
D016202_D009437 NONE nmda_15\NNP\0 (r_nmod) antagonists_17\NNS\7846 (r_nsubj) be_24\VB\14625458 (l_acomp) effective_25\JJ\0 (l_prep) in_26\IN\13603305 (l_pcomp) improving_27\VBG\126264 (l_dobj) analgesia_29\NN\14034177 (l_prep) in_30\IN\13603305 (l_pobj) syndromes_33\NNS\5870365 (l_prep) as_36\IN\14622893 (l_pobj) pain_38\NN\14299637
D016202_D010146 NONE aspartate_13\NNP\0 (r_nmod) antagonists_17\NNS\7846 (r_nsubj) be_24\VB\14625458 (l_acomp) effective_25\JJ\0 (l_prep) in_26\IN\13603305 (l_pcomp) improving_27\VBG\126264 (l_dobj) analgesia_29\NN\14034177 (l_prep) in_30\IN\13603305 (l_pobj) syndromes_33\NNS\5870365 (l_compound) pain_32\NN\14299637
D016202_D010146 NONE nmda_15\NNP\0 (r_nmod) antagonists_17\NNS\7846 (r_nsubj) be_24\VB\14625458 (l_acomp) effective_25\JJ\0 (l_prep) in_26\IN\13603305 (l_pcomp) improving_27\VBG\126264 (l_dobj) analgesia_29\NN\14034177 (l_prep) in_30\IN\13603305 (l_pobj) syndromes_33\NNS\5870365 (l_compound) pain_32\NN\14299637
D007649_D009437 NONE ketamine_21\NN\3054098 (r_pobj) as_20\IN\14622893 (r_prep) antagonists_17\NNS\7846 (r_nsubj) be_24\VB\14625458 (l_acomp) effective_25\JJ\0 (l_prep) in_26\IN\13603305 (l_pcomp) improving_27\VBG\126264 (l_dobj) analgesia_29\NN\14034177 (l_prep) in_30\IN\13603305 (l_pobj) syndromes_33\NNS\5870365 (l_prep) as_36\IN\14622893 (l_pobj) pain_38\NN\14299637
D007649_D009437 NONE ketamine_0\NNP\3054098 (r_nsubj) improve_2\VB\126264 (l_dobj) analgesia_4\NN\14034177 (l_prep) in_5\IN\13603305 (l_pobj) syndromes_8\NNS\5870365 (l_prep) as_11\IN\14622893 (l_pobj) pain_13\NN\14299637
D007649_D010146 NONE ketamine_21\NN\3054098 (r_pobj) as_20\IN\14622893 (r_prep) antagonists_17\NNS\7846 (r_nsubj) be_24\VB\14625458 (l_acomp) effective_25\JJ\0 (l_prep) in_26\IN\13603305 (l_pcomp) improving_27\VBG\126264 (l_dobj) analgesia_29\NN\14034177 (l_prep) in_30\IN\13603305 (l_pobj) syndromes_33\NNS\5870365 (l_compound) pain_32\NN\14299637
D007649_D010146 NONE ketamine_7\NN\3054098 (r_pobj) of_6\IN\0 (r_prep) doses_5\NNS\3740161 (r_pobj) of_3\IN\0 (r_prep) bolus_2\NN\13899404 (r_nsubjpass) given_16\VBN\5892096 (l_dative) to_17\IN\0 (l_pobj) patients_20\NNS\9898892 (l_relcl) was_23\VBD\0 (l_nsubj) pain_22\NN\14299637
D007649_D010146 NONE ketamine_0\NN\3054098 (r_nsubj) reduced_8\VBD\441445 (l_dobj) intensity_11\NN\5090441 (l_compound) pain_10\NN\14299637
D007649_D010146 NONE ketamine_0\NNP\3054098 (r_nsubj) improve_2\VB\126264 (l_dobj) analgesia_4\NN\14034177 (l_prep) in_5\IN\13603305 (l_pobj) syndromes_8\NNS\5870365 (l_compound) pain_7\NN\14299637
D007649_D009369 NONE ketamine_4\NN\3054098 (l_prep) in_5\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_compound) cancer_6\NN\14239425
D007649_D009369 NONE ketamine_7\NN\3054098 (r_pobj) of_6\IN\0 (r_prep) doses_5\NNS\3740161 (r_pobj) of_3\IN\0 (r_prep) bolus_2\NN\13899404 (r_nsubjpass) given_16\VBN\5892096 (l_dative) to_17\IN\0 (l_pobj) patients_20\NNS\9898892 (l_compound) cancer_19\NN\14239425
D009020_D009369 NONE morphine_9\NN\2707683 (r_compound) therapy_10\NN\657604 (r_pobj) on_8\IN\0 (r_prep) patients_7\NNS\9898892 (l_compound) cancer_6\NN\14239425
D009020_D009369 NONE morphine_26\NN\2707683 (r_pobj) by_25\IN\0 (r_prep) unrelieved_24\JJ\0 (r_acomp) was_23\VBD\0 (r_relcl) patients_20\NNS\9898892 (l_compound) cancer_19\NN\14239425
D009020_D009437 NONE morphine_3\NN\2707683 (r_compound) analgesia_4\NN\14034177 (l_prep) in_5\IN\13603305 (l_pobj) syndromes_8\NNS\5870365 (l_prep) as_11\IN\14622893 (l_pobj) pain_13\NN\14299637
D009020_D010146 NONE morphine_4\NN\2707683 (r_pobj) to_3\IN\0 (r_prep) responsive_2\JJ\0 (r_amod) pain_0\NN\14299637
D009020_D010146 NONE morphine_26\NN\2707683 (r_pobj) by_25\IN\0 (r_prep) unrelieved_24\JJ\0 (r_acomp) was_23\VBD\0 (l_nsubj) pain_22\NN\14299637
D009020_D010146 NONE morphine_3\NN\2707683 (r_compound) analgesia_4\NN\14034177 (l_prep) in_5\IN\13603305 (l_pobj) syndromes_8\NNS\5870365 (l_compound) pain_7\NN\14299637
3409645
D008727_D007172 CID methotrexate_23\NNP\2722166 (r_pobj) of_22\IN\0 (r_prep) taking_21\NN\37396 (r_conj) was_1\VBD\0 (l_nsubj) impotence_0\NN\4723816
7234705
D011342_D008133 NONE procainamide_5\NN\0 (r_nsubj) produce_7\VB\7555863 (l_dobj) syndrome_14\NN\5870365
D011342_D018879 NONE procainamide_6\NN\0 (r_nsubjpass) administered_8\VBN\2436349 (l_prep) for_10\IN\0 (l_pobj) treatment_11\NN\654885 (l_prep) of_12\IN\0 (l_pobj) contractions_16\NNS\358931
D011342_D017180 CID procainamide_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) tachycardia_5\NN\14110674
D011342_D017180 CID procainamide_3\RB\0 (r_advmod) induced_5\VBN\1627355 (r_amod) tachycardia_8\NNS\14110674
D011342_D017180 CID procainamide_17\NN\0 (r_pobj) of_16\IN\0 (r_prep) mg_15\IN\13717155 (r_pobj) of_11\IN\0 (r_prep) administration_10\NN\1133281 (r_pobj) after_8\IN\0 (r_prep) appeared_7\VBD\2604760 (l_nsubj) tachycardia_6\NN\14110674
D011342_D017180 CID procainamide_17\NN\0 (r_pobj) of_16\IN\0 (r_prep) mg_15\IN\13717155 (r_pobj) of_11\IN\0 (r_prep) administration_10\NN\1133281 (l_prep) for_18\IN\0 (l_pobj) treatment_20\NN\654885 (l_prep) of_21\IN\0 (l_pobj) tachycardia_24\NN\14110674
D011342_D017180 CID procainamide_16\NN\0 (r_amod) therapy_17\NN\657604 (r_pobj) of_15\IN\0 (r_prep) continuation_14\NN\407535 (r_pobj) despite_13\IN\7501545 (r_prep) reoccur_24\VB\0 (l_nsubj) tachycardia_21\NN\14110674
D011342_D017180 CID procainamide_5\NN\0 (r_nsubj) produce_7\VB\7555863 (l_prep) with_15\IN\0 (l_pobj) tachycardia_18\NN\14110674
D011342_D001282 NONE procainamide_6\NN\0 (r_nsubjpass) administered_8\VBN\2436349 (l_prep) for_10\IN\0 (l_pobj) treatment_11\NN\654885 (l_prep) of_12\IN\0 (l_pobj) contractions_16\NNS\358931 (l_conj) flutter_19\NN\331950
1549199
D007980_D011618 NONE levodopa_13\RB\14604959 (r_npadvmod) induced_15\VBN\1627355 (r_amod) psychosis_16\NN\14380140
D007980_D064420 NONE levodopa_9\NN\14604959 (r_compound) therapy_10\NN\657604 (r_pobj) for_8\IN\0 (r_prep) dose_7\NN\3740161 (r_dobj) starting_6\NN\457382 (r_acl) correct_5\JJ\138508 (r_attr) is_2\VBZ\0 (r_advcl) started_16\VBN\0 (l_prep) following_27\VBG\8180190 (l_pobj) rule_30\NN\5835747 (l_relcl) attempt_33\VB\407535 (l_xcomp) titrate_35\VB\489837 (l_dobj) levodopa_38\NN\14604959 (l_relcl) lead_49\VB\5155821 (l_prep) to_50\IN\0 (l_pobj) toxicity_51\NN\13576101
D007980_D064420 NONE levodopa_38\NN\14604959 (l_relcl) lead_49\VB\5155821 (l_prep) to_50\IN\0 (l_pobj) toxicity_51\NN\13576101
D007980_D020447 CID levodopa_13\RB\14604959 (r_npadvmod) induced_15\VBN\1627355 (r_amod) psychosis_16\NN\14380140 (l_conj) disturbances_19\NNS\407535 (l_conj) parasomnias_21\NNS\0
D002230_D064420 NONE carbidopa_36\NN\0 (r_compound) levodopa_38\NN\14604959 (l_relcl) lead_49\VB\5155821 (l_prep) to_50\IN\0 (l_pobj) toxicity_51\NN\13576101
D007980_D007024 CID levodopa_13\RB\14604959 (r_npadvmod) induced_15\VBN\1627355 (r_amod) psychosis_16\NN\14380140 (r_conj) hypotension_11\NN\14057371
D007980_D012893 NONE levodopa_13\RB\14604959 (r_npadvmod) induced_15\VBN\1627355 (r_amod) psychosis_16\NN\14380140 (l_conj) disturbances_19\NNS\407535
D007980_D005767 CID levodopa_13\RB\14604959 (r_npadvmod) induced_15\VBN\1627355 (r_amod) psychosis_16\NN\14380140 (r_conj) hypotension_11\NN\14057371 (r_conj) disorders_8\NNS\14034177
18308784
C035054_D007859 NONE rg1_1\NNP\0 (r_nsubj) restores_2\VBZ\1631072 (l_dobj) impairment_4\NN\7296428 (l_prep) of_5\IN\0 (l_pobj) learning_6\VBG\5701944
C035054_D007859 NONE rg1_0\NNP\0 (l_advcl) ameliorate_11\VB\126264 (l_dobj) impairment_14\NN\7296428
C035054_D007859 NONE rg1_11\NN\0 (r_pobj) of_10\IN\0 (r_prep) effect_9\NN\34213 (l_prep) on_12\IN\0 (l_pobj) impairment_14\NN\7296428
D009020_D007859 CID morphine_10\NN\2707683 (r_compound) administration_11\NN\1133281 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (r_acl) impairment_4\NN\7296428 (l_prep) of_5\IN\0 (l_pobj) learning_6\VBG\5701944
D009020_D007859 CID morphine_17\NN\2707683 (r_compound) administration_18\NN\1133281 (r_pobj) by_15\IN\0 (r_prep) impairment_14\NN\7296428
D036145_D007859 NONE ginsenoside_4\NN\0 (r_pobj) as_2\IN\14622893 (r_prep) ameliorate_11\VB\126264 (l_dobj) impairment_14\NN\7296428
18768591
D004317_D034141 CID doxorubicin_0\NNP\2716866 (r_compound) treatment_1\NN\654885 (r_nsubj) resulted_2\VBD\2633881 (l_conj) 15/44_21\CD\0 (l_prep) of_22\IN\0 (l_pobj) mice_25\NNS\2329401 (l_acl) leading_26\VBG\4339291 (l_prep) to_27\IN\0 (l_pobj) syndrome_30\NN\5870365 (l_prep) with_31\IN\0 (l_pobj) ascites_32\NNS\14204950 (l_conj) lipidemia_34\NN\14299637 (l_conj) hypoalbuminemia_37\VB\0
D000450_D009404 NONE aldosterone_1\NN\14751863 (r_compound) levels_2\NNS\4916342 (r_nsubj) increased_3\VBD\169651 (l_prep) in_4\IN\13603305 (l_pobj) mice_6\NNS\2329401 (l_amod) nephrotic_5\JJ\0
D012964_D007674 NONE sodium_7\NN\14625458 (r_compound) channel_8\NN\6251781 (r_pobj) to_5\IN\0 (r_prep) leads_4\VBZ\5155821 (l_nsubj) nephropathy_3\NN\14573196
D000450_D005355 NONE aldosterone_1\NN\14751863 (r_npadvmod) sensitive_3\JJ\10488309 (r_amod) sgk1_10\NNP\0 (r_nsubjpass) shown_13\VBN\2137132 (l_xcomp) participate_15\VB\2367363 (l_conj) mediate_23\VB\761713 (l_dobj) fibrosis_25\NN\14204950
D004317_D011507 CID doxorubicin_0\NNP\2716866 (r_compound) treatment_1\NN\654885 (r_nsubj) resulted_2\VBD\2633881 (l_prep) in_3\IN\13603305 (l_pobj) proteinuria_5\NN\14299637
D014508_D009404 NONE urea_8\NN\14727670 (r_compound) concentrations_9\NNS\4916342 (r_nsubj) increased_10\VBD\169651 (l_prep) during_0\IN\0 (l_pobj) course_2\NN\883297 (l_prep) of_3\IN\0 (l_pobj) syndrome_5\NN\5870365
D004317_D001201 CID doxorubicin_0\NNP\2716866 (r_compound) treatment_1\NN\654885 (r_nsubj) resulted_2\VBD\2633881 (l_conj) 15/44_21\CD\0 (l_prep) of_22\IN\0 (l_pobj) mice_25\NNS\2329401 (l_acl) leading_26\VBG\4339291 (l_prep) to_27\IN\0 (l_pobj) syndrome_30\NN\5870365 (l_prep) with_31\IN\0 (l_pobj) ascites_32\NNS\14204950
D004317_D009404 CID doxorubicin_8\NN\2716866 (r_npadvmod) induced_10\VBN\1627355 (r_amod) syndrome_12\NN\5870365
D004317_D009404 CID doxorubicin_0\NNP\2716866 (r_compound) treatment_1\NN\654885 (r_nsubj) resulted_2\VBD\2633881 (l_conj) 15/44_21\CD\0 (l_prep) of_22\IN\0 (l_pobj) mice_25\NNS\2329401 (l_acl) leading_26\VBG\4339291 (l_prep) to_27\IN\0 (l_pobj) syndrome_30\NN\5870365
D012964_D016055 NONE sodium_7\NN\14625458 (r_compound) channel_8\NN\6251781 (l_appos) retention_12\NN\809465
D004317_D005355 NONE doxorubicin_0\NNP\2716866 (r_npadvmod) induced_2\VBN\1627355 (r_amod) nephropathy_3\NN\14573196 (r_nsubj) leads_4\VBZ\5155821 (l_prep) to_5\IN\0 (l_pobj) channel_8\NN\6251781 (l_appos) retention_12\NN\809465 (l_conj) fibrosis_15\NN\14204950
D004317_D006949 CID doxorubicin_0\NNP\2716866 (r_compound) treatment_1\NN\654885 (r_nsubj) resulted_2\VBD\2633881 (l_conj) 15/44_21\CD\0 (l_prep) of_22\IN\0 (l_pobj) mice_25\NNS\2329401 (l_acl) leading_26\VBG\4339291 (l_prep) to_27\IN\0 (l_pobj) syndrome_30\NN\5870365 (l_prep) with_31\IN\0 (l_pobj) ascites_32\NNS\14204950 (l_conj) lipidemia_34\NN\14299637
D004317_D007674 NONE doxorubicin_0\NNP\2716866 (r_npadvmod) induced_2\VBN\1627355 (r_amod) nephropathy_3\NN\14573196
D004317_D016055 NONE doxorubicin_0\NNP\2716866 (r_npadvmod) induced_2\VBN\1627355 (r_amod) nephropathy_3\NN\14573196 (r_nsubj) leads_4\VBZ\5155821 (l_prep) to_5\IN\0 (l_pobj) channel_8\NN\6251781 (l_appos) retention_12\NN\809465
D012964_D005355 NONE sodium_7\NN\14625458 (r_compound) channel_8\NN\6251781 (l_appos) retention_12\NN\809465 (l_conj) fibrosis_15\NN\14204950
1967484
D013469_D004409 NONE sulpiride_11\NN\0 (r_npadvmod) induced_13\VBN\1627355 (l_dobj) dyskinesia_15\JJ\14084880
D013469_D010302 NONE sulpiride_11\NN\0 (r_npadvmod) induced_13\VBN\1627355 (l_dobj) dyskinesia_15\JJ\14084880 (l_conj) parkinsonism_17\NN\14085708
D013469_D004421 CID sulpiride_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) dystonia_4\NN\0
D013469_D004421 CID sulpiride_17\NN\0 (r_compound) therapy_18\NN\657604 (r_dobj) starting_16\VBG\457382 (r_pcomp) after_15\IN\0 (r_prep) developed_8\VBD\1753788 (l_dobj) dystonia_11\NN\0
D013469_D004421 CID sulpiride_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) dystonia_12\NN\0
12707296
D006854_D006973 NONE cortisol_7\NN\14751417 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hypertension_10\NN\14057371
D006854_D006973 NONE cortisol_12\NN\14751417 (r_npadvmod) induced_14\VBN\1627355 (r_amod) hypertension_15\NN\14057371
D006854_D006973 NONE cortisol_3\NN\14751417 (r_npadvmod) induced_5\VBN\1627355 (r_amod) increases_6\NNS\13576355 (l_prep) in_7\IN\13603305 (l_pobj) pressure_9\NN\11419404
D001120_D006973 NONE arginine_2\NN\14605787 (r_compound) transport_3\NN\3575240 (l_prep) with_6\IN\0 (l_pobj) hypertension_10\NN\14057371
D001120_D006973 NONE arginine_4\NN\14605787 (r_compound) nitric_6\NN\0 (r_compound) system_8\NN\3575240 (r_nsubjpass) implicated_10\VBN\2677097 (l_prep) in_11\IN\13603305 (l_pobj) hypertension_15\NN\14057371
D001120_D006973 NONE arginine_19\NN\14605787 (r_compound) system_21\NN\3575240 (r_pobj) in_15\IN\13603305 (r_prep) abnormalities_14\NNS\14034177 (r_pobj) with_13\IN\0 (r_prep) associated_12\VBN\628491 (l_nsubjpass) increases_6\NNS\13576355 (l_prep) in_7\IN\13603305 (l_pobj) pressure_9\NN\11419404
D009569_D006973 NONE oxide_7\NN\14818238 (r_compound) system_8\NN\3575240 (r_nsubjpass) implicated_10\VBN\2677097 (l_prep) in_11\IN\13603305 (l_pobj) hypertension_15\NN\14057371
2440413
D005680_D012640 NONE gaba_24\NNP\14601829 (r_compound) a_26\NNP\13649268 (r_nmod) channel_31\NN\6251781 (r_attr) be_22\VB\14625458 (l_nsubj) site_7\NN\8673395 (l_amod) responsible_8\JJ\0 (l_prep) for_9\IN\0 (l_pobj) decrease_11\NN\7296428 (l_prep) in_12\IN\13603305 (l_pobj) activity_14\NN\30358 (l_compound) seizure_13\NN\14081375
C034818_D012640 CID carboline-3-carboxylate_36\NNP\0 (r_conj) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (r_nsubj) was_46\VBD\0 (l_ccomp) decreased_12\VBN\169651 (l_nsubjpass) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
C034818_D012640 CID carboline-3-carboxylate_36\NNP\0 (r_conj) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
C034818_D012640 CID dmcm_38\NNP\0 (r_appos) carboline-3-carboxylate_36\NNP\0 (r_conj) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (r_nsubj) was_46\VBD\0 (l_ccomp) decreased_12\VBN\169651 (l_nsubjpass) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
C034818_D012640 CID dmcm_38\NNP\0 (r_appos) carboline-3-carboxylate_36\NNP\0 (r_conj) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D001640_D012640 CID bicuculline_26\NN\0 (r_conj) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (r_nsubj) was_46\VBD\0 (l_ccomp) decreased_12\VBN\169651 (l_nsubjpass) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D001640_D012640 CID bicuculline_26\NN\0 (r_conj) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D001640_D012640 CID bcc_28\NNP\0 (r_appos) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (r_nsubj) was_46\VBD\0 (l_ccomp) decreased_12\VBN\169651 (l_nsubjpass) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D001640_D012640 CID bcc_28\NNP\0 (r_appos) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D013331_D012640 CID strychnine_42\NN\14712692 (r_conj) carboline-3-carboxylate_36\NNP\0 (r_conj) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (r_nsubj) was_46\VBD\0 (l_ccomp) decreased_12\VBN\169651 (l_nsubjpass) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D013331_D012640 CID strychnine_42\NN\14712692 (r_conj) carboline-3-carboxylate_36\NNP\0 (r_conj) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D013331_D012640 CID str_44\NNP\0 (r_appos) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (r_nsubj) was_46\VBD\0 (l_ccomp) decreased_12\VBN\169651 (l_nsubjpass) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D013331_D012640 CID str_44\NNP\0 (r_appos) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D015097_D012640 CID acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (r_nsubj) was_46\VBD\0 (l_ccomp) decreased_12\VBN\169651 (l_nsubjpass) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D015097_D012640 CID acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D015097_D012640 CID mpa_23\NNP\0 (r_appos) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (r_nsubj) was_46\VBD\0 (l_ccomp) decreased_12\VBN\169651 (l_nsubjpass) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D015097_D012640 CID mpa_23\NNP\0 (r_appos) acid_21\NN\14818238 (r_pobj) to_19\IN\0 (r_pcomp) due_18\IN\5174653 (r_prep) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D010433_D012640 CID ptz_27\NNP\0 (r_pobj) to_24\TO\0 (r_prep) decrease_21\VB\7296428 (l_dobj) threshold_23\NN\15265518 (l_compound) seizure_22\NN\14081375
D010433_D012640 CID ptz_13\NNP\0 (r_npadvmod) induced_15\VBN\1627355 (r_amod) seizures_16\NNS\14081375
D010433_D012640 CID ptz_4\NNP\0 (r_pobj) due_2\IN\5174653 (r_amod) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D010433_D012640 CID ptz_4\NNP\0 (r_pobj) due_2\IN\5174653 (r_amod) activity_1\NN\30358 (r_nsubjpass) decreased_12\VBN\169651 (r_ccomp) was_46\VBD\0 (l_nsubj) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D010433_D012640 CID ptz_14\NNP\0 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_acl) activity_11\NN\30358 (l_compound) seizure_10\NN\14081375
D010433_D012640 CID ptz_14\NNP\0 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_acl) activity_11\NN\30358 (r_pobj) to_9\IN\0 (r_prep) occur_8\VB\0 (l_advcl) decreased_36\VBN\169651 (l_nsubjpass) response_26\NN\11410625 (l_prep) to_27\IN\0 (l_pobj) agents_34\NNS\7347 (l_amod) inducing_33\VBG\42311 (l_npadvmod) seizure_31\NN\14081375
D001556_D012640 NONE hexachlorocyclohexane_5\NN\0 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) on_9\IN\0 (l_pobj) seizures_13\NNS\14081375
D001556_D012640 NONE lindane_7\NN\14919948 (r_appos) hexachlorocyclohexane_5\NN\0 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) on_9\IN\0 (l_pobj) seizures_13\NNS\14081375
D001556_D012640 NONE hexachlorocyclohexane_2\NN\0 (r_nsubjpass) shown_19\VBN\2137132 (l_xcomp) decrease_21\VB\7296428 (l_dobj) threshold_23\NN\15265518 (l_compound) seizure_22\NN\14081375
D001556_D012640 NONE hch_6\NNP\0 (r_appos) hexachlorocyclohexane_2\NN\0 (r_nsubjpass) shown_19\VBN\2137132 (l_xcomp) decrease_21\VB\7296428 (l_dobj) threshold_23\NN\15265518 (l_compound) seizure_22\NN\14081375
D001556_D012640 NONE lindane_15\NN\14919948 (r_pobj) of_12\IN\0 (r_prep) ingredient_11\NN\3081021 (r_appos) hexachlorocyclohexane_2\NN\0 (r_nsubjpass) shown_19\VBN\2137132 (l_xcomp) decrease_21\VB\7296428 (l_dobj) threshold_23\NN\15265518 (l_compound) seizure_22\NN\14081375
D001556_D012640 NONE hch_7\NNP\0 (r_pobj) to_4\IN\0 (r_prep) exposure_3\NN\5042871 (r_pobj) after_2\IN\0 (r_prep) h_1\NN\14622893 (l_conj) increase_10\VB\13576355 (l_prep) to_12\IN\0 (l_pobj) seizures_16\NNS\14081375
D001556_D012640 NONE hch_24\NNP\0 (r_pobj) to_21\IN\0 (r_prep) exposure_20\NN\5042871 (r_pobj) after_19\IN\0 (r_prep) h_18\NN\14622893 (l_dep) h_1\NN\14622893 (l_conj) increase_10\VB\13576355 (l_prep) to_12\IN\0 (l_pobj) seizures_16\NNS\14081375
D001556_D012640 NONE hch_30\NNP\0 (r_pobj) of_25\IN\0 (r_prep) administration_24\NN\1133281 (r_pobj) after_22\IN\0 (r_prep) tested_15\VBN\670261 (l_nsubjpass) severity_5\NN\5036394 (l_prep) of_6\IN\0 (l_pobj) response_7\NN\11410625 (l_prep) to_8\IN\0 (l_pobj) agents_13\NNS\7347 (l_amod) inducing_12\VBG\42311 (l_npadvmod) seizure_10\NN\14081375
D001556_D012640 NONE hch_8\NNP\0 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_pobj) after_2\IN\0 (r_prep) increased_18\VBN\169651 (l_nsubjpass) activity_11\NN\30358 (l_prep) of_12\IN\0 (l_pobj) agents_16\NNS\7347 (l_amod) inducing_15\VBG\42311 (l_npadvmod) seizure_13\NN\14081375
D001556_D012640 NONE hch_31\NNP\0 (r_appos) h_27\NN\14622893 (r_dep) observed_36\VBN\2163746 (l_advcl) increased_18\VBN\169651 (l_nsubjpass) activity_11\NN\30358 (l_prep) of_12\IN\0 (l_pobj) agents_16\NNS\7347 (l_amod) inducing_15\VBG\42311 (l_npadvmod) seizure_13\NN\14081375
D001556_D012640 NONE hch_22\NNP\0 (r_pobj) after_19\IN\0 (r_prep) h_18\NN\14622893 (r_npadvmod) occur_8\VB\0 (l_prep) to_9\IN\0 (l_pobj) activity_11\NN\30358 (l_compound) seizure_10\NN\14081375
D001556_D012640 NONE hch_22\NNP\0 (r_pobj) after_19\IN\0 (r_prep) h_18\NN\14622893 (r_npadvmod) occur_8\VB\0 (l_advcl) decreased_36\VBN\169651 (l_nsubjpass) response_26\NN\11410625 (l_prep) to_27\IN\0 (l_pobj) agents_34\NNS\7347 (l_amod) inducing_33\VBG\42311 (l_npadvmod) seizure_31\NN\14081375
D001556_D012640 NONE hch_20\NNP\0 (r_nsubj) be_22\VB\14625458 (l_nsubj) site_7\NN\8673395 (l_amod) responsible_8\JJ\0 (l_prep) for_9\IN\0 (l_pobj) decrease_11\NN\7296428 (l_prep) in_12\IN\13603305 (l_pobj) activity_14\NN\30358 (l_compound) seizure_13\NN\14081375
D010852_D012640 CID picrotoxin_6\NN\0 (r_conj) ptz_4\NNP\0 (r_pobj) due_2\IN\5174653 (r_amod) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D010852_D012640 CID picrotoxin_6\NN\0 (r_conj) ptz_4\NNP\0 (r_pobj) due_2\IN\5174653 (r_amod) activity_1\NN\30358 (r_nsubjpass) decreased_12\VBN\169651 (r_ccomp) was_46\VBD\0 (l_nsubj) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D010852_D012640 CID ptx_8\NNP\0 (r_appos) ptz_4\NNP\0 (r_pobj) due_2\IN\5174653 (r_amod) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D010852_D012640 CID ptx_8\NNP\0 (r_appos) ptz_4\NNP\0 (r_pobj) due_2\IN\5174653 (r_amod) activity_1\NN\30358 (r_nsubjpass) decreased_12\VBN\169651 (r_ccomp) was_46\VBD\0 (l_nsubj) activity_17\NN\30358 (l_compound) seizure_16\NN\14081375
D010852_D012640 CID ptx_16\NNP\0 (r_conj) ptz_14\NNP\0 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_acl) activity_11\NN\30358 (l_compound) seizure_10\NN\14081375
D010852_D012640 CID ptx_16\NNP\0 (r_conj) ptz_14\NNP\0 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_acl) activity_11\NN\30358 (r_pobj) to_9\IN\0 (r_prep) occur_8\VB\0 (l_advcl) decreased_36\VBN\169651 (l_nsubjpass) response_26\NN\11410625 (l_prep) to_27\IN\0 (l_pobj) agents_34\NNS\7347 (l_amod) inducing_33\VBG\42311 (l_npadvmod) seizure_31\NN\14081375
1527456
D008012_D014012 NONE lignocaine_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) instillation_5\NN\320852 (r_pobj) by_3\IN\0 (r_prep) treatment_0\NN\654885 (l_prep) of_1\IN\0 (l_pobj) tinnitus_2\NN\14299637
D008012_D014012 NONE lidocaine_9\NN\3681148 (r_appos) lignocaine_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) instillation_5\NN\320852 (r_pobj) by_3\IN\0 (r_prep) treatment_0\NN\654885 (l_prep) of_1\IN\0 (l_pobj) tinnitus_2\NN\14299637
D008012_D014012 NONE lignocaine_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) instillation_10\NN\320852 (r_pobj) by_8\IN\0 (r_prep) treating_6\VBG\2376958 (l_dobj) ist_7\NNP\0
D008012_D014012 NONE lidocaine_14\NN\3681148 (r_appos) lignocaine_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) instillation_10\NN\320852 (r_pobj) by_8\IN\0 (r_prep) treating_6\VBG\2376958 (l_dobj) ist_7\NNP\0
2515254
D005996_D008881 CID nitroglycerin_11\NN\15015501 (r_pobj) of_10\IN\0 (r_prep) application_9\NN\947128 (r_dobj) received_4\VBD\2210855 (l_nsubj) patients_3\NNS\9898892 (l_compound) migraine_2\NN\14326607
D005996_D008881 CID nitroglycerin_7\NN\15015501 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (l_nsubjpass) attacks_3\NNS\955060 (l_compound) migraine_2\NN\14326607
D005996_D008881 CID nitroglycerin_13\NN\15015501 (r_pobj) with_11\IN\0 (r_prep) attack_10\NN\955060 (r_dobj) developed_6\VBD\1753788 (r_relcl) patients_3\NNS\9898892 (l_compound) migraine_2\NN\14326607
D005996_D008881 CID nitroglycerin_7\NN\15015501 (r_pobj) of_6\IN\0 (r_prep) effect_5\NN\34213 (l_amod) inducing_4\VBG\42311 (l_npadvmod) migraine_2\NN\14326607
D005996_D008881 CID nitroglycerin_7\NN\15015501 (r_pobj) of_6\IN\0 (r_prep) effect_5\NN\34213 (r_nsubj) seems_8\VBZ\2604760 (l_advcl) suggesting_21\VBG\1010118 (l_ccomp) is_26\VBZ\0 (l_prep) of_27\IN\0 (l_pobj) importance_29\NN\5138488 (l_prep) in_30\IN\13603305 (l_pobj) development_32\NN\248977 (l_prep) of_33\IN\0 (l_pobj) crisis_36\NN\14411243 (l_compound) migraine_35\JJ\14326607
D005996_D010146 NONE nitroglycerin_7\NN\15015501 (r_pobj) of_6\IN\0 (r_prep) effect_5\NN\34213 (r_nsubj) seems_8\VBZ\2604760 (l_xcomp) depend_10\VB\2604760 (l_prep) on_11\IN\0 (l_pobj) stimulation_13\NN\242808 (l_prep) of_14\IN\0 (l_pobj) site_17\NN\8673395 (l_prep) of_18\IN\0 (l_pobj) pain_19\NN\14299637
20080983
D003042_D012893 CID cocaine_23\NN\3492717 (r_compound) users_24\NNS\7846 (r_pobj) in_21\IN\13603305 (r_prep) sleepiness_20\NN\14015731
D003042_D012893 CID cocaine_18\NN\3492717 (r_compound) users_19\NNS\7846 (r_pobj) in_16\IN\13603305 (r_prep) sleepiness_15\NN\14015731
C048833_D012893 NONE modafinil_15\NN\0 (l_conj) sleepiness_20\NN\14015731
C048833_D012893 NONE modafinil_0\NNP\0 (r_nsubjpass) associated_2\VBN\628491 (l_advcl) measured_10\VBN\697589 (l_conj) decrease_22\NN\7296428 (l_prep) in_23\IN\13603305 (l_pobj) sleepiness_26\NN\14015731
C048833_D012893 NONE modafinil_3\NN\0 (r_nsubj) promotes_4\VBZ\2556126 (l_conj) normalizes_8\VBZ\109660 (l_conj) decreases_13\VBZ\7296428 (l_dobj) sleepiness_15\NN\14015731
3125768
D015760_D009127 CID alfentanil_4\NN\0 (r_npadvmod) induced_6\VBN\1627355 (r_amod) rigidity_7\NN\5023233
D015760_D009127 CID alfentanil_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) rigidity_11\NN\5023233
D015760_D009127 CID alfentanil_9\NN\0 (r_advcl) prevented_7\VBN\0 (l_nsubjpass) rigidity_4\NN\5023233
C032943_D009127 NONE metocurine_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) abolished_8\VBN\0 (l_nsubjpass) rigidity_6\NN\5023233
20698227
C473478_D006461 CID sunitinib_16\JJ\0 (r_pobj) as_15\IN\14622893 (r_prep) inhibitors_13\NNS\20090 (r_pobj) of_11\IN\0 (r_prep) number_10\NN\5107765 (r_nsubjpass) found_21\VBN\13279262 (l_advcl) cause_23\VB\7323922 (l_dobj) hemolysis_25\NN\13509528
D012254_D006461 NONE ribavirin_1\RB\2725367 (r_nsubjpass) found_4\VBN\13279262 (l_conj) found_21\VBN\13279262 (l_advcl) cause_23\VB\7323922 (l_dobj) hemolysis_25\NN\13509528
C471405_D006461 CID sorafenib_18\NNS\0 (r_conj) sunitinib_16\JJ\0 (r_pobj) as_15\IN\14622893 (r_prep) inhibitors_13\NNS\20090 (r_pobj) of_11\IN\0 (r_prep) number_10\NN\5107765 (r_nsubjpass) found_21\VBN\13279262 (l_advcl) cause_23\VB\7323922 (l_dobj) hemolysis_25\NN\13509528
C100416_D019698 NONE 2a_14\CD\0 (r_pobj) by_10\IN\0 (r_agent) treated_9\VBN\2376958 (l_csubjpass) infected_3\VBN\2316868 (l_prep) with_4\IN\0 (l_pobj) virus_7\NN\9312843
D012254_D019698 NONE ribavirin_16\RB\2725367 (r_conj) 2a_14\CD\0 (r_pobj) by_10\IN\0 (r_agent) treated_9\VBN\2376958 (l_csubjpass) infected_3\VBN\2316868 (l_prep) with_4\IN\0 (l_pobj) virus_7\NN\9312843
D012254_D019698 NONE ribavirin_16\RB\2725367 (r_conj) markers_14\NNS\21939 (r_dobj) angiogenesis_12\NN\13489037 (r_pobj) between_11\IN\0 (r_prep) link_10\NN\13792579 (r_dobj) investigating_8\VBG\575741 (r_acl) study_4\NN\635850 (r_attr) is_1\VBZ\0 (l_advcl) induced_17\VBD\1627355 (l_dobj) anemia_18\NN\14189204 (l_prep) in_19\IN\13603305 (l_pobj) patients_20\NNS\9898892 (l_prep) with_21\IN\0 (l_pobj) c_23\NNP\13714184
D012254_D000740 NONE ribavirin_16\RB\2725367 (r_conj) markers_14\NNS\21939 (r_dobj) angiogenesis_12\NN\13489037 (r_pobj) between_11\IN\0 (r_prep) link_10\NN\13792579 (r_dobj) investigating_8\VBG\575741 (r_acl) study_4\NN\635850 (r_attr) is_1\VBZ\0 (l_advcl) induced_17\VBD\1627355 (l_dobj) anemia_18\NN\14189204
D012254_D000743 NONE ribavirin_8\RB\2725367 (r_pobj) for_7\IN\0 (r_prep) treatment_6\NN\654885 (r_pobj) of_5\IN\0 (r_prep) target_4\NN\7258332 (l_acl) associated_9\VBN\628491 (l_dobj) anemia_11\NN\14189204
18261172
D000806_D007674 NONE acei_5\NNP\0 (r_nmod) therapy_8\NN\657604 (r_pobj) with_4\IN\0 (r_prep) used_3\VBN\0 (l_conj) increased_15\VBD\169651 (l_dobj) dysfunction_17\NN\14204950
D020123_D011507 CID sirolimus_6\NN\0 (r_npadvmod) based_8\VBN\0 (r_amod) immunosuppression_9\NN\13973990 (r_pobj) to_5\IN\0 (r_prep) switch_4\NN\3096960 (r_pobj) after_3\IN\0 (r_prep) development_0\NN\248977 (l_prep) of_1\IN\0 (l_pobj) proteinuria_2\NN\14299637
D020123_D011507 CID sirolmus_7\NN\0 (r_nsubj) lacks_11\VBZ\14449126 (r_ccomp) reported_23\VBN\831651 (l_nsubjpass) proteinuria_17\NN\14299637
D020123_D011507 CID srl_9\NNP\0 (r_appos) sirolmus_7\NN\0 (r_nsubj) lacks_11\VBZ\14449126 (r_ccomp) reported_23\VBN\831651 (l_nsubjpass) proteinuria_17\NN\14299637
D020123_D011507 CID srl_20\NNP\0 (r_pobj) with_19\IN\0 (r_prep) associated_18\VBN\628491 (r_acl) proteinuria_17\NN\14299637
D020123_D011507 CID srl_10\NNP\0 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (r_acl) incidence_5\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) proteinuria_7\NN\14299637
D020123_D011507 CID srl_12\NNP\0 (r_pobj) to_11\IN\0 (r_prep) switch_10\NN\3096960 (r_pobj) after_9\IN\0 (r_prep) develop_4\VB\1753788 (l_nsubj) proteinuria_2\NN\14299637
D020123_D011507 CID srl_0\NNP\0 (r_nsubjpass) used_3\VBN\0 (l_prep) with_4\IN\0 (l_pobj) therapy_8\NN\657604 (l_acl) monitored_11\VBD\2169352 (l_prep) for_12\IN\0 (l_pobj) proteinuria_13\NN\14299637
D057911_D007674 NONE arb_7\NNP\9882007 (r_compound) therapy_8\NN\657604 (r_pobj) with_4\IN\0 (r_prep) used_3\VBN\0 (l_conj) increased_15\VBD\169651 (l_dobj) dysfunction_17\NN\14204950
D057911_D011507 NONE blocker_6\NN\10101634 (r_nmod) therapy_10\NN\657604 (r_conj) inhibitor_1\NN\20090 (r_nsubj) reduced_11\VBN\441445 (l_dobj) development_13\NN\248977 (l_compound) proteinuria_12\NN\14299637
D057911_D011507 NONE arb_8\NNP\9882007 (r_nmod) therapy_10\NN\657604 (r_conj) inhibitor_1\NN\20090 (r_nsubj) reduced_11\VBN\441445 (l_dobj) development_13\NN\248977 (l_compound) proteinuria_12\NN\14299637
D057911_D011507 NONE arb_7\NNP\9882007 (r_compound) therapy_8\NN\657604 (l_acl) monitored_11\VBD\2169352 (l_prep) for_12\IN\0 (l_pobj) proteinuria_13\NN\14299637
D000806_D011507 NONE inhibitor_1\NN\20090 (r_nsubj) reduced_11\VBN\441445 (l_dobj) development_13\NN\248977 (l_compound) proteinuria_12\NN\14299637
D000806_D011507 NONE acei_5\NNP\0 (r_nmod) therapy_8\NN\657604 (l_acl) monitored_11\VBD\2169352 (l_prep) for_12\IN\0 (l_pobj) proteinuria_13\NN\14299637
D020123_D007674 NONE sirolmus_7\NN\0 (r_nsubj) lacks_11\VBZ\14449126 (l_dobj) effects_13\NNS\13245626 (l_amod) nephrotoxic_12\JJ\0
D020123_D007674 NONE srl_9\NNP\0 (r_appos) sirolmus_7\NN\0 (r_nsubj) lacks_11\VBZ\14449126 (l_dobj) effects_13\NNS\13245626 (l_amod) nephrotoxic_12\JJ\0
D020123_D007674 NONE srl_20\NNP\0 (r_pobj) with_19\IN\0 (r_prep) associated_18\VBN\628491 (r_acl) proteinuria_17\NN\14299637 (r_nsubjpass) reported_23\VBN\831651 (l_ccomp) lacks_11\VBZ\14449126 (l_dobj) effects_13\NNS\13245626 (l_amod) nephrotoxic_12\JJ\0
D020123_D007674 NONE srl_0\NNP\0 (r_nsubjpass) used_3\VBN\0 (l_conj) increased_15\VBD\169651 (l_dobj) dysfunction_17\NN\14204950
7834920
D007538_D014397 NONE isoniazid_9\NN\2716205 (l_prep) for_10\IN\0 (l_pobj) tuberculosis_12\NN\14127211
D012293_D005921 CID rifampin_6\NN\2716205 (r_amod) therapy_7\NN\657604 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) glomerulonephritis_2\NN\14113798
D012293_D005921 CID rifampin_17\NN\2716205 (r_pobj) with_16\IN\0 (r_prep) treated_15\VBN\2376958 (r_acl) patient_14\NN\9898892 (r_pobj) in_12\IN\13603305 (r_prep) finding_6\NN\43195 (l_prep) of_7\IN\0 (l_pobj) glomerulonephritis_11\NN\14113798
D012293_D005921 CID rifampin_20\NN\2716205 (r_pobj) with_19\IN\0 (r_prep) treated_18\VBN\2376958 (r_acl) patient_17\NN\9898892 (r_pobj) in_15\IN\13603305 (r_prep) occurrence_5\NN\29378 (l_prep) of_6\IN\0 (l_pobj) glomerulonephritis_9\NN\14113798
D012293_D005921 CID rifampin_20\NN\2716205 (r_pobj) with_19\IN\0 (r_prep) treated_18\VBN\2376958 (r_acl) patient_17\NN\9898892 (r_pobj) in_15\IN\13603305 (r_prep) occurrence_5\NN\29378 (l_prep) of_6\IN\0 (l_pobj) glomerulonephritis_9\NN\14113798 (l_prep) with_10\IN\0 (l_pobj) crescents_11\NNS\13867641 (l_conj) glomerulonephritis_14\NN\14113798
D012293_D014397 NONE rifampin_6\NN\2716205 (r_amod) therapy_7\NN\657604 (l_prep) for_8\IN\0 (l_pobj) tuberculosis_10\NN\14127211
D012293_D014397 NONE rifampin_7\NN\2716205 (r_pobj) of_6\IN\0 (r_prep) regimen_5\NN\5898568 (r_dobj) underwent_2\VBD\109660 (l_conj) isoniazid_9\NN\2716205 (l_prep) for_10\IN\0 (l_pobj) tuberculosis_12\NN\14127211
D007538_D051437 NONE isoniazid_9\NN\2716205 (r_conj) underwent_2\VBD\109660 (l_conj) discovered_15\VBN\2163746 (l_xcomp) developed_18\VBN\1753788 (l_dobj) signs_19\NNS\6643763 (l_prep) of_20\IN\0 (l_pobj) failure_23\NN\66216
D012293_D051437 CID rifampin_7\NN\2716205 (r_pobj) of_6\IN\0 (r_prep) regimen_5\NN\5898568 (r_dobj) underwent_2\VBD\109660 (l_conj) discovered_15\VBN\2163746 (l_xcomp) developed_18\VBN\1753788 (l_dobj) signs_19\NNS\6643763 (l_prep) of_20\IN\0 (l_pobj) failure_23\NN\66216
11928786
D016642_D062787 NONE zyban_0\NNP\0 (r_nsubj) caused_1\VBD\1617192 (l_dobj) toxicity_6\NN\13576101 (l_prep) in_7\IN\13603305 (l_pobj) overdose_8\NN\84738
D016642_D064420 NONE bupropion_0\NNP\0 (r_nmod) toxicity_4\NN\13576101
D016642_D064420 NONE zyban_2\NNP\0 (r_nmod) toxicity_4\NN\13576101
D000241_D012640 NONE adenosine_14\NN\14964367 (r_pobj) with_13\IN\0 (r_prep) treated_12\VBN\2376958 (r_conj) treated_3\VBN\2376958 (l_nsubjpass) seizures_1\NNS\14081375
D003975_D013610 NONE diazepam_5\NN\2830852 (l_conj) tachycardia_9\NN\14110674
D016642_D002318 NONE zyban_0\NNP\0 (r_nsubj) caused_1\VBD\1617192 (l_dobj) toxicity_6\NN\13576101
D016642_D020258 NONE zyban_0\NNP\0 (r_nsubj) caused_1\VBD\1617192 (l_dobj) toxicity_6\NN\13576101
D000241_D013610 NONE adenosine_14\NN\14964367 (r_pobj) with_13\IN\0 (r_prep) treated_12\VBN\2376958 (r_conj) treated_3\VBN\2376958 (l_prep) with_4\IN\0 (l_pobj) diazepam_5\NN\2830852 (l_conj) tachycardia_9\NN\14110674
D003975_D012640 NONE diazepam_5\NN\2830852 (r_pobj) with_4\IN\0 (r_prep) treated_3\VBN\2376958 (l_nsubjpass) seizures_1\NNS\14081375
3560095
D005480_D001171 NONE flurbiprofen_0\NNP\3828465 (l_prep) in_1\IN\13603305 (l_pobj) treatment_3\NN\654885 (l_prep) of_4\IN\0 (l_pobj) arthritis_7\NN\14171682
D005480_D001171 NONE flurbiprofen_13\JJ\3828465 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (r_relcl) arthritis_7\NN\14171682
D005480_D001168 NONE flurbiprofen_13\JJ\3828465 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (r_relcl) arthritis_7\NN\14171682 (r_pobj) with_4\IN\0 (r_prep) patients_3\NNS\9898892 (r_nsubj) had_26\VBD\0 (l_dobj) decreases_29\NNS\7296428 (l_prep) in_32\IN\13603305 (l_pobj) indices_35\NNS\13850304 (l_compound) arthritis_34\NN\14171682
8701950
D001241_D000743 NONE aspirin_20\NN\2707683 (r_conj) corticosteroids_18\NNS\14745635 (r_conj) replacement_16\NN\196485 (r_appos) discontinuation_4\NN\209943 (r_nsubj) led_24\VBD\3202760 (l_prep) to_25\IN\0 (l_pobj) resolution_26\NN\6470073 (l_prep) of_27\IN\0 (l_pobj) maha_28\NNP\9654687
D016572_D000743 NONE a_19\NNP\13649268 (l_appos) drug_28\NN\14778436 (l_acl) known_30\VBN\0 (l_xcomp) induce_32\VB\1627355 (l_dobj) maha_33\NNP\9654687
D016572_D000743 NONE cya_21\NN\0 (r_appos) a_19\NNP\13649268 (l_appos) drug_28\NN\14778436 (l_acl) known_30\VBN\0 (l_xcomp) induce_32\VB\1627355 (l_dobj) maha_33\NNP\9654687
D016559_D000743 CID fk506_4\NNP\0 (r_dobj) complicating_3\VBG\126264 (l_nsubj) anemia_2\NN\14189204
D016559_D000743 CID tacrolimus_6\NNP\0 (r_nmod) therapy_8\NN\657604 (r_appos) fk506_4\NNP\0 (r_dobj) complicating_3\VBG\126264 (l_nsubj) anemia_2\NN\14189204
D016559_D000743 CID fk506_17\NNP\0 (r_nmod) therapy_21\NN\657604 (r_pobj) under_16\IN\0 (r_prep) recipients_15\NNS\9764201 (r_pobj) in_11\IN\13603305 (r_prep) episodes_3\NNS\7283608 (l_prep) of_4\IN\0 (l_pobj) anemia_7\NN\14189204
D016559_D000743 CID fk506_17\NNP\0 (r_nmod) therapy_21\NN\657604 (r_pobj) under_16\IN\0 (r_prep) recipients_15\NNS\9764201 (r_pobj) in_11\IN\13603305 (r_prep) episodes_3\NNS\7283608 (l_prep) of_4\IN\0 (l_pobj) anemia_7\NN\14189204 (l_appos) maha_9\NNP\9654687
D016559_D000743 CID tacrolimus_19\NNP\0 (r_nmod) therapy_21\NN\657604 (r_pobj) under_16\IN\0 (r_prep) recipients_15\NNS\9764201 (r_pobj) in_11\IN\13603305 (r_prep) episodes_3\NNS\7283608 (l_prep) of_4\IN\0 (l_pobj) anemia_7\NN\14189204
D016559_D000743 CID tacrolimus_19\NNP\0 (r_nmod) therapy_21\NN\657604 (r_pobj) under_16\IN\0 (r_prep) recipients_15\NNS\9764201 (r_pobj) in_11\IN\13603305 (r_prep) episodes_3\NNS\7283608 (l_prep) of_4\IN\0 (l_pobj) anemia_7\NN\14189204 (l_appos) maha_9\NNP\9654687
D016559_D000743 CID fk506_6\NNP\0 (r_pobj) of_5\IN\0 (r_prep) discontinuation_4\NN\209943 (r_nsubj) led_24\VBD\3202760 (l_prep) to_25\IN\0 (l_pobj) resolution_26\NN\6470073 (l_prep) of_27\IN\0 (l_pobj) maha_28\NNP\9654687
D016559_D000743 CID fk506_6\NNP\0 (r_pobj) of_5\IN\0 (r_prep) reintroduction_4\NN\7217349 (r_nsubj) led_7\VBD\3202760 (l_prep) to_8\IN\0 (l_pobj) recurrence_10\NN\7342049 (l_prep) of_11\IN\0 (l_pobj) maha_12\NNP\9654687
D016559_D000743 CID fk506-associated_0\VBN\0 (r_amod) maha_1\NNP\9654687
D016559_D000743 CID fk506_9\NNP\0 (r_nsubj) seem_12\VB\2604760 (l_oprd) a_19\NNP\13649268 (l_appos) drug_28\NN\14778436 (l_acl) known_30\VBN\0 (l_xcomp) induce_32\VB\1627355 (l_dobj) maha_33\NNP\9654687
D000305_D000743 NONE corticosteroids_18\NNS\14745635 (r_conj) replacement_16\NN\196485 (r_appos) discontinuation_4\NN\209943 (r_nsubj) led_24\VBD\3202760 (l_prep) to_25\IN\0 (l_pobj) resolution_26\NN\6470073 (l_prep) of_27\IN\0 (l_pobj) maha_28\NNP\9654687
D004176_D000743 NONE dipyridamole_23\NN\0 (r_conj) aspirin_20\NN\2707683 (r_conj) corticosteroids_18\NNS\14745635 (r_conj) replacement_16\NN\196485 (r_appos) discontinuation_4\NN\209943 (r_nsubj) led_24\VBD\3202760 (l_prep) to_25\IN\0 (l_pobj) resolution_26\NN\6470073 (l_prep) of_27\IN\0 (l_pobj) maha_28\NNP\9654687
18809400
D008063_D010523 NONE acid_7\NN\14818238 (r_nsubj) reduce_9\VB\441445 (l_dobj) risk_11\NN\14541044 (l_prep) of_12\IN\0 (l_pcomp) developing_13\VBG\13541167 (l_dobj) toxicity_16\NN\13576101
D017239_D028361 NONE paclitaxel_7\NN\0 (r_conj) cisplatin_5\NN\0 (r_nsubj) cause_8\VBP\7323922 (l_dobj) impairment_11\NN\7296428
D017239_D028361 NONE paclitaxel_11\NN\0 (r_pobj) in_10\IN\13603305 (r_prep) event_8\NN\23100 (r_attr) is_4\VBZ\0 (l_nsubj) toxicity_3\NN\13576101
D002945_D020258 NONE cisplatin_13\NN\0 (r_conj) in_10\IN\13603305 (r_prep) event_8\NN\23100 (r_attr) is_4\VBZ\0 (l_advcl) induced_14\VBN\1627355 (l_dobj) neurotoxicity_15\NN\0
D017239_D020258 NONE paclitaxel_11\NN\0 (r_pobj) in_10\IN\13603305 (r_prep) event_8\NN\23100 (r_attr) is_4\VBZ\0 (l_advcl) induced_14\VBN\1627355 (l_dobj) neurotoxicity_15\NN\0
D008063_D001480 NONE acid_10\NN\14818238 (r_pobj) of_6\IN\0 (r_prep) efficacy_5\NN\5199286 (l_prep) in_11\IN\13603305 (l_pcomp) preventing_12\VBG\0 (l_dobj) damage_14\NN\7296428
D008063_D001480 NONE acid_34\NN\14818238 (r_conj) agents_29\NNS\7347 (r_pobj) to_27\IN\0 (r_prep) exposure_26\NN\5042871 (r_pobj) after_25\IN\0 (r_prep) function_19\NN\13783581 (r_conj) apoptosis_16\NN\11486178 (r_conj) investigating_3\VBG\575741 (l_dobj) efficacy_5\NN\5199286 (l_prep) in_11\IN\13603305 (l_pcomp) preventing_12\VBG\0 (l_dobj) damage_14\NN\7296428
D017239_D010523 CID paclitaxel_32\NN\0 (r_pobj) to_31\IN\0 (r_prep) neurons_30\NNS\5430628 (r_appos) ganglion_25\NN\5462674 (r_pobj) of_22\IN\0 (r_prep) cultures_21\NNS\7966140 (r_dobj) exposing_19\VBG\2110927 (r_pcomp) by_18\IN\0 (r_prep) mimic_13\VBP\10200365 (r_relcl) model_5\NN\5888929 (r_dobj) used_1\VBD\0 (l_xcomp) induced_8\VBD\1627355 (l_dobj) neuropathy_10\NN\14204950
D002945_D010523 CID cisplatin_34\NN\0 (r_conj) paclitaxel_32\NN\0 (r_pobj) to_31\IN\0 (r_prep) neurons_30\NNS\5430628 (r_appos) ganglion_25\NN\5462674 (r_pobj) of_22\IN\0 (r_prep) cultures_21\NNS\7966140 (r_dobj) exposing_19\VBG\2110927 (r_pcomp) by_18\IN\0 (r_prep) mimic_13\VBP\10200365 (r_relcl) model_5\NN\5888929 (r_dobj) used_1\VBD\0 (l_xcomp) induced_8\VBD\1627355 (l_dobj) neuropathy_10\NN\14204950
D008063_D009410 NONE acid_7\NN\14818238 (r_nsubj) is_8\VBZ\0 (l_advcl) plays_18\VBZ\7007684 (l_dobj) role_21\NN\719494 (l_prep) in_22\IN\13603305 (l_pobj) cascade_25\NN\9475292
D008063_D009410 NONE acid_35\NN\14818238 (r_pobj) of_31\IN\0 (r_prep) effects_30\NNS\13245626 (r_nsubj) depend_36\VBP\2604760 (r_conj) plays_18\VBZ\7007684 (l_dobj) role_21\NN\719494 (l_prep) in_22\IN\13603305 (l_pobj) cascade_25\NN\9475292
D002945_D028361 NONE cisplatin_5\NN\0 (r_nsubj) cause_8\VBP\7323922 (l_dobj) impairment_11\NN\7296428
D002945_D028361 NONE cisplatin_13\NN\0 (r_conj) in_10\IN\13603305 (r_prep) event_8\NN\23100 (r_attr) is_4\VBZ\0 (l_nsubj) toxicity_3\NN\13576101
D008063_D020258 NONE acid_3\NN\14818238 (r_nsubj) prevents_4\VBZ\0 (l_dobj) damage_6\NN\7296428 (l_conj) neurotoxicity_8\NN\0
D008063_D020258 NONE acid_7\NN\14818238 (r_nsubj) is_8\VBZ\0 (l_advcl) induced_12\VBN\1627355 (l_dobj) neurotoxicity_13\NN\0
D008063_D020258 NONE acid_35\NN\14818238 (r_pobj) of_31\IN\0 (r_prep) effects_30\NNS\13245626 (r_nsubj) depend_36\VBP\2604760 (r_conj) plays_18\VBZ\7007684 (r_advcl) is_8\VBZ\0 (l_advcl) induced_12\VBN\1627355 (l_dobj) neurotoxicity_13\NN\0
D008063_D020258 NONE acid_3\NN\14818238 (r_nsubj) exerts_4\VBZ\1158872 (l_conj) induced_9\VBN\1627355 (l_dobj) neurotoxicity_10\NN\0
D008063_D009422 NONE acid_3\NN\14818238 (r_nsubj) prevents_4\VBZ\0 (l_dobj) damage_6\NN\7296428 (l_prep) in_9\IN\13603305 (l_pobj) neuropathy_12\NN\14204950
D008063_D028361 NONE acid_3\NN\14818238 (r_nsubj) prevents_4\VBZ\0 (l_dobj) damage_6\NN\7296428
D008063_D028361 NONE acid_7\NN\14818238 (r_nsubj) is_8\VBZ\0 (l_advcl) plays_18\VBZ\7007684 (l_nsubj) damage_17\NN\7296428
D008063_D028361 NONE acid_35\NN\14818238 (r_pobj) of_31\IN\0 (r_prep) effects_30\NNS\13245626 (r_nsubj) depend_36\VBP\2604760 (r_conj) plays_18\VBZ\7007684 (l_nsubj) damage_17\NN\7296428
D008063_D028361 NONE acid_3\NN\14818238 (r_nsubj) exerts_4\VBZ\1158872 (r_ccomp) rescues_16\VBZ\45907 (l_dobj) toxicity_19\NN\13576101
11961407
D011692_D011507 CID pan_21\NNP\3101986 (r_compound) injection_22\NN\320852 (r_pobj) after_20\IN\0 (r_prep) days_19\NNS\15140892 (r_npadvmod) analyzed_2\VBN\0 (l_advcl) include_26\VB\0 (l_dobj) phase_30\NN\15113229 (l_prep) of_31\IN\0 (l_pobj) proteinuria_32\NN\14299637
D011692_D011507 CID pan_21\NNP\3101986 (r_compound) injection_22\NN\320852 (r_pobj) after_20\IN\0 (r_prep) days_19\NNS\15140892 (r_npadvmod) analyzed_2\VBN\0 (l_advcl) include_26\VB\0 (l_dobj) phase_30\NN\15113229 (l_appos) days_39\NNS\15140892 (l_conj) phase_47\NN\15113229 (l_prep) of_48\IN\0 (l_pobj) proteinuria_49\NN\14299637
D014443_D009401 NONE tyrosine_2\NN\14601829 (r_compound) phosphatase_3\NN\14732946 (l_prep) in_7\IN\13603305 (l_pobj) nephrosis_10\NN\14304060
D011692_D005921 NONE pan_21\NNP\3101986 (r_compound) injection_22\NN\320852 (r_pobj) after_20\IN\0 (r_prep) days_19\NNS\15140892 (r_npadvmod) analyzed_2\VBN\0 (l_advcl) include_26\VB\0 (l_dobj) phase_30\NN\15113229 (l_appos) days_39\NNS\15140892 (l_conj) phase_47\NN\15113229 (l_acl) associated_50\VBN\628491 (l_prep) with_51\IN\0 (l_pobj) glomerulosclerosis_52\NN\0
D011692_D009401 CID pan_9\NNP\3101986 (r_compound) nephrosis_10\NN\14304060
D011692_D009401 CID aminonucleoside_1\JJ\0 (r_amod) nephrosis_2\NN\14304060
D011692_D009401 CID aminonucleoside_11\NN\0 (r_advmod) induced_4\VBN\1627355 (l_nsubjpass) nephrosis_2\NN\14304060
D011692_D009401 CID pan_13\NNP\3101986 (r_appos) aminonucleoside_11\NN\0 (r_advmod) induced_4\VBN\1627355 (l_nsubjpass) nephrosis_2\NN\14304060
11581460
D005283_D009127 NONE fentanyl_5\NN\2707683 (r_compound) administration_6\NN\1133281 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (r_nsubj) include_7\VBP\0 (l_dobj) rigidity_10\NN\5023233
D005283_D001745 CID fentanyl_22\NN\2707683 (r_pobj) of_21\IN\0 (r_prep) infusion_20\NN\14589223 (r_pobj) of_18\IN\0 (r_prep) result_17\NN\34213 (r_pobj) as_15\IN\14622893 (r_prep) mimicking_13\VBG\1742886 (r_acl) dilatation_12\NN\14034177 (r_pobj) to_9\IN\0 (r_prep) leading_8\VBG\4339291 (r_acl) cases_3\NNS\7283608 (l_prep) of_4\IN\0 (l_pobj) retention_7\NN\809465
D005283_D006869 NONE fentanyl_22\NN\2707683 (r_pobj) of_21\IN\0 (r_prep) infusion_20\NN\14589223 (r_pobj) of_18\IN\0 (r_prep) result_17\NN\34213 (r_pobj) as_15\IN\14622893 (r_prep) mimicking_13\VBG\1742886 (l_dobj) hydronephrosis_14\NN\14204950
D005283_D001919 CID fentanyl_5\NN\2707683 (r_compound) administration_6\NN\1133281 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (r_nsubj) include_7\VBP\0 (l_dobj) rigidity_10\NN\5023233 (l_conj) hypotension_12\NN\14057371 (l_conj) depression_15\NN\14373582 (l_conj) bradycardia_18\NN\14110674
D005283_D016055 CID fentanyl_12\NN\2707683 (r_pobj) of_11\IN\0 (r_prep) infusion_10\NN\14589223 (r_pobj) of_7\IN\0 (r_prep) result_6\NN\34213 (r_pobj) as_4\IN\14622893 (r_prep) retention_1\NN\809465 (l_prep) of_2\IN\0 (l_pobj) urine_3\NN\14853947
D005283_D007022 CID fentanyl_5\NN\2707683 (r_compound) administration_6\NN\1133281 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (r_nsubj) include_7\VBP\0 (l_dobj) rigidity_10\NN\5023233 (l_conj) hypotension_12\NN\14057371
D005283_D012131 CID fentanyl_5\NN\2707683 (r_compound) administration_6\NN\1133281 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (r_nsubj) include_7\VBP\0 (l_dobj) rigidity_10\NN\5023233 (l_conj) hypotension_12\NN\14057371 (l_conj) depression_15\NN\14373582
2024540
D004656_D006333 NONE enalapril_11\NN\2673637 (r_pobj) of_10\IN\0 (r_prep) safety_9\NN\13920835 (l_prep) in_14\IN\13603305 (l_pobj) phase_18\NN\15113229 (l_prep) of_19\IN\0 (l_pobj) patients_20\NNS\9898892 (l_prep) with_21\IN\0 (l_pobj) failure_24\NN\66216
D000806_D007022 CID inhibitors_10\NNS\20090 (r_appos) enzyme_6\NN\14723628 (r_dobj) converting_5\VBG\126264 (l_prep) into_11\IN\0 (l_pobj) treatment_14\NN\654885 (l_prep) of_15\IN\0 (l_pobj) patients_16\NNS\9898892 (l_prep) with_17\IN\0 (l_pobj) failure_20\NN\66216 (l_conj) cases_22\NNS\7283608 (l_prep) of_23\IN\0 (l_pobj) hypotension_25\NN\14057371
D000806_D007022 CID inhibitor_7\NN\20090 (r_pobj) of_4\IN\0 (r_prep) safety_3\NN\13920835 (r_dobj) assess_1\VB\5220461 (r_advcl) designed_19\VBN\1631534 (l_prep) compared_21\VBD\644583 (l_pobj) incidence_23\NN\13821570 (l_prep) of_26\IN\0 (l_pobj) hypotension_28\NN\14057371
D000806_D006333 NONE inhibitors_10\NNS\20090 (r_appos) enzyme_6\NN\14723628 (r_dobj) converting_5\VBG\126264 (l_prep) into_11\IN\0 (l_pobj) treatment_14\NN\654885 (l_prep) of_15\IN\0 (l_pobj) patients_16\NNS\9898892 (l_prep) with_17\IN\0 (l_pobj) failure_20\NN\66216
D004656_D007022 NONE enalapril_8\NN\2673637 (r_appos) inhibitor_7\NN\20090 (r_pobj) of_4\IN\0 (r_prep) safety_3\NN\13920835 (r_dobj) assess_1\VB\5220461 (r_advcl) designed_19\VBN\1631534 (l_prep) compared_21\VBD\644583 (l_pobj) incidence_23\NN\13821570 (l_prep) of_26\IN\0 (l_pobj) hypotension_28\NN\14057371
D004656_D007022 NONE enalapril_3\RB\2673637 (r_dobj) received_2\VBD\2210855 (r_relcl) patients_0\NNS\9898892 (r_nsubj) experienced_4\VBD\2108377 (l_dobj) hypotension_11\NN\14057371
D011224_D007022 CID prazosin_14\NN\2698769 (r_npadvmod) controlled_16\VBN\0 (r_amod) trial_17\NN\786195 (r_nsubjpass) designed_19\VBN\1631534 (l_prep) compared_21\VBD\644583 (l_pobj) incidence_23\NN\13821570 (l_prep) of_26\IN\0 (l_pobj) hypotension_28\NN\14057371
D011224_D007022 CID prazosin_21\NN\2698769 (r_dobj) received_20\VBD\2210855 (r_relcl) patients_18\NNS\9898892 (r_pobj) than_16\IN\0 (r_prep) hypotension_11\NN\14057371
D011224_D006333 NONE prazosin_13\NN\2698769 (r_conj) enalapril_11\NN\2673637 (r_pobj) of_10\IN\0 (r_prep) safety_9\NN\13920835 (l_prep) in_14\IN\13603305 (l_pobj) phase_18\NN\15113229 (l_prep) of_19\IN\0 (l_pobj) patients_20\NNS\9898892 (l_prep) with_21\IN\0 (l_pobj) failure_24\NN\66216
19300402
D001920_D003929 NONE bradykinin_0\NN\0 (r_compound) antagonists_2\NNS\7846 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hyperalgesia_13\NN\0 (l_prep) in_14\IN\13603305 (l_pobj) chemotherapy_15\NN\661091 (l_conj) model_20\NN\5888929 (l_compound) rat_19\NN\2329401 (l_compound) neuropathy_18\NN\14204950
D013311_D006930 CID streptozotocin_11\NNS\0 (r_conj) antagonists_2\NNS\7846 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hyperalgesia_13\NN\0
D013311_D006930 CID streptozotocin_1\JJ\0 (r_npadvmod) induced_3\VBN\1627355 (r_amod) hyperalgesia_4\NN\0
D013311_D006930 CID streptozotocin_1\JJ\0 (r_npadvmod) induced_3\VBN\1627355 (r_amod) hyperalgesia_4\NN\0 (r_pobj) in_0\IN\13603305 (r_prep) participates_9\VBZ\2367363 (l_advcl) induced_20\VBN\1627355 (l_dobj) hyperalgesia_21\NN\0
D014750_D006930 CID vincristine_9\NN\3917455 (r_pobj) in_8\IN\13603305 (r_prep) antagonists_2\NNS\7846 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hyperalgesia_13\NN\0
D014750_D006930 CID vincristine_26\NN\3917455 (r_pobj) by_25\IN\0 (r_agent) produced_24\VBN\1617192 (r_acl) hyperalgesia_23\NN\0
D014750_D006930 CID vincristine_18\NN\3917455 (r_pobj) in_17\IN\13603305 (r_prep) induced_20\VBN\1627355 (r_advcl) participates_9\VBZ\2367363 (l_prep) in_0\IN\13603305 (l_pobj) hyperalgesia_4\NN\0
D014750_D006930 CID vincristine_18\NN\3917455 (r_pobj) in_17\IN\13603305 (r_prep) induced_20\VBN\1627355 (l_dobj) hyperalgesia_21\NN\0
D001920_D009437 NONE bradykinin_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) doses_6\NNS\3740161 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_nsubj) be_16\VB\14625458 (l_acomp) effective_17\JJ\0 (l_prep) in_18\IN\13603305 (l_pobj) alleviation_19\NN\7492516 (l_prep) of_20\IN\0 (l_pobj) pain_22\NN\14299637
D013311_D003929 CID streptozotocin_11\NNS\0 (r_conj) antagonists_2\NNS\7846 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hyperalgesia_13\NN\0 (l_prep) in_14\IN\13603305 (l_pobj) chemotherapy_15\NN\661091 (l_conj) model_20\NN\5888929 (l_compound) rat_19\NN\2329401 (l_compound) neuropathy_18\NN\14204950
D009569_D003929 NONE oxide_5\NN\14818238 (r_compound) synthase_6\NN\0 (r_compound) inhibitors_7\NNS\20090 (r_conj) antagonists_2\NNS\7846 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hyperalgesia_13\NN\0 (l_prep) in_14\IN\13603305 (l_pobj) chemotherapy_15\NN\661091 (l_conj) model_20\NN\5888929 (l_compound) rat_19\NN\2329401 (l_compound) neuropathy_18\NN\14204950
D014750_D003929 NONE vincristine_9\NN\3917455 (r_pobj) in_8\IN\13603305 (r_prep) antagonists_2\NNS\7846 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hyperalgesia_13\NN\0 (l_prep) in_14\IN\13603305 (l_pobj) chemotherapy_15\NN\661091 (l_conj) model_20\NN\5888929 (l_compound) rat_19\NN\2329401 (l_compound) neuropathy_18\NN\14204950
D001920_D006930 NONE bradykinin_0\NN\0 (r_compound) antagonists_2\NNS\7846 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hyperalgesia_13\NN\0
D001920_D006930 NONE bradykinin_9\NN\0 (r_compound) receptors_10\NNS\5225602 (r_pobj) of_8\IN\0 (r_prep) inhibition_7\NN\1068773 (r_nsubj) reduces_21\VBZ\441445 (l_dobj) hyperalgesia_23\NN\0
D001920_D006930 NONE bradykinin_19\NN\0 (r_conj) activation_15\NN\13561719 (r_conj) synthase_10\NN\0 (r_pobj) of_7\IN\0 (r_prep) products_6\NNS\3076708 (r_nsubjpass) involved_21\VBN\2676054 (l_prep) in_22\IN\13603305 (l_pobj) hyperalgesia_23\NN\0
D001920_D006930 NONE bradykinin_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) activity_12\NN\30358 (r_pobj) in_10\IN\13603305 (r_prep) participates_9\VBZ\2367363 (l_prep) in_0\IN\13603305 (l_pobj) hyperalgesia_4\NN\0
D001920_D006930 NONE bradykinin_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) activity_12\NN\30358 (r_pobj) in_10\IN\13603305 (r_prep) participates_9\VBZ\2367363 (l_advcl) induced_20\VBN\1627355 (l_dobj) hyperalgesia_21\NN\0
D001920_D006930 NONE bradykinin_22\NN\0 (r_nsubj) seemed_23\VBD\2604760 (r_conj) participates_9\VBZ\2367363 (l_prep) in_0\IN\13603305 (l_pobj) hyperalgesia_4\NN\0
D001920_D006930 NONE bradykinin_22\NN\0 (r_nsubj) seemed_23\VBD\2604760 (r_conj) participates_9\VBZ\2367363 (l_advcl) induced_20\VBN\1627355 (l_dobj) hyperalgesia_21\NN\0
D009569_D009437 NONE no_12\DT\7204911 (r_det) inhibitors_14\NNS\20090 (r_conj) antagonists_10\NNS\7846 (r_dobj) bradykinin_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) doses_6\NNS\3740161 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_nsubj) be_16\VB\14625458 (l_acomp) effective_17\JJ\0 (l_prep) in_18\IN\13603305 (l_pobj) alleviation_19\NN\7492516 (l_prep) of_20\IN\0 (l_pobj) pain_22\NN\14299637
D009569_D006930 NONE oxide_5\NN\14818238 (r_compound) synthase_6\NN\0 (r_compound) inhibitors_7\NNS\20090 (r_conj) antagonists_2\NNS\7846 (r_nsubj) induced_12\VBD\1627355 (l_dobj) hyperalgesia_13\NN\0
D009569_D006930 NONE no_13\DT\7204911 (r_det) synthase_14\NN\0 (r_conj) inhibition_7\NN\1068773 (r_nsubj) reduces_21\VBZ\441445 (l_dobj) hyperalgesia_23\NN\0
D009569_D006930 NONE no_18\DT\7204911 (r_det) activity_20\NN\30358 (r_nsubj) reduces_21\VBZ\441445 (l_dobj) hyperalgesia_23\NN\0
D009569_D006930 NONE no_9\DT\7204911 (r_compound) synthase_10\NN\0 (r_pobj) of_7\IN\0 (r_prep) products_6\NNS\3076708 (r_nsubjpass) involved_21\VBN\2676054 (l_prep) in_22\IN\13603305 (l_pobj) hyperalgesia_23\NN\0
D009569_D006930 NONE no_13\DT\7204911 (r_det) activation_15\NN\13561719 (r_conj) synthase_10\NN\0 (r_pobj) of_7\IN\0 (r_prep) products_6\NNS\3076708 (r_nsubjpass) involved_21\VBN\2676054 (l_prep) in_22\IN\13603305 (l_pobj) hyperalgesia_23\NN\0
D009569_D006930 NONE no_7\DT\7204911 (r_compound) synthase_8\NN\0 (r_nsubj) participates_9\VBZ\2367363 (l_prep) in_0\IN\13603305 (l_pobj) hyperalgesia_4\NN\0
D009569_D006930 NONE no_7\DT\7204911 (r_compound) synthase_8\NN\0 (r_nsubj) participates_9\VBZ\2367363 (l_advcl) induced_20\VBN\1627355 (l_dobj) hyperalgesia_21\NN\0
D009569_D006930 NONE no_27\DT\7204911 (r_det) pathway_29\NN\5483677 (r_dobj) activate_25\VB\1641914 (r_xcomp) seemed_23\VBD\2604760 (r_conj) participates_9\VBZ\2367363 (l_prep) in_0\IN\13603305 (l_pobj) hyperalgesia_4\NN\0
D009569_D006930 NONE no_27\DT\7204911 (r_det) pathway_29\NN\5483677 (r_dobj) activate_25\VB\1641914 (r_xcomp) seemed_23\VBD\2604760 (r_conj) participates_9\VBZ\2367363 (l_advcl) induced_20\VBN\1627355 (l_dobj) hyperalgesia_21\NN\0
11642480
D015283_D003865 NONE citalopram_8\NN\0 (r_pobj) with_7\IN\0 (r_prep) treatment_6\NN\654885 (l_prep) by_9\IN\0 (l_pobj) boy_14\NN\9624168 (l_prep) with_15\IN\0 (l_pobj) depression_17\NN\14373582
D015283_D003866 NONE citalopram_7\NN\0 (r_pobj) on_6\IN\0 (r_prep) adolescent_5\NN\9622049 (l_amod) depressed_4\JJ\1819147
D015283_D004409 CID citalopram_7\NN\0 (r_pobj) on_6\IN\0 (r_prep) adolescent_5\NN\9622049 (r_pobj) in_2\IN\13603305 (r_prep) twitching_1\VBG\14360459
D015283_D004409 CID citalopram_8\NN\0 (r_pobj) with_7\IN\0 (r_prep) treatment_6\NN\654885 (l_prep) by_9\IN\0 (l_pobj) boy_14\NN\9624168 (l_prep) with_15\IN\0 (l_pobj) depression_17\NN\14373582 (l_relcl) exhibited_19\VBD\2632167 (l_dobj) twitching_21\NN\14360459
15859940
D016572_D057049 CID cyclosporine_18\NN\0 (r_pobj) to_17\IN\0 (r_prep) secondary_15\JJ\8426461 (r_amod) related_13\VBN\628491 (r_acomp) was_11\VBD\0 (l_nsubj) cause_7\NN\7323922 (l_prep) of_8\IN\0 (l_pobj) microangiopathy_10\NN\0
D016572_D064420 NONE cyclosporine_7\NN\0 (r_nmod) toxicity_11\NN\13576101
D016559_D064420 NONE tacrolimus_9\NN\0 (r_conj) cyclosporine_7\NN\0 (r_nmod) toxicity_11\NN\13576101
8595686
D013874_D010146 NONE thiopentone_0\NN\0 (r_compound) pretreatment_1\NN\0 (l_prep) for_2\IN\0 (l_pobj) pain_5\NN\14299637
D013874_D010146 NONE thiopentone_17\NN\0 (r_nsubj) reduces_19\VBZ\441445 (r_advcl) reduces_4\VBZ\441445 (l_dobj) incidence_6\NN\13821570 (l_prep) of_9\IN\0 (l_pobj) pain_12\NN\14299637
D015742_D010146 CID propofol_3\JJ\0 (r_amod) pain_5\NN\14299637
D015742_D010146 CID propofol_10\JJ\0 (r_amod) pain_12\NN\14299637
D008012_D010146 NONE lidocaine_3\NN\3681148 (r_nsubj) reduces_4\VBZ\441445 (l_dobj) incidence_6\NN\13821570 (l_prep) of_9\IN\0 (l_pobj) pain_12\NN\14299637
11263551
D016572_-1 NONE cyclosporine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) effect_16\NN\34213 (r_attr) is_10\VBZ\0 (l_nsubj) syndrome_6\NNP\5870365 (l_appos) cips_8\NNP\0
D016559_-1 NONE tacrolimus_20\NN\0 (r_conj) cyclosporine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) effect_16\NN\34213 (r_attr) is_10\VBZ\0 (l_nsubj) syndrome_6\NNP\5870365 (l_appos) cips_8\NNP\0
D016559_D010146 CID tacrolimus_5\VB\0 (r_compound) trough_6\NN\9366017 (r_compound) levels_7\NNS\4916342 (r_pobj) of_2\IN\0 (r_prep) reduction_1\NN\351485 (r_nsubj) led_15\VBD\3202760 (l_prep) to_16\IN\0 (l_pobj) relief_17\NN\7492516 (l_prep) of_18\IN\0 (l_pobj) pain_19\NN\14299637
D016559_D010146 CID tacrolimus_20\NN\0 (r_conj) cyclosporine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) effect_16\NN\34213 (r_attr) is_10\VBZ\0 (l_nsubj) syndrome_6\NNP\5870365 (l_compound) pain_5\NNP\14299637
D016572_D010146 CID cyclosporine-_3\NN\0 (r_nmod) levels_7\NNS\4916342 (r_pobj) of_2\IN\0 (r_prep) reduction_1\NN\351485 (r_nsubj) led_15\VBD\3202760 (l_prep) to_16\IN\0 (l_pobj) relief_17\NN\7492516 (l_prep) of_18\IN\0 (l_pobj) pain_19\NN\14299637
D016572_D010146 CID cyclosporine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) effect_16\NN\34213 (r_attr) is_10\VBZ\0 (l_nsubj) syndrome_6\NNP\5870365 (l_compound) pain_5\NNP\14299637
D002118_D010146 NONE calcium_12\NN\14625458 (r_compound) channel_13\NN\6251781 (r_compound) blockers_14\NNS\10101634 (r_pobj) of_11\IN\0 (r_prep) administration_10\NN\1133281 (r_conj) reduction_1\NN\351485 (r_nsubj) led_15\VBD\3202760 (l_prep) to_16\IN\0 (l_pobj) relief_17\NN\7492516 (l_prep) of_18\IN\0 (l_pobj) pain_19\NN\14299637
2572625
C013295_D056486 NONE thienodiazepine_27\NN\0 (r_amod) derivative_28\NN\5802185 (r_appos) patient_6\NN\9898892 (l_relcl) developed_8\VBD\1753788 (l_dobj) hepatitis_10\NN\14127211
C013295_D047508 NONE thienodiazepine_27\NN\0 (r_amod) derivative_28\NN\5802185 (r_appos) patient_6\NN\9898892 (l_relcl) developed_8\VBD\1753788 (l_prep) with_11\IN\0 (l_pobj) necrosis_14\NN\11444117
C084599_D056486 CID clotiazepam_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hepatitis_4\NN\14127211
C084599_D056486 CID clotiazepam_24\NN\0 (r_pobj) of_23\IN\0 (r_prep) administration_22\NN\1133281 (r_pobj) of_21\IN\0 (r_prep) onset_20\NN\7325190 (r_pobj) after_18\IN\0 (r_prep) developed_8\VBD\1753788 (l_dobj) hepatitis_10\NN\14127211
C084599_D056486 CID clotiazepam_9\NN\0 (r_xcomp) related_7\VBN\628491 (r_acl) administration_1\NN\1133281 (r_nsubj) interfere_13\VB\2451370 (l_conj) induce_19\VB\1627355 (l_dobj) relapse_21\NN\66636 (l_prep) of_22\IN\0 (l_pobj) hepatitis_23\NN\14127211
C084599_D056486 CID clotiazepam_4\NN\0 (r_nsubj) induce_6\VB\1627355 (l_dobj) hepatitis_8\NN\14127211
C084599_D056486 CID clotiazepam_4\NN\0 (r_nsubj) induce_6\VB\1627355 (l_conj) suggests_10\VBZ\1010118 (l_ccomp) is_13\VBZ\0 (l_attr) hepatotoxicity_16\NN\0
C084599_D056486 CID clotiazepam_18\NN\0 (r_pobj) between_17\IN\0 (r_prep) hepatotoxicity_16\NN\0 (r_attr) is_13\VBZ\0 (r_ccomp) suggests_10\VBZ\1010118 (r_conj) induce_6\VB\1627355 (l_dobj) hepatitis_8\NN\14127211
C084599_D056486 CID clotiazepam_18\NN\0 (r_pobj) between_17\IN\0 (r_prep) hepatotoxicity_16\NN\0
C084599_D047508 NONE clotiazepam_24\NN\0 (r_pobj) of_23\IN\0 (r_prep) administration_22\NN\1133281 (r_pobj) of_21\IN\0 (r_prep) onset_20\NN\7325190 (r_pobj) after_18\IN\0 (r_prep) developed_8\VBD\1753788 (l_prep) with_11\IN\0 (l_pobj) necrosis_14\NN\11444117
D001569_D056486 NONE benzodiazepines_4\NNS\3771443 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) interfere_13\VB\2451370 (l_conj) induce_19\VB\1627355 (l_dobj) relapse_21\NN\66636 (l_prep) of_22\IN\0 (l_pobj) hepatitis_23\NN\14127211
D001569_D056486 NONE benzodiazepines_21\NNS\3771443 (r_conj) clotiazepam_18\NN\0 (r_pobj) between_17\IN\0 (r_prep) hepatotoxicity_16\NN\0 (r_attr) is_13\VBZ\0 (r_ccomp) suggests_10\VBZ\1010118 (r_conj) induce_6\VB\1627355 (l_dobj) hepatitis_8\NN\14127211
D001569_D056486 NONE benzodiazepines_21\NNS\3771443 (r_conj) clotiazepam_18\NN\0 (r_pobj) between_17\IN\0 (r_prep) hepatotoxicity_16\NN\0
10406016
C007789_D007249 NONE fucoidan_0\NNP\0 (r_npadvmod) treated_2\VBN\2376958 (r_amod) rats_3\NNS\2329401 (r_nsubj) exhibited_4\VBD\2632167 (l_conj) had_13\VBD\0 (l_conj) tended_18\VBD\2604760 (l_xcomp) have_20\VB\7846 (l_dobj) inflammation_22\NN\14299637
C007789_D020141 CID fucoidan_0\NNP\0 (r_npadvmod) treated_2\VBN\2376958 (r_amod) rats_3\NNS\2329401 (r_nsubj) exhibited_4\VBD\2632167 (l_dobj) evidence_5\NN\5816287 (l_prep) of_6\IN\0 (l_pobj) clotting_9\NN\13518963
C007789_D020141 CID fucoidan_0\NNP\0 (r_npadvmod) treated_2\VBN\2376958 (r_amod) rats_3\NNS\2329401 (r_nsubj) exhibited_4\VBD\2632167 (l_dobj) evidence_5\NN\5816287 (l_prep) of_6\IN\0 (l_pobj) clotting_9\NN\13518963 (l_conj) hemodilution_11\NN\0
C007789_D001925 NONE fucoidan_5\RB\0 (l_relcl) reported_10\VBN\831651 (l_xcomp) reduce_12\VB\441445 (l_dobj) damage_15\NN\7296428
C007789_D002543 NONE fucoidan_2\JJ\0 (r_compound) treatment_3\NN\654885 (l_prep) on_4\IN\0 (l_pobj) hemorrhage_9\NN\14285662
C007789_D002543 NONE fucoidan_5\RB\0 (r_dobj) tested_1\VBD\670261 (l_prep) in_17\IN\13603305 (l_pobj) model_20\NN\5888929 (l_prep) of_21\IN\0 (l_pobj) hemorrhage_23\NN\14285662
C007789_D006406 NONE fucoidan_0\NNP\0 (r_npadvmod) treated_2\VBN\2376958 (r_amod) rats_3\NNS\2329401 (r_nsubj) exhibited_4\VBD\2632167 (l_conj) had_13\VBD\0 (l_dobj) hematomas_15\NNS\14317720
C007789_D006406 NONE fucoidan_0\NNP\0 (r_npadvmod) treated_2\VBN\2376958 (r_amod) rats_3\NNS\2329401 (r_nsubj) exhibited_4\VBD\2632167 (l_conj) had_13\VBD\0 (l_conj) tended_18\VBD\2604760 (l_xcomp) have_20\VB\7846 (l_dobj) inflammation_22\NN\14299637 (l_prep) in_23\IN\13603305 (l_pobj) vicinity_25\NN\8648322 (l_prep) of_26\IN\0 (l_pobj) hematoma_28\NN\14317720
12820454
D016729_D000740 CID acetate_6\NN\15010703 (r_dobj) received_2\VBD\2210855 (l_conj) evaluated_32\VBN\670261 (l_prep) for_33\IN\0 (l_pobj) anemia_34\NN\14189204
D016729_D000740 CID a_10\NNP\13649268 (r_appos) acetate_6\NN\15010703 (r_dobj) received_2\VBD\2210855 (l_conj) evaluated_32\VBN\670261 (l_prep) for_33\IN\0 (l_pobj) anemia_34\NN\14189204
D005485_D000740 CID flutamide_23\NN\0 (r_nmod) tid_25\NN\0 (r_conj) days_19\NNS\15140892 (r_appos) acetate_6\NN\15010703 (r_dobj) received_2\VBD\2210855 (l_conj) evaluated_32\VBN\670261 (l_prep) for_33\IN\0 (l_pobj) anemia_34\NN\14189204
2476560
D001556_D012532 NONE lindane_12\NN\14919948 (r_dobj) consider_11\VBP\689344 (l_ccomp) initiated_5\VBN\1617192 (l_nsubjpass) treatment_0\NN\654885 (l_prep) for_1\IN\0 (l_pobj) scabies_2\NNS\14174549
D001556_D012532 NONE hexachloride_16\NN\0 (r_appos) lindane_12\NN\14919948 (r_dobj) consider_11\VBP\689344 (l_ccomp) initiated_5\VBN\1617192 (l_nsubjpass) treatment_0\NN\654885 (l_prep) for_1\IN\0 (l_pobj) scabies_2\NNS\14174549
D001556_D000741 CID lindane_4\NN\14919948 (r_dobj) accumulating_2\VBG\2281093 (r_csubj) be_6\VB\14625458 (l_conj) associated_16\VBN\628491 (l_prep) with_17\IN\0 (l_pobj) anaemia_19\NN\14299637
D001556_D002493 CID lindane_4\NN\14919948 (r_dobj) accumulating_2\VBG\2281093 (r_csubj) be_6\VB\14625458 (l_acomp) toxic_7\JJ\0 (l_prep) to_8\IN\0 (l_pobj) system_12\NN\3575240
3560096
D011188_D006947 NONE potassium_8\NN\14625458 (r_dobj) effect_6\NN\34213 (r_xcomp) known_4\VBN\0 (r_acl) medications_3\NNS\3247620 (r_nsubjpass) given_11\VBN\5892096 (r_advcl) is_18\VBZ\0 (l_acomp) suggestive_19\JJ\0 (l_prep) of_20\IN\0 (l_pobj) relationship_27\NN\31921 (l_prep) between_28\IN\0 (l_pobj) sulindac_29\NN\3828465 (l_conj) hyperkalemia_31\NN\14299637
D007213_D006947 CID indomethacin_17\NN\3828465 (r_pobj) as_16\IN\14622893 (r_prep) nsaid_13\NNP\2721538 (r_appos) agents_11\NNS\7347 (r_pobj) of_8\IN\0 (r_prep) complication_7\NN\1073995 (r_pobj) as_5\IN\14622893 (r_prep) recognized_4\VBN\686447 (l_nsubjpass) hyperkalemia_0\NNP\14299637
D013467_D006947 CID sulindac_3\NN\3828465 (r_compound) therapy_4\NN\657604 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) hyperkalemia_0\NNP\14299637
D013467_D006947 CID sulindac_22\NN\3828465 (r_compound) administration_23\NN\1133281 (r_pobj) of_21\IN\0 (r_prep) days_20\NNS\15140892 (r_pobj) within_16\IN\0 (r_prep) developed_15\VBD\1753788 (l_nsubj) hyperkalemia_6\VBD\14299637
D013467_D006947 CID sulindac_29\NN\3828465 (l_conj) hyperkalemia_31\NN\14299637
1009330
D011206_D003556 CID iodine_10\NN\14622893 (r_conj) colistin_6\NN\0 (r_nmod) irrigations_11\NNS\1057200 (r_pobj) of_3\IN\0 (r_prep) percentage_2\NN\13815742 (r_nsubjpass) associated_13\VBN\628491 (l_prep) with_14\IN\0 (l_pobj) cystitis_16\NN\14566129
C004658_D003556 NONE choloroaniline_10\NN\0 (r_appos) product_7\NN\3076708 (r_nsubj) is_11\VBZ\0 (l_attr) factor_15\NN\7326557 (l_prep) in_16\IN\13603305 (l_pobj) cystitis_22\NN\14566129
C010882_D003556 CID digluconate_19\NN\0 (r_npadvmod) associated_20\VBN\628491 (r_amod) cystitis_22\NN\14566129
D003091_D003556 CID colistin_6\NN\0 (r_nmod) irrigations_11\NNS\1057200 (r_pobj) of_3\IN\0 (r_prep) percentage_2\NN\13815742 (r_nsubjpass) associated_13\VBN\628491 (l_prep) with_14\IN\0 (l_pobj) cystitis_16\NN\14566129
C005253_D003556 NONE picloxydine_0\NNP\0 (r_compound) irrigations_1\NNS\1057200 (r_nsubj) appeared_2\VBD\2604760 (l_xcomp) have_4\VB\7846 (l_dobj) incidence_7\NN\13821570 (l_prep) of_8\IN\0 (l_pobj) cystitis_10\NN\14566129
D007612_D003556 CID kanamycin_4\NN\2716866 (r_compound) colistin_6\NN\0 (r_nmod) irrigations_11\NNS\1057200 (r_pobj) of_3\IN\0 (r_prep) percentage_2\NN\13815742 (r_nsubjpass) associated_13\VBN\628491 (l_prep) with_14\IN\0 (l_pobj) cystitis_16\NN\14566129
19387625
D002211_D006930 CID capsaicin_7\NN\15032661 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hyperalgesia_11\NN\0
D002211_D006930 CID capsaicin_16\NN\15032661 (r_npadvmod) induced_18\VBN\1627355 (r_amod) hyperalgesia_20\NN\0
D002211_D006930 CID capsaicin_20\NN\15032661 (r_npadvmod) untreated_22\VBN\0 (r_amod) condition_25\NN\24720 (r_pobj) of_19\IN\0 (r_prep) that_18\DT\0 (r_pobj) to_17\IN\0 (r_prep) similar_16\JJ\0 (r_acomp) is_14\VBZ\0 (l_nsubj) magnitude_7\NN\4916342 (l_prep) of_8\IN\0 (l_pobj) modulation_10\NN\7044917 (l_prep) in_11\IN\13603305 (l_pobj) hyperalgesia_13\NN\0
D002211_D006930 CID capsaicin_7\NN\15032661 (r_compound) treatment_8\NN\654885 (r_pobj) between_6\IN\0 (r_prep) interaction_5\NN\37396 (r_dobj) showing_3\VBG\6887726 (r_csubj) suggest_12\VBP\1010118 (l_ccomp) affect_22\VB\26192 (l_nsubj) hyperalgesia_18\NN\0
D002211_D006930 CID capsaicin_14\NN\15032661 (r_npadvmod) induced_16\VBN\1627355 (r_amod) hyperalgesia_18\NN\0
D002211_D010146 NONE capsaicin_7\NN\15032661 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hyperalgesia_11\NN\0 (r_pobj) in_6\IN\13603305 (r_prep) intensity_5\NN\5090441 (l_compound) pain_4\NN\14299637
D002211_D010146 NONE capsaicin_16\NN\15032661 (r_npadvmod) induced_18\VBN\1627355 (r_amod) hyperalgesia_20\NN\0 (r_pobj) in_15\IN\13603305 (r_prep) attention_14\NN\5701944 (r_pobj) by_13\IN\0 (r_agent) affected_12\VBN\126264 (l_nsubjpass) ratings_10\NNS\5733583 (l_compound) intensity_9\NN\5090441 (l_compound) pain_8\NN\14299637
D002211_D010146 NONE capsaicin_7\NN\15032661 (r_compound) treatment_8\NN\654885 (r_pobj) between_6\IN\0 (r_prep) interaction_5\NN\37396 (r_dobj) showing_3\VBG\6887726 (r_csubj) suggest_12\VBP\1010118 (l_ccomp) affect_22\VB\26192 (l_dobj) pain_24\NN\14299637
D002211_D010146 NONE capsaicin_14\NN\15032661 (r_npadvmod) induced_16\VBN\1627355 (r_amod) hyperalgesia_18\NN\0 (r_nsubj) affect_22\VB\26192 (l_dobj) pain_24\NN\14299637
18821488
C068820_D064420 NONE hexyloxy)-6-methoxy-4-methylquinoline_16\NNP\0 (r_nmod) wr242511_18\NNP\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) following_4\VBG\8180190 (r_prep) toxicity_0\NN\13576101
C068820_D064420 NONE wr242511_18\NNP\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) following_4\VBG\8180190 (r_prep) toxicity_0\NN\13576101
C068820_D064420 NONE wr242511_4\NNP\0 (r_nsubjpass) pursued_8\VBN\10192926 (l_advcl) dissociated_27\VBN\2431320 (l_prep) from_28\IN\0 (l_pobj) those_29\DT\0 (l_acl) producing_30\VBG\1617192 (l_dobj) toxicity_32\NN\13576101
C068820_D011041 NONE wr242511_4\NNP\0 (r_nsubjpass) pursued_8\VBN\10192926 (l_prep) as_9\IN\14622893 (l_pobj) pretreatment_11\NN\0 (l_prep) for_12\IN\0 (l_pobj) poisoning_14\NN\14034177
C068820_D006456 CID wr242511_11\NNP\0 (r_pobj) of_10\IN\0 (r_prep) postinjection_9\NN\0 (r_dobj) noted_5\VBN\1009240 (l_nsubjpass) hemoglobinuria_3\NN\14299637
C080436_D064420 NONE 8-aminoquinoline_8\JJ\0 (r_compound) 8-[(4-amino_9\CD\0 (r_compound) l_11\NN\13616054 (r_compound) methylbutyl)amino]-_13\NN\0 (r_punct) wr242511_18\NNP\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) following_4\VBG\8180190 (r_prep) toxicity_0\NN\13576101
C068820_D008708 NONE wr242511_4\NNP\0 (l_relcl) produced_7\VBD\1617192 (l_dobj) methemoglobinemia_9\NN\0
3782049
D008972_D058186 CID molindone_18\NN\3713736 (r_compound) administration_19\NN\1133281 (r_pobj) following_17\VBG\8180190 (r_prep) rhabdomyolysis_11\NN\0 (l_conj) failure_16\NN\66216
D008972_D012206 CID molindone_6\NN\3713736 (r_compound) administration_7\NN\1133281 (r_pobj) following_5\VBG\8180190 (r_prep) rhabdomyolysis_4\NN\0
D008972_D012206 CID molindone_18\NN\3713736 (r_compound) administration_19\NN\1133281 (r_pobj) following_17\VBG\8180190 (r_prep) rhabdomyolysis_11\NN\0
D008972_D012559 NONE molindone_18\NN\3713736 (r_compound) administration_19\NN\1133281 (r_pobj) following_17\VBG\8180190 (r_prep) rhabdomyolysis_11\NN\0 (r_dobj) illustrate_9\VB\955601 (r_xcomp) reported_7\VBN\831651 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) patient_5\NN\9898892 (l_amod) schizophrenic_4\JJ\10490141
8690168
D006497_D003928 NONE sulphate_3\NN\15010703 (r_npadvmod) associated_5\VBN\628491 (r_amod) sites_7\NNS\8673395 (l_prep) in_8\IN\13603305 (l_pobj) membrane_12\NN\4188643 (l_prep) of_13\IN\0 (l_pobj) rats_14\NNS\2329401 (l_prep) with_15\IN\0 (l_pobj) nephropathy_20\NN\14573196
D013311_D003928 CID streptozotocin_16\NNS\0 (r_npadvmod) induced_18\VBN\1627355 (r_amod) nephropathy_20\NN\14573196
C015445_D003920 NONE blue_38\JJ\4959672 (r_dobj) employing_33\VBG\0 (r_advcl) studied_12\VBN\0 (l_prep) after_17\IN\0 (l_pobj) induction_18\NN\7450842 (l_prep) of_19\IN\0 (l_pobj) diabetes_20\NNS\14075199
D013311_D003920 NONE streptozotocin_22\NNS\0 (r_pobj) by_21\IN\0 (r_prep) induction_18\NN\7450842 (l_prep) of_19\IN\0 (l_pobj) diabetes_20\NNS\14075199
D013311_D003920 NONE streptozotocin_4\JJ\0 (r_amod) diabetic_6\JJ\10595647
D006497_D003920 NONE sulphate_1\NN\15010703 (r_npadvmod) associated_3\VBN\628491 (r_amod) sites_5\NNS\8673395 (r_nsubjpass) studied_12\VBN\0 (l_prep) after_17\IN\0 (l_pobj) induction_18\NN\7450842 (l_prep) of_19\IN\0 (l_pobj) diabetes_20\NNS\14075199
D006497_D003920 NONE sulphate_18\NN\15010703 (r_compound) charge_19\NN\972621 (r_compound) density_22\NN\4941325 (r_nsubjpass) found_24\VBN\13279262 (l_prep) in_3\IN\13603305 (l_pobj) rats_7\NNS\2329401 (l_amod) diabetic_6\JJ\10595647
1468485
D015237_D006470 NONE alpha_14\NN\6828818 (r_pobj) of_11\IN\0 (r_prep) saline_8\NN\14849367 (r_pobj) with_6\IN\0 (r_prep) irrigation_5\NN\1057200 (r_pobj) including_3\VBG\0 (r_prep) treatment_1\NN\654885 (r_nsubj) failed_16\VBD\0 (l_xcomp) control_19\VB\5190804 (l_dobj) hemorrhage_20\NN\14285662
D003520_D006470 CID cyclophosphamide_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) cystitis_11\NN\14566129
D003520_D006470 CID cyclophosphamide_10\NN\0 (r_compound) therapy_11\NN\657604 (r_pobj) due_8\IN\5174653 (r_prep) report_1\VBP\6470073 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) cystitis_7\NN\14566129
D003520_D006470 CID cyclophosphamide_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) treatment_14\NN\654885 (r_pobj) in_12\IN\13603305 (r_prep) alternative_11\NN\5788149 (r_dobj) offer_8\VB\7160883 (l_dobj) cystitis_20\NN\14566129
D010100_D006470 NONE oxygen_1\NN\14622893 (r_compound) therapy_2\NN\657604 (l_prep) for_3\IN\0 (l_pobj) control_4\NN\5190804 (l_prep) of_5\IN\0 (l_pobj) cystitis_11\NN\14566129
D010100_D003556 NONE oxygen_1\NN\14622893 (r_compound) therapy_2\NN\657604 (l_prep) for_3\IN\0 (l_pobj) control_4\NN\5190804 (l_prep) of_5\IN\0 (l_pobj) cystitis_11\NN\14566129
D003520_D003556 CID cyclophosphamide_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) cystitis_11\NN\14566129
D003520_D003556 CID cyclophosphamide_10\NN\0 (r_compound) therapy_11\NN\657604 (r_pobj) due_8\IN\5174653 (r_prep) report_1\VBP\6470073 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) cystitis_7\NN\14566129
D003520_D003556 CID cyclophosphamide_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) treatment_14\NN\654885 (r_pobj) in_12\IN\13603305 (r_prep) alternative_11\NN\5788149 (r_dobj) offer_8\VB\7160883 (l_dobj) cystitis_20\NN\14566129
D003520_D014890 NONE cyclophosphamide_10\NN\0 (r_compound) therapy_11\NN\657604 (l_prep) for_12\IN\0 (l_pobj) granulomatosis_15\NN\0
88336
D002719_D013375 NONE chlormethiazole_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) doses_4\NNS\3740161 (r_dobj) received_2\VBD\2210855 (l_prep) for_7\IN\0 (l_pobj) symptoms_10\NNS\5823932
D002719_D003128 CID chlormethiazole_10\NN\0 (r_compound) intoxication_11\NN\14034177 (r_pobj) with_9\IN\0 (r_prep) those_8\DT\0 (r_pobj) of_7\IN\0 (r_prep) two_6\CD\13741022 (r_conj) overdose_4\NN\84738 (r_pobj) with_2\IN\0 (r_prep) patient_1\NN\9898892 (r_nsubj) conformed_12\VBD\0 (l_prep) to_13\IN\0 (l_pobj) criteria_15\NNS\13577171 (l_prep) of_16\IN\0 (l_pobj) coma_19\NN\5678932
D009567_D013375 NONE nitrazepam_19\NN\2830852 (r_pobj) of_18\IN\0 (r_prep) overdose_17\NN\84738 (r_dobj) took_14\VBD\2367363 (r_conj) received_2\VBD\2210855 (l_prep) for_7\IN\0 (l_pobj) symptoms_10\NNS\5823932
D000431_D062787 NONE alcohol_8\NN\7881800 (r_compound) withdrawal_9\NN\7206096 (r_compound) symptoms_10\NNS\5823932 (r_pobj) for_7\IN\0 (r_prep) received_2\VBD\2210855 (l_conj) took_14\VBD\2367363 (l_dobj) overdose_17\NN\84738
D000431_D013375 NONE alcohol_8\NN\7881800 (r_compound) withdrawal_9\NN\7206096 (r_compound) symptoms_10\NNS\5823932
D009567_D003128 CID nitrazepam_3\JJ\2830852 (r_amod) overdose_4\NN\84738 (r_pobj) with_2\IN\0 (r_prep) patient_1\NN\9898892 (r_nsubj) conformed_12\VBD\0 (l_prep) to_13\IN\0 (l_pobj) criteria_15\NNS\13577171 (l_prep) of_16\IN\0 (l_pobj) coma_19\NN\5678932
D002719_D062787 NONE chlormethiazole_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) doses_4\NNS\3740161 (r_dobj) received_2\VBD\2210855 (l_conj) took_14\VBD\2367363 (l_dobj) overdose_17\NN\84738
D002719_D062787 NONE chlormethiazole_10\NN\0 (r_compound) intoxication_11\NN\14034177 (r_pobj) with_9\IN\0 (r_prep) those_8\DT\0 (r_pobj) of_7\IN\0 (r_prep) two_6\CD\13741022 (r_conj) overdose_4\NN\84738
D009567_D062787 CID nitrazepam_19\NN\2830852 (r_pobj) of_18\IN\0 (r_prep) overdose_17\NN\84738
D009567_D062787 CID nitrazepam_3\JJ\2830852 (r_amod) overdose_4\NN\84738
9334596
D013739_D020018 CID testosterone_5\NN\14747587 (r_pobj) for_4\IN\0 (r_prep) screened_3\VBN\2533282 (l_conj) screened_9\VBN\2533282 (l_prep) on_12\IN\0 (l_pobj) basis_14\NN\13790712 (l_prep) of_15\IN\0 (l_pobj) desire_18\NN\26192
D013739_D020018 CID testosterone_22\NN\14747587 (r_conj) gynecomastia_20\NN\14501726 (r_conj) desire_18\NN\26192
D013739_D020018 CID testosterone_1\NN\14747587 (r_dobj) determining_0\VBG\0 (l_prep) in_3\IN\13603305 (l_pobj) cases_4\NNS\7283608 (l_prep) of_5\IN\0 (l_pobj) desire_8\NN\26192
D013739_D020018 CID testosterone_23\NN\14747587 (r_pobj) with_21\IN\0 (r_prep) cases_20\NNS\7283608 (r_pobj) of_18\IN\0 (r_prep) %_17\NN\0 (r_dobj) missed_15\VBN\0 (l_csubj) determining_0\VBG\0 (l_prep) in_3\IN\13603305 (l_pobj) cases_4\NNS\7283608 (l_prep) of_5\IN\0 (l_pobj) desire_8\NN\26192
D013739_D020018 CID testosterone_8\NN\14747587 (r_nsubjpass) determined_10\VBN\0 (l_prep) in_12\IN\13603305 (l_pobj) cases_13\NNS\7283608 (l_prep) of_14\IN\0 (l_pobj) desire_17\NN\26192
D013739_D020018 CID testosterone_14\NN\14747587 (r_conj) gynecomastia_12\NN\14501726 (r_conj) desire_10\NN\26192
D013739_D007027 NONE testosterone_5\NN\14747587 (r_compound) levels_6\NNS\4916342 (r_pobj) of_1\IN\0 (r_prep) most_0\JJS\0 (r_nsubj) seemed_7\VBD\2604760 (l_xcomp) result_9\VB\34213 (l_prep) from_10\IN\0 (l_pobj) dysfunction_13\NN\14204950
D001971_D006966 NONE bromocriptine_13\NN\0 (l_prep) for_14\IN\0 (l_pobj) hyperprolactinemia_15\NN\0
D013739_D006177 NONE testosterone_5\NN\14747587 (r_pobj) for_4\IN\0 (r_prep) screened_3\VBN\2533282 (l_conj) screened_9\VBN\2533282 (l_prep) on_12\IN\0 (l_pobj) basis_14\NN\13790712 (l_prep) of_15\IN\0 (l_pobj) desire_18\NN\26192 (l_conj) gynecomastia_20\NN\14501726
D013739_D006177 NONE testosterone_22\NN\14747587 (r_conj) gynecomastia_20\NN\14501726
D013739_D006177 NONE testosterone_14\NN\14747587 (r_conj) gynecomastia_12\NN\14501726
D013739_D010911 NONE testosterone_6\NN\14747587 (r_compound) determination_7\NN\43195 (r_pobj) after_5\IN\0 (r_prep) discovered_4\VBN\2163746 (l_nsubjpass) tumors_2\NNS\14234074
C004648_D007006 NONE heptylate_5\NN\0 (l_conj) gonadotropin_9\NN\5407119 (l_prep) for_10\IN\0 (l_pobj) hypogonadism_11\NN\14076126
C004648_D006966 NONE heptylate_5\NN\0 (l_conj) gonadotropin_9\NN\5407119 (l_prep) for_10\IN\0 (l_pobj) hypogonadism_11\NN\14076126 (l_conj) bromocriptine_13\NN\0 (l_prep) for_14\IN\0 (l_pobj) hyperprolactinemia_15\NN\0
D001971_D007006 NONE bromocriptine_13\NN\0 (r_conj) hypogonadism_11\NN\14076126
D013739_D007172 NONE testosterone_6\NN\14747587 (r_pobj) of_4\IN\0 (r_prep) results_3\NNS\34213 (l_prep) in_10\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_acl) referred_13\VBD\730052 (l_prep) because_14\IN\0 (l_pobj) dysfunction_17\NN\14204950
D013739_D007172 NONE testosterone_5\NN\14747587 (r_compound) levels_6\NNS\4916342 (r_pobj) of_1\IN\0 (r_prep) most_0\JJS\0 (r_nsubj) seemed_7\VBD\2604760 (l_xcomp) result_9\VB\34213 (l_prep) because_14\IN\0 (l_conj) have_24\VB\7846 (l_dobj) role_28\NN\719494 (l_prep) in_29\IN\13603305 (l_pobj) dysfunction_31\NN\14204950
D013739_D007172 NONE testosterone_6\NN\14747587 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (l_prep) in_10\IN\13603305 (l_pobj) dysfunction_12\NN\14204950
1919871
D000082_D007681 CID paracetamol_22\JJ\0 (r_conj) aspirin_20\NN\2707683 (r_pobj) with_19\IN\0 (r_prep) treatment_18\NN\654885 (r_pobj) during_13\IN\0 (r_prep) developed_12\VBN\1753788 (r_acl) ability_11\NN\4723816 (r_conj) necrosis_2\NN\11444117
D000082_D007681 CID paracetamol_22\JJ\0 (r_conj) aspirin_20\NN\2707683 (r_pobj) with_19\IN\0 (r_prep) treatment_18\NN\654885 (r_pobj) during_13\IN\0 (r_prep) developed_12\VBN\1753788 (r_acl) ability_11\NN\4723816 (r_conj) necrosis_2\NN\11444117 (l_appos) rpn_4\NNP\0
D001241_D007681 CID aspirin_20\NN\2707683 (r_pobj) with_19\IN\0 (r_prep) treatment_18\NN\654885 (r_pobj) during_13\IN\0 (r_prep) developed_12\VBN\1753788 (r_acl) ability_11\NN\4723816 (r_conj) necrosis_2\NN\11444117
D001241_D007681 CID aspirin_20\NN\2707683 (r_pobj) with_19\IN\0 (r_prep) treatment_18\NN\654885 (r_pobj) during_13\IN\0 (r_prep) developed_12\VBN\1753788 (r_acl) ability_11\NN\4723816 (r_conj) necrosis_2\NN\11444117 (l_appos) rpn_4\NNP\0
8955532
D003911_D006973 NONE dextran_15\NN\0 (r_pobj) of_11\IN\0 (r_prep) clearance_10\NN\5089947 (l_prep) before_16\IN\0 (l_conj) during_18\IN\0 (l_pobj) hypertension_23\NN\14057371
D001920_D006973 NONE bradykinin_4\NN\0 (l_prep) in_7\IN\13603305 (l_pobj) disruption_8\NN\1066163 (l_prep) during_15\IN\0 (l_pobj) hypertension_17\NN\14057371
D001920_D006973 NONE bradykinin_15\NN\0 (r_pobj) of_14\IN\0 (r_prep) release_13\NN\3748886 (r_pobj) of_10\IN\0 (r_prep) role_9\NN\719494 (r_dobj) determine_7\VB\0 (l_xcomp) activate_17\VB\1641914 (l_prep) in_20\IN\13603305 (l_pobj) disruption_21\NN\1066163 (l_prep) during_28\IN\0 (l_pobj) hypertension_30\NN\14057371
D001920_D006973 NONE bradykinin_23\NN\0 (r_pobj) of_22\IN\0 (r_prep) release_21\NN\3748886 (r_pobj) to_17\IN\0 (r_prep) related_16\VBN\628491 (l_auxpass) is_14\VBZ\0 (l_nsubj) disruption_4\NN\1066163 (l_prep) during_11\IN\0 (l_pobj) hypertension_13\NN\14057371
D010656_D006973 CID phenylephrine_19\NN\2682038 (r_npadvmod) induced_21\VBN\1627355 (r_amod) hypertension_23\NN\14057371
C065679_D006973 NONE hoe-140_30\NNP\0 (r_conj) vehicle_28\NN\3100490 (r_pobj) with_27\IN\0 (r_prep) treated_26\VBN\2376958 (r_acl) rats_25\NNS\2329401 (r_pobj) in_24\IN\13603305 (r_prep) hypertension_23\NN\14057371
19037603
D019259_D012216 NONE lamivudine_3\NN\3834836 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (l_prep) with_4\IN\0 (l_pobj) therapy_7\NN\657604 (l_prep) for_8\IN\0 (l_pobj) disorders_10\NNS\14034177
D019259_D012216 NONE lamivudine_18\NN\3834836 (r_pobj) of_17\IN\0 (r_prep) administration_16\NN\1133281 (r_pobj) of_13\IN\0 (r_prep) effectiveness_12\NN\5190804 (r_pobj) concerning_10\VBG\0 (r_prep) report_7\VB\6470073 (r_xcomp) was_5\VBD\0 (l_attr) patients_30\NNS\9898892 (l_prep) with_31\IN\0 (l_pobj) disease_33\NN\14061805
D019259_D012216 NONE lamivudine_23\JJ\3834836 (r_compound) therapies_24\NNS\657604 (r_pobj) on_18\IN\0 (r_prep) were_17\VBD\0 (r_relcl) diseases_14\NNS\14061805
D006514_D012216 NONE antigen_24\NN\20090 (r_pobj) in_19\IN\13603305 (r_prep) administration_16\NN\1133281 (r_pobj) of_13\IN\0 (r_prep) effectiveness_12\NN\5190804 (r_pobj) concerning_10\VBG\0 (r_prep) report_7\VB\6470073 (r_xcomp) was_5\VBD\0 (l_attr) patients_30\NNS\9898892 (l_prep) with_31\IN\0 (l_pobj) disease_33\NN\14061805
D006514_D012216 NONE ag_27\NNP\14821043 (r_appos) antigen_24\NN\20090 (r_pobj) in_19\IN\13603305 (r_prep) administration_16\NN\1133281 (r_pobj) of_13\IN\0 (r_prep) effectiveness_12\NN\5190804 (r_pobj) concerning_10\VBG\0 (r_prep) report_7\VB\6470073 (r_xcomp) was_5\VBD\0 (l_attr) patients_30\NNS\9898892 (l_prep) with_31\IN\0 (l_pobj) disease_33\NN\14061805
D006514_D012216 NONE ag_9\NNP\14821043 (r_nmod) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) diseases_14\NNS\14061805
809711
D005996_D007022 CID nitroglycerin_0\NNP\15015501 (r_nsubjpass) shown_3\VBN\2137132 (r_ccomp) potentiated_17\VBN\229605 (l_agent) by_21\IN\0 (l_pobj) agents_22\NNS\7347 (l_relcl) reverse_24\VBP\13854649 (l_dobj) hypotension_28\NN\14057371
D005996_D007022 CID nitroglycerin_25\NN\15015501 (r_npadvmod) induced_27\VBN\1627355 (r_amod) hypotension_28\NN\14057371
D005996_D009203 NONE nitroglycerin_9\NN\15015501 (r_pobj) of_7\IN\0 (r_prep) effects_6\NNS\13245626 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) infarction_15\NN\14204950
D005996_D009203 NONE nitroglycerin_0\NNP\15015501 (r_nsubjpass) shown_3\VBN\2137132 (l_xcomp) reduce_5\VB\441445 (l_prep) during_10\IN\0 (l_pobj) infarction_13\NN\14204950
D005996_D009203 NONE nitroglycerin_25\NN\15015501 (r_npadvmod) induced_27\VBN\1627355 (r_amod) hypotension_28\NN\14057371 (r_dobj) reverse_24\VBP\13854649 (r_relcl) agents_22\NNS\7347 (r_pobj) by_21\IN\0 (r_agent) potentiated_17\VBN\229605 (l_ccomp) shown_3\VBN\2137132 (l_xcomp) reduce_5\VB\441445 (l_prep) during_10\IN\0 (l_pobj) infarction_13\NN\14204950
D005996_D009203 NONE nitroglycerin_9\NN\15015501 (r_dobj) received_7\VBD\2210855 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) infarctions_6\NNS\14204950
D005996_D009203 NONE nitroglycerin_8\NN\15015501 (r_pobj) to_7\IN\0 (r_prep) phenylephrine_6\NN\2682038 (r_pobj) of_5\IN\0 (r_prep) addition_4\NN\3081021 (r_nsubj) is_9\VBZ\0 (l_acomp) beneficial_11\JJ\0 (l_prep) in_12\IN\13603305 (l_pobj) treatment_14\NN\654885 (l_prep) of_15\IN\0 (l_pobj) patients_16\NNS\9898892 (l_prep) with_17\IN\0 (l_pobj) infarction_20\NN\14204950
D010656_D009203 NONE phenylephrine_2\NN\2682038 (l_prep) of_3\IN\0 (l_pobj) effects_6\NNS\13245626 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) infarction_15\NN\14204950
D010656_D009203 NONE phenylephrine_6\NN\2682038 (r_pobj) of_5\IN\0 (r_prep) addition_4\NN\3081021 (r_nsubj) is_9\VBZ\0 (l_acomp) beneficial_11\JJ\0 (l_prep) in_12\IN\13603305 (l_pobj) treatment_14\NN\654885 (l_prep) of_15\IN\0 (l_pobj) patients_16\NNS\9898892 (l_prep) with_17\IN\0 (l_pobj) infarction_20\NN\14204950
17600377
C524754_D009410 NONE coumarate_17\NN\0 (r_nsubj) is_18\VBZ\0 (l_attr) candidate_22\NN\10450303 (l_relcl) characterized_29\VBN\609683 (l_agent) by_30\IN\0 (l_pobj) death_34\NN\7296428
D012601_D003072 CID scopolamine_17\NN\14712692 (r_npadvmod) injected_19\VBN\81072 (r_amod) rats_20\NNS\2329401 (r_pobj) in_16\IN\13603305 (r_prep) decline_15\NN\13458571
C544092_D003072 NONE beta_24\NN\6828818 (r_pobj) in_22\IN\13603305 (r_conj) in_16\IN\13603305 (r_prep) decline_15\NN\13458571
C544092_D003072 NONE 42)-infused_34\VBN\0 (r_amod) rats_35\NNS\2329401 (r_dobj) beta_31\NN\6828818 (r_advcl) found_5\VBN\13279262 (l_xcomp) attenuate_7\VB\224901 (l_dobj) deficits_9\NNS\5113133
C524754_D003704 NONE coumarate_7\NN\0 (r_appos) compound_2\NN\5869584 (r_nsubj) attenuates_9\VBZ\224901 (l_conj) shows_13\VBZ\429048 (l_dobj) effects_15\NNS\13245626 (l_prep) in_16\IN\13603305 (l_amod) vitro_17\FW\0 (l_conj) in_19\IN\13603305 (l_pobj) models_22\NNS\5888929 (l_compound) dementia_21\NN\14395018
C524754_D003072 NONE coumarate_7\NN\0 (r_appos) compound_2\NN\5869584 (r_nsubj) attenuates_9\VBZ\224901 (l_dobj) deficits_11\NNS\5113133
C524754_D003072 NONE coumarate_11\NN\0 (r_nsubj) improve_13\VB\126264 (l_dobj) decline_15\NN\13458571
C524754_D003072 NONE coumarate_3\NN\0 (r_nsubjpass) found_5\VBN\13279262 (l_xcomp) attenuate_7\VB\224901 (l_dobj) deficits_9\NNS\5113133
C524754_D003072 NONE coumarate_17\NN\0 (r_nsubj) is_18\VBZ\0 (l_attr) candidate_22\NN\10450303 (l_relcl) characterized_29\VBN\609683 (l_agent) by_30\IN\0 (l_pobj) death_34\NN\7296428 (l_conj) decline_37\NN\13458571 (l_prep) of_38\IN\0 (l_pobj) function_40\NN\13783581
C524754_D000544 NONE coumarate_17\NN\0 (r_nsubj) is_18\VBZ\0 (l_attr) candidate_22\NN\10450303 (l_prep) against_23\IN\0 (l_pobj) disease_26\NN\14061805
10526274
C056507_D064420 NONE gem_1\NNP\2743547 (r_nsubj) obtain_4\VB\2210855 (l_prep) with_17\IN\0 (l_pobj) toxicity_19\NN\13576101
C056507_D064420 NONE gem_12\NNP\2743547 (r_pobj) of_11\IN\0 (r_prep) combination_10\NN\7951464 (r_pobj) of_8\IN\0 (r_prep) efficacy_5\NN\5199286 (l_conj) toxicity_7\NN\13576101
C030852_D064420 NONE vnb_14\NNP\0 (r_conj) gem_12\NNP\2743547 (r_pobj) of_11\IN\0 (r_prep) combination_10\NN\7951464 (r_pobj) of_8\IN\0 (r_prep) efficacy_5\NN\5199286 (l_conj) toxicity_7\NN\13576101
D002945_D064420 NONE cisplatin_28\NN\0 (r_dobj) receiving_27\VBG\2210855 (r_pcomp) to_26\IN\0 (r_prep) contraindication_25\NN\5819149 (r_pobj) with_23\IN\0 (r_prep) those_22\DT\0 (r_conj) nsclc_20\NNP\0 (r_pobj) with_18\IN\0 (r_prep) patients_17\NNS\9898892 (r_pobj) in_15\IN\13603305 (r_prep) combination_10\NN\7951464 (r_pobj) of_8\IN\0 (r_prep) efficacy_5\NN\5199286 (l_conj) toxicity_7\NN\13576101
D002945_D002289 NONE cisplatin_20\NN\0 (r_dobj) receive_19\VB\2210855 (r_relcl) years_11\NNS\15144371 (r_npadvmod) age_9\NN\4916342 (l_nsubj) gemcitabine_0\NNP\0 (l_conj) vinorelbine_2\NN\0 (l_prep) in_3\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_compound) carcinoma_7\NN\14239918
D002945_D002289 NONE cisplatin_28\NN\0 (r_dobj) receiving_27\VBG\2210855 (r_pcomp) to_26\IN\0 (r_prep) contraindication_25\NN\5819149 (r_pobj) with_23\IN\0 (r_prep) those_22\DT\0 (r_conj) nsclc_20\NNP\0
D002945_D002289 NONE cisplatin_33\NN\0 (r_dobj) receiving_32\VBG\2210855 (r_pcomp) to_31\IN\0 (r_prep) contraindication_30\NN\5819149 (r_dobj) had_28\VBD\0 (r_conj) were_21\VBD\0 (r_conj) /=_16\NFP\0 (r_punct) included_8\VBN\0 (l_nsubjpass) patients_3\NNS\9898892 (l_prep) with_4\IN\0 (l_pobj) nsclc_6\NNP\0
C030852_D002289 NONE vinorelbine_2\NN\0 (l_prep) in_3\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_compound) carcinoma_7\NN\14239918
C030852_D002289 NONE vnb_14\NNP\0 (r_conj) gem_12\NNP\2743547 (r_pobj) of_11\IN\0 (r_prep) combination_10\NN\7951464 (l_prep) in_15\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) nsclc_20\NNP\0
C056507_D002289 NONE gemcitabine_0\NNP\0 (l_conj) vinorelbine_2\NN\0 (l_prep) in_3\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_compound) carcinoma_7\NN\14239918
C056507_D002289 NONE gem_12\NNP\2743547 (r_pobj) of_11\IN\0 (r_prep) combination_10\NN\7951464 (l_prep) in_15\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) nsclc_20\NNP\0
6692345
D005200_D063646 NONE fanft_16\NNP\0 (r_compound) carcinogenesis_17\NN\0
D005200_D063646 NONE fanft_30\NNP\0 (r_pobj) on_29\IN\0 (r_prep) effect_28\NN\34213 (r_nsubj) is_34\VBZ\0 (r_conj) involved_14\VBN\2676054 (l_prep) in_15\IN\13603305 (l_pobj) carcinogenesis_17\NN\0
D001241_D063646 NONE aspirin_26\NN\2707683 (r_poss) effect_28\NN\34213 (r_nsubj) is_34\VBZ\0 (r_conj) involved_14\VBN\2676054 (l_prep) in_15\IN\13603305 (l_pobj) carcinogenesis_17\NN\0
D005200_D013274 CID n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide_7\NNP\0 (r_pobj) with_6\IN\0 (r_prep) aspirin_5\NN\2707683 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_nsubj) resulted_13\VBD\2633881 (l_prep) in_14\IN\13603305 (l_pobj) incidence_17\NN\13821570 (l_conj) induction_27\NN\7450842 (l_prep) of_28\IN\0 (l_pobj) tumors_30\NNS\14234074
D005200_D013274 CID fanft_9\NNP\0 (r_appos) n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide_7\NNP\0 (r_pobj) with_6\IN\0 (r_prep) aspirin_5\NN\2707683 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_nsubj) resulted_13\VBD\2633881 (l_prep) in_14\IN\13603305 (l_pobj) incidence_17\NN\13821570 (l_conj) induction_27\NN\7450842 (l_prep) of_28\IN\0 (l_pobj) tumors_30\NNS\14234074
D005200_D013274 CID fanft_19\NNP\0 (r_npadvmod) induced_21\VBN\1627355 (r_amod) carcinomas_23\NNS\14239918 (r_pobj) of_18\IN\0 (r_prep) incidence_17\NN\13821570 (l_conj) induction_27\NN\7450842 (l_prep) of_28\IN\0 (l_pobj) tumors_30\NNS\14234074
D001241_D001749 NONE aspirin_5\NN\2707683 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_nsubj) resulted_13\VBD\2633881 (l_prep) in_14\IN\13603305 (l_pobj) incidence_17\NN\13821570 (l_prep) of_18\IN\0 (l_pobj) carcinomas_23\NNS\14239918
D001241_D013274 NONE aspirin_5\NN\2707683 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_nsubj) resulted_13\VBD\2633881 (l_prep) in_14\IN\13603305 (l_pobj) incidence_17\NN\13821570 (l_conj) induction_27\NN\7450842 (l_prep) of_28\IN\0 (l_pobj) tumors_30\NNS\14234074
D005200_D001749 CID n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide_7\NNP\0 (r_pobj) with_6\IN\0 (r_prep) aspirin_5\NN\2707683 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_nsubj) resulted_13\VBD\2633881 (l_prep) in_14\IN\13603305 (l_pobj) incidence_17\NN\13821570 (l_prep) of_18\IN\0 (l_pobj) carcinomas_23\NNS\14239918
D005200_D001749 CID fanft_9\NNP\0 (r_appos) n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide_7\NNP\0 (r_pobj) with_6\IN\0 (r_prep) aspirin_5\NN\2707683 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_nsubj) resulted_13\VBD\2633881 (l_prep) in_14\IN\13603305 (l_pobj) incidence_17\NN\13821570 (l_prep) of_18\IN\0 (l_pobj) carcinomas_23\NNS\14239918
D005200_D001749 CID fanft_19\NNP\0 (r_npadvmod) induced_21\VBN\1627355 (r_amod) carcinomas_23\NNS\14239918
2950248
D004176_D017202 NONE dipyridamole_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) ischemia_4\NN\14195315
D004176_D017202 NONE dipyridamole_16\NN\0 (r_compound) therapy_17\NN\657604 (r_pobj) of_14\IN\0 (r_prep) effect_13\NN\34213 (r_pobj) as_10\IN\14622893 (r_prep) reported_9\VBN\831651 (l_advcl) demonstrated_27\VBN\2137132 (l_nsubjpass) ischemia_24\NN\14195315
D004176_D017202 NONE dipyridamole_20\NN\0 (r_dep) induced_22\VBN\1627355 (r_amod) ischemia_24\NN\14195315
D004176_D003324 NONE dipyridamole_16\NN\0 (r_compound) therapy_17\NN\657604 (r_pobj) of_14\IN\0 (r_prep) effect_13\NN\34213 (r_pobj) as_10\IN\14622893 (r_prep) reported_9\VBN\831651 (l_advcl) demonstrated_27\VBN\2137132 (l_xcomp) occur_29\VB\0 (l_prep) with_34\IN\0 (l_pobj) disease_37\NN\14061805
D004176_D003324 NONE dipyridamole_20\NN\0 (r_dep) induced_22\VBN\1627355 (r_amod) ischemia_24\NN\14195315 (r_nsubjpass) demonstrated_27\VBN\2137132 (l_xcomp) occur_29\VB\0 (l_prep) with_34\IN\0 (l_pobj) disease_37\NN\14061805
D004176_D007511 NONE dipyridamole_23\NN\0 (r_npadvmod) induced_25\VBN\1627355 (r_amod) ischemia_26\NN\14195315
D004176_D000787 CID dipyridamole_10\NN\0 (r_pobj) of_8\IN\0 (r_prep) administration_7\NN\1133281 (r_pobj) after_6\IN\0 (r_prep) occurred_5\VBD\0 (l_nsubj) angina_0\NNP\14171682
18791946
D002939_D015746 CID ciprofloxacin_16\NNS\2716866 (r_pobj) of_14\IN\0 (r_prep) administration_13\NN\1133281 (r_pobj) after_11\IN\0 (r_prep) reported_5\VBN\831651 (l_prep) with_6\IN\0 (l_pobj) pain_8\NN\14299637
D002939_D000743 CID ciprofloxacin_7\NNS\2716866 (r_pobj) with_6\IN\0 (r_prep) associated_5\VBN\628491 (r_acl) thrombocytopenia_1\JJ\14189204 (l_conj) anaemia_4\NN\14299637
D002939_D000743 CID ciprofloxacin_5\NNS\2716866 (r_nsubj) precipitate_7\VB\15046900 (l_dobj) thrombocytopenia_11\JJ\14189204 (l_conj) anaemia_14\NN\14299637
D002939_D013921 CID ciprofloxacin_7\NNS\2716866 (r_pobj) with_6\IN\0 (r_prep) associated_5\VBN\628491 (r_acl) thrombocytopenia_1\JJ\14189204
D002939_D013921 CID ciprofloxacin_5\NNS\2716866 (r_nsubj) precipitate_7\VB\15046900 (l_dobj) thrombocytopenia_11\JJ\14189204
D002939_D014552 NONE ciprofloxacin_16\NNS\2716866 (r_pobj) of_14\IN\0 (r_prep) administration_13\NN\1133281 (l_prep) for_17\IN\0 (l_pobj) suspect_19\NN\7846 (l_prep) of_20\IN\0 (l_pobj) infection_23\NN\14052046
D002939_D007565 CID ciprofloxacin_16\NNS\2716866 (r_pobj) of_14\IN\0 (r_prep) administration_13\NN\1133281 (r_pobj) after_11\IN\0 (r_prep) reported_5\VBN\831651 (l_prep) with_6\IN\0 (l_pobj) pain_8\NN\14299637 (l_conj) jaundice_10\NN\14299637
17344566
D013974_D007037 NONE thyroxine_7\NN\5413241 (l_compound) taking_6\VBG\37396 (l_nsubj) male_5\NN\15388 (l_amod) hypothyroid_4\JJ\0
D013974_D009135 NONE thyroxine_7\NN\5413241 (r_nsubj) presented_10\VBD\2137132 (l_prep) with_11\IN\0 (l_pobj) syndrome_15\NN\5870365 (l_conj) myonecrosis_17\NN\11486708
D019821_D009135 NONE simvastatin_0\NNP\3676175 (r_npadvmod) induced_2\VBN\1627355 (r_amod) syndrome_6\NN\5870365 (l_conj) myonecrosis_8\NN\11486708
D019821_D009135 NONE simvastatin_9\NN\3676175 (r_conj) thyroxine_7\NN\5413241 (r_nsubj) presented_10\VBD\2137132 (l_prep) with_11\IN\0 (l_pobj) syndrome_15\NN\5870365 (l_conj) myonecrosis_17\NN\11486708
D019821_D007037 NONE simvastatin_0\NNP\3676175 (r_npadvmod) induced_2\VBN\1627355 (r_amod) syndrome_6\NN\5870365 (l_acl) associated_9\VBN\628491 (l_prep) with_10\IN\0 (l_pobj) hypothyroidism_11\NN\14059928
D019821_D007037 NONE simvastatin_9\NN\3676175 (r_conj) thyroxine_7\NN\5413241 (l_compound) taking_6\VBG\37396 (l_nsubj) male_5\NN\15388 (l_amod) hypothyroid_4\JJ\0
D019821_D003161 CID simvastatin_0\NNP\3676175 (r_npadvmod) induced_2\VBN\1627355 (r_amod) syndrome_6\NN\5870365
D019821_D003161 CID simvastatin_9\NN\3676175 (r_conj) thyroxine_7\NN\5413241 (r_nsubj) presented_10\VBD\2137132 (l_prep) with_11\IN\0 (l_pobj) syndrome_15\NN\5870365
D013974_D003161 NONE thyroxine_7\NN\5413241 (r_nsubj) presented_10\VBD\2137132 (l_prep) with_11\IN\0 (l_pobj) syndrome_15\NN\5870365
